Number NNP O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
and CC O
their PRP$ O
sensitivity NN O
to TO O
hormone VB O
action NN O
. . O

The DT O
study NN O
demonstrated VBD O
a DT O
decreased JJ O
level NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
in IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
from IN O
hypercholesterolemic JJ O
subjects NNS O
, , O
and CC O
an DT O
elevated JJ O
level NN O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

In IN O
the DT O
lymphocytes NNS O
with IN O
a DT O
high JJ O
GR NNP B-Gene
number NN O
, , O
dexamethasone NN O
inhibited VBD O
[ $ O
3H CD O
] NNP O
- : O
thymidine NN O
and CC O
[ $ O
3H CD O
] NNP O
- : O
acetate NN O
incorporation NN O
into IN O
DNA NNP O
and CC O
cholesterol NN O
, , O
respectively RB O
, , O
in IN O
the DT O
same JJ O
manner NN O
as IN O
in IN O
the DT O
control NN O
cells NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
a DT O
decreased JJ O
GR NNP B-Gene
number NN O
resulted VBD O
in IN O
a DT O
less RBR O
efficient JJ O
dexamethasone NN O
inhibition NN O
of IN O
the DT O
incorporation NN O
of IN O
labeled JJ O
compounds NNS O
. . O

These DT O
data NNS O
showed VBD O
that IN O
the DT O
sensitivity NN O
of IN O
lymphocytes NNS O
to TO O
glucocorticoids NNS O
changed VBN O
only RB O
with IN O
a DT O
decrease NN O
of IN O
GR NNP B-Gene
level NN O
. . O

[ RB O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
- : I-Gene
Dihydroxyvitamin NNP I-Gene
D3 NNP I-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
and CC O
T NNP O
- : O
and CC O
B NNP O
- : O
lymphocyte NN O
count NN O
in IN O
patients NNS O
with IN O
glomerulonephritis NN O
] NN O

Content NN O
of IN O
receptors NNS O
to TO O
hormonal JJ O
form NN O
of IN O
vitamin NN O
D3 NNP O
, , O
1 CD O
. . O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
, , O
constituted VBD O
27 CD O
. . O
3 CD O
fmole JJ O
/ NNP O
mg NN O
of IN O
protein NN O
in IN O
lymphocytes NNS O
of IN O
peripheric JJ O
blood NN O
of IN O
children NNS O
with IN O
glomerulonephritis NN O
. . O

In IN O
the DT O
patients NNS O
concentration NN O
of IN O
total JJ O
and CC O
ionized JJ O
form NN O
of IN O
Ca2 NNP O
+ NNP O
was VBD O
decreased VBN O
down RB O
to TO O
2 CD O
. . O
4 CD O
mmole JJ O
/ NN O
L NNP O
and CC O
1 CD O
. . O
9 CD O
mmole JJ O
/ NN O
L NNP O
, , O
respectively RB O
, , O
while IN O
an DT O
increase NN O
in IN O
parathormone NN O
( ( O
PTH NNP O
) ) O
by IN O
36 CD O
% NN O
and CC O
a DT O
distinct JJ O
decrease NN O
in IN O
25 CD O
( ( O
OH NNP O
) ) O
D NNP O
concentration NN O
( ( O
lower JJR O
than IN O
1 CD O
. . O
25 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
was VBD O
found VBN O
in IN O
blood NN O
; : O
content NN O
of IN O
cAMP NN O
was VBD O
also RB O
decreased VBN O
in IN O
lymphocytes NNS O
by IN O
33 CD O
% NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
total JJ O
content NN O
of IN O
T NNP O
lymphocytes NNS O
was VBD O
decreased VBN O
1 CD O
. . O
5 CD O
- : O
fold NN O
in IN O
peripheric JJ O
blood NN O
. . O

Treatment NN O
with IN O
I PRP O
- : O
hydroxyvitamin NN O
D3 NNP O
( ( O
1 CD O
- : O
1 CD O
. . O
5 CD O
mg JJ O
daily RB O
, , O
within IN O
4 CD O
weeks NNS O
) ) O
led VBD O
to TO O
normalization NN O
of IN O
total JJ O
and CC O
ionized JJ O
form NN O
of IN O
Ca2 NNP O
+ NNP O
and CC O
of IN O
25 CD O
( ( O
OH NNP O
) ) O
D NNP O
, , O
but CC O
did VBD O
not RB O
affect VB O
the DT O
PTH NNP O
content NN O
in IN O
blood NN O
. . O

Concentration NN O
of IN O
the DT O
receptors NNS B-Gene
to TO O
1 CD O
. . O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
was VBD O
elevated VBN O
up RB O
to TO O
39 CD O
. . O
7 CD O
fmole JJ O
/ NN O
mg NN O
after IN O
I PRP O
week NN O
of IN O
the DT O
treatment NN O
, , O
whereas IN O
it PRP O
was VBD O
decreased VBN O
to TO O
the DT O
initial JJ O
level NN O
24 CD O
. . O
8 CD O
fmole JJ O
/ NN O
mg NN O
within IN O
4 CD O
weeks NNS O
; : O
simultaneous JJ O
alteration NN O
in IN O
the DT O
cAMP NN O
content NN O
was VBD O
observed VBN O
in IN O
lymphocytes NNS O
. . O

Treatment NN O
with IN O
1 CD O
- : O
( ( O
OH NNP O
) ) O
D3 NNP O
normalized VBN O
also RB O
the DT O
T NNP O
lymphocytes VBZ O
content NN O
in IN O
peripheric JJ O
blood NN O
. . O

The DT O
data NN O
obtained VBD O
suggest JJS O
that IN O
under IN O
conditions NNS O
of IN O
glomerulonephritis NN O
only RB O
high JJ O
content NN O
of IN O
receptors NNS B-Gene
to TO O
1 CD O
. . O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
in IN O
lymphocytes NNS O
enabled VBD O
to TO O
perform VB O
the DT O
cell NN O
response NN O
to TO O
the DT O
hormone NN O
effect NN O
. . O

Tumor NN O
and CC O
serum NN O
beta NN O
- : O
2 CD O
- : O
microglobulin NN O
expression NN O
in IN O
women NNS O
with IN O
breast NN O
cancer NN O
. . O

To TO O
investigate VB O
whether IN O
the DT O
tumor NN O
expression NN O
of IN O
beta NN B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
( ( O
beta $ B-Gene
2 CD I-Gene
- : I-Gene
M NN I-Gene
) ) O
could MD O
serve VB O
as IN O
a DT O
marker NN O
of IN O
tumor NN O
biologic NN O
behavior NN O
, , O
the DT O
authors NNS O
studied VBD O
specimens NNS O
of IN O
breast NN O
carcinomas NN O
from IN O
60 CD O
consecutive JJ O
female NN O
patients NNS O
. . O

Presence NN O
of IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
M NN I-Gene
was VBD O
analyzed VBN O
by IN O
immunohistochemistry NN O
. . O

No DT O
significant JJ O
correlations NNS O
were VBD O
found VBN O
between IN O
tumor NN B-Gene
beta NN I-Gene
2 CD I-Gene
- : I-Gene
M NNP I-Gene
expression NN O
and CC O
several JJ O
histologic JJ O
attributes NNS O
such JJ O
as IN O
type NN O
, , O
histologic NN O
and CC O
nuclear JJ O
grades NNS O
, , O
mitotic JJ O
index NN O
, , O
necrosis NN O
, , O
vascular JJ O
invasion NN O
, , O
and CC O
lymphocytic JJ O
infiltration NN O
. . O

Likewise RB O
, , O
beta VBD B-Gene
2 CD I-Gene
- : I-Gene
M NN I-Gene
was VBD O
not RB O
associated VBN O
with IN O
markers NNS O
of IN O
disease NN O
extension NN O
such JJ O
as IN O
TNM NNP O
, , O
( ( O
UICC NNP O
, , O
classification NN O
of IN O
malignant JJ O
tumors NNS O
) ) O
staging NN O
and CC O
axillary JJ O
lymph NN O
node JJ O
involvement NN O
or CC O
with IN O
estrogen NN O
, , O
progesterone NN O
, , O
and CC O
glucocorticoid JJ O
receptor NN O
levels NNS O
. . O

However RB O
, , O
there EX O
was VBD O
a DT O
significantly RB O
positive JJ O
association NN O
between IN O
tumor NN B-Gene
beta NN I-Gene
2 CD I-Gene
- : I-Gene
M NNP I-Gene
expression NN O
and CC O
the DT O
degree NN O
of IN O
lymphocytic JJ O
infiltration NN O
in IN O
the DT O
tumor NN O
tissue NN O
. . O

Beta NNP B-Gene
2 CD I-Gene
- : I-Gene
M NNP I-Gene
serum NN O
levels NNS O
were VBD O
determined VBN O
by IN O
an DT O
enzyme JJ O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
in IN O
samples NNS O
from IN O
22 CD O
of IN O
the DT O
above JJ O
women NNS O
. . O

Although IN O
some DT O
of IN O
the DT O
highest JJS O
values NNS O
had VBD O
been VBN O
obtained VBN O
in IN O
women NNS O
with IN O
larger JJR O
( ( O
T4 NNP O
) ) O
primary NN O
tumors NNS O
, , O
the DT O
authors NNS O
failed VBD O
to TO O
detect VB O
any DT O
statistical JJ O
relationship NN O
between IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
M NNP I-Gene
expression NN O
in IN O
the DT O
tumor NN O
with IN O
serum NN O
levels NNS O
or CC O
between IN O
serum JJ B-Gene
beta NN I-Gene
2 CD I-Gene
- : I-Gene
M NN I-Gene
and CC O
the DT O
above JJ O
histologic NN O
, , O
laboratory NN O
, , O
and CC O
clinical JJ O
factors NNS O
. . O

[ JJ O
Preliminary NNP O
observation NN O
of IN O
level NN O
free JJ B-Gene
- : I-Gene
form NN I-Gene
E NNP I-Gene
receptor NN I-Gene
levels NNS O
in IN O
serum NN O
of IN O
normal JJ O
childbearing VBG O
- : O
aged VBN O
and CC O
pregnant JJ O
women NNS O
] VBP O

In IN O
137 CD O
cases NNS O
of IN O
childbearing VBG O
- : O
aged VBN O
and CC O
pregnant JJ O
women NNS O
, , O
free JJ B-Gene
form NN I-Gene
E NNP I-Gene
receptor NN I-Gene
levels NNS O
( ( O
sE NN B-Gene
) ) O
in IN O
serum NN O
were VBD O
measured VBN O
by IN O
ELISA NNP O
. . O

The DT O
level NN O
of IN O
sE NN B-Gene
was VBD O
significantly RB O
decreased VBN O
during IN O
the DT O
first JJ O
trimester NN O
, , O
slightly RB O
higher JJR O
in IN O
the DT O
second JJ O
trimester NN O
, , O
and CC O
recovered VBD O
to TO O
normal JJ O
in IN O
the DT O
third JJ O
trimester NN O
. . O

The DT O
level NN O
remained VBD O
lower JJR O
in IN O
29 CD O
PIH NNP O
women NNS O
but CC O
appeared VBD O
higher JJR O
in IN O
overdue JJ O
pregnancies NNS O
as IN O
compared VBN O
with IN O
the DT O
normal JJ O
3rd CD O
trimester NN O
range NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
there EX O
is VBZ O
a DT O
relationship NN O
between IN O
a DT O
change NN O
in IN O
T NNP O
cell NN O
function NN O
and CC O
pregnancy NN O
. . O

Kappa NNP B-Gene
B NNP I-Gene
- : I-Gene
specific JJ I-Gene
DNA NNP I-Gene
binding NN I-Gene
proteins NNS I-Gene
: : O
role NN O
in IN O
the DT O
regulation NN O
of IN O
human JJ B-Gene
interleukin JJ I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
expression NN O
. . O

Transcriptional JJ O
activation NN O
of IN O
the DT O
human JJ B-Gene
interleukin NN I-Gene
- : I-Gene
2 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
gene NN I-Gene
, , O
like IN O
induction NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) I-Gene
gene NN I-Gene
and CC O
the DT O
type NN O
1 CD O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
, , O
is VBZ O
shown VBN O
to TO O
be VB O
modulated VBN O
by IN O
a DT O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
like IN I-Gene
enhancer DT I-Gene
element NN I-Gene
. . O

Mutation NN O
of IN O
a DT O
kappa NN B-Gene
B NNP I-Gene
core NN I-Gene
sequence NN I-Gene
identified VBN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
( ( O
- : O
206 CD O
to TO O
- : O
195 CD O
) ) O
partially RB O
inhibits VBZ O
both DT O
mitogen FW O
- : O
and CC O
HTLV NNP O
- : O
I PRP O
Tax VBP O
- : O
mediated VBN O
activation NN O
of IN O
this DT O
transcription NN B-Gene
unit NN I-Gene
and CC O
blocks VBZ O
the DT O
specific JJ O
binding NN O
of IN O
two CD O
inducible JJ B-Gene
cellular JJ I-Gene
factors NNS I-Gene
. . O

These DT O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
specific JJ I-Gene
proteins NNS I-Gene
( ( O
80 CD O
to TO O
90 CD O
and CC O
50 CD O
to TO O
55 CD O
kilodaltons NNS O
) ) O
similarly RB O
interact JJ O
with IN O
the DT O
functional JJ O
kappa NN B-Gene
B NNP I-Gene
enhancer NN I-Gene
present NN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
promoter NN I-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
these DT O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
specific JJ I-Gene
proteins NNS I-Gene
have VBP O
a DT O
role NN O
in IN O
the DT O
coordinate NN O
regulation NN O
of IN O
this DT O
growth NN O
factor NN O
- : O
growth NN O
factor NN O
receptor NN O
gene NN O
system NN O
that WDT O
controls VBZ O
T NNP O
cell NN O
proliferation NN O
. . O

Novel JJ O
region NN O
within IN O
the DT O
V NNP B-Gene
kappa NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
is VBZ O
responsible JJ O
for IN O
tissue NN O
and CC O
stage NN O
- : O
specific JJ O
expression NN O
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
in IN O
human JJ O
lymphoid JJ O
neoplasms NN O
. . O

Immunoglobulin NNP B-Gene
gene NN I-Gene
- : I-Gene
specific JJ I-Gene
transacting VBG I-Gene
factors NNS I-Gene
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
lymphoid JJ O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
. . O

The DT O
role NN O
of IN O
these DT O
factors NNS O
in IN O
B NNP O
- : O
cell NN O
differentiation NN O
and CC O
stage NN O
- : O
specific JJ O
expression NN O
of IN O
these DT O
genes NNS O
is VBZ O
, , O
however RB O
, , O
not RB O
fully RB O
understood JJ O
. . O

We PRP O
have VBP O
used VBN O
a DT O
model NN O
of IN O
human JJ O
lymphoid JJ O
neoplasia NN O
to TO O
address VB O
this DT O
question NN O
. . O

Different JJ O
fragments NNS O
of IN O
unrearranged JJ B-Gene
human JJ I-Gene
variable JJ I-Gene
region NN I-Gene
of IN O
immunoglobulin NN B-Gene
kappa NNS I-Gene
gene NN I-Gene
( ( O
V NNP B-Gene
kappa NN I-Gene
) ) O
were VBD O
used VBN O
for IN O
cell NN O
- : O
free JJ O
in IN O
vitro JJ O
transcription NN O
and CC O
DNA NNP O
mobility NN O
shift NN O
assays NNS O
. . O

Previously RB O
described VBN O
enhancement NN O
of IN O
in IN O
vitro JJ O
transcription NN O
that WDT O
was VBD O
only RB O
seen VBN O
with IN O
nuclear JJ O
extracts NNS O
derived VBN O
from IN O
B NNP O
- : O
cell NN O
neoplasms RB O
corresponding VBG O
to TO O
the DT O
late JJ O
stages NNS O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
was VBD O
shown VBN O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
actions NNS O
of IN O
these DT O
factor NN O
( ( O
s PRP O
) ) O
on IN O
the DT O
DNA NN O
region NN O
within IN O
the DT O
V NNP B-Gene
kappa NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

This DT O
region NN O
is VBZ O
located VBN O
within IN O
the DT O
920 CD O
bp NN O
fragment NN O
located VBD O
210 CD O
bp NN O
upstream NN O
from IN O
the DT O
coding VBG O
region NN O
and CC O
this DT O
fragment JJ O
represents VBZ O
a DT O
possible JJ O
novel NN O
DNA NNP O
region NN O
, , O
which WDT O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
stage NN O
- : O
and CC O
tissue VB O
- : O
specific JJ O
expression NN O
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
. . O

[ JJ O
Determination NNP O
of IN O
the DT O
sensitivity NN O
to TO O
glucocorticoids NNS B-Gene
in IN O
vitro NN O
] NN O

A DT O
modified JJ O
method NN O
for IN O
the DT O
determination NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
human JJ O
lymphocytes NNS O
is VBZ O
suggested VBN O
. . O

The DT O
principal JJ O
distinction NN O
of IN O
the DT O
method NN O
is VBZ O
standardization VBN O
by IN O
the DT O
lymphocyte NN O
count NN O
in IN O
a DT O
sample NN O
( ( O
1 CD O
mln NN O
) ) O
and CC O
the DT O
labeled JJ O
hormone NN B-Gene
concentration NN O
. . O

The DT O
modification NN O
saves VBZ O
time NN O
and CC O
money NN O
, , O
limits VBZ O
the DT O
range NN O
of IN O
the DT O
data NN O
variations NNS O
, , O
and CC O
makes VBZ O
use NN O
of IN O
a DT O
lesser JJR O
volume NN O
of IN O
blood NN O
. . O

Examinations NNS O
of IN O
70 CD O
children NNS O
aged VBD O
4 CD O
to TO O
15 CD O
suffering NN O
from IN O
the DT O
nephrotic JJ O
form NN O
of IN O
glomerulonephritis NN O
have VBP O
made VBN O
it PRP O
possible JJ O
to TO O
distinguish VB O
two CD O
groups NNS O
of IN O
patients NNS O
: : O
with IN O
relatively RB O
high JJ O
values NNS O
of IN O
specific JJ O
binding VBG O
X NN O
= NN O
6820 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
530 CD O
. . O
0 CD O
( ( O
n JJ O
= NN O
30 CD O
, , O
p NN O
= VBD O
0 CD O
. . O
95 CD O
, , O
t NN O
= VBD O
2 CD O
. . O
4 CD O
) ) O
, , O
this DT O
corresponding VBG O
to TO O
a DT O
clinical JJ O
form NN O
of IN O
hormone NN B-Gene
- : O
sensitive JJ O
glomerulonephritis NN O
, , O
and CC O
with IN O
relatively RB O
low JJ O
values NNS O
of IN O
specific JJ O
binding VBG O
X NN O
= NN O
1815 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
302 CD O
. . O
8 CD O
( ( O
n JJ O
= NN O
40 CD O
, , O
p NN O
= VBD O
0 CD O
. . O
95 CD O
, , O
t NN O
= VBD O
1 CD O
. . O
96 CD O
) ) O
, , O
that WDT O
corresponds VBZ O
to TO O
hormone VB B-Gene
- : O
resistant JJ O
glomerulonephritis NN O
. . O

Dynamic NNP O
studies NNS O
have VBP O
not RB O
shown VBN O
any DT O
statistically RB O
significant JJ O
changes NNS O
in IN O
the DT O
specific JJ O
binding NN O
values NNS O
. . O

These DT O
results NNS O
permit VBP O
regarding VBG O
the DT O
specific NN O
binding VBG O
value NN O
as IN O
a DT O
prognostic JJ O
criterion NN O
in IN O
the DT O
assessment NN O
of IN O
corticosteroid JJ B-Gene
therapy NN O
; : O
this DT O
allows VBZ O
a DT O
wide JJ O
employment NN O
of IN O
the DT O
described JJ O
method NN O
in IN O
practical JJ O
nephrology NN O
. . O

Octamer NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
from IN O
B NNP O
or CC O
HeLa NNP O
cells NNS O
stimulate JJ O
transcription NN O
of IN O
the DT O
immunoglobulin NN B-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
promoter NN I-Gene
in IN O
vitro NN O
. . O

The DT O
B NNP O
- : O
cell NN O
- : O
type NN O
specificity NN O
of IN O
the DT O
immunoglobulin NN B-Gene
( ( O
Ig NNP B-Gene
) ) O
heavy VBD O
- : O
chain NN O
and CC O
light JJ O
- : O
chain NN O
promoters NNS O
is VBZ O
mediated VBN O
by IN O
an DT O
octanucleotide NN B-Gene
( ( I-Gene
OCTA NNP I-Gene
) ) I-Gene
element NN I-Gene
, , O
ATGCAAAT NNP O
, , O
that WDT O
is VBZ O
also RB O
a DT O
functional JJ O
component NN O
of IN O
other JJ O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
promoters NNS I-Gene
, , O
such JJ O
as IN O
snRNA NN O
and CC O
histone NN O
H2B NNP O
promoters NNS O
. . O

Two CD O
nuclear JJ B-Gene
proteins NNS I-Gene
that WDT O
bind VBP O
specifically RB O
and CC O
with IN O
high JJ O
affinity NN O
to TO O
the DT O
OCTA NNP B-Gene
element NN I-Gene
have VBP O
been VBN O
identified VBN O
. . O

NF NNP B-Gene
- : I-Gene
A1 NNP I-Gene
is VBZ O
present JJ O
in IN O
a DT O
variety NN O
of IN O
cell NN O
types NNS O
, , O
whereas IN O
the DT O
presence NN O
of IN O
NF NNP B-Gene
- : I-Gene
A2 NNP I-Gene
is VBZ O
essentially RB O
confined VBN O
to TO O
B NNP O
cells NNS O
, , O
leading VBG O
to TO O
the DT O
hypothesis NN O
that WDT O
NF NNP B-Gene
- : I-Gene
A2 NNP I-Gene
activates VBZ O
cell SYM O
- : O
type NN O
- : O
specific JJ O
transcription NN O
of IN O
the DT O
Ig NNP B-Gene
promoter NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
A1 NNP I-Gene
mediates VBZ O
the DT O
other JJ O
responses NNS O
of IN O
the DT O
OCTA NNP B-Gene
element NN I-Gene
. . O

Extracts NNS O
of IN O
the DT O
B NNP O
- : O
cell NN O
line NN O
, , O
BJA NNP O
- : O
B NNP O
, , O
contain VBP O
high JJ O
levels NNS O
of IN O
NF NNP B-Gene
- : I-Gene
A2 NNP I-Gene
and CC O
specifically RB O
transcribe JJ O
Ig NNP B-Gene
promoters NNS I-Gene
. . O

In IN O
contrast NN O
, , O
extracts VBZ O
from IN O
HeLa NNP O
cells NNS O
transcribed VBD O
the DT O
Ig NNP B-Gene
promoter NN I-Gene
poorly RB O
. . O

Surprisingly RB O
, , O
addition NN O
of IN O
either DT O
affinity NN O
- : O
enriched VBN O
NF NNP O
- : O
A2 NN O
or CC O
NF NNP O
- : O
A1 NN O
to TO O
either VB O
a DT O
HeLa NNP O
extract NN O
or CC O
a DT O
partially RB O
purified VBN O
reaction NN O
system NN O
specifically RB O
stimulates VBZ O
the DT O
Ig NNP B-Gene
promoter NN I-Gene
. . O

This DT O
suggests VBZ O
that IN O
the DT O
constitutive JJ O
OCTA NNP B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
A1 NN I-Gene
can MD O
activate VB O
transcription NN O
of IN O
the DT O
Ig NNP B-Gene
promoter NN I-Gene
and CC O
that IN O
B NNP O
- : O
cell NN O
- : O
specific JJ O
transcription NN O
of IN O
this DT O
promoter NN O
, , O
at IN O
least JJS O
in IN O
vitro NN O
, , O
is VBZ O
partially RB O
due JJ O
to TO O
a DT O
quantitative JJ O
difference NN O
in IN O
the DT O
amount NN O
of IN O
OCTA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

Because IN O
NF NNP B-Gene
- : I-Gene
A1 NN I-Gene
can MD O
stimulate VB O
Ig NNP B-Gene
transcription NN O
, , O
the DT O
inability NN O
of IN O
this DT O
factor NN O
to TO O
activate VB O
in IN O
vivo NN O
the DT O
Ig NNP B-Gene
promoter NN I-Gene
to TO O
the DT O
same JJ O
degree NN O
as IN O
the DT O
snRNA NN B-Gene
promoters NNS I-Gene
probably RB O
reflects VBZ O
a DT O
difference NN O
in IN O
the DT O
context NN O
of IN O
the DT O
OCTA NNP B-Gene
element NN I-Gene
in IN O
these DT O
two CD O
types NNS O
of IN O
promoters NNS B-Gene
. . O

Identification NN O
of IN O
a DT O
putative JJ O
regulator NN O
of IN O
early JJ B-Gene
T NNP I-Gene
cell NN I-Gene
activation NN I-Gene
genes NNS I-Gene
. . O

Molecules NNS O
involved VBN O
in IN O
the DT O
antigen NN O
receptor NN O
- : O
dependent JJ O
regulation NN O
of IN O
early JJ B-Gene
T NNP I-Gene
cell NN I-Gene
activation NN I-Gene
genes NNS I-Gene
were VBD O
investigated VBN O
with IN O
the DT O
use NN O
of IN O
functional JJ O
sequences NNS O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
activation NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
of IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

One CD O
of IN O
these DT O
sequences NNS O
forms VBP O
a DT O
protein NN O
complex NN O
, , O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
specifically RB O
with IN O
nuclear JJ O
extracts NNS O
of IN O
activated JJ O
T NNP O
cells NNS O
. . O

This DT O
complex JJ O
appeared VBD O
10 CD O
to TO O
25 CD O
minutes NNS O
before IN O
the DT O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

Studies NNS O
with IN O
inhibitors NNS O
of IN O
protein JJ O
synthesis NN O
indicated VBD O
that IN O
the DT O
time NN O
of IN O
synthesis NN O
of IN O
the DT O
activator NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
Jurkat NNP O
T NNP O
cells NNS O
corresponds VBZ O
to TO O
the DT O
time NN O
of IN O
appearance NN O
of IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
or CC O
a DT O
very RB O
similar JJ O
protein NN O
, , O
bound IN O
functional JJ O
sequences NNS O
of IN O
the DT O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
; : O
the DT O
LTR NNP B-Gene
of IN O
this DT O
virus NN O
is VBZ O
known VBN O
to TO O
be VB O
stimulated VBN O
during IN O
early JJ O
T NNP O
cell NN O
activation NN O
. . O

The DT O
binding NN B-Gene
site NN I-Gene
for IN O
this DT O
complex JJ O
activated VBD O
a DT O
linked VBN O
promoter NN O
after IN O
transfection NN O
into IN O
antigen NN O
receptor NN O
- : O
activated VBN O
T NNP O
cells NNS O
but CC O
not RB O
other JJ O
cell NN O
types NNS O
. . O

These DT O
characteristics NNS O
suggest VBP O
that IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
transmits NNS O
signals NNS O
initiated VBN O
at IN O
the DT O
T NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
. . O

Characterization NN O
of IN O
thyroid JJ B-Gene
hormone NN I-Gene
receptors NNS I-Gene
in IN O
human JJ O
IM NNP O
- : O
9 CD O
lymphocytes NNS O
. . O

Although IN O
putatively RB O
identified VBN O
more JJR O
than IN O
10 CD O
years NNS O
ago RB O
, , O
thyroid VB B-Gene
hormone NN I-Gene
receptors NNS I-Gene
in IN O
human JJ O
tissues NNS O
remain VBP O
poorly RB O
characterized VBN O
. . O

As IN O
a DT O
first JJ O
step NN O
towards NNS O
understanding VBG O
the DT O
mechanism NN O
of IN O
thyroid JJ O
hormone NN O
action NN O
in IN O
man NN O
we PRP O
have VBP O
characterized VBN O
T3 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
nuclei NN O
of IN O
the DT O
human JJ O
lymphoblastoid NN O
line NN O
, , O
IM NNP O
- : O
9 CD O
cells NNS O
. . O

In IN O
whole JJ O
cell NN O
experiments NNS O
at IN O
37 CD O
degrees NNS O
C NNP O
, , O
nuclear JJ O
binding NN O
of IN O
[ $ B-Gene
125I CD I-Gene
] NNP I-Gene
T3 NNP I-Gene
was VBD O
saturable JJ O
( ( O
Kd NNP O
34 CD O
+ NNP O
/ NNP O
- : O
6 CD O
pmol NN O
/ NNP O
l NN O
) ) O
and CC O
of IN O
finite JJ O
capacity NN O
( ( O
approximately RB O
equal JJ O
to TO O
350 CD O
sites NNS O
/ NNP O
cell NN O
) ) O
. . O

The DT O
binding NN B-Gene
sites NNS I-Gene
were VBD O
extracted VBN O
from IN O
a DT O
nuclear JJ O
pellet NN O
by IN O
treatment NN O
with IN O
0 CD O
. . O
4 CD O
mol JJ O
/ NNP O
l NN O
KCl NNP O
and CC O
sonication NN O
. . O

Separation NN O
of IN O
bound NN O
from IN O
free JJ O
[ NN B-Gene
125I CD I-Gene
] NN I-Gene
T3 NNP I-Gene
in IN O
the DT O
extracts NNS O
was VBD O
achieved VBN O
using VBG O
the DT O
calcium NN O
phosphate NN O
matrix NN O
, , O
hydroxyapatite NN O
at IN O
a DT O
concentration NN O
of IN O
0 CD O
. . O
3 CD O
ml NN O
of IN O
a DT O
150 CD O
g NN O
/ NNP O
l NN O
slurry NN O
. . O

Rectilinear JJ O
Scatchard NNP O
plots NNS O
were VBD O
obtained VBN O
only RB O
when WRB O
the DT O
hydroxyapatite NN O
was VBD O
washed VBN O
with IN O
a DT O
buffer NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
X NNP O
- : O
100 CD O
. . O

Under IN O
these DT O
conditions NNS O
T3 VBP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
nuclear JJ O
extracts NNS O
were VBD O
present JJ O
at IN O
a DT O
concentration NN O
of IN O
22 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
8 CD O
. . O
6 CD O
fmol JJ O
/ NNP O
mg NN O
protein NN O
and CC O
showed VBD O
an DT O
affinity NN O
of IN O
( ( O
Kd NNP O
, , O
room NN O
temperature NN O
) ) O
140 CD O
+ JJ O
/ NNP O
- : O
10 CD O
pmol NN O
/ NNP O
l NN O
. . O

The DT O
same JJ O
assay NN O
system NN O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
hierarchy NN O
of IN O
affinities NNS O
for IN O
a DT O
range NN O
of IN O
natural JJ O
and CC O
synthetic JJ O
analogues NNS O
. . O

Calling VBG O
T3 NNP O
100 CD O
, , O
the DT O
order NN O
of IN O
potencies NNS O
observed VBN O
was VBD O
: : O
Triac NNP O
, , O
500 CD O
; : O
3 CD O
, , O
5 CD O
- : O
diiodo NN O
- : O
3 CD O
' '' O
- : O
isopropylthyronine NN O
, , O
89 CD O
; : O
T4 NNP O
, , O
32 CD O
; : O
3 CD O
, , O
5 CD O
- : O
dimethyl NN O
- : O
3 CD O
' POS O
isopropylthyronine JJ O
2 CD O
; : O
3 CD O
, , O
5 CD O
- : O
T2 NN O
, , O
0 CD O
. . O
7 CD O
, , O
rT3 NN O
, , O
0 CD O
. . O
4 CD O
; : O
3 CD O
' POS O
5 CD O
' POS O
- : O
T2 NN O
, , O
less JJR O
than IN O
0 CD O
. . O
1 CD O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
T3 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
present VBP O
in IN O
human JJ O
IM NNP O
- : O
9 CD O
lymphocyte NN O
nuclei NN O
and CC O
extracts NNS O
thereof NNS O
are VBP O
thyroid JJ B-Gene
hormone NN I-Gene
receptors NNS I-Gene
. . O

These DT O
cells NNS O
may MD O
be VB O
a DT O
useful JJ O
tool NN O
to TO O
increase VB O
our PRP$ O
understanding NN O
of IN O
human JJ B-Gene
T3 NNP I-Gene
receptors NNS I-Gene

Definition NN O
of IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
specific JJ I-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
factors NNS I-Gene
that IN O
interact NN O
with IN O
a DT O
3 CD B-Gene
' POS I-Gene
- : I-Gene
silencer NN I-Gene
in IN O
the DT O
CD4 NNP B-Gene
+ NNP I-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
gene NN I-Gene
Rpt NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Analysis NN O
of IN O
the DT O
region NN O
3 CD O
' '' O
to TO O
the DT O
CD4 NNP B-Gene
+ NNP I-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
gene NN I-Gene
Rpt NNP I-Gene
- : I-Gene
1 CD I-Gene
( ( O
encoding VBG O
regulatory JJ O
protein NN O
T NNP B-Gene
- : I-Gene
lymphocyte NN I-Gene
1 CD I-Gene
) ) O
led VBN O
to TO O
the DT O
definition NN O
of IN O
a DT O
silencer NN B-Gene
element NN I-Gene
that IN O
inhibits VBZ O
heterologous JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
certain JJ O
CD4 NNP O
+ NNP O
T NNP O
- : O
cell NN O
lines NNS O
but CC O
not RB O
in IN O
B NNP O
- : O
cell NN O
or CC O
non JJ O
- : O
lymphoid NN O
cell NN O
lines NNS O
. . O

Functional JJ O
silencer NN B-Gene
activity NN O
in IN O
vivo NN O
was VBD O
associated VBN O
with IN O
the DT O
presence NN O
of IN O
a DT O
specific JJ O
silencer NN B-Gene
- : I-Gene
DNA NN I-Gene
- : I-Gene
protein NN I-Gene
complex NN I-Gene
in IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
with IN O
T NNP O
- : O
cell NN O
extracts NNS O
. . O

Formation NN O
of IN O
this DT O
complex NN O
was VBD O
selectively RB O
inhibited VBN O
by IN O
the DT O
region NN O
in IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
containing VBG O
a DT O
silencer NN B-Gene
element NN I-Gene
. . O

We PRP O
discuss VBP O
the DT O
possibility NN O
that IN O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
factors NNS I-Gene
may MD O
coregulate VB O
HIV NNP O
- : O
1 CD O
and CC O
Rpt NNP O
- : O
1 CD O
gene NN O
expression NN O
through IN O
a DT O
common JJ O
transcriptional JJ B-Gene
silencer NN I-Gene
element NN I-Gene
. . O

Congenital JJ O
immunodeficiencies NNS O
associated VBN O
with IN O
absence NN O
of IN O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
antigens VBZ I-Gene
on IN O
lymphocytes NNS O
result VBP O
from IN O
distinct JJ O
mutations NNS O
in IN O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
factors NNS I-Gene
. . O

Coordinate NNP O
regulation NN O
of IN O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
expression NN O
during IN O
development NN O
and CC O
coinduction NN O
of IN O
class NN B-Gene
II NNP I-Gene
genes NNS I-Gene
by IN O
soluble JJ B-Gene
factors NNS I-Gene
suggests VBZ O
that IN O
common JJ O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
factor NN I-Gene
( ( O
s PRP O
) ) O
control NN O
expression NN O
of IN O
these DT O
genes NNS O
. . O

In IN O
B NNP O
- : O
lymphoblastoid NN O
cell NN O
lines NNS O
derived VBN O
from IN O
two CD O
independent JJ O
class NN O
II NNP O
- : O
deficient NN O
bare NN O
lymphocyte JJ O
syndrome NN O
patients NNS O
, , O
we PRP O
observed VBD O
a DT O
drastic JJ O
decrease NN O
in IN O
transcription NN O
rates NNS O
of IN O
the DT O
class NN B-Gene
II NNP I-Gene
genes NNS I-Gene
. . O

When WRB O
these DT O
cell NN O
lines NNS O
are VBP O
fused VBN O
, , O
class NN B-Gene
II NNP I-Gene
genes NNS I-Gene
are VBP O
reexpressed VBN O
, , O
indicating VBG O
that IN O
immunodeficiencies NNS O
in IN O
bare NN O
lymphocyte JJ O
syndrome NN O
patients NNS O
are VBP O
the DT O
result NN O
of IN O
two CD O
distinct JJ O
mutations NNS O
. . O

Further JJ O
studies NNS O
show VBP O
that IN O
genes NNS O
governing VBG O
the DT O
expression NN O
of IN O
class NN B-Gene
II NNP I-Gene
antigens VBZ I-Gene
fall NN O
into IN O
at IN O
least JJS O
three CD O
complementation NN O
groups NNS O
; : O
two CD O
of IN O
these DT O
were VBD O
previously RB O
unidentified VBN O
in IN O
mutant NN O
cell NN O
lines NNS O
generated VBD O
in IN O
vitro NN O
. . O

In IN O
addition NN O
, , O
we PRP O
report VBP O
the DT O
identification NN O
of IN O
two CD O
discrete JJ O
complexes NNS O
, , O
NFX1 NNP B-Gene
. . I-Gene
1 CD I-Gene
and CC O
NFX1 NNP B-Gene
. . I-Gene
2 CD I-Gene
, , O
that WDT O
bind VBZ O
to TO O
the DT O
DRA NNP B-Gene
X NNP I-Gene
consensus NN I-Gene
element NN I-Gene
. . O

Though IN O
the DT O
mutation NN O
in IN O
at IN O
least JJS O
one CD O
mutant JJ O
line NN O
generated VBN O
in IN O
vitro NN O
( ( O
RJ2 NNP O
. . O
2 CD O
. . O
5 CD O
) ) O
affects NNS O
products NNS O
functioning VBG O
via IN O
interaction NN O
with IN O
the DT O
X NNP B-Gene
box NN I-Gene
, , O
clear JJ O
alterations NNS O
in IN O
either DT O
NFX1 NNP B-Gene
. . I-Gene
1 CD I-Gene
or CC O
NFX1 NNP B-Gene
. . I-Gene
2 CD I-Gene
are VBP O
not RB O
found VBN O
in IN O
any DT O
of IN O
the DT O
mutant NN O
cell NN O
lines NNS O
. . O

In IN O
vivo JJ O
responsiveness NN O
to TO O
glucocorticoid VB O
correlated VBN O
with IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
in IN O
normal JJ O
humans NNS O
. . O

Dexamethasone CD O
loading NN O
tests NNS O
( ( O
0 CD O
. . O
1 CD O
mg NN O
dexamethasone NN O
/ NNP O
kg NN O
, , O
iv NN O
) ) O
were VBD O
performed VBN O
in IN O
18 CD O
normal JJ O
males NNS O
to TO O
evaluate VB O
the DT O
individual JJ O
responsiveness NN O
to TO O
glucocorticoid VB O
. . O

There EX O
were VBD O
inter JJR O
- : O
individual JJ O
differences NNS O
in IN O
increase NN O
in IN O
peripheral JJ O
blood NN O
polymorphonuclear NN O
leukocyte NN O
count NN O
, , O
decrease NN O
in IN O
peripheral JJ O
blood NN O
lymphocyte NN O
count NN O
, , O
and CC O
increase VB O
in IN O
plasma JJ O
free JJ O
fatty JJ O
acids NNS O
levels NNS O
after IN O
dexamethasone NN O
injection NN O
. . O

In IN O
addition NN O
, , O
there EX O
was VBD O
a DT O
significant JJ O
correlation NN O
between IN O
the DT O
maximum JJ O
increase NN O
in IN O
polymorphonuclear JJ O
leukocytes NNS O
and CC O
the DT O
maximum JJ O
decrease NN O
in IN O
lymphocytes NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
7514 CD O
, , O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
3 CD O
) ) O
. . O

Simultaneous JJ O
measurements NNS O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
by IN O
whole JJ O
- : O
cell NN O
assay VBP O
revealed VBN O
that IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
in IN O
polymorphonuclear JJ O
leukocytes NNS O
linearly RB O
correlated VBN O
with IN O
that DT O
in IN O
the DT O
corresponding JJ O
lymphocytes NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
9482 CD O
, , O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

There EX O
were VBD O
also RB O
significant JJ O
correlations NNS O
between IN O
the DT O
maximum JJ O
increase NN O
in IN O
polymorphonuclear JJ O
leukocytes NNS O
and CC O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
in IN O
polymorphonuclear JJ O
leukocytes NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
7239 CD O
, , O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
7 CD O
) ) O
, , O
and CC O
between IN O
the DT O
maximum JJ O
decrease NN O
in IN O
lymphocytes NNS O
and CC O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
in IN O
lymphocytes NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
7703 CD O
, , O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
individual JJ O
differences NNS O
are VBP O
preserved VBN O
both DT O
in IN O
glucocorticoid NN O
responsiveness NN O
and CC O
in IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
in IN O
normal JJ O
humans NNS O
. . O

Estradiol JJ O
receptors NNS O
in IN O
the DT O
cytosol NN O
of IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
in IN O
hepatitis NN O
B NNP O
virus NN O
carriers NNS O
treated VBD O
with IN O
interferon NN B-Gene
- : I-Gene
alpha NN I-Gene
. . O

Estradiol JJ B-Gene
receptors NNS I-Gene
in IN O
the DT O
cytosol NN O
of IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
and CC O
the DT O
effects NNS O
of IN O
interferon NN B-Gene
- : I-Gene
alpha NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
on IN O
estradiol NN B-Gene
receptors NNS I-Gene
were VBD O
studied VBN O
in IN O
asymptomatic JJ O
hepatitis NN O
B NNP O
virus NN O
( ( O
HBV NNP O
) ) O
carriers NNS O
, , O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
B NNP O
and CC O
normal JJ O
controls NNS O
. . O

The DT O
level NN O
of IN O
estradiol JJ B-Gene
receptors NNS I-Gene
in IN O
the DT O
cytosol NN O
of IN O
mononuclear JJ O
cells NNS O
was VBD O
significantly RB O
lower JJR O
in IN O
asymptomatic JJ O
HBV NNP O
carriers NNS O
and CC O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
B NNP O
, , O
compared VBN O
to TO O
normal JJ O
controls NNS O
. . O

This DT O
low JJ O
level NN O
of IN O
cytosol NN O
estradiol NN B-Gene
receptors NNS I-Gene
in IN O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
B NNP O
was VBD O
increased VBN O
by IN O
the DT O
administration NN O
of IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

In IN O
addition NN O
, , O
when WRB O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
from IN O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
B NNP O
were VBD O
incubated VBN O
with IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
in IN O
vitro NN O
, , O
the DT O
level NN O
of IN O
cytosol NN O
estradiol NN B-Gene
receptors NNS I-Gene
also RB O
increased VBN O
by IN O
increasing VBG O
the DT O
concentration NN O
of IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

We PRP O
previously RB O
reported VBD O
that IN O
the DT O
response NN O
of IN O
mononuclear JJ O
cells NNS O
to TO O
estrogen VB O
is VBZ O
impaired VBN O
in IN O
HBV NNP O
carriers NNS O
, , O
and CC O
our PRP$ O
present JJ O
results NNS O
suggested VBD O
that IN O
this DT O
may MD O
be VB O
due JJ O
to TO O
the DT O
low JJ O
level NN O
of IN O
estradiol JJ B-Gene
receptors NNS I-Gene
in IN O
the DT O
cytosol NN O
of IN O
mononuclear JJ O
cells NNS O
. . O

Association NNP O
of IN O
increased VBN O
lytic JJ O
effector NN O
cell NN O
function NN O
with IN O
high JJ O
estrogen NN B-Gene
receptor NN I-Gene
levels NNS O
in IN O
tumor NN O
- : O
bearing NN O
patients NNS O
with IN O
breast JJ O
cancer NN O
. . O

Tumor NNP O
- : O
bearing NN O
patients NNS O
with IN O
breast JJ O
cancer NN O
were VBD O
assayed VBN O
for IN O
their PRP$ O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
cell NN O
activity NN O
and CC O
for IN O
the DT O
function NN O
of IN O
activated JJ O
cytotoxic NN O
T NNP O
- : O
cells NNS O
, , O
as IN O
assessed VBN O
by IN O
lectin JJ O
- : O
dependent NN O
cellular JJ O
cytotoxicity NN O
( ( O
LDCC NNP O
) ) O
. . O

Tumor NNP O
- : O
bearing NN O
patients NNS O
with IN O
breast NN O
cancer NN O
had VBD O
a DT O
significant JJ O
increase NN O
in IN O
NK NNP O
activity NN O
and CC O
in IN O
LDCC NNP O
, , O
as IN O
compared VBN O
with IN O
healthy JJ O
control NN O
individuals NNS O
. . O

Although IN O
the DT O
enhanced JJ O
NK NNP O
cell NN O
activity NN O
and CC O
LDCC NNP O
were VBD O
closely RB O
associated VBN O
with IN O
high JJ O
levels NNS O
( ( O
greater JJR O
than IN O
31 CD O
fmol JJ O
/ NNP O
mg NN O
) ) O
of IN O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
content NN O
in IN O
the DT O
primary JJ O
tumor NN O
, , O
no DT O
other JJ O
clinical JJ O
or CC O
histologic JJ O
correlation NN O
between IN O
the DT O
increase NN O
in IN O
either DT O
parameter NN O
of IN O
cytotoxic NN O
effector NN O
cell NN O
function NN O
could MD O
be VB O
found VBN O
. . O

Thus RB O
, , O
ER NNP B-Gene
levels NNS O
greater JJR O
than IN O
31 CD O
fmol JJ O
/ NNP O
mg NN O
might MD O
be VB O
associated VBN O
with IN O
increased JJ O
cytotoxic NN O
effector NN O
cell NN O
function NN O
in IN O
tumor NN O
- : O
bearing NN O
patients NNS O
with IN O
breast JJ O
cancer NN O
. . O

Properties NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
Epstein NNP O
- : O
Barr NNP O
virus SYM O
- : O
transformed VBN O
lymphocytes NNS O
from IN O
patients NNS O
with IN O
familial JJ O
cortisol NN O
resistance NN O
. . O

In IN O
a DT O
previous JJ O
report NN O
of IN O
two CD O
patients NNS O
with IN O
familial JJ O
glucocorticoid NN O
resistance NN O
due JJ O
to TO O
reduced JJ O
numbers NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
, , O
we PRP O
have VBP O
shown VBN O
decreased JJ O
numbers NNS O
of IN O
GR NNP B-Gene
in IN O
peripheral JJ O
mononuclear JJ O
cells NNS O
and CC O
cultured JJ O
fibroblasts NNS O
but CC O
normal JJ O
affinity NN O
of IN O
GR NNP B-Gene
in IN O
both DT O
patients NNS O
. . O

In IN O
this DT O
study NN O
, , O
peripheral JJ O
lymphocytes NNS O
from IN O
these DT O
patients NNS O
, , O
one CD O
patient NN O
' '' O
s JJ O
son NN O
and CC O
daughter NN O
, , O
and CC O
normal JJ O
subjects NNS O
were VBD O
transformed VBN O
with IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
. . O

Reduced VBN O
numbers NNS O
and CC O
normal JJ O
affinity NN O
of IN O
GR NNP B-Gene
were VBD O
found VBN O
in IN O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus SYM O
- : O
transformed VBN O
lymphocytes NNS O
from IN O
both DT O
patients NNS O
while IN O
the DT O
son NN O
and CC O
daughter NN O
had VBD O
normal JJ O
numbers NNS O
and CC O
affinity NN O
of IN O
GR NNP B-Gene
. . O

The DT O
thermal JJ O
stability NN O
of IN O
GR NNP B-Gene
and CC O
thermal JJ O
activation NN O
of IN O
cytosolic JJ B-Gene
receptors NNS I-Gene
in IN O
both DT O
patients NNS O
were VBD O
found VBN O
to TO O
be VB O
normal JJ O
. . O

Although IN O
the DT O
percentages NNS O
of IN O
nuclear JJ O
bound IN O
GR NNP B-Gene
were VBD O
similar JJ O
in IN O
both DT O
patients NNS O
and CC O
normal JJ O
controls NNS O
, , O
the DT O
absolute JJ O
amounts NNS O
of IN O
nuclear JJ O
bound IN O
GR NNP B-Gene
of IN O
the DT O
patients NNS O
were VBD O
about IN O
one CD O
- : O
half NN O
that IN O
of IN O
normal JJ O
controls NNS O
. . O

These DT O
abnormal JJ O
properties NNS O
of IN O
GR NNP B-Gene
( ( O
reduced JJ O
numbers NNS O
of IN O
GR NNP B-Gene
) ) O
were VBD O
preserved VBN O
in IN O
the DT O
transformed JJ O
cells NNS O
from IN O
the DT O
patients NNS O
. . O

Octamer NNP O
transcription NN O
factors NNS O
1 CD O
and CC O
2 CD O
each DT O
bind NN O
to TO O
two CD O
different JJ O
functional JJ B-Gene
elements NNS I-Gene
in IN O
the DT O
immunoglobulin NN B-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
promoter NN I-Gene
. . O

Immunoglobulin NNP B-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
genes NNS I-Gene
contain VBP O
two CD O
conserved VBD B-Gene
sequence NN I-Gene
elements NNS I-Gene
5 CD O
' '' O
to TO O
the DT O
site NN O
of IN O
transcription NN O
initiation NN O
: : O
the DT O
octamer NN O
ATGCAAAT NNP O
and CC O
the DT O
heptamer NN O
CTCATGA NNP O
. . O

Both DT O
of IN O
these DT O
elements NNS O
are VBP O
required VBN O
for IN O
normal JJ B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
promoter NN I-Gene
function NN O
. . O

The DT O
present JJ O
study NN O
demonstrates VBZ O
that IN O
both DT O
the DT O
ubiquitous JJ B-Gene
and CC I-Gene
lymphoid JJ I-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
octamer JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
( ( O
OTF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
OTF NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
respectively RB O
) ) O
interact VB O
specifically RB O
with IN O
each DT O
of IN O
the DT O
two CD O
conserved VBD B-Gene
sequence NN I-Gene
elements NNS I-Gene
, , O
forming VBG O
either CC O
homo JJ B-Gene
- : I-Gene
or CC I-Gene
heterodimeric JJ I-Gene
complexes NNS I-Gene
. . O

This DT O
was VBD O
surprising JJ O
, , O
since IN O
the DT O
heptamer NN O
and CC O
octamer JJ O
sequence NN O
motifs NNS O
bear VBP O
no DT O
obvious JJ O
similarity NN O
to TO O
each DT O
other JJ O
. . O

Binding NNP O
of IN O
either DT O
factor NN O
to TO O
the DT O
octamer JJ B-Gene
element NN I-Gene
occurred VBD O
independently RB O
. . O

However RB O
, , O
OTF NNP B-Gene
interaction NN O
with IN O
the DT O
heptamer NN B-Gene
sequence NN I-Gene
appeared VBD O
to TO O
require VB O
the DT O
presence NN O
of IN O
an DT O
intact JJ O
octamer NN O
motif NN O
and CC O
occurred VBD O
with IN O
a DT O
spacing NN O
of IN O
either CC O
2 CD B-Gene
or CC I-Gene
14 CD I-Gene
base NN I-Gene
pairs NN I-Gene
between IN O
the DT O
two CD O
elements NNS O
, , O
suggesting VBG O
coordinate NN O
binding VBG O
resulting VBG O
from IN O
protein NN O
- : O
protein NN O
interactions NNS O
. . O

The DT O
degeneracy NN O
in IN O
sequences NNS O
recognized VBN O
by IN O
the DT O
OTFs NNP B-Gene
may MD O
be VB O
important JJ O
in IN O
widening VBG O
the DT O
range NN O
over IN O
which WDT O
gene NN O
expression NN O
can MD O
be VB O
modulated VBN O
and CC O
in IN O
establishing VBG O
cell NN O
type NN O
specificity NN O
. . O

Identification NN O
of IN O
a DT O
novel JJ O
lymphoid NN B-Gene
specific JJ I-Gene
octamer NN I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
OTF NNP B-Gene
- : I-Gene
2B CD I-Gene
) ) O
by IN O
proteolytic JJ O
clipping VBG O
bandshift NN O
assay NN O
( ( O
PCBA NNP O
) ) O
. . O

The DT O
octamer JJ O
sequence NN O
ATGCAAAT NNP O
is VBZ O
found VBN O
in IN O
the DT O
promoters NNS O
of IN O
immunoglobulin NN B-Gene
( ( I-Gene
Ig NNP I-Gene
) ) I-Gene
heavy NN I-Gene
and CC I-Gene
light JJ I-Gene
chain NN I-Gene
genes NNS I-Gene
and CC O
in IN O
the DT O
heavy JJ B-Gene
chain NN I-Gene
enhancer NN I-Gene
and CC O
is VBZ O
a DT O
major JJ O
determinant NN O
of IN O
the DT O
cell NN O
type NN O
specific JJ O
expression NN O
of IN O
Ig NNP B-Gene
genes NNS I-Gene
in IN O
B NNP O
cells NNS O
. . O

An DT O
apparent JJ O
paradox NN O
is VBZ O
that IN O
the DT O
same JJ O
sequence NN O
serves NNS O
as IN O
an DT O
upstream JJ B-Gene
promoter NN I-Gene
or CC I-Gene
enhancer NN I-Gene
element NN I-Gene
in IN O
a DT O
variety NN O
of IN O
housekeeping VBG B-Gene
genes NNS I-Gene
such JJ O
as IN O
the DT O
histone NN B-Gene
H2B NNP I-Gene
and CC I-Gene
U NNP I-Gene
snRNA VBP I-Gene
genes NNS I-Gene
. . O

The DT O
differential JJ O
usage NN O
of IN O
this DT O
regulatory JJ O
sequence NN O
motif NN O
is VBZ O
thought VBN O
to TO O
be VB O
mediated VBN O
by IN O
different JJ O
species NNS O
of IN O
octamer NN B-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

One CD O
species NNS O
of IN O
100 CD O
kd NNS O
, , O
designated VBN O
OTF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
is VBZ O
present JJ O
in IN O
all DT O
cell NN O
types NNS O
and CC O
may MD O
exert VB O
its PRP$ O
activating VBG O
function NN O
only RB O
when WRB O
it PRP O
can MD O
interact VB O
with IN O
additional JJ O
adjacent JJ O
transcription NN B-Gene
factors NNS I-Gene
. . O

The DT O
lymphoid NN B-Gene
cell NN I-Gene
specific JJ I-Gene
octamer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
of IN O
60 CD O
kd NNS O
( ( O
OTF NNP B-Gene
- : I-Gene
2A CD I-Gene
) ) O
specifically RB O
stimulates VBZ O
Ig NNP B-Gene
promoters NNS I-Gene
which WDT O
consist VBP O
essentially RB O
of IN O
a DT O
TATA NNP B-Gene
- : I-Gene
box NN I-Gene
and CC O
an DT O
octamer JJ B-Gene
sequence NN I-Gene
upstream NN O
of IN O
it PRP O
. . O

Here RB O
we PRP O
present JJ O
evidence NN O
for IN O
yet RB O
another DT O
B NNP B-Gene
cell NN I-Gene
specific JJ I-Gene
octamer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
of IN O
75 CD O
kd NNS O
( ( O
OTF NNP B-Gene
- : I-Gene
2B CD I-Gene
) ) O
. . O

From IN O
several JJ O
findings NNS O
, , O
including VBG O
the DT O
absence NN O
of IN O
OTF NNP B-Gene
- : I-Gene
2B CD I-Gene
( ( O
but CC O
not RB O
OTF NNP B-Gene
- : I-Gene
2A CD I-Gene
) ) O
from IN O
a DT O
lymphocyte JJ O
line NN O
that WDT O
can MD O
not RB O
respond VB O
to TO O
the DT O
IgH NNP B-Gene
enhancer NN I-Gene
, , O
we PRP O
propose VBP O
a DT O
role NN O
of IN O
the DT O
novel JJ B-Gene
octamer NN I-Gene
factor NN I-Gene
in IN O
the DT O
long JJ O
range NN O
activation NN O
by IN O
the DT O
IgH NNP B-Gene
enhancer NN I-Gene
. . O

We PRP O
have VBP O
used VBN O
the DT O
proteolytic JJ O
clipping NN O
bandshift NN O
assay NN O
( ( O
PCBA NNP O
) ) O
technique NN O
to TO O
distinguish VB O
the DT O
three CD O
different JJ O
forms NNS O
found VBN O
in IN O
B NNP O
cells NNS O
. . O

This DT O
analysis NN O
indicates VBZ O
that IN O
the DT O
75 CD O
kd SYM O
- : O
species NNS O
OTF NNP B-Gene
- : I-Gene
2B CD I-Gene
is VBZ O
closely RB O
related VBN O
to TO O
the DT O
60 CD B-Gene
kd NN I-Gene
species NNS I-Gene
OTF NNP I-Gene
- : I-Gene
2A CD I-Gene
. . O

Inhibition NN O
of IN O
interleukin JJ B-Gene
2 CD I-Gene
- : O
induced JJ O
proliferation NN O
of IN O
cloned JJ O
murine NN O
T NNP O
cells NNS O
by IN O
glucocorticoids NNS O
. . O

Possible JJ O
involvement NN O
of IN O
an DT O
inhibitory JJ B-Gene
protein NN I-Gene
. . O

The DT O
ability NN O
of IN O
glucocorticoids NNS O
to TO O
inhibit VB O
interleukin JJ B-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
2 CD I-Gene
) ) O
- : O
induced VBN O
T NNP O
cell NN O
proliferation NN O
in IN O
two CD O
cytotoxic NN O
T NNP O
cell NN O
( ( O
CTL NNP O
) ) O
clones NNS O
has VBZ O
been VBN O
studied VBN O
. . O

A DT O
complete JJ O
inhibition NN O
of IN O
DNA NNP O
synthesis NN O
by IN O
dexamethasone NN O
( ( O
Dx NNP O
) ) O
could MD O
be VB O
observed VBN O
when WRB O
IL NNP O
2 CD O
- : O
depleted VBN O
cultures NNS O
of IN O
CTL NNP O
were VBD O
either RB O
incubated VBN O
for IN O
6 CD O
h NN O
with IN O
the DT O
hormone NN B-Gene
prior RB O
to TO O
the DT O
addition NN O
of IN O
IL NNP B-Gene
2 CD I-Gene
or CC O
treated VBD O
simultaneously RB O
with IN O
Dx NNP O
and CC O
a DT O
low JJ O
concentration NN O
of IN O
IL NNP B-Gene
2 CD I-Gene
. . O

No DT O
significant JJ O
reduction NN O
in IN O
the DT O
number NN O
and CC O
affinity NN O
of IN O
IL NNP B-Gene
2 CD I-Gene
receptors NNS I-Gene
was VBD O
seen VBN O
after IN O
6 CD O
h JJ O
incubation NN O
with IN O
Dx NNP O
. . O

The DT O
order NN O
of IN O
potency NN O
observed VBN O
with IN O
the DT O
different JJ O
steroids NNS O
indicated VBD O
that IN O
this DT O
inhibitory JJ O
effect NN O
was VBD O
mediated VBN O
through IN O
binding NN O
to TO O
a DT O
specific JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
. . O

The DT O
action NN O
of IN O
these DT O
hormones NNS B-Gene
possibly RB O
involves VBZ O
the DT O
synthesis NN O
of IN O
an DT O
inhibitory NN B-Gene
protein NN I-Gene
( ( O
s PRP O
) ) O
, , O
since IN O
the DT O
presence NN O
of IN O
cycloheximide NN O
during IN O
the DT O
incubation NN O
with IN O
Dx NNP O
prevented VBD O
the DT O
inhibition NN O
of IN O
DNA NNP O
synthesis NN O
. . O

Furthermore RB O
, , O
supernatant NN O
from IN O
Dx NNP O
- : O
treated VBD O
CTL NNP O
contained VBD O
a DT O
nondialyzable JJ O
factor NN O
which WDT O
inhibited VBD O
DNA NNP O
synthesis NN O
and CC O
cell NN O
growth NN O
of IN O
CTL NNP O
clones NNS O
induced VBN O
by IN O
IL NNP B-Gene
2 CD I-Gene
. . O

Blocking NNP O
of IN O
IL NNP B-Gene
2 CD I-Gene
synthesis NN O
and CC O
IL NNP B-Gene
2 CD I-Gene
receptor NN I-Gene
formation NN O
have VBP O
been VBN O
proposed VBN O
as IN O
one CD O
of IN O
the DT O
major JJ O
mechanisms NNS O
of IN O
glucocorticoid JJ O
- : O
induced JJ O
immunosuppression NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
these DT O
hormones NNS B-Gene
may MD O
also RB O
affect VB O
T NNP O
cell NN O
proliferation NN O
by IN O
inhibiting VBG O
IL NNP B-Gene
2 CD I-Gene
activity NN O
. . O

Identification NN O
and CC O
purification NN O
of IN O
a DT O
human JJ B-Gene
immunoglobulin NN I-Gene
- : I-Gene
enhancer NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
that WDT O
activates VBZ O
transcription NN O
from IN O
a DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
promoter NN I-Gene
in IN O
vitro NN O
. . O

The DT O
enhancer NN B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
which WDT O
is VBZ O
found VBN O
only RB O
in IN O
cells NNS O
that IN O
transcribe JJ O
immunoglobulin NN B-Gene
light NN I-Gene
chain NN I-Gene
genes NNS I-Gene
, , O
has VBZ O
been VBN O
purified VBN O
from IN O
nuclear JJ O
extracts NNS O
of IN O
Namalwa NNP O
cells NNS O
( ( O
human JJ O
Burkitt NNP O
lymphoma NN O
cells NNS O
) ) O
by IN O
sequence NN O
- : O
specific JJ O
DNA NNP O
affinity NN O
chromatography NN O
. . O

The DT O
purified JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
51 CD B-Gene
- : I-Gene
kDa NN I-Gene
polypeptide NN I-Gene
by IN O
UV NNP O
- : O
crosslinking NN O
analysis NN O
. . O

` `` O
` `` O
Footprint NN O
' '' O
' POS O
and CC O
methylation NN O
- : O
interference NN O
analyses NNS O
have VBP O
shown VBN O
that IN O
purified VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
has VBZ O
a DT O
binding NN O
activity NN O
specific NN O
for IN O
the DT O
kappa NN B-Gene
light NN I-Gene
chain NN I-Gene
enhancer JJ I-Gene
sequence NN I-Gene
. . O

The DT O
purified JJ O
factor NN O
activated VBD O
in IN O
vitro JJ O
transcription NN O
of IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
I PRP I-Gene
promoter VBP I-Gene
by IN O
binding VBG O
to TO O
an DT O
upstream JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene

Lymphocyte NNP O
glucocorticoid NN B-Gene
receptor NN I-Gene
binding NN O
in IN O
depression NN O
: : O
normal JJ O
values NNS O
following VBG O
recovery NN O
. . O

The DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
sites NNS O
in IN O
lymphocytes NNS O
and CC O
plasma NN O
cortisol NN O
concentrations NNS O
were VBD O
measured VBN O
in IN O
20 CD O
patients NNS O
who WP O
had VBD O
recovered VBN O
from IN O
major JJ O
depressive JJ O
disorder NN O
and CC O
20 CD O
healthy JJ O
control NN O
subjects NNS O
. . O

The DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
sites NNS O
in IN O
lymphocytes NNS O
from IN O
the DT O
recovered VBN O
depressed JJ O
group NN O
was VBD O
not RB O
significantly RB O
different JJ O
from IN O
that DT O
of IN O
the DT O
control NN O
group NN O
. . O

Although IN O
the DT O
mean JJ O
plasma NN O
cortisol NN O
concentration NN O
in IN O
recovered JJ O
depressives NNS O
was VBD O
higher JJR O
than IN O
in IN O
control NN O
subjects NNS O
, , O
the DT O
difference NN O
only RB O
just RB O
reached VBN O
significance NN O
. . O

This DT O
study NN O
shows VBZ O
that IN O
the DT O
reduction NN O
in IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
numbers NNS O
which WDT O
occurs VBP O
during IN O
acute JJ O
depressive JJ O
illness NN O
does VBZ O
not RB O
persist VB O
on IN O
recovery NN O
and CC O
is VBZ O
, , O
therefore RB O
, , O
state NN O
- : O
dependent NN O
. . O

Identification NN O
and CC O
purification NN O
of IN O
a DT O
human JJ B-Gene
lymphoid NN I-Gene
- : I-Gene
specific JJ I-Gene
octamer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
OTF NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
that WDT O
activates VBZ O
transcription NN O
of IN O
an DT O
immunoglobulin NN B-Gene
promoter NN I-Gene
in IN O
vitro NN O
. . O

The DT O
octamer JJ O
sequence NN O
5 CD O
' '' O
- : O
ATGCAAAT NNP O
, , O
in IN O
either DT O
orientation NN O
, , O
serves VBZ O
as IN O
an DT O
upstream JJ B-Gene
element NN I-Gene
in IN O
a DT O
variety NN O
of IN O
promoters NNS B-Gene
and CC O
also RB O
occurs VBZ O
as IN O
a DT O
modular JJ B-Gene
enhancer NN I-Gene
element NN I-Gene
. . O

It PRP O
is VBZ O
of IN O
particular JJ O
interest NN O
in IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
since IN O
it PRP O
is VBZ O
found VBN O
in IN O
the DT O
upstream JJ B-Gene
regions NNS I-Gene
of IN O
all DT O
heavy JJ B-Gene
and CC I-Gene
light JJ I-Gene
chain NN I-Gene
promoters NNS I-Gene
and CC O
in IN O
the DT O
heavy JJ B-Gene
chain NN I-Gene
enhancer NN I-Gene
, , O
both DT O
of IN O
which WDT O
are VBP O
known VBN O
to TO O
be VB O
necessary JJ O
for IN O
cell NN O
- : O
specific JJ O
expression NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
chromatographic JJ O
separation NN O
of IN O
ubiquitous JJ B-Gene
and CC I-Gene
B NNP I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
octamer SYM I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

The DT O
B NNP B-Gene
cell NN I-Gene
factor NN I-Gene
was VBD O
purified VBN O
to TO O
homogeneity NN O
using VBG O
affinity NN O
chromatography NN O
and CC O
consists NNS O
of IN O
three CD O
peptides NNS O
of IN O
62 CD O
, , O
61 CD O
, , O
and CC O
58 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
5 CD O
kd NN O
. . O

Each DT O
of IN O
the DT O
polypeptides NNS O
was VBD O
renatured VBN O
after IN O
SDS NNP O
- : O
PAGE NN O
and CC O
shown VBN O
to TO O
bind VB O
to TO O
the DT O
octamer JJ O
sequence NN O
. . O

The DT O
specific JJ O
DNA NNP O
binding NN O
activity NN O
of IN O
the DT O
pure NN O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
was VBD O
indistinguishable JJ O
from IN O
that DT O
of IN O
the DT O
affinity NN B-Gene
- : I-Gene
purified VBN I-Gene
ubiquitous JJ I-Gene
factor NN I-Gene
. . O

This DT O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
octamer SYM I-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
, , O
in IN O
pure JJ O
form NN O
, , O
activated VBN O
transcription NN O
from IN O
a DT O
kappa NN B-Gene
light NN I-Gene
chain NN I-Gene
promoter NN I-Gene
in IN O
vitro NN O
, , O
thus RB O
demonstrating VBG O
that IN O
it PRP O
is VBZ O
indeed RB O
a DT O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
for IN O
this DT O
gene NN O
. . O

In IN O
addition NN O
to TO O
the DT O
ubiquitous JJ B-Gene
and CC I-Gene
B NNP I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
octamer SYM I-Gene
- : I-Gene
binding NN I-Gene
factors NNS I-Gene
, , O
we PRP O
identified VBD O
several JJ O
additional JJ O
proteins NNS O
, , O
one CD O
of IN O
which WDT O
is VBZ O
B NNP O
cell NN O
- : O
specific NN O
, , O
that IN O
interact NN O
with IN O
the DT O
kappa NN B-Gene
promoter NN I-Gene
. . O

Decreased VBN O
deoxyribonucleic JJ O
acid JJ O
binding NN O
of IN O
glucocorticoid JJ B-Gene
- : I-Gene
receptor NN I-Gene
complex NN I-Gene
in IN O
cultured JJ O
skin NN O
fibroblasts NNS O
from IN O
a DT O
patient NN O
with IN O
the DT O
glucocorticoid JJ O
resistance NN O
syndrome NN O
. . O

A DT O
patient NN O
with IN O
the DT O
syndrome NN O
of IN O
glucocorticoid JJ O
resistance NN O
was VBD O
studied VBN O
. . O

A DT O
27 CD O
- : O
yr NN O
- : O
old JJ O
woman NN O
initially RB O
was VBD O
diagnosed VBN O
as IN O
having VBG O
Cushing VBG O
' '' O
s JJ O
disease NN O
, , O
based VBN O
on IN O
the DT O
findings NNS O
of IN O
high JJ O
plasma NN O
ACTH NNP O
and CC O
serum VB O
cortisol NN O
levels NNS O
, , O
increased VBD O
urinary JJ O
cortisol NN O
secretion NN O
, , O
resistance NN O
to TO O
adrenal JJ O
suppression NN O
with IN O
dexamethasone NN O
, , O
and CC O
bilateral JJ O
adrenal JJ O
hyperplasia NN O
by IN O
computed JJ O
tomography NN O
and CC O
scintigraphy NN O
of IN O
the DT O
adrenal JJ O
glands NNS O
. . O

However RB O
, , O
she PRP O
had VBD O
no DT O
signs NNS O
or CC O
symptoms NNS O
of IN O
Cushing VBG O
' '' O
s JJ O
syndrome NN O
. . O

During IN O
a DT O
5 CD O
- : O
yr NN O
follow SYM O
- : O
up RB O
, , O
no DT O
clinical JJ O
abnormalities NNS O
developed VBD O
, , O
although IN O
hypercortisolism NN O
persisted VBN O
. . O

End SYM O
- : O
organ JJ O
resistance NN O
to TO O
cortisol VB O
was VBD O
suspected VBN O
. . O

To TO O
explain VB O
the DT O
end NN O
- : O
organ JJ O
resistance NN O
to TO O
cortisol VB O
, , O
the DT O
glucocorticoid NN B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
in IN O
peripheral JJ O
mononuclear NN O
leukocytes NNS O
and CC O
cultured VBD O
skin JJ O
fibroblasts NNS O
from IN O
a DT O
forearm NN O
skin NN O
biopsy NN O
were VBD O
characterized VBN O
and CC O
compared VBN O
with IN O
the DT O
results NNS O
of IN O
similar JJ O
studies NNS O
in IN O
normal JJ O
subjects NNS O
. . O

The DT O
patient NN O
' POS O
s NN O
GR NNP B-Gene
in IN O
whole JJ O
cell NN O
assays NNS O
had VBD O
an DT O
increased VBN O
dissociation NN O
constant NN O
( ( O
Kd NNP O
) ) O
. . O

In IN O
the DT O
cytosol NN O
of IN O
cultured JJ O
skin NN O
fibroblasts NNS O
from IN O
the DT O
patient NN O
, , O
there EX O
was VBD O
also RB O
decreased VBN O
binding NN O
capacity NN O
. . O

The DT O
thermal JJ O
stability NN O
and CC O
the DT O
sedimentation NN O
coefficient NN O
in IN O
a DT O
sucrose JJ O
density NN O
gradient NN O
of IN O
the DT O
receptors NNS O
in IN O
the DT O
cytosol NN O
of IN O
cultured JJ O
skin NN O
fibroblasts NNS O
from IN O
the DT O
patient NN O
and CC O
normal JJ O
subjects NNS O
were VBD O
similar JJ O
. . O

GR NNP O
complex JJ O
activation NN O
, , O
analyzed VBN O
by IN O
DEAE NNP O
- : O
cellulose NN O
chromatography NN O
, , O
was VBD O
decreased VBN O
in IN O
the DT O
patient NN O
. . O

DNA NN B-Gene
binding NN O
of IN O
the DT O
GR NNP B-Gene
complex NN I-Gene
after IN O
temperature NN O
- : O
induced JJ O
activation NN O
was VBD O
lower JJR O
in IN O
the DT O
patient NN O
than IN O
in IN O
normal JJ O
subjects NNS O
. . O

Nuclear JJ O
translocation NN O
of IN O
GR NNP B-Gene
complexes NNS I-Gene
from IN O
the DT O
patient NN O
was VBD O
also RB O
slightly RB O
decreased VBN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
patient NN O
' POS O
s NN O
glucocorticoid NN O
resistance NN O
was VBD O
due JJ O
to TO O
a DT O
decrease NN O
in IN O
the DT O
affinity NN O
of IN O
the DT O
receptor NN O
for IN O
glucocorticoids NNS O
and CC O
a DT O
decrease NN O
in IN O
the DT O
binding NN O
of IN O
the DT O
GR NNP B-Gene
complex NN I-Gene
to TO O
DNA NNP B-Gene
. . O

Granulocyte NNP B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
. . O

Sensitive JJ O
and CC O
receptor JJ O
- : O
mediated VBN O
regulation NN O
by IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
in IN O
normal JJ O
human JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

We PRP O
show VBP O
that IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
( ( O
1 CD O
, , O
25 CD O
[ NN O
OH NNP O
] NNP O
2D3 CD O
) ) O
, , O
the DT O
most RBS O
hormonally RB O
active JJ O
metabolite NN O
of IN O
vitamin NN O
D3 NNP O
, , O
modulates VBZ O
sensitively RB O
and CC O
specifically RB O
both DT O
the DT O
protein NN O
and CC O
messenger NN B-Gene
RNA NNP I-Gene
accumulation NN O
of IN O
the DT O
multilineage NN B-Gene
growth NN I-Gene
factor NN I-Gene
granulocyte SYM B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
. . O

The DT O
regulation NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
expression NN O
is VBZ O
seen VBN O
in IN O
both DT O
normal JJ O
human JJ O
mitogen NN O
- : O
activated VBN O
T NNP O
lymphocytes NNS O
and CC O
T NNP O
lymphocytes VBZ O
from IN O
a DT O
line NN O
( ( O
S NNP O
- : O
LB1 NNP O
) ) O
transformed VBD O
with IN O
human JJ O
T NNP O
cell NN O
lymphotropic NN O
virus NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
. . O

In IN O
contrast NN O
, , O
cells NNS O
from IN O
a DT O
HTLV NNP O
- : O
1 CD O
transformed VBD O
T NNP O
lymphocyte JJ O
line NN O
( ( O
Ab NNP O
- : O
VDR NN O
) ) O
established VBN O
from IN O
a DT O
patient NN O
with IN O
vitamin NN O
D NNP O
- : O
resistant JJ O
rickets NNS O
type JJ O
II NNP O
with IN O
undetectable JJ O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
cellular JJ I-Gene
receptors NNS I-Gene
are VBP O
resistant JJ O
to TO O
the DT O
action NN O
of IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
. . O

Inhibition NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
expression NN O
by IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
can MD O
occur VB O
independently RB O
of IN O
interleukin JJ B-Gene
2 CD I-Gene
regulation NN O
and CC O
is VBZ O
probably RB O
mediated VBN O
through IN O
cellular JJ B-Gene
1 CD I-Gene
, , I-Gene
25 CD I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptors NNS I-Gene
. . O

We PRP O
conclude VBP O
that IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
may MD O
be VB O
important JJ O
in IN O
the DT O
physiology NN O
of IN O
hematopoiesis NN O
. . O

Altered VBN O
interaction NN O
between IN O
triiodothyronine NN O
and CC O
its PRP$ O
nuclear JJ B-Gene
receptors NNS I-Gene
in IN O
absence NN O
of IN O
cortisol NN O
: : O
a DT O
proposed VBN O
mechanism NN O
for IN O
increased VBN O
thyrotropin NN O
secretion NN O
in IN O
corticosteroid JJ O
deficiency NN O
states NNS O
. . O

Thyroid NNP O
hormones NNS O
occasionally RB O
appear VBP O
less RBR O
effective JJ O
when WRB O
administered VBN O
alone RB O
to TO O
patients NNS O
with IN O
panhypopituitarism NN O
, , O
and CC O
manifestations NNS O
suggestive VBP O
of IN O
hypothyroidism NN O
have VBP O
been VBN O
reported VBN O
in IN O
patients NNS O
suffering VBG O
from IN O
untreated JJ O
Addison NNP O
' POS O
s JJ O
disease NN O
. . O

In IN O
the DT O
latter JJ O
condition NN O
, , O
thyrotropin JJ O
secretion NN O
is VBZ O
increased VBN O
: : O
this DT O
occurs VBZ O
already RB O
after IN O
as RB O
little JJ O
as IN O
2 CD O
days NNS O
of IN O
temporary JJ O
withdrawal NN O
of IN O
therapy NN O
with IN O
substitution NN O
doses NNS O
of IN O
corticosteroids NNS O
while IN O
circulating VBG O
levels NNS O
of IN O
thyroid NN O
hormones NNS O
remain VBP O
within IN O
normal JJ O
limits NNS O
. . O

Therefore RB O
, , O
a DT O
possible JJ O
role NN O
of IN O
cortisol NN O
in IN O
interaction NN O
between IN O
triiodothyronine NN O
and CC O
its PRP$ O
nuclear JJ B-Gene
receptors NNS I-Gene
was VBD O
examined VBN O
at IN O
the DT O
level NN O
of IN O
circulating VBG O
lymphocytes NNS O
obtained VBN O
from IN O
patients NNS O
with IN O
primary JJ O
or CC O
secondary JJ O
adrenocortical JJ O
failure NN O
. . O

The DT O
affinity NN O
of IN O
these DT O
receptors NNS O
was VBD O
found VBN O
to TO O
be VB O
decreased VBN O
, , O
by IN O
more JJR O
than IN O
50 CD O
% NN O
on IN O
average NN O
, , O
in IN O
the DT O
absence NN O
of IN O
cortisol NN O
treatments NNS O
. . O

This DT O
change NN O
was VBD O
promptly RB O
corrected VBN O
upon IN O
resumption NN O
of IN O
therapy NN O
. . O

The DT O
number NN O
of IN O
binding VBG O
sites NNS O
was VBD O
not RB O
significantly RB O
modified VBN O
. . O

The DT O
influence NN O
of IN O
cortisol NN O
on IN O
thyroid NN B-Gene
hormone NN I-Gene
receptors NNS I-Gene
discussed VBD O
here RB O
might MD O
account VB O
for IN O
the DT O
clinical JJ O
observations NNS O
mentioned VBN O
above IN O
. . O

Inhibition NN O
by IN O
cortisol NN O
of IN O
human JJ O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
cell NN O
activity NN O
. . O

The DT O
effects NNS O
of IN O
cortisol NN O
on IN O
the DT O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
activity NN O
of IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
( ( O
PBM NNP O
) ) O
cells NNS O
were VBD O
studied VBN O
in IN O
vitro NN O
using VBG O
a DT O
direct JJ O
4 CD O
- : O
h NN O
51Cr CD O
- : O
release NN O
assay NN O
and CC O
K NNP O
562 NNP O
cell NN O
line NN O
as IN O
a DT O
target NN O
. . O

Preincubation NN O
for IN O
20 CD O
h NN O
of IN O
PBM NNP O
cells NNS O
drawn VBN O
from IN O
healthy JJ O
donors NNS O
with IN O
1 CD O
X NNS O
10 CD O
( ( O
- : O
8 CD O
) ) O
to TO O
1 CD O
X NNS O
10 CD O
( ( O
- : O
5 CD O
) ) O
M NNP O
cortisol NN O
resulted VBD O
in IN O
a DT O
significant JJ O
decrease NN O
of IN O
NK NNP O
cell NN O
activity NN O
. . O

The DT O
magnitude NN O
of IN O
the DT O
suppression NN O
was VBD O
directly RB O
related VBN O
to TO O
the DT O
steroid JJ O
concentration NN O
and CC O
inversely RB O
related VBN O
to TO O
the DT O
number NN O
of IN O
effector NN O
cells NNS O
. . O

Cortisol NNP O
was VBD O
able JJ O
to TO O
minimize VB O
the DT O
enhancement NN O
of IN O
NK NNP O
cytotoxicity NN O
obtainable NN O
in IN O
the DT O
presence NN O
of IN O
immune JJ O
interferon NN O
( ( O
IFN NNP O
- : O
gamma NN O
) ) O
. . O

A DT O
significantly RB O
higher JJR O
suppression NN O
was VBD O
achieved VBN O
after IN O
sequential JJ O
exposure NN O
of IN O
PBM NNP O
cells NNS O
to TO O
cortisol VB O
and CC O
equimolar JJ O
levels NNS O
of IN O
prostaglandin NN O
E2 NNP O
( ( O
PgE2 NNP O
) ) O
. . O

The DT O
concomitant JJ O
incubation NN O
with IN O
theophylline NN O
and CC O
isobutyl JJ O
- : O
methylxanthine NN O
failed VBD O
to TO O
enhance VB O
the DT O
cortisol NN O
- : O
induced JJ O
suppression NN O
, , O
whereas WP O
PgE2 NNP O
- : O
dependent JJ O
inhibition NN O
significantly RB O
increased VBD O
after IN O
exposure NN O
of IN O
PBM NNP O
cells NNS O
to TO O
methyl VB O
- : O
xanthines NNS O
. . O

The DT O
inhibitory JJ O
effect NN O
of IN O
cortisol NN O
was VBD O
partially RB O
or CC O
totally RB O
prevented VBN O
by IN O
the DT O
concomitant JJ O
incubation NN O
with IN O
equimolar JJ O
amounts NNS O
of IN O
11 CD O
- : O
deoxycortisol NN O
and CC O
RU NNP O
486 CD O
but CC O
not RB O
of IN O
progesterone NN O
. . O

Treatment NN O
of IN O
NK NNP O
effectors NNS O
with IN O
a DT O
monoclonal JJ B-Gene
anti NN I-Gene
- : I-Gene
human JJ I-Gene
corticosteroid NN I-Gene
- : I-Gene
binding NN I-Gene
globulin NN I-Gene
( ( I-Gene
CBG NNP I-Gene
) ) I-Gene
antibody NN I-Gene
produced VBD O
an DT O
enhancement NN O
of IN O
the DT O
spontaneous JJ O
NK NNP O
activity NN O
and CC O
a DT O
partial JJ O
suppression NN O
of IN O
cortisol NN O
- : O
mediated JJ O
effects NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
endogenous JJ O
glucocorticoids NNS O
play VBP O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
NK NNP O
cell NN O
- : O
mediated VBN O
cytotoxicity NN O
. . O

Since IN O
the DT O
effect NN O
of IN O
cortisol NN O
was VBD O
additive JJ O
to TO O
that DT O
of IN O
PgE2 NNP O
and CC O
was VBD O
not RB O
changed VBN O
by IN O
phosphodiesterase NN B-Gene
inhibitors NNS O
, , O
it PRP O
is VBZ O
conceivable JJ O
that IN O
the DT O
hormone NN O
acts VBZ O
at IN O
a DT O
level JJ O
different JJ O
from IN O
the DT O
adenylate NN B-Gene
cyclase NN I-Gene
- : O
phosphodiesterase NN B-Gene
system NN O
. . O

Data NNS O
obtained VBN O
with IN O
the DT O
use NN O
of IN O
antiglucocorticoids NNS O
and CC O
the DT O
anti JJ B-Gene
- : I-Gene
CBG NN I-Gene
antibody NN I-Gene
are VBP O
compatible JJ O
with IN O
a DT O
role NN O
both DT O
of IN O
high JJ O
- : O
affinity NN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
and CC O
of IN O
CBG NNP B-Gene
in IN O
mediating VBG O
cortisol JJ O
action NN O
on IN O
the DT O
human JJ O
NK NNP O
cell NN O
activity NN O
. . O

Interaction NN O
of IN O
cell NN B-Gene
- : I-Gene
type NN I-Gene
- : I-Gene
specific JJ I-Gene
nuclear JJ I-Gene
proteins NNS I-Gene
with IN O
immunoglobulin JJ B-Gene
VH NNP I-Gene
promoter NN I-Gene
region NN I-Gene
sequences NNS I-Gene
. . O

All DT O
human JJ B-Gene
and CC I-Gene
murine JJ I-Gene
immunoglobulin NN I-Gene
heavy NN I-Gene
chain NN I-Gene
variable JJ I-Gene
region NN I-Gene
( ( I-Gene
VH NNP I-Gene
) ) I-Gene
genes NNS I-Gene
contain VBP O
the DT O
sequence NN O
ATGCAAAT NNP O
approximately RB O
70 CD O
nucleotides NNS O
5 CD O
' '' O
from IN O
the DT O
site NN O
of IN O
transcription NN O
initiation NN O
. . O

This DT O
octanucleotide NN O
, , O
in IN O
reverse JJ O
orientation NN O
, , O
is VBZ O
also RB O
found VBN O
in IN O
all DT O
light JJ B-Gene
chain NN I-Gene
variable JJ I-Gene
region NN I-Gene
( ( I-Gene
VL NNP I-Gene
) ) I-Gene
genes NNS I-Gene
, , O
and CC O
in IN O
the DT O
immunoglobulin NN B-Gene
heavy NN I-Gene
chain NN I-Gene
transcriptional JJ I-Gene
enhancer NN I-Gene
. . O

Transfection NN O
studies NNS O
have VBP O
established VBN O
that IN O
this DT O
octamer NN O
is VBZ O
involved VBN O
in IN O
the DT O
lymphoid JJ O
- : O
specific JJ O
transcription NN O
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
. . O

Octamer NNP B-Gene
- : I-Gene
containing VBG I-Gene
fragments NNS I-Gene
have VBP O
been VBN O
reported VBN O
to TO O
bind VB O
a DT O
factor NN O
present NN O
in IN O
nuclear JJ O
extracts NNS O
of IN O
human JJ O
cell NN O
lines NNS O
; : O
however RB O
, , O
identical JJ O
binding NN O
activity NN O
was VBD O
detected VBN O
in IN O
both DT O
B NNP O
lymphoid NN O
and CC O
non JJ O
- : O
lymphoid NN O
cells NNS O
. . O

Here RB O
we PRP O
establish VB O
that IN O
nuclear JJ O
extracts NNS O
from IN O
distinct JJ O
cell NN O
types NNS O
differ VBP O
in IN O
their PRP$ O
ability NN O
to TO O
interact VB O
with IN O
octamer JJ B-Gene
- : I-Gene
containing NN I-Gene
fragments NNS I-Gene
. . O

We PRP O
have VBP O
also RB O
detected VBN O
a DT O
DNA NNP O
- : O
protein NN O
interaction NN O
that WDT O
may MD O
be VB O
involved VBN O
in IN O
the DT O
cell NN O
- : O
type NN O
specificity NN O
of IN O
immunoglobulin JJ B-Gene
expression NN O
, , O
and CC O
we PRP O
have VBP O
determined VBN O
that IN O
a DT O
sequence NN O
upstream NN O
of IN O
the DT O
octamer NN O
participates VBZ O
in IN O
an DT O
interaction NN O
with IN O
a DT O
nuclear JJ B-Gene
protein NN I-Gene
( ( O
s JJ O
) ) O
. . O

Preferential JJ O
transcription NN O
of IN O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
LTR VBP I-Gene
in IN O
cell NN O
- : O
free JJ O
extracts NNS O
of IN O
human JJ O
T NNP O
cells NNS O
producing VBG O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
viral JJ I-Gene
proteins NNS I-Gene
. . O

The DT O
promoters NNS B-Gene
of IN O
the DT O
adenovirus NN B-Gene
2 CD I-Gene
major JJ I-Gene
late JJ I-Gene
gene NN I-Gene
, , O
the DT O
mouse NN B-Gene
beta SYM I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
, , O
the DT O
mouse NN B-Gene
immunoglobulin NN I-Gene
VH NNP I-Gene
gene NN I-Gene
and CC O
the DT O
LTR NNP B-Gene
of IN O
the DT O
human JJ O
T NNP O
- : O
lymphotropic NN O
retrovirus NN O
type NN O
I PRP O
were VBD O
tested VBN O
for IN O
their PRP$ O
transcription NN O
activities NNS O
in IN O
cell NN O
- : O
free JJ O
extracts NNS O
of IN O
four CD O
cell NN O
lines NNS O
; : O
HeLa NNP O
, , O
CESS NNP O
( ( O
Epstein NNP O
- : O
Barr NNP O
virus SYM O
- : O
transformed VBN O
human JJ O
B NNP O
cell NN O
line NN O
) ) O
, , O
MT NNP O
- : O
1 CD O
( ( O
HTLV NNP O
- : O
I PRP O
- : O
infected VBN O
human JJ O
T NNP O
cell NN O
line NN O
without IN O
viral JJ O
protein NN O
synthesis NN O
) ) O
, , O
and CC O
MT NNP O
- : O
2 CD O
( ( O
HTLV NNP O
- : O
I PRP O
- : O
infected VBN O
human JJ O
T NNP O
cell NN O
line NN O
producing VBG O
viral JJ B-Gene
proteins NNS I-Gene
) ) O
. . O

LTR NNP B-Gene
was VBD O
preferentially RB O
transcribed VBN O
in IN O
the DT O
extracts NNS O
of IN O
MT NNP O
- : O
2 CD O
although IN O
the DT O
other JJ O
three CD O
genes NNS O
were VBD O
transcribed VBN O
with IN O
relatively RB O
constant JJ O
efficiencies NNS O
in IN O
different JJ O
extracts NNS O
. . O

The DT O
results NNS O
agree VBP O
well RB O
with IN O
the DT O
previous JJ O
in IN O
vivo JJ O
studies NNS O
on IN O
the DT O
promoter NN O
activity NN O
of IN O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
LTR NNP I-Gene
. . O

Mixing VBG O
of IN O
HeLa NNP O
and CC O
MT NNP O
- : O
2 CD O
extracts NNS O
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
LTR NNP O
- : O
specific JJ O
stimulating VBG O
activity NN O
in IN O
MT NNP O
- : O
2 CD O
extracts NNS O
. . O

A DT O
nuclear JJ B-Gene
factor NN I-Gene
that WDT O
binds VBZ O
to TO O
a DT O
conserved VBN O
sequence NN O
motif NN O
in IN O
transcriptional JJ B-Gene
control NN I-Gene
elements NNS I-Gene
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
. . O

Trans NNP B-Gene
- : I-Gene
acting VBG I-Gene
factors NNS I-Gene
that WDT O
mediate VBP O
B NNP O
- : O
cell NN O
specific JJ O
transcription NN O
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
have VBP O
been VBN O
postulated VBN O
based VBN O
on IN O
an DT O
analysis NN O
of IN O
the DT O
expression NN O
of IN O
exogenously RB O
introduced VBN O
immunoglobulin JJ B-Gene
gene NN I-Gene
recombinants NNS I-Gene
in IN O
lymphoid NN O
and CC O
non JJ O
- : O
lymphoid NN O
cells NNS O
. . O

Two CD O
B NNP O
- : O
cell NN O
- : O
specific NN O
, , O
cis JJ B-Gene
- : I-Gene
acting VBG I-Gene
transcriptional JJ I-Gene
regulatory JJ I-Gene
elements NNS I-Gene
have VBP O
been VBN O
identified VBN O
. . O

One CD O
element NN O
is VBZ O
located VBN O
in IN O
the DT O
intron NN O
between IN O
the DT O
variable JJ O
( ( O
V NNP O
) ) O
and CC O
constant JJ O
( ( O
C NNP O
) ) O
regions NNS O
of IN O
both DT O
heavy JJ B-Gene
and CC I-Gene
kappa JJ I-Gene
light JJ I-Gene
- : I-Gene
chain NN I-Gene
genes NNS I-Gene
and CC O
acts NNS O
as IN O
a DT O
transcriptional JJ O
enhancer NN O
. . O

The DT O
second JJ O
element NN B-Gene
is VBZ O
found VBN O
upstream NN O
of IN O
both DT O
heavy JJ B-Gene
and CC I-Gene
kappa JJ I-Gene
light JJ I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
promoters NNS I-Gene
. . O

This DT O
element NN O
directs VBZ O
lymphoid JJ O
- : O
specific JJ O
transcription NN O
even RB O
in IN O
the DT O
presence NN O
of IN O
viral JJ B-Gene
enhancers NNS I-Gene
. . O

We PRP O
have VBP O
sought VBN O
nuclear JJ O
factors NNS O
that WDT O
might MD O
bind VB O
specifically RB O
to TO O
these DT O
two CD O
regulatory JJ B-Gene
elements NNS I-Gene
by IN O
application NN O
of IN O
a DT O
modified JJ O
gel NN O
electrophoresis NN O
DNA NNP O
binding NN O
assay NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
a DT O
human JJ B-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( O
IgNF NNP B-Gene
- : I-Gene
A NN I-Gene
) ) O
that WDT O
binds VBZ O
to TO O
DNA VB B-Gene
sequences NNS I-Gene
in IN O
the DT O
upstream JJ B-Gene
regions NNS I-Gene
of IN O
both DT O
the DT O
mouse NN B-Gene
heavy JJ I-Gene
and CC I-Gene
kappa JJ I-Gene
light JJ I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
promoters NNS I-Gene
and CC O
also RB O
to TO O
the DT O
mouse NN B-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
enhancer NN I-Gene
. . O

This DT O
sequence NN O
- : O
specific JJ O
binding NN O
is VBZ O
probably RB O
mediated VBN O
by IN O
a DT O
highly RB O
conserved VBN O
sequence NN O
motif NN O
, , O
ATTTGCAT NNP O
, , O
present NN O
in IN O
all DT O
three CD O
transcriptional JJ B-Gene
elements NNS I-Gene
. . O

Interestingly RB O
, , O
a DT O
factor NN O
showing VBG O
similar JJ O
binding NN O
specificity NN O
to TO O
IgNF NNP B-Gene
- : I-Gene
A DT I-Gene
is VBZ O
also RB O
present JJ O
in IN O
human JJ O
HeLa NNP O
cells NNS O
. . O

The DT O
new JJ O
world NN O
primates VBZ O
as IN O
animal JJ O
models NNS O
of IN O
glucocorticoid JJ O
resistance NN O
. . O

Many JJ O
New NNP O
World NNP O
primate NN O
species NNS O
have VBP O
greatly RB O
increased VBN O
plasma NN O
cortisol NN O
concentrations NNS O
, , O
decreased VBD O
plasma NN O
cortisol NN O
binding VBG O
globulin NN O
capacity NN O
and CC O
affinity NN O
, , O
marked VBD O
resistance NN O
of IN O
the DT O
hypothalamic JJ O
- : O
pituitary JJ O
- : O
adrenal JJ O
axis NN O
to TO O
suppression NN O
by IN O
dexamethasone NN O
, , O
and CC O
no DT O
biological JJ O
evidence NN O
of IN O
glucocorticoid JJ O
excess NN O
. . O

These DT O
primates NNS O
also RB O
have VBP O
high JJ O
levels NNS O
of IN O
circulating VBG O
progesterone NN O
, , O
estrogen NN O
, , O
mineralocorticoid NN O
, , O
androgen NN O
and CC O
vitamin NN O
D NNP O
. . O

The DT O
glucocorticoid NN O
target NN O
tissues NNS O
that WDT O
have VBP O
been VBN O
examined VBN O
( ( O
circulating VBG O
mononuclear NN O
lymphocytes NNS O
and CC O
cultured VBD O
skin JJ O
fibroblasts NNS O
) ) O
have VBP O
normal JJ O
concentrations NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
with IN O
decreased JJ O
affinity NN O
for IN O
dexamethasone NN O
. . O

Transformation NN O
of IN O
B NNP O
- : O
lymphocytes VBZ O
with IN O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
leads VBZ O
to TO O
glucocorticoid VB B-Gene
receptor NN I-Gene
induction NN O
that WDT O
is VBZ O
less JJR O
than IN O
that DT O
observed VBD O
with IN O
cells NNS O
from IN O
Old NNP O
World NNP O
primates VBZ O
. . O

The DT O
receptor NN O
in IN O
these DT O
cells NNS O
has VBZ O
a DT O
low JJ O
affinity NN O
for IN O
dexamethasone NN O
. . O

The DT O
low JJ O
affinity NN O
leads VBZ O
to TO O
an DT O
increased VBN O
loss NN O
of IN O
specific JJ O
bound NN O
ligand NN O
during IN O
thermal JJ O
activation NN O
. . O

Meroreceptor NNP O
generation NN O
is VBZ O
normal JJ O
. . O

The DT O
molecular JJ O
weight NN O
of IN O
the DT O
receptor NN O
, , O
determined VBN O
by IN O
SDS NNP O
- : O
PAGE NN O
, , O
is VBZ O
similar JJ O
to TO O
that DT O
of IN O
Old NNP O
World NNP O
primates VBZ O
( ( O
approximately RB O
92 CD O
, , O
0 CD O
) ) O
and CC O
the DT O
activation NN O
pattern NN O
per IN O
se NN O
, , O
examined VBN O
in IN O
vitro NN O
by IN O
heating VBG O
cytosol NN O
and CC O
performing VBG O
phosphocellulose JJ O
chromatography NN O
, , O
appears VBZ O
similar JJ O
to TO O
that DT O
of IN O
human JJ O
controls NNS O
. . O

The DT O
ratios NNS O
of IN O
nuclear JJ O
to TO O
cytosolic VB B-Gene
hormone CD I-Gene
- : I-Gene
receptor NN I-Gene
- : I-Gene
complexes NNS I-Gene
and CC O
of IN O
cytosolic JJ O
activated VBN O
to TO O
unactivated JJ B-Gene
receptor NN I-Gene
complexes NNS I-Gene
in IN O
intact JJ O
cells NNS O
are VBP O
similar JJ O
to TO O
Old NNP O
World NNP O
primates VBZ O
. . O

Results NNS O
from IN O
mixing VBG O
studies NNS O
do VBP O
not RB O
support VB O
the DT O
hypothesis NN O
that IN O
a DT O
binding NN O
inhibitor NN O
( ( O
s JJ O
) ) O
or CC O
a DT O
deficient JJ O
cytosolic JJ O
positive JJ O
modifier NN O
( ( O
s JJ O
) ) O
of IN O
binding VBG O
underlies NNS O
the DT O
findings NNS O
in IN O
these DT O
primates NNS O
. . O

The DT O
New NNP O
World NNP O
primates VBZ O
, , O
unlike IN O
men NNS O
with IN O
the DT O
syndrome NN O
of IN O
primary JJ O
cortisol NN O
resistance NN O
, , O
have VBP O
compensated VBN O
for IN O
their PRP$ O
condition NN O
with IN O
intra JJ O
- : O
adrenal JJ O
and CC O
mineralocorticoid JJ O
receptor NN O
adaptations NNS O
. . O

Thus RB O
, , O
unlike IN O
Old NNP O
World NNP O
primates VBZ O
, , O
cortisol NN O
in IN O
New NNP O
World NNP O
primates VBZ O
has VBZ O
only RB O
weak JJ O
sodium NN O
- : O
retaining NN O
potency NN O
because IN O
the DT O
aldosterone NN B-Gene
receptor NN I-Gene
has VBZ O
a DT O
low JJ O
affinity NN O
for IN O
cortisol NN O
. . O

The DT O
common JJ O
element NN O
that WDT O
would MD O
explain VB O
the DT O
apparent JJ O
resistance NN O
to TO O
six CD O
steroid JJ O
hormones NNS O
in IN O
New NNP O
World NNP O
primates VBZ O

Acetylation NN O
and CC O
modulation NN O
of IN O
erythroid NN B-Gene
Kruppel NNP I-Gene
- : I-Gene
like IN I-Gene
factor NN I-Gene
( ( O
EKLF NNP B-Gene
) ) O
activity NN O
by IN O
interaction NN O
with IN O
histone NN B-Gene
acetyltransferases NNS I-Gene
. . O

Erythroid NNP B-Gene
Kruppel NNP I-Gene
- : I-Gene
like IN I-Gene
factor NN I-Gene
( ( O
EKLF NNP B-Gene
) ) O
is VBZ O
a DT O
red JJ B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
transcriptional JJ I-Gene
activator NN I-Gene
that WDT O
is VBZ O
crucial JJ O
for IN O
consolidating VBG O
the DT O
switch NN O
to TO O
high JJ O
levels NNS O
of IN O
adult NN O
beta SYM O
- : O
globin JJ O
expression NN O
during IN O
erythroid JJ O
ontogeny NN O
. . O

EKLF NNP B-Gene
is VBZ O
required VBN O
for IN O
integrity NN O
of IN O
the DT O
chromatin NN O
structure NN O
at IN O
the DT O
beta NN B-Gene
- : I-Gene
like IN I-Gene
globin NN I-Gene
locus NN I-Gene
, , O
and CC O
it PRP O
interacts VBZ O
with IN O
a DT O
positive JJ B-Gene
- : I-Gene
acting VBG I-Gene
factor NN I-Gene
in IN O
vivo NN O
. . O

We PRP O
find VBP O
that DT O
EKLF NNP B-Gene
is VBZ O
an DT O
acetylated JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
and CC O
that IN O
it PRP O
interacts VBZ O
in IN O
vivo NN O
with IN O
CBP NNP B-Gene
, , O
p300 NN B-Gene
, , O
and CC O
P NNP B-Gene
/ NNP I-Gene
CAF NNP I-Gene
. . O

However RB O
, , O
its PRP$ O
interactions NNS O
with IN O
these DT O
histone NN B-Gene
acetyltransferases NNS I-Gene
are VBP O
not RB O
equivalent JJ O
, , O
as IN O
CBP NNP B-Gene
and CC O
p300 NN B-Gene
, , O
but CC O
not RB O
P NNP B-Gene
/ NNP I-Gene
CAF NNP I-Gene
, , O
utilize JJ O
EKLF NNP B-Gene
as IN O
a DT O
substrate NN O
for IN O
in IN O
vitro JJ O
acetylation NN O
within IN O
its PRP$ O
trans NNS O
- : O
activation NN O
region NN O
. . O

The DT O
functional JJ O
effects NNS O
of IN O
these DT O
interactions NNS O
are VBP O
that IN O
CBP NNP B-Gene
and CC O
p300 NN B-Gene
, , O
but CC O
not RB O
P NNP B-Gene
/ NNP I-Gene
CAF NNP I-Gene
, , O
enhance NN O
EKLF NNP B-Gene
' POS O
s JJ O
transcriptional JJ O
activation NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
in IN O
erythroid JJ O
cells NNS O
. . O

These DT O
results NNS O
establish VB O
EKLF NNP B-Gene
as IN O
a DT O
tissue NN B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
undergoes VBZ O
post RBS O
- : O
translational JJ O
acetylation NN O
and CC O
suggest VB O
a DT O
mechanism NN O
by IN O
which WDT O
EKLF NNP B-Gene
is VBZ O
able JJ O
to TO O
alter VB O
chromatin NN O
structure NN O
and CC O
induce VB O
beta SYM O
- : O
globin NN O
expression NN O
within IN O
the DT O
beta NN B-Gene
- : I-Gene
like IN I-Gene
globin NN I-Gene
cluster NN I-Gene
. . O

Recognition NN O
of IN O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
type NN I-Gene
2 CD I-Gene
tegument NN I-Gene
proteins NNS I-Gene
by IN O
CD4 NNP O
T NNP O
cells NNS O
infiltrating VBG O
human JJ O
genital JJ O
herpes NNS O
lesions NNS O
. . O

The DT O
local JJ O
cellular JJ O
immune NN O
response NN O
to TO O
herpes VB O
simplex JJ O
virus NN O
( ( O
HSV NNP O
) ) O
is VBZ O
important JJ O
in IN O
the DT O
control NN O
of IN O
recurrent NN O
HSV NNP O
infection NN O
. . O

The DT O
antiviral JJ O
functions NNS O
of IN O
infiltrating VBG O
CD4 NNP O
- : O
bearing NN O
T NNP O
cells NNS O
may MD O
include VB O
cytotoxicity NN O
, , O
inhibition NN O
of IN O
viral JJ O
growth NN O
, , O
lymphokine JJ O
secretion NN O
, , O
and CC O
support NN O
of IN O
humoral JJ O
and CC O
CD8 NNP O
responses NNS O
. . O

The DT O
antigens NNS O
recognized VBN O
by IN O
many JJ O
HSV NNP O
- : O
specific JJ O
CD4 NNP O
T NNP O
cells NNS O
localizing VBG O
to TO O
genital VB O
HSV NNP O
- : O
2 CD O
lesions NNS O
are VBP O
unknown JJ O
. . O

T NNP O
cells NNS O
recognizing VBG O
antigens NNS O
encoded VBD O
within IN O
map JJ O
units NNS O
0 CD O
. . O
67 CD O
to TO O
0 CD O
. . O
73 CD O
of IN O
HSV NNP B-Gene
DNA NNP I-Gene
are VBP O
frequently RB O
recovered VBN O
from IN O
herpetic JJ O
lesions NNS O
. . O

Expression NN O
cloning VBG O
with IN O
this DT O
region NN O
of IN O
DNA NN O
now RB O
shows VBZ O
that IN O
tegument NN B-Gene
protein NN I-Gene
VP22 NNP B-Gene
and CC O
the DT O
viral JJ B-Gene
dUTPase NN I-Gene
, , O
encoded VBN O
by IN O
genes NNS B-Gene
UL49 NNP I-Gene
and CC I-Gene
UL50 NNP I-Gene
, , O
respectively RB O
, , O
are VBP O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
antigens NNS I-Gene
. . O

Separate JJ O
epitopes NNS B-Gene
in IN O
VP22 NNP B-Gene
were VBD O
defined VBN O
for IN O
T NNP O
- : O
cell NN O
clones NNS O
from IN O
each DT O
of IN O
three CD O
patients NNS O
. . O

Reactivity NN O
with IN O
the DT O
tegument NN B-Gene
protein NN I-Gene
encoded VBN O
by IN O
UL21 NNP B-Gene
was VBD O
identified VBN O
for IN O
an DT O
additional JJ O
patient NN O
. . O

Three CD O
new JJ O
epitopes NNS O
were VBD O
identified VBN O
in IN O
VP16 NNP B-Gene
, , O
a DT O
tegument NN B-Gene
protein NN I-Gene
associated VBN O
with IN O
VP22 NNP B-Gene
. . O

Some DT O
tegument NN O
- : O
specific JJ O
CD4 NNP O
T NNP O
- : O
cell NN O
clones NNS O
exhibited VBD O
cytotoxic JJ O
activity NN O
against IN O
HSV NNP O
- : O
infected JJ O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
herpes NNS B-Gene
simplex JJ I-Gene
tegument NN I-Gene
proteins NNS I-Gene
are VBP O
processed VBN O
for IN O
antigen NN O
presentation NN O
in IN O
vivo NN O
and CC O
are VBP O
possible JJ O
candidate NN O
compounds NNS O
for IN O
herpes NNS O
simplex JJ O
vaccines NNS O
. . O

Fibrinogen NNP B-Gene
activates VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
mononuclear JJ O
phagocytes NNS O
. . O

Adhesion NN O
to TO O
extracellular JJ O
matrices NNS O
is VBZ O
known VBN O
to TO O
modulate VB O
leukocyte JJ O
activation NN O
, , O
although IN O
the DT O
mechanisms NNS O
are VBP O
not RB O
fully RB O
understood JJ O
. . O

Mononuclear JJ O
phagocytes NNS O
are VBP O
exposed VBN O
to TO O
fibrinous JJ O
provisional JJ O
matrix NN O
throughout IN O
migration NN O
into IN O
inflammatory JJ O
foci NN O
, , O
so IN O
this DT O
study NN O
was VBD O
undertaken VBN O
to TO O
determine VB O
whether IN O
fibrinogen NN O
triggers NNS O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

U937 NNP O
cells NNS O
differentiated VBN O
with IN O
PMA NNP O
in IN O
nonadherent JJ O
culture NN O
were VBD O
shown VBN O
to TO O
express VB O
two CD O
fibrinogen NN B-Gene
- : I-Gene
binding NN I-Gene
integrins NNS I-Gene
, , O
predominately RB O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
, , O
and CC O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
CD11c NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
. . O

Cells NNS O
stimulated VBN O
with IN O
fibrinogen NN B-Gene
( ( O
10 CD O
- : O
100 CD O
microg NN O
/ NNP O
ml NN O
) ) O
/ VBZ O
Mn2 NNP O
+ NNP O
( ( O
50 CD O
microM NN O
) ) O
for IN O
2 CD O
h NNS O
were VBD O
examined VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
minimal JJ O
in IN O
unstimulated JJ O
cells NNS O
, , O
was VBD O
substantially RB O
up RP O
- : O
regulated VBN O
by IN O
fibrinogen NN B-Gene
. . O

Fibrinogen NNP B-Gene
also RB O
caused VBD O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
not RB O
SP1 NNP B-Gene
or CC O
cAMP JJ B-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( I-Gene
CREB NNP I-Gene
) ) I-Gene
factors NNS I-Gene
. . O

Blocking VBG O
mAbs NN B-Gene
against IN O
CD18 NNP B-Gene
and CC O
CD11b NNP B-Gene
abrogated VBD O
fibrinogen SYM B-Gene
- : O
induced VBN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

To TO O
determine VB O
the DT O
effects NNS O
on IN O
transcriptional JJ O
regulation NN O
, , O
U937 NNP O
cells NNS O
were VBD O
transfected VBN O
with IN O
a DT O
plasmid NN O
containing VBG O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
enhancer NN I-Gene
( ( O
bearing VBG O
two CD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
sites VBZ I-Gene
) ) O
coupled VBN O
to TO O
a DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( I-Gene
CAT NNP I-Gene
) ) I-Gene
reporter NN I-Gene
. . O

Cells NNS O
were VBD O
subsequently RB O
stimulated VBN O
with IN O
1 CD O
) ) O
PMA NNP O
for IN O
24 CD O
h NN O
, , O
inducing VBG O
CAT NNP O
activity NN O
by IN O
2 CD O
. . O
6 CD O
- : O
fold NN O
, , O
2 CD O
) ) O
fibrinogen NN B-Gene
/ NNP O
Mn2 NNP O
+ NNP O
for IN O
2 CD O
h NN O
, , O
inducing VBG O
CAT NNP O
activity NN O
by IN O
3 CD O
. . O
2 CD O
- : O
fold NN O
, , O
or CC O
3 CD O
) ) O
costimulation NN O
with IN O
fibrinogen NN B-Gene
and CC O
PMA NNP O
, , O
inducing VBG O
5 CD O
. . O
7 CD O
- : O
fold VBD O
the DT O
CAT NNP O
activity NN O
induced VBN O
by IN O
PMA NNP O
alone RB O
. . O

We PRP O
conclude VBP O
that IN O
contact NN O
with IN O
fibrinogen NN B-Gene
- : I-Gene
derived JJ I-Gene
proteins NNS I-Gene
may MD O
contribute VB O
to TO O
mononuclear VB O
phagocyte JJ O
activation NN O
by IN O
signaling VBG O
through IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
, , O
resulting VBG O
in IN O
selective JJ O
activation NN O
of IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
factors NNS I-Gene
, , O
including VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Peripheral JJ O
blood NN O
T NNP O
cells NNS O
and CC O
monocytes NNS O
and CC O
B NNP O
cell NN O
lines NNS O
derived VBN O
from IN O
patients NNS O
with IN O
lupus JJ O
express NN O
estrogen NN O
receptor NN O
transcripts NNS O
similar JJ O
to TO O
those DT O
of IN O
normal JJ O
cells NNS O
. . O

OBJECTIVE NN O
: : O
To TO O
identify VB O
and CC O
characterize VB O
estrogen NN B-Gene
receptor NN I-Gene
( ( I-Gene
ER NNP I-Gene
) ) I-Gene
transcripts NNS I-Gene
expressed VBN O
in IN O
immune JJ O
cells NNS O
of IN O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
( ( O
SLE NNP O
) ) O
and CC O
healthy JJ O
donors NNS O
. . O

METHODS NN O
: : O
Peripheral JJ O
blood NN O
monocytes NNS O
and CC O
T NNP O
cells NNS O
were VBD O
prepared VBN O
from IN O
patients NNS O
with IN O
SLE NNP O
( ( O
n JJ O
= NNP O
6 CD O
) ) O
and CC O
healthy JJ O
donors NNS O
( ( O
n JJ O
= NNP O
8 CD O
) ) O
. . O

T NNP O
cells NNS O
were VBD O
separated VBN O
into IN O
CD4 NNP O
and CC O
CD8 NNP O
. . O

Some DT O
monocytes NNS O
and CC O
T NNP O
cells NNS O
were VBD O
stimulated VBN O
with IN O
estradiol NN O
, , O
PMA NNP O
, , O
and CC O
ionomycin NN O
. . O

Epstein NNP O
- : O
Barr NNP O
virus SYM O
- : O
transformed VBN O
B NNP O
cell NN O
lines NNS O
( ( O
n JJ O
= NNP O
7 CD O
) ) O
and CC O
B NNP O
cell NN O
hybridomas NN O
( ( O
n JJ O
= NNP O
2 CD O
) ) O
established VBN O
from IN O
patients NNS O
with IN O
SLE NNP O
and CC O
a DT O
healthy JJ O
individual NN O
were VBD O
used VBN O
as IN O
a DT O
B NNP O
cell NN O
source NN O
. . O

These DT O
cells NNS O
were VBD O
examined VBN O
for IN O
ER NNP B-Gene
mRNA NN I-Gene
by IN O
reverse JJ O
transcription NN O
nested VBD O
polymerase NN O
chain NN O
reaction NN O
. . O

Amplified NNP O
cDNA NN B-Gene
were VBD O
sequenced VBN O
by IN O
standard JJ O
methods NNS O
. . O

RESULTS NN O
: : O
In IN O
all DT O
cells NNS O
tested VBN O
, , O
ER NNP B-Gene
mRNA NN I-Gene
was VBD O
expressed VBN O
without IN O
prior RB O
in IN O
vitro JJ O
stimulation NN O
. . O

Partial JJ O
sequences NNS O
from IN O
exons NNS B-Gene
1 CD I-Gene
- : I-Gene
8 CD I-Gene
were VBD O
nearly RB O
identical JJ O
to TO O
the DT O
published VBN O
sequence NN O
of IN O
the DT O
human JJ B-Gene
ER NNP I-Gene
mRNA NN I-Gene
. . O

There EX O
were VBD O
no DT O
notable JJ O
differences NNS O
in IN O
the DT O
ER NNP B-Gene
transcripts NNS I-Gene
between IN O
patients NNS O
and CC O
healthy JJ O
controls NNS O
. . O

Variant NNP O
receptor NN O
transcripts NNS O
lacking VBG O
exon JJ B-Gene
5 CD I-Gene
or CC O
exon VB B-Gene
7 CD I-Gene
, , O
which WDT O
encodes VBZ O
the DT O
hormone NN B-Gene
binding NN I-Gene
domain NN I-Gene
, , O
were VBD O
identified VBN O
in IN O
the DT O
majority NN O
of IN O
the DT O
cells NNS O
. . O

Precise NNP O
deletion NN O
of IN O
the DT O
exons NNS O
suggests VBZ O
that IN O
they PRP O
are VBP O
alternatively RB O
spliced JJ O
transcripts NNS O
. . O

Whether IN O
the DT O
detected VBN O
transcripts NNS O
are VBP O
translated VBN O
into IN O
functional JJ B-Gene
receptor NN I-Gene
proteins NNS I-Gene
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

In IN O
vitro JJ O
stimulation NN O
did VBD O
not RB O
affect VB O
ER NNP B-Gene
mRNA JJ I-Gene
expression NN O
. . O

The DT O
presence NN O
of IN O
variants NNS O
did VBD O
not RB O
correlate VB O
with IN O
disease NN O
activity NN O
or CC O
medication NN O
. . O

CONCLUSION NN O
: : O
Monocytes NNS O
, , O
T NNP O
cells NNS O
, , O
and CC O
B NNP O
cells NNS O
in IN O
patients NNS O
express JJ O
transcripts NNS O
of IN O
the DT O
normal JJ O
wild JJ B-Gene
type NN I-Gene
ER NNP I-Gene
and CC O
the DT O
hormone NN B-Gene
binding VBG I-Gene
domain NN I-Gene
variants NNS I-Gene
in IN O
vivo NN O
. . O

DNA NN O
damaging VBG O
agents NNS O
induce JJ O
expression NN O
of IN O
Fas NNP B-Gene
ligand NN I-Gene
and CC O
subsequent JJ O
apoptosis NN O
in IN O
T NNP O
lymphocytes VBZ O
via IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Apoptosis NN O
induced VBN O
by IN O
DNA NNP O
damage NN O
and CC O
other JJ O
stresses NNS O
can MD O
proceed VB O
via IN O
expression NN O
of IN O
Fas NNP B-Gene
ligand NN I-Gene
( ( O
FasL NNP B-Gene
) ) O
and CC O
ligation NN O
of IN O
its PRP$ O
receptor NN O
, , O
Fas NNP O
( ( O
CD95 NNP O
) ) O
. . O

We PRP O
report VBP O
that DT O
activation NN O
of IN O
the DT O
two CD O
transcription NN B-Gene
factors NNS I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
crucially RB O
involved VBN O
in IN O
FasL NNP B-Gene
expression NN O
induced VBN O
by IN O
etoposide NN O
, , O
teniposide NN O
, , O
and CC O
UV NNP O
irradiation NN O
. . O

A DT O
nondegradable JJ B-Gene
mutant NN I-Gene
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
blocked VBD O
both DT O
FasL NNP B-Gene
expression NN O
and CC O
apoptosis NN O
induced VBN O
by IN O
DNA NNP O
damage NN O
but CC O
not RB O
Fas NNP O
ligation NN O
. . O

These DT O
stimuli NNS O
also RB O
induced VBD O
the DT O
stress NN O
- : O
activated JJ O
kinase NN O
pathway NN O
( ( O
SAPK NNP O
/ NNP O
JNK NNP O
) ) O
, , O
which WDT O
was VBD O
required VBN O
for IN O
the DT O
maximal JJ O
induction NN O
of IN O
apoptosis NN O
. . O

A DT O
1 CD O
. . O
2 CD O
kb JJ O
FasL NNP B-Gene
promoter NN I-Gene
responded VBD O
to TO O
DNA NNP O
damage NN O
, , O
as RB O
well RB O
as IN O
coexpression NN O
with IN O
p65 JJ B-Gene
Rel NNP I-Gene
or CC O
Fos NNP B-Gene
/ NNP I-Gene
Jun NNP I-Gene
. . O

Mutations NNS O
in IN O
the DT O
relevant JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
eliminated VBD O
these DT O
responses NNS O
. . O

Thus RB O
, , O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
contributes NNS O
to TO O
stress VB O
- : O
induced JJ O
apoptosis NN O
via IN O
the DT O
expression NN O
of IN O
FasL NNP B-Gene
. . O

A DT O
small JJ O
, , O
nonpeptidyl JJ O
mimic NN O
of IN O
granulocyte NN B-Gene
- : I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
[ NNP O
see VBP O
commetns JJ O
] NN O

A DT O
nonpeptidyl JJ O
small JJ O
molecule NN O
SB NNP O
247464 CD O
, , O
capable JJ O
of IN O
activating VBG O
granulocyte JJ B-Gene
- : I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
signal NN O
transduction NN O
pathways NNS O
, , O
was VBD O
identified VBN O
in IN O
a DT O
high JJ O
- : O
throughput NN O
assay VBP O
in IN O
cultured JJ O
cells NNS O
. . O

Like IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
, , O
SB NNP O
247464 CD O
induced VBD O
tyrosine JJ O
phosphorylation NN O
of IN O
multiple JJ B-Gene
signaling VBG I-Gene
proteins NNS I-Gene
and CC O
stimulated VBD O
primary JJ O
murine NN O
bone NN O
marrow NN O
cells NNS O
to TO O
form VB O
granulocytic JJ O
colonies NNS O
in IN O
vitro NN O
. . O

It PRP O
also RB O
elevated VBD O
peripheral JJ O
blood NN O
neutrophil NN O
counts NNS O
in IN O
mice NN O
. . O

The DT O
extracellular JJ O
domain NN O
of IN O
the DT O
murine NN B-Gene
G NNP I-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
was VBD O
required VBN O
for IN O
the DT O
activity NN O
of IN O
SB NNP O
247464 CD O
, , O
suggesting VBG O
that IN O
the DT O
compound NN O
acts VBZ O
by IN O
oligomerizing VBG B-Gene
receptor NN I-Gene
chains NNS I-Gene
. . O

The DT O
results NNS O
indicate VBP O
that IN O
a DT O
small JJ O
molecule NN O
can MD O
activate VB O
a DT O
receptor NN O
that WDT O
normally RB O
binds VBZ O
a DT O
relatively RB O
large JJ O
protein NNS O
ligand VBP O
. . O

Minimal JJ O
residual JJ O
disease NN O
in IN O
acute JJ O
myelogenous JJ O
leukemia NN O
with IN O
PML NNP B-Gene
/ NNP I-Gene
RAR NNP I-Gene
alpha NN I-Gene
or CC O
AML1 NNP B-Gene
/ NNP I-Gene
ETO NNP I-Gene
mRNA NN I-Gene
and CC O
phenotypic NN O
analysis NN O
of IN O
possible JJ O
T NNP O
and CC O
natural JJ O
killer NN O
cells NNS O
in IN O
bone NN O
marrow NN O
. . O

Here RB O
we PRP O
studied VBD O
minimal JJ O
residual JJ O
disease NN O
( ( O
MRD NNP O
) ) O
of IN O
patients NNS O
with IN O
acute JJ O
myeloid NN O
leukemia NN O
( ( O
AML NNP O
) ) O
who WP O
have VBP O
PML NNP B-Gene
/ NNP I-Gene
RAR NNP I-Gene
alpha NN I-Gene
or CC O
AML1 NNP B-Gene
/ NNP I-Gene
ETO NNP I-Gene
as RB O
well RB O
as IN O
the DT O
phenotypic NN O
analysis NN O
of IN O
lymphocyte JJ O
subsets NNS O
involved VBN O
in IN O
antitumor NN O
immunity NN O
. . O

Eight CD O
patients NNS O
in IN O
long JJ O
- : O
term NN O
( ( O
LT NNP O
; : O
3 CD O
to TO O
15 CD O
years NNS O
) ) O
and CC O
15 CD O
patients NNS O
in IN O
short JJ O
- : O
term NN O
( ( O
ST NNP O
; : O
up RB O
to TO O
3 CD O
years NNS O
) ) O
remission NN O
were VBD O
studied VBN O
. . O

Using VBG O
the DT O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
) ) O
assay VBP O
, , O
the DT O
limit NN O
of IN O
detection NN O
was VBD O
10 CD O
( ( O
- : O
5 CD O
) ) O
to TO O
10 CD O
( ( O
- : O
6 CD O
) ) O
for IN O
PML NNP B-Gene
/ NNP I-Gene
RAR NNP I-Gene
alpha NN I-Gene
transcript NN I-Gene
and CC O
10 CD O
( ( O
- : O
4 CD O
) ) O
to TO O
10 CD O
( ( O
- : O
5 CD O
) ) O
for IN O
the DT O
AML1 NNP B-Gene
/ NNP I-Gene
ETO NNP I-Gene
transcript NN I-Gene
. . O

Simultaneously RB O
, , O
T NNP O
lymphocyte VBZ O
subsets NNS O
and CC O
NK NNP O
cells NNS O
from IN O
the DT O
peripheral JJ O
blood NN O
( ( O
PB NNP O
) ) O
and CC O
bone NN O
marrow NN O
( ( O
BM NNP O
) ) O
were VBD O
investigated VBN O
by IN O
flow JJ O
cytometric JJ O
analysis NN O
. . O

Four CD O
of IN O
the DT O
eight CD O
patients NNS O
in IN O
LT NNP O
and CC O
7 CD O
of IN O
the DT O
15 CD O
patients NNS O
in IN O
ST NNP O
remission NN O
were VBD O
MRD NNP O
- : O
positive JJ O
. . O

Although IN O
all DT O
MRD NNP O
- : O
positive JJ O
patients NNS O
in IN O
LT NNP O
remission NN O
are VBP O
still RB O
until IN O
now RB O
event NN O
- : O
free JJ O
, , O
3 CD O
of IN O
the DT O
7 CD O
MRD NNP O
- : O
positive JJ O
( ( O
MRD NNP O
+ NNP O
) ) O
patients NNS O
in IN O
ST NNP O
remission NN O
soon RB O
relapsed VBD O
. . O

The DT O
total JJ O
populations NNS O
of IN O
CD4 NNP B-Gene
+ NNP O
, , O
CD8 NNP B-Gene
+ NNP O
and CC O
CD56 NNP B-Gene
+ NNP O
[ NNP O
possible JJ O
T NNP O
- : O
cell NN O
and CC O
natural JJ O
killer NN O
( ( O
T NNP O
/ NNP O
NK NNP O
) ) O
populations NNS O
] VBP O
in IN O
the DT O
BM NNP O
of IN O
ST NNP O
patients NNS O
and CC O
MRD NNP O
+ NNP O
/ NNP O
LT NNP O
patients NNS O
were VBD O
significantly RB O
( ( O
p JJ O
< NNP O
. . O
1 CD O
) ) O
low NN O
. . O

The DT O
CD8 NNP O
+ NNP O
CD28 NNP O
+ NNP O
population NN O
showed VBD O
the DT O
same JJ O
tendency NN O
( ( O
p JJ O
< NNP O
. . O
1 CD O
- : O
. . O
2 CD O
) ) O
. . O

The DT O
T NNP O
/ NNP O
NK NNP O
subsets NNS O
in IN O
the DT O
BM NNP O
of IN O
MRD NNP O
- : O
negative JJ O
( ( O
MRD NNP O
- : O
) ) O
LT NNP O
( ( O
MRD NNP O
- : O
/ NN O
LT NNP O
) ) O
patients NNS O
showed VBD O
similar JJ O
numbers NNS O
of IN O
cells NNS O
as IN O
normal JJ O
volunteers NNS O
. . O

Basically RB O
, , O
the DT O
total JJ O
percentage NN O
of IN O
the DT O
CD4 NNP O
+ NNP O
, , O
CD8 NNP O
+ NNP O
and CC O
CD56 NNP O
+ NNP O
cell NN O
populations NNS O
in IN O
the DT O
BM NNP O
was VBD O
increased VBN O
and CC O
in IN O
the DT O
following JJ O
order NN O
: : O
MRD NNP O
- : O
/ NN O
LT NNP O
patients NNS O
, , O
normal JJ O
volunteers NNS O
, , O
MRD NNP O
+ NNP O
/ NNP O
LT NNP O
patients NNS O
and CC O
MRD NNP O
+ NNP O
or CC O
- : O
/ JJ O
ST NNP O
patients NNS O
. . O

The DT O
percentages NNS O
of IN O
the DT O
T NNP O
/ NNP O
NK NNP O
- : O
cell NN O
subsets NNS O
in IN O
the DT O
PB NNP O
were VBD O
not RB O
significantly RB O
different JJ O
among IN O
these DT O
groups NNS O
. . O

Thus RB O
, , O
the DT O
difference NN O
of IN O
the DT O
possible JJ O
T NNP O
/ NNP O
NK NNP O
- : O
cell NN O
phenotype NN O
in IN O
the DT O
BM NNP O
may MD O
strongly RB O
influence VB O
clinical JJ O
and CC O
molecular JJ O
remission NN O
. . O

These DT O
results NNS O
still RB O
remain VBP O
to TO O
be VB O
confirmed VBN O
by IN O
further JJ O
studies NNS O
of IN O
the DT O
functional JJ O
anti NN O
- : O
tumor NN O
immunity NN O
of IN O
T NNP O
/ NNP O
NK NNP O
cells NNS O
of IN O
AML NNP O
in IN O
remission NN O
. . O

Mycobacterium NNP O
tuberculosis NN O
mannose VBD O
- : O
capped VBN O
lipoarabinomannan NN O
can MD O
induce VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
dependent JJ O
activation NN O
of IN O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type VBD I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

Tuberculosis NN O
has VBZ O
emerged VBN O
as IN O
an DT O
epidemic JJ O
, , O
extended VBN O
by IN O
the DT O
large JJ O
number NN O
of IN O
individuals NNS O
infected VBN O
with IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
. . O

The DT O
major JJ O
goal NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
whether IN O
the DT O
mycobacterial NN O
cell NN O
wall NN O
component NN O
mannose SYM O
- : O
capped VBN O
lipoarabinomannan NN O
( ( O
ManLAM NNP O
) ) O
of IN O
Mycobacterium NNP O
tuberculosis NN O
( ( O
M NNP O
. . O
tuberculosis NN O
) ) O
could MD O
activate VB O
transcription NN O
of IN O
HIV NNP O
- : O
1 CD O
in IN O
T NNP O
cells NNS O
with IN O
the DT O
use NN O
of IN O
an DT O
in IN O
vitro NN O
cell NN O
culture NN O
system NN O
. . O

These DT O
experiments NNS O
are VBP O
of IN O
prime JJ O
importance NN O
considering VBG O
that IN O
CD4 NNP B-Gene
- : O
expressing VBG O
T NNP O
lymphocytes VBZ O
represent VBP O
the DT O
major JJ O
virus NN O
reservoir NN O
in IN O
the DT O
peripheral JJ O
blood NN O
of IN O
infected JJ O
individuals NNS O
. . O

Using VBG O
the DT O
1G5 CD O
cell NN O
line NN O
harbouring VBG O
the DT O
luciferase NN O
reporter NN O
gene NN O
under IN O
the DT O
control NN O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
, , O
it PRP O
was VBD O
first RB O
found VBN O
that IN O
culture NN O
protein NN O
filtrates NNS O
( ( O
CFP NNP O
) ) O
from IN O
M NNP O
. . O
tuberculosis NN O
or CC O
purified VBN O
ManLAM NNP O
could MD O
activate VB O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
- : I-Gene
dependent JJ I-Gene
gene NN I-Gene
expression NN O
unlike IN O
similarly RB O
prepared JJ O
CFP NNP O
extracts VBZ O
devoid NN O
of IN O
ManLAM NNP O
. . O

The DT O
implication NN O
of IN O
protein JJ B-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
( ( I-Gene
s NN I-Gene
) ) I-Gene
, , O
protein JJ B-Gene
kinase VBD I-Gene
A DT I-Gene
and CC O
/ NN O
or CC O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
was VBD O
highlighted VBN O
by IN O
the DT O
abrogation NN O
of IN O
the DT O
ManLAM NNP O
- : O
mediated VBD O
activation NN O
of IN O
HIV NNP O
- : O
1 CD O
LTR NNP O
- : O
driven VBN O
gene NN O
expression NN O
using VBG O
herbimycin PDT O
A DT O
and CC O
H7 NNP O
. . O

It PRP O
was VBD O
also RB O
determined VBN O
, , O
using VBG O
electrophoresis NN O
mobility NN O
shift NN O
assays NNS O
, , O
that DT O
M NNP O
. . O
tuberculosis NN O
ManLAM NNP O
led VBD O
to TO O
the DT O
nuclear JJ O
translocation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
. . O

M NNP O
. . O
tuberculosis NN O
ManLAM NNP O
resulted VBD O
in IN O
clear JJ O
induction NN O
of IN O
the DT O
luciferase NN B-Gene
gene NN I-Gene
placed VBN O
under IN O
the DT O
control NN O
of IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
, , I-Gene
but CC I-Gene
not RB I-Gene
the DT I-Gene
kappaB NN I-Gene
- : I-Gene
mutated VBN I-Gene
, , I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
region NN I-Gene
. . O

Finally RB O
, , O
the DT O
ManLAM NNP O
- : O
mediated VBD O
activation NN O
of IN O
HIV NNP O
- : O
1 CD O
LTR NNP O
transcription NN O
was VBD O
found VBN O
to TO O
be VB O
independent JJ O
of IN O
the DT O
autocrine NN O
or CC O
paracrine JJ O
action NN O
of IN O
endogenous JJ B-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
. . O

The DT O
results NNS O
suggest VBP O
that IN O
M NNP O
. . O
tuberculosis NN O
can MD O
upregulate VB O
HIV NNP O
- : O
1 CD O
expression NN O
in IN O
T NNP O
cells NNS O
and CC O
could MD O
thus RB O
have VB O
the DT O
potential JJ O
to TO O
influence VB O
the DT O
pathogenesis NN O
of IN O
HIV NNP O
- : O
1 CD O
infection NN O
. . O

Human NNP B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type VBD I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
quasispecies NNS O
differ VBP O
in IN O
basal NN O
transcription NN O
and CC O
nuclear JJ O
factor NN O
recruitment NN O
in IN O
human JJ O
glial JJ O
cells NNS O
and CC O
lymphocytes NNS O
. . O

The DT O
generation NN O
of IN O
genomic JJ O
diversity NN O
during IN O
the DT O
course NN O
of IN O
infection NN O
has VBZ O
the DT O
potential JJ O
to TO O
affect VB O
all DT O
aspects NNS O
of IN O
HIV NNP O
- : O
1 CD O
replication NN O
, , O
including VBG O
expression NN O
of IN O
the DT O
proviral JJ O
genome NN O
. . O

To TO O
gain VB O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
impact NN O
of IN O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
sequence NN O
diversity NN O
on IN O
LTR NNP B-Gene
- : I-Gene
directed VBD I-Gene
gene NN I-Gene
expression NN O
in IN O
cells NNS O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
( ( O
CNS NNP O
) ) O
and CC O
immune JJ O
system NN O
, , O
we PRP O
amplified VBD O
and CC O
cloned VBD O
LTRs NNP B-Gene
from IN O
proviral JJ O
DNA NNP O
in IN O
HIV NNP O
- : O
1 CD O
- : O
infected JJ O
peripheral JJ O
blood NN O
. . O

Sequence NNP O
analysis NN O
of IN O
nineteen JJ O
LTRs NNP B-Gene
cloned VBD O
from IN O
2 CD O
adult NN O
and CC O
3 CD O
pediatric JJ O
patients NNS O
revealed VBD O
an DT O
average NN O
of IN O
33 CD O
nucleotide JJ O
changes NNS O
( ( O
with IN O
respect NN O
to TO O
the DT O
sequence NN O
of IN O
the DT O
LAI NNP B-Gene
LTR NNP I-Gene
) ) O
within IN O
the DT O
455 CD B-Gene
- : I-Gene
bp NN I-Gene
U3 NNP I-Gene
region NN I-Gene
. . O

Transient JJ O
expression NN O
analyses NNS O
in IN O
cells NNS O
of IN O
neuroglial JJ O
and CC O
lymphocytic JJ O
origin NN O
demonstrated VBD O
that IN O
some DT O
of IN O
these DT O
LTRs NNP B-Gene
had VBD O
activities NNS O
which WDT O
varied VBD O
significantly RB O
from IN O
the DT O
LAI NNP B-Gene
LTR NNP I-Gene
in IN O
U NNP O
- : O
373 CD O
MG NNP O
cells NNS O
( ( O
an DT O
astrocytoma NN O
cell NN O
line NN O
) ) O
as RB O
well RB O
as IN O
in IN O
Jurkat NNP O
cells NNS O
( ( O
a DT O
CD4 NNP O
- : O
positive JJ O
lymphocyte NN O
cell NN O
line NN O
) ) O
. . O

While IN O
LTRs NNP B-Gene
which WDT O
demonstrated VBD O
the DT O
highest JJS O
activities NNS O
in IN O
U NNP O
- : O
373 CD O
MG NNP O
cells NNS O
also RB O
yielded VBD O
high JJ O
activities NNS O
in IN O
Jurkat NNP O
cells NNS O
, , O
the DT O
LTRs NNP B-Gene
were VBD O
generally RB O
more RBR O
active JJ O
in IN O
Jurkat NNP O
cells NNS O
when WRB O
compared VBN O
to TO O
the DT O
LAI NNP B-Gene
LTR NNP I-Gene
. . O

Differences NNS O
in IN O
LTR NNP B-Gene
sequence NN I-Gene
also RB O
resulted VBD O
in IN O
differences NNS O
in IN O
transcription NN O
factor NN O
recruitment NN O
to TO O
cis VB B-Gene
- : I-Gene
acting VBG I-Gene
sites NNS I-Gene
within IN O
the DT O
U3 NNP B-Gene
region NN I-Gene
of IN O
the DT O
LTR NNP B-Gene
, , O
as IN O
demonstrated VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
. . O

In IN O
particular JJ O
, , O
naturally RB O
occurring VBG O
sequence NN O
variation NN O
impacted VBN O
transcription NN B-Gene
factor NN I-Gene
binding VBG O
to TO O
an DT O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
/ NNP O
cAMP NN B-Gene
response NN I-Gene
element NN I-Gene
binding NN I-Gene
( ( O
ATF NNP B-Gene
/ NNP O
CREB NNP B-Gene
) ) O
binding VBG O
site NN O
( ( O
located VBN O
between IN O
the DT O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
distal JJ I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN I-Gene
factor NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
) ) O
that IN O
we PRP O
identified VBD O
in IN O
previous JJ O
studies NNS O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
LTR NNP B-Gene
sequence NN I-Gene
changes NNS O
can MD O
significantly RB O
affect VB O
basal NN O
LTR NNP O
function NN O
and CC O
transcription NN O
factor NN O
recruitment NN O
, , O
which WDT O
may MD O
, , O
in IN O
turn NN O
, , O
alter VBP O
the DT O
course NN O
of IN O
viral JJ O
replication NN O
in IN O
cells NNS O
of IN O
CNS NNP O
and CC O
immune JJ O
system NN O
origin NN O
. . O

HMG NNP B-Gene
box NN I-Gene
containing VBG I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
lymphocyte JJ O
differentiation NN O
. . O

The DT O
identification NN O
of IN O
the DT O
mammalian JJ B-Gene
sex NN I-Gene
- : I-Gene
determining VBG I-Gene
gene NN I-Gene
Sry NNP I-Gene
has VBZ O
led VBN O
to TO O
the DT O
discovery NN O
of IN O
a DT O
large JJ O
family NN O
of IN O
related JJ O
( ( O
' POS O
HMG NNP B-Gene
box NN I-Gene
' '' O
) ) O
transcription NN B-Gene
factors NNS I-Gene
that WDT O
control VBP O
developmental JJ O
events NNS O
in IN O
yeast NN O
, , O
C NNP O
. . O
elegans NNS O
, , O
Drosophila NNP O
and CC O
vertebrates NNS O
. . O

In IN O
lymphocyte JJ O
differentiation NN O
, , O
several JJ O
HMG NNP B-Gene
box NN I-Gene
proteins NNS I-Gene
play VBP O
a DT O
decisive JJ O
role NN O
. . O

Sox NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
important JJ O
for IN O
very RB O
early JJ O
B NNP O
- : O
cell NN O
differentiation NN O
, , O
while IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
/ NN O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
play NN O
a DT O
crucial JJ O
role NN O
in IN O
early JJ O
thymocyte NN O
development NN O
. . O

TCF NNP B-Gene
/ NNP I-Gene
LEF NNP I-Gene
proteins NNS I-Gene
have VBP O
recently RB O
been VBN O
found VBN O
to TO O
constitute VB O
a DT O
downstream JJ O
component NN O
of IN O
the DT O
Wingless NNP O
/ NNP O
Wnt NNP O
signal JJ O
transduction NN O
pathway NN O
. . O

In IN O
flies NNS O
, , O
this DT O
pathway NN O
controls VBZ O
segment NN O
polarity NN O
; : O
in IN O
Xenopus NN O
it PRP O
controls VBZ O
the DT O
definition NN O
of IN O
the DT O
body NN O
axis NN O
. . O

Deregulation NN O
of IN O
the DT O
pathway NN O
occurs VBZ O
in IN O
several JJ O
human JJ O
tumors NNS O
. . O

These DT O
insights NNS O
in IN O
the DT O
molecular JJ O
events NNS O
that WDT O
are VBP O
involved VBN O
in IN O
TCF NNP B-Gene
/ NNP I-Gene
LEF NNP I-Gene
function NN O
in IN O
these DT O
organisms NNS O
may MD O
eventually RB O
lead VB O
to TO O
the DT O
understanding NN O
of IN O
the DT O
function NN O
of IN O
these DT O
HMG NNP B-Gene
box NN I-Gene
proteins NNS I-Gene
in IN O
lymphoid NN O
development NN O

Transcriptional JJ O
regulation NN O
by IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
beta NN I-Gene
in IN O
the DT O
expression NN O
of IN O
the DT O
gene NN O
for IN O
the DT O
MRP14 NNP B-Gene
myeloid NN I-Gene
calcium NN I-Gene
binding VBG I-Gene
protein NN I-Gene
. . O

Transcriptional JJ O
regulation NN O
of IN O
the DT O
gene NN O
for IN O
the DT O
myeloid JJ B-Gene
calcium NN I-Gene
binding VBG I-Gene
protein NN I-Gene
, , O
MRP14 NNP B-Gene
, , O
was VBD O
investigated VBN O
in IN O
human JJ O
monocytic JJ O
leukemia NN O
cell NN O
lines NNS O
. . O

The DT O
MRP14 NNP B-Gene
gene NN I-Gene
was VBD O
not RB O
expressed VBN O
in IN O
monoblastic JJ O
ML NNP O
- : O
1 CD O
cells NNS O
, , O
promonocytic JJ O
U NNP O
- : O
937 CD O
cells NNS O
, , O
or CC O
promyelocytic JJ O
HL NNP O
- : O
60 CD O
cells NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
gene NN O
was VBD O
expressed VBN O
in IN O
monocytic JJ O
THP NNP O
- : O
1 CD O
cells NNS O
and CC O
in IN O
the DT O
HL NNP O
- : O
60 CD O
cells NNS O
treated VBN O
with IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
( ( O
VD3 NNP O
) ) O
. . O

The DT O
level NN O
of IN O
MRP14 NNP B-Gene
in IN O
VD3 NNP O
- : O
treated VBD O
HL NNP O
- : O
60 CD O
cells NNS O
was VBD O
two CD O
- : O
fold NN O
higher JJR O
than IN O
that DT O
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Among IN O
several JJ O
known VBN O
transcription NN B-Gene
factor NN I-Gene
binding VBG I-Gene
motifs NNS I-Gene
, , O
nuclear JJ B-Gene
protein NN I-Gene
( ( I-Gene
s JJ I-Gene
) ) I-Gene
of IN O
VD3 NNP O
- : O
treated VBD O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
THP NNP O
- : O
1 CD O
cells NNS O
bound VBN O
to TO O
the DT O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) I-Gene
- : I-Gene
binding VBG I-Gene
motif NN I-Gene
that WDT O
was VBD O
located VBN O
in IN O
the DT O
upstream JJ B-Gene
region NN I-Gene
of IN O
the DT O
MRP14 NNP B-Gene
gene NN I-Gene
( ( O
- : O
81 CD O
) ) O
, , O
as IN O
evidenced VBN O
by IN O
the DT O
competitive JJ O
gel NN O
mobility NN O
- : O
shift NN O
assay NN O
. . O

An DT O
antibody NN O
for IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha VBZ I-Gene
super JJR O
- : O
shifted VBD O
the DT O
nucleoprotein NN B-Gene
complex NN I-Gene
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
but CC O
not RB O
in IN O
the DT O
VD3 NNP O
- : O
treated VBD O
HL NNP O
- : O
60 CD O
cells NNS O
, , O
whereas IN O
an DT O
antibody NN O
for IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
blocked VBD O
the DT O
formation NN O
of IN O
the DT O
complex NN O
with IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN O
the DT O
HL NNP O
- : O
60 CD O
cells NNS O
but CC O
not RB O
with IN O
that DT O
of IN O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

An DT O
anti JJ B-Gene
- : I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
delta NN I-Gene
antibody NN I-Gene
had VBD O
no DT O
effect NN O
on IN O
the DT O
complex NN O
in IN O
either DT O
cell NN O
. . O

Thus RB O
, , O
it PRP O
was VBD O
concluded VBN O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
beta NN I-Gene
were VBD O
able JJ O
to TO O
bind VB O
to TO O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
motif NN I-Gene
, , O
and CC O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha RB I-Gene
bound VBD O
to TO O
the DT O
motif NN O
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
bound NN O
to TO O
that DT O
in IN O
the DT O
VD3 NNP O
- : O
treated VBD O
HL NNP O
- : O
60 CD O
cells NNS O
. . O

Furthermore RB O
, , O
to TO O
examine VB O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
motif NN I-Gene
, , O
we PRP O
transfected VBD O
several JJ O
constructed JJ O
luciferase NN B-Gene
reporter NN I-Gene
DNAs NNP I-Gene
into IN O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

The DT O
luciferase NN O
activity NN O
of IN O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
motif NN I-Gene
in IN O
HL NNP O
- : O
60 CD O
cells NNS O
was VBD O
increased VBN O
by IN O
VD3 NNP O
treatment NN O
. . O

The DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
motif NN I-Gene
in IN O
the DT O
MRP14 NNP B-Gene
gene NN I-Gene
was VBD O
confirmed VBN O
to TO O
function NN O
as IN O
a DT O
regulatory JJ O
region NN O
in IN O
VD3 NNP O
- : O
treated VBD O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
THP NNP O
- : O
1 CD O
cells NNS O
by IN O
the DT O
assay NN O
. . O

Since IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
was VBD O
also RB O
detected VBN O
in IN O
VD3 NNP O
- : O
untreated JJ O
HL NNP O
- : O
60 CD O
cells NNS O
by IN O
immunoblotting VBG O
, , O
VD3 NNP O
activated VBD O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
to TO O
bind VB O
to TO O
the DT O
motif NN O
, , O
probably RB O
through IN O
post NN O
- : O
translational JJ O
modification NN O
. . O

Patients NNS O
with IN O
high JJ O
- : O
risk NN O
myelodysplastic JJ O
syndrome NN O
can MD O
have VB O
polyclonal JJ O
or CC O
clonal JJ O
haemopoiesis NN O
in IN O
complete JJ O
haematological JJ O
remission NN O
. . O

The DT O
clonality NN O
of IN O
mature JJ O
peripheral JJ O
blood NN O
- : O
derived VBN O
myeloid NN O
and CC O
lymphoid JJ O
cells NNS O
and CC O
bone NN O
marrow NN O
haemopoietic JJ O
progenitors NNS O
from IN O
18 CD O
females NNS O
with IN O
myelodysplasia NN O
( ( O
MDS NNP O
) ) O
( ( O
five CD O
refractory NN O
anaemia NN O
, , O
RA NNP O
; : O
one CD O
RA NNP O
with IN O
ringed JJ O
sideroblasts NNS O
, , O
RARS NNP O
; : O
three CD O
chronic JJ O
myelomonocytic JJ O
leukaemia NN O
, , O
CMML NNP O
; : O
four CD O
RA NNP O
with IN O
excess NN O
of IN O
blasts NNS O
, , O
RAEB NNP O
; : O
five CD O
RAEB NNP O
in IN O
transformation NN O
, , O
RAEB NNP O
- : O
t NN O
) ) O
was VBD O
studied VBN O
by IN O
X NNP B-Gene
- : I-Gene
chromosome NN I-Gene
inactivation NN O
analysis NN O
. . O

Using VBG O
the DT O
human JJ O
androgen NN O
- : O
receptor NN O
( ( O
HUMARA NNP O
) ) O
assay VBP O
, , O
we PRP O
analysed VBD O
the DT O
clonal JJ O
patterns NNS O
of IN O
highly RB O
purified JJ O
immature NN O
CD34 NNP O
+ VBZ O
38 CD O
- : O
and CC O
committed JJ O
CD34 NNP O
+ NNP O
38 CD O
+ NNP O
marrow SYM O
- : O
derived VBN O
progenitors NNS O
, , O
and CC O
CD16 NNP O
+ NNP O
14 CD O
- : O
granulocytes NNS O
, , O
CD14 NNP O
+ NNP O
monocytes NNS O
, , O
CD3 NNP O
+ NNP O
T NNP O
and CC O
CD19 NNP O
+ NNP O
B NNP O
lymphocytes VBZ O
from IN O
peripheral JJ O
blood NN O
. . O

In IN O
high JJ O
- : O
risk NN O
patients NNS O
( ( O
RAEB NNP O
, , O
RAEB NNP O
- : O
t NN O
) ) O
, , O
clonality NN O
analysis NN O
was VBD O
performed VBN O
before IN O
and CC O
after IN O
intensive JJ O
remission NN O
- : O
induction NN O
treatment NN O
. . O

All DT O
patients NNS O
, , O
except IN O
one CD O
with IN O
RA NNP O
, , O
had VBD O
predominance NN O
of IN O
a DT O
single JJ O
clone NN O
in IN O
their PRP$ O
granulocytes NNS O
and CC O
monocytes NNS O
. . O

The DT O
same JJ O
clonal JJ O
pattern NN O
was VBD O
found VBN O
in IN O
CD34 NNP O
+ NNP O
progenitor NN O
cells NNS O
. . O

In IN O
contrast NN O
, , O
CD3 NNP O
+ NNP O
T NNP O
lymphocytes NNS O
were VBD O
polyclonal JJ O
or CC O
oligoclonal JJ O
in IN O
14 CD O
/ JJ O
18 CD O
patients NNS O
. . O

X LS B-Gene
- : I-Gene
chromosome NN I-Gene
inactivation NN O
patterns NNS O
of IN O
CD19 NNP O
+ NNP O
B NNP O
cells NNS O
were VBD O
highly RB O
concordant JJ O
with IN O
CD3 NNP O
+ NNP O
T NNP O
cells NNS O
except IN O
for IN O
two CD O
patients NNS O
( ( O
one CD O
RA NNP O
, , O
one CD O
CMML NNP O
) ) O
with IN O
monoclonal JJ O
B NNP O
and CC O
polyclonal JJ O
T NNP O
lymphocytes NNS O
, , O
therefore RB O
suggesting VBG O
a DT O
clonal JJ O
mutation NN O
in IN O
a DT O
progenitor NN O
common JJ O
to TO O
the DT O
myeloid NN O
and CC O
B NNP O
- : O
lymphoid NN O
lineages VBZ O
or CC O
the DT O
coexistence NN O
of IN O
MDS NNP O
and CC O
a DT O
B NNP O
- : O
cell NN O
disorder NN O
in IN O
these DT O
particular JJ O
patients NNS O
. . O

After IN O
high JJ O
- : O
dose NN O
non SYM O
- : O
myeloablative JJ O
chemotherapy NN O
, , O
polyclonal JJ O
haemopoiesis NN O
was VBD O
reinstalled VBN O
in IN O
the DT O
mature NN O
myeloid NN O
cells NNS O
and CC O
immature NN O
and CC O
committed JJ O
marrow NN O
progenitors NNS O
in IN O
three CD O
of IN O
four CD O
patients NNS O
achieving VBG O
complete JJ O
haematological JJ O
remission NN O
. . O

Therefore IN O
we PRP O
conclude VBP O
that IN O
most JJS O
haematological JJ O
remissions NNS O
in IN O
MDS NNP O
are VBP O
associated VBN O
with IN O
restoration NN O
of IN O
polyclonal JJ O
haemopoiesis NN O
. . O

Prominent JJ O
sex NN O
steroid JJ O
metabolism NN O
in IN O
human JJ O
lymphocytes NNS O
. . O

Steroid JJ O
metabolism NN O
was VBD O
investigated VBN O
in IN O
cultured JJ O
human NN O
B NNP O
- : O
lymphoblastoid NN O
cells NNS O
( ( O
B NNP O
- : O
LCL NN O
) ) O
, , O
and CC O
peripheral JJ O
blood NN O
T NNP O
and CC O
B NNP O
cells NNS O
. . O

Gene NNP O
expression NN O
was VBD O
examined VBN O
by IN O
reverse NN O
- : O
transcription NN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
. . O

Appropriate NNP O
sized VBD O
transcripts NNS B-Gene
were VBD O
detected VBN O
in IN O
both DT O
cultured JJ O
and CC O
fresh JJ O
peripheral JJ O
lymphocytes NNS O
for IN O
CYP11A NNP B-Gene
, , O
CYP17 NNP B-Gene
, , O
HSD11L NNP B-Gene
( ( O
11beta CD B-Gene
- : I-Gene
hydroxysteroid NN I-Gene
dehydrogenase NN I-Gene
I PRP I-Gene
) ) O
, , O
HSD17B1 NNP B-Gene
( ( O
17beta CD B-Gene
- : I-Gene
hydroxysteroid NN I-Gene
dehydrogenase NN I-Gene
type NN I-Gene
I PRP I-Gene
) ) O
and CC O
SRD5A1 NNP B-Gene
( ( O
5alpha CD B-Gene
- : I-Gene
reductase NN I-Gene
I PRP I-Gene
) ) O
. . O

B NNP O
- : O
LCL NN O
, , O
but CC O
not RB O
T NNP O
and CC O
B NNP O
cells NNS O
, , O
expressed VBD O
CYP11B NNP B-Gene
. . O

There EX O
was VBD O
minimal JJ O
expression NN O
of IN O
HSD3B1 NNP B-Gene
and CC O
HSD3B2 NNP B-Gene
( ( O
3beta CD B-Gene
- : I-Gene
hydroxysteroid NN I-Gene
dehydrogenase NN I-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
) ) O
in IN O
B NNP O
- : O
LCL NN O
and CC O
T NNP O
cells NNS O
. . O

Transcripts NNS O
for IN O
CYP19 NNP B-Gene
and CC O
HSD11K NNP B-Gene
were VBD O
not RB O
detected VBN O
. . O

Corresponding VBG O
enzymatic JJ O
activity NN O
was VBD O
detectable JJ O
only RB O
for IN O
17 CD B-Gene
- : I-Gene
hydroxysteroid NN I-Gene
dehydrogenase NN I-Gene
and CC O
5alpha CD B-Gene
- : I-Gene
reductase NN I-Gene
, , O
respectively RB O
producing VBG O
testosterone NN O
and CC O
5alpha CD O
- : O
dihydrotestosterone NN O
. . O

Steroid JJ O
identities NNS O
were VBD O
confirmed VBN O
by IN O
gas NN O
chromatography NN O
/ NNP O
mass NN O
spectrometry NN O
( ( O
GC NNP O
/ NNP O
MS NNP O
) ) O
. . O

One CD O
metabolite NN O
thought VBD O
to TO O
be VB O
deoxycorticosterone NN O
was VBD O
identified VBN O
by IN O
GC NNP O
/ NNP O
MS NNP O
as IN O
6alpha CD O
- : O
hydroxypregnanolone NN O
. . O

It PRP O
was VBD O
concluded VBN O
that IN O
sex NN O
hormone NN O
metabolism NN O
, , O
including VBG O
androgen NN O
synthesis NN O
, , O
occurs VBZ O
in IN O
lymphocytes NNS O
, , O
and CC O
may MD O
modulate VB O
immune JJ O
response NN O
. . O

Human NNP O
white JJ O
blood NN O
cells NNS O
and CC O
hair NN O
follicles NNS O
are VBP O
good JJ O
sources NNS O
of IN O
mRNA NN B-Gene
for IN O
the DT O
pterin NN B-Gene
carbinolamine NN I-Gene
dehydratase NN I-Gene
/ NNP I-Gene
dimerization NN I-Gene
cofactor NN I-Gene
of IN O
HNF1 NNP B-Gene
for IN O
mutation NN O
detection NN O
. . O

Pterin NNP B-Gene
carbinolamine NN I-Gene
dehydratase NN I-Gene
/ NNP I-Gene
dimerization NN I-Gene
cofactor NN I-Gene
of IN O
HNF1 NNP B-Gene
( ( O
PCD NNP B-Gene
/ NNP I-Gene
DCoH NNP I-Gene
) ) O
is VBZ O
a DT O
protein NN O
that WDT O
has VBZ O
a DT O
dual JJ O
function NN O
. . O

It PRP O
is VBZ O
a DT O
pterin NN B-Gene
4alpha CD I-Gene
- : I-Gene
carbinolamine NN I-Gene
dehydratase NN I-Gene
that WDT O
is VBZ O
involved VBN O
in IN O
the DT O
regeneration NN O
of IN O
the DT O
cofactor NN B-Gene
tetrahydrobiopterin NN I-Gene
during IN O
the DT O
phenylalanine NN O
hydroxylase NN O
- : O
catalyzed JJ O
hydroxylation NN O
of IN O
phenylalanine NN O
. . O

In IN O
addition NN O
, , O
it PRP O
is VBZ O
the DT O
dimerization NN O
cofactor NN O
of IN O
HNF1 NNP B-Gene
that WDT O
is VBZ O
able JJ O
to TO O
activate VB O
the DT O
transcriptional JJ O
activity NN O
of IN O
HNF1 NNP B-Gene
. . O

Deficiencies NNS O
in IN O
the DT O
gene NN O
for IN O
this DT O
dual JJ B-Gene
functional JJ I-Gene
protein NN I-Gene
result NN O
in IN O
hyperphenylalaninemi NN O
. . O

Here RB O
we PRP O
report VBP O
for IN O
the DT O
first JJ O
time NN O
that IN O
the DT O
PCD NNP B-Gene
/ NNP I-Gene
DCoH NNP I-Gene
mRNA NN I-Gene
is VBZ O
present JJ O
in IN O
human JJ O
white JJ O
blood NN O
cells NNS O
and CC O
hair NN O
follicles NNS O
. . O

Taking VBG O
advantage NN O
of IN O
this DT O
finding NN O
, , O
a DT O
sensitive JJ O
, , O
rapid JJ O
and CC O
convenient JJ O
method NN O
for IN O
screening VBG O
mutations NNS O
occurring VBG O
in IN O
the DT O
coding JJ O
region NN O
of IN O
this DT O
gene NN O
has VBZ O
been VBN O
described VBN O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

Biochemical JJ O
characterization NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
Y PRP$ I-Gene
transcription NN I-Gene
factor NN I-Gene
complex NN I-Gene
during IN O
B NNP O
lymphocyte NN O
development NN O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
, , O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
, , O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
tissue NN O
- : O
specific JJ O
major JJ B-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
transcription NN O
. . O

In IN O
this DT O
report NN O
the DT O
biochemical JJ O
properties NNS O
of IN O
the DT O
heterotrimeric JJ B-Gene
NF NNP I-Gene
- : I-Gene
Y NN I-Gene
complex NN I-Gene
have VBP O
been VBN O
characterized VBN O
during IN O
stage NN O
- : O
specific NN O
B NNP O
- : O
cell NN O
development NN O
, , O
and CC O
in IN O
several JJ O
class NN O
II NNP O
- : O
mutant NN O
B NNP O
- : O
cell NN O
lines NNS O
, , O
which WDT O
represent VBP O
distinct JJ O
bare NN O
lymphocyte JJ O
syndrome JJ O
class NN O
II NNP O
genetic JJ O
complementation NN O
groups NNS O
. . O

The DT O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
complex JJ I-Gene
derived VBN O
from IN O
class NN O
II NNP O
+ NNP O
mature NN O
B NNP O
- : O
cells NNS O
bound IN O
with IN O
high JJ O
affinity NN O
to TO O
anion NN B-Gene
exchangers NNS I-Gene
, , O
and CC O
eluted VBD O
as IN O
an DT O
intact JJ O
trimeric NN B-Gene
complex NN I-Gene
, , O
whereas NNS O
, , O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
derived VBN O
from IN O
class NN O
II NNP O
- : O
plasma NN O
B NNP O
- : O
cells NNS O
, , O
and CC O
from IN O
bare JJ O
lymphocyte JJ O
syndrome NN O
group NN O
II NNP O
cell NN O
lines NNS O
, , O
RJ2 NNP O
. . O
2 CD O
. . O
5 CD O
and CC O
RM3 NNP O
, , O
dissociated VBD O
into IN O
discrete JJ O
NF NNP B-Gene
- : I-Gene
YA NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
YB NN I-Gene
: : I-Gene
C NNP I-Gene
subunit NN B-Gene
fractions NNS I-Gene
. . O

Recombination NN O
of IN O
the DT O
MPC11 NNP B-Gene
plasma NN I-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
derived VBD I-Gene
NF NNP I-Gene
- : I-Gene
Y VBZ I-Gene
A DT I-Gene
: : I-Gene
B NN I-Gene
: : I-Gene
C NNP I-Gene
complex NN I-Gene
with IN O
the DT O
low JJ O
molecular JJ O
mass NN O
protein NN O
fraction NN O
, , O
NF NNP B-Gene
- : I-Gene
Y SYM I-Gene
- : I-Gene
associated VBN I-Gene
factors NNS I-Gene
( ( O
YAFs NNP B-Gene
) ) O
, , O
derived VBN O
from IN O
mature NN O
A20 NNP O
B NNP O
- : O
cell NN O
nuclei RB O
, , O
conferred VBD O
high JJ O
affinity NN O
anion NN O
exchange NN O
binding NN O
to TO O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
as IN O
an DT O
intact JJ B-Gene
trimeric JJ I-Gene
complex NN I-Gene
. . O

Recombination NN O
of IN O
the DT O
native JJ B-Gene
NF NNP I-Gene
- : I-Gene
YA NN I-Gene
: : I-Gene
B NN I-Gene
: : I-Gene
C NNP I-Gene
complex NN I-Gene
with IN O
the DT O
transcriptional JJ B-Gene
cofactor NN I-Gene
, , O
PC4 NNP B-Gene
, , O
likewise RB O
conferred VBN O
high JJ B-Gene
affinity NN I-Gene
NF NNP I-Gene
- : I-Gene
Y NN I-Gene
binding NN O
to TO O
anion NN B-Gene
exchangers NNS I-Gene
, , O
and CC O
stabilized VBD O
NF NNP B-Gene
- : I-Gene
Y PRP$ I-Gene
interaction NN O
with IN O
CCAAT NNP B-Gene
- : I-Gene
box NN I-Gene
DNA NNP I-Gene
motifs NN I-Gene
in IN O
vitro NN O
. . O

Interaction NN O
between IN O
PC4 NNP B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
was VBD O
mapped VBN O
to TO O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
of IN O
PC4 NNP B-Gene
, , O
and CC O
the DT O
subunit NN B-Gene
interaction NN I-Gene
subdomain NN I-Gene
of IN O
the DT O
highly RB B-Gene
conserved VBN I-Gene
DNA NNP I-Gene
binding VBG I-Gene
- : I-Gene
subunit NN I-Gene
interaction NN I-Gene
domain NN I-Gene
( ( O
DBD NNP B-Gene
) ) O
of IN O
NF NNP B-Gene
- : I-Gene
YA NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
in IN O
class NN O
II NNP O
+ NNP O
mature NN O
B NNP O
- : O
cells NNS O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
is VBZ O
associated VBN O
with IN O
the DT O
protein NN O
cofactor NN O
, , O
PC4 NNP B-Gene
, , O
which WDT O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
NF NNP O
- : O
Y SYM O
- : O
mediated VBN O
transcriptional JJ O
control NN O
of IN O
class NN B-Gene
II NNP I-Gene
genes NNS I-Gene
. . O

Arrest NNP O
of IN O
B NNP O
lymphocyte FW O
terminal JJ O
differentiation NN O
by IN O
CD40 NNP O
signaling NN O
: : O
mechanism NN O
for IN O
lack NN O
of IN O
antibody NN O
- : O
secreting VBG O
cells NNS O
in IN O
germinal JJ O
centers NNS O
. . O

Despite IN O
extensive JJ O
research NN O
, , O
the DT O
role NN O
of IN O
CD40 NNP B-Gene
signaling VBG O
in IN O
B NNP O
cell VBP O
terminal JJ O
differentiation NN O
remains VBZ O
controversial JJ O
. . O

Here RB O
we PRP O
show VBP O
that IN O
CD40 NNP B-Gene
engagement NN O
arrests VBZ O
B NNP O
cell NN O
differentiation NN O
prior RB O
to TO O
plasma VB O
cell NN O
formation NN O
. . O

This DT O
arrest NN O
is VBZ O
manifested VBN O
at IN O
a DT O
molecular JJ O
level NN O
as IN O
a DT O
reduction NN O
in IN O
mRNA NN O
levels NNS O
of IN O
secretory NN O
immunoglobulin NN O
gene NN O
products NNS O
such JJ O
as IN O
mu NN O
( ( O
s NN O
) ) O
and CC O
J NNP O
chain NN O
as RB O
well RB O
as IN O
the DT O
loss NN O
of IN O
the DT O
transcriptional JJ B-Gene
regulator NN I-Gene
BLIMP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Furthermore RB O
, , O
the DT O
inhibition NN O
of IN O
B NNP O
cell NN O
differentiation NN O
by IN O
CD40 NNP B-Gene
engagement NN O
could MD O
not RB O
be VB O
overcome VBN O
by IN O
either DT O
mitogens NNS B-Gene
or CC O
cytokines NNS B-Gene
, , O
but CC O
could MD O
be VB O
reversed VBN O
by IN O
antibodies NNS O
that WDT O
interfere VBP O
with IN O
the DT O
CD40 NNP B-Gene
/ NNP O
gp39 NN B-Gene
interaction NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
secretory JJ O
immunoglobulin NN O
is VBZ O
not RB O
produced VBN O
by IN O
B NNP O
cells NNS O
that WDT O
are VBP O
actively RB O
engaged VBN O
by IN O
gp39 JJ O
- : O
expressing VBG O
T NNP O
cells NNS O
. . O

A DT O
positively RB O
charged VBN O
alpha SYM O
- : O
lipoic NN O
acid VBZ O
analogue JJ O
with IN O
increased JJ O
cellular JJ O
uptake NN O
and CC O
more RBR O
potent JJ O
immunomodulatory JJ O
activity NN O
. . O

alpha SYM O
- : O
Lipoic JJ O
acid NN O
( ( O
LA NNP O
) ) O
is VBZ O
taken VBN O
up RP O
by IN O
cells NNS O
and CC O
reduced VBD O
to TO O
its PRP$ O
potent JJ O
dithiol JJ O
form NN O
, , O
dihydrolipoate NN O
( ( O
DHLA NNP O
) ) O
, , O
much RB O
of IN O
which WDT O
is VBZ O
rapidly RB O
effluxed VBN O
out RP O
from IN O
cells NNS O
. . O

To TO O
improve VB O
retention NN O
in IN O
cells NNS O
, , O
the DT O
LA NNP O
molecule NN O
was VBD O
modified VBN O
to TO O
confer VB O
a DT O
positive JJ O
charge NN O
at IN O
physiological JJ O
pH NN O
. . O

N NNP O
, , O
N NNP O
- : O
dimethyl NN O
, , O
N NNP O
' POS O
- : O
2 CD O
- : O
amidoethyl NN O
- : O
lipoate NN O
was VBD O
synthesized VBN O
. . O

The DT O
protonated JJ O
form NN O
of IN O
the DT O
new JJ O
molecule NN O
is VBZ O
referred VBN O
to TO O
as IN O
LA NNP O
- : O
Plus CC O
. . O

The DT O
uptake NN O
of IN O
LA NNP O
- : O
Plus CC O
by IN O
human JJ O
Wurzburg NNP O
T NNP O
cells NNS O
was VBD O
higher JJR O
compared VBN O
to TO O
that DT O
of IN O
LA NNP O
. . O

Several JJ O
- : O
fold NN O
higher JJR O
amounts NNS O
of IN O
DHLA NNP O
- : O
Plus CC O
, , O
the DT O
corresponding NN O
reduced VBD O
form NN O
of IN O
LA NNP O
- : O
Plus CC O
, , O
were VBD O
detected VBN O
in IN O
LA NNP O
- : O
Plus CC O
treated JJ O
cells NNS O
compared VBN O
to TO O
the DT O
amount NN O
of IN O
DHLA NNP O
found VBD O
in IN O
cells NNS O
treated VBN O
with IN O
LA NNP O
. . O

At IN O
100 CD O
microM NN O
, , O
LA NNP O
did VBD O
not RB O
but CC O
LA NNP O
- : O
Plus CC O
inhibited JJ O
H2O2 NNP O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
directed VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
expression NN O
. . O

Both DT O
LA NNP O
and CC O
LA NNP O
- : O
Plus CC O
synergised JJ O
with IN O
selenium NN O
in IN O
inhibiting VBG O
H2O2 NNP O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

At IN O
150 CD O
microM NN O
LA NNP O
- : O
Plus CC O
, , O
but CC O
not RB O
LA NNP O
, , O
inhibited VBD O
TNFalpha NNP B-Gene
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

At IN O
5 CD O
microM NN O
LA NNP O
- : O
Plus CC O
, , O
but CC O
not RB O
LA NNP O
, , O
protected VBN O
against IN O
both DT O
spontaneous JJ O
and CC O
etoposide RB O
induced JJ O
apoptosis NN O
in IN O
rat NN O
thymocytes NNS O
. . O

LA NNP O
- : O
Plus CC O
is VBZ O
thus RB O
an DT O
improved JJ O
form NN O
of IN O
LA NNP O
with IN O
increased VBN O
therapeutic JJ O
potential NN O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

Carrier NNP O
identification NN O
in IN O
X NNP O
- : O
linked VBD O
immunodeficiency NN O
diseases NNS O
. . O

OBJECTIVE NN O
: : O
Carrier NNP O
identification NN O
in IN O
X NNP O
- : O
linked VBD O
immunodeficiency NN O
disorders NNS O
can MD O
be VB O
based VBN O
on IN O
the DT O
demonstration NN O
of IN O
non JJ O
- : O
random NN O
X NNP O
inactivation NN O
( ( O
NRXI NNP O
) ) O
in IN O
affected JJ O
blood NN O
cell NN O
lineages VBZ O
when WRB O
growth NN O
is VBZ O
impaired VBN O
in IN O
cells NNS O
expressing VBG O
the DT O
abnormal JJ B-Gene
gene NN I-Gene
. . O

We PRP O
examined VBD O
the DT O
utility NN O
of IN O
seeking VBG O
evidence NN O
of IN O
NRXI NNP O
to TO O
test VB O
the DT O
carrier NN O
status NN O
of IN O
women NNS O
in IN O
families NNS O
affected VBN O
by IN O
X NNP O
- : O
linked VBN O
severe JJ O
combined VBN O
immunodeficiency NN O
( ( O
XSCID NNP O
) ) O
and CC O
X NNP O
- : O
linked VBN O
hypogammaglobulinaem NN O
( ( O
XLH NNP O
) ) O
, , O
to TO O
identify VB O
as IN O
carriers NNS O
the DT O
mothers NNS O
of IN O
boys NNS O
with IN O
SCID NNP O
or CC O
hypogammaglobulinaem PRP$ O
whose WP$ O
phenotype NN O
suggested VBD O
X NNP O
- : O
linkage NN O
and CC O
to TO O
infer VB O
X NNP O
- : O
linkage NN O
in IN O
boys NNS O
with IN O
SCID NNP O
or CC O
hypogammaglobulinaem PRP$ O
whose WP$ O
disease NN O
was VBD O
not RB O
clearly RB O
X SYM O
- : O
linked VBN O
on IN O
the DT O
basis NN O
either DT O
of IN O
family NN O
history NN O
or CC O
clinical JJ O
and CC O
immunological JJ O
characteristics NNS O
. . O

METHODOLOGY NN O
: : O
A DT O
polymerase NN O
chain NN O
reaction NN O
- : O
based VBN O
method NN O
was VBD O
used VBN O
to TO O
amplify VB O
a DT O
polymorphic JJ O
CAG NNP B-Gene
repeat NN I-Gene
in IN O
the DT O
first JJ B-Gene
exon NN I-Gene
of IN O
the DT O
androgen NN B-Gene
receptor NN I-Gene
gene NN I-Gene
after IN O
selective JJ O
digestion NN O
of IN O
the DT O
active JJ B-Gene
X NNP I-Gene
chromosome NN I-Gene
with IN O
a DT O
methylation NN B-Gene
- : I-Gene
sensitive JJ I-Gene
enzyme NN I-Gene
, , O
HpaII NNP B-Gene
to TO O
distinguish VB O
between IN O
the DT O
paternal JJ B-Gene
and CC I-Gene
maternal JJ I-Gene
alleles NNS I-Gene
and CC O
to TO O
identify VB O
their PRP$ O
methylation NN O
status NN O
. . O

RESULTS NN O
: : O
Heterozygosity NNP O
was VBD O
found VBN O
in IN O
24 CD O
of IN O
31 CD O
female JJ O
subjects NNS O
( ( O
77 CD O
% NN O
) ) O
. . O

As IN O
anticipated VBN O
, , O
NRXI NNP O
could MD O
be VB O
demonstrated VBN O
in IN O
all DT O
lymphoid JJ O
cells NNS O
studied VBN O
from IN O
obligate JJ O
carriers NNS O
of IN O
XSCID NNP O
and CC O
an DT O
obligate NN O
carrier NN O
of IN O
XLH NN O
but CC O
not RB O
on IN O
a DT O
carrier NN O
of IN O
X NNP O
- : O
linked VBD O
immunodeficiency NN O
with IN O
hyper JJ B-Gene
- : I-Gene
IgM NN I-Gene
. . O

The DT O
finding NN O
of IN O
NRXI NNP O
in IN O
the DT O
mother NN O
of IN O
a DT O
boy NN O
with IN O
a DT O
SCID NNP O
variant NN O
showed VBD O
her PRP O
to TO O
be VB O
a DT O
carrier NN O
of IN O
XSCID NN O
and CC O
establishes NNS O
that IN O
her PRP$ O
son NN O
has VBZ O
XSCID VBN O
, , O
not RB O
otherwise RB O
evident JJ O
from IN O
available JJ O
data NNS O
. . O

CONCLUSIONS NN O
: : O
This DT O
PCR NNP O
assay VBP O
provides VBZ O
a DT O
rapid JJ O
method NN O
for IN O
carrier NN O
detection NN O
of IN O
X NNP O
- : O
linked VBN O
immunodeficiencies NNS O
, , O
and CC O
has VBZ O
allowed VBN O
us PRP O
to TO O
expand VB O
the DT O
phenotype NN O
of IN O
XSCID NN O

Leukocyte NNP O
- : O
endothelial JJ O
interaction NN O
is VBZ O
augmented VBN O
by IN O
high JJ O
glucose JJ O
concentrations NNS O
and CC O
hyperglycemia NN O
in IN O
a DT O
NF NNP O
- : O
kB NN O
- : O
dependent JJ O
fashion NN O
. . O

We PRP O
addressed VBD O
the DT O
role NN O
of IN O
hyperglycemia NN O
in IN O
leukocyte JJ O
- : O
endothelium NN O
interaction NN O
under IN O
flow JJ O
conditions NNS O
by IN O
exposing VBG O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cells NNS O
for IN O
24 CD O
h NN O
to TO O
normal JJ O
( ( O
5 CD O
mM NN O
) ) O
, , O
high JJ O
concentration NN O
of IN O
glucose NN O
( ( O
30 CD O
mM NN O
) ) O
, , O
advanced VBD O
glycosylation JJ O
end NN O
product NN B-Gene
- : I-Gene
albumin NN I-Gene
( ( O
100 CD O
microg NN O
/ NNP O
ml NN O
) ) O
, , O
or CC O
hyperglycemic JJ O
( ( O
174 CD O
- : O
316 CD O
mg NN O
/ NNP O
dl NN O
) ) O
sera NN O
from IN O
patients NNS O
with IN O
diabetes NNS O
and CC O
abnormal JJ O
hemoglobin NN O
A1c NNP O
( ( O
8 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
% NN O
) ) O
. . O

At IN O
the DT O
end NN O
of IN O
incubation NN O
endothelial JJ O
cells NNS O
were VBD O
perfused VBN O
with IN O
total JJ O
leukocyte JJ O
suspension NN O
in IN O
a DT O
parallel JJ O
plate NN O
flow JJ O
chamber NN O
under IN O
laminar NN O
flow NN O
( ( O
1 CD O
. . O
5 CD O
dyn JJ O
/ NNP O
cm2 NN O
) ) O
. . O

Rolling VBG O
and CC O
adherent JJ O
cells NNS O
were VBD O
evaluated VBN O
by IN O
digital JJ O
image NN O
processing NN O
. . O

Results NNS O
showed VBD O
that IN O
30 CD O
mM NNS O
glucose VBP O
significantly RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
increased VBD O
the DT O
number NN O
of IN O
adherent JJ O
leukocytes NNS O
to TO O
endothelial JJ O
cells NNS O
in IN O
respect NN O
to TO O
control VB O
( ( O
5 CD O
mM NN O
glucose NN O
; : O
151 CD O
+ NN O
/ NNP O
- : O
19 CD O
versus NN O
33 CD O
+ NN O
/ NNP O
- : O
8 CD O
cells NNS O
/ JJ O
mm2 NN O
) ) O
. . O

A DT O
similar JJ O
response NN O
was VBD O
induced VBN O
by IN O
endothelial JJ O
stimulation NN O
with IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
here RB O
used VBN O
as IN O
positive JJ O
control NN O
( ( O
195 CD O
+ NN O
/ NNP O
- : O
20 CD O
cells NNS O
/ JJ O
mm2 NN O
) ) O
. . O

The DT O
number NN O
of IN O
rolling VBG O
cells NNS O
on IN O
endothelial JJ O
surface NN O
was VBD O
not RB O
affected VBN O
by IN O
high JJ O
glucose JJ O
level NN O
. . O

Stable JJ O
adhesion NN O
of IN O
leukocytes NNS O
to TO O
glucose VB O
- : O
treated VBN O
as RB O
well RB O
as IN O
to TO O
IL NNP O
- : O
1beta CD O
- : O
stimulated VBN O
endothelial JJ O
cells NNS O
was VBD O
preceded VBN O
by IN O
short JJ O
interaction NN O
of IN O
leukocytes NNS O
with IN O
the DT O
endothelial JJ O
surface NN O
. . O

The DT O
distance NN O
travelled VBN O
by IN O
leukocytes NNS O
before IN O
arrest NN O
on IN O
30 CD O
mM NNS O
glucose JJ O
, , O
or CC O
on IN O
IL NNP O
- : O
1beta CD O
- : O
treated VBN O
endothelial JJ O
cells NNS O
, , O
was VBD O
significantly RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
higher JJR O
than IN O
that DT O
observed VBD O
for IN O
leukocytes NNS O
adhering VBG O
on IN O
control NN O
endothelium NN O
( ( O
30 CD O
mM NN O
glucose NN O
: : O
76 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
5 CD O
; : O
IL1beta NNP O
: : O
69 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
4 CD O
versus NN O
5 CD O
mM NN O
glucose NN O
: : O
21 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
5 CD O
microm NN O
) ) O
. . O

Functional JJ O
blocking NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
intercellular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
vascular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
on IN O
endothelial JJ O
cells NNS O
with IN O
the DT O
corresponding JJ O
mouse NN B-Gene
mAb NN I-Gene
significantly RB O
inhibited VBD O
glucose JJ O
- : O
induced JJ O
increase NN O
in IN O
leukocyte JJ O
adhesion NN O
( ( O
67 CD O
+ NN O
/ NNP O
- : O
16 CD O
, , O
83 CD O
+ NN O
/ NNP O
- : O
12 CD O
, , O
62 CD O
+ NN O
/ NNP O
- : O
8 CD O
versus NN O
144 CD O
+ NN O
/ NNP O
- : O
21 CD O
cells NNS O
/ JJ O
mm2 NN O
) ) O
. . O

Confocal JJ O
fluorescence NN O
microscopy NN O
studies NNS O
showed VBD O
that IN O
30 CD O
mM NNS O
glucose RB O
induced VBD O
an DT O
increase NN O
in IN O
endothelial JJ O
surface NN O
expression NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
intercellular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
vascular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
of IN O
nuclear JJ O
extracts NNS O
of IN O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cells NNS O
( ( O
HUVEC NNP O
) ) O
exposed VBD O
for IN O
1 CD O
h NN O
to TO O
30 CD O
mM NNS O
glucose RB O
revealed VBD O
an DT O
intense JJ O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
activation NN O
. . O

Treatment NN O
of IN O
HUVEC NNP O
exposed VBD O
to TO O
high JJ O
glucose NN O
with IN O
the DT O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
inhibitors NNS I-Gene
pyrrolidinedithiocar VBP O
( ( O
100 CD O
microM NN O
) ) O
and CC O
tosyl $ O
- : O
phe NN O
- : O
chloromethylketone NN O
( ( O
25 CD O
microM NN O
) ) O
significantly RB O
reduced VBN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
leukocyte NN O
adhesion NN O
in IN O
respect NN O
to TO O
HUVEC NNP O
treated VBN O
with IN O
glucose JJ O
alone NN O
. . O

A DT O
significant JJ O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
inhibitory NN O
effect NN O
on IN O
glucose JJ O
- : O
induced JJ O
leukocyte JJ O
adhesion NN O
was VBD O
observed VBN O
after IN O
blocking VBG O
protein JJ B-Gene
kinase JJ I-Gene
C NNP I-Gene
activity NN O
with IN O
staurosporine NN O
( ( O
5 CD O
nM NN O
) ) O
. . O

When WRB O
HUVEC NNP O
were VBD O
treated VBN O
with IN O
specific JJ O
antisense JJ O
oligodesoxynucleotid NN O
against IN O
PKCalpha NNP B-Gene
and CC I-Gene
PKCepsilon NNP I-Gene
isoforms NNS I-Gene
before IN O
the DT O
addition NN O
of IN O
30 CD O
mM NNS O
glucose RB O
, , O
a DT O
significant JJ O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
reduction NN O
in IN O
the DT O
adhesion NN O
was VBD O
also RB O
seen VBN O
. . O

Advanced NNP O
glycosylation NN O
end NN O
product NN B-Gene
- : I-Gene
albumin NN I-Gene
significantly RB O
increased VBD O
the DT O
number NN O
of IN O
adhering VBG O
leukocytes NNS O
in IN O
respect NN O
to TO O
native JJ B-Gene
albumin NN I-Gene
used VBN O
as IN O
control NN O
( ( O
110 CD O
+ NN O
/ NNP O
- : O
16 CD O
versus NN O
66 CD O
+ NN O
/ NNP O
- : O
7 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Sera NN O
from IN O
diabetic JJ O
patients NNS O
significantly RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
enhanced VBD O
leukocyte JJ O
adhesion NN O
as IN O
compared VBN O
with IN O
controls NNS O
, , O
despite IN O
normal JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
and CC O
TNFalpha NNP B-Gene
in IN O
these DT O
sera NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
high JJ O
glucose JJ O
concentration NN O
and CC O
hyperglycemia NN O
promote VBP O
leukocyte JJ O
adhesion NN O
to TO O
the DT O
endothelium NN O
through IN O
upregulation NN O
of IN O
cell NN O
surface NN O
expression NN O
of IN O
adhesive JJ O
proteins NNS O
, , O
possibly RB O
depending VBG O
on IN O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
activation NN O
. . O

Ikaros NNS B-Gene
in IN O
hemopoietic JJ O
lineage NN O
determination NN O
and CC O
homeostasis NN O
. . O

Studies NNS O
on IN O
the DT O
molecular JJ O
mechanisms NNS O
that WDT O
control VBP O
hemopoietic JJ O
differentiation NN O
have VBP O
focused VBN O
on IN O
signaling VBG O
cascades NNS O
and CC O
nuclear JJ O
effectors NNS O
that WDT O
drive VBP O
this DT O
complex JJ O
developmental NN O
system NN O
in IN O
a DT O
regulated JJ O
fashion NN O
. . O

Here RB O
we PRP O
review VBP O
the DT O
role NN O
of IN O
Ikaros NNP B-Gene
, , O
the DT O
founding JJ O
member NN O
of IN O
a DT O
unique JJ O
family NN O
of IN O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
this DT O
developmental JJ O
process NN O
. . O

Studies NNS O
on IN O
an DT O
Ikaros NNP B-Gene
null NN O
mutation NN O
have VBP O
revealed VBN O
an DT O
essential JJ O
role NN O
for IN O
this DT O
factor NN O
in IN O
lymphoid NN O
cell NN O
fate NN O
determination NN O
and CC O
at IN O
subsequent JJ O
branch NN O
points NNS O
of IN O
the DT O
T NNP O
cell NN O
differentiation NN O
pathway NN O
. . O

Differences NNS O
in IN O
the DT O
phenotypes NNS O
of IN O
a DT O
null NN O
and CC O
a DT O
dominant JJ B-Gene
negative JJ I-Gene
( ( I-Gene
DN NNP I-Gene
) ) I-Gene
Ikaros NNP I-Gene
mutation NN I-Gene
provide NN O
insight VBD O
into IN O
a DT O
regulatory JJ O
network NN O
through IN O
which WDT O
Ikaros NNP B-Gene
proteins VBZ I-Gene
exert VB O
their PRP$ O
effects NNS O
in IN O
development NN O
. . O

In IN O
addition NN O
a DT O
comparative JJ O
analysis NN O
of IN O
the DT O
hemopoietic JJ O
stem NN O
cell NN O
and CC O
precursor NN O
compartment NN O
resulting VBG O
from IN O
the DT O
two CD O
Ikaros NNP B-Gene
mutations NNS I-Gene
reveals VBZ O
a DT O
profound NN O
yet RB O
not RB O
absolute JJ O
requirement NN O
for IN O
Ikaros NNP B-Gene

Induction NN O
of IN O
early JJ B-Gene
B NNP I-Gene
cell NN I-Gene
factor NN I-Gene
( ( O
EBF NNP B-Gene
) ) O
and CC O
multiple JJ B-Gene
B NNP I-Gene
lineage NN I-Gene
genes NNS I-Gene
by IN O
the DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
transcription NN I-Gene
factor NN I-Gene
E12 NNP B-Gene
. . O

The DT O
transcription NN B-Gene
factors NNS I-Gene
encoded VBN O
by IN O
the DT O
E2A NNP B-Gene
and CC O
early RB B-Gene
B NNP I-Gene
cell NN I-Gene
factor NN I-Gene
( ( O
EBF NNP B-Gene
) ) O
genes NNS O
are VBP O
required VBN O
for IN O
the DT O
proper JJ O
development NN O
of IN O
B NNP O
lymphocytes NNS O
. . O

However RB O
, , O
the DT O
absence NN O
of IN O
B NNP O
lineage NN O
cells NNS O
in IN O
E2A NNP O
- : O
and CC O
EBF NNP O
- : O
deficient NN O
mice NN O
has VBZ O
made VBN O
it PRP O
difficult JJ O
to TO O
determine VB O
the DT O
function NN O
or CC O
relationship NN O
between IN O
these DT O
proteins NNS O
. . O

We PRP O
report VBP O
the DT O
identification NN O
of IN O
a DT O
novel JJ O
model NN O
system NN O
in IN O
which WDT O
the DT O
role NN O
of IN O
E2A NNP B-Gene
and CC O
EBF NNP B-Gene
in IN O
the DT O
regulation NN O
of IN O
multiple JJ O
B NNP O
lineage NN O
traits NNS O
can MD O
be VB O
studied VBN O
. . O

We PRP O
found VBD O
that IN O
the DT O
conversion NN O
of IN O
70Z CD O
/ JJ O
3 CD O
pre NN O
- : O
B NN O
lymphocytes VBZ O
to TO O
cells NNS O
with IN O
a DT O
macrophage NN O
- : O
like IN O
phenotype NN O
is VBZ O
associated VBN O
with IN O
the DT O
loss NN O
of IN O
E2A NNP B-Gene
and CC O
EBF NNP B-Gene
. . O

Moreover RB O
, , O
we PRP O
show VBP O
that IN O
ectopic JJ O
expression NN O
of IN O
the DT O
E2A NNP B-Gene
protein NN O
E12 NNP B-Gene
in IN O
this DT O
macrophage NN O
line NN O
results NNS O
in IN O
the DT O
induction NN O
of IN O
many JJ B-Gene
B NNP I-Gene
lineage NN I-Gene
genes NNS I-Gene
, , O
including VBG O
EBF NNP B-Gene
, , O
IL7Ralpha NNP B-Gene
, , O
lambda5 NN B-Gene
, , O
and CC O
Rag NNP O
- : O
1 CD O
, , O
and CC O
the DT O
ability NN O
to TO O
induce VB O
kappa JJ B-Gene
light NN I-Gene
chain NN I-Gene
in IN O
response NN O
to TO O
mitogen NN O
. . O

Activation NN O
of IN O
EBF NNP B-Gene
may MD O
be VB O
one CD O
of IN O
the DT O
critical JJ O
functions NNS O
of IN O
E12 NNP B-Gene
in IN O
regulating VBG O
the DT O
B NNP O
lineage NN O
phenotype NN O
since IN O
expression NN O
of IN O
EBF NNP B-Gene
alone RB O
leads VBZ O
to TO O
the DT O
activation NN O
of IN O
a DT O
subset NN O
of IN O
E12 NNP B-Gene
- : O
inducible JJ O
traits NNS O
. . O

Our PRP$ O
data NNS O
demonstrate NN O
that IN O
, , O
in IN O
the DT O
context NN O
of IN O
this DT O
macrophage NN O
line NN O
, , O
E12 NNP B-Gene
induces VBZ O
expression NN O
of IN O
EBF NNP B-Gene
and CC O
together RB O
these DT O
transcription NN B-Gene
factors NNS I-Gene
coordinately RB O
regulate VBP O
numerous JJ O
B NNP B-Gene
lineage NN I-Gene
- : I-Gene
associated VBN I-Gene
genes NNS I-Gene
. . O

Activation NNP O
- : O
induced VBD O
down IN O
- : O
regulation NN O
of IN O
retinoid JJ B-Gene
receptor NN I-Gene
RXRalpha NNP I-Gene
expression NN O
in IN O
human JJ O
T NNP O
lymphocytes NNS O
. . O

Role NNP O
of IN O
cell NN O
cycle NN O
regulation NN O
. . O

A DT O
5 CD B-Gene
. . I-Gene
4 CD I-Gene
- : I-Gene
kilobase NN I-Gene
mRNA NN I-Gene
, , O
the DT O
expression NN O
of IN O
which WDT O
is VBZ O
down RP O
- : O
regulated VBN O
after IN O
treatment NN O
of IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMCs NNP O
) ) O
with IN O
various JJ O
T NNP O
cell NN O
- : O
activating VBG O
agents NNS O
, , O
was VBD O
isolated VBN O
using VBG O
an DT O
mRNA JJ O
differential JJ O
display NN O
method NN O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
identified VBD O
the DT O
5 CD B-Gene
' POS I-Gene
end NN I-Gene
of IN O
this DT O
RNA NNP B-Gene
as IN O
human JJ B-Gene
retinoid NN I-Gene
receptor NN I-Gene
RXRalpha NNP I-Gene
mRNA NN I-Gene
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
nucleotide JJ O
sequence NN O
of IN O
3 CD B-Gene
. . I-Gene
6 CD I-Gene
kilobases NNS I-Gene
of IN O
this DT O
RNA NNP O
, , O
which WDT O
represents VBZ O
the DT O
3 CD B-Gene
' POS I-Gene
end NN I-Gene
of IN O
RXRalpha NNP B-Gene
mRNA NN I-Gene
, , O
the DT O
sequence NN O
of IN O
which WDT O
has VBZ O
not RB O
been VBN O
previously RB O
described VBN O
. . O

Activated VBN O
PBMCs NNP O
also RB O
expressed VBD O
lower JJR O
levels NNS O
of IN O
RXRalpha NNP B-Gene
protein NN O
, , O
and CC O
a DT O
DNA NN O
binding VBG O
assay NN O
showed VBD O
that IN O
the DT O
activation NN O
- : O
induced JJ O
loss NN O
of IN O
RXRalpha NNP B-Gene
mRNA NN I-Gene
and CC O
protein JJ O
expression NN O
correlated VBN O
with IN O
the DT O
loss NN O
of IN O
DNA NNP O
binding VBG O
activity NN O
of IN O
this DT O
protein NN O
. . O

We PRP O
present JJ O
evidence NN O
that IN O
the DT O
transition NN O
from IN O
G0 NNP O
/ NNP O
G1 NNP O
to TO O
S NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
results NNS O
in IN O
the DT O
down JJ O
- : O
regulation NN O
of IN O
RXRalpha NNP B-Gene
expression NN O
and CC O
that DT O
cell NN O
cycle NN O
inhibitors NNS O
, , O
which WDT O
block VBP O
the DT O
cells NNS O
in IN O
G1 NNP O
phase NN O
, , O
prevent NN O
this DT O
down RP O
- : O
regulation NN O
. . O

The DT O
decrease NN O
in IN O
the DT O
levels NNS O
of IN O
RXRalpha NNP B-Gene
mRNA NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
regulated VBN O
at IN O
the DT O
post NN O
- : O
transcriptional JJ O
level NN O
and CC O
involved JJ O
new JJ O
protein NN O
synthesis NN O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
the DT O
levels NNS O
of IN O
RXRalpha NNP B-Gene
expression NN O
in IN O
T NNP O
lymphocytes NNS O
are VBP O
coupled VBN O
to TO O
cell VB O
cycle NN O
progression NN O
, , O
and CC O
there EX O
is VBZ O
tight JJ O
regulatory JJ O
control NN O
of IN O
RXRalpha NNP B-Gene
expression NN O
during IN O
the DT O
transition NN O
from IN O
G0 NNP O
/ NNP O
G1 NNP O
to TO O
S NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
. . O

Epidemiology NN O
and CC O
pathogenesis NN O
of IN O
AIDS NNP O
- : O
related JJ O
lymphomas NN O
. . O

Among IN O
patients NNS O
with IN O
congenital JJ O
and CC O
acquired JJ O
immunodeficiencies NNS O
, , O
non SYM O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
( ( O
NHLs NNP O
) ) O
are VBP O
the DT O
most RBS O
common JJ O
tumors NNS O
of IN O
the DT O
immune NN O
system NN O
. . O

In IN O
the DT O
setting NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
infection NN O
, , O
as RB O
many JJ O
as IN O
10 CD O
% NN O
to TO O
20 CD O
% NN O
of IN O
people NNS O
ultimately RB O
developed VBD O
NHLs NNP O
. . O

These DT O
tumors NNS O
are VBP O
clinically RB O
aggressive JJ O
, , O
frequently RB O
involve VBP O
extranodal NN O
sites NNS O
, , O
and CC O
often RB O
exhibit NN O
unique JJ O
features NNS O
that WDT O
distinguish VBP O
them PRP O
from IN O
NHL NNP O
arising VBG O
in IN O
individuals NNS O
with IN O
other JJ O
forms NNS O
of IN O
immunosuppression NN O
. . O

Important NN O
in IN O
the DT O
development NN O
of IN O
HIV NNP O
- : O
associated VBN O
NHL NNP O
are VBP O
cytokines NNS B-Gene
and CC O
other JJ O
factors NNS O
that IN O
induce NN O
B NNP O
- : O
cell NN O
proliferation NN O
and CC O
increase VB O
the DT O
likelihood NN O
of IN O
mutations NNS O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
, , O
bcl SYM B-Gene
- : I-Gene
6 CD I-Gene
, , O
and CC O
other JJ O
tumor NN B-Gene
- : I-Gene
suppressor NN I-Gene
genes NNS I-Gene
with IN O
carcinogenic JJ O
potential NN O
. . O

Specific JJ O
forms NNS O
of IN O
HIV NNP O
- : O
associated VBN O
NHL NNP O
are VBP O
linked VBN O
to TO O
expression NN O
of IN O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
- : I-Gene
latent JJ I-Gene
proteins NNS I-Gene
; : O
the DT O
newly RB O
described VBN O
DNA NNP O
virus NN O
, , O
Karposi NNP O
' POS O
s NN O
sarcoma NN O
- : O
associated VBN O
herpesvirus NN O
/ NNP O
human JJ O
herpesvirus NN O
- : O
8 CD O
( ( O
KSHV NNP O
/ NNP O
HHV NNP O
- : O
8 CD O
) ) O
; : O
and CC O
perhaps RB O
HIV NNP O
. . O

Elucidation NN O
of IN O
the DT O
factors NNS O
that WDT O
contribute VBP O
to TO O
the DT O
high JJ O
incidence NN O
of IN O
NHL NNP O
among IN O
patients NNS O
infected VBN O
with IN O
HIV NNP O
provides VBZ O
insights NNS O
into IN O
important JJ O
elements NNS O
of IN O
lymphomagenesis NN O
. . O

Matrix NNP B-Gene
metalloproteinase NN I-Gene
expression NN O
in IN O
human JJ O
breast NN O
cancer NN O
: : O
an DT O
immunohistochemical JJ O
study NN O
including VBG O
correlation NN O
with IN O
cathepsin NN B-Gene
D NNP I-Gene
, , O
type NN B-Gene
IV NNP I-Gene
collagen NN I-Gene
, , O
laminin NN B-Gene
, , O
fibronectin NN B-Gene
, , O
EGFR NNP B-Gene
, , O
c SYM B-Gene
- : I-Gene
erbB SYM I-Gene
- : I-Gene
2 CD I-Gene
oncoprotein NN I-Gene
, , O
p53 NN B-Gene
, , O
steroid JJ O
receptors NNS O
status NN O
and CC O
proliferative JJ O
indices NNS O
. . O

Matrix NNP B-Gene
metalloproteinase NN I-Gene
s NN O
( ( O
MMPs NNP B-Gene
) ) O
are VBP O
a DT O
group NN O
of IN O
enzymes NNS O
thought VBN O
to TO O
be VB O
responsible JJ O
for IN O
both DT O
normal JJ O
connective JJ O
tissue NN O
matrix NN O
remodelling NN O
and CC O
accelerated VBD O
breakdown RB O
associated VBN O
with IN O
tumour NN O
development NN O
. . O

The DT O
current JJ O
study NN O
aimed VBD O
to TO O
investigate VB O
the DT O
immunohistochemical JJ O
expression NN O
of IN O
matrix JJ B-Gene
metalloproteinase NN I-Gene
3 CD I-Gene
( ( O
MMP NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
stromelysin VBD B-Gene
- : I-Gene
1 CD I-Gene
) ) O
in IN O
correlation NN O
with IN O
the DT O
expression NN O
of IN O
Basement NNP B-Gene
Membrane NNP I-Gene
( ( I-Gene
BM NNP I-Gene
) ) I-Gene
antigen NN I-Gene
( ( O
type JJ B-Gene
IV NNP I-Gene
collagen NN I-Gene
, , O
laminin NN B-Gene
) ) O
, , O
fibronectin RB B-Gene
, , O
cathepsin NN B-Gene
D NNP I-Gene
, , O
p53 NN B-Gene
, , O
c SYM B-Gene
- : I-Gene
erbB SYM I-Gene
- : I-Gene
2 CD I-Gene
, , O
proliferative JJ O
activity NN O
( ( O
Ki NNP B-Gene
- : I-Gene
67 CD I-Gene
, , O
PCNA NNP B-Gene
) ) O
, , O
steroid JJ O
receptor NN O
content NN O
as RB O
well RB O
as IN O
to TO O
the DT O
other JJ O
conventional JJ O
clinicopathological JJ O
parameters NNS O
in IN O
breast NN O
cancer NN O
. . O

This DT O
study NN O
was VBD O
performed VBN O
on IN O
a DT O
series NN O
of IN O
frozen JJ O
and CC O
paraffin JJ O
sections NNS O
from IN O
84 CD O
breast NN O
cancer NN O
specimens NNS O
by IN O
immunohistochemistry NN O
using VBG O
the DT O
monoclonal JJ B-Gene
antibody NN I-Gene
MMP NNP I-Gene
- : I-Gene
3 CD I-Gene
( ( O
Ab NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Stromelysin NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
ST1 NNP B-Gene
) ) O
was VBD O
observed VBN O
in IN O
about RB O
10 CD O
% NN O
of IN O
epithelial JJ O
cells NNS O
in IN O
the DT O
control NN O
groups NNS O
( ( O
cases NNS O
of IN O
fibrocystic JJ O
and CC O
benign JJ O
proliferative JJ O
breast NN O
disease NN O
) ) O
, , O
while IN O
expression NN O
( ( O
> JJ O
10 CD O
% NN O
of IN O
expression NN O
) ) O
was VBD O
detected VBN O
in IN O
89 CD O
. . O
7 CD O
% NN O
of IN O
tumours NN O
. . O

The DT O
expression NN O
of IN O
ST1 NNP B-Gene
in IN O
carcinoma NN O
cells NNS O
was VBD O
strongly RB O
associated VBN O
with IN O
its PRP$ O
presence NN O
in IN O
the DT O
stroma NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
. . O

A DT O
significantly RB O
positive JJ O
correlation NN O
was VBD O
found VBN O
between IN O
ST1 NNP B-Gene
expression NN O
, , O
and CC O
p53 VB B-Gene
tumour NN O
suppressor NN O
gene NN O
product NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
4 CD O
) ) O
, , O
and CC O
a DT O
relationship NN O
with IN O
c SYM B-Gene
- : I-Gene
erbB SYM I-Gene
- : I-Gene
2 CD I-Gene
protein NN O
and CC O
progesterone NN O
receptor NN O
status NN O
was VBD O
also RB O
indicated VBN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
ST1 NNP B-Gene
expression NN O
in IN O
breast NN O
cancer NN O
tissue NN O
is VBZ O
irrespective JJ O
of IN O
the DT O
expression NN O
of IN O
the DT O
extracellular JJ O
matrix NN O
component NN O
, , O
the DT O
proteolytic JJ B-Gene
enzyme NN I-Gene
cathepsin NN B-Gene
D NNP I-Gene
and CC O
the DT O
growth NN O
fraction NN O
of IN O
the DT O
tumour NN O
, , O
and CC O
that IN O
it PRP O
could MD O
be VB O
a DT O
potential JJ O
new JJ O
prognostic JJ O
marker NN O
in IN O
breast NN O
cancer NN O
. . O

Use NNP O
of IN O
transfected VBN O
liver NN O
cells NNS O
to TO O
evaluate VB O
potential JJ O
mechanisms NNS O
of IN O
alcohol NN O
- : O
induced VBN O
liver JJ O
injury NN O
[ NNP O
see VBP O
comments NNS O
] VB O

There EX O
is VBZ O
increased JJ O
activity NN O
of IN O
the DT O
proinflammatory NN B-Gene
cytokine NN I-Gene
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
in IN O
alcoholic JJ O
liver NN O
disease NN O
( ( O
ALD NNP O
) ) O
. . O

Hepatic JJ O
neutrophil DT O
infiltration NN O
is VBZ O
a DT O
principal JJ O
injurious JJ O
manifestation NN O
of IN O
ALD NNP O
. . O

TNF NNP B-Gene
can MD O
induce VB O
cellular JJ O
oxidative JJ O
injury NN O
directly RB O
, , O
and CC O
indirectly RB O
by IN O
inducing VBG O
neutrophil JJ O
chemotactic JJ O
factor NN O
( ( O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
production NN O
by IN O
hepatocytes NNS O
. . O

IL NNP B-Gene
- : I-Gene
8 CD I-Gene
activates NNS O
and CC O
chemotactically RB O
attracts VBZ O
neutrophils NNS O
to TO O
the DT O
liver NN O
where WRB O
they PRP O
release VBP O
oxidizing VBG O
substances NNS O
. . O

Patients NNS O
with IN O
ALD NNP O
also RB O
have VBP O
decreased VBN O
protective JJ B-Gene
factors NNS I-Gene
for IN O
cellular JJ O
oxidative JJ O
injury NN O
. . O

Manganous JJ B-Gene
superoxide NN I-Gene
dismutase NN I-Gene
( ( O
MnSOD NNP B-Gene
) ) O
is VBZ O
an DT O
antioxidant JJ B-Gene
protective JJ I-Gene
factor NN I-Gene
. . O

The DT O
objectives NNS O
of IN O
these DT O
studies NNS O
were VBD O
to TO O
investigate VB O
mechanisms NNS O
for IN O
induction NN O
of IN O
an DT O
injurious JJ B-Gene
factor NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
and CC O
a DT O
protective JJ B-Gene
factor NN I-Gene
( ( O
MnSOD NNP B-Gene
) ) O
in IN O
the DT O
HepG2 NNP O
human JJ O
hepatoma NN O
cell NN O
line NN O
. . O

In IN O
the DT O
first JJ O
set NN O
of IN O
experiments NNS O
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
gene NN I-Gene
reporter NN I-Gene
constructs NNS I-Gene
were VBD O
used VBN O
to TO O
transiently RB O
transfect VB O
a DT O
derivative JJ O
( ( O
MVh2E1 NNP O
- : O
9 CD O
) ) O
of IN O
the DT O
HepG2 NNP O
cell NN O
line NN O
which WDT O
expresses VBZ O
P NNP B-Gene
- : I-Gene
45020 CD I-Gene
and CC O
metabolizes NNS O
ethanol VBP O
. . O

Inactivation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC I-Gene
3 CD I-Gene
' '' I-Gene
NF NNP I-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
DNA NN I-Gene
binding NN I-Gene
sites NNS I-Gene
decreased VBD O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
gene NN I-Gene
transcriptional JJ O
activation NN O
in IN O
response NN O
to TO O
TNF NNP B-Gene
while IN O
inactivation NN O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
NF NNP I-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
binding VBG I-Gene
site NN I-Gene
increased VBD O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
gene NN I-Gene
transcriptional JJ O
activity NN O
in IN O
response NN O
to TO O
TNF NNP B-Gene
. . O

This DT O
system NN O
may MD O
be VB O
useful JJ O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
ethanol NN O
on IN O
TNF NNP B-Gene
- : O
induced VBD O
hepatocyte JJ O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
production NN O
. . O

In IN O
the DT O
second JJ O
set NN O
of IN O
experiments NNS O
, , O
HepG2 NNP O
cells NNS O
were VBD O
cultured VBN O
in IN O
25 CD O
to TO O
100 CD O
mmol JJ O
concentrations NNS O
of IN O
ethanol NN O
. . O

Both DT O
TNF NNP B-Gene
and CC O
ethanol NN O
increased VBD O
HepG2 NNP O
cell NN O
MnSOD NNP B-Gene
activity NN O
in IN O
short JJ O
- : O
term NN O
( ( O
72 CD O
hr NN O
) ) O
cultures VBZ O
with IN O
ethanol NN O
. . O

However RB O
, , O
after IN O
long JJ O
- : O
term NN O
( ( O
10 CD O
weeks NNS O
) ) O
culture NN O
with IN O
ethanol NN O
, , O
there EX O
was VBD O
no DT O
induction NN O
of IN O
MnSOD NNP B-Gene
by IN O
ethanol NN O
and CC O
there EX O
was VBD O
a DT O
diminished JJ O
induction NN O
of IN O
MnSOD NNP B-Gene
in IN O
response NN O
to TO O
TNF NNP B-Gene
. . O

Further JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
assess VB O
the DT O
effect NN O
of IN O
this DT O
diminished JJ O
induction NN O
of IN O
MnSOD NNP B-Gene
with IN O
chronic JJ O
ethanol JJ O
culture NN O
on IN O
HepG2 NNP O
cell NN O
susceptibility NN O
to TO O
TNF NNP O
cytotoxicity NN O
. . O

We PRP O
conclude VBP O
that IN O
transfected VBD O
liver RB O
cell NN O
lines NNS O
can MD O
be VB O
used VBN O
to TO O
evaluate VB O
mechanisms NNS O
for IN O
increased JJ O
injurious JJ B-Gene
factors NNS I-Gene
and CC O
decreased JJ O
protective JJ B-Gene
factors NNS I-Gene
in IN O
alcoholic JJ O
liver JJ O
injury NN O
. . O

Tissue NNP O
factor NN O
transcription NN O
driven VBN O
by IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
a DT O
critical JJ O
mechanism NN O
of IN O
murine NN B-Gene
pulmonary JJ I-Gene
fibrin NN I-Gene
deposition NN O
in IN O
hypoxia NN O
. . O

Local JJ O
hypoxemia NN O
and CC O
stasis NN O
trigger NN O
thrombosis NN O
. . O

We PRP O
have VBP O
demonstrated VBN O
previously RB O
that IN O
in IN O
a DT O
murine JJ O
model NN O
of IN O
normobaric JJ O
hypoxia NN O
pulmonary JJ O
fibrin NN B-Gene
deposition NN O
is VBZ O
a DT O
result NN O
of IN O
expression NN O
of IN O
tissue NN B-Gene
factor NN I-Gene
, , O
especially RB O
in IN O
oxygen NN B-Gene
- : I-Gene
deprived VBN I-Gene
mononuclear JJ I-Gene
phagocytes NNS I-Gene
( ( O
MPs NNP B-Gene
) ) O
. . O

We PRP O
now RB O
show VBP O
that IN O
transcription NN B-Gene
factor NN I-Gene
early JJ I-Gene
- : I-Gene
growth NN I-Gene
- : I-Gene
response NN I-Gene
gene NN I-Gene
product NN I-Gene
( ( O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
rapidly RB O
activated VBN O
in IN O
hypoxia NN O
, , O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
, , O
and CC O
is VBZ O
responsible JJ O
for IN O
transcription NN O
and CC O
expression NN O
of IN O
tissue NN B-Gene
factor NN I-Gene
in IN O
hypoxic NN O
lung NN O
. . O

MPs NNP B-Gene
and CC O
HeLa NNP O
cells NNS O
subjected VBD O
to TO O
hypoxia VB O
( ( O
pO2 VB O
approximately RB O
13 CD O
torr NN O
) ) O
had VBD O
increased VBN O
levels NNS O
of IN O
tissue NN B-Gene
factor NN I-Gene
transcripts NNS I-Gene
( ( O
approximately RB O
18 CD O
- : O
fold NN O
) ) O
and CC O
an DT O
increased JJ O
rate NN O
of IN O
transcription NN O
( ( O
approximately RB O
15 CD O
- : O
fold NN O
) ) O
, , O
based VBN O
on IN O
nuclear JJ O
run VBN O
- : O
on IN O
analysis NN O
. . O

Gel NNP O
- : O
shift NN O
analysis NN O
of IN O
nuclear JJ O
extracts NNS O
from IN O
hypoxic NN B-Gene
MPs NNP I-Gene
and CC O
HeLa NNP O
cells NNS O
demonstrated VBD O
increased JJ O
DNA NNP O
- : O
binding NN O
activity NN O
at IN O
the DT O
serum NN B-Gene
response NN I-Gene
region NN I-Gene
( ( O
SRR NNP O
; : O
- : O
111 CD O
/ JJ O
+ $ O
14 CD O
bp NN O
) ) O
of IN O
the DT O
tissue NN B-Gene
factor NN I-Gene
promoter NN I-Gene
at IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
motifs NNS I-Gene
. . O

Using VBG O
32P CD O
- : O
labeled VBN O
Egr NNP O
consensus NN O
oligonucleotide RB O
, , O
we PRP O
observed VBD O
induction NN O
of IN O
DNA NNP O
- : O
binding NN O
activity NN O
in IN O
nuclear JJ O
extracts NNS O
from IN O
hypoxic NN O
lung NN O
and CC O
HeLa NNP O
cells NNS O
because IN O
of IN O
activation NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
by IN O
means NNS O
of IN O
supershift NN O
analysis NN O
. . O

Transient JJ O
transfection NN O
of IN O
HeLa NNP O
cells NNS O
with IN O
chimeric JJ B-Gene
plasmids NNS I-Gene
containing VBG O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
or CC I-Gene
mutant JJ I-Gene
SRR NN I-Gene
from IN O
the DT O
tissue NN B-Gene
factor NN I-Gene
promoter NN I-Gene
showed VBD O
that IN O
intact JJ B-Gene
Sp1 NNP I-Gene
sites NNS I-Gene
are VBP O
necessary JJ O
for IN O
basal JJ O
promoter NN O
activity NN O
, , O
whereas IN O
the DT O
integrity NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
sites NNS I-Gene
was VBD O
required VBN O
for IN O
hypoxia JJ O
- : O
enhanced JJ O
expression NN O
. . O

A DT O
central JJ O
role NN O
for IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
hypoxia NN O
- : O
mediated VBN O
tissue NN O
factor NN O
expression NN O
was VBD O
confirmed VBN O
by IN O
experiments NNS O
with IN O
homozygous JJ O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
null JJ O
mice NN O
; : O
wild JJ O
- : O
type NN O
mice NN O
subjected VBD O
to TO O
oxygen VB B-Gene
deprivation NN I-Gene
expressed VBN I-Gene
tissue NN I-Gene
factor NN I-Gene
and CC O
showed VBD O
fibrin JJ B-Gene
deposition NN O
, , O
but CC O
hypoxic RB O
homozygous JJ O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
null JJ O
mice NN O
displayed VBD O
neither CC O
tissue NN B-Gene
factor NN I-Gene
nor CC O
fibrin NN B-Gene
. . O

These DT O
data NNS O
delineate VBP O
a DT O
novel JJ O
biology NN O
for IN O
hypoxia JJ O
- : O
induced JJ O
fibrin JJ B-Gene
deposition NN O
, , O
in IN O
which WDT O
oxygen NN O
deprivation NN O
- : O
induced JJ O
activation NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
resulting VBG O
in IN O
expression NN O
of IN O
tissue NN B-Gene
factor NN I-Gene
, , O
has VBZ O
an DT O
unexpected JJ O
and CC O
central JJ O
role NN O
. . O

Kinetics NNS O
of IN O
cytokine NN O
and CC O
NFAT NNP O
gene NN O
expression NN O
in IN O
human JJ O
interleukin JJ O
- : O
2 CD O
- : O
dependent NN O
T NNP O
lymphoblasts VBZ O
stimulated VBD O
via IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
. . O

T NNP O
cells NNS O
respond NN O
to TO O
mitogenic VB O
or CC O
antigenic JJ O
stimulation NN O
by IN O
proliferation NN O
and CC O
by IN O
turning VBG O
on IN O
cytokine NN O
gene NN O
expression NN O
. . O

Here RB O
we PRP O
have VBP O
analysed VBN O
the DT O
kinetics NNS O
and CC O
nature NN O
of IN O
cytokine NN O
production NN O
in IN O
human JJ O
peripheral JJ O
blood NN O
- : O
derived VBN O
T NNP O
lymphoblasts NNS O
stimulated VBD O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
antibodies NNS I-Gene
or CC O
Lens NNP B-Gene
culinaris VBP I-Gene
lectin NN I-Gene
( ( O
LCL NNP B-Gene
) ) O
. . O

T NNP O
cells NNS O
were VBD O
purified VBN O
from IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
and CC O
primarily RB O
activated VBN O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
antibodies NNS I-Gene
and CC O
cultured VBN O
in IN O
the DT O
presence NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

Anti NNP O
- : O
CD3 NNP O
- : O
restimulated VBD O
T NNP O
cells NNS O
( ( O
mainly RB O
CD8 NNP O
+ NNP O
) ) O
produced VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
interferon SYM B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
and CC O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
and CC O
low JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC I-Gene
IL NNP I-Gene
- : I-Gene
10 CD I-Gene
transcripts NNS I-Gene
and CC O
proteins NNS O
. . O

No DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
expression NN O
was VBD O
observed VBN O
. . O

In IN O
LCL NNP O
- : O
stimulated VBD O
cells NNS O
the DT O
cytokine NN O
production NN O
pattern NN O
was VBD O
very RB O
similar JJ O
. . O

Steady JJ O
- : O
state NN O
mRNA NN O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
peaked VBD O
at IN O
3 CD O
hr NN O
after IN O
anti JJ O
- : O
CD3 NNP O
stimulation NN O
and CC O
declined VBD O
rapidly RB O
thereafter RB O
. . O

The DT O
kinetics NNS O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
mRNA JJ I-Gene
expression NN O
was VBD O
faster RBR O
, , O
being VBG O
at IN O
its PRP$ O
peak JJ O
level NN O
1 CD O
hr NN O
after IN O
stimulation NN O
. . O

Anti NNP O
- : O
CD3 NNP O
- : O
stimulated VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
expression NN O
was VBD O
down RB O
- : O
regulated VBN O
by IN O
protein JJ O
synthesis NN O
inhibitor NN O
, , O
whereas WP O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
, , I-Gene
IFN NNP I-Gene
- : I-Gene
gamma NN I-Gene
and CC I-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
genes NNS I-Gene
were VBD O
readily RB O
induced JJ O
independent JJ O
of IN O
ongoing VBG O
protein NN O
synthesis NN O
. . O

T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
stimulation NN O
also RB O
induced VBD O
a DT O
very RB O
rapid JJ O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
, , I-Gene
c SYM I-Gene
- : I-Gene
fos NN I-Gene
and CC I-Gene
NFATc1 NNP I-Gene
( ( I-Gene
NFATc NNP I-Gene
) ) I-Gene
genes NNS I-Gene
, , O
the DT O
gene NN O
products NNS O
of IN O
which WDT O
are VBP O
involved VBN O
in IN O
cytokine JJ O
gene NN O
expression NN O
. . O

In IN O
conclusion NN O
, , O
the DT O
cytokines NNS B-Gene
synthesized VBN O
by IN O
IL NNP O
- : O
2 CD O
- : O
dependent NN O
T NNP O
cells NNS O
were VBD O
predominantly RB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

An DT O
animal JJ O
model NN O
to TO O
study VB O
local JJ O
oxidation NN O
of IN O
LDL NNP O
and CC O
its PRP$ O
biological JJ O
effects NNS O
in IN O
the DT O
arterial JJ O
wall NN O
. . O

Oxidized VBN O
LDL NNP O
( ( O
oxLDL NN O
) ) O
is VBZ O
present JJ O
in IN O
atherosclerotic JJ O
lesions NNS O
and CC O
is VBZ O
believed VBN O
to TO O
play VB O
a DT O
key JJ O
role NN O
in IN O
atherogenesis NN O
. . O

Mainly RB O
on IN O
the DT O
basis NN O
of IN O
cell NN O
culture NN O
studies NNS O
, , O
oxLDL NN O
has VBZ O
been VBN O
shown VBN O
to TO O
produce VB O
many JJ O
biological JJ O
effects NNS O
that WDT O
influence VBP O
the DT O
atherosclerotic JJ O
process NN O
. . O

To TO O
study VB O
LDL NNP O
oxidation NN O
in IN O
vivo NN O
, , O
we PRP O
have VBP O
established VBN O
a DT O
model NN O
in IN O
which WDT O
Sprague NNP O
- : O
Dawley NNP O
rats NNS O
are VBP O
given VBN O
a DT O
single JJ O
injection NN O
of IN O
unmodified JJ O
human JJ O
LDL NNP O
( ( O
> CD O
or CC O
= VB O
4 CD O
mg NN O
/ NNP O
kg VBZ O
body NN O
weight NN O
) ) O
. . O

Within IN O
6 CD O
hours NNS O
, , O
an DT O
accumulation NN O
of IN O
apolipoprotein NN O
B NNP O
and CC O
epitopes VBZ B-Gene
present JJ O
on IN O
oxLDL NN O
are VBP O
detected VBN O
in IN O
the DT O
arterial JJ O
endothelium NN O
and CC O
media NNS O
. . O

The DT O
presence NN O
of IN O
oxLDL NN O
is VBZ O
associated VBN O
with IN O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
the DT O
endothelium NN O
as RB O
well RB O
as IN O
endothelial JJ O
expression NN O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

Injection NN O
of IN O
LDL NNP O
enriched VBD O
with IN O
the DT O
antioxidant JJ O
probucol NN O
resulted VBD O
in IN O
arterial JJ O
accumulation NN O
of IN O
apolipoprotein NN O
B NNP O
, , O
but CC O
the DT O
expression NN O
of IN O
oxLDL JJ O
- : O
specific JJ O
epitopes NNS O
was VBD O
reduced VBN O
at IN O
24 CD O
hours NNS O
. . O

Thus RB O
, , O
this DT O
simple JJ O
model NN O
has VBZ O
the DT O
potential JJ O
to TO O
analyze VB O
the DT O
mechanisms NN O
behind IN O
and CC O
biological JJ O
effects NNS O
of IN O
LDL NNP O
oxidation NN O
in IN O
vivo NN O
. . O

Molecular JJ O
mechanisms NNS O
of IN O
promoter NN O
regulation NN O
of IN O
the DT O
gp34 NN B-Gene
gene NN I-Gene
that WDT O
is VBZ O
trans JJ O
- : O
activated VBN O
by IN O
an DT O
oncoprotein JJ B-Gene
Tax NN I-Gene
of IN O
human JJ O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
. . O

We PRP O
investigated VBD O
the DT O
molecular JJ O
mechanism NN O
of IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
gp34 NN B-Gene
gene NN I-Gene
by IN O
the DT O
Tax NNP B-Gene
oncoprotein NN I-Gene
of IN O
human JJ O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
. . O

gp34 NN B-Gene
is VBZ O
a DT O
type NN B-Gene
II NNP I-Gene
transmembrane NN I-Gene
molecule NN I-Gene
belonging VBG O
to TO O
the DT O
tumor NN O
necrosis NN O
factor NN O
family NN O
and CC O
is VBZ O
constitutively RB O
expressed VBN O
on IN O
HTLV NNP O
- : O
I PRP O
- : O
producing VBG O
cells NNS O
but CC O
not RB O
normal JJ O
resting VBG O
T NNP O
cells NNS O
. . O

The DT O
transcriptional JJ O
regulatory JJ O
region NN O
of IN O
the DT O
gp34 NN B-Gene
gene NN I-Gene
was VBD O
activated VBN O
by IN O
HTLV NNP O
- : O
I PRP O
Tax VBP B-Gene
in IN O
the DT O
human JJ O
T NNP O
cell NN O
line NN O
Jurkat NNP O
, , O
in IN O
which WDT O
endogenous JJ O
gp34 NN B-Gene
is VBZ O
induced VBN O
by IN O
Tax NNP B-Gene
. . O

Sequence NN O
analysis NN O
demonstrated VBD O
that IN O
two CD O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
( ( O
1 CD O
and CC O
2 CD O
) ) O
were VBD O
present JJ O
in IN O
the DT O
regulatory JJ B-Gene
region NN I-Gene
. . O

Both DT O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
were VBD O
able JJ O
to TO O
bind VB O
to TO O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
or CC O
its PRP$ O
related JJ O
factor NN O
( ( O
s NN O
) ) O
in IN O
a DT O
Tax NNP B-Gene
- : O
dependent NN O
manner NN O
. . O

Chloramphenicol NNP B-Gene
acetyltransferase NN I-Gene
assays NNS O
indicated VBD O
that IN O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
element NN I-Gene
1 CD I-Gene
was VBD O
Tax NNP B-Gene
- : O
responsive NN O
, , O
although IN O
the DT O
activity NN O
was VBD O
lower JJR O
than IN O
that IN O
the DT O
native JJ B-Gene
promoter NN I-Gene
. . O

NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : O
like IN O
element NN O
2 CD O
elevated JJ O
promoter NN O
activity NN O
when WRB O
combined VBN O
with IN O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
element NN I-Gene
1 CD I-Gene
, , O
indicating VBG O
cooperative JJ O
function NN O
of IN O
the DT O
elements NNS O
for IN O
maximum JJ O
promoter NN O
function NN O
. . O

Unlike IN O
typical JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
elements NNS I-Gene
, , O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
in IN O
gp34 NN B-Gene
were VBD O
not RB O
activated VBN O
by IN O
treatment NN O
of IN O
Jurkat NNP O
cells NNS O
with IN O
phorbol NN O
ester NN O
despite IN O
induction NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : O
like IN O
binding VBG O
activity NN O
. . O

Chloramphenicol NNP B-Gene
acetyltransferase NN I-Gene
reporter NN O
assays NNS O
using VBG O
the DT O
region NN O
upstream NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
identified VBN O
an DT O
upstream JJ O
region NN O
that IN O
reduced VBD O
transcription NN O
from IN O
cognate NN B-Gene
and CC I-Gene
noncognate NN I-Gene
core NN I-Gene
promoters NNS I-Gene
in IN O
a DT O
Tax NNP O
- : O
independent JJ O
manner NN O
. . O

Our PRP$ O
results NNS O
imply VB O
complex JJ O
regulation NN O
of IN O
expression NN O
of IN O
the DT O
gp34 JJ B-Gene
gene NN I-Gene
and CC O
suggest JJS O
implication NN O
of IN O
gp34 NN B-Gene
in IN O
proliferation NN O
of IN O
HTLV NNP O
- : O
I PRP O
infected VBD O
T NNP O
cells NNS O
. . O

beta SYM B-Gene
- : I-Gene
Amyloid NNP I-Gene
fibrils VBZ I-Gene
activate VBP O
parallel JJ O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathways NNS O
in IN O
microglia NN O
and CC O
THP1 NNP O
monocytes NNS O
. . O

The DT O
senile JJ O
plaques NNS O
of IN O
Alzheimer NNP O
' POS O
s NN O
disease NN O
are VBP O
foci VBN O
of IN O
local JJ O
inflammatory NN O
responses NNS O
, , O
as IN O
evidenced VBN O
by IN O
the DT O
presence NN O
of IN O
acute JJ B-Gene
phase NN I-Gene
proteins NNS I-Gene
and CC O
oxidative JJ O
damage NN O
. . O

Fibrillar JJ B-Gene
forms NNS I-Gene
of IN O
beta NN B-Gene
- : I-Gene
amyloid NN I-Gene
( ( O
Abeta NNP B-Gene
) ) O
, , O
which WDT O
are VBP O
the DT O
primary JJ O
constituents NNS O
of IN O
senile NN O
plaques NNS O
, , O
have VBP O
been VBN O
shown VBN O
to TO O
activate VB O
tyrosine JJ O
kinase NN O
- : O
dependent JJ O
signal JJ O
transduction NN O
cascades NNS O
, , O
resulting VBG O
in IN O
inflammatory JJ O
responses NNS O
in IN O
microglia NN O
. . O

However RB O
, , O
the DT O
downstream NN O
signaling VBG O
pathways NNS O
mediating VBG O
Abeta NNP B-Gene
- : O
induced JJ O
inflammatory JJ O
events NNS O
are VBP O
not RB O
well RB O
characterized VBN O
. . O

We PRP O
report VBP O
that DT O
exposure NN O
of IN O
primary JJ O
rat NN O
microglia NN O
and CC O
human JJ O
THP1 NNP O
monocytes NNS O
to TO O
fibrillar JJ B-Gene
Abeta NNP I-Gene
results NNS O
in IN O
the DT O
tyrosine NN B-Gene
kinase NN I-Gene
- : O
dependent JJ O
activation NN O
of IN O
two CD O
parallel JJ O
signal JJ O
transduction NN O
cascades NNS O
involving VBG O
members NNS O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( I-Gene
MAPK NNP I-Gene
) ) I-Gene
superfamily RB I-Gene
. . O

Abeta NNP B-Gene
stimulated VBD O
the DT O
rapid JJ O
, , O
transient JJ O
activation NN O
of IN O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
( ( O
ERK1 NNP B-Gene
) ) O
and CC O
ERK2 NNP B-Gene
in IN O
microglia NN O
and CC O
ERK2 NNP B-Gene
in IN O
THP1 NNP O
monocytes NNS O
. . O

A DT O
second JJ O
superfamily JJ B-Gene
member NN I-Gene
, , O
p38 NN B-Gene
MAPK NNP I-Gene
, , O
was VBD O
also RB O
activated VBN O
with IN O
similar JJ O
kinetics NNS O
. . O

Scavenger NNP B-Gene
receptor NN I-Gene
and CC O
receptor NN B-Gene
for IN I-Gene
advanced JJ I-Gene
glycated JJ I-Gene
end NN I-Gene
products NNS I-Gene
( ( O
RAGE NNP B-Gene
) ) O
ligands VBZ O
failed JJ O
to TO O
activate VB O
ERK NNP B-Gene
and CC O
p38 JJ B-Gene
MAPK NNP I-Gene
in IN O
the DT O
absence NN O
of IN O
significant JJ O
increases NNS O
in IN O
protein JJ O
tyrosine JJ O
phosphorylation NN O
, , O
demonstrating VBG O
that IN O
scavenger NN B-Gene
receptors NNS I-Gene
and CC O
RAGE NNP B-Gene
are VBP O
not RB O
linked VBN O
to TO O
these DT O
pathways NNS O
. . O

Importantly RB O
, , O
the DT O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinases NNS I-Gene
( ( O
SAPKs NNP B-Gene
) ) O
were VBD O
not RB O
significantly RB O
activated VBN O
in IN O
response NN O
to TO O
Abeta NNP B-Gene
. . O

Downstream NNP O
effectors NNS O
of IN O
the DT O
MAPK NNP O
signal JJ O
transduction NN O
cascades NNS O
include VBP O
MAPKAP NNP B-Gene
kinases NNS I-Gene
, , O
such JJ O
as IN O
RSK1 NNP B-Gene
and CC O
RSK2 NNP B-Gene
, , O
as RB O
well RB O
as IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

Exposure NN O
of IN O
microglia NN O
and CC O
THP1 NNP O
monocytes NNS O
to TO O
Abeta NNP B-Gene
resulted VBD O
in IN O
the DT O
activation NN O
of IN O
RSK1 NNP B-Gene
and CC O
RSK2 NNP B-Gene
and CC O
phosphorylation NN O
of IN O
cAMP NN B-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
at IN O
Ser133 NNP O
, , O
providing VBG O
a DT O
mechanism NN O
for IN O
Abeta NNP B-Gene
- : O
induced JJ O
changes NNS O
in IN O
gene NN O
expression NN O

Regulation NN O
of IN O
cellular JJ B-Gene
retinoic NN I-Gene
acid NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
CRABP NNP B-Gene
II NNP I-Gene
) ) O
during IN O
human JJ O
monocyte JJ O
differentiation NN O
in IN O
vitro NN O
. . O

Cellular JJ B-Gene
retinoic NN I-Gene
acid NN I-Gene
binding VBG I-Gene
proteins NNS I-Gene
( ( O
CRABP NNP B-Gene
) ) O
are VBP O
low JJ B-Gene
molecular JJ I-Gene
weight NN I-Gene
proteins NNS I-Gene
whose WP$ O
precise JJ O
function NN O
remains VBZ O
unknown JJ O
. . O

They PRP O
bind VBP O
retinoids NNS O
and CC O
may MD O
thereby VB O
modulate VB O
the DT O
intracellular JJ O
steady JJ O
- : O
state NN O
concentration NN O
of IN O
retinoids NNS O
. . O

Whereas IN O
CRABP NNP B-Gene
I PRP I-Gene
is VBZ O
ubiquitously RB O
expressed VBN O
, , O
CRABP NNP B-Gene
II NNP I-Gene
is VBZ O
mainly RB O
detected VBN O
in IN O
various JJ O
cell NN O
types NNS O
of IN O
the DT O
skin NN O
. . O

By IN O
representative JJ O
difference NN O
analysis NN O
we PRP O
found VBD O
that IN O
CRABP NNP B-Gene
II NNP I-Gene
is VBZ O
also RB O
strongly RB O
expressed VBN O
in IN O
human JJ O
monocyte NN O
- : O
derived VBN O
macrophages NNS O
( ( O
MAC NNP O
) ) O
but CC O
not RB O
in IN O
freshly RB O
isolated VBN O
monocytes NNS O
( ( O
MO NNP O
) ) O
. . O

The DT O
CRABP NNP B-Gene
II NNP I-Gene
mRNA NN I-Gene
was VBD O
gradually RB O
upregulated JJ O
during IN O
differentiation NN O
from IN O
MO NNP O
to TO O
MAC NNP O
in IN O
the DT O
presence NN O
of IN O
2 CD O
% NN O
serum NN O
. . O

Adherence NNP O
, , O
which WDT O
is VBZ O
important JJ O
for IN O
MO NNP O
differentiation NN O
, , O
induced VBD O
CRABP NNP B-Gene
II NNP I-Gene
expression NN O
, , O
but CC O
the DT O
addition NN O
of IN O
10 CD O
( ( O
- : O
7 CD O
) ) O
M NNP O
retinoic NN O
acid NN O
inhibited VBD O
the DT O
upregulation NN O
of IN O
CRABP NNP B-Gene
II NNP I-Gene
expression NN O
during IN O
MO NNP O
/ NNP O
MAC NNP O
differentiation NN O
. . O

As IN O
MO NNP O
can MD O
differentiate VB O
along IN O
the DT O
classical JJ O
pathway NN O
not RB O
only RB O
to TO O
MAC NNP O
but CC O
also RB O
to TO O
dendritic JJ O
cells NNS O
we PRP O
analyzed VBD O
the DT O
expression NN O
of IN O
CRABP NNP B-Gene
II NNP I-Gene
in IN O
MO NNP O
- : O
derived VBD O
dendritic JJ O
cells NNS O
cultured VBN O
with IN O
10 CD O
% NN O
FCS NNP B-Gene
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
and CC O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

In IN O
contrast NN O
to TO O
MAC NNP O
, , O
MO NNP O
- : O
derived VBD O
dendritic JJ O
cells NNS O
showed VBD O
an DT O
extremely RB O
low JJ O
expression NN O
of IN O
CRABP NNP B-Gene
II NNP I-Gene
. . O

From IN O
these DT O
results NNS O
we PRP O
conclude VBP O
( ( O
1 CD O
) ) O
that IN O
the DT O
availability NN O
and CC O
the DT O
metabolism NN O
of IN O
retinoids NNS O
may MD O
be VB O
different JJ O
in IN O
MAC NNP O
compared VBN O
to TO O
MO NNP O
and CC O
dendritic JJ O
cells NNS O
and CC O
( ( O
2 CD O
) ) O
that IN O
this DT O
may MD O
influence VB O
differentiation NN O
and CC O
activation NN O
of IN O
those DT O
cells NNS O
. . O

Transcription NNP B-Gene
factor NN I-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
( ( O
BSAP NNP B-Gene
) ) O
is VBZ O
differentially RB O
expressed VBN O
in IN O
B NNP O
cells NNS O
and CC O
in IN O
subsets NNS O
of IN O
B NNP O
- : O
cell NN O
lymphomas NN O
. . O

The DT O
paired JJ B-Gene
box NN I-Gene
containing VBG I-Gene
gene NN I-Gene
PAX NNP B-Gene
- : I-Gene
5 CD I-Gene
encodes IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
BSAP NNP B-Gene
( ( O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
) ) O
, , O
which WDT O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
B NNP O
- : O
lymphocyte NN O
development NN O
. . O

Despite IN O
its PRP$ O
known JJ O
involvement NN O
in IN O
a DT O
rare JJ O
subtype NN O
of IN O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
( ( O
NHL NNP O
) ) O
, , O
a DT O
detailed JJ O
examination NN O
of IN O
BSAP NNP B-Gene
expression NN O
in IN O
NHL NNP O
has VBZ O
not RB O
been VBN O
previously RB O
reported VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
analyzed VBD O
normal JJ O
and CC O
malignant JJ O
lymphoid NN O
tissues NNS O
and CC O
cell NN O
lines NNS O
, , O
including VBG O
102 CD O
cases NNS O
of IN O
B NNP O
- : O
cell NN O
NHL NNP O
, , O
23 CD O
cases NNS O
of IN O
T NNP O
- : O
and CC O
null JJ O
- : O
cell NN O
NHL NNP O
, , O
and CC O
18 CD O
cases NNS O
of IN O
Hodgkin NNP O
' POS O
s JJ O
disease NN O
. . O

Normal NNP O
lymphoid NN O
tissues NNS O
showed VBD O
strong JJ O
nuclear JJ O
BSAP NNP B-Gene
expression NN O
in IN O
mantle JJ O
zone NN O
B NNP O
cells NNS O
, , O
less JJR O
intense JJ O
reactivity NN O
in IN O
follicular JJ O
center NN O
B NNP O
cells NNS O
, , O
and CC O
no DT O
expression NN O
in IN O
cells NNS O
of IN O
the DT O
T NNP O
- : O
cell NN O
- : O
rich JJ O
zones NNS O
. . O

Monocytoid NNP O
B NNP O
cells NNS O
showed VBD O
weak JJ O
expression NN O
, , O
whereas WP O
plasma VBP O
cells NNS O
and CC O
extrafollicular JJ O
large JJ O
transformed VBN O
B NNP O
cells NNS O
were VBD O
negative JJ O
. . O

Of IN O
the DT O
102 CD O
B NNP O
- : O
cell NN O
NHLs NNP O
, , O
83 CD O
( ( O
81 CD O
% NN O
) ) O
demonstrated VBD O
BSAP NNP B-Gene
expression NN O
. . O

All DT O
of IN O
the DT O
13 CD O
( ( O
100 CD O
% NN O
) ) O
B NNP O
- : O
cell NN O
chronic JJ O
lymphocytic JJ O
leukemias NN O
( ( O
B NNP O
- : O
CLLs NN O
) ) O
, , O
21 CD O
of IN O
( ( O
100 CD O
% NN O
) ) O
mantle NN O
cells NNS O
( ( O
MCLs NNP O
) ) O
, , O
and CC O
20 CD O
of IN O
21 CD O
( ( O
95 CD O
% NN O
) ) O
follicular NN O
lymphomas NN O
( ( O
FLs NNP O
) ) O
were VBD O
positive JJ O
. . O

Moderate NNP O
staining VBG O
intensities NNS O
were VBD O
found VBN O
in IN O
most JJS O
B NNP O
- : O
CLL NN O
and CC O
FL NNP O
cases NNS O
, , O
whereas VBP O
most JJS O
MCLs NNP O
showed VBD O
strong JJ O
reactions NNS O
, , O
paralleling VBG O
the DT O
strong JJ O
reactivity NN O
of IN O
nonmalignant JJ O
mantle JJ O
cells NNS O
. . O

Eight CD O
of IN O
12 CD O
( ( O
67 CD O
% NN O
) ) O
marginal JJ O
zone NN O
lymphoma NN O
cases NNS O
showed VBD O
negative JJ O
or CC O
low JJ O
BSAP NNP B-Gene
levels NNS O
, , O
and CC O
17 CD O
of IN O
24 CD O
( ( O
71 CD O
% NN O
) ) O
large JJ O
B NNP O
- : O
cell NN O
lymphomas VBZ O
displayed VBN O
moderate JJ O
to TO O
strong JJ O
expression NN O
. . O

None NN O
of IN O
the DT O
23 CD O
T NNP O
- : O
and CC O
null JJ O
- : O
cell NN O
lymphomas RB O
reacted VBD O
with IN O
the DT O
BSAP NNP B-Gene
antisera NN O
, , O
whereas NNS O
in IN O
Hodgkin NNP O
' POS O
s NN O
disease NN O
, , O
2 CD O
of IN O
4 CD O
( ( O
50 CD O
% NN O
) ) O
nodular JJ O
lymphocytic JJ O
predominance NN O
and CC O
5 CD O
of IN O
14 CD O
( ( O
36 CD O
% NN O
) ) O
classical JJ O
cases NNS O
showed VBD O
weak JJ O
nuclear JJ O
or CC O
nucleolar JJ O
BSAP NNP B-Gene
reactions NNS O
in IN O
a DT O
fraction NN O
of IN O
the DT O
tumor NN O
cells NNS O
. . O

Western JJ O
blot NN O
analysis NN O
showed VBD O
a DT O
52 CD O
- : O
kD NN O
BSAP NNP B-Gene
band NN O
in IN O
B NNP O
- : O
cell NN O
lines NNS O
, , O
but CC O
not RB O
in IN O
non JJ O
- : O
B NNP O
- : O
cell NN O
or CC O
plasma NN O
cell NN O
lines NNS O
. . O

We PRP O
conclude VBP O
that IN O
BSAP NNP B-Gene
expression NN O
is VBZ O
largely RB O
restricted VBN O
to TO O
lymphomas VB O
of IN O
B NNP O
- : O
cell NN O
lineage NN O
and CC O
that IN O
BSAP NNP B-Gene
expression NN O
varies NNS O
in IN O
B NNP O
- : O
cell NN O
subsets NNS O
and CC O
subtypes NNS O
of IN O
B NNP O
- : O
cell NN O
NHL NNP O
. . O

The DT O
high JJ O
levels NNS O
of IN O
BSAP NNP B-Gene
, , O
especially RB O
those DT O
found VBN O
in IN O
large JJ O
- : O
cell NN O
lymphomas NN O
and CC O
in IN O
some DT O
follicular JJ O
lymphomas NNS O
, , O
may MD O
be VB O
a DT O
consequence NN O
of IN O
deregulated JJ O
gene NN O
expression NN O
and CC O
suggest VB O
a DT O
possible JJ O
involvement NN O
of IN O
PAX NNP B-Gene
- : I-Gene
5 CD I-Gene
in IN O
certain JJ O
B NNP O
- : O
cell NN O
malignancies NNS O
. . O

This DT O
is VBZ O
a DT O
US JJ O
government NN O
work NN O
. . O

There EX O
are VBP O
no DT O
restrictions NNS O
on IN O
its PRP$ O
use NN O
. . O

Mitogen NN O
and CC O
growth NN O
factor NN O
- : O
induced JJ O
activation NN O
of IN O
a DT O
STAT NNP B-Gene
- : I-Gene
like IN I-Gene
molecule NN I-Gene
in IN O
channel NN O
catfish JJ O
lymphoid NN O
cells NNS O
. . O

This DT O
article NN O
describes VBZ O
the DT O
identification NN O
of IN O
a DT O
putative JJ B-Gene
STAT NNP I-Gene
molecule NN I-Gene
in IN O
the DT O
channel NN O
catfish NN O
( ( O
Ictalurus NNP O
punctatus NN O
) ) O
, , O
the DT O
first JJ O
report NN O
of IN O
such JJ O
a DT O
molecule NN O
in IN O
a DT O
' '' O
lower JJR O
' POS O
vertebrate NN O
. . O

A DT O
monoclonal JJ B-Gene
antibody NN I-Gene
against IN O
human JJ B-Gene
STAT6 NNP I-Gene
recognizes VBZ O
an DT O
approximately RB O
100 CD B-Gene
kDa NNS I-Gene
molecule NN I-Gene
that IN O
becomes VBZ O
activated JJ O
and CC O
translocates VBZ O
to TO O
the DT O
nucleus NN O
upon IN O
both DT O
growth NN O
factor NN O
and CC O
mitogen NN O
stimulation NN O
of IN O
catfish JJ O
leukocytes NNS O
. . O

This DT O
presumed JJ O
catfish JJ B-Gene
STAT NNP I-Gene
binds VBZ O
the DT O
mammalian JJ B-Gene
interferon NN I-Gene
- : I-Gene
gamma NN I-Gene
activation NN I-Gene
site NN I-Gene
, , O
a DT O
known JJ O
motif NN O
of IN O
mammalian JJ O
STAT NNP O
binding NN O
, , O
as IN O
shown VBN O
by IN O
electromobility NN O
shift NN O
assays NNS O
. . O

Purification NN O
of IN O
the DT O
proteins NNS O
present JJ O
in IN O
these DT O
DNA NNP B-Gene
complexes NNS I-Gene
confirms VBZ O
that IN O
the DT O
catfish JJ O
reactive JJ O
molecule NN O
binds NNS O
to TO O
the DT O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
activation NN I-Gene
site NN I-Gene
sequence NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
STAT NNP B-Gene
molecules NNS I-Gene
have VBP O
been VBN O
highly RB O
conserved VBN O
in IN O
vertebrate JJ O
evolution NN O
. . O

Isolation NN O
and CC O
analysis NN O
of IN O
a DT O
T NNP O
cell NN O
clone NN O
variant NN O
exhibiting VBG O
constitutively RB O
phosphorylated VBN B-Gene
Ser133 NNP I-Gene
cAMP NN I-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

In IN O
driving VBG O
T NNP O
cell NN O
proliferation NN O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulates VBZ O
a DT O
new JJ O
program NN O
of IN O
gene NN O
expression NN O
that WDT O
includes VBZ O
proliferating VBG B-Gene
cell NN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
( ( O
PCNA NNP B-Gene
) ) O
, , O
a DT O
requisite JJ O
processivity NN O
factor NN O
for IN O
DNA NNP B-Gene
polymerase NN I-Gene
delta NN I-Gene
. . O

PCNA NNP B-Gene
transcription NN O
is VBZ O
regulated VBN O
in IN O
part NN O
through IN O
tandem NN O
CRE NNP B-Gene
sequences NNS I-Gene
in IN O
the DT O
promoter NN B-Gene
and CC I-Gene
CRE NNP I-Gene
binding NN I-Gene
proteins NNS I-Gene
; : O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulates NNS O
CREB NNP O
phosphorylation NN O
in IN O
the DT O
resting NN O
cloned VBD O
T NNP O
lymphocyte NN O
, , O
L2 NNP O
. . O

After IN O
culturing VBG O
L2 NNP O
cells NNS O
for IN O
greater JJR O
than IN O
91 CD O
days NNS O
, , O
we PRP O
consistently RB O
isolate VBP O
a DT O
stable JJ O
variant NN O
that IN O
exhibits VBZ O
constitutive JJ O
CREB NNP O
phosphorylation NN O
. . O

L2 NNP O
and CC O
L2 NNP O
variant VBP O
cells NNS O
were VBD O
tested VBN O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
responsiveness NN O
and CC O
rapamycin JJ O
sensitivity NN O
with IN O
respect NN O
to TO O
specific JJ O
kinase NN O
activity NN O
, , O
PCNA NNP O
expression NN O
and CC O
proliferation NN O
. . O

In IN O
L2 NNP O
cells NNS O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulated VBN O
and CC O
rapamycin VB O
inhibited VBN O
the DT O
following NN O
: : O
cAMP JJ O
- : O
independent JJ O
CREB NNP B-Gene
kinase NN I-Gene
activity NN O
, , O
PCNA NNP O
expression NN O
and CC O
proliferation NN O
. . O

In IN O
L2 NNP O
variant NN O
cells NNS O
, , O
CREB NNP B-Gene
kinase NN I-Gene
activity NN O
was VBD O
constitutively RB O
high JJ O
; : O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulated VBN O
and CC O
rapamycin VB O
blocked VBN O
PCNA NNP O
expression NN O
and CC O
proliferation NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
induces NNS O
a DT O
rapamycin NN O
- : O
sensitive JJ O
, , O
cAMP JJ O
- : O
independent JJ O
CREB NNP B-Gene
kinase NN I-Gene
activity NN O
in IN O
L2 NNP O
cells NNS O
. . O

However RB O
, , O
phosphorylation NN O
of IN O
CREB NNP B-Gene
alone RB O
is VBZ O
not RB O
sufficient JJ O
to TO O
drive VB O
PCNA NNP B-Gene
expression NN O
and CC O
L2 NNP O
cell NN O
proliferation NN O
in IN O
the DT O
absence NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Serotonin NNP O
derivative NN O
, , O
N NNP O
- : O
( ( O
p JJ O
- : O
coumaroyl NN O
) ) O
serotonin NN O
, , O
inhibits VBZ O
the DT O
production NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
by IN O
endotoxin NN O
- : O
stimulated VBN O
human JJ O
blood NN O
monocytes NNS O
. . O

We PRP O
have VBP O
reported VBN O
that IN O
N NNP O
- : O
( ( O
p JJ O
- : O
coumaroyl NN O
) ) O
serotonin NN O
( ( O
CS NNP O
) ) O
and CC O
its PRP$ O
derivatives NNS O
with IN O
antioxidative JJ O
activity NN O
are VBP O
present JJ O
in IN O
safflower NN O
seeds NNS O
. . O

As IN O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
are VBP O
implicated VBN O
in IN O
the DT O
signaling NN O
of IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
, , O
we PRP O
examined VBD O
whether IN O
CS NNP O
has VBZ O
a DT O
suppressive JJ O
effect NN O
on IN O
inflammatory JJ B-Gene
cytokine JJ I-Gene
generation NN O
from IN O
human JJ O
monocyte NN O
s NN O
in IN O
vitro NN O
. . O

CS NNP O
at IN O
50 CD O
- : O
200 CD O
microM NN O
reduced VBN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
, , O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
activities NNS O
in IN O
the DT O
culture NN O
supernatants NNS O
from IN O
LPS NNP O
- : O
stimulated VBD O
human JJ O
blood NN O
monocytes NNS O
without IN O
cytotoxicity NN O
. . O

ELISA NNP O
assay VBP O
revealed VBD O
that IN O
the DT O
production NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
was VBD O
inhibited VBN O
by IN O
CS NNP O
. . O

Northern NNP O
blot NN O
analysis NN O
showed VBD O
that IN O
LPS NNP O
- : O
induced JJ O
expression NN O
of IN O
these DT O
cytokine JJ B-Gene
mRNA NN I-Gene
in IN O
monocytes NNS O
was VBD O
suppressed VBN O
by IN O
CS NNP O
. . O

NF NNP O
- : O
kappaB NN O
activation NN O
was VBD O
also RB O
inhibited VBN O
by IN O
CS NNP O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
CS NNP O
has VBZ O
a DT O
suppressive JJ O
effect NN O
on IN O
proinflammatory NN O
cytokine NN O
production NN O
from IN O
monocytes NNS O
, , O
and CC O
this DT O
effect NN O
is VBZ O
based VBN O
in IN O
part NN O
on IN O
the DT O
suppression NN O
of IN O
cytokine NN B-Gene
mRNA NN I-Gene
expression NN O
through IN O
inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

Elevated JJ O
expression NN O
of IN O
differentiation NN B-Gene
inhibitory NN I-Gene
factor NN I-Gene
nm23 JJ I-Gene
mRNA NN I-Gene
in IN O
monoblastic JJ O
crisis NN O
of IN O
a DT O
patient NN O
with IN O
chronic JJ O
myelogenous JJ O
leukemia NN O
. . O

Differentiation NNP B-Gene
inhibitory NN I-Gene
factor NN I-Gene
nm23 JJ B-Gene
gene NN I-Gene
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
expressed VBN O
in IN O
high JJ O
quantities NNS O
in IN O
acute JJ O
myelogenous JJ O
leukemia NN O
( ( O
AML NNP O
) ) O
, , O
especially RB O
in IN O
acute JJ O
monocytic JJ O
leukemia NN O
( ( O
AML NNP O
- : O
M5 NN O
) ) O
and CC O
is VBZ O
suggested VBN O
as IN O
a DT O
new JJ O
prognostic JJ O
factor NN O
in IN O
AML NNP O
- : O
M5 NN O
. . O

We PRP O
report VBP O
an DT O
example NN O
of IN O
elevated JJ O
expression NN O
of IN O
nm23 JJ B-Gene
mRNA NN I-Gene
in IN O
a DT O
patient NN O
with IN O
chronic JJ O
myelogenous JJ O
leukemia NN O
( ( O
CML NNP O
) ) O
who WP O
developed VBD O
monoblastic JJ O
crisis NN O
. . O

Relative JJ O
levels NNS O
of IN O
nm23 JJ B-Gene
- : I-Gene
H1 NN I-Gene
and CC I-Gene
- : I-Gene
H2 NNP I-Gene
mRNA NN I-Gene
extracted VBD O
from IN O
the DT O
patient NN O
' POS O
s JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
and CC O
bone NN O
marrow NN O
mononuclear JJ O
cells NNS O
were VBD O
measured VBN O
by IN O
quantitative JJ O
reverse NN O
transcriptase NN O
polymerase NN O
chain NN O
reaction NN O
. . O

The DT O
level NN O
of IN O
nm23 JJ B-Gene
- : I-Gene
H1 NNP I-Gene
mRNA NN I-Gene
in IN O
CML NNP O
cells NNS O
at IN O
the DT O
chronic JJ O
phase NN O
was VBD O
as RB O
high JJ O
as IN O
that DT O
in IN O
bone NN O
marrow NN O
cells NNS O
from IN O
healthy JJ O
volunteers NNS O
. . O

The DT O
mRNA JJ O
level NN O
of IN O
nm23 JJ B-Gene
- : I-Gene
H2 NN I-Gene
was VBD O
slightly RB O
below IN O
the DT O
normal JJ O
level NN O
. . O

At IN O
blastic JJ O
crisis NN O
, , O
however RB O
, , O
expression NN O
of IN O
both DT O
nm23 JJ B-Gene
- : I-Gene
H1 NN I-Gene
and CC I-Gene
- : I-Gene
H2 NNP I-Gene
mRNA NN I-Gene
was VBD O
elevated VBN O
to TO O
about RB O
three CD O
to TO O
nine CD O
times NNS O
of IN O
that DT O
at IN O
the DT O
chronic JJ O
phase NN O
. . O

Proliferated VBN O
blastic JJ O
cells NNS O
were VBD O
positive JJ O
for IN O
non JJ B-Gene
- : I-Gene
specific JJ I-Gene
esterase NN I-Gene
, , O
and CC O
the DT O
serum NN O
lysozyme VBD O
level NN O
was VBD O
elevated VBN O
and CC O
diagnosed VBN O
as IN O
monoblastic JJ O
crisis NN O
. . O

The DT O
patient NN O
received VBD O
combined JJ O
chemotherapy NN O
but CC O
response NN O
was VBD O
partial JJ O
. . O

These DT O
findings NNS O
are VBP O
compatible JJ O
with IN O
our PRP$ O
previous JJ O
report NN O
that IN O
nm23 JJ B-Gene
gene NN I-Gene
is VBZ O
overexpressed VBN O
in IN O
monocytic JJ O
leukemia NN O
. . O

Increased VBN O
transcription NN O
decreases VBZ O
the DT O
spontaneous JJ O
mutation NN O
rate NN O
at IN O
the DT O
thymidine NN B-Gene
kinase NN I-Gene
locus NN I-Gene
in IN O
human JJ O
cells NNS O
. . O

Transcription NN O
increases NNS O
DNA NNP O
repair NN O
efficiency NN O
and CC O
modulates VBZ O
the DT O
distribution NN O
of IN O
certain JJ O
types NNS O
of IN O
DNA NNP O
damage NN O
. . O

Furthermore RB O
, , O
increased VBD O
transcription NN O
level NN O
stimulates VBZ O
spontaneous JJ O
mutation NN O
rate NN O
in IN O
yeast NN O
. . O

We PRP O
explored VBD O
whether IN O
transcription NN O
level NN O
affects VBZ O
spontaneous JJ O
mutation NN O
rate NN O
in IN O
human JJ O
cells NNS O
. . O

We PRP O
first RB O
developed VBD O
two CD O
thymidine JJ O
kinase NN O
( ( O
tk NN O
) ) O
inducible JJ O
human JJ O
cell NN O
lines NNS O
using VBG O
the DT O
Gal4 NNP O
- : O
Estrogen NNP O
receptor NN O
system NN O
. . O

In IN O
our PRP$ O
TK6i NNP O
- : O
G3 NNP O
and CC O
G9 NNP O
tk VBP O
heterozygous JJ O
cell NN O
lines NNS O
, , O
the DT O
active JJ O
tk NN B-Gene
allele NN I-Gene
is VBZ O
linked VBN O
to TO O
an DT O
inducible JJ O
promoter NN B-Gene
element NN I-Gene
. . O

Tk NNP B-Gene
mRNA NN I-Gene
is VBZ O
induced VBN O
following VBG O
treatment NN O
with IN O
estrogen NN O
. . O

Spontaneous JJ O
mutation NN O
rate NN O
was VBD O
significantly RB O
decreased VBN O
in IN O
human JJ O
cell NN O
lines NNS O
after IN O
induction NN O
in IN O
contrast NN O
to TO O
the DT O
report NN O
in IN O
yeast NN O
. . O

Thus RB O
, , O
humans NNS O
may MD O
have VB O
evolved VBN O
different JJ O
or CC O
additional JJ O
mechanisms NNS O
to TO O
deal VB O
with IN O
transcription NN O
related VBN O
spontaneous JJ O
mutagenesis NN O
. . O

Copyright JJ O
1998 CD O
Elsevier NNP O
Science NNP O
B NNP O
. . O
V NNP O
. . O

All DT O
rights NNS O
reserved VBN O
. . O

Mutation NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
in IN O
normal JJ O
B NNP O
cells NNS O
by IN O
the DT O
process NN O
of IN O
somatic JJ O
hypermutation NN O
of IN O
Ig NNP B-Gene
genes NNS I-Gene
. . O

Immunoglobulin NNP B-Gene
( ( I-Gene
Ig NNP I-Gene
) ) I-Gene
genes NNS I-Gene
are VBP O
hypermutated VBN O
in IN O
B NNP O
lymphocytes NNS O
that WDT O
are VBP O
the DT O
precursors NNS O
to TO O
memory NN O
B NNP O
cells NNS O
. . O

The DT O
mutations NNS O
are VBP O
linked VBN O
to TO O
transcription NN O
initiation NN O
, , O
but CC O
non SYM B-Gene
- : I-Gene
Ig NN I-Gene
promoters NNS I-Gene
are VBP O
permissible JJ O
for IN O
the DT O
mutation NN O
process NN O
; : O
thus RB O
, , O
other JJ O
genes NNS O
expressed VBN O
in IN O
mutating VBG O
B NNP O
cells NNS O
may MD O
also RB O
be VB O
subject JJ O
to TO O
somatic JJ O
hypermutation NN O
. . O

Significant JJ O
mutations NNS O
were VBD O
not RB O
observed VBN O
in IN O
c JJ B-Gene
- : I-Gene
MYC NN I-Gene
, , I-Gene
S14 NNP I-Gene
, , I-Gene
or CC I-Gene
alpha SYM I-Gene
- : I-Gene
fetoprotein NN I-Gene
( ( I-Gene
AFP NNP I-Gene
) ) I-Gene
genes NNS I-Gene
, , O
but CC O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
was VBD O
highly RB O
mutated VBN O
in IN O
a DT O
large JJ O
proportion NN O
of IN O
memory NN O
B NNP O
cells NNS O
of IN O
normal JJ O
individuals NNS O
. . O

The DT O
mutation NN O
pattern NN O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
Ig NNP B-Gene
genes NNS I-Gene
. . O

CD28 NNP O
- : O
mediated VBN O
activation NN O
in IN O
CD45RA NNP O
+ NNP O
and CC O
CD45RO NNP O
+ NNP O
T NNP O
cells NNS O
: : O
enhanced JJ O
levels NNS O
of IN O
reactive JJ O
oxygen NN O
intermediates NNS O
and CC O
c SYM O
- : O
Rel JJ O
nuclear JJ O
translocation NN O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
effect NN O
of IN O
complete JJ O
T NNP O
cell NN O
activation NN O
( ( O
anti JJ O
- : O
CD3 NNP O
plus CC O
anti JJ O
- : O
CD28 NN O
) ) O
on IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
CD45RA NNP O
+ NNP O
( ( O
naive JJ O
) ) O
and CC O
CD45RO NNP O
+ NNP O
( ( O
memory NN O
/ NNP O
effector NN O
) ) O
T NNP O
cells NNS O
. . O

Long JJ O
exposure NN O
( ( O
24 CD O
h NN O
) ) O
induced VBD O
stronger JJR O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NN O
binding NN O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
than IN O
in IN O
CD45RO NNP O
+ NNP O
cells NNS O
. . O

Analysis NN O
of IN O
the DT O
nuclear JJ B-Gene
c SYM I-Gene
- : I-Gene
Rel NNP I-Gene
protein NN I-Gene
indicated VBD O
that IN O
after IN O
anti JJ O
- : O
CD3 NNP O
+ NNP O
anti SYM O
- : O
CD28 NNP O
stimulation NN O
the DT O
level NN O
of IN O
c JJ B-Gene
- : I-Gene
Rel NN I-Gene
was VBD O
higher RBR O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
. . O

Analysis NN O
of IN O
the DT O
cytoplasmic JJ B-Gene
inhibitor NN I-Gene
IkappaBalpha NNP B-Gene
indicated VBD O
that IN O
anti SYM O
- : O
CD3 NNP O
+ NNP O
anti SYM O
- : O
CD28 NNP O
stimulation NN O
induced VBD O
a DT O
long JJ O
- : O
lasting VBG O
degradation NN O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
but CC O
in IN O
CD45RO NNP O
+ NNP O
cells NNS O
the DT O
degradation NN O
process NN O
was VBD O
more RBR O
rapid JJ O
. . O

Because IN O
the DT O
CD28 NNP B-Gene
costimulus NN O
is VBZ O
known VBN O
to TO O
induce VB O
the DT O
production NN O
of IN O
reactive JJ O
oxygen NN O
intermediates NNS O
( ( O
ROIs NNP O
) ) O
, , O
the DT O
intracellular JJ O
ROI NNP O
levels NNS O
in IN O
CD45RA NNP O
+ NNP O
and CC O
CD45RO NNP O
+ NNP O
cells NNS O
were VBD O
compared VBN O
by IN O
flow JJ O
cytometry NN O
. . O

ROIs NNP O
were VBD O
produced VBN O
in IN O
both DT O
cell NN O
types NNS O
, , O
but CC O
more JJR O
strongly RB O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
. . O

The DT O
data NN O
presented VBN O
in IN O
this DT O
study NN O
further RB O
emphasize VB O
the DT O
differences NNS O
between IN O
CD45RA NNP O
+ NNP O
and CC O
CD45RO NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
in IN O
ROI NNP O
- : O
dependent NN O
signaling VBG O
pathways NNS O
. . O

Non NNP O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
involving VBG O
bilateral JJ O
breasts NNS O
[ VBP O
see VBP O
comments NNS O
] VB O

We PRP O
describe VBP O
here RB O
two CD O
cases NNS O
of IN O
diffuse NN O
large JJ O
cell NN O
type NN O
non SYM O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
affecting VBG O
the DT O
bilateral JJ O
breasts NNS O
. . O

The DT O
contralateral JJ O
tumor NN O
in IN O
one CD O
case NN O
appeared VBD O
17 CD O
months NNS O
after IN O
the DT O
first JJ O
mastectomy NN O
, , O
whereas IN O
the DT O
bilateral JJ O
tumors NNS O
occurred VBD O
concurrently RB O
in IN O
the DT O
other JJ O
patient NN O
who WP O
was VBD O
pregnant JJ O
and CC O
showed VBD O
widespread JJ O
dissemination NN O
at IN O
initial JJ O
presentation NN O
. . O

Lymphoma NNP O
cells NNS O
from IN O
both DT O
cases NNS O
showed VBD O
the DT O
mature NN O
B NNP O
- : O
cell NN O
immunophenotype NN O
and CC O
had VBD O
rearrangements NNS O
of IN O
the DT O
BCL6 NNP B-Gene
gene NN I-Gene
. . O

Both DT O
patients NNS O
developed VBD O
progressive JJ O
disease NN O
despite IN O
chemo JJ O
- : O
radiotherapy NN O
and CC O
died VBD O
of IN O
leukemic JJ O
manifestations NNS O
. . O

There EX O
were VBD O
no DT O
apparent JJ O
pathological JJ O
features NNS O
of IN O
lymphomas NN O
of IN O
mucosa JJ O
- : O
associated VBN O
lymphoid JJ O
tissue NN O
origin NN O

Biochemical JJ O
characterization NN O
of IN O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha JJ I-Gene
nuclear JJ I-Gene
protein NN I-Gene
. . O

A DT O
family NN O
of IN O
hematopoietic JJ B-Gene
specific JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha JJ I-Gene
nuclear JJ I-Gene
protein NN I-Gene
( ( I-Gene
MNP NNP I-Gene
) ) I-Gene
family NN I-Gene
, , O
has VBZ O
recently RB O
been VBN O
identified VBN O
. . O

They PRP O
are VBP O
intimately RB O
involved VBN O
in IN O
regulating VBG O
the DT O
transcription NN O
of IN O
the DT O
huMIP NN B-Gene
- : I-Gene
1 CD I-Gene
alpha JJ I-Gene
gene NN I-Gene
in IN O
monocytes NNS O
, , O
T NNP O
- : O
cells NNS O
, , O
and CC O
transformed VBD O
B NNP O
- : O
cells NNS O
. . O

One CD O
member NN O
of IN O
the DT O
family NN O
( ( O
MNP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
essential JJ O
for IN O
promoter NN O
activity NN O
in IN O
monocytes NNS O
and CC O
B NNP O
- : O
cells NNS O
, , O
while IN O
another DT O
( ( O
MNP NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
is VBZ O
required VBN O
for IN O
full JJ O
promotor NN O
activity NN O
in IN O
T NNP O
- : O
cells NNS O
. . O

A DT O
third JJ O
member NN O
of IN O
the DT O
family NN O
( ( O
MNP NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
is VBZ O
expressed VBN O
in IN O
PMA NNP O
induced VBD O
HL60 NNP O
cells NNS O
and CC O
probably RB O
has VBZ O
a DT O
role NN O
in IN O
monocyte JJ O
differentiation NN O
. . O

In IN O
this DT O
communication NN O
we PRP O
demonstrate VBP O
by IN O
two CD O
techniques NNS O
that IN O
MNP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
MNP NNP B-Gene
- : I-Gene
2 CD I-Gene
are VBP O
distinct JJ O
but CC O
related JJ O
factors NNS O
, , O
and CC O
we PRP O
present VBP O
further JJ O
evidence NN O
to TO O
show VB O
that IN O
MNP NNP B-Gene
- : I-Gene
1 CD I-Gene
acts NNS O
as IN O
a DT O
heterodimer NN B-Gene
. . O

Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
and CC O
nuclear JJ O
translocation NN O
are VBP O
induced VBN O
by IN O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
and CC O
erythropoietin NN B-Gene
in IN O
proliferating VBG O
human JJ O
erythroid JJ O
precursors NNS O
. . O

Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
is VBZ O
a DT O
proto JJ B-Gene
- : I-Gene
oncogene NN I-Gene
involved VBN O
in IN O
the DT O
chromosomal JJ O
translocation NN O
t NN B-Gene
( ( I-Gene
14 CD I-Gene
; : I-Gene
19 CD I-Gene
) ) I-Gene
found VBN O
in IN O
some DT O
patients NNS O
with IN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
. . O

It PRP O
shares NNS O
structural JJ O
similarities NNS O
with IN O
and CC O
is VBZ O
a DT O
member NN O
of IN O
the DT O
IkappaB NNP B-Gene
family NN I-Gene
of IN O
proteins NNS O
. . O

In IN O
this DT O
report NN O
, , O
involvement NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
hematopoietic JJ O
growth NN O
factor NN O
- : O
stimulated VBN O
erythroid JJ O
proliferation NN O
and CC O
differentiation NN O
was VBD O
examined VBN O
. . O

In IN O
TF NNP O
- : O
1 CD O
cells NNS O
, , O
an DT O
erythroleukemia NN O
cell NN O
line NN O
, , O
granulocyte SYM B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
and CC O
erythropoietin NN B-Gene
( ( O
Epo NNP B-Gene
) ) O
greatly RB O
enhanced VBD O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
at IN O
both DT O
the DT O
protein NN O
and CC O
mRNA NN O
levels NNS O
in IN O
association NN O
with IN O
stimulation NN O
of IN O
proliferation NN O
. . O

Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
protein NN O
was VBD O
also RB O
highly RB O
expressed VBN O
in IN O
early JJ O
burst NN O
- : O
forming NN O
unit NN O
- : O
erythroid NN O
( ( O
BFU NNP O
- : O
E NN O
) ) O
- : O
derived VBN O
erythroid JJ O
precursors NNS O
( ( O
day NN O
7 CD O
) ) O
and CC O
decreased VBN O
during IN O
maturation NN O
( ( O
days NNS O
10 CD O
and CC O
14 CD O
) ) O
, , O
suggesting VBG O
that IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
is VBZ O
involved VBN O
in IN O
normal JJ O
erythroid JJ O
proliferation NN O
. . O

In IN O
these DT O
hematopoietic JJ O
cells NNS O
, , O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
was VBD O
hyperphosphorylated VBN O
. . O

GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
Epo NNP B-Gene
modulated VBD O
the DT O
subcellular JJ O
localization NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

Upon IN O
stimulation NN O
of IN O
TF NNP O
- : O
1 CD O
cells NNS O
with IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
or CC O
Epo NNP B-Gene
, , O
the DT O
nuclear JJ O
translocation NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
was VBD O
dramatically RB O
enhanced VBN O
. . O

Overexpression NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
TF NNP O
- : O
1 CD O
cells NNS O
by IN O
transient JJ O
transfection NN O
along IN O
with IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
factors NNS I-Gene
p50 VBP I-Gene
or CC I-Gene
p52 VBP I-Gene
resulted VBN O
in IN O
significant JJ O
induction NN O
of IN O
an DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
- : I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
kappaB FW I-Gene
- : I-Gene
TATA NNP I-Gene
- : I-Gene
luceriferase NN I-Gene
reporter NN I-Gene
plasmid NN I-Gene
, , O
demonstrating VBG O
that IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
has VBZ O
a DT O
positive JJ O
role NN O
in IN O
transactivation NN O
of IN O
kappaB FW B-Gene
- : I-Gene
containing VBG I-Gene
genes NNS I-Gene
in IN O
erythroid JJ O
cells NNS O
. . O

Stimulation NN O
with IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
enhanced VBD O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
mRNA JJ I-Gene
expression NN O
in IN O
these DT O
cells NNS O
. . O

Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
nuclear JJ O
extracts NNS O
of IN O
TF NNP O
- : O
1 CD O
cells NNS O
bound VBN O
to TO O
a DT O
kappaB JJ B-Gene
enhancer NN I-Gene
in IN O
the DT O
c NN B-Gene
- : I-Gene
myb NN I-Gene
promoter NN I-Gene
together RB O
with IN O
NF NNP B-Gene
- : I-Gene
kappaB2 NN I-Gene
/ NN I-Gene
p52 NN I-Gene
and CC O
this DT O
binding NN O
activity NN O
was VBD O
enhanced VBN O
by IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
stimulation NN O
. . O

Furthermore RB O
, , O
cotransfection NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
with IN O
p52 NN B-Gene
or CC O
p50 NN B-Gene
in IN O
TF NNP O
- : O
1 CD O
cells NNS O
resulted VBD O
in IN O
significant JJ O
activation NN O
of IN O
a DT O
c JJ B-Gene
- : I-Gene
myb NN I-Gene
kappaB SYM I-Gene
- : I-Gene
TATA NNP I-Gene
- : I-Gene
luceriferase NN I-Gene
reporter NN I-Gene
plasmid NN I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
may MD O
participate VB O
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
certain JJ O
kappaB FW B-Gene
- : I-Gene
containing VBG I-Gene
genes NNS I-Gene
involved VBN O
in IN O
hematopoiesis NN O
, , O
including VBG O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
. . O

Copyright JJ O
1998 CD O
by IN O
The DT O
American JJ O
Society NNP O
of IN O
Hematology NNP O
. . O

5 CD B-Gene
- : I-Gene
Lipoxygenase NN I-Gene
compartmentalization NN O
in IN O
granulocytic JJ O
cells NNS O
is VBZ O
modulated VBN O
by IN O
an DT O
internal JJ B-Gene
bipartite NN I-Gene
nuclear JJ I-Gene
localizing NN I-Gene
sequence NN I-Gene
and CC O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
complex JJ I-Gene
formation NN O
. . O

A DT O
region NN O
of IN O
basic JJ O
amino NN O
acids NNS O
spanning VBG O
residues NNS B-Gene
639 CD I-Gene
- : I-Gene
656 CD I-Gene
in IN O
the DT O
human JJ B-Gene
5 CD I-Gene
- : I-Gene
lipoxygenase NN I-Gene
sequence NN I-Gene
resembles VBZ O
a DT O
consensus NN B-Gene
bipartite JJ I-Gene
nuclear JJ I-Gene
localizing VBG I-Gene
sequence NN I-Gene
. . O

A DT O
synthetic JJ O
peptide NN O
consisting NN O
of IN O
the DT O
Kaposi NNP B-Gene
fibroblast NN I-Gene
growth NN I-Gene
factor VBP I-Gene
signal JJ I-Gene
sequence NN I-Gene
fused VBD O
to TO O
the DT O
5 CD B-Gene
- : I-Gene
lipoxygenase639 NN I-Gene
- : I-Gene
656 CD I-Gene
bipartite JJ I-Gene
nuclear JJ I-Gene
localizing VBG I-Gene
sequence NN I-Gene
has VBZ O
a DT O
prominent JJ O
inhibitory NN O
effect NN O
on IN O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
catalysis NN O
in IN O
granulocytic JJ O
HL NNP O
- : O
60 CD O
cells NNS O
activated VBN O
by IN O
calcium NN O
ionophor NN O
A23187 NNP O
. . O

Recombinant JJ O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
was VBD O
not RB O
affected VBN O
by IN O
the DT O
peptide NN O
. . O

The DT O
peptide NN O
also RB O
inhibited JJ O
redistribution NN O
of IN O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
from IN O
the DT O
cytosol NN O
to TO O
the DT O
nuclear JJ O
membrane NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
stimulated VBN O
by IN O
A23187 NNP O
. . O

5 CD B-Gene
- : I-Gene
Lipoxygenase NN I-Gene
protein NN I-Gene
was VBD O
detected VBN O
in IN O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
) ) I-Gene
p65 NN I-Gene
subunit NN I-Gene
immunoprecipitate JJ O
fractions NNS O
prepared VBD O
from IN O
HL NNP O
- : O
60 CD O
cell NN O
lysates NNS O
. . O

The DT O
amount NN O
of IN O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
protein NN I-Gene
coimmunoprecipitated VBN O
by IN O
NF NNP O
- : O
kappaB NN O
antiserum NN O
was VBD O
increased VBN O
following VBG O
A23187 NNP O
stimulation NN O
. . O

In IN O
cells NNS O
treated VBN O
with IN O
agents NNS O
that WDT O
block VBP O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
translocation NN O
to TO O
the DT O
nucleus NN O
, , O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
protein NN O
appearing VBG O
in IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
immunoprecipitate NN O
was VBD O
diminished VBN O
. . O

Our PRP$ O
results NNS O
implicate VBP O
an DT O
internal JJ B-Gene
bipartite NN I-Gene
nuclear JJ I-Gene
localizing VBG I-Gene
sequence NN I-Gene
as IN O
a DT O
regulatory JJ O
domain NN O
that WDT O
modulates VBZ O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
redistribution NN O
and CC O
catalysis NN O
in IN O
granulocytic JJ O
cells NNS O
. . O

Additionally RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
molecular JJ O
determinants NNS O
which WDT O
govern VBP O
5 CD O
- : O
lipoxygenase NN O
and CC O
NF NNP O
- : O
kappaB NN O
redistribution NN O
to TO O
the DT O
nucleus NN O
may MD O
be VB O
coordinately RB O
controlled VBN O
in IN O
granulocytic JJ O
cells NNS O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

Inhibition NN O
of IN O
CD28 NNP O
/ NNP O
CD3 NNP O
- : O
mediated VBD O
costimulation NN O
of IN O
naive JJ O
and CC O
memory JJ O
human JJ O
T NNP O
lymphocytes NNS O
by IN O
intracellular JJ O
incorporation NN O
of IN O
polyclonal JJ B-Gene
antibodies NNS I-Gene
specific VBP O
for IN O
the DT O
activator NN B-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
transcriptional JJ I-Gene
complex NN I-Gene
. . O

A DT O
number NN O
of IN O
indirect JJ O
methods NNS O
have VBP O
been VBN O
utilized VBN O
in IN O
demonstrating VBG O
activator NN B-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
transcription NN O
factor NN O
function NN O
in IN O
IL NNP O
- : O
2 CD O
promoter NN O
activity NN O
. . O

However RB O
, , O
there EX O
has VBZ O
been VBN O
no DT O
direct JJ O
demonstration NN O
that IN O
activator NN B-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
involved VBN O
in IN O
CD28 NNP O
- : O
dependent JJ O
costimulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
transcription NN O
in IN O
freshly RB O
isolated VBN O
naive JJ O
and CC O
memory JJ O
human JJ O
T NNP O
lymphocytes NNS O
. . O

To TO O
address VB O
this DT O
issue NN O
, , O
the DT O
method NN O
of IN O
scrape NN O
loading NN O
was VBD O
applied VBN O
to TO O
purified VB O
peripheral JJ O
blood NN O
T NNP O
lymphocytes VBZ O
. . O

Since IN O
scrape NN O
loading VBG O
relies NNS O
on IN O
adherent NN O
cells NNS O
, , O
peripheral JJ O
blood NN O
human JJ O
T NNP O
( ( O
PB NNP O
- : O
T NN O
) ) O
cells NNS O
were VBD O
immobilized VBN O
on IN O
the DT O
nonspecific NN O
cell NN O
attachment JJ O
factor NN O
poly SYM O
- : O
L NNP O
- : O
lysine NN O
. . O

Cells NNP O
scraped VBD O
off RP O
poly JJ O
- : O
L NNP O
- : O
lysine NN O
in IN O
the DT O
presence NN O
of IN O
Ig NNP B-Gene
FITC NNP I-Gene
efficiently RB O
incorporated VBD O
Ig NNP O
, , O
with IN O
relatively RB O
uniform JJ O
fluorescence NN O
. . O

T NNP O
cells NNS O
retained VBD O
their PRP$ O
physical JJ O
parameters NNS O
as IN O
measured VBN O
by IN O
forward NN O
and CC O
side NN O
light NN O
scatter NN O
, , O
and CC O
functional JJ O
activity NN O
as IN O
measured VBN O
by IN O
costimulation NN O
of IN O
proliferation NN O
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
after IN O
being VBG O
scraped VBD O
off RP O
this DT O
substrate NN O
. . O

CD28 NNP O
/ NNP O
CD3 NNP O
- : O
costimulated VBD O
T NNP O
cells NNS O
produced VBD O
intracellular JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
from IN O
all DT O
subsets NNS O
measured VBN O
( ( O
CD4 NNP O
+ NNP O
, , O
CD4 NNP O
- : O
, , O
CD45RO NNP O
+ NNP O
, , O
and CC O
CD45RO NNP O
- : O
) ) O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
and CC O
intracellular JJ O
accumulation NN O
in IN O
nonscraped JJ O
PB NNP O
- : O
T NNP O
cells NNS O
activated VBN O
with IN O
CD28 NNP O
/ NNP O
CD3 NNP O
coligation NN O
were VBD O
skewed VBN O
favoring VBG O
CD45RO NNP O
+ NNP O
and CC O
CD4 NNP O
+ NNP O
subsets NNS O
, , O
as IN O
was VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
in IN O
scraped JJ O
PB NNP O
- : O
T NNP O
cells NNS O
. . O

The DT O
intracellular JJ O
incorporation NN O
of IN O
Abs NNP O
specific NN O
for IN O
c JJ B-Gene
- : I-Gene
Fos NN I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Jun NNP I-Gene
family NN I-Gene
members NNS I-Gene
by IN O
scrape NN O
loading NN O
inhibited VBD O
the DT O
production NN O
and CC O
intracellular JJ O
accumulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
within IN O
6 CD O
h NN O
of IN O
costimulation NN O
with IN O
PMA NNP O
/ NNP O
ionomycin NN O
, , O
or CC O
costimulation NN O
by IN O
CD28 NNP O
and CC O
CD3 NNP O
ligation NN O
. . O

Scrape NNP O
loading VBG O
thus RB O
provides VBZ O
an DT O
efficient JJ O
mechanism NN O
for IN O
intracellular JJ O
incorporation NN O
of IN O
macromolecules NNS O
, , O
and CC O
the DT O
first JJ O
direct JJ O
evidence NN O
that IN O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
are VBP O
involved VBN O
in IN O
transcription NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
within IN O
its PRP$ O
correct JJ O
chromosomal JJ O
context NN O
, , O
in IN O
resting VBG O
human JJ O
T NNP O
lymphocyte NN O
subpopulations NNS O
. . O

Differential JJ O
expression NN O
of IN O
Nur77 NNP B-Gene
family NN I-Gene
members NNS I-Gene
in IN O
human JJ O
T NNP O
- : O
lymphotropic NN O
virus NN O
type NN O
1 CD O
- : O
infected JJ O
cells NNS O
: : O
transactivation NN O
of IN O
the DT O
TR3 NNP B-Gene
/ NNP I-Gene
nur77 JJ I-Gene
gene NN I-Gene
by IN O
Tax NNP B-Gene
protein NN I-Gene
. . O

We PRP O
analyzed VBD O
the DT O
differential JJ O
expression NN O
and CC O
regulation NN O
of IN O
three CD O
members NNS O
of IN O
the DT O
Nur77 NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
by IN O
the DT O
human JJ O
T NNP O
- : O
lymphotropic NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
Tax NNP B-Gene
protein NN I-Gene
. . O

We PRP O
have VBP O
demonstrated VBN O
that IN O
in IN O
both DT O
HTLV NNP O
- : O
1 CD O
- : O
infected VBN O
cells NNS O
and CC O
Tax NNP O
- : O
expressing VBG O
JPX NNP O
- : O
9 CD O
cells NNS O
, , O
TR3 NNP B-Gene
/ NNP I-Gene
nur77 NN I-Gene
is VBZ O
highly RB O
expressed VBN O
, , O
whereas IN O
neither DT O
NOR NNP O
- : O
1 CD O
nor CC O
NOT NNP O
expression NN O
is VBZ O
detectable JJ O
. . O

Transient JJ O
transfection NN O
analysis NN O
further RBR O
confirmed VBD O
the DT O
Tax NNP B-Gene
transactivation NN O
of IN O
the DT O
TR3 NNP B-Gene
/ NNP I-Gene
nur77 JJ I-Gene
promoter NN O
but CC O
not RB O
the DT O
NOR NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
in IN O
different JJ O
cell NN O
types NNS O
. . O

Furthermore RB O
, , O
expression NN O
of IN O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
driven VBN O
by IN O
the DT O
NGFI NNP B-Gene
- : I-Gene
B NNP I-Gene
( ( I-Gene
rat JJ I-Gene
homolog NN I-Gene
of IN I-Gene
TR3 NNP I-Gene
/ NNP I-Gene
Nur77 NNP I-Gene
) ) I-Gene
response NN I-Gene
element NN I-Gene
( ( O
NBRE NNP B-Gene
) ) O
provided VBD O
evidence NN O
that IN O
Tax NNP B-Gene
- : O
mediated VBN O
transactivation NN O
resulted VBD O
in IN O
the DT O
induction NN O
of IN O
a DT O
functional JJ O
protein NN O
. . O

Cotransfection NNP O
assays VBZ O
with IN O
the DT O
TR3 NNP B-Gene
/ NNP I-Gene
nur77 RB I-Gene
promoter NN I-Gene
sequence NN I-Gene
or CC O
the DT O
NBRE NNP B-Gene
binding NN O
motif NN O
together RB O
with IN O
a DT O
series NN O
of IN O
Tax NNP B-Gene
mutants NNS O
have VBP O
shown VBN O
that IN O
Tax NNP B-Gene
- : O
induced VBD O
TR3 NNP B-Gene
/ NNP I-Gene
nur77 JJ I-Gene
expression NN O
is VBZ O
mediated VBN O
by IN O
CREB NNP B-Gene
/ NNP I-Gene
ATF NNP I-Gene
- : I-Gene
related JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

Negative JJ O
regulation NN O
of IN O
the DT O
heat NN O
shock NN O
transcriptional JJ O
response NN O
by IN O
HSBP1 NNP B-Gene
. . O

In IN O
response NN O
to TO O
stress VB O
, , O
heat NN B-Gene
shock NN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
HSF1 NNP B-Gene
) ) O
acquires VBZ O
rapid JJ O
DNA NNP O
binding NN O
and CC O
transient JJ O
transcriptional JJ O
activity NN O
while IN O
undergoing VBG O
conformational JJ O
transition NN O
from IN O
an DT O
inert NN O
non SYM B-Gene
- : I-Gene
DNA NN I-Gene
- : I-Gene
binding VBG I-Gene
monomer NN I-Gene
to TO O
active JJ O
functional JJ O
trimers NNS O
. . O

Attenuation NN O
of IN O
the DT O
inducible JJ O
transcriptional JJ O
response NN O
occurs VBZ O
during IN O
heat NN O
shock NN O
or CC O
upon JJ O
recovery NN O
at IN O
non JJ O
- : O
stress NN O
conditions NNS O
and CC O
involves VBZ O
dissociation NN O
of IN O
the DT O
HSF1 NNP B-Gene
trimer NN I-Gene
and CC O
loss NN O
of IN O
activity NN O
. . O

We PRP O
have VBP O
used VBN O
the DT O
hydrophobic JJ B-Gene
repeats NNS I-Gene
of IN O
the DT O
HSF1 NNP B-Gene
trimerization NN O
domain NN O
in IN O
the DT O
yeast NN O
two CD O
- : O
hybrid JJ O
protein NN O
interaction NN O
assay VBP O
to TO O
identify VB O
heat NN B-Gene
shock NN I-Gene
factor NN I-Gene
binding VBG I-Gene
protein NN I-Gene
1 CD I-Gene
( ( O
HSBP1 NNP B-Gene
) ) O
, , O
a DT O
novel NN O
, , O
conserved VBD O
, , O
76 CD B-Gene
- : I-Gene
amino NN I-Gene
- : I-Gene
acid NN I-Gene
protein NN I-Gene
that WDT O
contains VBZ O
two CD O
extended JJ O
arrays NNS O
of IN O
hydrophobic JJ B-Gene
repeats NNS I-Gene
that WDT O
interact VBP O
with IN O
the DT O
HSF1 NNP B-Gene
heptad NN I-Gene
repeats NNS I-Gene
. . O

HSBP1 NNP B-Gene
is VBZ O
nuclear JJ O
- : O
localized VBN O
and CC O
interacts NNS O
in IN O
vivo NN O
with IN O
the DT O
active JJ O
trimeric JJ O
state NN O
of IN O
HSF1 NNP B-Gene
that WDT O
appears VBZ O
during IN O
heat NN O
shock NN O
. . O

During IN O
attenuation NN O
of IN O
HSF1 NNP B-Gene
to TO O
the DT O
inert JJ O
monomer NN O
, , O
HSBP1 NNP B-Gene
associates VBZ O
with IN O
Hsp70 NNP O
. . O

HSBP1 NNP B-Gene
negatively RB O
affects VBZ O
HSF1 NNP B-Gene
DNA NNP O
- : O
binding NN O
activity NN O
, , O
and CC O
overexpression NN O
of IN O
HSBP1 NNP B-Gene
in IN O
mammalian JJ O
cells NNS O
represses VBZ O
the DT O
transactivation NN O
activity NN O
of IN O
HSF1 NNP B-Gene
. . O

To TO O
establish VB O
a DT O
biological JJ O
role NN O
for IN O
HSBP1 NNP B-Gene
, , O
the DT O
homologous JJ O
Caenorhabditis NNP B-Gene
elegans NNS I-Gene
protein NN I-Gene
was VBD O
overexpressed VBN O
in IN O
body NN O
wall JJ O
muscle NN O
cells NNS O
and CC O
was VBD O
shown VBN O
to TO O
block VB O
activation NN O
of IN O
the DT O
heat NN O
shock NN O
response NN O
from IN O
a DT O
heat NN B-Gene
shock NN I-Gene
promoter NN I-Gene
- : I-Gene
reporter NN I-Gene
construct NN I-Gene
. . O

Alteration NN O
in IN O
the DT O
level NN O
of IN O
HSBP1 NNP B-Gene
expression NN O
in IN O
C NNP O
. . O
elegans NNS O
has VBZ O
severe JJ O
effects NNS O
on IN O
survival NN O
of IN O
the DT O
animals NNS O
after IN O
thermal JJ O
and CC O
chemical JJ O
stress NN O
, , O
consistent NN O
with IN O
a DT O
role NN O
for IN O
HSBP1 NNP B-Gene
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
the DT O
heat NN O
shock NN O
response NN O
. . O

Long NNP O
- : O
range NN O
transcriptional JJ O
regulation NN O
of IN O
cytokine JJ O
gene NN O
expression NN O
. . O

Most JJS O
studies NNS O
on IN O
the DT O
control NN O
of IN O
cytokine JJ O
gene NN O
expression NN O
have VBP O
involved VBN O
the DT O
functional JJ O
analysis NN O
of IN O
proximal JJ B-Gene
promoters NNS I-Gene
. . O

Recent JJ O
work NN O
has VBZ O
identified VBN O
distal JJ B-Gene
elements NNS I-Gene
that WDT O
mediate VBP O
long JJ O
- : O
range NN O
cytokine NN O
gene NN O
regulation NN O
and CC O
has VBZ O
implicated VBN O
chromatin NN O
reorganization NN O
in IN O
regulation NN O
of IN O
cytokine JJ B-Gene
gene NN I-Gene
loci NN I-Gene
. . O

These DT O
studies NNS O
have VBP O
begun VBN O
to TO O
elucidate VB O
the DT O
basis NN O
for IN O
cell NN O
- : O
specificity NN O
and CC O
high JJ O
- : O
level NN O
expression NN O
of IN O
cytokine NN B-Gene
genes NNS I-Gene
. . O

A DT O
signaling VBG O
complex NN O
of IN O
Ca2 NNP B-Gene
+ NNP I-Gene
- : I-Gene
calmodulin NN I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
IV NNP I-Gene
and CC O
protein VB B-Gene
phosphatase NN I-Gene
2A CD I-Gene
[ NN O
see NN O
comments NNS O
] VB O

Stimulation NN O
of IN O
T NNP O
lymphocytes VBZ O
results NNS O
in IN O
a DT O
rapid JJ O
increase NN O
in IN O
intracellular JJ O
calcium NN O
concentration NN O
( ( O
[ JJ O
Ca2 NNP O
+ NNP O
] NNP O
i NN O
) ) O
that WDT O
parallels VBZ O
the DT O
activation NN O
of IN O
Ca2 NNP B-Gene
+ NNP I-Gene
- : I-Gene
calmodulin NN I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
IV NNP I-Gene
( ( O
CaMKIV NNP B-Gene
) ) O
, , O
a DT O
nuclear JJ B-Gene
enzyme NN I-Gene
that WDT O
can MD O
phosphorylate VB O
and CC O
activate VB O
the DT O
cyclic JJ B-Gene
adenosine NN I-Gene
monophosphate NN I-Gene
( ( I-Gene
cAMP NN I-Gene
) ) I-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
. . O

However RB O
, , O
inactivation NN O
of IN O
CaMKIV NNP B-Gene
occurs VBZ O
despite IN O
the DT O
sustained JJ O
increase NN O
in IN O
[ JJ O
Ca2 NNP O
+ NNP O
] NNP O
i NN O
that WDT O
is VBZ O
required VBN O
for IN O
T NNP O
cell NN O
activation NN O
. . O

A DT O
stable JJ O
and CC O
stoichiometric JJ O
complex NN O
of IN O
CaMKIV NNP B-Gene
with IN O
protein NN B-Gene
serine NN I-Gene
- : I-Gene
threonine NN I-Gene
phosphatase NN I-Gene
2A CD I-Gene
( ( O
PP2A NNP B-Gene
) ) O
was VBD O
identified VBN O
in IN O
which WDT O
PP2A NNP B-Gene
dephosphorylates VBZ O
CaMKIV NNP B-Gene
and CC O
functions NNS O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
CaMKIV NNP B-Gene
signaling VBG O
. . O

In IN O
Jurkat NNP O
T NNP O
cells NNS O
, , O
inhibition NN O
of IN O
PP2A NNP B-Gene
activity NN O
by IN O
small JJ O
t NNS O
antigen NN O
enhanced VBD O
activation NN O
of IN O
CREB NNP B-Gene
- : O
mediated VBN O
transcription NN O
by IN O
CaMKIV NNP B-Gene
. . O

These DT O
findings NNS O
reveal VBP O
an DT O
intracellular JJ O
signaling NN O
mechanism NN O
whereby WRB O
a DT O
protein NN B-Gene
serine NN I-Gene
- : I-Gene
threonine NN I-Gene
kinase NN I-Gene
( ( O
CaMKIV NNP B-Gene
) ) O
is VBZ O
regulated VBN O
by IN O
a DT O
tightly RB O
associated VBN O
protein NN B-Gene
serine NN I-Gene
- : I-Gene
threonine NN I-Gene
phosphatase NN I-Gene
( ( O
PP2A NNP B-Gene
) ) O
. . O

Hypoxia NNP O
down RP O
- : O
regulates NNS O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
: : O
implications NNS O
for IN O
macrophage NN O
distribution NN O
in IN O
tumors NNS O
. . O

Monocyte NNP B-Gene
chemoattractant NN I-Gene
protein NN I-Gene
1 CD I-Gene
( ( O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
likely JJ O
to TO O
contribute VB O
to TO O
the DT O
macrophage NN O
infiltrate NN O
in IN O
human JJ O
ovarian JJ O
carcinomas NN O
. . O

Although IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
predominantly RB O
expressed VBN O
by IN O
the DT O
tumor NN O
parenchyma NN O
, , O
macrophages NNS O
accumulate VBP O
at IN O
highest JJS O
density NN O
in IN O
necrotic JJ O
regions NNS O
, , O
which WDT O
are VBP O
associated VBN O
with IN O
low JJ O
oxygen NN O
tensions NNS O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
can MD O
stimulate VB O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
production NN O
and CC O
is VBZ O
also RB O
present JJ O
within IN O
ovarian JJ O
carcinomas NN O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
effect NN O
of IN O
hypoxia NN O
both DT O
on IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
in IN O
ovarian JJ O
cancer NN O
cell NN O
lines NNS O
and CC O
monocyte JJ O
migration NN O
. . O

Hypoxia NNP O
down RP O
- : O
regulated VBN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : I-Gene
induced JJ I-Gene
MCP NNP I-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
and CC O
protein NN O
production NN O
by IN O
ovarian JJ O
cancer NN O
cells NNS O
. . O

The DT O
effect NN O
was VBD O
mimicked VBN O
by IN O
cobalt NN O
chloride NN O
and CC O
desferrioxamine NN O
, , O
consistent JJ O
with IN O
a DT O
specific JJ O
oxygen NN O
- : O
sensing NN O
mechanism NN O
. . O

Unlike IN O
antioxidants NNS O
, , O
hypoxia NN O
did VBD O
not RB O
inhibit VB O
nuclear JJ O
factor NN O
KB NNP O
mobilization NN O
. . O

Monocyte NNP O
migration NN O
in IN O
response NN O
to TO O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
also RB O
diminished VBN O
under IN O
hypoxic JJ O
conditions NNS O
. . O

Down NNP O
- : O
regulation NN O
of IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
the DT O
inhibition NN O
of IN O
monocyte JJ O
migration NN O
are VBP O
independent JJ O
effects NNS O
of IN O
hypoxia NN O
that WDT O
may MD O
contribute VB O
to TO O
the DT O
distribution NN O
of IN O
macrophages NNS O
within IN O
ovarian JJ O
tumors NNS O
. . O

Activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
inflammatory NN O
bowel NN O
disease NN O
[ NNP O
see VBP O
comments NNS O
] VB O

BACKGROUND NN O
: : O
Expression NN O
of IN O
pro JJ B-Gene
- : I-Gene
inflammatory NN I-Gene
cytokines NNS I-Gene
is VBZ O
increased VBN O
in IN O
the DT O
intestinal JJ O
lamina NN O
propria NN O
of IN O
patients NNS O
with IN O
inflammatory JJ O
bowel NN O
disease NN O
( ( O
IBD NNP O
) ) O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
kappa NNP I-Gene
B NNP I-Gene
) ) O
controls VBZ O
transcription NN O
of IN O
inflammation NN B-Gene
genes NNS I-Gene
. . O

On IN O
activation NN O
, , O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
rapidly RB O
released VBN O
from IN O
its PRP$ O
cytoplasmic JJ B-Gene
inhibitor NN I-Gene
( ( O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
) ) O
, , O
transmigrates VBZ O
into IN O
the DT O
nucleus NN O
, , O
and CC O
binds VBZ O
to TO O
DNA VB B-Gene
response NN I-Gene
elements NNS I-Gene
in IN O
gene NN O
promoter NN O
regions NNS O
. . O

AIMS NNS O
: : O
To TO O
investigate VB O
whether IN O
increased JJ O
activation NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
important JJ O
in IN O
IBD NNP O
and CC O
may MD O
be VB O
down RP O
- : O
regulated VBN O
by IN O
anti JJ O
- : O
inflammatory NN O
treatment NN O
. . O

METHODS NN O
: : O
Activation NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
determined VBN O
by IN O
western JJ O
blot NN O
assessment NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
in IN O
nuclear JJ O
extracts NNS O
of IN O
colonic JJ O
biopsy NN O
samples NNS O
as RB O
well RB O
as IN O
lamina NN O
propria NN O
mononuclear JJ O
cells NNS O
. . O

RESULTS NN O
: : O
Nuclear JJ O
levels NNS O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
p65 NN B-Gene
are VBP O
increased VBN O
in IN O
lamina NN O
propria NN O
biopsy NN O
specimens NNS O
from IN O
patients NNS O
with IN O
Crohn NNP O
' POS O
s JJ O
disease NN O
in IN O
comparison NN O
with IN O
patients NNS O
with IN O
ulcerative JJ O
colitis NN O
and CC O
controls NNS O
. . O

Increased VBN O
activation NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
detected VBN O
in IN O
lamina JJ O
propria NNS O
mononuclear VBP O
cells NNS O
from IN O
patients NNS O
with IN O
active JJ O
IBD NNP O
. . O

Corticosteroids NNP O
strongly RB O
inhibit VBZ O
intestinal JJ O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
in IN O
IBD NNP O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
by IN O
stabilising VBG O
the DT O
cytosolic JJ B-Gene
inhibitor NN I-Gene
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN O
against IN O
activation NN O
induced VBN O
degradation NN O
. . O

CONCLUSIONS NN O
: : O
In IN O
both DT O
IBDs NNP O
, , O
but CC O
particularly RB O
Crohn NNP O
' POS O
s NN O
disease NN O
, , O
increased JJ O
activation NN O
of IN O
NF NNP B-Gene
kappa NNP I-Gene
B NNP I-Gene
may MD O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
the DT O
inflammatory JJ O
response NN O
. . O

Inhibition NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
may MD O
represent VB O
a DT O
mechanism NN O
by IN O
which WDT O
steroids NNS O
exert VBP O
an DT O
anti JJ O
- : O
inflammatory JJ O
effect NN O
in IN O
IBD NNP O

Insufficient JJ O
glycemic JJ O
control NN O
increases VBZ O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
activity NN O
in IN O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
isolated VBN O
from IN O
patients NNS O
with IN O
type JJ O
1 CD O
diabetes NNS O
. . O

OBJECTIVE NN O
: : O
The DT O
redox NN B-Gene
- : I-Gene
sensitive JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
is VBZ O
believed VBN O
to TO O
contribute VB O
to TO O
late VB O
diabetic JJ O
complications NNS O
. . O

It PRP O
is VBZ O
unknown JJ O
whether IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
influenced VBN O
by IN O
glycemic JJ O
control NN O
. . O

RESEARCH NNP O
DESIGN NNP O
AND NNP O
METHODS NNP O
: : O
To TO O
determine VB O
whether IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
activated VBN O
in IN O
patients NNS O
with IN O
insufficient JJ O
glycemic NNS O
control NN O
( ( O
HbA1c NNP O
> RB O
10 CD O
% NN O
) ) O
, , O
we PRP O
developed VBD O
a DT O
tissue NN O
culture NN O
- : O
independent JJ O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
( ( O
EMSA NNP O
) ) O
- : O
based VBN O
semiquantitative JJ O
detection NN O
system NN O
that WDT O
allowed VBD O
us PRP O
to TO O
determine VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
in IN O
ex NN O
vivo FW O
- : O
isolated JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMCs NNP O
) ) O
. . O

We PRP O
included VBD O
43 CD O
patients NNS O
with IN O
type JJ O
1 CD O
diabetes NNS O
in IN O
this DT O
cross NN O
- : O
sectional JJ O
study NN O
. . O

10 CD O
of IN O
those DT O
received VBN O
the DT O
antioxidant JJ O
thioctic JJ O
acid NN O
( ( O
600 CD O
mg NNS O
/ JJ O
day NN O
p NN O
. . O
o NN O
. . O
) ) O
for IN O
2 CD O
weeks NNS O
. . O

RESULTS NN O
: : O
Monocytes NNS O
of IN O
patients NNS O
with IN O
HbA1c NNP O
levels NNS O
> VBP O
10 CD O
% NN O
demonstrated VBD O
significantly RB O
higher JJR O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
activity NN O
in IN O
an DT O
EMSA NNP O
and CC O
a DT O
stronger JJR O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
staining NN O
in IN O
immunohistochemistry NN O
than IN O
monocytes NNS O
of IN O
patients NNS O
with IN O
HbA1c NNP O
levels NNS O
of IN O
6 CD O
- : O
8 CD O
% NN O
. . O

The DT O
increase NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
correlated VBD O
with IN O
an DT O
increase NN O
in IN O
plasmatic JJ O
markers NNS O
of IN O
lipid JJ O
peroxidation NN O
. . O

Treatment NN O
with IN O
the DT O
antioxidant JJ O
thioctic JJ O
acid NN O
decreased VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
activity NN O
. . O

CONCLUSIONS NN O
: : O
Hyperglycemia NNP O
induces VBZ O
activation NN O
of IN O
the DT O
transcription NN O
factor NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
ex NN O
vivo FW O
- : O
isolated JJ O
PBMCs NNP O
of IN O
patients NNS O
with IN O
type JJ O
1 CD O
diabetes NNS O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
is VBZ O
at IN O
least JJS O
partially RB O
dependent JJ O
on IN O
oxidative JJ O
stress NN O
, , O
since IN O
the DT O
antioxidant JJ O
thioctic JJ O
acid NN O
significantly RB O
lowered VBD O
the DT O
extent NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
activity NN O
. . O

Synergistic JJ O
activation NN O
of IN O
MAP NNP B-Gene
kinase NNP I-Gene
( ( O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
) ) O
by IN O
erythropoietin NN B-Gene
and CC O
stem NN B-Gene
cell NN I-Gene
factor NN I-Gene
is VBZ O
essential JJ O
for IN O
expanded JJ O
erythropoiesis NN O
. . O

Stem NNP B-Gene
cell NN I-Gene
factor NN I-Gene
( ( O
SCF NNP B-Gene
) ) O
and CC O
erythropoietin NN B-Gene
( ( O
EPO NNP B-Gene
) ) O
work NN O
synergistically RB O
to TO O
support VB O
erythropoiesis NN O
, , O
but CC O
the DT O
mechanism NN O
for IN O
this DT O
synergism NN O
is VBZ O
unknown JJ O
. . O

By IN O
using VBG O
purified JJ O
human JJ O
erythroid NN O
colony NN O
- : O
forming NN O
cells NNS O
( ( O
ECFC NNP O
) ) O
, , O
we PRP O
have VBP O
found VBN O
that IN O
SCF NNP B-Gene
and CC O
EPO NNP B-Gene
synergistically RB O
activate VBP O
MAP NNP B-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
, , O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
) ) O
, , O
which WDT O
correlates VBZ O
with IN O
the DT O
cell NN O
growth NN O
and CC O
thus RB O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
synergistic JJ O
effects NNS O
. . O

Treatment NN O
of IN O
the DT O
cells NNS O
with IN O
PD98059 NNP O
and CC O
wortmannin NN O
, , O
inhibitors NNS O
of IN O
MEK NNP B-Gene
and CC O
PI NNP B-Gene
- : I-Gene
3 CD I-Gene
kinase NN I-Gene
, , O
respectively RB O
, , O
inhibited VBD O
the DT O
synergistic JJ O
activation NN O
of IN O
MAPK NNP B-Gene
and CC O
also RB O
the DT O
cell NN O
growth NN O
, , O
further RB O
supporting VBG O
this DT O
conclusion NN O
. . O

Wortmannin NNP O
only RB O
inhibits VBZ O
MAPK NNP B-Gene
activation NN O
induced VBN O
by IN O
EPO NNP B-Gene
but CC O
not RB O
that IN O
by IN O
SCF NNP B-Gene
, , O
suggesting VBG O
that IN O
SCF NNP B-Gene
and CC O
EPO NNP B-Gene
may MD O
activate VB O
MAPK NNP B-Gene
through IN O
different JJ O
pathways NNS O
, , O
which WDT O
would MD O
facilitate VB O
synergy NN O
. . O

Furthermore RB O
, , O
EPO NNP B-Gene
, , O
but CC O
not RB O
SCF NNP B-Gene
, , O
led VBD O
to TO O
activation NN O
of IN O
STAT5 NNP B-Gene
, , O
whereas JJ O
SCF NNP B-Gene
and CC O
wortmannin NN O
had VBD O
no DT O
effect NN O
on IN O
the DT O
EPO NNP B-Gene
- : O
induced VBD O
STAT5 NNP B-Gene
activation NN O
, , O
suggesting VBG O
that IN O
STAT5 NNP B-Gene
is VBZ O
not RB O
involved VBN O
in IN O
the DT O
synergistic JJ O
action NN O
of IN O
SCF NNP B-Gene
and CC O
EPO NNP B-Gene
. . O

Together RB O
, , O
the DT O
data NN O
suggest NN O
that IN O
synergistic JJ O
activation NN O
of IN O
MAPK NNP B-Gene
by IN O
SCF NNP B-Gene
and CC O
EPO NNP B-Gene
is VBZ O
essential JJ O
for IN O
expanded JJ O
erythropoiesis NN O
. . O

Copyright JJ O
1998 CD O
by IN O
The DT O
American JJ O
Society NNP O
of IN O
Hematology NNP O
. . O

The DT O
molecular JJ O
and CC O
phenotypic JJ O
profile NN O
of IN O
primary JJ O
central JJ O
nervous JJ O
system NN O
lymphoma JJ O
identifies NNS O
distinct JJ O
categories NNS O
of IN O
the DT O
disease NN O
and CC O
is VBZ O
consistent JJ O
with IN O
histogenetic JJ O
derivation NN O
from IN O
germinal JJ O
center NN O
- : O
related JJ O
B NNP O
cells NNS O
. . O

Primary JJ O
central JJ O
nervous JJ O
system NN O
lymphoma NN O
( ( O
PCNSL NNP O
) ) O
is VBZ O
a DT O
major JJ O
cause NN O
of IN O
morbidity NN O
and CC O
mortality NN O
among IN O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
- : O
infected VBN O
individuals NNS O
. . O

The DT O
precise JJ O
histogenetic JJ O
derivation NN O
and CC O
the DT O
molecular JJ O
pathogenesis NN O
of IN O
PCNSL NNP O
is VBZ O
poorly RB O
understood JJ O
. . O

In IN O
an DT O
attempt NN O
to TO O
clarify VB O
the DT O
histogenesis NN O
and CC O
pathogenesis NN O
of IN O
these DT O
lymphomas NNS O
, , O
49 CD O
PCNSL NNP O
( ( O
26 CD O
acquired VBN O
immunodeficiency NN O
syndrome NN O
[ NNP O
AIDS NNP O
] NNP O
- : O
related VBN O
and CC O
23 CD O
AIDS NNP O
- : O
unrelated JJ O
) ) O
were VBD O
analyzed VBN O
for IN O
multiple JJ O
biologic NN O
markers NNS O
, , O
which WDT O
are VBP O
known VBN O
to TO O
bear VB O
histogenetic JJ O
and CC O
pathogenetic JJ O
significance NN O
for IN O
mature NN O
B NNP O
- : O
cell NN O
neoplasms NNS O
. . O

PCNSL NNP O
associated VBN O
frequently RB O
( ( O
50 CD O
. . O
0 CD O
% NN O
) ) O
with IN O
mutations NNS O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
5 CD I-Gene
' '' I-Gene
noncoding JJ I-Gene
regions NNS I-Gene
, , O
which WDT O
are VBP O
regarded VBN O
as IN O
a DT O
marker NN O
of IN O
B NNP O
- : O
cell NN O
transition NN O
through IN O
the DT O
germinal JJ O
center NN O
( ( O
GC NNP O
) ) O
. . O

Expression NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
protein NN I-Gene
, , O
which WDT O
is VBZ O
restricted VBN O
to TO O
GC NNP O
B NNP O
cells NNS O
throughout IN O
physiologic NN O
B NNP O
- : O
cell NN O
maturation NN O
, , O
was VBD O
detected VBN O
in IN O
100 CD O
% NN O
AIDS NNP O
- : O
unrelated JJ O
PCNSL NNP O
and CC O
in IN O
56 CD O
. . O
2 CD O
% NN O
AIDS NNP O
- : O
related JJ O
cases NNS O
. . O

Notably RB O
, , O
among IN O
AIDS NNP O
- : O
related JJ O
PCNSL NNP O
, , O
expression NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
was VBD O
mutually RB O
exclusive JJ O
with IN O
expression NN O
of IN O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
- : I-Gene
encoded VBN I-Gene
latent JJ I-Gene
membrane NN I-Gene
protein NN I-Gene
( ( I-Gene
LMP NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
and CC O
, , O
with IN O
few JJ O
exceptions NNS O
, , O
also RB O
of IN O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

All DT O
but CC O
one CD O
PCNSL NNP O
expressed VBD O
hMSH2 NN O
, , O
which WDT O
among IN O
mature NN O
B NNP O
cells NNS O
selectively RB O
stains VBZ O
GC NNP O
B NNP O
cells NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
PCNSL NNP O
may MD O
be VB O
frequently RB O
related VBN O
to TO O
GC NNP O
B NNP O
cells NNS O
and CC O
may MD O
be VB O
segregated VBN O
into IN O
two CD O
major JJ O
biologic NN O
categories NNS O
based VBN O
on IN O
the DT O
expression NN O
pattern NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
+ NN O
) ) O
/ NN O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
- : O
) ) O
/ VBP O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( O
- : O
) ) O
PCNSL NNP O
occur VBP O
both DT O
in IN O
the DT O
presence NN O
and CC O
in IN O
the DT O
absence NN O
of IN O
HIV NNP O
infection NN O
and CC O
consistently RB O
display VB O
a DT O
large JJ O
noncleaved VBN O
cell NN O
morphology NN O
. . O

Conversely RB O
, , O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
- : O
) ) O
/ VBP O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
+ NN O
) ) O
/ NN O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( O
+ NN O
) ) O
PCNSL NNP O
are VBP O
restricted VBN O
to TO O
HIV NNP O
- : O
infected JJ O
hosts NNS O
and CC O
are VBP O
represented VBN O
by IN O
lymphomas NN O
with IN O
immunoblastic JJ O
features NNS O
. . O

These DT O
data NNS O
are VBP O
relevant JJ O
for IN O
the DT O
pathogenesis NN O
and CC O
histogenesis NN O
of IN O
PCNSL NNP O
and CC O
may MD O
be VB O
helpful JJ O
to TO O
segregate VB O
distinct JJ O
biologic NN O
and CC O
prognostic JJ O
categories NNS O
of IN O
these DT O
lymphomas NNS O
. . O

Copyright JJ O
1998 CD O
by IN O
The DT O
American JJ O
Society NNP O
of IN O
Hematology NNP O
. . O

Antioxidant NNP O
regulation NN O
of IN O
phorbol NN O
ester NN O
- : O
induced JJ O
adhesion NN O
of IN O
human JJ O
Jurkat NNP O
T NNP O
- : O
cells NNS O
to TO O
endothelial JJ O
cells NNS O
. . O

Regulation NN O
of IN O
adhesion NN O
molecule NN O
expression NN O
and CC O
function NN O
by IN O
reactive JJ O
oxygen NN O
species NNS O
via IN O
specific JJ O
redox JJ O
sensitive JJ O
mechanisms NNS O
have VBP O
been VBN O
reported VBN O
. . O

The DT O
effects NNS O
of IN O
clinically RB O
safe JJ O
antioxidants NNS O
in IN O
the DT O
regulation NN O
of IN O
adhesion NN O
molecule NN O
expression NN O
in IN O
human JJ O
endothelial JJ O
cells NNS O
( ( O
ECV NNP O
) ) O
, , O
and CC O
adherence NN O
of IN O
human JJ O
Jurkat NNP O
T NNP O
cells NNS O
to TO O
ECV NNP O
cells NNS O
were VBD O
investigated VBN O
. . O

The DT O
thiol NN O
antioxidant NN O
, , O
alpha SYM O
- : O
lipoate NN O
, , O
at IN O
clinically RB O
relevant JJ O
doses NNS O
down RP O
- : O
regulated JJ O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
- : O
induced VBN O
adhesion NN O
molecule NN O
expression NN O
and CC O
cell NN O
- : O
cell NN O
adhesion NN O
. . O

Inhibition NN O
of IN O
PMA NNP O
- : O
induced VBD O
ICAM NNP O
- : O
1 CD O
and CC O
VCAM NNP O
- : O
1 CD O
expression NN O
as RB O
well RB O
as IN O
PMA NNP O
- : O
induced JJ O
adhesion NN O
of IN O
Jurkat NNP O
T NNP O
- : O
cells NNS O
to TO O
ECV NNP O
cells NNS O
by IN O
alpha JJ O
- : O
lipoate NN O
was VBD O
dose JJ O
dependent NN O
( ( O
50 CD O
- : O
250 CD O
microM NN O
) ) O
. . O

The DT O
effect NN O
was VBD O
significant JJ O
for IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
p JJ O
< NNP O
. . O
1 CD O
) ) O
and CC O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
p JJ O
< NNP O
. . O
1 CD O
) ) O
expression NN O
in IN O
cells NNS O
pretreated VBN O
with IN O
100 CD O
microM NNS O
alpha JJ O
- : O
lipoate NN O
compared VBN O
to TO O
PMA NNP O
- : O
activated VBD O
untreated JJ O
cells NNS O
. . O

Inhibition NN O
of IN O
PMA NNP O
- : O
induced JJ O
adhesion NN O
molecule NN O
expression NN O
and CC O
cell NN O
- : O
cell NN O
adhesion NN O
was VBD O
more RBR O
pronounced JJ O
when WRB O
a DT O
combination NN O
of IN O
antioxidants NNS O
, , O
alpha SYM O
- : O
lipoate NN O
and CC O
alpha JJ O
- : O
tocopherol NN O
, , O
were VBD O
used VBN O
compared VBN O
to TO O
the DT O
use NN O
of IN O
either DT O
of IN O
these DT O
antioxidant JJ O
alone NN O
. . O

The DT O
regulation NN O
of IN O
adhesion NN O
molecule NN O
expression NN O
and CC O
function NN O
by IN O
low JJ O
concentration NN O
of IN O
antioxidants NNS O
investigated VBN O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
regulated VBD O
or CC O
transcription NN O
dependent NN O
because IN O
no DT O
change NN O
in IN O
the DT O
mRNA NN O
response NN O
was VBD O
observed VBN O
. . O

Protein NNP B-Gene
kinase VBD I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
has VBZ O
been VBN O
suggested VBN O
to TO O
regulate VB O
PMA NNP O
- : O
induced JJ O
adhesion NN O
molecule NN O
expression NN O
by IN O
post NN O
- : O
transcriptional JJ O
stabilization NN O
of IN O
adhesion NN B-Gene
molecule NN I-Gene
mRNA NN I-Gene
. . O

Alpha NNP O
- : O
lipoate NN O
pretreatment NN O
did VBD O
not RB O
influence VB O
the DT O
response NN O
of IN O
PKC NNP B-Gene
activity NN O
to TO O
PMA NNP O
. . O

Oxidants NNS O
are VBP O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
adhesion NN O
processes VBZ O
. . O

Treatment NN O
of IN O
ECV NNP O
cells NNS O
with IN O
PMA NNP O
induced JJ O
generation NN O
of IN O
intracellular JJ O
oxidants NNS O
. . O

Alpha NNP O
- : O
lipoate NN O
( ( O
100 CD O
or CC O
250 CD O
microM NN O
) ) O
treatment NN O
decreased VBN O
PMA NNP O
- : O
induced JJ O
generation NN O
of IN O
intracellular JJ O
oxidants NNS O
. . O

The DT O
inhibitory JJ O
effect NN O
of IN O
low JJ O
concentration NN O
of IN O
alpha JJ O
- : O
lipaote NN O
alone RB O
or CC O
in IN O
combination NN O
with IN O
alpha JJ O
- : O
tocopherol NN O
on IN O
agonist JJ O
- : O
induced JJ O
adhesion NN O
processes VBZ O
observed VBN O
in IN O
this DT O
study NN O
may MD O
be VB O
of IN O
potential JJ O
therapeutic JJ O
value NN O
. . O

Binding NNP O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
to TO O
CD4 NNP B-Gene
and CC I-Gene
CXCR4 NNP I-Gene
receptors NNS I-Gene
differentially RB O
regulates VBZ O
expression NN O
of IN O
inflammatory JJ B-Gene
genes NNS I-Gene
and CC O
activates VBZ O
the DT O
MEK NNP B-Gene
/ NNP O
ERK NNP O
signaling VBG O
pathway RB O
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
binding NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
virions NNS O
to TO O
CD4 NNP B-Gene
receptors NNS I-Gene
stimulates VBZ O
association NN O
of IN O
Lck NNP B-Gene
with IN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
results NNS O
in IN O
the DT O
activation NN O
of IN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
kinase NN O
in IN O
a DT O
Ras NNP O
- : O
independent JJ O
manner NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
demonstrate VBP O
that IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
envelope NN I-Gene
glycoproteins NNS I-Gene
of IN O
both DT O
T NNP O
- : O
cell NN O
- : O
tropic NN O
and CC O
macrophagetropic NN O
strains NNS O
rapidly RB O
activate VBP O
the DT O
ERK NNP O
/ NNP O
mitogen NN O
- : O
activated VBN O
protein NN O
( ( O
MAP NNP O
) ) O
kinase VB O
pathway NN O
and CC O
the DT O
binding NN O
of IN O
nuclear JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) O
and CC O
stimulate JJ O
expression NN O
of IN O
cytokine NN B-Gene
and CC I-Gene
chemokine NN I-Gene
genes NNS I-Gene
. . O

The DT O
activation NN O
of IN O
this DT O
signaling VBG O
pathway NN O
requires VBZ O
functional JJ O
CD4 NNP B-Gene
receptors NNS I-Gene
and CC O
is VBZ O
independent JJ O
of IN O
binding VBG O
to TO O
CXCR4 NNP B-Gene
. . O

Binding NN O
of IN O
the DT O
natural JJ O
ligand NN O
stromal NN B-Gene
cell NN I-Gene
- : I-Gene
derived VBN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
to TO O
CXCR4 NNP B-Gene
, , O
which WDT O
inhibits VBZ O
entry NN O
of IN O
T NNP O
- : O
cell NN O
- : O
tropic NN O
HIV NNP O
- : O
1 CD O
, , O
activates NNS O
also RB O
the DT O
ERK NNP O
/ NNP O
MAP NNP B-Gene
kinase VB I-Gene
pathway NN O
. . O

However RB O
, , O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
did VBD O
not RB O
affect VB O
the DT O
CD4 NNP O
- : O
mediated VBD O
expression NN O
of IN O
cytokine NN B-Gene
and CC I-Gene
chemokine NN I-Gene
genes NNS I-Gene
. . O

These DT O
results NNS O
provide VBP O
firm JJ O
molecular JJ O
evidence NN O
that IN O
binding NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
envelope NN I-Gene
glycoproteins NNS I-Gene
to TO O
CD4 NNP B-Gene
receptor NN I-Gene
initiates VBZ O
a DT O
signaling VBG O
pathway NN O
( ( O
s PRP O
) ) O
independent JJ O
of IN O
the DT O
binding NN O
to TO O
the DT O
chemokine NN B-Gene
receptor NN I-Gene
that WDT O
leads VBZ O
to TO O
the DT O
aberrant JJ O
expression NN O
of IN O
inflammatory JJ B-Gene
genes NNS I-Gene
and CC O
may MD O
contribute VB O
significantly RB O
to TO O
HIV NNP O
- : O
1 CD O
replication NN O
as RB O
well RB O
as IN O
to TO O
deregulation NN O
of IN O
the DT O
immune NN O
system NN O
. . O

Antigen NNP O
receptor NN O
signaling VBG O
induces NNS O
MAP NNP O
kinase VBD O
- : O
mediated VBN O
phosphorylation NN O
and CC O
degradation NN O
of IN O
the DT O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
transcription NN B-Gene
factor NN I-Gene
. . O

The DT O
bcl NN B-Gene
- : I-Gene
6 CD I-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
encodes VBZ O
a DT O
POZ NNP B-Gene
/ NNP I-Gene
zinc NNP I-Gene
finger VBD I-Gene
transcriptional JJ I-Gene
repressor NN I-Gene
expressed VBN O
in IN O
germinal JJ O
center NN O
( ( O
GC NNP O
) ) O
B NNP O
and CC O
T NNP O
cells NNS O
and CC O
required VBN O
for IN O
GC NNP O
formation NN O
and CC O
antibody NN O
affinity NN O
maturation NN O
. . O

Deregulation NN O
of IN O
bcl NN B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
by IN O
chromosomal JJ O
rearrangements NNS O
and CC O
point NN O
mutations NNS O
of IN O
the DT O
bcl NN B-Gene
- : I-Gene
6 CD I-Gene
promoter NN I-Gene
region NN I-Gene
are VBP O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
B NNP O
- : O
cell NN O
lymphoma NN O
. . O

The DT O
signals NNS O
regulating VBG O
bcl SYM B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
are VBP O
not RB O
known VBN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
antigen NN O
receptor NN O
activation NN O
leads VBZ O
to TO O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
phosphorylation NN O
by IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
. . O

Phosphorylation NN O
, , O
in IN O
turn NN O
, , O
targets NNS O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
for IN O
rapid JJ O
degradation NN O
by IN O
the DT O
ubiquitin JJ B-Gene
/ JJ O
proteasome NN B-Gene
pathway NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
is VBZ O
directly RB O
controlled VBN O
by IN O
the DT O
antigen NN O
receptor NN O
via IN O
MAPK NNP B-Gene
activation NN O
. . O

This DT O
signaling VBG O
pathway NN O
may MD O
be VB O
crucial JJ O
for IN O
the DT O
control NN O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
and CC O
antibody NN O
response NN O
and CC O
has VBZ O
implications NNS O
for IN O
the DT O
regulation NN O
of IN O
other JJ O
POZ NNP B-Gene
/ NNP I-Gene
zinc NNP I-Gene
finger NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
other JJ O
tissues NNS O
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
are VBP O
differentially RB O
expressed VBN O
in IN O
the DT O
cells NNS O
and CC O
tissues NNS O
of IN O
the DT O
immune NN O
system NN O
. . O

Cytosolic NNP B-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
binding VBG O
studies NNS O
on IN O
immune JJ O
tissues NNS O
demonstrate VBP O
that IN O
the DT O
thymus NN O
exhibits VBZ O
three CD O
to TO O
four CD O
times NNS O
higher JJR O
levels NNS O
of IN O
GR NNP B-Gene
protein NN I-Gene
than IN O
the DT O
spleen NN O
. . O

High JJ O
levels NNS O
of IN O
GR NNP B-Gene
are VBP O
consistent JJ O
with IN O
the DT O
exquisite JJ O
sensitivity NN O
of IN O
the DT O
thymus NN O
to TO O
glucocorticoid VB O
exposure NN O
. . O

Nevertheless RB O
, , O
whole JJ O
cell NN O
binding VBG O
studies NNS O
reveal VBP O
similar JJ O
levels NNS O
of IN O
GR NNP B-Gene
in IN O
immature NN O
thymic JJ O
T NNP O
lymphocytes NNS O
and CC O
more JJR O
mature NN O
, , O
splenic JJ O
T NNP O
lymphocytes NNS O
. . O

Moreover RB O
, , O
whole JJ O
cell NN O
binding VBG O
techniques NNS O
indicate VBP O
that IN O
neutrophils NNS O
( ( O
which WDT O
represent VBP O
roughly RB O
30 CD O
% NN O
of IN O
splenic JJ O
leukocytes NNS O
) ) O
exhibit NN O
higher JJR O
GR NNP B-Gene
than IN O
both DT O
T NNP O
and CC O
B NNP O
lymphocytes NNS O
, , O
further RB O
contradicting VBG O
results NNS O
from IN O
cytosolic JJ O
binding VBG O
studies NNS O
. . O

To TO O
address VB O
these DT O
inconsistencies NNS O
, , O
GR NNP B-Gene
protein NN I-Gene
was VBD O
assessed VBN O
in IN O
immune JJ O
cells NNS O
and CC O
tissues NNS O
using VBG O
cytosolic JJ O
radioligand NN O
binding NN O
. . O

Western JJ O
blot NN O
analysis NN O
, , O
and CC O
immunocytochemistry NN O
. . O

Consistent JJ O
with IN O
previous JJ O
cytosolic JJ O
receptor NN O
binding VBG O
studies NNS O
on IN O
immune JJ O
tissue NN O
homogenates NNS O
, , O
thymic JJ O
T NNP O
cells NNS O
were VBD O
found VBN O
to TO O
have VB O
higher JJR O
levels NNS O
of IN O
GR NNP B-Gene
than IN O
T NNP O
cells NNS O
isolated VBN O
from IN O
the DT O
spleen NN O
. . O

In IN O
addition NN O
, , O
neutrophils NNS O
were VBD O
found VBN O
to TO O
have VB O
fewer JJR O
GR NNP B-Gene
than IN O
lymphocytes NNS O
and CC O
monocytes NNS O
. . O

These DT O
results NNS O
indicate VBP O
a DT O
meaningful JJ O
relationship NN O
between IN O
receptor NN O
expression NN O
and CC O
known VBN O
sensitivity NN O
to TO O
glucocorticoids NNS O
. . O

Functional JJ O
replacement NN O
of IN O
the DT O
mouse NN B-Gene
E2A NNP I-Gene
gene NN I-Gene
with IN O
a DT O
human JJ B-Gene
HEB NNP I-Gene
cDNA NN I-Gene
. . O

The DT O
mammalian JJ B-Gene
E2A NNP I-Gene
, , I-Gene
HEB NNP I-Gene
, , I-Gene
and CC I-Gene
E2 NNP I-Gene
- : I-Gene
2 CD I-Gene
genes NNS I-Gene
encode VBD O
a DT O
unique JJ O
class NN O
of IN O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
bHLH NN I-Gene
) ) I-Gene
transcription NN I-Gene
factors NNS I-Gene
that WDT O
are VBP O
evolutionarily RB O
conserved VBN O
and CC O
essential JJ O
for IN O
embryonic JJ O
and CC O
postnatal JJ O
development NN O
. . O

While IN O
the DT O
structural JJ O
and CC O
functional JJ O
similarities NNS O
among IN O
the DT O
gene NN B-Gene
products NNS I-Gene
are VBP O
well RB O
demonstrated VBN O
, , O
it PRP O
is VBZ O
not RB O
clear JJ O
why WRB O
deletion NN O
of IN O
E2A NNP B-Gene
, , O
but CC O
not RB O
HEB NNP B-Gene
or CC O
E2 NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
leads VBZ O
to TO O
a DT O
complete JJ O
arrest NN O
in IN O
B NNP O
- : O
lymphocyte NN O
development NN O
. . O

To TO O
understand VB O
the DT O
molecular JJ O
basis NN O
of IN O
the DT O
functional JJ O
specificity NN O
between IN O
E2A NNP B-Gene
and CC O
HEB NNP B-Gene
/ NNP O
E2 NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
mammalian JJ O
development NN O
, , O
we PRP O
generated VBD O
and CC O
tested VBD O
a DT O
panel NN O
of IN O
E2A NNP B-Gene
knockin FW O
mutations NNS O
including VBG O
subtle JJ O
mutations NNS O
in IN O
the DT O
E12 NNP B-Gene
and CC I-Gene
E47 NNP I-Gene
exons NNS I-Gene
and CC O
substitution NN O
of IN O
both DT O
E12 NNP B-Gene
and CC I-Gene
E47 NNP I-Gene
exons NNS I-Gene
with IN O
a DT O
human JJ B-Gene
HEB NNP I-Gene
cDNA NN I-Gene
. . O

We PRP O
find VBP O
that IN O
the DT O
alternatively RB O
spliced JJ O
E12 NNP B-Gene
and CC I-Gene
E47 NNP I-Gene
bHLH VBP I-Gene
proteins NNS I-Gene
of IN O
the DT O
E2A NNP B-Gene
gene NN I-Gene
play NN O
similar JJ O
and CC O
additive JJ O
roles NNS O
in IN O
supporting VBG O
B NNP O
lymphopoiesis NN O
. . O

Further RB O
, , O
we PRP O
find VBP O
that IN O
HEB NNP B-Gene
driven RB O
by IN O
the DT O
endogenous JJ B-Gene
E2A NNP I-Gene
promoter NN I-Gene
can MD O
functionally RB O
replace VB O
E2A NNP B-Gene
in IN O
supporting VBG O
B NNP O
- : O
cell NN O
commitment NN O
and CC O
differentiation NN O
toward IN O
completion NN O
. . O

Finally RB O
, , O
the DT O
postnatal JJ O
lethality NN O
associated VBN O
with IN O
E2A NNP B-Gene
disruption NN O
is VBZ O
fully RB O
rescued VBN O
by IN O
the DT O
addition NN O
of IN O
HEB NNP B-Gene
. . O

This DT O
study NN O
suggests VBZ O
that IN O
the DT O
functional JJ O
divergence NN O
among IN O
E12 NNP B-Gene
, , O
E47 NNP B-Gene
, , O
and CC O
HEB NNP B-Gene
in IN O
different JJ O
cell NN O
types NNS O
is VBZ O
partially RB O
defined VBN O
by IN O
the DT O
context NN O
of IN O
gene NN O
expression NN O
. . O

Biased JJ O
dependency NN O
of IN O
CD80 NNP B-Gene
versus NN O
CD86 NNP B-Gene
in IN O
the DT O
induction NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
regulating VBG O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

In IN O
addition NN O
to TO O
the DT O
signals NNS O
obtained VBN O
by IN O
ligation NN O
of IN O
the DT O
TCR NNP O
, , O
T NNP O
cells NNS O
need VBP O
additional JJ O
, , O
co JJ O
- : O
stimulatory NN O
signals NNS O
to TO O
be VB O
activated VBN O
. . O

One CD O
such JJ O
co SYM O
- : O
stimulatory JJ O
signal NN O
is VBZ O
delivered VBN O
when WRB O
CD28 NNP B-Gene
on IN O
T NNP O
cells NNS O
binds VBZ O
to TO O
CD80 NNP B-Gene
or CC O
CD86 NNP B-Gene
on IN O
antigen NN O
- : O
presenting NN O
cells NNS O
( ( O
APC NNP O
) ) O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
analyzed VBD O
the DT O
ability NN O
of IN O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
to TO O
co VB O
- : O
stimulate NN O
human JJ O
T NNP O
cells NNS O
activated VBN O
by IN O
superantigen NN O
. . O

Using VBG O
the DT O
Raji NNP O
B NNP O
cell NN O
lymphoma NN O
, , O
which WDT O
express VBP O
similar JJ O
levels NNS O
of IN O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
, , O
it PRP O
was VBD O
found VBN O
that IN O
T NNP O
cell NN O
proliferation NN O
was VBD O
mainly RB O
co JJ O
- : O
stimulated VBN O
by IN O
CD80 NNP B-Gene
. . O

To TO O
further RBR O
characterize VB O
the DT O
consequences NNS O
of IN O
this DT O
biased VBN O
co NN O
- : O
stimulatory NN O
dependency NN O
, , O
we PRP O
employed VBD O
a DT O
well RB O
- : O
defined JJ O
system NN O
of IN O
transfected JJ O
CHO NNP O
cells NNS O
expressing VBG O
human JJ B-Gene
MHC NNP I-Gene
class NN I-Gene
II NNP I-Gene
together RB O
with IN O
CD80 NNP B-Gene
, , O
CD86 NNP B-Gene
or CC O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
. . O

Proliferation NN O
of IN O
freshly RB O
prepared JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
required VBD O
the DT O
presence NN O
of IN O
either DT O
CD80 NNP B-Gene
or CC O
CD86 NNP B-Gene
. . O

However RB O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
reached VBD O
only RB O
suboptimal JJ O
levels NNS O
in IN O
the DT O
presence NN O
of IN O
CD86 NNP B-Gene
but CC O
optimal JJ O
levels NNS O
with IN O
CD80 NNP B-Gene
. . O

To TO O
analyze VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
transcriptional JJ O
activity NN O
in IN O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
co VBP O
- : O
stimulated VBN O
T NNP O
cells NNS O
we PRP O
used VBD O
Jurkat NNP O
T NNP O
cells NNS O
transfected VBD O
with IN O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
constructs NNS I-Gene
. . O

CD80 NNP B-Gene
induced VBD O
higher JJR O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
- : O
enhancer NN O
activity NN O
compared VBN O
to TO O
CD86 NNP B-Gene
. . O

Furthermore RB O
, , O
the DT O
activity NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
regulating VBG O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
- : I-Gene
enhancer NN I-Gene
region NN I-Gene
including VBG O
activation NN B-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
CD28 NNP B-Gene
response NN I-Gene
element NN I-Gene
and CC O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
were VBD O
4 CD O
- : O
8 CD O
times NNS O
higher RBR O
after IN O
CD80 NNP B-Gene
compared VBN O
to TO O
CD86 NNP B-Gene
ligation NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
eventual JJ O
appearance NN O
of IN O
CD80 NNP B-Gene
on IN O
recently RB O
activated VBN O
CD86 NNP O
+ NNP O
APC NNP O
is VBZ O
important JJ O
for IN O
the DT O
superinduction NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
and CC O
to TO O
support VB O
vigorous JJ O
T NNP O
cell NN O
proliferation NN O
. . O

Duplication NN O
of IN O
the DT O
DR3 NNP B-Gene
gene NN I-Gene
on IN O
human JJ B-Gene
chromosome NN I-Gene
1p36 CD I-Gene
and CC O
its PRP$ O
deletion NN O
in IN O
human JJ O
neuroblastoma NN O
. . O

The DT O
human JJ B-Gene
DR3 NNP I-Gene
gene NN I-Gene
, , O
whose WP$ O
product NN O
is VBZ O
also RB O
known VBN O
as IN O
Wsl NNP B-Gene
- : I-Gene
1 CD I-Gene
/ NN I-Gene
APO NNP I-Gene
- : I-Gene
3 CD I-Gene
/ NN I-Gene
TRAMP NNP I-Gene
/ NNP I-Gene
LARD NNP I-Gene
, , O
encodes VBZ O
a DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
related JJ I-Gene
receptor NN I-Gene
that WDT O
is VBZ O
expressed VBN O
primarily RB O
on IN O
the DT O
surface NN O
of IN O
thymocytes NNS O
and CC O
lymphocytes NNS O
. . O

DR3 NNP B-Gene
is VBZ O
capable JJ O
of IN O
inducing VBG O
both DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
and CC O
apoptosis NN O
when WRB O
overexpressed VBN O
in IN O
mammalian JJ O
cells NNS O
, , O
although IN O
its PRP$ O
ligand NN O
has VBZ O
not RB O
yet RB O
been VBN O
identified VBN O
. . O

We PRP O
report VBP O
here RB O
that IN O
the DT O
DR3 NNP B-Gene
gene NN I-Gene
locus NN I-Gene
is VBZ O
tandemly RB O
duplicated VBN O
on IN O
human JJ B-Gene
chromosome NN I-Gene
band NN I-Gene
1p36 CD I-Gene
. . I-Gene
2 CD I-Gene
- : I-Gene
p36 NN I-Gene
. . I-Gene
3 CD I-Gene
and CC O
that IN O
these DT O
genes NNS O
are VBP O
hemizygously RB O
deleted VBN O
and CC O
/ CD O
or CC O
translocated VBN O
to TO O
another DT O
chromosome NN O
in IN O
neuroblastoma NN O
( ( O
NB NNP O
) ) O
cell NN O
lines NNS O
with IN O
amplified JJ O
MYCN NNP O
. . O

Duplication NN O
of IN O
at IN O
least JJS O
a DT O
portion NN O
of IN O
the DT O
DR3 NNP B-Gene
gene NN I-Gene
, , O
including VBG O
the DT O
extracellular NN B-Gene
and CC I-Gene
transmembrane NN I-Gene
regions NNS I-Gene
but CC O
not RB O
the DT O
cytoplasmic JJ B-Gene
domain NN I-Gene
, , O
was VBD O
demonstrated VBN O
by IN O
both DT O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
and CC O
genomic JJ O
Southern NNP O
blotting NN O
. . O

In IN O
most JJS O
NB NNP O
cell NN O
lines NNS O
, , O
both CC O
the DT O
DR3 NNP B-Gene
and CC I-Gene
the DT I-Gene
DR3L NNP I-Gene
sequences NNS I-Gene
are VBP O
simultaneously RB O
deleted VBN O
and CC O
/ CD O
or CC O
translocated VBN O
to TO O
another DT O
chromosome NN B-Gene
. . O

Finally RB O
, , O
DR3 NNP B-Gene
/ NNP I-Gene
Wsl NNP I-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
expression NN O
is VBZ O
quite RB O
variable JJ O
among IN O
these DT O
NB NNP O
cell NN O
lines NNS O
, , O
with IN O
very RB O
low JJ O
or CC O
undetectable JJ O
levels NNS O
in IN O
7 CD O
of IN O
17 CD O
NB NNP O
cell NN O
lines NNS O

Differential JJ O
protection NN O
of IN O
normal JJ O
and CC O
malignant JJ O
human JJ O
myeloid NN O
progenitors NNS O
( ( O
CFU NNP O
- : O
GM NNP O
) ) O
from IN O
Ara NNP O
- : O
C NNP O
toxicity NN O
using VBG O
cycloheximide NN O
. . O

Cycloheximide NNP O
, , O
a DT O
reversible JJ O
protein NN O
synthesis NN O
inhibitor NN O
, , O
is VBZ O
thought VBN O
to TO O
block VB O
DNA NNP O
replication NN O
in IN O
normal JJ O
cells NNS O
by IN O
preventing VBG O
synthesis NN O
of IN O
a DT O
labile JJ B-Gene
protein NN I-Gene
. . O

In IN O
animal JJ O
systems NNS O
, , O
cycloheximide JJ O
protects NNS O
normal JJ O
cells NNS O
from IN O
cytotoxic NN O
S NNP O
- : O
phase NN O
specific JJ O
agents NNS O
, , O
such JJ O
as IN O
cytosine NN O
arabinoside NN O
( ( O
Ara NNP O
- : O
C NNP O
) ) O
. . O

Malignant JJ O
cells NNS O
appear VBP O
not RB O
to TO O
be VB O
susceptible JJ O
to TO O
cycloheximide VB O
- : O
induced JJ O
cycle NN O
arrest NN O
and CC O
, , O
subsequently RB O
, , O
may MD O
not RB O
be VB O
protected VBN O
from IN O
Ara NNP O
- : O
C NNP O
cytotoxicity NN O
. . O

The DT O
effect NN O
of IN O
cycloheximide NN O
on IN O
granulocyte NN O
/ NN O
macrophage NN O
progenitors NNS O
( ( O
CFU NNP O
- : O
GM NNP O
) ) O
after IN O
in IN O
vitro NN O
Ara NNP O
- : O
C NNP O
exposure NN O
was VBD O
examined VBN O
using VBG O
normal JJ O
human JJ O
bone NN O
marrow NN O
, , O
malignant JJ O
progenitors NNS O
from IN O
patients NNS O
with IN O
chronic JJ O
myelogenous JJ O
leukemia NN O
( ( O
CML NNP O
) ) O
, , O
and CC O
clonogenic JJ O
cells NNS O
from IN O
the DT O
human JJ O
acute NN O
nonlymphocytic JJ O
leukemia NN O
cell NN O
lines NNS O
HL NNP O
- : O
60 CD O
and CC O
KG NNP O
- : O
1 CD O
. . O

Mononuclear NNP O
or CC O
clonogenic JJ O
cells NNS O
were VBD O
incubated VBN O
for IN O
one CD O
hour NN O
with IN O
cycloheximide NN O
, , O
followed VBN O
by IN O
the DT O
addition NN O
, , O
for IN O
three CD O
or CC O
17 CD O
hours NNS O
, , O
of IN O
Ara NNP O
- : O
C NN O
before IN O
being VBG O
plated VBN O
in IN O
a DT O
methylcellulose JJ O
culture NN O
system NN O
. . O

CFU NNP O
- : O
GM NNP O
survival NN O
was VBD O
significantly RB O
increase JJ O
if IN O
normal JJ O
cells NNS O
were VBD O
treated VBN O
with IN O
cycloheximide NN O
before IN O
Ara NNP O
- : O
C NN O
exposure NN O
. . O

Similar JJ O
cycloheximide NN O
pretreatment NN O
of IN O
CML NNP O
progenitors NNS O
and CC O
clonogenic JJ O
HL NNP O
- : O
60 CD O
and CC O
KG NNP O
- : O
1 CD O
cells NNS O
failed VBD O
to TO O
protect VB O
CFU NNP O
- : O
GM NNP O
from IN O
Ara NNP O
- : O
C NNP O
- : O
induced JJ O
cytotoxicity NN O
. . O

Primary JJ O
cortisol NN O
resistance NN O
accompanied VBN O
by IN O
a DT O
reduction NN O
in IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
two CD O
members NNS O
of IN O
the DT O
same JJ O
family NN O
. . O

This DT O
report NN O
describes VBZ O
studies NNS O
of IN O
a DT O
man NN O
suspected VBN O
of IN O
having VBG O
primary JJ O
cortisol NN O
resistance NN O
. . O

This DT O
conclusion NN O
is VBZ O
based VBN O
on IN O
his PRP$ O
high JJ O
plasma NN O
cortisol NN O
levels NNS O
and CC O
high JJ O
24 CD O
- : O
h NN O
urinary JJ O
17 CD O
- : O
hydroxycorticosteroi NN O
and CC O
cortisol NN O
excretion NN O
, , O
plus CC O
the DT O
fact NN O
that IN O
he PRP O
had VBD O
no DT O
manifestations NNS O
of IN O
Cushing VBG O
' '' O
s JJ O
syndrome NN O
. . O

Among IN O
family NN O
members NNS O
tested VBN O
, , O
his PRP$ O
mother NN O
also RB O
had VBD O
hypercortisolemia NN O
. . O

Both DT O
mother NN O
and CC O
son NN O
had VBD O
high JJ O
levels NNS O
of IN O
unbound JJ O
plasma NN O
cortisol NN O
, , O
but CC O
their PRP$ O
plasma NN O
ACTH NNP O
concentrations NNS O
were VBD O
within IN O
the DT O
normal JJ O
range NN O
. . O

Both DT O
were VBD O
partially RB O
resistant JJ O
to TO O
dexamethasone VB O
adrenal JJ O
suppression NN O
, , O
and CC O
both DT O
had VBD O
mild VBN O
hypertension NN O
without IN O
hypokalemia NN O
. . O

To TO O
study VB O
this DT O
apparent JJ O
end NN O
- : O
organ JJ O
resistance NN O
to TO O
cortisol VB O
, , O
we PRP O
examined VBD O
the DT O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
peripheral JJ O
mononuclear JJ O
cells NNS O
. . O

Using VBG O
whole JJ O
cell NN O
assays NNS O
, , O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
both DT O
patients NNS O
were VBD O
found VBN O
to TO O
have VB O
reduced VBN O
total JJ O
binding NN O
capacity NN O
. . O

We PRP O
conclude VBP O
that IN O
these DT O
two CD O
patients NNS O
, , O
members NNS O
of IN O
the DT O
same JJ O
family NN O
, , O
have VBP O
primary JJ O
cortisol NNS O
resistance NN O
accompanied VBN O
by IN O
a DT O
reduced JJ O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
. . O

[ JJ O
Glucocorticoid NNP B-Gene
receptors NNS I-Gene
and CC O
response NN O
to TO O
polychemotherapy VB O
in IN O
acute JJ O
lymphatic JJ O
leukemia NN O
] NN O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
levels NNS O
were VBD O
quantified VBN O
in IN O
leukemic JJ O
blasts NNS O
from IN O
peripheral JJ O
blood NN O
of IN O
86 CD O
patients NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
. . O

The DT O
subsequent JJ O
achievement NN O
of IN O
complete JJ O
remission NN O
after IN O
combination NN O
chemotherapy NN O
was VBD O
correlated VBN O
with IN O
high JJ O
receptor NN O
levels NNS O
. . O

Forty NNP O
- : O
seven CD O
of IN O
50 CD O
patients NNS O
with IN O
leukemic JJ O
cells NNS O
containing VBG O
more JJR O
than IN O
6 CD O
, , O
0 CD O
receptor NN O
sites NNS O
and CC O
22 CD O
of IN O
36 CD O
patients NNS O
with IN O
cells NNS O
containing VBG O
less JJR O
than IN O
6 CD O
, , O
0 CD O
receptor NN O
sites NNS O
achieved VBN O
remission NN O
. . O

The DT O
study NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
leukemic JJ O
cells NNS O
may MD O
predict VB O
response NN O
to TO O
combination NN O
chemotherapy NN O
in IN O
patients NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
. . O

Specific JJ O
uptake NN O
of IN O
1 CD O
, , O
25 CD O
- : O
dihydroxycholecalcif NN O
by IN O
human JJ O
chronic JJ O
myeloid NN O
leukemia NN O
cells NNS O
. . O

We PRP O
have VBP O
examined VBN O
mononuclear JJ O
cell NN O
preparations NNS O
from IN O
patients NNS O
with IN O
chronic JJ O
myeloid NN O
leukemia NN O
[ NNP O
CML NNP O
] NNP O
for IN O
binding NN O
of IN O
and CC O
response NN O
to TO O
1 CD O
, , O
25 CD O
- : O
dihydroxycholecalcif NN O
[ VBZ O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
] NN O
. . O

Whole JJ O
cells NNS O
specifically RB O
took VBD O
up RP O
[ JJ O
3H CD O
] SYM O
- : O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
with IN O
high JJ O
affinity NN O
( ( O
Kd NNP O
3 CD O
. . O
6 CD O
X JJ O
10 CD O
( ( O
- : O
11 CD O
) ) O
M NNP O
) ) O
and CC O
low JJ O
capacity NN O
. . O

Subcellular JJ O
fractionation NN O
of IN O
labeled JJ O
cells NNS O
showed VBD O
that IN O
binding NN O
was VBD O
restricted VBN O
to TO O
cytosols NNS O
and CC O
nuclei NN O
. . O

Sucrose NNP O
gradient JJ O
centrifugation NN O
of IN O
cells NNS O
preincubated VBN O
with IN O
[ JJ O
3H CD O
] SYM O
- : O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
revealed VBD O
a DT O
single JJ O
3 CD O
. . O
6S CD O
peak NN O
which WDT O
was VBD O
totally RB O
displaced VBN O
with IN O
100 CD O
- : O
fold NN O
excess JJ O
nonradioactive JJ O
hormone NN O
. . O

However RB O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
demonstrate VB O
specific JJ O
binding NN O
of IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
by IN O
postlabeling VBG O
standard JJ O
cytosol NN O
preparations NNS O
. . O

In IN O
addition NN O
, , O
cytosols NNS O
prepared VBD O
from IN O
a DT O
mixture NN O
of IN O
CML NNP O
cells NNS O
and CC O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
receptor NN O
- : O
positive JJ O
T47D NNP O
( ( O
human JJ O
breast NN O
cancer NN O
) ) O
cells NNS O
had VBD O
less JJR O
than IN O
10 CD O
% NN O
of IN O
the DT O
binding NN O
measured VBN O
in IN O
T47D NNP O
cytosol NN O
alone RB O
. . O

However RB O
, , O
the DT O
levels NNS O
of IN O
binding NN O
in IN O
T47D NNP O
cytosols NNS O
were VBD O
not RB O
reduced VBN O
if IN O
the DT O
receptors NNS O
were VBD O
occupied VBN O
with IN O
[ JJ O
3H CD O
] SYM O
- : O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
prior RB O
to TO O
the DT O
addition NN O
of IN O
the DT O
CML NNP O
cytosols NNS O
. . O

Thus RB O
, , O
CML NNP O
cells NNS O
appear VBP O
to TO O
contain VB O
both DT O
the DT O
receptor NN O
for IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
and CC O
an DT O
unknown JJ O
substance NN O
which WDT O
prevents VBZ O
its PRP$ O
detection NN O
following VBG O
the DT O
preparation NN O
of IN O
cytosol NN O
. . O

Cells NNS O
from IN O
patients NNS O
with IN O
CML NNP O
in IN O
the DT O
chronic JJ O
phase NN O
specifically RB O
bound VBD O
more JJR O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
[ $ O
18 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
2 CD O
( ( O
S NNP O
. . O
E NNP O
. . O
) ) O
fmol VBD O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
] $ O
than IN O
did VBD O
those DT O
in IN O
acute JJ O
myeloid JJ O
transformation NN O
[ VBD O
7 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
5 CD O
] NN O
or CC O
than IN O
did VBD O
cells NNS O
from IN O
patients NNS O
with IN O
acute JJ O
myeloid NN O
leukemia NN O
[ VBD O
2 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
] NN O
. . O

Only RB O
cells NNS O
from IN O
the DT O
first JJ O
group NN O
of IN O
patients NNS O
responded VBD O
to TO O
the DT O
addition NN O
of IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
by IN O
differentiating VBG O
along IN O
the DT O
monocyte NN O
- : O
macrophage NN O
pathway NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
differentiation NN O
- : O
induction NN O
effect NN O
of IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
is VBZ O
likely JJ O
to TO O
depend VB O
on IN O
adequate JJ O
levels NNS O
of IN O
receptor NN O
and CC O
that IN O
intact JJ O
cells NNS O
rather RB O
than IN O
cytosol VB O
preparations NNS O
should MD O
be VB O
studied VBN O
before IN O
cells NNS O
of IN O
a DT O
particular JJ O
tissue NN O
are VBP O
designated VBN O
as IN O
receptor NN O
negative JJ O
. . O

Effect NN O
of IN O
cell NN O
cycle NN O
position NN O
on IN O
dexamethasone NN O
binding NN O
by IN O
mouse NN O
and CC O
human JJ O
lymphoid NN O
cell NN O
lines NNS O
: : O
correlation NN O
between IN O
an DT O
increase NN O
in IN O
dexamethasone JJ O
binding NN O
during IN O
S NNP O
phase NN O
and CC O
dexamethasone NN O
sensitivity NN O
. . O

We PRP O
determined VBD O
the DT O
effect NN O
of IN O
cell NN O
cycle NN O
position NN O
on IN O
the DT O
amount NN O
of IN O
dexamethasone NN O
that WDT O
was VBD O
specifically RB O
bound VBN O
by IN O
mouse NN O
and CC O
human JJ O
lymphoid NN O
cell NN O
lines NNS O
. . O

Cell NNP O
lines NNS O
that WDT O
were VBD O
either RB O
sensitive JJ O
or CC O
resistant JJ O
to TO O
growth NN O
inhibition NN O
by IN O
dexamethasone NN O
were VBD O
compared VBN O
. . O

Exponentially RB O
growing VBG O
cells NNS O
were VBD O
separated VBN O
by IN O
centrifugal JJ O
elutriation NN O
into IN O
fractions NNS O
that WDT O
corresponded VBD O
to TO O
different JJ O
positions NNS O
in IN O
the DT O
cell NN O
cycle NN O
. . O

The DT O
cell NN O
cycle NN O
phase NN O
distribution NN O
of IN O
each DT O
fraction NN O
was VBD O
estimated VBN O
by IN O
flow JJ O
cytometry NN O
and CC O
autoradiography NN O
. . O

The DT O
amount NN O
of IN O
dexamethasone NN O
bound NN O
per IN O
cell NN O
in IN O
each DT O
fraction NN O
was VBD O
measured VBN O
by IN O
a DT O
whole JJ O
cell NN O
binding VBG O
assay NN O
. . O

In IN O
three CD O
dexamethasone NN O
- : O
sensitive JJ O
cell NN O
lines NNS O
( ( O
two CD O
mouse NN O
and CC O
one CD O
human NN O
) ) O
, , O
we PRP O
found VBD O
that IN O
the DT O
amount NN O
of IN O
dexamethasone NN O
bound NN O
per IN O
cell NN O
increased VBD O
2 CD O
- : O
4 CD O
- : O
fold NN O
between IN O
G1 NNP O
phase NN O
and CC O
S NNP O
phase NN O
, , O
and CC O
then RB O
decreased VBD O
during IN O
G2 NNP O
/ NNP O
M NNP O
phase NN O
. . O

Results NNS O
were VBD O
the DT O
same JJ O
when WRB O
the DT O
amount NN O
of IN O
dexamethasone NN O
bound NN O
per IN O
milligram NN O
of IN O
cell NN B-Gene
protein NN I-Gene
was VBD O
measured VBN O
. . O

Binding VBG O
affinity NN O
was VBD O
the DT O
same JJ O
during IN O
G1 NNP O
phase NN O
and CC O
S NNP O
phase NN O
, , O
but CC O
the DT O
proportion NN O
of IN O
bound NN O
dexamethasone NN O
that WDT O
translocated VBD O
to TO O
the DT O
nucleus NN O
was VBD O
greater JJR O
during IN O
S NNP O
phase NN O
. . O

In IN O
contrast NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
amount NN O
of IN O
dexamethasone NN O
bound NN O
per IN O
cell NN O
by IN O
three CD O
dexamethasone NN O
- : O
resistant NN O
cell NN O
lines NNS O
( ( O
two CD O
mouse NN O
and CC O
one CD O
human NN O
) ) O
did VBD O
not RB O
increase VB O
during IN O
S NNP O
phase NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
cell NN O
cycle NN O
changes NNS O
in IN O
dexamethasone NN O
binding NN O
are VBP O
not RB O
simply RB O
related VBN O
to TO O
changes NNS O
in IN O
cell NN B-Gene
protein NN I-Gene
or CC O
cell NN O
volume NN O
during IN O
the DT O
cell NN O
cycle NN O
. . O

An DT O
increase NN O
in IN O
dexamethasone JJ O
binding NN O
during IN O
S NNP O
phase NN O
may MD O
be VB O
required VBN O
for IN O
dexamethasone NN O
to TO O
inhibit VB O
cell NN O
growth NN O
, , O
and CC O
a DT O
failure NN O
of IN O
dexamethasone NN O
binding NN O
to TO O
increase VB O
during IN O
S NNP O
phase NN O
might MD O
represent VB O
a DT O
new JJ O
mechanism NN O
of IN O
dexamethasone NN O
resistance NN O
in IN O
lymphoid JJ O
cells NNS O
. . O

Presence NN O
and CC O
steroid JJ O
inducibility NN O
of IN O
glutamine JJ B-Gene
synthetase NN I-Gene
in IN O
human JJ O
leukemic JJ O
cells NNS O
. . O

Glutamine NNP B-Gene
synthetase NN I-Gene
( ( O
EC NNP O
6 CD O
. . O
3 CD O
. . O
1 CD O
. . O
2 CD O
; : O
GS NNP O
) ) O
is VBZ O
present JJ O
in IN O
lymphoblasts NNS O
from IN O
patients NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
( ( O
ALL NNP O
) ) O
as RB O
well RB O
as IN O
in IN O
normal JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

In IN O
16 CD O
out IN O
of IN O
20 CD O
ALL NNP O
patients NNS O
studied VBD O
exposure NN O
of IN O
the DT O
cells NNS O
to TO O
physiological JJ O
concentrations NNS O
of IN O
dexamethasone NN O
in IN O
vitro NN O
increased VBD O
enzyme JJ B-Gene
activity NN O
above IN O
the DT O
control NN O
levels NNS O
. . O

The DT O
increase NN O
was VBD O
specific JJ O
for IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
ligands NNS O
. . O

A DT O
direct JJ O
correlation NN O
was VBD O
found VBN O
between IN O
the DT O
magnitude NN O
of IN O
glucocorticoid JJ O
- : O
mediated JJ O
increase NN O
of IN O
GS NNP O
activity NN O
and CC O
the DT O
cellular JJ O
levels NNS O
of IN O
specific JJ O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
assayed VBN O
in IN O
the DT O
same JJ O
cell NN O
specimen NNS O
. . O

Moreover RB O
, , O
the DT O
basal NN O
levels NNS O
of IN O
the DT O
enzyme NN B-Gene
measured VBN O
in IN O
cells NNS O
prior RB O
to TO O
exposure VB O
to TO O
dexamethasone VB O
correlated VBN O
negatively RB O
with IN O
receptor NN O
density NN O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
presence NN O
of IN O
steroid JJ B-Gene
- : I-Gene
inducible JJ I-Gene
GS NNP I-Gene
in IN O
ALL NNP O
cells NNS O
may MD O
prove VB O
to TO O
be VB O
a DT O
marker NN O
for IN O
functional JJ B-Gene
receptor NN I-Gene
sites NNS I-Gene
. . O

Binding NNP O
of IN O
progestins NNS O
to TO O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
. . O

Correlation NN O
to TO O
their PRP$ O
glucocorticoid JJ O
- : O
like JJ O
effects NNS O
on IN O
in IN O
vitro JJ O
functions NNS O
of IN O
human JJ O
mononuclear JJ O
leukocytes NNS O
. . O

A DT O
number NN O
of IN O
physiological JJ O
and CC O
synthetic JJ O
progestins NNS O
were VBD O
tested VBN O
for IN O
their PRP$ O
ability NN O
to TO O
compete VB O
with IN O
[ JJ O
3H CD O
] NN O
dexamethasone NN O
for IN O
the DT O
binding NN O
to TO O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
of IN O
human JJ O
mononuclear NN O
leukocytes NNS O
and CC O
their PRP$ O
ability NN O
to TO O
elicit VB O
glucocorticoid JJ O
- : O
like JJ O
effects NNS O
on IN O
the DT O
same JJ O
cells NNS O
. . O

As IN O
compared VBN O
to TO O
the DT O
reference NN O
compound NN O
dexamethasone NN O
( ( O
relative JJ O
receptor NN O
binding VBG O
affinity NN O
defined VBD O
as IN O
100 CD O
% NN O
) ) O
, , O
two CD O
potent NN O
synthetic JJ O
progestins NNS O
with IN O
a DT O
pregnane NN O
- : O
type NN O
structure NN O
, , O
megestrol NN O
acetate NN O
and CC O
medroxyprogesterone NN O
acetate NN O
, , O
were VBD O
found VBN O
to TO O
display VB O
a DT O
considerable JJ O
binding NN O
affinity NN O
towards IN O
the DT O
receptor NN O
( ( O
46 CD O
and CC O
42 CD O
% NN O
, , O
respectively RB O
) ) O
. . O

The DT O
relative JJ O
binding NN O
affinity NN O
of IN O
the DT O
naturally RB O
occurring VBG O
ligand NN O
, , O
cortisol NN O
, , O
to TO O
the DT O
receptor NN O
was VBD O
clearly RB O
lower JJR O
( ( O
25 CD O
% NN O
) ) O
. . O

The DT O
effective JJ O
binding NN O
of IN O
medroxyprogesterone NN O
acetate NN O
to TO O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
was VBD O
confirmed VBN O
by IN O
direct JJ O
binding NN O
studies NNS O
utilizing VBG O
a DT O
tritiated JJ O
derivative NN O
of IN O
this DT O
steroid NN O
. . O

No DT O
evidence NN O
for IN O
the DT O
existence NN O
of IN O
a DT O
specific JJ O
progesterone NN B-Gene
receptor NN I-Gene
in IN O
human JJ O
mononuclear NN O
leukocytes NNS O
was VBD O
obtained VBN O
as IN O
judged VBN O
by IN O
the DT O
results NNS O
of IN O
competition NN O
experiments NNS O
where WRB O
a DT O
progesterone NN O
receptor NN O
- : O
specific JJ O
ligand NN O
[ $ O
3H CD O
] NNP O
Org NNP O
2058 CD O
was VBD O
used VBN O
. . O

Medroxyprogesterone NNP O
acetate NN O
and CC O
megestrol NN O
acetate NN O
also RB O
induced VBD O
glucocorticoid JJ O
- : O
like JJ O
effects NNS O
on IN O
the DT O
lymphocyte JJ O
functions NNS O
. . O

These DT O
included VBD O
inhibition NN O
of IN O
the DT O
proliferative JJ O
responses NNS O
to TO O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
mitogens VBZ I-Gene
concanavalin VBZ B-Gene
A NNP I-Gene
and CC O
phytohaemagglutinin NN B-Gene
and CC O
an DT O
enhanced JJ O
accumulation NN O
of IN O
immunoglobulin NN O
secreting VBG O
cells NNS O
in IN O
pokeweed NN O
mitogen NN O
- : O
stimulated JJ O
cultures NNS O
. . O

The DT O
progestin NN O
effect NN O
appears VBZ O
to TO O
be VB O
mediated VBN O
through IN O
a DT O
radiosensitive JJ O
( ( O
suppressor NN O
) ) O
subpopulation NN O
of IN O
T NNP O
lymphocytes NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
synthetic JJ O
progestins NNS O
related VBN O
structurally RB O
to TO O
19 CD O
- : O
nortestosterone NN O
, , O
norethisterone NN O
and CC O
d VB O
- : O
norgestrel NN O
, , O
were VBD O
virtually RB O
devoid JJ O
of IN O
binding VBG O
affinity NN O
towards IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
nor CC O
did VBD O
they PRP O
measurably RB O
influence VBP O
the DT O
in IN O
vitro JJ O
lymphocyte JJ O
functions NNS O
. . O

These DT O
studies NNS O
demonstrate VBP O
that IN O
certain JJ O
progestins NNS O
in IN O
common JJ O
clinical JJ O
use NN O
probably RB O
possess JJ O
inherent JJ O
glucocorticoid NN O
activity NN O
and CC O
suggest VBP O
that IN O
side NN O
effects NNS O
attributable JJ O
to TO O
this DT O
character NN O
( ( O
e NN O
. . O
g NN O
. . O
suppression NN O
of IN O
the DT O
pituitary JJ O
- : O
adrenal JJ O
axis NN O
) ) O
might MD O
be VB O
expected VBN O
when WRB O
these DT O
compounds NNS O
are VBP O
used VBN O
in IN O
pharmacological JJ O
doses NNS O
. . O

Metabolic NNP O
and CC O
ultrastructural JJ O
aspects NNS O
of IN O
the DT O
in IN O
vitro JJ O
lysis NN O
of IN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
cells NNS O
by IN O
glucocorticoids NNS O
. . O

Human NNP O
chronic JJ O
lymphocytic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
cells NNS O
like IN O
prothymocytes NNS O
and CC O
immunoactivated VBN O
T NNP O
- : O
lymphocytes NNS O
are VBP O
readily RB O
lysed VBN O
in IN O
vitro NN O
by IN O
pharmacological JJ O
concentrations NNS O
of IN O
glucocorticoids NNS O
such JJ O
as IN O
cortisol NN O
, , O
whereas JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
and CC O
thymocytes NNS O
are VBP O
unaffected VBN O
by IN O
the DT O
hormone NN B-Gene
. . O

In IN O
this DT O
study NN O
, , O
metabolic JJ O
and CC O
ultrastructural JJ O
aspects NNS O
of IN O
the DT O
cortisol NN O
- : O
induced JJ O
killing VBG O
process NN O
of IN O
CLL NNP O
cells NNS O
are VBP O
recorded VBN O
. . O

In IN O
vitro JJ O
lysis NN O
was VBD O
found VBN O
to TO O
be VB O
temperature JJ O
dependent JJ O
and CC O
was VBD O
detected VBN O
only RB O
after IN O
6 CD O
to TO O
8 CD O
hr NNS O
incubation NN O
with IN O
cortisol NN O
by IN O
means NNS O
of IN O
the DT O
trypan NN O
blue JJ O
exclusion NN O
test NN O
. . O

However RB O
, , O
30 CD O
min NN O
of IN O
incubation NN O
with IN O
cortisol NN O
at IN O
either DT O
37 CD O
degrees NNS O
or CC O
4 CD O
degrees NNS O
followed VBN O
by IN O
the DT O
removal NN O
of IN O
the DT O
hormone NN B-Gene
was VBD O
still RB O
sufficient JJ O
to TO O
induce VB O
the DT O
lytic JJ O
process NN O
. . O

Ultrastructural JJ O
studies NNS O
demonstrated VBD O
sequential JJ O
changes NNS O
in IN O
the DT O
cytoplasm NN O
, , O
including VBG O
swelling VBG O
of IN O
mitochondria NNS O
and CC O
cytoplasmic JJ O
decompartmentalizati NN O
, , O
followed VBN O
by IN O
loss NN O
of IN O
surface NN O
microvilli NN O
with IN O
the DT O
appearance NN O
of IN O
` `` O
` `` O
holes NNS O
' '' O
' '' O
in IN O
the DT O
cell NN O
membrane NN O
, , O
and CC O
subsequent JJ O
condensation NN O
of IN O
nuclear JJ B-Gene
chromatin NN I-Gene
. . O

The DT O
large JJ O
holes NNS O
in IN O
the DT O
membrane NN O
appearing VBG O
after IN O
6 CD O
hr NN O
of IN O
incubation NN O
with IN O
the DT O
hormone NN B-Gene
may MD O
be VB O
the DT O
cause NN O
for IN O
the DT O
penetration NN O
of IN O
the DT O
viable JJ O
stain NN O
into IN O
the DT O
dead JJ O
cells NNS O
, , O
as IN O
seen VBN O
by IN O
light JJ O
microscopy NN O
. . O

Addition NN O
of IN O
metabolic JJ O
inhibitors NNS O
including VBG O
actinomycin JJ O
D NNP O
, , O
puromycin NN O
, , O
and CC O
cycloheximide RB O
following VBG O
administration NN O
of IN O
cortisol NN O
resulted VBN O
in IN O
inhibition NN O
of IN O
the DT O
cell NN O
lysis NN O
. . O

An DT O
excess NN O
of IN O
an DT O
antagonist NN O
such JJ O
as IN O
cortexolone NN O
was VBD O
found VBN O
to TO O
inhibit VB O
the DT O
cortisol NN O
- : O
induced JJ O
cytolysis NN O
of IN O
the DT O
CLL NNP O
cells NNS O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
glucocorticoid JJ O
- : O
induced JJ O
lysis NN O
of IN O
human JJ O
CLL NNP O
cells NNS O
is VBZ O
similar JJ O
to TO O
the DT O
phenomenon NN O
observed VBD O
in IN O
rat NN O
or CC O
murine NN O
lymphocytes NNS O
and CC O
is VBZ O
mediated VBN O
by IN O
interaction NN O
of IN O
the DT O
steroid JJ O
molecule NN O
with IN O
the DT O
cytoplasmic JJ B-Gene
receptor NN I-Gene
. . O

The DT O
resulting VBG O
complex JJ O
appears VBZ O
to TO O
activate VB O
specific JJ O
gene NN B-Gene
( ( O
s PRP O
) ) O
the DT O
products NNS O
of IN O
which WDT O
eventually RB O
cause VBP O
cytolysis NN O
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
lymphoid JJ O
tumors NNS O
. . O

There EX O
is VBZ O
a DT O
range NN O
of IN O
levels NNS O
of IN O
glucocorticoid NN B-Gene
receptor NN I-Gene
numbers NNS O
seen VBN O
in IN O
the DT O
various JJ O
subclasses NNS O
of IN O
acute JJ O
lymphatic JJ O
leukemia NN O
( ( O
ALL DT O
) ) O
. . O

This DT O
variability NN O
can MD O
not RB O
be VB O
explained VBN O
by IN O
the DT O
known VBN O
correlation NN O
between IN O
active JJ O
cell NN O
proliferation NN O
and CC O
an DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
receptors NNS O
, , O
since IN O
the DT O
tumors NNS O
with IN O
the DT O
highest JJS O
growth NN O
fraction NN O
( ( O
i JJ O
. . O
e NN O
. . O
, , O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
and CC O
T NNP O
- : O
cell NN O
leukemia NN O
) ) O
tend VBP O
to TO O
have VB O
lower JJR O
average NN O
receptor NN O
numbers NNS O
than IN O
do VBP O
tumors NNS O
with IN O
lower JJR O
growth NN O
fractions NNS O
such JJ O
as IN O
common JJ O
ALL NNP O
. . O

All DT O
clinical JJ O
specimens NNS O
from IN O
patients NNS O
with IN O
lymphatic JJ O
leukemia NN O
have VBP O
some DT O
measurable JJ O
level NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
; : O
therefore RB O
, , O
the DT O
resistance NN O
seen VBN O
in IN O
vivo NN O
can MD O
not RB O
be VB O
explained VBN O
by IN O
the DT O
lack NN O
of IN O
receptors NNS O
. . O

However RB O
, , O
there EX O
has VBZ O
been VBN O
a DT O
positive JJ O
correlation NN O
, , O
in IN O
our PRP$ O
hands NNS O
, , O
with IN O
receptor NN O
level NN O
and CC O
prognosis NN O
. . O

On IN O
the DT O
basis NN O
of IN O
in IN O
vitro NN O
models NNS O
, , O
it PRP O
is VBZ O
proposed VBN O
that IN O
perhaps RB O
the DT O
high JJ O
receptor NN O
cell NN O
lines NNS O
( ( O
i NN O
. . O
e NN O
. . O
, , O
common JJ O
ALL NNP O
of IN O
childhood NN O
) ) O
have VBP O
relative JJ O
stability NN O
of IN O
their PRP$ O
genetic JJ O
material NN O
making NN O
glucocorticoid JJ O
- : O
resistant JJ O
mutations NNS O
less RBR O
likely JJ O
to TO O
occur VB O
in IN O
patients NNS O
with IN O
these DT O
cells NNS O
than IN O
in IN O
low JJ O
- : O
receptor NN O
cell NN O
lines NNS O
( ( O
i NN O
. . O
e NN O
. . O
, , O
T NNP O
- : O
cell NN O
leukemia NN O
) ) O
. . O

This DT O
greater JJR O
genetic JJ O
variability NN O
in IN O
the DT O
low JJ O
- : O
receptor NN O
lines NNS O
could MD O
account VB O
for IN O
the DT O
earlier JJR O
emergence NN O
of IN O
clinical JJ O
glucocorticoid NN O
resistance NN O
in IN O
these DT O
patients NNS O
. . O

[ JJ O
Tumor NNP O
histology NN O
and CC O
steroid JJ B-Gene
receptors NNS I-Gene
in IN O
breast NN O
carcinoma NN O
] NN O

In IN O
Specimens NNP O
of IN O
115 CD O
patients NNS O
with IN O
breast JJ O
cancer NN O
4 CD O
tumorparameters NNS O
( ( O
tumorsize VB O
, , O
tumorboder NN O
, , O
nucleargrade NN O
, , O
lymphocytic JJ O
stromal JJ O
reaction NN O
) ) O
3 CD O
features NNS O
of IN O
regional JJ O
lymphnodes NNS O
( ( O
sinushistiocytosis NN O
, , O
T NNP O
- : O
cellreaction NN O
, , O
lymphnode JJ O
metastases NNS O
) ) O
and CC O
estrogen NN B-Gene
and CC I-Gene
progesteron NN I-Gene
receptors NNS I-Gene
were VBD O
determined VBN O
. . O

A DT O
strong JJ O
sinushistiocytosis NN O
and CC O
T NNP O
- : O
cellreaction NN O
could MD O
be VB O
verified VBN O
mainly RB O
in IN O
metastases NNS O
in IN O
free JJ O
lymphnodes NNS O
. . O

The DT O
steroid JJ B-Gene
receptor NN I-Gene
content NN O
does VBZ O
not RB O
correlate VB O
with IN O
histological JJ O
parameters NNS O

Aldosterone NNP B-Gene
- : I-Gene
receptor NN I-Gene
deficiency NN O
in IN O
pseudohypoaldosteron NN O
. . O

Pseudohypoaldosteron NNP O
, , O
a DT O
syndrome JJ O
characterized VBN O
by IN O
salt NN O
wasting NN O
and CC O
failure NN O
to TO O
thrive VB O
, , O
usually RB O
presents VBZ O
in IN O
infancy NN O
as IN O
high JJ O
urinary JJ O
levels NNS O
of IN O
sodium NN O
despite IN O
hyponatremia NN O
, , O
hyperkalemia NN O
, , O
hyperreninemia NN O
, , O
and CC O
elevated VBD O
aldosterone NN O
levels NNS O
. . O

We PRP O
have VBP O
investigated VBN O
this DT O
syndrome NN O
for IN O
the DT O
possibility NN O
of IN O
abnormal JJ B-Gene
Type NNP I-Gene
I PRP I-Gene
or CC O
` `` B-Gene
` `` I-Gene
mineralocorticoid VB I-Gene
- : I-Gene
like IN I-Gene
' '' I-Gene
' POS I-Gene
receptors NNS I-Gene
, , O
which WDT O
have VBP O
intrinsic JJ O
steroid JJ O
specificity NN O
indistinguishable NN O
from IN O
that DT O
of IN O
renal JJ B-Gene
mineralocorticoid NN I-Gene
receptors NNS I-Gene
and CC O
are VBP O
found VBN O
in IN O
many JJ O
tissues NNS O
and CC O
cells NNS O
, , O
including VBG O
mononuclear JJ O
leukocytes NNS O
. . O

We PRP O
have VBP O
studied VBN O
three CD O
patients NNS O
with IN O
pseudohypoaldosteron NN O
: : O
the DT O
28 CD O
- : O
year NN O
- : O
old JJ O
index NN O
case NN O
in IN O
Melbourne NNP O
( ( O
Patient NNP O
1 CD O
) ) O
and CC O
two CD O
siblings NNS O
in IN O
Munich NNP O
, , O
eight CD O
and CC O
two CD O
years NNS O
of IN O
age NN O
( ( O
Patients NNPS O
2 CD O
and CC O
3 CD O
) ) O
; : O
clinically RB O
, , O
Patient NNP O
3 CD O
had VBD O
a DT O
less RBR O
severe JJ O
case NN O
than IN O
his PRP$ O
sister NN O
. . O

Percoll NNP O
- : O
separated VBD O
control NN O
monocytes NNS O
bound VBP O
[ $ O
3H CD O
] NNP O
aldosterone NN O
with IN O
high JJ O
affinity NN O
( ( O
Kd NNP O
approximately RB O
3 CD O
nM NNS O
) ) O
and CC O
limited JJ O
capacity NN O
( ( O
150 CD O
to TO O
600 CD O
sites NNS O
per IN O
cell NN O
) ) O
. . O

On IN O
repeated VBN O
examination NN O
, , O
no DT O
[ JJ O
3H CD O
] JJ O
aldosterone NN O
binding NN O
was VBD O
found VBN O
in IN O
monocytes NNS O
from IN O
Patients NNS O
1 CD O
and CC O
2 CD O
; : O
in IN O
Patient NNP O
3 CD O
, , O
the DT O
levels NNS O
were VBD O
62 CD O
sites NNS O
per IN O
cell NN O
, , O
more JJR O
than IN O
2 CD O
S NNP O
. . O
D NNP O
. . O
below IN O
those DT O
of IN O
the DT O
control NN O
. . O

Levels NNS O
in IN O
the DT O
parents NNS O
of IN O
the DT O
Munich NNP O
patients NNS O
( ( O
first JJ O
cousins NNS O
) ) O
were VBD O
normal JJ O
. . O

It PRP O
appears VBZ O
that IN O
pseudohypoaldosteron NN O
is VBZ O
caused VBN O
by IN O
a DT O
Type NN O
I PRP O
receptor VBP O
defect JJ O
, , O
that IN O
the DT O
defect NN O
may MD O
be VB O
complete JJ O
or CC O
partial JJ O
, , O
that IN O
transmission NN O
may MD O
be VB O
autosomal JJ O
recessive JJ O
, , O
and CC O
that IN O
the DT O
study NN O
of IN O
patients NNS O
with IN O
pseudohypoaldosteron NN O
may MD O
indicate VB O
physiologic NN O
roles NNS O
for IN O
Type NNP B-Gene
I PRP I-Gene
receptors VBP I-Gene
in IN O
nonepithelial JJ O
tissues NNS O
. . O

Glucocorticoid NNP O
inhibition NN O
of IN O
urokinase JJ B-Gene
- : I-Gene
like IN I-Gene
plasminogen NN I-Gene
activators NNS I-Gene
in IN O
cultured JJ O
human JJ O
lymphoblasts NNS O
. . O

Two CD O
human JJ O
lymphoblast NN O
cell NN O
lines NNS O
, , O
LICR NNP O
- : O
LON NNP O
- : O
HMy2 NNP O
( ( O
HMy2 NNP O
cells NNS O
) ) O
and CC O
GM4672A NNP O
cells NNS O
, , O
are VBP O
moderately RB O
growth NN O
inhibited VBN O
by IN O
dexamethasone NN O
( ( O
1 CD O
, , O
4 CD O
- : O
pregnadien NN O
- : O
9 CD O
- : O
fluoro NN O
- : O
16 CD O
alpha SYM O
- : O
methyl NN O
- : O
11 CD O
beta NN O
, , O
17 CD O
alpha NN O
, , O
21 CD O
- : O
triol NN O
- : O
3 CD O
, , O
20 CD O
- : O
dione NN O
) ) O
( ( O
Dex NNP O
) ) O
. . O

Both DT O
cell VBP O
types NNS O
secrete VBP O
a DT O
urokinase NN B-Gene
( ( I-Gene
UK NNP I-Gene
) ) I-Gene
- : I-Gene
like IN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
PA NNP B-Gene
) ) O
. . O

Treatment NN O
of IN O
both DT O
HMy2 NNP O
and CC O
GM4672A NNP O
cells NNS O
with IN O
Dex NNP O
for IN O
1 CD O
- : O
4 CD O
days NNS O
inhibits NNS O
extracellular JJ O
PA NNP B-Gene
activity NN O
in IN O
a DT O
concentration NN O
- : O
dependent JJ O
manner NN O
, , O
being VBG O
half JJ O
- : O
maximal NN O
at IN O
approximately RB O
1 CD O
X NNS O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
. . O

Inhibition NN O
of IN O
PA NNP B-Gene
in IN O
both DT O
cell NN O
types NNS O
is VBZ O
specific JJ O
for IN O
active JJ O
glucocorticoids NNS O
, , O
and CC O
this DT O
specificity NN O
parallels VBZ O
the DT O
ability NN O
of IN O
various JJ O
steroids NNS O
to TO O
bind VB O
to TO O
glucocorticoid VB B-Gene
receptors NNS I-Gene
. . O

HMy2 NNP O
cell NN O
PA NNP B-Gene
is VBZ O
fully RB O
suppressible JJ O
by IN O
Dex NNP O
, , O
whereas VBZ O
up IN O
to TO O
one CD O
third NN O
of IN O
the DT O
activator NN O
expressed VBN O
by IN O
GM4672A NNP O
cells NNS O
is VBZ O
resistant JJ O
to TO O
glucocorticoid VB O
inhibition NN O
. . O

Mixing VBG O
experiments NNS O
using VBG O
a DT O
UK NNP O
standard NN O
and CC O
conditioned JJ O
media NNS O
from IN O
Dex NNP O
- : O
treated VBD O
cells NNS O
suggest VBP O
an DT O
absence NN O
of IN O
glucocorticoid JJ B-Gene
- : I-Gene
inducible JJ I-Gene
inhibitors NNS I-Gene
to TO O
UK NNP B-Gene
or CC O
plasmin NN B-Gene
in IN O
both DT O
cell NN O
types NNS O
. . O

However RB O
, , O
conditioned VBD O
media NNS O
from IN O
Dex NNP O
- : O
treated VBD O
GM4672A NNP O
cells NNS O
inhibits VBZ O
a DT O
portion NN O
of IN O
the DT O
homologous JJ O
cellular JJ O
activator NN O
in IN O
conditioned JJ O
media NNS O
from IN O
control NN O
GM4672A NNP O
cells NNS O
. . O

Thus RB O
, , O
low JJ O
levels NNS O
of IN O
glucocorticoid JJ B-Gene
- : I-Gene
inducible JJ I-Gene
inhibitors NNS I-Gene
may MD O
contribute VB O
to TO O
, , O
but CC O
can MD O
not RB O
fully RB O
account VBP O
for IN O
, , O
Dex NNP O
inhibition NN O
of IN O
GM4672A NNP B-Gene
PA NNP I-Gene
activity NN O
. . O

Glucocorticoid NNP B-Gene
- : I-Gene
inducible JJ I-Gene
inhibitors NNS I-Gene
in IN O
HMy2 NNP O
cells NNS O
are VBP O
either DT O
totally RB O
absent JJ O
or CC O
are VBP O
present JJ O
at IN O
undetectable JJ O
levels NNS O
. . O

Thus RB O
, , O
regulation NN O
of IN O
UK NNP B-Gene
- : I-Gene
like IN I-Gene
PAs NNP I-Gene
in IN O
HMy2 NNP O
and CC O
GM4672A NNP O
cells NNS O
differs NNS O
with IN O
respect NN O
to TO O
the DT O
extent NN O
to TO O
which WDT O
glucocorticoids NNS O
inhibit VBP O
constitutively RB B-Gene
expressed VBN I-Gene
activator NN I-Gene
levels NNS O
, , O
as RB O
well RB O
as IN O
the DT O
possible JJ O
contribution NN O
of IN O
glucocorticoid JJ B-Gene
- : I-Gene
inducible JJ I-Gene
inhibitors NNS I-Gene
to TO O
the DT O
regulatory JJ O
process NN O
in IN O
GM4672A NNP O
cells NNS O
. . O

Characterization NN O
of IN O
aldosterone NN O
binding VBG O
sites NNS O
in IN O
circulating VBG O
human JJ O
mononuclear JJ O
leukocytes NNS O
. . O

Aldosterone NNP O
binding VBG O
sites NNS O
in IN O
human JJ O
mononuclear JJ O
leukocytes NNS O
were VBD O
characterized VBN O
after IN O
separation NN O
of IN O
cells NNS O
from IN O
blood NN O
by IN O
a DT O
Percoll NNP O
gradient NN O
. . O

After IN O
washing VBG O
and CC O
resuspension NN O
in IN O
RPMI NNP O
- : O
1640 CD O
medium NN O
, , O
cells NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NNP O
for IN O
1 CD O
h NN O
with IN O
different JJ O
concentrations NNS O
of IN O
[ $ O
3H CD O
] NNP O
aldosterone NN O
plus CC O
a DT O
100 CD O
- : O
fold JJ O
concentration NN O
of IN O
RU NNP O
- : O
26988 CD O
( ( O
11 CD O
alpha NN O
, , O
17 CD O
alpha SYM O
- : O
dihydroxy JJ O
- : O
17 CD O
beta SYM O
- : O
propynylandrost NN O
- : O
1 CD O
, , O
4 CD O
, , O
6 CD O
- : O
trien NN O
- : O
3 CD O
- : O
one NN O
) ) O
, , O
with IN O
or CC O
without IN O
an DT O
excess NN O
of IN O
unlabeled JJ O
aldosterone NN O
. . O

Aldosterone NNP O
binds VBZ O
to TO O
a DT O
single JJ O
class NN O
of IN O
receptors NNS O
with IN O
an DT O
affinity NN O
of IN O
2 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
nM NN O
( ( O
means VBZ O
+ VBP O
/ SYM O
- : O
SD NN O
, , O
n JJ O
= NNP O
14 CD O
) ) O
and CC O
a DT O
capacity NN O
of IN O
290 CD O
+ NNS O
/ SYM O
- : O
108 CD O
sites NNS O
/ VBP O
cell NN O
( ( O
n JJ O
= NNP O
14 CD O
) ) O
. . O

The DT O
specificity NN O
data NNS O
show VBP O
a DT O
hierarchy NN O
of IN O
affinity NN O
of IN O
desoxycorticosterone NN O
= NNP O
corticosterone NN O
= NNP O
aldosterone NN O
greater JJR O
than IN O
hydrocortisone NN O
greater JJR O
than IN O
dexamethasone NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
mononuclear VBP O
leukocytes NNS O
could MD O
be VB O
useful JJ O
for IN O
studying VBG O
the DT O
physiological JJ O
significance NN O
of IN O
these DT O
mineralocorticoid JJ B-Gene
receptors NNS I-Gene
and CC O
their PRP$ O
regulation NN O
in IN O
humans NNS O
. . O

Mineralocorticoid NNP B-Gene
and CC I-Gene
glucocorticoid JJ I-Gene
receptors NNS I-Gene
in IN O
circulating VBG O
mononuclear JJ O
leukocytes NNS O
of IN O
patients NNS O
with IN O
primary JJ O
hyperaldosteronism NN O
. . O

Mineralocorticoid NNP B-Gene
and CC I-Gene
glucocorticoid JJ I-Gene
receptors NNS I-Gene
were VBD O
measured VBN O
in IN O
circulating VBG O
mononuclear JJ O
leukocytes NNS O
in IN O
5 CD O
patients NNS O
affected VBN O
by IN O
Conn NNP O
' POS O
s JJ O
syndrome NN O
( ( O
3 CD O
cases NNS O
of IN O
bilateral JJ O
adrenal JJ O
hyperplasia NN O
and CC O
2 CD O
cases NNS O
of IN O
adenoma NN O
plus CC O
unilateral JJ O
hyperplasia NN O
) ) O
. . O

The DT O
number NN O
of IN O
the DT O
binding NN O
sites VBZ O
per IN O
cell NN O
resulted VBD O
significantly RB O
lower JJR O
( ( O
189 CD O
+ NN O
/ NNP O
- : O
114 CD O
, , O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
, , O
as IN O
compared VBN O
with IN O
the DT O
normal JJ O
controls NNS O
( ( O
298 CD O
+ NN O
/ NNP O
- : O
105 CD O
) ) O
. . O

The DT O
affinity NN O
of IN O
aldosterone NN O
for IN O
the DT O
receptor NN O
was VBD O
found VBN O
to TO O
be VB O
not RB O
different JJ O
than IN O
that DT O
of IN O
healthy JJ O
control NN O
subjects NNS O
. . O

The DT O
capacity NN O
and CC O
the DT O
affinity NN O
of IN O
dexamethasone NN O
for IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
ranged VBD O
in IN O
the DT O
normal JJ O
values NNS O
. . O

These DT O
data NNS O
suggest VBP O
a DT O
possible JJ O
down RP O
- : O
regulation NN O
of IN O
mineralocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
humans NNS O
. . O

Short NNP O
- : O
term NN O
and CC O
long JJ O
- : O
term NN O
effects NNS O
of IN O
estrogen NN O
on IN O
lymphoid JJ O
tissues NNS O
and CC O
lymphoid JJ O
cells NNS O
with IN O
some DT O
remarks NNS O
on IN O
the DT O
significance NN O
for IN O
carcinogenesis NN O
. . O

Estrogens NNS O
have VBP O
long RB O
been VBN O
thought VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
regulating VBG O
the DT O
immune NN O
system NN O
. . O

The DT O
difference NN O
in IN O
some DT O
types NNS O
of IN O
immune JJ O
responses NNS O
between IN O
males NNS O
and CC O
females NNS O
is VBZ O
well RB O
- : O
known VBN O
, , O
as IN O
is VBZ O
the DT O
pronounced JJ O
thymic JJ O
involution NN O
induced VBN O
by IN O
exogenous JJ O
estrogens NNS O
. . O

Estrogens NNS O
stimulate VBP O
some DT O
aspects NNS O
of IN O
macrophage NN O
activity NN O
and CC O
, , O
depending VBG O
on IN O
dose NN O
and CC O
mitogen NN B-Gene
, , O
inhibit NN O
or CC O
stimulate VB O
lymphocyte JJ O
proliferative JJ O
response NN O
in IN O
vitro NN O
. . O

Another DT O
example NN O
is VBZ O
the DT O
estrogen NN O
effect NN O
on IN O
the DT O
delayed VBN O
type NN O
hypersensitivity NN O
response NN O
. . O

A DT O
broad JJ O
review NN O
is VBZ O
given VBN O
of IN O
such JJ O
estrogen JJ O
effects NNS O
on IN O
lymphoid JJ O
tissue NN O
and CC O
immune JJ O
response NN O
. . O

Most JJS O
of IN O
the DT O
studies NNS O
published VBN O
so RB O
far RB O
are VBP O
phenomenological JJ O
. . O

However RB O
, , O
the DT O
recent JJ O
description NN O
of IN O
estrogen NN B-Gene
receptors NNS I-Gene
in IN O
the DT O
thymus NN O
and CC O
in IN O
some DT O
lymphocyte JJ O
subpopulations NNS O
, , O
as RB O
well RB O
as IN O
a DT O
deeper JJR O
understanding NN O
of IN O
regulating VBG O
factors NNS O
in IN O
the DT O
immune NN O
system NN O
, , O
open VB O
the DT O
possibility NN O
of IN O
a DT O
more RBR O
detailed JJ O
understanding NN O
of IN O
the DT O
estrogen NN O
mechanism NN O
of IN O
interference NN O
. . O

Estrogen NN O
effects NNS O
in IN O
adults NNS O
are VBP O
reversible JJ O
. . O

After IN O
treating VBG O
neonatal JJ O
mice NN O
with IN O
the DT O
synthetic JJ O
estrogen NN O
diethylstilbestrol NN O
( ( O
DES NNP O
) ) O
, , O
disturbances NNS O
are VBP O
induced VBN O
in IN O
lymphocyte JJ O
populations NNS O
and CC O
lymphocyte NN O
functions NNS O
which WDT O
are VBP O
permanent JJ O
and CC O
irreversible JJ O
. . O

Lymphocytes NNS O
from IN O
adult NN O
, , O
neonatally RB O
DES NNP O
- : O
treated VBD O
female JJ O
mice NNS O
have VBP O
a DT O
reduced VBN O
mitogen NN O
response NN O
to TO O
ConA NNP B-Gene
and CC O
LPS NNP B-Gene
( ( O
T NNP B-Gene
and CC I-Gene
B NNP I-Gene
cell VBP I-Gene
mitogen NN I-Gene
) ) O
and CC O
the DT O
delayed JJ O
type NN O
hypersensitivity NN O
response NN O
is VBZ O
depressed VBN O
. . O

A DT O
detailed JJ O
analysis NN O
demonstrated VBD O
a DT O
decreased JJ O
T NNP O
helper NN O
cell NN O
population NN O
. . O

The DT O
activity NN O
of IN O
Natural NNP O
Killer NNP O
cells NNS O
is VBZ O
permanently RB O
reduced VBN O
and CC O
this DT O
functional JJ O
impairment NN O
is VBZ O
related VBN O
to TO O
a DT O
decreased JJ O
number NN O
of IN O
these DT O
cells NNS O
, , O
in IN O
turn NN O
determined VBN O
at IN O
the DT O
bone NN O
marrow NN O
level NN O
. . O

The DT O
same JJ O
animals NNS O
have VBP O
an DT O
increased VBN O
sensitivity NN O
to TO O
chemical NN O
carcinogens NNS O
( ( O
methylcholanthrene NN O
) ) O
and CC O
they PRP O
spontaneously RB O
develop VBP O
epithelial JJ O
changes NNS O
in IN O
the DT O
uterine NN O
cervix NN O
which WDT O
morphologically RB O
are VBP O
similar JJ O
to TO O
adenocarcinoma VB O
. . O

The DT O
association NN O
between IN O
estrogen NN O
- : O
associated VBN O
malignancy NN O
and CC O
estrogen NN O
effects NNS O
in IN O
lymphocyte JJ O
functions NNS O
deserves VBZ O
further JJ O
study NN O
. . O

Drugs NNS O
affecting VBG O
the DT O
hormonal JJ O
receptors NNS O
of IN O
normal JJ O
and CC O
leukaemic JJ O
peripheral JJ O
leucocytes NNS O
. . O

The DT O
authors NNS O
investigated VBD O
the DT O
behaviour NN O
of IN O
steroid JJ O
hormone NN O
uptake NN O
in IN O
leukaemic JJ O
cells NNS O
( ( O
CML NNP O
, , O
CLL NNP O
, , O
AML NNP O
, , O
ALL NNP O
) ) O
, , O
in IN O
basal JJ O
conditions NNS O
and CC O
after IN O
incubation NN O
with IN O
drugs NNS O
which WDT O
modify VBP O
the DT O
cellular JJ O
concentration NN O
of IN O
cAMP NN O
, , O
PGE NNP O
and CC O
PGF NNP O
. . O

The DT O
results NNS O
demonstrated VBD O
the DT O
presence NN O
in IN O
leukaemic JJ O
cells NNS O
of IN O
an DT O
alteration NN O
in IN O
the DT O
incorporation NN O
of IN O
steroid JJ O
hormones NNS O
. . O

This DT O
alteration NN O
was VBD O
scarcely RB O
modified VBN O
by IN O
incubation NN O
with IN O
theophylline NN B-Gene
, , O
which WDT O
increases VBZ O
cellular JJ O
concentration NN O
of IN O
cAMP NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
it PRP O
was VBD O
moderately RB O
counteracted VBN O
by IN O
thioproline NN O
and CC O
was VBD O
evidently RB O
inhibited VBN O
by IN O
flurbiprofen NN O
, , O
which WDT O
also RB O
reduced VBD O
cellular JJ O
concentrations NNS O
of IN O
prostaglandins NNS O
, , O
particularly RB O
PGE2 NNP O
, , O
with IN O
the DT O
exception NN O
of IN O
PGF2 NNP O
which WDT O
showed VBD O
a DT O
poor JJ O
response NN O
. . O

Differences NNS O
were VBD O
observed VBN O
in IN O
the DT O
behavior NN O
of IN O
hormonal JJ O
uptake NN O
of IN O
CML NNP O
, , O
in IN O
contrast NN O
to TO O
that DT O
of IN O
AML NNP O
, , O
CLL NNP O
and CC O
ALL NNP O
peripheral JJ O
leucocytes NNS O
. . O

Human NNP O
breast NN O
cancer NN O
and CC O
impaired JJ O
NK NNP O
cell NN O
function NN O
. . O

Recent JJ O
advances NNS O
in IN O
tumor NN O
immunology NN O
have VBP O
led VBN O
to TO O
the DT O
discovery NN O
of IN O
a DT O
new JJ O
lymphoid NN O
cell NN O
with IN O
unique JJ O
antitumor NN O
activity NN O
. . O

Natural NNP O
killer NN O
( ( O
NK NNP O
) ) O
cells NNS O
form VBP O
an DT O
antitumor NN O
surveillance NN O
system NN O
and CC O
appear VB O
to TO O
be VB O
vital JJ O
in IN O
preventing VBG O
tumor NN O
growth NN O
and CC O
metastasis NN O
in IN O
animal JJ O
models NNS O
. . O

We PRP O
studied VBD O
NK NNP O
activity NN O
in IN O
patients NNS O
with IN O
benign JJ O
and CC O
malignant JJ O
breast NN O
disease NN O
, , O
using VBG O
a DT O
chromium NN O
- : O
51 CD O
release NN O
microtiter NN O
cytotoxicity NN O
assay VBP O
with IN O
K562 NNP O
cells NNS O
as IN O
targets NNS O
. . O

Compared VBN O
with IN O
benign NN O
controls NNS O
, , O
patients NNS O
with IN O
malignancies NNS O
had VBD O
significantly RB O
depressed VBN O
NK NNP O
- : O
mediated VBN O
lysis NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Furthermore RB O
, , O
lysis NN O
in IN O
those DT O
with IN O
advanced JJ O
disease NN O
( ( O
stages VBZ O
II NNP O
, , O
III NNP O
, , O
and CC O
IV NNP O
) ) O
was VBD O
significantly RB O
less JJR O
than IN O
in IN O
those DT O
with IN O
limited JJ O
disease NN O
( ( O
stage NN O
I PRP O
) ) O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

NK NNP O
activity NN O
was VBD O
not RB O
correlated VBN O
to TO O
estrogen VB O
or CC O
progesterone VB O
receptor NN O
states NNS O
. . O

Positive JJ O
correlation NN O
of IN O
a DT O
depressed JJ O
natural JJ O
killer NN O
activity NN O
with IN O
the DT O
extent NN O
of IN O
tumor NN O
spread NN O
supports VBZ O
the DT O
concept NN O
of IN O
an DT O
NK NNP O
cell NN O
immune NN O
surveillance NN O
system NN O
in IN O
breast NN O
cancer NN O
and CC O
emphasizes VBZ O
its PRP$ O
importance NN O
in IN O
this DT O
malignancy NN O
. . O

Immunosuppressive JJ O
effect NN O
of IN O
serum NN O
progesterone NN O
during IN O
pregnancy NN O
depends VBZ O
on IN O
the DT O
progesterone NN O
binding VBG O
capacity NN O
of IN O
the DT O
lymphocytes NNS O
. . O

Cytotoxic NNP O
activity NN O
and CC O
progesterone NN O
binding NN O
capacity NN O
of IN O
the DT O
lymphocytes NNS O
, , O
together RB O
with IN O
serum NN O
progesterone NN O
concentrations NNS O
, , O
were VBD O
determined VBN O
in IN O
women NNS O
with IN O
normal JJ O
pregnancy NN O
or CC O
with IN O
a DT O
clinical JJ O
diagnosis NN O
of IN O
threatened JJ O
abortion NN O
or CC O
threatened JJ O
premature NN O
labour NN O
. . O

The DT O
lymphocytes NNS O
of IN O
women NNS O
with IN O
threatened JJ O
abortion NN O
or CC O
threatened JJ O
premature NN O
labour NN O
showed VBD O
significantly RB O
higher JJR O
cytotoxic NN O
activity NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
significantly RB O
lower JJR O
progesterone NN O
binding NN O
capacity NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
than IN O
did VBD O
lymphocytes NNS O
obtained VBN O
from IN O
the DT O
healthy JJ O
pregnant JJ O
women NNS O
. . O

Significant JJ O
inverse JJ O
correlation NN O
was VBD O
found VBN O
between IN O
progesterone NN O
binding NN O
capacity NN O
and CC O
cytotoxic JJ O
activity NN O
of IN O
the DT O
lymphocytes NNS O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
, , O
but CC O
the DT O
progesterone NN O
concentration NN O
of IN O
the DT O
pregnancy NN O
serum NN O
appeared VBD O
to TO O
have VB O
no DT O
influence NN O
on IN O
the DT O
other JJ O
two CD O
parameters NNS O
. . O

The DT O
findings NNS O
indicate VBP O
that IN O
intact JJ O
progesterone NN O
binding VBG O
capacity NN O
of IN O
the DT O
lymphocytes NNS O
is VBZ O
an DT O
essential JJ O
factor NN O
for IN O
the DT O
manifestation NN O
of IN O
the DT O
blocking VBG O
effect NN O
exerted VBN O
by IN O
pregnancy NN O
serum NN O
on IN O
lymphocyte JJ O
cytotoxicity NN O
in IN O
vitro NN O
. . O

Serum NNP O
sex NN O
steroid NN O
and CC O
peptide VB O
hormone NN O
concentrations NNS O
, , O
and CC O
endometrial JJ O
estrogen NN O
and CC O
progestin NN O
receptor NN O
levels NNS O
during IN O
administration NN O
of IN O
human JJ B-Gene
leukocyte NN I-Gene
interferon NN I-Gene
. . O

Five CD O
normally RB O
cycling VBG O
healthy JJ O
women NNS O
were VBD O
given VBN O
daily RB O
subcutaneous JJ O
injections NNS O
of IN O
human JJ B-Gene
leukocyte NN I-Gene
interferon NN I-Gene
( ( O
3 CD O
X RB O
10 CD O
( ( O
6 CD O
) ) O
units NNS O
/ NNP O
day NN O
) ) O
from IN O
the DT O
3rd CD O
through IN O
23rd CD O
day NN O
of IN O
the DT O
menstrual JJ O
cycle NN O
, , O
and CC O
serum NN O
steroid NN O
and CC O
peptide VB O
hormone NN O
concentrations NNS O
monitored VBD O
at IN O
3 CD O
- : O
day NN O
intervals NNS O
during IN O
the DT O
treatment NN O
and CC O
the DT O
preceding VBG O
control NN O
cycle NN O
. . O

Concentrations NNS O
of IN O
cytosol NN B-Gene
and CC I-Gene
nuclear JJ I-Gene
estrogen NN I-Gene
receptors NNS I-Gene
( ( O
ERC NNP B-Gene
and CC O
ERN NNP B-Gene
, , O
respectively RB O
) ) O
and CC O
progestin JJ B-Gene
receptors NNS I-Gene
( ( O
PRC NNP B-Gene
and CC O
PRN NNP B-Gene
) ) O
were VBD O
also RB O
measured VBN O
from IN O
endometrial JJ O
biopsies NNS O
taken VBN O
on IN O
the DT O
24th JJ O
day NN O
of IN O
the DT O
control NN O
and CC O
treatment NN O
cycle NN O
. . O

In IN O
addition NN O
, , O
an DT O
extensive JJ O
monitoring NN O
of IN O
clinical JJ O
chemical NN O
and CC O
hematological JJ O
tests NNS O
from IN O
the DT O
blood NN O
samples NNS O
were VBD O
performed VBN O
. . O

Serum NNP O
estradiol NN O
and CC O
progesterone NN O
concentrations NNS O
were VBD O
significantly RB O
decreased VBN O
during IN O
the DT O
treatment NN O
cycle NN O
, , O
suggesting VBG O
that IN O
interferon NN B-Gene
interacts NNS O
in IN O
vivo NN O
with IN O
the DT O
function NN O
of IN O
both DT O
FSH NNP O
and CC O
LH NNP O
. . O

No DT O
significant JJ O
changes NNS O
were VBD O
observed VBN O
in IN O
the DT O
serum NN O
peptide IN O
hormone NN O
concentrations NNS O
measured VBN O
( ( O
FSH NNP O
, , O
LH NNP O
, , O
prolactin NN O
, , O
insulin NN O
, , O
growth NN O
hormone NN O
and CC O
TSH NNP O
) ) O
; : O
neither CC O
were VBD O
the DT O
levels NNS O
of IN O
endometrial JJ B-Gene
ERC NNP I-Gene
, , I-Gene
ERN NNP I-Gene
, , I-Gene
PRC NNP I-Gene
and CC I-Gene
PRN NNP I-Gene
affected VBN O
by IN O
interferon JJ B-Gene
administration NN O
. . O

As IN O
expected VBN O
, , O
interferon VB B-Gene
administration NN O
resulted VBD O
in IN O
decreased JJ O
leukocyte NN O
counts NNS O
. . O

Moreover RB O
, , O
an DT O
increasing VBG O
tendency NN O
in IN O
the DT O
activities NNS O
of IN O
serum NN B-Gene
alkaline NN I-Gene
phosphatase NN I-Gene
and CC O
gamma NN B-Gene
- : I-Gene
glutamyltransferase NN I-Gene
during IN O
the DT O
interferon NN B-Gene
therapy NN O
shows VBZ O
that IN O
interferon NN B-Gene
may MD O
slightly RB O
interfere VB O
with IN O
the DT O
liver NN O
function NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
one CD O
of IN O
the DT O
mechanisms NNS O
by IN O
which WDT O
interferon NN B-Gene
treatment NN O
may MD O
affect VB O
the DT O
growth NN O
of IN O
hormone NN O
- : O
dependent JJ O
neoplasms NNS O
could MD O
be VB O
the DT O
interaction NN O
with IN O
production NN O
and CC O
/ NN O
or CC O
function NN O
of IN O
circulating VBG O
hormonal JJ O
compounds NNS O
. . O

[ JJ O
Glucocorticoid NNP B-Gene
receptor NN I-Gene
level NN O
in IN O
the DT O
blood NN O
leukocytes VBZ O
in IN O
different JJ O
acute NN O
diseases NNS O
] VBP O

Content NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
cytosol NN O
of IN O
blood NN O
leukocytes NNS O
, , O
concentration NN O
of IN O
cortisol NN O
and CC O
amount NN O
of IN O
leukocytes NNS O
in IN O
blood NN O
were VBD O
studied VBN O
in IN O
20 CD O
patients NNS O
with IN O
acute JJ O
impairments NNS O
within IN O
the DT O
second JJ O
day NN O
of IN O
the DT O
disease NN O
. . O

Content NN O
of IN O
receptors NNS O
in IN O
cytosol NN O
of IN O
blood NN O
leukocytes NNS O
was VBD O
studied VBN O
using VBG O
3H CD O
- : O
triamcinolone NN O
acetonide NN O
. . O

Distinct JJ O
increase NN O
in IN O
amount NN O
of IN O
the DT O
leukocyte NN B-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
was VBD O
found VBN O
in IN O
patients NNS O
with IN O
poisoning NN O
by IN O
dichlorethane NN O
and CC O
hypnotic JJ O
drugs NNS O
under IN O
conditions NNS O
of IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

In IN O
acute JJ O
pancreatitis NN O
content NN O
of IN O
the DT O
leukocyte NN B-Gene
receptors NNS I-Gene
was VBD O
not RB O
altered VBN O
as IN O
compared VBN O
with IN O
controls NNS O
. . O

Concentration NN O
of IN O
endogenous JJ O
cortisol NN O
was VBD O
increased VBN O
in IN O
blood NN O
of IN O
all PDT O
the DT O
patients NNS O
, , O
except IN O
of IN O
the DT O
cases NNS O
of IN O
acetate JJ O
intoxication NN O
. . O

Reverse NNP O
correlation NN O
was VBD O
observed VBN O
between IN O
concentration NN O
of IN O
cortisol NN O
in IN O
blood NN O
and CC O
content NN O
of IN O
glucocorticoid JJ O
receptors NNS O
in IN O
leukocytes NNS O
. . O

But CC O
in IN O
the DT O
patients NNS O
with IN O
acute JJ O
pancreatitis NN O
the DT O
decrease NN O
in IN O
content NN O
of IN O
leukocyte JJ B-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
was VBD O
not RB O
observed VBN O
although IN O
there EX O
was VBD O
an DT O
increase NN O
in IN O
cortisol JJ O
concentration NN O
in IN O
blood NN O
. . O

The DT O
role NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
immunological JJ O
processes NNS O
under IN O
conditions NNS O
of IN O
purulent NN O
complications NNS O
and CC O
possibility NN O
to TO O
regulate VB O
the DT O
metabolism NN O
in IN O
leukocytes NNS O

Therapeutic JJ O
concentrations NNS O
of IN O
glucocorticoids NNS O
suppress VBP O
the DT O
antimicrobial JJ O
activity NN O
of IN O
human JJ O
macrophages NNS O
without IN O
impairing VBG O
their PRP$ O
responsiveness NN O
to TO O
gamma VB B-Gene
interferon NN I-Gene
. . O

By IN O
exposing VBG O
human JJ O
blood NN O
- : O
derived VBN O
macrophages NNS O
and CC O
alveolar JJ O
macrophages NNS O
in IN O
vitro NN O
to TO O
dexamethasone VB O
, , O
we PRP O
showed VBD O
in IN O
these DT O
studies NNS O
that WDT O
glucocorticoids VBP O
markedly RB O
suppress VBP O
the DT O
antimicrobial JJ O
activity NN O
of IN O
macrophages NNS O
but CC O
not RB O
macrophage VB O
activation NN O
by IN O
lymphokines NNS O
. . O

As RB O
little JJ O
as IN O
2 CD O
. . O
5 CD O
X JJ O
10 CD O
( ( O
- : O
8 CD O
) ) O
mol NN O
/ JJ O
liter NN O
of IN O
dexamethasone NN O
prevented VBN O
macrophages NNS O
from IN O
inhibiting VBG O
germination NN O
of IN O
Aspergillus NNP O
spores NNS O
or CC O
from IN O
eliminating VBG O
ingested VBN O
bacteria NNS O
such JJ O
as IN O
Listeria NNP O
, , O
Nocardia NNP O
, , O
or CC O
Salmonella NNP O
. . O

Damage NN O
to TO O
macrophage VB O
function NN O
was VBD O
inhibited VBN O
by IN O
progesterone NN O
and CC O
appeared VBD O
to TO O
be VB O
receptor JJ O
- : O
mediated VBN O
. . O

In IN O
accordance NN O
with IN O
in IN O
vivo NN O
observations NNS O
, , O
dexamethasone NN O
required VBD O
24 CD O
- : O
36 CD O
h NN O
to TO O
suppress VB O
antimicrobial JJ O
activity NN O
. . O

While IN O
glucocorticoids NNS O
interfered VBN O
with IN O
base NN O
- : O
line NN O
activity NN O
of IN O
macrophages NNS O
, , O
dexamethasone NN O
concentrations NNS O
comparable JJ O
to TO O
drug NN O
levels NNS O
in IN O
patients NNS O
had VBD O
no DT O
effect NN O
on IN O
macrophage NN O
activation NN O
. . O

Proliferating VBG O
lymphocytes NNS O
and CC O
gamma JJ B-Gene
- : I-Gene
interferon NN I-Gene
thus RB O
increased VBD O
the DT O
antimicrobial JJ O
activity NN O
of IN O
phagocytes NNS O
exposed VBN O
to TO O
glucocorticoids NNS O
over IN O
that DT O
of IN O
control NN O
cells NNS O
. . O

Macrophage NN O
activation NN O
and CC O
correction NN O
of IN O
the DT O
dexamethasone NN O
effect NN O
by IN O
gamma NN B-Gene
- : I-Gene
interferon NN I-Gene
, , O
however RB O
, , O
was VBD O
dependent VBN O
on IN O
the DT O
pathogen NN O
. . O

The DT O
lymphokine NN B-Gene
enhanced VBD O
the DT O
antimicrobial JJ O
activity NN O
of IN O
dexamethasone NN O
- : O
treated JJ O
macrophages NNS O
against IN O
Listeria NNP O
and CC O
Salmonella NNP O
but CC O
not RB O
against IN O
Aspergillus NNP O
or CC O
Nocardia NNP O
. . O

Dexamethasone NNP O
- : O
induced JJ O
damage NN O
to TO O
the DT O
antimicrobial JJ O
activity NN O
of IN O
human JJ O
macrophages NNS O
in IN O
vitro NN O
parallels NNS O
observations NNS O
that WDT O
glucocorticoids NNS O
render VBP O
laboratory NN O
animals NNS O
susceptible JJ O
to TO O
listeriosis NN O
and CC O
aspergillosis NN O
by IN O
damaging VBG O
resident JJ O
macrophages NNS O
. . O

Suppression NN O
of IN O
macrophage JJ O
antimicrobial JJ O
activity NN O
should MD O
thus RB O
be VB O
considered VBN O
when WRB O
treating VBG O
patients NNS O
with IN O
glucocorticoids NNS O
; : O
its PRP$ O
prevention NN O
by IN O
gamma JJ B-Gene
- : I-Gene
interferon NN I-Gene
might MD O
be VB O
beneficial JJ O
for IN O
some DT O
but CC O
not RB O
all DT O
pathogens NNS O
. . O

Interleukin NNP B-Gene
2 CD I-Gene
receptor NN I-Gene
( ( O
Tac NNP B-Gene
antigen NN I-Gene
) ) O
expression NN O
in IN O
HTLV NNP O
- : O
I PRP O
- : O
associated VBN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
. . O

Interleukin NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
is VBZ O
a DT O
lymphokine JJ B-Gene
synthesized VBN O
by IN O
some DT O
T NNP O
- : O
cells NNS O
following VBG O
activation NN O
. . O

Resting VBG O
T NNP O
- : O
cells NNS O
do VBP O
not RB O
express VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptors NNS I-Gene
, , O
but CC O
receptors NNS O
are VBP O
rapidly RB O
expressed VBN O
on IN O
T NNP O
- : O
cells NNS O
following VBG O
interaction NN O
of IN O
antigens NNS O
, , O
mitogens NNS O
, , O
or CC O
monoclonal JJ B-Gene
antibodies NNS I-Gene
with IN O
the DT O
antigen NN B-Gene
- : I-Gene
specific JJ I-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
complex NN I-Gene
. . O

Using VBG O
anti SYM B-Gene
- : I-Gene
Tac NN I-Gene
, , O
a DT O
monoclonal JJ B-Gene
antibody NN I-Gene
that WDT O
recognizes VBZ O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
, , O
the DT O
receptor NN O
has VBZ O
been VBN O
purified VBN O
and CC O
shown VBN O
to TO O
be VB O
a DT O
Mr NNP O
33 CD O
, , O
0 CD O
peptide NN O
that WDT O
is VBZ O
posttranslationally RB O
glycosylated VBN O
to TO O
a DT O
Mr NNP O
55 CD O
, , O
0 CD O
mature NN O
form NN O
. . O

Normal JJ O
resting VBG O
T NNP O
- : O
cells NNS O
and CC O
most JJS O
leukemic JJ O
T NNP O
- : O
cell NN O
populations NNS O
do VBP O
not RB O
express VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptors NNS I-Gene
; : O
however RB O
, , O
the DT O
leukemic JJ O
cells NNS O
of IN O
the DT O
11 CD O
patients NNS O
examined VBN O
who WP O
had VBD O
human JJ O
T NNP O
- : O
cell NN O
lymphotropic NN O
virus NN O
- : O
associated VBN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
expressed VBD O
the DT O
Tac NNP B-Gene
antigen NN I-Gene
. . O

In IN O
human JJ O
T NNP O
- : O
cell NN O
lymphotropic NN O
virus IN O
- : O
I PRP O
infected VBD O
cells NNS O
, , O
the DT O
Mr NNP O
42 CD O
, , O
0 CD O
long JJ O
open JJ B-Gene
reading NN I-Gene
frame NN I-Gene
protein NN I-Gene
encoded VBD O
in IN O
part NN O
by IN O
the DT O
pX JJ B-Gene
region NN I-Gene
of IN O
this DT O
virus NN O
may MD O
act VB O
as IN O
a DT O
transacting VBG B-Gene
transcriptional JJ I-Gene
activator NN I-Gene
that WDT O
induces VBZ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
gene NN I-Gene
transcription NN O
, , O
thus RB O
providing VBG O
an DT O
explanation NN O
for IN O
the DT O
constant JJ O
association NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
expression NN O
with IN O
adult NN O
T NNP O
- : O
cell NN O
lymphotropic NN O
virus IN O
- : O
I PRP O
infection NN O
of IN O
lymphoid JJ O
cells NNS O
. . O

The DT O
constant JJ O
expression NN O
of IN O
large JJ O
numbers NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptors NNS I-Gene
which WDT O
may MD O
be VB O
aberrant NN O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
uncontrolled JJ O
growth NN O
of IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
cells NNS O
. . O

Two CD O
patients NNS O
with IN O
Tac NNP O
- : O
positive JJ O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
have VBP O
been VBN O
treated VBN O
with IN O
the DT O
anti JJ B-Gene
- : I-Gene
Tac NN I-Gene
. . O

One CD O
of IN O
the DT O
patients NNS O
had VBD O
6 CD O
- : O
and CC O
3 CD O
- : O
mo NN O
remissions NNS O
of IN O
his PRP$ O
leukemia NN O
following VBG O
two CD O
courses NNS O
of IN O
therapy NN O
with IN O
this DT O
monoclonal JJ B-Gene
antibody NN I-Gene
directed VBD O
toward IN O
this DT O
growth NN B-Gene
factor NN I-Gene
receptor NN I-Gene
. . O

Lymphocyte NNP O
glucocorticoid NN B-Gene
receptor NN I-Gene
binding NN O
in IN O
depressed JJ O
patients NNS O
with IN O
hypercortisolemia NN O
. . O

Despite IN O
elevated JJ O
levels NNS O
of IN O
serum NN O
and CC O
urinary JJ O
cortisol NN O
, , O
patients NNS O
with IN O
depressive JJ O
illness NN O
manifest JJS O
none NN O
of IN O
the DT O
clinical JJ O
stigmata NN O
of IN O
glucocorticoid JJ O
excess NN O
. . O

This DT O
hypercortisolemia NN O
in IN O
the DT O
absence NN O
of IN O
clinical JJ O
effects NNS O
suggests VBZ O
a DT O
state NN O
of IN O
hormone NN O
resistance NN O
and CC O
could MD O
be VB O
mediated VBN O
by IN O
alterations NNS O
in IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
. . O

Earlier JJR O
studies NNS O
have VBP O
shown VBN O
that IN O
small JJ O
doses NNS O
of IN O
glucocorticoids NNS O
cause VBP O
a DT O
decrease NN O
in IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
binding VBG O
in IN O
normal JJ O
human JJ O
lymphocytes NNS O
. . O

White NNP O
cells NNS O
from IN O
depressed JJ O
patients NNS O
with IN O
significant JJ O
hypercortisolemia NN O
would MD O
be VB O
expected VBN O
to TO O
show VB O
a DT O
similar JJ O
change NN O
in IN O
receptor NN O
concentration NN O
if IN O
peripheral JJ O
tissues NNS O
are VBP O
adequately RB O
exposed VBN O
to TO O
and CC O
sensitive JJ O
to TO O
the DT O
hormone NN O
. . O

In IN O
this DT O
study NN O
we PRP O
compared VBN O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
to TO O
lymphocytes NNS O
from IN O
normal JJ O
subjects NNS O
and CC O
depressed JJ O
patients NNS O
with IN O
hypercortisolemia NN O
. . O

Lymphocytes NNS O
from IN O
normal JJ O
subjects NNS O
had VBD O
a DT O
mean JJ O
receptor NN O
concentration NN O
of IN O
10 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
66 CD O
fm JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
( ( O
S NNP O
. . O
E NNP O
. . O
M NNP O
. . O
) ) O
and CC O
a DT O
dissociation NN O
constant NN O
of IN O
4 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
47 CD O
nM NN O
. . O

Lymphocytes NNS O
from IN O
depressed JJ O
patients NNS O
with IN O
abnormal JJ O
800 CD O
h NN O
serum NN O
cortisol NN O
after IN O
dexamethasone NN O
had VBD O
a DT O
mean JJ O
receptor NN O
concentration NN O
of IN O
8 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
75 CD O
fm JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
, , O
which WDT O
was VBD O
not RB O
significantly RB O
different JJ O
from IN O
that DT O
in IN O
lymphocytes NNS O
from IN O
normal JJ O
subjects NNS O
or CC O
from IN O
depressed JJ O
subjects NNS O
with IN O
normal JJ O
post NN O
- : O
dexamethasone NN O
cortisol NN O
levels NNS O
( ( O
9 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
95 CD O
fm JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
) ) O
. . O

Lymphocytes NNS O
from IN O
depressed JJ O
patients NNS O
with IN O
elevated JJ O
urinary JJ O
free JJ O
cortisol NN O
excretion NN O
( ( O
UFC NNP O
) ) O
also RB O
had VBD O
normal JJ O
receptor NN O
concentration NN O
and CC O
binding NN O
affinity NN O
for IN O
dexamethasone NN O
. . O

The DT O
lack NN O
of IN O
a DT O
change NN O
in IN O
lymphocyte NN O
glucocorticoid NN B-Gene
receptor NN I-Gene
concentration NN O
in IN O
the DT O
presence NN O
of IN O
cortisol NN O
excess JJ O
suggests VBZ O
the DT O
possibility NN O
that WDT O
hypercortisolemia NN O
in IN O
depressive JJ O
illness NN O
represents VBZ O
a DT O
state NN O
of IN O
peripheral JJ O
glucocorticoid NN O
resistance NN O
. . O

Structure NN O
and CC O
regulation NN O
of IN O
the DT O
glucocorticoid NN B-Gene
hormone NN I-Gene
receptor NN I-Gene
. . O

The DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
is VBZ O
an DT O
intracellular JJ B-Gene
protein NN I-Gene
which WDT O
possesses VBZ O
three CD O
distinct NN O
domains NNS O
, , O
one CD O
that WDT O
binds VBZ O
agonist JJ O
and CC O
antagonist JJ O
steroids NNS O
, , O
one CD O
that WDT O
binds VBZ O
DNA NNP O
, , O
and CC O
one CD O
that WDT O
binds VBZ O
anti JJ B-Gene
- : I-Gene
receptor NN I-Gene
antibodies NNS I-Gene
and CC O
is VBZ O
required VBN O
for IN O
glucocorticoid JJ O
modulation NN O
of IN O
gene NN O
expression NN O
. . O

In IN O
intact JJ O
cells NNS O
, , O
receptor NN O
number NN O
, , O
affinity NN O
and CC O
activity NN O
can MD O
change VB O
in IN O
response NN O
to TO O
factors NNS O
that WDT O
bind VBP O
to TO O
the DT O
receptor NN O
, , O
or CC O
that IN O
act NN O
indirectly RB O
through IN O
ill JJ O
- : O
defined VBN O
mechanisms NNS O
which WDT O
may MD O
include VB O
resumption NN O
or CC O
arrest NN O
of IN O
cell NN O
cycling NN O
and CC O
variations NNS O
in IN O
intracellular JJ O
calcium NN O
ion NN O
concentrations NNS O
. . O

Some DT O
of IN O
these DT O
factors NNS O
appear VBP O
to TO O
exert VB O
their PRP$ O
effect NN O
by IN O
controlling VBG O
critical JJ O
receptor NN O
properties NNS O
such JJ O
as IN O
ATP NNP O
- : O
dependent JJ O
phosphorylation NN O
, , O
integrity NN O
of IN O
thiol NN B-Gene
groups NNS I-Gene
, , O
and CC O
exposure NN O
of IN O
key JJ B-Gene
amino NN I-Gene
acid NN I-Gene
residues NNS I-Gene
. . O

Glucocorticoid JJ O
agonists NNS O
promote VBP O
the DT O
' POS O
transformation NN O
' '' O
of IN O
the DT O
receptor NN O
into IN O
the DT O
DNA NNP O
- : O
binding NN O
state NN O
, , O
which WDT O
is VBZ O
competent NN O
for IN O
modulating VBG O
gene NN O
expression NN O
. . O

Glucocorticoid JJ O
antagonists NNS O
are VBP O
steroids NNS O
that IN O
interact NN O
with IN O
the DT O
receptor NN O
but CC O
either CC O
fail VBP O
to TO O
produce VB O
a DT O
stable JJ B-Gene
complex NN I-Gene
or CC O
produce VB O
a DT O
stable JJ B-Gene
but CC I-Gene
inefficient JJ I-Gene
complex NN I-Gene
. . O

Although IN O
substituent NN O
groups NNS O
that WDT O
confer VBP O
agonist JJ O
or CC O
antagonist JJ O
activity NN O
to TO O
the DT O
steroid NN O
have VBP O
been VBN O
identified VBN O
, , O
the DT O
molecular JJ O
determinants NNS O
of IN O
this DT O
difference NN O
at IN O
the DT O
receptor NN O
level NN O
remain VBP O
unknown JJ O
. . O

Most JJS O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
data NNS O
on IN O
receptor NN O
regulation NN O
can MD O
be VB O
accommodated VBN O
by IN O
postulating VBG O
the DT O
existence NN O
of IN O
an DT O
intracellular JJ O
cycle NN O
that WDT O
involves VBZ O
five CD O
states NNS O
of IN O
the DT O
receptor NN O
. . O

The DT O
active JJ O
free JJ O
receptor NN O
is VBZ O
phosphorylated VBN O
, , O
reduced VBN O
, , O
and CC O
presumably RB O
oligomeric JJ O
( ( O
state NN O
A DT O
) ) O
. . O

Following VBG O
binding NN O
of IN O
an DT O
agonist NN O
( ( O
state NN O
B NNP O
) ) O
, , O
it PRP O
can MD O
become VB O
transformed VBN O
by IN O
dissociation NN O
into IN O
its PRP$ O
subunits NNS O
and CC O
dephosphorylation NN O
( ( O
state NN O
C NNP O
) ) O
. . O

The DT O
transformed JJ B-Gene
receptor NN I-Gene
then RB O
interacts VBZ O
with IN O
chromatin NN B-Gene
( ( O
state NN O
D NNP O
) ) O
. . O

Dissociation NN O
of IN O
the DT O
steroid NN O
and CC O
oxidation NN O
of IN O
receptor NN B-Gene
thiol NN I-Gene
group NN I-Gene
( ( O
s PRP O
) ) O
lead NN O
to TO O
the DT O
inactive JJ O
receptor NN O
form NN O
( ( O
state NN O
E NNP O
) ) O
. . O

Reduction NN O
and CC O
rephosphorylation NN O
of IN O
the DT O
receptor NN O
enable VB O
it PRP O
to TO O
bind VB O
steroids NNS O
again RB O
so IN O
that IN O
the DT O
cycle NN O
is VBZ O
closed VBN O
. . O

Thermodynamics NNS O
of IN O
steroid JJ O
binding NN O
to TO O
the DT O
human JJ B-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
. . O

The DT O
thermodynamics NNS O
of IN O
the DT O
interaction NN O
of IN O
glucocorticoids NNS O
with IN O
their PRP$ O
receptor NN O
were VBD O
studied VBN O
in IN O
cytosol NN O
from IN O
human JJ O
lymphoblastoid NN O
cells NNS O
. . O

The DT O
rate NN O
and CC O
affinity NN O
constants NNS O
of IN O
dexamethasone NN O
and CC O
cortisol NN O
between IN O
0 CD O
degree NN O
and CC O
25 CD O
degrees NNS O
C NNP O
were VBD O
calculated VBN O
by IN O
curve NN O
- : O
fitting NN O
from IN O
time NN O
- : O
course NN O
and CC O
equilibrium NN O
kinetics NNS O
. . O

The DT O
data NNS O
were VBD O
consistent JJ O
with IN O
a DT O
simple JJ O
reversible JJ O
bimolecular JJ O
interaction NN O
. . O

Arrhenius NNP O
and CC O
Va NNP O
n NNP O
' POS O
t NN O
Hoff NNP O
plots NNS O
were VBD O
curvilinear JJ O
for IN O
both DT O
steroids NNS O
. . O

At IN O
equilibrium NN O
, , O
the DT O
solution NN O
for IN O
the DT O
equation NN O
delta NN O
G NNP O
= NNP O
delta NN O
H NNP O
- : O
T NNP O
X NNP O
delta NN O
S NNP O
( ( O
eqn NN O
. . O
1 CD O
) ) O
was VBD O
( ( O
in IN O
kJ NN O
X NNP O
mol NNP O
- : O
1 CD O
) ) O
- : O
47 CD O
= $ O
36 CD O
- : O
83 CD O
( ( O
dexamethasone NN O
) ) O
and CC O
- : O
42 CD O
= SYM O
- : O
9 CD O
- : O
33 CD O
( ( O
cortisol NN O
) ) O
at IN O
0 CD O
degree JJ O
C NNP O
. . O

Enthalpy NNP O
and CC O
entropy NN O
changes NNS O
decreased VBD O
quasi SYM O
- : O
linearly RB O
with IN O
temperature NN O
such JJ O
that IN O
, , O
at IN O
25 CD O
degrees NNS O
C NNP O
, , O
the DT O
respective JJ O
values NNS O
were VBD O
- : O
50 CD O
= SYM O
- : O
75 CD O
+ JJ O
25 CD O
and CC O
- : O
43 CD O
= SYM O
- : O
48 CD O
+ JJ O
5 CD O
. . O

Thus RB O
, , O
for IN O
both DT O
steroids NNS O
, , O
the DT O
interaction NN O
was VBD O
entropy JJ O
- : O
driven VBN O
at IN O
low JJ O
temperature NN O
and CC O
became VBD O
entirely RB O
enthalpy JJ O
- : O
driven NN O
at IN O
20 CD O
degrees NNS O
C NNP O
. . O

Thermodynamic NNP O
values NNS O
for IN O
the DT O
transition NN O
state NN O
were VBD O
calculated VBN O
from IN O
the DT O
rate NN O
constants NNS O
. . O

For IN O
the DT O
forward JJ O
reaction NN O
, , O
eqn NN O
. . O
( ( O
1 CD O
) ) O
gave VBD O
45 CD O
= NN O
84 CD O
- : O
39 CD O
( ( O
dexamethasone NN O
) ) O
and CC O
46 CD O
= NN O
60 CD O
- : O
14 CD O
( ( O
cortisol NN O
) ) O
at IN O
0 CD O
degree JJ O
C NNP O
, , O
and CC O
44 CD O
= NNS O
24 CD O
+ JJ O
20 CD O
( ( O
dexamethasone NN O
) ) O
and CC O
46 CD O
= NNS O
28 CD O
+ JJ O
18 CD O
( ( O
cortisol NN O
) ) O
at IN O
25 CD O
degrees NNS O
C NNP O
. . O

These DT O
data NNS O
fit NN O
quite RB O
well RB O
with IN O
a DT O
two CD O
- : O
step NN O
model NN O
[ NNP O
Ross NNP O
& CC O
Subramanian NNP O
( ( O
1981 CD O
) ) O
Biochemistry NNP O
20 CD O
, , O
3096 CD O
- : O
3102 CD O
] NN O
proposed VBN O
for IN O
ligand NN O
- : O
protein NN O
interactions NNS O
, , O
which WDT O
involves VBZ O
a DT O
partial JJ O
immobilization NN O
of IN O
the DT O
reacting VBG O
species NNS O
governed VBN O
by IN O
hydrophobic JJ O
forces NNS O
, , O
followed VBN O
by IN O
stabilization NN O
of IN O
the DT O
complex JJ O
by IN O
short JJ O
- : O
range NN O
interactions NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
this DT O
model NN O
, , O
an DT O
analysis NN O
of IN O
the DT O
transition NN O
- : O
state NN O
thermodynamics NNS O
led VBD O
to TO O
the DT O
conclusion NN O
that IN O
no DT O
more JJR O
than IN O
half NN O
of IN O
the DT O
steroid JJ O
molecular JJ O
area NN O
is VBZ O
engaged VBN O
in IN O
the DT O
binding NN O
process NN O
. . O

Cell NNP O
cycle NN O
- : O
related JJ O
changes NNS O
in IN O
number NN O
of IN O
T NNP B-Gene
- : I-Gene
lymphocyte NN I-Gene
receptors NNS I-Gene
for IN O
glucocorticoids NNS O
and CC O
insulin NN O
. . O

Enriched NNP O
human JJ O
peripheral JJ O
T NNP O
- : O
lymphocytes NNS O
were VBD O
stimulated VBN O
with IN O
PHA NNP O
and CC O
examined VBN O
for IN O
variations NNS O
in IN O
insulin NN O
and CC O
glucocorticoid NN O
( ( O
dexamethasone NN O
) ) O
receptor NN O
numbers NNS O
during IN O
the DT O
early JJ O
phases NNS O
of IN O
the DT O
cell NN O
cycle NN O
. . O

Cells NNS O
in IN O
G0 NNP O
, , O
G1a NNP O
and CC O
G1b NNP O
phases NNS O
, , O
where WRB O
the DT O
G1a NNP O
- : O
G1b NNP O
transition NN O
is VBZ O
an DT O
Interleukin NNP B-Gene
2 CD I-Gene
dependent JJ O
event NN O
, , O
were VBD O
quantitated VBN O
by IN O
flow JJ O
cytometry NN O
. . O

Few JJ O
but CC O
significant JJ O
numbers NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
2700 CD O
/ NNP O
cell NN O
) ) O
and CC O
no DT O
insulin NN B-Gene
receptors NNS I-Gene
( ( O
- : O
1 CD O
/ NNP O
cell NN O
) ) O
were VBD O
found VBN O
in IN O
the DT O
resting NN O
( ( O
G0 NNP O
) ) O
phase NN O
. . O

As IN O
cells NNS O
entered VBD O
the DT O
G1a NNP O
phase NN O
the DT O
specific JJ O
binding NN O
of IN O
dexamethasone NN O
increased VBN O
and CC O
of IN O
insulin NN O
took VBD O
place NN O
. . O

Although IN O
the DT O
specific JJ O
binding VBG O
further JJ O
increased VBN O
as IN O
T NNP O
- : O
cells NNS O
entered VBD O
the DT O
G1b NNP O
phase NN O
( ( O
as IN O
measured VBN O
at IN O
44 CD O
h NN O
of IN O
incubation NN O
and CC O
using VBG O
hydroxyurea JJ O
- : O
treated JJ O
cells NNS O
) ) O
, , O
the DT O
major JJ O
changes NNS O
in IN O
the DT O
specific JJ O
binding NN O
of IN O
dexamethasone NN O
took VBD O
place NN O
during IN O
the DT O
period NN O
16 CD O
- : O
20 CD O
h NN O
after IN O
stimulation NN O
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
it PRP O
is VBZ O
concluded VBN O
that IN O
both DT O
receptor NN O
types NNS O
( ( O
cell NN B-Gene
membrane NN I-Gene
and CC I-Gene
cytoplasmic JJ I-Gene
receptors NNS I-Gene
) ) O
are VBP O
being VBG O
formed VBN O
and CC O
increased VBN O
at IN O
G1 NNP O
phase NN O
prior RB O
to TO O
cell VB O
proliferation NN O
, , O
indicating VBG O
the DT O
importance NN O
of IN O
G1 NNP O
phase NN O
in IN O
immunoregulation NN O
. . O

Glucocorticoid NNP B-Gene
receptors NNS I-Gene
and CC O
cortico SYM O
- : O
sensitivity NN O
in IN O
a DT O
human JJ O
clonal JJ O
monocytic NN O
cell NN O
line NN O
, , O
CM NNP O
- : O
SM NN O
. . O

CM NNP O
- : O
SM NN O
is VBZ O
a DT O
clonal JJ O
line NN O
of IN O
human JJ O
precursor NN O
mononuclear NN O
phagocytes VBZ O
inducible JJ O
to TO O
macrophage VB O
differentiation NN O
in IN O
response NN O
to TO O
the DT O
tumor NN O
promoter NN O
phorbol NN O
ester NN O
12 CD O
- : O
O NNP O
- : O
tetradecanoyl NN O
- : O
phorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
. . O

Untreated VBN O
CM NNP O
- : O
SM NNP O
cells NNS O
contain VBP O
single JJ O
class NN O
, , O
high JJ O
- : O
affinity NN O
( ( O
KD NNP O
= VBZ O
4 CD O
. . O
0 CD O
X JJ O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
) ) O
glucocorticoid VBP O
- : O
specific JJ O
receptor NN O
sites NNS O
( ( O
approximately RB O
60 CD O
, , O
0 CD O
per IN O
cell NN O
) ) O
, , O
as IN O
measured VBN O
by IN O
a DT O
whole JJ O
cell NN O
assay NN O
, , O
at IN O
37 CD O
degrees NNS O
C NNP O
, , O
using VBG O
[ JJ O
3H CD O
] JJ O
triamcinolone NN O
acetonide NN O
( ( O
TA NNP O
) ) O
. . O

Exposure NN O
of IN O
CM NNP O
- : O
SM NN O
to TO O
dexamethasone VB O
( ( O
DEX NNP O
) ) O
produced VBD O
a DT O
progressive JJ O
, , O
dose JJ O
- : O
and CC O
time NN O
- : O
related JJ O
series NN O
of IN O
changes NNS O
in IN O
CM NNP O
- : O
SM NNP O
cell NN O
growth NN O
, , O
saturation NN O
density NN O
, , O
morphology NN O
, , O
and CC O
functional JJ O
properties NNS O
, , O
with IN O
half PDT O
- : O
maximal JJ O
effects NNS O
at IN O
about IN O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
for IN O
DEX NNP O
. . O

TA NNP O
- : O
receptor NN O
sites VBZ O
rapidly RB O
decreased VBN O
( ( O
about IN O
70 CD O
% NN O
) ) O
after IN O
DEX NNP O
treatment NN O
, , O
without IN O
any DT O
apparent JJ O
change NN O
in IN O
steroid JJ O
specificity NN O
and CC O
affinity NN O
. . O

After IN O
5 CD O
days NNS O
in IN O
culture NN O
with IN O
a DT O
saturating VBG O
concentration NN O
( ( O
3 CD O
. . O
6 CD O
X JJ O
10 CD O
( ( O
- : O
8 CD O
) ) O
M NNP O
) ) O
of IN O
hormone NN O
, , O
the DT O
cells NNS O
reached VBD O
a DT O
saturation NN O
density NN O
of IN O
about IN O
9 CD O
. . O
0 CD O
X JJ O
10 CD O
( ( O
6 CD O
) ) O
viable JJ O
cells NNS O
/ JJ O
ml NN O
( ( O
about IN O
4 CD O
. . O
0 CD O
X JJ O
10 CD O
( ( O
6 CD O
) ) O
viable JJ O
cells NNS O
/ JJ O
ml NN O
in IN O
the DT O
controls NNS O
) ) O
, , O
while IN O
the DT O
modal JJ O
volume NN O
of IN O
the DT O
resulting VBG O
cell NN O
population NN O
was VBD O
approximately RB O
60 CD O
% NN O
, , O
as IN O
compared VBN O
to TO O
the DT O
volume NN O
of IN O
untreated JJ O
cells NNS O
. . O

DEX NNP O
- : O
treated VBD O
cells NNS O
appeared VBD O
less RBR O
differentiated VBN O
than IN O
controls NNS O
, , O
as IN O
assessed VBN O
by IN O
combined JJ O
morphologic NN O
, , O
antigenic JJ O
, , O
and CC O
cytoenzymatic JJ O
analyses NNS O
. . O

DEX NNP O
almost RB O
completely RB O
inhibited JJ O
TPA NNP O
activation NN O
of IN O
the DT O
following JJ O
macrophage NN O
functions NNS O
: : O
adherency NN O
to TO O
the DT O
culture NN O
plate NN O
, , O
expression NN O
of IN O
lysosomal JJ B-Gene
enzymes NNS I-Gene
, , O
Fc NNP B-Gene
and CC I-Gene
C3 NNP I-Gene
receptors NNS I-Gene
, , O
and CC O
stimulation NN O
of IN O
phagocytosis NN O
. . O

After IN O
removal NN O
of IN O
DEX NNP O
, , O
the DT O
cells NNS O
, , O
within IN O
a DT O
few JJ O
passages NNS O
, , O
returned VBD O
to TO O
a DT O
state NN O
apparently RB O
identical JJ O
to TO O
the DT O
untreated JJ O
controls NNS O
and CC O
could MD O
be VB O
induced VBN O
to TO O
macrophage VB O
differentiation NN O
in IN O
response NN O
to TO O
TPA NNP O
. . O

Acute NNP O
lymphoblastic JJ O
leukemia NN O
in IN O
children NNS O
: : O
current JJ O
status NN O
, , O
controversies NNS O
, , O
and CC O
future JJ O
perspective NN O
. . O

Disease NNP O
- : O
free JJ O
survival NN O
( ( O
DFS NNP O
) ) O
in IN O
childhood NN O
ALL NNP O
is VBZ O
60 CD O
% NN O
, , O
and CC O
survival NN O
in IN O
good JJ O
, , O
average JJ O
, , O
and CC O
poor JJ O
prognostic JJ O
groups NNS O
defined VBN O
by IN O
initial JJ O
WBC NNP O
and CC O
age NN O
is VBZ O
90 CD O
, , O
60 CD O
, , O
and CC O
45 CD O
% NN O
, , O
respectively RB O
. . O

Additional NNP O
immunological NN O
, , O
morphological JJ O
, , O
biochemical JJ O
, , O
cytokinetic JJ O
, , O
and CC O
cytogenetic JJ O
factors NNS O
have VBP O
been VBN O
identified VBN O
, , O
illustrating VBG O
the DT O
heterogeneity NN O
of IN O
ALL NNP O
and CC O
its PRP$ O
derivation NN O
from IN O
malignant JJ O
clones NNS O
at IN O
various JJ O
stages NNS O
of IN O
differentiation NN O
and CC O
with IN O
varying VBG O
rates NNS O
of IN O
proliferation NN O
. . O

Of IN O
biologic JJ O
importance NN O
, , O
these DT O
factors NNS O
may MD O
refine VB O
further JJR O
the DT O
characteristic JJ O
features NNS O
of IN O
clinically RB O
- : O
determined VBN O
prognostic JJ O
groups NNS O
. . O

Multivariate NNP O
analysis NN O
of IN O
large JJ O
prospective JJ O
trials NNS O
with IN O
homogeneous JJ O
therapy NN O
will MD O
be VB O
required VBN O
to TO O
determine VB O
the DT O
independent JJ O
prognostic JJ O
importance NN O
of IN O
these DT O
factors NNS O
. . O

Current JJ O
treatment NN O
strategies NNS O
in IN O
ALL NNP O
include VBP O
( ( O
1 CD O
) ) O
tailoring VBG O
therapy NN O
and CC O
its PRP$ O
intensity NN O
to TO O
prognostic JJ O
groups NNS O
; : O
( ( O
2 CD O
) ) O
multiple SYM O
- : O
drug NN O
combinations NNS O
in IN O
induction NN O
; : O
( ( O
3 CD O
) ) O
early RB O
use NN O
of IN O
intrathecal JJ O
( ( O
IT NNP O
) ) O
methotrexate NN O
( ( O
MTX NNP O
) ) O
; : O
( ( O
4 CD O
) ) O
CNS NNP O
prophylaxis NN O
with IN O
IT NNP O
MTX NNP O
alone RB O
in IN O
good JJ O
prognosis NN O
patients NNS O
and CC O
combined VBN O
cranial JJ O
radiation NN O
( ( O
CXRT NNP O
) ) O
, , O
1800 CD O
rads NNS O
plus CC O
IT NNP O
MTX NNP O
, , O
in IN O
average NN O
and CC O
poor JJ O
prognosis NN O
patients NNS O
. . O

Current JJ O
studies NNS O
show VBP O
a DT O
CNS NNP O
relapse NN O
rate NN O
of IN O
5 CD O
% NN O
in IN O
all DT O
prognostic JJ O
groups NNS O
. . O

Late RB O
neuropsychological JJ O
defects NNS O
caused VBN O
by IN O
cranial JJ O
XRT NN O
and CC O
IT NNP O
MTX NNP O
have VBP O
prompted VBN O
programs NNS O
designed VBN O
to TO O
reduce VB O
the DT O
potential JJ O
late JJ O
toxicity NN O
of IN O
CNS NNP O
prophylaxis NN O
. . O

More RBR O
pronounced JJ O
in IN O
younger JJR O
children NNS O
, , O
these DT O
abnormalities NNS O
include VBP O
decreased JJ O
IQ NNP O
, , O
visual JJ O
- : O
motor NN O
incoordination NN O
, , O
poor JJ O
performance NN O
in IN O
mathematics NNS O
, , O
and CC O
memory NN O
dysfunction NN O
. . O

Until IN O
1980 CD O
, , O
more RBR O
intensive JJ O
induction NN O
, , O
consolidation NN O
, , O
and CC O
maintenance NN O
therapy NN O
had VBD O
failed VBN O
to TO O
prolong VB O
DFS NNP O
in IN O
children NNS O
with IN O
a DT O
poor JJ O
prognosis NN O
. . O

In IN O
West NNP O
Germany NNP O
( ( O
Berlin NNP O
- : O
Frankfurt NNP O
- : O
Muenster NNP O
protocol NN O
) ) O
a DT O
70 CD O
to TO O
75 CD O
% NN O
DFS NNP O
is VBZ O
seen VBN O
in IN O
all DT O
patients NNS O
regardless RB O
of IN O
initial JJ O
WBC NNP O
, , O
suggesting VBG O
that IN O
effective JJ O
therapy NN O
will MD O
override VB O
prognostic JJ O
factors NNS O
. . O

Ultra NNP O
- : O
high JJ O
- : O
dose NN O
MTX NNP O
, , O
without IN O
cranial JJ O
radiation NN O
, , O
is VBZ O
also RB O
showing VBG O
promise NN O
in IN O
poor JJ O
prognosis NN O
patients NNS O
. . O

Other JJ O
issues NNS O
include VBP O
the DT O
optimal JJ O
duration NN O
of IN O
therapy NN O
, , O
the DT O
role NN O
of IN O
testicular JJ O
biopsies NNS O
, , O
and CC O
prophylactic JJ O
testicular NN O
radiation NN O
. . O

Recent JJ O
studies NNS O
suggest VBP O
that IN O
prognostic JJ O
factors NNS O
lose VBP O
their PRP$ O
significance NN O
after IN O
2 CD O
years NNS O
of IN O
continuous JJ O
complete JJ O
remission NN O
and CC O
that IN O
2 CD O
years NNS O
of IN O
maintenance NN O
therapy NN O
is VBZ O
adequate JJ O
. . O

Bilateral NNP O
open JJ O
- : O
wedge NN O
testicular JJ O
biopsies NNS O
have VBP O
identified VBN O
occult IN O
testicular JJ O
disease NN O
in IN O
8 CD O
to TO O
10 CD O
% NN O
of IN O
males NNS O
. . O

A DT O
unified JJ O
approach NN O
to TO O
children NNS O
with IN O
leukemia NN O
/ NNP O
lymphoma NN O
, , O
a DT O
group NN O
with IN O
a DT O
particularly RB O
poor JJ O
prognosis NN O
, , O
utilizing VBG O
NHL NNP O
- : O
type NN O
therapy NN O
may MD O
be VB O
more RBR O
effective JJ O
than IN O
conventional JJ O
ALL NNP O
therapy NN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
and CC O
in IN O
vitro JJ O
sensitivity NN O
to TO O
steroid VB O
hormones NNS O
in IN O
human JJ O
lymphoproliferative JJ O
diseases NNS O
and CC O
myeloid NN O
leukemia NN O
. . O

The DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
quantitation NN O
by IN O
a DT O
whole JJ O
- : O
cell NN O
assay NN O
and CC O
/ NN O
or CC O
cytosol NN O
technique NN O
and CC O
the DT O
in IN O
vitro JJ O
sensitivity NN O
to TO O
steroids NNS O
have VBP O
been VBN O
assessed VBN O
in IN O
peripheral JJ O
blood NN O
cells NNS O
from IN O
normal JJ O
donors NNS O
and CC O
patients NNS O
with IN O
chronic JJ O
lymphatic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
, , O
acute JJ O
lymphoblastic JJ O
leukemia NN O
( ( O
ALL NNP O
) ) O
, , O
lymphosarcoma RB O
cell NN O
leukemia NN O
( ( O
LSCL NNP O
) ) O
, , O
acute JJ O
nonlymphatic JJ O
leukemia NN O
( ( O
ANLL NNP O
) ) O
, , O
and CC O
chronic JJ O
myeloid NN O
leukemia NN O
( ( O
CML NNP O
) ) O
. . O

Within IN O
the DT O
lymphoproliferative JJ O
diseases NNS O
, , O
ALL NNP O
cells NNS O
exhibited VBD O
the DT O
highest JJS O
GR JJ B-Gene
concentration NN O
( ( O
regardless NN O
of IN O
the DT O
method NN O
used VBN O
) ) O
and CC O
the DT O
highest JJS O
in IN O
vitro JJ O
inhibition NN O
of IN O
spontaneous JJ O
[ FW O
3H CD O
] JJ O
thymidine NN O
( ( O
[ JJ O
3H CD O
] NNP O
TdR NNP O
) ) O
uptake NN O
by IN O
glucocorticoids NNS O
. . O

A DT O
significant JJ O
relationship NN O
between IN O
GR NNP B-Gene
concentration NN O
( ( O
whole JJ O
- : O
cell NN O
assay NN O
) ) O
and CC O
in IN O
vitro JJ O
sensitivity NN O
to TO O
dexamethasone NN O
was VBD O
also RB O
found VBN O
. . O

On IN O
the DT O
contrary JJ O
, , O
CLL NNP O
cells NNS O
presented VBD O
the DT O
highest JJS O
sensitivity NN O
to TO O
glucocorticoids NNS O
in IN O
PHA NNP O
- : O
stimulated VBD O
cell NN O
cultures NNS O
. . O

Cells NNS O
from IN O
the DT O
only JJ O
two CD O
ALL NNP O
patients NNS O
who WP O
did VBD O
not RB O
undergo VB O
a DT O
remission NN O
after IN O
glucocorticoid JJ O
- : O
inclusive JJ O
chemotherapy NN O
had VBD O
both DT O
the DT O
lowest JJS O
in IN O
vitro JJ O
sensitivity NN O
to TO O
dexamethasone VB O
and CC O
the DT O
lowest JJS O
GR NNP O
concentration NN O
with IN O
whole JJ O
- : O
cell NN O
assay NN O
. . O

Concerning VBG O
myeloid NN O
leukemia NN O
, , O
ANLL NNP O
patients NNS O
had VBD O
GR NNP B-Gene
concentrations NNS O
slightly RB O
higher JJR O
than IN O
those DT O
found VBN O
in IN O
the DT O
ALL NNP O
group NN O
but CC O
exhibited VBD O
the DT O
lowest JJS O
degree NN O
of IN O
inhibition NN O
of IN O
spontaneous JJ O
[ FW O
3H CD O
] NN O
TdR NNP O
uptake NN O
by IN O
dexamethasone NN O
( ( O
stimulatory JJ O
effects NNS O
occurred VBD O
in IN O
some DT O
cases NNS O
) ) O
. . O

CML NNP O
cells NNS O
exhibited VBD O
an DT O
inhibition NN O
degree NN O
by IN O
in IN O
vitro JJ O
glucocorticoids NNS O
significantly RB O
higher JJR O
than IN O
that DT O
of IN O
ANLL NNP O
cells NNS O
but CC O
not RB O
different JJ O
from IN O
that DT O
of IN O
lymphoproliferative JJ O
diseases NNS O
. . O

No DT O
clear JJ O
relationship NN O
among IN O
GR NNP O
pattern NN O
, , O
in IN O
vitro NN O
cell NN O
sensitivity NN O
to TO O
glucocorticoids NNS O
, , O
and CC O
clinicohematologic JJ O
parameters NNS O
was VBD O
observed VBN O
in IN O
myeloid NN O
leukemia NN O
- : O
bearing NN O
patients NNS O
. . O

Glucocorticoid NNP B-Gene
receptors NNS I-Gene
and CC O
in IN O
vitro JJ O
corticosensitivity NN O
of IN O
peanut NN O
- : O
positive JJ O
and CC O
peanut JJ O
- : O
negative JJ O
human JJ O
thymocyte NN O
subpopulations NNS O
. . O

In IN O
6 CD O
human JJ O
thymus NN O
glands NNS O
, , O
the DT O
immature NN O
subset NN O
of IN O
thymocytes NNS O
was VBD O
separated VBN O
from IN O
the DT O
more JJR O
mature JJ O
one CD O
, , O
by IN O
differential JJ O
peanut NN O
lectin NN O
agglutination NN O
. . O

These DT O
2 CD O
cell NN O
subpopulations NNS O
were VBD O
analyzed VBN O
for IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
by IN O
using VBG O
a DT O
whole JJ O
cell NN O
assay NN O
, , O
with IN O
( ( O
3H CD O
) ) O
- : O
triamcinolone NN O
acetonide RB O
as IN O
tracer NN O
. . O

The DT O
unagglutinated JJ O
thymocytes NNS O
( ( O
peanut JJ O
negative NN O
) ) O
contained VBD O
about IN O
2 CD O
times NNS O
more RBR O
receptor NN O
sites VBZ O
per IN O
cell NN O
than IN O
agglutinated VBN O
( ( O
peanut JJ O
positive JJ O
) ) O
ones NNS O
( ( O
7650 CD O
+ NNP O
/ NNP O
- : O
1550 CD O
S NNP O
. . O
D NNP O
. . O
verus NN O
3195 CD O
+ NN O
/ NNP O
- : O
896 CD O
S NNP O
. . O
D NNP O
. . O
) ) O
. . O

The DT O
affinity NN O
for IN O
steroid NN O
was VBD O
similar JJ O
in IN O
both DT O
cell NN O
subsets NNS O
, , O
as IN O
was VBD O
the DT O
stereospecificity NN O
for IN O
glucocorticoids NNS O
, , O
the DT O
time NN O
- : O
course NN O
of IN O
steroid JJ O
- : O
receptor NN O
association NN O
, , O
and CC O
cytoplasmic JJ O
to TO O
nuclear JJ O
translocation NN O
. . O

Despite IN O
the DT O
greater JJR O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
sites NNS O
, , O
the DT O
peanut NN O
- : O
negative JJ O
thymocyte JJ O
subpopulation NN O
did VBD O
not RB O
differ VB O
from IN O
the DT O
peanut NN O
- : O
positive JJ O
one CD O
in IN O
its PRP$ O
sensitivity NN O
to TO O
the DT O
inhibitory JJ O
effects NNS O
of IN O
triamcinolone NN O
acetonide NN O
, , O
as IN O
determined VBN O
by IN O
measurements NNS O
of IN O
the DT O
incorporation NN O
of IN O
radiolabeled JJ O
precursors NNS O
of IN O
protein NN O
and CC O
DNA NNP O
. . O

Moreover RB O
, , O
the DT O
peanut NN O
- : O
negative JJ O
subset NN O
appeared VBD O
more RBR O
resistant JJ O
in IN O
vitro NN O
to TO O
the DT O
steroid JJ O
- : O
induced VBN O
cell NN O
lysis NN O
as IN O
compared VBN O
to TO O
the DT O
peanut NN O
- : O
positive JJ O
one CD O
. . O

Thus RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
glucocorticoid JJ O
receptor NN O
density NN O
and CC O
corticosensitivity NN O
are VBP O
not RB O
directly RB O
correlated VBN O
and CC O
that IN O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
sites NNS O
may MD O
be VB O
dependent JJ O
on IN O
the DT O
degree NN O
of IN O
immunologic JJ O
maturation NN O

Defective JJ O
binding NN O
and CC O
function NN O
of IN O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
- : I-Gene
dihydroxyvitamin NN I-Gene
D3 NNP I-Gene
receptors NNS I-Gene
in IN O
peripheral JJ O
mononuclear JJ O
cells NNS O
of IN O
patients NNS O
with IN O
end JJ O
- : O
organ JJ O
resistance NN O
to TO O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D NNP O
. . O

Lectin NNP O
- : O
induced VBD O
DNA NNP O
synthesis NN O
by IN O
peripheral JJ O
mononuclear JJ O
cells NNS O
from IN O
17 CD O
normal JJ O
donors NNS O
was VBD O
inhibited VBN O
( ( O
40 CD O
- : O
60 CD O
% NN O
) ) O
by IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
( ( O
1 CD O
, , O
25 CD O
[ NN O
OH NNP O
] NNP O
2D3 CD O
) ) O
at IN O
physiological JJ O
concentrations NNS O
( ( O
10 CD O
( ( O
- : O
10 CD O
) ) O
- : O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
) ) O
. . O

The DT O
lymphocytes NNS O
acquire VB O
specific JJ O
receptors NNS O
for IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
upon IN O
activation NN O
by IN O
the DT O
lectins NNS B-Gene
. . O

This DT O
process NN O
precedes VBZ O
the DT O
inhibitory JJ O
effect NN O
of IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
. . O

We PRP O
studied VBD O
lymphocytes NNS O
from IN O
six CD O
patients NNS O
from IN O
four CD O
different JJ O
kindreds NNS O
with IN O
the DT O
syndrome NN O
of IN O
hereditary JJ O
end NN O
- : O
organ JJ O
resistance NN O
to TO O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D CD O
( ( O
the DT O
so RB O
- : O
called VBN O
vitamin NN O
D NNP O
- : O
dependent JJ O
rickets NNS O
type VBP O
II NNP O
) ) O
. . O

In IN O
five CD O
patients NNS O
( ( O
three CD O
kindreds NNS O
) ) O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
did VBD O
not RB O
acquire VB O
receptors NNS O
for IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
upon IN O
phytohemagglutinin NN O
- : O
induced JJ O
activation NN O
. . O

Moreover RB O
, , O
in IN O
contrast NN O
to TO O
normal JJ O
lymphocytes NNS O
, , O
the DT O
mitogenic JJ O
stimulation NN O
of IN O
these DT O
patients NNS O
' POS O
lymphocytes NNS O
by IN O
phytohemagglutinin NN B-Gene
and CC O
concanavalin VB O
A NNP O
was VBD O
not RB O
inhibited VBN O
by IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
. . O

Activated VBN O
lymphocytes NNS O
of IN O
the DT O
sixth JJ O
patient NN O
from IN O
a DT O
fourth JJ O
kindred VBN O
exhibited VBD O
normal JJ O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
but CC O
the DT O
hormone NN O
failed VBD O
to TO O
inhibit VB O
the DT O
mitogenic JJ O
stimulation NN O
. . O

A DT O
similar JJ O
pattern NN O
of IN O
the DT O
vitamin NN O
D NNP O
effector NN O
system NN O
was VBD O
previously RB O
observed VBN O
in IN O
fibroblasts NNS O
cultured VBD O
from IN O
skin JJ O
biopsies NNS O
of IN O
the DT O
same JJ O
group NN O
of IN O
patients NNS O
. . O

The DT O
conclusions NNS O
from IN O
these DT O
findings NNS O
are VBP O
: : O
( ( O
a DT O
) ) O
the DT O
inhibition NN O
of IN O
mitogenic JJ O
stimulation NN O
by IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
is VBZ O
mediated VBN O
by IN O
specific JJ B-Gene
functional JJ I-Gene
receptors NNS I-Gene
to TO O
the DT O
hormone NN O
; : O
and CC O
( ( O
b NN O
) ) O
the DT O
receptors NNS O
for IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
in IN O
mononuclear JJ O
cells NNS O
are VBP O
probably RB O
controlled VBN O
genetically RB O
by IN O
the DT O
same JJ O
mechanisms NN O
as IN O
the DT O
effector NN O
system NN O
in IN O
well RB O
- : O
characterized VBN O
target NN O
organs NNS O
of IN O
the DT O
hormone NN O
, , O
such JJ O
as IN O
intestine NN O
and CC O
kidney NN O
. . O

Glucocorticoid NNP B-Gene
receptors NNS I-Gene
of IN O
mononuclear JJ O
leukocytes NNS O
from IN O
myasthenia NN O
gravis NN O
patients NNS O
. . O

The DT O
present JJ O
study NN O
was VBD O
performed VBN O
to TO O
analyse VB O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
binding NN O
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
leukocytes VBZ O
( ( O
MNL NNP O
) ) O
from IN O
39 CD O
myasthenia NN O
gravis NN O
( ( O
MG NNP O
) ) O
patients NNS O
( ( O
unoperated JJ O
patients NNS O
( ( O
n JJ O
= NNP O
13 CD O
) ) O
, , O
thymectomized JJ O
patients NNS O
( ( O
n JJ O
= NNP O
14 CD O
) ) O
and CC O
patients NNS O
receiving VBG O
glucocorticoids NNS O
: : O
thymectomized VBN O
( ( O
n JJ O
= NNP O
11 CD O
) ) O
and CC O
unoperated JJ O
( ( O
n JJ O
= $ O
6 CD O
] NN O
. . O

A DT O
whole JJ O
cell NN O
binding VBG O
assay NN O
with IN O
3 CD O
( ( O
H NNP O
) ) O
dexamethasone NN O
was VBD O
used VBN O
. . O

GR NNP B-Gene
mean NN O
values NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
MNL NNP O
of IN O
MG NNP O
patients NNS O
( ( O
thymectomized VBN O
or CC O
not RB O
) ) O
not RB O
receiving VBG O
glucocorticoid NN O
than IN O
in IN O
the DT O
MNL NNP O
of IN O
healthy JJ O
donors NNS O
. . O

Affinity NN O
was VBD O
within IN O
the DT O
normal JJ O
range NN O
. . O

Sex NN O
, , O
age NN O
or CC O
clinical JJ O
forms NNS O
of IN O
illness NN O
did VBD O
not RB O
influence VB O
the DT O
results NNS O
. . O

In IN O
patients NNS O
receiving VBG O
prednisone NN O
( ( O
Pd NNP O
) ) O
the DT O
GR NNP B-Gene
values NNS O
were VBD O
significantly RB O
lower JJR O
than IN O
in IN O
MG NNP O
patients NNS O
without IN O
Pd NNP O
therapy NN O
, , O
independent JJ O
of IN O
Pd NNP O
dose NN O
or CC O
time NN O
of IN O
administration NN O
. . O

No DT O
differences NNS O
in IN O
receptor NN O
binding NN O
between IN O
normal JJ O
subjects NNS O
and CC O
MG NNP O
patients NNS O
receiving VBG O
Pd NNP O
have VBP O
been VBN O
found VBN O
. . O

Immunological JJ O
interference NN O
of IN O
high JJ O
dose JJ O
corticosteroids NNS O
. . O

High JJ O
- : O
dose JJ O
corticosteroids NNS O
( ( O
HDC NNP O
) ) O
will MD O
influence VB O
cellular JJ O
as RB O
well RB O
as IN O
humoral JJ O
participants NNS O
of IN O
the DT O
immune JJ O
response NN O
. . O

The DT O
lymphoid JJ O
tissue NN O
will MD O
decrease VB O
in IN O
size NN O
and CC O
weight NN O
after IN O
prolonged JJ O
treatment NN O
with IN O
HDC NNP O
. . O

Lymphocyte NNP O
functions NNS O
will MD O
be VB O
impaired VBN O
. . O

Reduced VBN O
synthesis NN O
of IN O
B NNP O
- : O
as RB O
well RB O
as IN O
T NNP O
- : O
lymphocytes NNS O
will MD O
be VB O
seen VBN O
. . O

The DT O
inhibitory JJ O
effect NN O
on IN O
B NNP O
- : O
cell NN O
function NN O
can MD O
be VB O
observed VBN O
both DT O
as IN O
decreased VBN O
serum NN O
levels NNS O
of IN O
immunoglobulins NNS B-Gene
and CC O
as IN O
impaired JJ O
binding NN O
of IN O
antibodies NNS B-Gene
and CC O
complement NN O
to TO O
the DT O
cellular JJ O
surface NN O
. . O

Reduced VBN O
T NNP O
- : O
cell NN O
function NN O
indicated VBN O
by IN O
impaired JJ O
stimulation NN O
by IN O
PHA NNP B-Gene
and CC O
porkweed NN B-Gene
as RB O
well RB O
as IN O
by IN O
impaired JJ O
lymphokinin JJ O
effects NNS O
on IN O
leukocyte JJ O
migration NN O
inhibition NN O
has VBZ O
been VBN O
reported VBN O
. . O

Reduced VBN O
lymphocyte JJ O
adherence NN O
to TO O
antigen VB O
and CC O
suppressed VBN O
lymphocyte JJ O
reaction NN O
have VBP O
also RB O
been VBN O
observed VBN O
. . O

Humoral JJ O
factors NNS O
involved VBN O
in IN O
chemotaxis NN O
, , O
opsonisation NN O
, , O
phagocytosis NN O
, , O
vascular JJ O
permeability NN O
leading VBG O
to TO O
leakage VB O
of IN O
fluid NN O
and CC O
cells NNS O
and CC O
factors NNS O
involved VBN O
in IN O
lysis NN O
of IN O
antigens NNS O
are VBP O
impaired VBN O
. . O

This DT O
can MD O
be VB O
explained VBN O
partly RB O
by IN O
the DT O
observed JJ O
reduced JJ O
complement NN O
activation NN O
via IN O
the DT O
alternative NN O
as RB O
well RB O
as IN O
the DT O
classical JJ O
pathway NN O
in IN O
association NN O
with IN O
HDC NNP O
therapy NN O
. . O

Acute JJ O
processes VBZ O
with IN O
increased JJ O
vascular JJ O
permeability NN O
and CC O
accumulation NN O
of IN O
leukocytes NNS O
as IN O
impairing JJ O
factors NNS O
could MD O
be VB O
influenced VBN O
beneficially RB O
by IN O
HDC NNP O
therapy NN O
. . O

This DT O
positive JJ O
effect NN O
can MD O
be VB O
seen VBN O
in IN O
treatment NN O
of IN O
septic JJ O
shock NN O
or CC O
rejection NN O
of IN O
a DT O
transplant NN O
. . O

However RB O
, , O
if IN O
sepsis NN O
or CC O
rejection NN O
is VBZ O
not RB O
rapidly RB O
reversed VBN O
, , O
complications NNS O
such JJ O
as IN O
multisystem NN O
organ JJ O
failure NN O
and CC O
bacteremia NN O
are VBP O
prone NN O
to TO O
appear VB O
. . O

Identification NN O
of IN O
human JJ B-Gene
leukemic JJ I-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
using VBG O
affinity NN O
labeling NN O
and CC O
anti JJ B-Gene
- : I-Gene
human JJ I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
antibodies NNS I-Gene
. . O

Antisera NNP O
raised VBD O
against IN O
human JJ B-Gene
lymphoid JJ I-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
were VBD O
used VBN O
in IN O
combination NN O
with IN O
the DT O
glucocorticoid NN O
receptor NN O
affinity NN O
label NN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
21 CD O
- : O
mesylate NN O
[ NN O
( ( O
3H CD O
] NNP O
DM NNP O
) ) O
to TO O
identify VB O
the DT O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
of IN O
the DT O
human JJ O
B NNP O
- : O
lymphoblastoid NN O
cell NN O
line NN O
IM NNP O
- : O
9 CD O
and CC O
the DT O
human JJ O
T NNP O
- : O
cell NN O
leukemic JJ O
cell NN O
line NN O
CEM NNP O
- : O
C7 NN O
. . O

Antisera NN O
were VBD O
obtained VBN O
following VBG O
immunization NN O
of IN O
New NNP O
Zealand NNP O
White NNP O
rabbits VBZ O
with IN O
[ JJ B-Gene
3H CD I-Gene
] JJ I-Gene
triamcinolone NN I-Gene
acetonide NN I-Gene
[ NNP I-Gene
( ( I-Gene
3H CD I-Gene
] NNP I-Gene
TA NNP I-Gene
) ) I-Gene
- : I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
complexes NNS I-Gene
partially RB O
purified VBN O
by IN O
two CD O
- : O
stage NN O
DNA NNP O
- : O
cellulose NN O
chromatography NN O
. . O

The DT O
presence NN O
of IN O
anti JJ B-Gene
- : I-Gene
human JJ I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
antibodies NNS I-Gene
was VBD O
verified VBN O
by IN O
: : O
( ( O
a DT O
) ) O
adsorption NN O
of IN O
[ $ B-Gene
3H CD I-Gene
] NNP I-Gene
TA NNP I-Gene
- : I-Gene
receptor NN I-Gene
- : I-Gene
antibody NN I-Gene
complexes NNS I-Gene
to TO O
Protein VB B-Gene
A NNP I-Gene
; : O
( ( O
b NN O
) ) O
a DT O
shift NN O
to TO O
higher JJR O
apparent JJ O
molecular JJ O
weight NN O
in IN O
the DT O
elution NN O
position NN O
from IN O
Sephacryl NNP O
S300 NNP O
of IN O
[ NNP B-Gene
3H CD I-Gene
] NNP I-Gene
TA NNP I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
incubated VBN O
with IN O
immune JJ O
serum NN O
; : O
and CC O
( ( O
c NN O
) ) O
the DT O
ability NN O
of IN O
immune JJ O
serum NN O
to TO O
displace VB O
[ JJ B-Gene
3H CD I-Gene
] NN I-Gene
TA NNP I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
on IN O
sucrose JJ O
gradients NNS O
. . O

These DT O
antibodies NNS B-Gene
also RB O
recognized VBN O
rat NN O
liver NN O
and CC O
murine NN B-Gene
S49 NNP I-Gene
cell NN I-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
. . O

Sodium NNP O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel JJ O
electrophoresis NN O
of IN O
[ $ O
3H CD O
] NNP O
DM NNP O
- : O
labeled VBD O
IM NNP O
- : O
9 CD O
cytosol NN O
identified VBD O
a DT O
major JJ O
competable JJ O
band NN O
with IN O
a DT O
molecular JJ O
weight NN O
of IN O
approximately RB O
90 CD O
, , O
0 CD O
, , O
three CD O
minor JJ O
competable JJ O
components NNS O
with IN O
molecular JJ O
weights NNS O
of IN O
approximately RB O
78 CD O
, , O
0 CD O
, , O
approximately RB O
51 CD O
, , O
0 CD O
, , O
and CC O
approximately RB O
38 CD O
, , O
500 CD O
, , O
and CC O
at IN O
least JJS O
21 CD O
other JJ O
noncompetable JJ O
components NNS O
. . O

Following VBG O
immunoprecipitation NN O
of IN O
[ $ O
3H CD O
] NNP O
DM NNP O
- : O
labeled VBD O
cytosol NN O
with IN O
immune JJ O
serum NN O
, , O
only RB O
the DT O
Mr NNP O
90 CD O
, , O
0 CD O
and CC O
78 CD O
, , O
0 CD O
components NNS O
were VBD O
seen VBN O
. . O

Sodium NNP O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel JJ O
electrophoresis NN O
of IN O
[ $ O
3H CD O
] NNP O
DM NNP O
- : O
labeled VBD O
CEM NNP O
- : O
C7 NNP O
cytosol NN O
revealed VBD O
a DT O
larger JJR O
number NN O
of IN O
[ $ O
3H CD O
] NNP O
DM NNP O
- : O
labeled VBD O
components NNS O
. . O

However RB O
, , O
after IN O
immunoprecipitation NN O
of IN O
[ $ O
3H CD O
] NNP O
DM NNP O
- : O
labeled VBD O
CEM NNP O
- : O
C7 NNP O
cytosol NN O
, , O
a DT O
predominant NN O
competable JJ O
component NN O
with IN O
a DT O
molecular JJ O
weight NN O
of IN O
90 CD O
, , O
0 CD O
was VBD O
easily RB O
identified VBN O
. . O

This DT O
component NN O
was VBD O
markedly RB O
diminished VBN O
when WRB O
cytosols NNS O
from IN O
the DT O
glucocorticoid NN O
receptor NN O
- : O
deficient NN O
cell NN O
line NN O
ICR NNP O
- : O
27 CD O
were VBD O
used VBN O
. . O

Thus RB O
, , O
the DT O
combination NN O
of IN O
affinity NN O
labeling NN O
and CC O
anti JJ B-Gene
- : I-Gene
human JJ I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
antibodies NNS I-Gene
is VBZ O
capable JJ O
of IN O
providing VBG O
direct JJ O
physical JJ O
identification NN O
of IN O
human JJ B-Gene
lymphoid JJ I-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
. . O

Effect NN O
of IN O
thymosin NN O
on IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
activity NN O
and CC O
glucocorticoid JJ O
sensitivity NN O
of IN O
human JJ O
thymocytes NNS O
. . O

Incubation NN O
with IN O
thymosin JJ O
fraction NN O
5 CD O
, , O
( ( O
TMS NNP O
F5 NNP O
at IN O
300 CD O
micrograms NNS O
/ NNP O
ml NN O
) ) O
a DT O
partially RB O
purified JJ O
thymic JJ O
factor NN O
, , O
reduced VBD O
the DT O
steroid JJ O
binding NN O
activity NN O
of IN O
human JJ O
infant NN O
thymocytes NNS O
from IN O
9 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
1 CD O
fmole JJ O
/ NN O
ml NN O
to TO O
5 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
0 CD O
fmole JJ O
/ NN O
ml NN O
. . O

The DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
activity NN O
in IN O
normal JJ O
infant NN O
thymocytes NNS O
was VBD O
found VBN O
to TO O
be VB O
2 CD O
, , O
146 CD O
+ NN O
/ NNP O
- : O
726 CD O
( ( O
s NN O
. . O
d NN O
. . O
) ) O
sites VBZ O
per IN O
cell NN O
with IN O
dissociation NN O
constant NN O
of IN O
1 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
X JJ O
10 CD O
( ( O
- : O
8 CD O
) ) O
M NNP O
. . O

TMS NNP O
F5 NNP O
also RB O
increased VBD O
the DT O
resistance NN O
of IN O
human JJ O
thymocytes NNS O
to TO O
the DT O
cytolytic JJ O
effect NN O
of IN O
dexamethasone NN O
( ( O
2 CD O
. . O
5 CD O
X JJ O
10 CD O
( ( O
- : O
8 CD O
) ) O
M NNP O
) ) O
to TO O
168 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
30 CD O
. . O
2 CD O
% NN O
of IN O
control NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

In IN O
animals NNS O
, , O
medullary JJ O
and CC O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
are VBP O
more RBR O
resistant JJ O
to TO O
glucocorticoids NNS O
than IN O
immature NN O
thymic JJ O
T NNP O
cells NNS O
. . O

The DT O
results NNS O
show VBP O
that IN O
thymosin NN O
can MD O
induce VB O
changes NNS O
consistent JJ O
with IN O
differentiation NN O
in IN O
human JJ O
thymocytes NNS O
. . O

These DT O
in IN O
vitro NN O
results NNS O
are VBP O
consistent JJ O
with IN O
a DT O
physiological JJ O
role NN O
of IN O
thymosin NN O
in IN O
intrathymic JJ O
T NNP O
cell NN O
maturation NN O
in IN O
man NN O
. . O

Incubation NN O
of IN O
a DT O
human JJ O
malignant JJ O
thymus NN O
derived VBD O
T NNP O
cell NN O
line NN O
( ( O
MOLT NNP O
3 CD O
) ) O
with IN O
TMS NNP O
F5 NNP O
also RB O
resulted VBD O
in IN O
a DT O
significant JJ O
reduction NN O
of IN O
the DT O
number NN O
of IN O
steroid JJ O
binding VBG O
sites NNS O
to TO O
44 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
15 CD O
. . O
3 CD O
% NN O
of IN O
control NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
, , O
but CC O
TMS NNP O
F5 NNP O
did VBD O
not RB O
significantly RB O
reduce VB O
the DT O
glucocorticoid JJ O
sensitivity NN O
of IN O
MOLT NNP O
3 CD O
cells NNS O
. . O

Specific JJ B-Gene
high JJ I-Gene
- : I-Gene
affinity NN I-Gene
receptors NNS I-Gene
for IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
in IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
: : O
presence NN O
in IN O
monocytes NNS O
and CC O
induction NN O
in IN O
T NNP O
lymphocytes VBZ O
following VBG O
activation NN O
. . O

Human NNP O
peripheral JJ O
blood NN O
monocytes NNS O
have VBP O
high JJ O
affinity NN O
binding NN O
sites NNS O
for IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
( ( O
Kd NNP O
0 CD O
. . O
14 CD O
nM NN O
, , O
sedimentation NN O
coefficient NN O
3 CD O
. . O
7S CD O
) ) O
. . O

Resting VBG O
human JJ O
peripheral JJ O
blood NN O
T NNP O
lymphocytes VBZ O
, , O
however RB O
, , O
do VBP O
not RB O
have VB O
a DT O
demonstrable JJ O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
- : I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptor NN I-Gene
. . O

After IN O
activation NN O
with IN O
phytohemagglutinin NN B-Gene
the DT O
T NNP O
cells NNS O
exhibit VBP O
the DT O
receptor NN O
within IN O
24 CD O
h NN O
, , O
and CC O
this DT O
expression NN O
is VBZ O
blocked VBN O
by IN O
cycloheximide NN O
. . O

The DT O
receptor NN O
in IN O
activated JJ O
T NNP O
lymphocytes VBZ O
has VBZ O
a DT O
sedimentation NN O
coefficient NN O
of IN O
3 CD O
. . O
7S CD O
and CC O
a DT O
high JJ O
affinity NN O
( ( O
Kd NNP O
0 CD O
. . O
10 CD O
nM NN O
) ) O
for IN O
the DT O
ligand NN O
. . O

Effects NNS O
of IN O
chronic JJ O
glucocorticoid NN O
excess NN O
in IN O
man NN O
on IN O
insulin NN O
binding NN O
to TO O
circulating VBG O
cells NNS O
: : O
differences NNS O
between IN O
endogenous JJ O
and CC O
exogenous JJ O
hypercorticism NN O
. . O

We PRP O
measured VBD O
[ $ O
125I CD O
] NNP O
insulin NN O
binding VBG O
to TO O
circulating VBG O
monocytes NNS O
or CC O
erythrocytes NNS O
from IN O
16 CD O
patients NNS O
with IN O
chronic JJ O
glucocorticoid NN O
excess NN O
, , O
9 CD O
chronically RB O
treated VBN O
with IN O
prednisone NN O
and CC O
7 CD O
with IN O
adrenocortical JJ O
hyperfunction NN O
. . O

With IN O
monocytes NNS O
, , O
[ VBP O
125I CD O
] JJ O
insulin NN O
binding NN O
was VBD O
iincreased VBN O
in IN O
all DT O
patients NNS O
. . O

Analysis NN O
of IN O
binding VBG O
data NNS O
indicated VBD O
that IN O
increased VBD O
binding NN O
in IN O
patients NNS O
treated VBN O
with IN O
prednisone NN O
was VBD O
due JJ O
to TO O
an DT O
ncrease NN O
in IN O
receptor NN O
concentration NN O
, , O
whereas NNS O
in IN O
patients NNS O
with IN O
adrenocortical JJ O
hyperfunction NN O
, , O
it PRP O
was VBD O
due JJ O
to TO O
an DT O
increase NN O
in IN O
receptor NN O
affinity NN O
. . O

With IN O
erythrocytes NNS O
from IN O
patients NNS O
with IN O
adrenocortical JJ O
hyperfunction NN O
there EX O
was VBD O
an DT O
increase NN O
in IN O
receptor NN O
affinity NN O
and CC O
a DT O
decrease NN O
in IN O
receptor NN O
concentration NN O
, , O
so IN O
that IN O
the DT O
binding NN O
of IN O
[ $ O
125I CD O
] NNP O
insulin NN O
was VBD O
normal JJ O
. . O

The DT O
disparity NN O
of IN O
results NNS O
between IN O
endogenous JJ O
and CC O
exogenous JJ O
hypercorticism NN O
, , O
between IN O
the DT O
two CD O
cell NN O
types NNS O
, , O
and CC O
between IN O
the DT O
present JJ O
studies NNS O
and CC O
previous JJ O
studies NNS O
suggest VBP O
that IN O
the DT O
effects NNS O
of IN O
glucocorticoid JJ O
excess NN O
on IN O
the DT O
insulin NN B-Gene
receptor NN I-Gene
are VBP O
extremely RB O
complex JJ O
and CC O
wide JJ O
- : O
ranging NN O
and CC O
that DT O
in IN O
this DT O
condition NN O
, , O
extrapolations NNS O
in IN O
humans NNS O
from IN O
data NNS O
with IN O
circulating VBG O
cells NNS O
to TO O
liver VB O
and CC O
muscle NN O
may MD O
not RB O
be VB O
appropriate JJ O
. . O

Reduced NNP O
level NN O
of IN O
cellular JJ B-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
in IN O
patients NNS O
with IN O
anorexia JJ O
nervosa NN O
. . O

Specific JJ O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
were VBD O
measured VBN O
in IN O
circulating VBG O
mononuclear JJ O
leukocytes NNS O
from IN O
12 CD O
patients NNS O
with IN O
anorexia JJ O
nervosa NNS O
and CC O
21 CD O
healthy JJ O
control NN O
subjects NNS O
. . O

Cells NNS O
from IN O
patients NNS O
were VBD O
found VBN O
to TO O
contain VB O
a DT O
significantly RB O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
lower JJR O
level NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( O
3830 CD O
+ NNP O
/ NNP O
- : O
210 CD O
sites NNS O
/ NNP O
cell NN O
, , O
mean JJ O
+ NNP O
/ NNP O
- : O
SE NN O
) ) O
than IN O
those DT O
from IN O
controls NNS O
( ( O
4930 CD O
+ NNP O
/ NNP O
- : O
250 CD O
sites NNS O
/ NNP O
cell NN O
) ) O
. . O

A DT O
partial JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
defect NN O
may MD O
well RB O
explain VB O
the DT O
abnormal JJ O
cortisol NN O
metabolism NN O
and CC O
glucocorticoid JJ O
resistance NN O
commonly RB O
found VBN O
in IN O
patients NNS O
with IN O
anorexia JJ O
nervosa NN O
. . O

Regulation NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
in IN O
human JJ O
lymphocytes NNS O
. . O

The DT O
presence NN O
of IN O
a DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
in IN O
human JJ O
lymphocytes NNS O
is VBZ O
well RB O
established VBN O
, , O
but CC O
factors NNS O
affecting VBG O
its PRP$ O
regulation NN O
have VBP O
not RB O
been VBN O
described VBN O
. . O

Using VBG O
a DT O
competitive JJ O
binding NN O
whole JJ O
cell NN O
assay RB O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
- : O
dexamethasone NN O
at IN O
24 CD O
and CC O
37 CD O
degrees NNS O
C NNP O
in IN O
untreated JJ O
normal JJ O
subjects NNS O
and CC O
in IN O
healthy JJ O
subjects NNS O
taking VBG O
various JJ O
glucocorticoid JJ O
preparations NNS O
. . O

At IN O
24 CD O
degrees NNS O
C NNP O
normal JJ O
human JJ O
lymphocytes NNS O
had VBD O
6000 CD O
binding VBG O
sites NNS O
/ NNP O
cell NN O
and CC O
a DT O
dissociation NN O
constant NN O
of IN O
4 CD O
x NNS O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
. . O

The DT O
administration NN O
of IN O
1 CD O
mg NN O
of IN O
dexamethasone NN O
, , O
5 CD O
mg NN O
of IN O
prednisone NN O
, , O
and CC O
37 CD O
. . O
5 CD O
mg NN O
of IN O
cortisone NN O
acetate NN O
resulted VBD O
in IN O
a DT O
30 CD O
% NN O
decrease NN O
in IN O
binding VBG O
sites NNS O
after IN O
1 CD O
week NN O
with IN O
no DT O
change NN O
in IN O
binding VBG O
affinity NN O
. . O

No DT O
changes NNS O
in IN O
the DT O
number NN O
of IN O
binding VBG O
sites NNS O
was VBD O
noted VBN O
before IN O
1 CD O
week NN O
and CC O
the DT O
diminished JJ O
number NN O
persisted VBN O
for IN O
1 CD O
week NN O
after IN O
discontinuation NN O
of IN O
glucocorticoid JJ O
treatment NN O
. . O

Lymphocytes NNS O
from IN O
hospitalized JJ O
patients NNS O
taking VBG O
40 CD O
- : O
60 CD O
mg NN O
of IN O
dexamethasone JJ O
daily JJ O
demonstrated VBD O
the DT O
same JJ O
change NN O
in IN O
number NN O
of IN O
binding VBG O
sites NNS O
that WDT O
was VBD O
seen VBN O
in IN O
normal JJ O
subjects NNS O
taking VBG O
1 CD O
mg NN O
of IN O
dexamethasone NN O
. . O

When WRB O
binding VBG O
assays NNS O
were VBD O
carried VBN O
out RP O
at IN O
physiologic JJ O
temperature NN O
there EX O
was VBD O
the DT O
same JJ O
decrease NN O
in IN O
number NN O
of IN O
binding VBG O
sites NNS O
after IN O
dexamethasone NN O
administration NN O
, , O
and CC O
in IN O
addition NN O
, , O
there EX O
was VBD O
a DT O
two CD O
- : O
fold JJ O
increase NN O
in IN O
binding VBG O
affinity NN O
. . O

Glucocorticoid NNP O
administration NN O
results NNS O
in IN O
a DT O
time NN O
- : O
dependent JJ O
decrease NN O
in IN O
the DT O
number NN O
of IN O
lymphocyte JJ O
glucocorticoid NN O
binding VBG O
sites NNS O
that WDT O
is VBZ O
independent JJ O
of IN O
the DT O
type NN O
of IN O
glucocorticoid NN O
administered VBN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
in IN O
vivo JJ O
demonstration NN O
that IN O
glucocorticoids NNS O
modulate VBP O
their PRP$ O
own JJ O
receptors NNS O
in IN O
man NN O
. . O

Immunoglobulin NNP O
localization NN O
in IN O
benign NN O
and CC O
malignant JJ O
lesions NNS O
of IN O
the DT O
human JJ O
mammary JJ O
gland NN O
. . O

Using VBG O
direct JJ O
imunofluorescence NN O
, , O
lesions NNS O
from IN O
266 CD O
human JJ O
breast NN O
specimens NNS O
were VBD O
studied VBN O
for IN O
the DT O
presence NN O
of IN O
IgA NNP O
, , O
IgM NNP O
, , O
or CC O
IgG NNP O
localization NN O
. . O

The DT O
lesions NNS O
included VBD O
benign JJ O
elements NNS O
from IN O
66 CD O
subcutaneous JJ O
mastectomy NN O
specimens NNS O
in IN O
which WDT O
the DT O
absence NN O
of IN O
simultaneous JJ O
breast NN O
malignancy NN O
was VBD O
documented VBN O
, , O
primary JJ O
breast NN O
carcinomas NN O
from IN O
153 CD O
mastectomy NN O
specimens NNS O
, , O
and CC O
47 CD O
biopsies NNS O
containing VBG O
metastatic JJ O
breast NN O
cancer NN O
. . O

A DT O
statistically RB O
significant JJ O
association NN O
of IN O
IgA NNP B-Gene
and CC O
IgM NNP B-Gene
with IN O
benign JJ O
lesions NNS O
was VBD O
contrasted VBN O
to TO O
the DT O
association NN O
of IN O
IgG NNP B-Gene
with IN O
malignant JJ O
lesions NNS O
. . O

In IN O
both DT O
primary JJ O
and CC O
metastatic JJ O
lesions NNS O
, , O
IgG NNP B-Gene
localization NN O
was VBD O
associated VBN O
with IN O
estrogen NN O
- : O
receptor NN O
- : O
poor JJ O
primary JJ O
cancers NNS O
as IN O
compared VBN O
with IN O
estrogen NN O
- : O
receptor NN O
- : O
rich JJ O
primary JJ O
cancers NNS O
. . O

Among IN O
primary JJ O
breast NN O
cancer NN O
patients NNS O
, , O
IgG NNP B-Gene
localization NN O
in IN O
the DT O
tumor NN O
correlated VBD O
with IN O
relative JJ O
lymphopenia NN O
. . O

A DT O
shorter JJR O
disease NN O
- : O
free JJ O
interval NN O
was VBD O
noted VBN O
in IN O
association NN O
with IN O
IgG NNP B-Gene
localization NN O
among IN O
the DT O
metastatic JJ O
breast NN O
lesions NNS O
. . O

No DT O
statistically RB O
significant JJ O
association NN O
between IN O
stage NN O
of IN O
disease NN O
and CC O
immunoglobulin NN O
presence NN O
was VBD O
demonstrable JJ O
. . O

Moderate NNP O
- : O
to TO O
- : O
severe JJ O
intraductal JJ O
epithelial JJ O
hyperplasias NN O
were VBD O
more RBR O
often RB O
associated VBN O
with IN O
immunoglobulin NN B-Gene
G NNP I-Gene
localization NN O
that WDT O
were VBD O
other JJ O
benign JJ O
lesions NNS O

Correlation NN O
of IN O
steroid JJ B-Gene
receptors NNS I-Gene
with IN O
histologic JJ O
differentiation NN O
in IN O
mammary JJ O
carcinoma NN O
. . O

A DT O
Singapore NNP O
experience NN O
. . O

Cancer NN O
of IN O
the DT O
breast NN O
is VBZ O
the DT O
most RBS O
common JJ O
tumor NN O
in IN O
females NNS O
in IN O
Singapore NNP O
, , O
with IN O
the DT O
rate NN O
of IN O
20 CD O
. . O
7 CD O
per IN O
100 CD O
, , O
0 CD O
per IN O
year NN O
( ( O
1977 CD O
estimate NN O
) ) O
, , O
which WDT O
is VBZ O
predicted VBN O
to TO O
increase VB O
to TO O
29 CD O
. . O
8 CD O
per IN O
100 CD O
, , O
0 CD O
women NNS O
per IN O
year NN O
by IN O
1995 CD O
. . O

A DT O
detailed JJ O
histopathologic NN O
review NN O
of IN O
50 CD O
primary JJ O
breast NN O
cancer NN O
tumors NNS O
analyzed VBD O
for IN O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
level NN O
was VBD O
carried VBN O
out RP O
and CC O
a DT O
variety NN O
of IN O
morphologic JJ O
features NNS O
correlated VBN O
with IN O
ER NNP B-Gene
results NNS O
to TO O
identify VB O
any DT O
factors NNS O
that WDT O
will MD O
improve VB O
the DT O
management NN O
and CC O
prognosis NN O
for IN O
breast NN O
cancer NN O
. . O

Cytosol NNP O
was VBD O
incubated VBN O
with IN O
3H CD O
- : O
estradiol NN O
in IN O
the DT O
presence NN O
and CC O
absence NN O
of IN O
cold JJ O
diethylstilbestrol NN O
, , O
and CC O
bound NN O
and CC O
free JJ O
hormone NN O
were VBD O
separated VBN O
by IN O
Dextran NNP O
- : O
coated VBD O
charcoal NN O
method NN O
. . O

Tumors NNS O
binding VBG O
more JJR O
than IN O
5 CD O
fmol JJ O
/ NNP O
mg NN O
cytosol NN B-Gene
protein NN I-Gene
were VBD O
classified VBN O
as IN O
ER NNP B-Gene
- : O
positive JJ O
. . O

Progesterone NN B-Gene
receptor NN I-Gene
( ( O
PR NNP B-Gene
) ) O
level NN O
was VBD O
analyzed VBN O
in IN O
some DT O
specimens NNS O
with IN O
the DT O
use NN O
of IN O
a DT O
similar JJ O
method NN O
. . O

Most JJS O
of IN O
the DT O
patients NNS O
were VBD O
Chinese NNP O
( ( O
90 CD O
% NN O
) ) O
. . O

Three CD O
patients NNS O
were VBD O
Malays NNP O
, , O
one CD O
was VBD O
Indian JJ O
, , O
and CC O
one CD O
was VBD O
European JJ O
in IN O
this DT O
series NN O
. . O

Results NNS O
indicated VBD O
that IN O
there EX O
was VBD O
strong JJ O
correlation NN O
between IN O
ER NNP B-Gene
level NN O
, , O
age NN O
, , O
and CC O
histologic JJ O
grade NN O
of IN O
the DT O
tumors NNS O
. . O

No DT O
correlation NN O
existed VBD O
between IN O
absence NN O
or CC O
presence NN O
of IN O
lymph JJ O
node NN O
metastases NNS O
and CC O
ER NNP B-Gene
. . O

Although IN O
there EX O
was VBD O
a DT O
trend NN O
for IN O
ER NNP B-Gene
- : O
positive JJ O
tumors NNS O
to TO O
have VB O
a DT O
low JJ O
- : O
grade NN O
lymphocytic JJ O
infiltration NN O
, , O
the DT O
difference NN O
was VBD O
not RB O
statistically RB O
significant JJ O
. . O

Mononuclear NNP O
cells NNS O
infiltrating VBG O
human JJ O
mammary JJ O
carcinomas NN O
: : O
immunohistochemical JJ O
analysis NN O
with IN O
monoclonal JJ B-Gene
antibodies NNS I-Gene
. . O

Breast NNP O
carcinomas NN O
were VBD O
examined VBN O
by IN O
the DT O
immunoperoxidase NN O
technique NN O
using VBG O
antisera NN O
specific NN O
for IN O
lymphocyte JJ O
subsets NNS O
, , O
monocytes NNS O
, , O
NK NNP O
cells NNS O
and CC O
major JJ B-Gene
histocompatibility NN I-Gene
antigens NNS I-Gene
( ( O
HLA NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
- : B-Gene
B NN I-Gene
, , O
- : O
C NNP O
; : O
Ia NNP B-Gene
- : I-Gene
like IN I-Gene
) ) O
. . O

Sixty NNP O
- : O
four CD O
per IN O
cent NN O
of IN O
the DT O
patients NNS O
had VBD O
a DT O
moderate JJ O
or CC O
strong JJ O
mononuclear NN O
cell NN O
infiltration NN O
, , O
77 CD O
% NN O
of IN O
the DT O
patients NNS O
without IN O
mononuclear JJ O
cell NN O
infiltration NN O
had VBD O
receptors NNS O
for IN O
estrogens NNS O
as IN O
compared VBN O
to TO O
51 CD O
% NN O
of IN O
the DT O
patients NNS O
with IN O
infiltration NN O
. . O

The DT O
majority NN O
of IN O
the DT O
infiltrating VBG O
mononuclear JJ O
cells NNS O
were VBD O
T NNP O
cells NNS O
; : O
generally RB O
the DT O
OKT8 NNP O
cells NNS O
were VBD O
predominant JJ O
. . O

The DT O
Leu NNP O
3A CD O
/ NNP O
OKT8 NNP O
cell NN O
ratio NN O
was VBD O
not RB O
related VBN O
to TO O
histological JJ O
type NN O
, , O
tumor NN O
size NN O
, , O
age NN O
of IN O
the DT O
patient NN O
or CC O
presence NN O
of IN O
metastases NNS O
. . O

Some DT O
of IN O
the DT O
T NNP O
cells NNS O
had VBD O
the DT O
Ia NNP B-Gene
antigen NN I-Gene
and CC O
were VBD O
thus RB O
probably RB O
activated VBN O
. . O

The DT O
B NNP O
cells NNS O
were VBD O
either RB O
absent JJ O
or CC O
less RBR O
numerous JJ O
than IN O
the DT O
T NNP O
cells NNS O
. . O

There EX O
was VBD O
no DT O
relation NN O
between IN O
their PRP$ O
distribution NN O
and CC O
the DT O
various JJ O
parameters NNS O
studied VBN O
. . O

A DT O
few JJ O
monocytes NNS O
were VBD O
heterogeneous JJ O
according VBG O
to TO O
their PRP$ O
markers NNS O
( ( O
OKM NNP B-Gene
I PRP I-Gene
and CC O
acid VB O
phosphatase NN O
) ) O
. . O

In IN O
6 CD O
cases NNS O
only RB O
there EX O
was VBD O
a DT O
strong JJ O
infiltration NN O
of IN O
mononuclear JJ O
cells NNS O
positive JJ O
for IN O
acid JJ B-Gene
phosphatase NN I-Gene
. . O

The DT O
number NN O
of IN O
the DT O
natural JJ O
killer NN O
cells NNS O
was VBD O
also RB O
low JJ O
. . O

Only RB O
a DT O
few JJ O
mononuclear JJ O
infiltrating VBG O
cells NNS O
had VBD O
receptors NNS O
for IN O
transferrin NN O
. . O

There EX O
was VBD O
a DT O
positive JJ O
correlation NN O
between IN O
the DT O
inflammatory JJ O
infiltration NN O
and CC O
the DT O
presence NN O
of IN O
HLA NNP B-Gene
class NN I-Gene
- : I-Gene
I PRP I-Gene
antigens VBP I-Gene
on IN O
tumor NN O
cell NN O
s NN O
. . O

Some DT O
of IN O
the DT O
antisera NN O
specific NN O
for IN O
lymphocyte JJ O
subsets NNS O
also RB O
stained VBD O
the DT O
breast NN O
carcinoma NN O
cells NNS O
. . O

The DT O
great JJ O
variations NNS O
in IN O
the DT O
subsets NNS O
of IN O
mononuclear JJ O
cells NNS O
in IN O
breast NN O
carcinomas NN O
may MD O
correspond VB O
to TO O
various JJ O
systems NNS O
of IN O
defense NN O
against IN O
neoplasm NN O
. . O

A DT O
case NN O
of IN O
male NN O
pseudohermaphroditis NN O
with IN O
normal JJ O
androgen NN B-Gene
receptor NN I-Gene
binding NN O
and CC O
47 CD O
, , O
XYY NNP O
karyotype NN O
. . O

A DT O
case NN O
of IN O
male NN O
pseudohermaphroditis NN O
with IN O
47 CD O
, , O
XYY NNP O
karyotype NN O
in IN O
blood NN O
and CC O
cutaneous JJ O
fibroblasts NNS O
is VBZ O
described VBN O
. . O

The DT O
plasma NN O
testosterone NN O
response NN O
to TO O
HCG NNP O
stimulation NN O
was VBD O
slightly RB O
below IN O
the DT O
normal JJ O
range NN O
on IN O
two CD O
occasions NNS O
suggesting VBG O
a DT O
deficit NN O
of IN O
gonadal JJ O
function NN O
. . O

A DT O
study NN O
of IN O
the DT O
receptors NNS O
for IN O
dihydrotestosterone NN O
in IN O
fibroblasts NNS O
of IN O
genital NN O
and CC O
nongenital JJ O
skin NN O
showed VBD O
a DT O
normal JJ O
concentration NN O
of IN O
receptors NNS O
in IN O
genital JJ O
skin NN O
; : O
5 CD B-Gene
- : I-Gene
alpha NN I-Gene
- : I-Gene
reductase NN I-Gene
activity NN O
in IN O
fibroblasts NNS O
of IN O
the DT O
genital JJ O
skin NN O
was VBD O
low JJ O
, , O
but CC O
the DT O
plasma NN O
relationship NN O
testosterone NN O
/ NNP O
dihydrotestosterone NN O
under IN O
HCG NNP O
stimulation NN O
was VBD O
normal JJ O
. . O

The DT O
diagnostic JJ O
possibility NN O
of IN O
a DT O
complete JJ O
testicular JJ O
feminization NN O
syndrome NN O
with IN O
normal JJ O
receptors NNS O
for IN O
dihydrotestosterone NN O
is VBZ O
commented VBN O
on IN O
. . O

1 CD O
, , O
25 CD O
- : O
Dihydroxyvitamin NNP O
D3 NNP O
inhibits VBZ O
antigen SYM O
- : O
induced JJ O
T NNP O
cell NN O
activation NN O
. . O

The DT O
proliferative JJ O
response NN O
of IN O
murine NN O
spleen NN O
and CC O
thymus NN O
cells NNS O
to TO O
antigen VB B-Gene
but CC O
not RB O
to TO O
lectin VB B-Gene
was VBD O
inhibited VBN O
by IN O
the DT O
active JJ O
metabolite NN O
of IN O
vitamin NN O
D3 NNP O
, , O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
. . O

To TO O
directly RB O
examine VB O
the DT O
effect NN O
of IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
on IN O
T NNP O
cell NN O
activation NN O
in IN O
the DT O
absence NN O
of IN O
other JJ O
complicating VBG O
interactions NNS O
, , O
we PRP O
utilized VBD O
a DT O
panel NN O
of IN O
cloned VBN O
Ia NNP O
- : O
restricted VBD O
T NNP O
cell NN O
hybridomas NN O
that WDT O
secrete JJ O
IL NNP B-Gene
2 CD I-Gene
on IN O
activation NN O
by IN O
cloned VBN O
Ia NNP O
- : O
bearing NN O
stimulator NN O
cells NNS O
( ( O
TA3 NNP O
) ) O
or CC O
when WRB O
stimulated VBN O
by IN O
mitogen NN O
. . O

Physiologic NNP O
concentrations NNS O
of IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
( ( O
0 CD O
. . O
1 CD O
to TO O
0 CD O
. . O
1 CD O
nm NN O
) ) O
inhibited VBD O
the DT O
antigen NN O
- : O
induced JJ O
secretion NN O
of IN O
IL NNP O
2 CD O
by IN O
several JJ O
of IN O
these DT O
T NNP O
cell NN O
hybridomas NN O
. . O

This DT O
inhibition NN O
was VBD O
dependent JJ O
on IN O
the DT O
concentration NN O
of IN O
the DT O
free JJ O
hormone NN O
and CC O
could MD O
be VB O
overcome VBN O
by IN O
increasing VBG O
the DT O
number NN O
of IN O
Ia NNP O
- : O
bearing NN O
stimulator NN O
cells NNS O
used VBN O
. . O

Pretreatment NN O
of IN O
the DT O
T NNP O
hybridoma NN O
but CC O
not RB O
the DT O
TA3 NNP O
stimulator NN O
cell NN O
with IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
resulted VBN O
in IN O
inhibition NN O
of IN O
activation NN O
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
finding NN O
that WDT O
specific JJ O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
- : I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptors NNS I-Gene
are VBP O
present JJ O
on IN O
the DT O
T NNP O
cell NN O
hybridomas NN O
but CC O
are VBP O
lacking VBG O
in IN O
TA3 NNP O
cells NNS O
. . O

1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
failed VBD O
, , O
however RB O
, , O
to TO O
inhibit VB O
the DT O
activation NN O
of IN O
the DT O
T NNP O
cell NN O
hybridomas NN O
by IN O
lectin NN B-Gene
or CC O
by IN O
an DT O
anti JJ B-Gene
- : I-Gene
Thy NNP I-Gene
- : I-Gene
1 CD I-Gene
antibody NN I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
may MD O
be VB O
interfering VBG O
with IN O
early JJ O
events NNS O
of IN O
antigen NN O
- : O
induced JJ O
T NNP O
cell NN O
activation NN O
, , O
perhaps RB O
by IN O
hindering VBG O
T NNP O
cell NN O
recognition NN O
of IN O
the DT O
relevant JJ O
antigen NN O
on IN O
stimulator NN O
cell NN O
surfaces NNS O
. . O

This DT O
system NN O
should MD O
prove VB O
useful JJ O
in IN O
studying VBG O
the DT O
molecular JJ O
mechanisms NNS O
by IN O
which WDT O
1 CD O
, , O
25 CD O
- : O
( ( O
OH NNP O
) ) O
2D3 CD O
acts NNS O
to TO O
inhibit VB O
T NNP O
cell NN O
activation NN O
and CC O
subsequent JJ O
IL NNP B-Gene
2 CD I-Gene
production NN O
. . O

Glucocorticoid NNP B-Gene
receptors NNS I-Gene
and CC O
steroid JJ O
sensitivity NN O
in IN O
normal JJ O
and CC O
neoplastic JJ O
human JJ O
lymphoid NN O
tissues NNS O
: : O
a DT O
review NN O
. . O

The DT O
determination NN O
of IN O
estrogen NN B-Gene
and CC I-Gene
progesterone NN I-Gene
receptors NNS I-Gene
in IN O
breast NN O
cancer NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
useful JJ O
in IN O
predicting VBG O
the DT O
response NN O
to TO O
endocrine VB O
therapy NN O
. . O

Given VBN O
their PRP$ O
well JJ O
- : O
known VBN O
inhibitory JJ O
effects NNS O
on IN O
lymphoid JJ O
tissue NN O
, , O
glucocorticoids NNS O
have VBP O
been VBN O
used VBN O
widely RB O
in IN O
the DT O
treatment NN O
of IN O
leukemia NN O
. . O

Given VBN O
these DT O
facts NNS O
, , O
over IN O
the DT O
last JJ O
10 CD O
years NNS O
, , O
several JJ O
investigators NNS O
have VBP O
measured VBN O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
normal JJ O
and CC O
neoplastic JJ O
lymphoid NN O
tissue NN O
to TO O
see VB O
whether IN O
their PRP$ O
number NN O
correlated VBN O
with IN O
glucocorticoid JJ O
responsiveness NN O
in IN O
vitro NN O
or CC O
in IN O
vivo NN O
. . O

No DT O
clear JJ O
correlation NN O
could MD O
be VB O
established VBN O
between IN O
the DT O
level NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
and CC O
the DT O
in IN O
vitro JJ O
action NN O
of IN O
steroids NNS O
in IN O
normal JJ O
and CC O
neoplastic JJ O
lymphoid NN O
tissue NN O
. . O

In IN O
contrast NN O
, , O
attempts NNS O
to TO O
correlate VB O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
in IN O
acute JJ O
lymphocytic JJ O
leukemia NN O
to TO O
in IN O
vivo JJ O
steroid JJ O
responsiveness NN O
and CC O
immunological JJ O
type NN O
using VBG O
the DT O
whole JJ O
- : O
cell NN O
- : O
binding NN O
assay NN O
for IN O
receptor NN O
determination NN O
and CC O
selecting VBG O
the DT O
patients NNS O
according VBG O
to TO O
age NN O
and CC O
immunological JJ O
criteria NNS O
have VBP O
been VBN O
more RBR O
successful JJ O
. . O

[ JJ O
Glucocorticoid NNP B-Gene
receptors NNS I-Gene
in IN O
normal JJ O
human JJ O
lymphocytes VBZ O
] NNS O

Glucocorticoid NNP O
( ( O
GC NNP O
) ) O
receptors NNS O
were VBD O
studied VBN O
in IN O
intact JJ O
lymphocytes NNS O
from IN O
11 CD O
donors NNS O
. . O

GC NNP O
binding VBG O
parameters NNS O
were VBD O
found VBN O
to TO O
be VB O
highly RB O
reproducible JJ O
in IN O
repeated JJ O
experiments NNS O
with IN O
lymphocytes NNS O
. . O

It PRP O
was VBD O
shown VBN O
that IN O
GC NNP B-Gene
receptors NNS I-Gene
in IN O
donors NNS O
' POS O
lymphocytes NNS O
could MD O
be VB O
distributed VBN O
into IN O
two CD O
different JJ O
classes NNS O
similarly RB O
to TO O
the DT O
pattern NN O
seen VBN O
in IN O
skin JJ O
fibroblasts NNS O
. . O

Human NNP O
lymphocytes NNS O
are VBP O
an DT O
adequate JJ O
object NN O
for IN O
studying VBG O
genetically RB O
determined VBN O
variability NN O
of IN O
GC NNP B-Gene
receptors NNS I-Gene
and CC O
its PRP$ O
clinical JJ O
importance NN O
. . O

Specific JJ O
estrogen NN B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
human JJ O
lymphoid NN O
cells NNS O
and CC O
thymic JJ O
cells NNS O
. . O

The DT O
binding NN O
of IN O
estrogen NN O
in IN O
preparations NNS O
of IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
, , O
as RB O
well RB O
as IN O
by IN O
splenic JJ O
and CC O
thymic JJ O
cells NNS O
is VBZ O
demonstrated VBN O
by IN O
three CD O
different JJ O
approaches NNS O
( ( O
Dextran NNP O
- : O
coated VBD O
charcoal NN O
method NN O
, , O
whole JJ O
cell NN O
assay NN O
, , O
and CC O
gel JJ O
filtration NN O
on IN O
a DT O
sepharose JJ O
4B CD O
column NN O
) ) O
. . O

Scatchard NNP O
' POS O
s JJ O
analysis NN O
of IN O
[ $ O
3H CD O
] NNP O
- : O
moxestrol NN O
( ( O
R2858 NNP O
) ) O
and CC O
[ $ O
3H CD O
] NNP O
- : O
estradiol NN O
binding VBG O
proves VBZ O
the DT O
existence NN O
of IN O
a DT O
single JJ O
class NN O
of IN O
receptor NN B-Gene
sites NNS I-Gene
having VBG O
a DT O
dissociation NN O
constant NN O
of IN O
0 CD O
. . O
18 CD O
- : O
2 CD O
. . O
4 CD O
X JJ O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
. . O

Physicochemical JJ O
properties NNS O
of IN O
the DT O
binder NN O
, , O
including VBG O
binding VBG O
capacity NN O
and CC O
steroid JJ O
specificity NN O
, , O
are VBP O
quite RB O
similar JJ O
to TO O
those DT O
reported VBN O
for IN O
the DT O
thymus NN O
of IN O
small JJ O
mammalian JJ O
species NNS O
or CC O
human JJ O
thymoma NN O
. . O

Administration NN O
of IN O
fibroblast JJ B-Gene
interferon NN I-Gene
to TO O
patients NNS O
with IN O
advanced JJ O
breast NN O
cancer NN O
: : O
possible JJ O
effects NNS O
on IN O
skin JJ O
metastasis NN O
and CC O
on IN O
hormone NN B-Gene
receptors NNS I-Gene
. . O

Eleven JJ O
patients NNS O
with IN O
metastasized JJ O
breast NN O
cancer NN O
received VBD O
8 CD O
intramuscular JJ O
injections NNS O
of IN O
6 CD O
x NNS O
10 CD O
( ( O
6 CD O
) ) O
units NNS O
of IN O
human JJ B-Gene
fibroblast NN I-Gene
interferon NN I-Gene
over IN O
a DT O
period NN O
of IN O
40 CD O
days NNS O
. . O

The DT O
injections NNS O
did VBD O
not RB O
cause VB O
local JJ O
irritation NN O
or CC O
inflammation NN O
. . O

Fever RB O
occurred VBN O
in IN O
only RB O
1 CD O
of IN O
the DT O
11 CD O
patients NNS O
. . O

Although IN O
several JJ O
types NNS O
of IN O
metastases NNS O
were VBD O
monitored VBN O
, , O
only RB O
skin JJ O
nodules NNS O
consistently RB O
( ( O
10 CD O
out IN O
of IN O
11 CD O
patients NNS O
) ) O
exhibited VBD O
changes NNS O
that WDT O
were VBD O
suggestive JJ O
of IN O
a DT O
therapeutic JJ O
effect NN O
of IN O
the DT O
treatment NN O
regimen NNS O
: : O
either CC O
a DT O
simple JJ O
decrease NN O
in IN O
size NN O
of IN O
some DT O
nodules NNS O
or CC O
central JJ O
necrosis NN O
accompanied VBN O
by IN O
an DT O
inflammatory JJ O
reaction NN O
. . O

NK NNP O
- : O
activity NN O
of IN O
peripheral JJ O
blood NN O
leukocytes NNS O
was VBD O
significantly RB O
increased VBN O
after IN O
administration NN O
of IN O
the DT O
first JJ O
dose NN O
; : O
the DT O
effect NN O
of IN O
subsequent JJ O
injections NNS O
was VBD O
less JJR O
clear JJ O
. . O

Receptors NNS O
for IN O
estrogens NNS O
and CC O
progestogens NNS O
were VBD O
increased VBN O
in IN O
the DT O
tumor NN O
biopsies NNS O
of IN O
2 CD O
out IN O
of IN O
2 CD O
and CC O
5 CD O
out IN O
of IN O
6 CD O
patients NNS O
tested VBN O
respectively RB O
. . O

Decreased VBN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
binding NN O
in IN O
adrenal JJ O
insufficiency NN O
. . O

To TO O
examine VB O
the DT O
effect NN O
of IN O
glucocorticoid JJ O
deficiency NN O
on IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
, , O
we PRP O
examine VBP O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
to TO O
lymphocytes NNS O
in IN O
normal JJ O
subjects NNS O
and CC O
patients NNS O
with IN O
adrenal JJ O
insufficiency NN O
before IN O
and CC O
after IN O
glucocorticoid JJ O
replacement NN O
therapy NN O
. . O

Using VBG O
a DT O
whole JJ O
cell NN O
competitive JJ O
binding NN O
assay NN O
, , O
normal JJ O
human JJ O
lymphocytes NNS O
had VBD O
5977 CD O
+ NNP O
/ NNP O
- : O
1487 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
binding NN O
sites NNS O
/ VBP O
cell NN O
and CC O
a DT O
dissociation NN O
constant NN O
of IN O
10 CD O
+ NNS O
/ SYM O
- : O
2 CD O
nM NN O
. . O

Lymphocytes NNS O
from IN O
patients NNS O
with IN O
untreated JJ O
adrenal JJ O
insufficiency NN O
had VBD O
fewer JJR O
binding NN B-Gene
sites NNS I-Gene
( ( O
3364 CD O
+ NNP O
/ NNP O
- : O
322 CD O
) ) O
and CC O
a DT O
2 CD O
- : O
fold JJ O
increase NN O
in IN O
binding VBG O
affinity NN O
( ( O
5 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
mM NN O
) ) O
. . O

The DT O
administration NN O
of IN O
conventional JJ O
replacement NN O
doses NNS O
of IN O
cortisone NN O
acetate NN O
for IN O
6 CD O
months NNS O
caused VBN O
no DT O
change NN O
in IN O
receptor NN O
number NN O
, , O
but CC O
was VBD O
associated VBN O
with IN O
a DT O
decrease NN O
in IN O
binding VBG O
affinity NN O
toward IN O
normal JJ O
. . O

After IN O
long JJ O
term NN O
glucocorticoid JJ O
replacement NN O
therapy NN O
, , O
binding VBG O
parameters NNS O
were VBD O
similar JJ O
to TO O
those DT O
in IN O
patients NNS O
before IN O
treatment NN O
. . O

The DT O
physiological JJ O
implications NNS O
of IN O
the DT O
decreased JJ O
receptor NN O
number NN O
and CC O
increased VBD O
binding VBG O
affinity NN O
in IN O
adrenal JJ O
insufficiency NN O
remain VBP O
to TO O
be VB O
elucidated VBN O
. . O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
concentrations NNS O
and CC O
terminal JJ O
transferase NN B-Gene
activity NN O
as IN O
indicators NNS O
of IN O
prognosis NN O
in IN O
acute NN O
non SYM O
- : O
lymphocytic JJ O
leukaemia NN O
. . O

Activity NN O
of IN O
terminal JJ B-Gene
deoxynucleotidyl NN I-Gene
transferase NN I-Gene
( ( O
TdT NNP B-Gene
) ) O
, , O
adenosine JJ B-Gene
deaminase NN I-Gene
, , O
and CC O
5 CD B-Gene
' '' I-Gene
nucleotidase NN I-Gene
and CC O
the DT O
cellular JJ O
concentration NN O
of IN O
glucocorticoid NN B-Gene
( ( I-Gene
dexamethasone NN I-Gene
) ) I-Gene
receptor NN I-Gene
were VBD O
determined VBN O
in IN O
25 CD O
patients NNS O
with IN O
acute JJ O
non SYM O
- : O
lymphocytic JJ O
leukaemia NN O
. . O

All DT O
patients NNS O
were VBD O
treated VBN O
according VBG O
to TO O
a DT O
common JJ O
protocol NN O
. . O

Increased VBN O
activity NN O
of IN O
TdT NNP B-Gene
( ( O
greater JJR O
than IN O
0 CD O
. . O
1 CD O
unit NN O
/ JJ O
microgram NNP O
DNA NNP O
) ) O
was VBD O
found VBN O
in IN O
11 CD O
patients NNS O
. . O

This DT O
group NN O
of IN O
patients NNS O
was VBD O
shown VBN O
to TO O
have VB O
higher JJR O
remission NN O
and CC O
survival NN O
rates NNS O
( ( O
p VB O
= RB O
0 CD O
. . O
6 CD O
) ) O
compared VBN O
with IN O
patients NNS O
with IN O
low JJ O
activity NN O
of IN O
TdT NNP O
. . O

The DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
concentration NN O
of IN O
the DT O
leukaemic JJ O
blast NN O
cells NNS O
ranged VBD O
from IN O
0 CD O
to TO O
0 CD O
. . O
94 CD O
fmol JJ O
/ NNP O
microgram NN O
DNA NNP O
. . O

Thirteen JJ O
patients NNS O
had VBD O
blast VBN O
cells NNS O
with IN O
a DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
concentration NN O
over IN O
0 CD O
. . O
22 CD O
fmol JJ O
/ NNP O
microgram NN O
DNA NNP O
. . O

These DT O
patients NNS O
had VBD O
significantly RB O
increased VBN O
remission NN O
and CC O
survival NN O
rates NNS O
( ( O
p VB O
= RB O
0 CD O
. . O
6 CD O
) ) O
compared VBN O
with IN O
those DT O
with IN O
a DT O
low JJ O
receptor NN O
concentration NN O
. . O

This DT O
finding NN O
can MD O
not RB O
be VB O
explained VBN O
by IN O
a DT O
difference NN O
in IN O
sensitivity NN O
to TO O
glucocorticoids NNS O
since IN O
these DT O
were VBD O
not RB O
used VBN O
as IN O
therapeutic JJ O
agents NNS O
. . O

Adenosine NNP B-Gene
deaminase NN I-Gene
and CC O
5 CD B-Gene
' '' I-Gene
nucleotidase NN I-Gene
activities NNS O
both DT O
varied VBN O
within IN O
two CD O
orders NNS O
of IN O
magnitude NN O
. . O

No DT O
correlation NN O
could MD O
be VB O
found VBN O
between IN O
activities NNS O
of IN O
these DT O
enzymes NNS O
and CC O
remission NN O
or CC O
survival JJ O
rate NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
measurements NNS O
of IN O
TdT NNP B-Gene
activity NN O
and CC O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
concentration NN O
yield NN O
valuable JJ O
prognostic JJ O
information NN O
in IN O
acute NN O
non SYM O
- : O
lymphocytic JJ O
leukaemia NN O

[ RB O
3H CD O
] JJ O
cortivazol NN O
: : O
a DT O
unique JJ O
high JJ O
affinity NN O
ligand NN O
for IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
. . O

Cortivazol NNP O
( ( O
CVZ NNP O
) ) O
and CC O
deacylcortivazol NN O
( ( O
DAC NNP O
) ) O
are VBP O
pyrazolosteroids NNS O
with IN O
potent JJ O
glucocorticoid JJ O
activity NN O
. . O

In IN O
previous JJ O
work NN O
we PRP O
showed VBD O
that IN O
DAC NNP O
is VBZ O
40 CD O
- : O
fold NN O
more RBR O
potent JJ O
than IN O
dexamethasone NN O
( ( O
DEX NNP O
) ) O
in IN O
lysing VBG O
leukemic JJ O
lymphoblasts NNS O
. . O

To TO O
assess VB O
the DT O
interaction NN O
between IN O
these DT O
atypical JJ O
steroids NNS O
and CC O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
, , O
we PRP O
examined VBD O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
CVZ NNP O
to TO O
cytosol VB O
from IN O
glucocorticoid JJ O
- : O
sensitive JJ O
and CC O
- : O
resistant JJ O
variants NNS O
of IN O
the DT O
human JJ O
leukemic JJ O
cell NN O
line NN O
CEM NNP O
C7 NNP O
. . O

In IN O
glucocorticoid JJ O
- : O
sensitive JJ O
cells NNS O
[ VBP O
3H CD O
] JJ O
CVZ NNP O
causes VBZ O
a DT O
2 CD O
- : O
fold JJ O
induction NN O
of IN O
glutamine JJ B-Gene
synthetase NN I-Gene
and CC O
binds VBZ O
to TO O
a DT O
protein NN O
in IN O
the DT O
4 CD O
. . O
6 CD O
S JJ O
region NN O
of IN O
high JJ O
salt NN O
sucrose JJ O
gradients NNS O
. . O

On IN O
DEAE NNP O
- : O
cellulose NN O
chromatography NN O
, , O
[ VBZ B-Gene
3H CD I-Gene
] NN I-Gene
CVZ NNP I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
show VBP O
a DT O
shift NN O
from IN O
high JJ O
( ( O
0 CD O
. . O
25 CD O
M NNP O
KP NNP O
) ) O
to TO O
low JJ O
salt NN O
( ( O
0 CD O
. . O
9 CD O
M NNP O
KP NNP O
) ) O
eluting VBG O
forms NNS O
upon IN O
activation NN O
. . O

CVZ NNP O
competes VBZ O
for IN O
a DT O
97 CD O
, , O
0 CD O
- : O
dalton NN O
protein NN O
labeled VBN O
by IN O
[ NN O
3H CD O
] NNP O
dexamethasone NN O
mesylate NN O
. . O

Scatchard NNP O
analysis NN O
of IN O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
CVZ NNP O
in IN O
glucocorticoid JJ O
- : O
sensitive JJ O
cells NNS O
revealed VBD O
a DT O
curvilinear NN O
plot NN O
which WDT O
resolved VBD O
into IN O
high JJ O
( ( O
0 CD O
. . O
4 CD O
nM NN O
) ) O
and CC O
low JJ O
( ( O
11 CD O
nM NN O
) ) O
affinity NN O
components NNS O
. . O

The DT O
receptor NN O
concentration NN O
of IN O
the DT O
low JJ O
affinity NN O
site NN O
( ( O
0 CD O
. . O
30 CD O
pmol JJ O
/ NNP O
mg NNP O
protein NN O
) ) O
was VBD O
approximately RB O
twice JJ O
that IN O
of IN O
the DT O
high JJ B-Gene
affinity NN I-Gene
site NN I-Gene
( ( O
0 CD O
. . O
14 CD O
pmol JJ O
/ NNP O
mg NNP O
protein NN O
) ) O
. . O

Dissociation NN O
experiments NNS O
with IN O
dilution NN O
and CC O
/ NN O
or CC O
excess NN O
unlabeled JJ O
CVZ NNP O
supported VBD O
the DT O
presence NN O
of IN O
independent JJ O
sites NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
DEX NNP O
to TO O
C7 NNP O
cytosol NN O
revealed VBD O
a DT O
single JJ O
class NN O
of IN O
binding VBG O
sites NNS O
( ( O
Kd NNP O
= VBZ O
1 CD O
. . O
9 CD O
nM NN O
; : O
receptor NN O
concentration NN O
, , O
0 CD O
. . O
46 CD O
pmol JJ O
/ NNP O
mg NNP O
protein NN O
) ) O
. . O

Examination NN O
of IN O
the DT O
binding NN O
of IN O
[ $ O
3H CD O
] NNP O
CVZ NNP O
using VBG O
10 CD O
( ( O
- : O
5 CD O
) ) O
M NNP O
DEX NNP O
as IN O
the DT O
competing VBG O
ligand NN O
showed VBD O
that IN O
DEX NNP O
binds VBZ O
only RB O
to TO O
the DT O
low JJ O
affinity NN O
site NN O
detected VBN O
by IN O
[ $ O
3H CD O
] NNP O
CVZ NNP O
. . O

In IN O
cytosol NN O
from IN O
a DT O
glucocorticoid JJ O
- : O
resistant NN O
cell NN O
line NN O
with IN O
virtually RB O
no DT O
[ NN O
3H CD O
] NNP O
DEX NNP O
binding NN O
, , O
[ VBZ O
3H CD O
] NN O
CVZ NNP O
detected VBD O
a DT O
single JJ O
high JJ B-Gene
affinity NN I-Gene
binding VBG I-Gene
site NN I-Gene
that WDT O
was VBD O
similar JJ O
in IN O
dissociation NN O
constant NN O
( ( O
0 CD O
. . O
8 CD O
nM NN O
) ) O
and CC O
receptor NN O
concentration NN O
( ( O
0 CD O
. . O
13 CD O
pmol JJ O
/ NNP O
mg NNP O
protein NN O
) ) O
to TO O
the DT O
high JJ B-Gene
affinity NN I-Gene
site NN I-Gene
detected VBN O
in IN O
the DT O
glucocorticoid JJ O
- : O
sensitive JJ O
cell NN O
line NN O
C7 NNP O
. . O

A DT O
controlled VBN O
pore NN O
glass NN O
bead NN O
assay NN O
for IN O
the DT O
measurement NN O
of IN O
cytoplasmic JJ B-Gene
and CC I-Gene
nuclear JJ I-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
. . O

An DT O
assay NN O
for IN O
the DT O
quantitation NN O
of IN O
cytoplasmic JJ B-Gene
and CC I-Gene
nuclear JJ I-Gene
glucocorticoid NN I-Gene
receptors NNS I-Gene
in IN O
lymphoid JJ O
tissue NN O
has VBZ O
been VBN O
developed VBN O
using VBG O
controlled VBN O
pore NN O
glass NN O
( ( O
CPG NNP O
) ) O
beads NNS O
. . O

Soluble JJ O
receptor NN B-Gene
- : I-Gene
- : I-Gene
3H CD I-Gene
- : I-Gene
steroid NN I-Gene
complex NN I-Gene
( ( O
cytosol NN O
or CC O
nuclear JJ O
extract NN O
) ) O
is VBZ O
adsorbed VBN O
quantitatively RB O
within IN O
the DT O
crevasses NNS O
of IN O
porous JJ O
glass NN O
beads NNS O
. . O

Excess NNP O
labeled VBD O
steroid NN O
as RB O
well RB O
as IN O
most JJS O
non JJ O
- : O
specifically RB O
bound IN O
steroid NN O
is VBZ O
easily RB O
washed VBN O
away RB O
, , O
leaving VBG O
the DT O
hormone NN B-Gene
- : I-Gene
receptor NN I-Gene
complex NN I-Gene
retained VBN O
by IN O
the DT O
beads NNS O
. . O

Bound IN O
3H CD O
- : O
steroid NN O
is VBZ O
eluted VBN O
with IN O
ethanol NN O
and CC O
measured VBN O
for IN O
radioactivity NN O
. . O

This DT O
procedure NN O
which WDT O
is VBZ O
simple JJ O
, , O
rapid JJ O
, , O
and CC O
highly RB O
reproducible JJ O
is VBZ O
carried VBN O
out IN O
using VBG O
frozen JJ O
samples NNS O
( ( O
stable JJ O
for IN O
many JJ O
months NNS O
) ) O
containing VBG O
as RB O
few JJ O
as IN O
1 CD O
X $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
. . O

A DT O
comparison NN O
of IN O
the DT O
CPG NNP O
assay VBP O
to TO O
dextran VB O
coated JJ O
charcoal NN O
and CC O
a DT O
whole JJ O
cell NN O
assay VB O
demonstrates VBZ O
that IN O
CPG NNP O
and CC O
dextran NN O
coated VBD O
charcoal NNS O
give VB O
equivalent JJ O
measurements NNS O
of IN O
cytosolic JJ B-Gene
receptor NN I-Gene
concentration NN O
, , O
while IN O
the DT O
CPG NNP O
and CC O
whole JJ O
cell NN O
assays NNS O
provide VBP O
equivalent JJ O
values NNS O
for IN O
total JJ O
receptor NN O
content NN O
. . O

Plasmacytoid NNP O
blast NN O
crisis NN O
in IN O
B NNP O
- : O
cell NN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
: : O
effect NN O
of IN O
estradiol NN O
on IN O
growth NN O
and CC O
differentiation NN O
in IN O
vitro NN O
. . O

Evolution NN O
of IN O
a DT O
case NN O
of IN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
into IN O
blast NN O
crisis NN O
was VBD O
found VBN O
to TO O
be VB O
characterized VBN O
by IN O
three CD O
unusual JJ O
features NNS O
( ( O
1 CD O
) ) O
the DT O
phenotype NN O
of IN O
the DT O
emerging VBG O
blast NN O
cells NNS O
was VBD O
that IN O
of IN O
pre NN O
- : O
plasmacytoid NN O
cells NNS O
as IN O
shown VBN O
by IN O
plasma NN O
cell NN O
morphology NN O
and CC O
an DT O
immunological JJ O
phenotype NN O
corresponding VBG O
partially RB O
with IN O
CLL NNP O
- : O
or CC O
intermediate VB O
B NNP O
- : O
cells NNS O
, , O
partially RB O
with IN O
plasma NN O
cells NNS O
( ( O
terminal JJ B-Gene
transferase NN I-Gene
- : O
, , O
common JJ O
acute NN B-Gene
lymphocytic JJ I-Gene
leukemia NN I-Gene
antigen NN I-Gene
- : O
, , O
Ia NNP B-Gene
+ NNP I-Gene
, , O
surface NN B-Gene
immunoglobulin NN I-Gene
heavy JJ I-Gene
chains NNS I-Gene
- : O
, , O
surface NN B-Gene
kappa NN I-Gene
light NN I-Gene
chains NNS I-Gene
+ VBP O
, , O
intracytoplasmic JJ B-Gene
immunoglobulin NN I-Gene
A NNP I-Gene
+ NN I-Gene
and CC I-Gene
G NNP I-Gene
+ NNP I-Gene
, , O
BA NNP B-Gene
- : I-Gene
1 CD I-Gene
+ NN I-Gene
, , O
polyclonal JJ O
gammaglobulin NN O
production NN O
) ) O
; : O
( ( O
2 CD O
) ) O
cytogenetic JJ O
analysis NN O
of IN O
spontaneous JJ O
metaphases NNS O
revealed VBD O
that IN O
in IN O
addition NN O
to TO O
the DT O
typical JJ O
CLL NNP O
abnormality NN O
, , O
trisomy JJ O
12 CD O
, , O
in IN O
all DT O
of IN O
the DT O
cells NNS O
, , O
an DT O
additional JJ O
translocation NN O
between IN O
chromosomes NNS B-Gene
14 CD I-Gene
and CC I-Gene
17 CD I-Gene
was VBD O
present JJ O
in IN O
40 CD O
% NN O
with IN O
a DT O
presumptive JJ O
breakpoint NN O
on IN O
chromosome NN B-Gene
14 CD I-Gene
( ( O
q12 SYM O
- : O
3 CD O
) ) O
never RB O
described VBN O
before IN O
( ( O
commonly RB O
q32 RB O
) ) O
and CC O
( ( O
3 CD O
) ) O
the DT O
progression NN O
of IN O
the DT O
disease NN O
was VBD O
associated VBN O
with IN O
a DT O
striking JJ O
increase NN O
in IN O
the DT O
expression NN O
by IN O
the DT O
transformed JJ O
cells NNS O
of IN O
specific JJ O
binding VBG O
sites NNS O
for IN O
estradiol NN O
( ( O
E2 NNP O
) ) O
due RB O
to TO O
an DT O
actual JJ O
increase NN O
in IN O
total JJ O
cellular JJ B-Gene
receptor NN I-Gene
proteins NNS I-Gene
and CC O
not RB O
to TO O
a DT O
change NN O
in IN O
receptor NN O
affinity NN O
for IN O
E2 NNP O
. . O

The DT O
functional JJ O
status NN O
of IN O
the DT O
steroid JJ B-Gene
receptors NNS I-Gene
was VBD O
confirmed VBN O
by IN O
nuclear JJ O
transfer NN O
of IN O
the DT O
cytoplasmic JJ B-Gene
hormone NN I-Gene
- : I-Gene
receptor NN I-Gene
complex JJ I-Gene
upon IN O
temperature NN O
activation NN O
. . O

Since IN O
the DT O
rise NN O
in IN O
E2 NNP B-Gene
- : I-Gene
receptor NN I-Gene
display NN O
paralleled VBD O
a DT O
large JJ O
increase NN O
in IN O
the DT O
proliferative JJ O
activity NN O
of IN O
the DT O
cells NNS O
as RB O
well RB O
as IN O
a DT O
change NN O
in IN O
their PRP$ O
maturation NN O
status NN O
the DT O
question NN O
was VBD O
raised VBN O
as IN O
to TO O
whether IN O
the DT O
E2 NNP B-Gene
- : I-Gene
receptor NN I-Gene
should MD O
be VB O
considered VBN O
as IN O
a DT O
physiological JJ O
marker NN O
of IN O
growth NN O
rate NN O
or CC O
of IN O
cellular JJ O
differentiation NN O
. . O

Exposure NN O
of IN O
the DT O
patient NN O
' POS O
s NN O
blast NN O
cells NNS O
to TO O
E2 NNP O
in IN O
vitro NN O
resulted VBD O
in IN O
cessation NN O
of IN O
cell NN O
growth NN O
following VBG O
at IN O
least JJS O
one CD O
mitosis NN O
after IN O
addition NN O
of IN O
the DT O
inducer NN O
as IN O
seen VBN O
from IN O
the DT O
replacement NN O
of IN O
the DT O
large JJ O
blasts NNS O
by IN O
small JJ O
CLL NNP O
- : O
like IN O
cells NNS O
without IN O
definite JJ O
signs NNS O
of IN O
alteration NN O
of IN O
the DT O
differentiation NN O
status NN O
. . O

This DT O
suggests VBZ O
the DT O
association NN O
of IN O
E2 NNP B-Gene
- : I-Gene
receptor NN I-Gene
expression NN O
with IN O
control NN O
of IN O
growth NN O
rather RB O
than IN O
cell VB O
maturation NN O
. . O

Multiple JJ O
forms NNS O
and CC O
fragments NNS O
of IN O
cytosolic JJ B-Gene
glucocorticoid JJ I-Gene
receptors NNS I-Gene
from IN O
human JJ O
leukemic JJ O
cells NNS O
and CC O
normal JJ O
lymphocytes NNS O
. . O

Therapy NN O
with IN O
glucocorticoids NNS O
is VBZ O
generally RB O
more RBR O
effective JJ O
in IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
than IN O
in IN O
other JJ O
types NNS O
of IN O
human JJ O
leukemia NN O
. . O

Previous JJ O
studies NNS O
, , O
however RB O
, , O
have VBP O
not RB O
revealed VBN O
any DT O
consistent JJ O
relationship NN O
between IN O
clinical JJ O
responsiveness NN O
and CC O
the DT O
cellular JJ O
or CC O
cytosolic JJ O
concentration NN O
of IN O
glucocorticoid JJ B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

The DT O
objectives NNS O
of IN O
this DT O
study NN O
were VBD O
to TO O
determine VB O
whether IN O
there EX O
are VBP O
intrinsic JJ O
structural JJ O
differences NNS O
among IN O
the DT O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
various JJ O
types NNS O
of IN O
leukemic JJ O
cells NNS O
and CC O
normal JJ O
lymphocytes NNS O
and CC O
to TO O
investigate VB O
the DT O
role NN O
of IN O
endogenous JJ B-Gene
peptidases NNS I-Gene
in IN O
receptor NN O
degradation NN O
. . O

Cytosols NNS O
were VBD O
prepared VBN O
from IN O
fresh JJ O
or CC O
rapidly RB O
frozen JJ O
leukocytes NNS O
from IN O
6 CD O
healthy JJ O
adults NNS O
and CC O
35 CD O
high JJ O
- : O
risk NN O
leukemia NN O
patients NNS O
( ( O
median JJ O
white JJ O
blood NN O
cell NN O
count NN O
, , O
150 CD O
, , O
0 CD O
cells NNS O
/ JJ O
microliter NN O
; : O
median JJ O
age NN O
, , O
13 CD O
years NNS O
) ) O
. . O

Receptors NNS O
were VBD O
labeled VBN O
with IN O
[ JJ O
3H CD O
] JJ O
triamcinolone NN O
acetonide NN O
and CC O
quantitated VBN O
by IN O
charcoal NN O
- : O
dextran NN O
treatment NN O
or CC O
Sephadex NNP O
LH NNP O
- : O
20 CD O
chromatography NN O
. . O

Mean NNP O
and CC O
median JJ O
cytosolic NN O
receptor NN O
concentrations NNS O
in IN O
12 CD O
acute JJ O
lymphoblastic JJ O
leukemia NN O
specimens NNS O
lacking VBG O
the DT O
standard NN O
B NNP O
- : O
cell NN O
or CC O
T NNP O
- : O
cell NN O
markers NNS O
( ( O
` `` O
` `` O
null RB O
cells NNS O
' POS O
' POS O
) ) O
were VBD O
approximately RB O
4 CD O
- : O
fold NN O
higher JJR O
than IN O
in IN O
23 CD O
other JJ O
leukemic JJ O
cell NN O
specimens NNS O
. . O

No DT O
other JJ O
consistent JJ O
differences NNS O
in IN O
receptor NN O
content NN O
were VBD O
observed VBN O
. . O

Agarose NNP O
filtration NN O
and CC O
ultracentrifugation NN O
in IN O
hypotonic JJ O
buffers NNS O
containing VBG O
20 CD O
mM JJ O
Na2MoO4 NNP O
revealed VBD O
complexes NNS O
of IN O
similar JJ O
size NN O
and CC O
shape NN O
in IN O
all DT O
clinical JJ O
specimens NNS O
tested VBN O
and CC O
two CD O
established VBN O
leukemic JJ O
cell NN O
lines NNS O
. . O

They PRP O
had VBD O
Stokes NNP O
radii NN O
( ( O
Rs NNP O
) ) O
of IN O
8 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
( ( O
S NNP O
. . O
D NNP O
. . O
) ) O
nm NN O
( ( O
n JJ O
= NNP O
50 CD O
) ) O
, , O
sedimentation JJ O
coefficients NNS O
of IN O
9 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3S CD O
( ( O
n JJ O
= NNP O
40 CD O
) ) O
, , O
molecular JJ O
weights NNS O
of IN O
approximately RB O
330 CD O
, , O
0 CD O
, , O
and CC O
axial JJ O
ratios NNS O
( ( O
a DT O
/ NN O
b NN O
) ) O
of IN O
approximately RB O
12 CD O
. . O

In IN O
hypertonic JJ O
, , O
molybdate JJ O
- : O
free JJ O
buffer NN O
, , O
these DT O
oligomeric JJ B-Gene
complexes NNS I-Gene
were VBD O
dissociated VBN O
into IN O
subunits NNS O
with IN O
Rs NNP O
of IN O
5 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
nm NN O
( ( O
n JJ O
= NNP O
12 CD O
) ) O
and CC O
a DT O
/ NN O
b NN O
of IN O
11 CD O
to TO O
12 CD O
, , O
as IN O
observed VBN O
previously RB O
for IN O
other JJ O
receptors NNS O
. . O

Fragmentation NN O
of IN O
the DT O
oligomer NN B-Gene
and CC O
the DT O
subunit NN B-Gene
was VBD O
evident JJ O
in IN O
some DT O
cytosols NNS O
. . O

High JJ O
activities NNS O
of IN O
peptidases NNS B-Gene
of IN O
various JJ O
specificities NNS O
were VBD O
detected VBN O
in IN O
leukemic JJ O
cell NN O
cytosols NNS O
, , O
as IN O
in IN O
other JJ O
cytosols NNS O
, , O
by IN O
fluorometric JJ O
assays NNS O
with IN O
derivatives NNS O
of IN O
7 CD O
- : O
amino NN O
- : O
4 CD O
- : O
methylcoumarin NN O
. . O

Receptor NNP O
cleavage NN O
by IN O
these DT O
and CC O
other JJ O
endogenous JJ B-Gene
enzymes NNS I-Gene
may MD O
account VB O
for IN O
previous JJ O
observations NNS O
of IN O
` `` O
` `` O
abnormal JJ O
' '' O
' POS O
receptors NNS O
in IN O
cytosols NNS O
from IN O
some DT O
leukemic JJ O
specimens NNS O
. . O

We PRP O
conclude VBP O
that IN O
intrinsic JJ O
structural JJ O
defects NNS O
in IN O
the DT O
receptors NNS O
are VBP O
unlikely JJ O
explanations NNS O
for IN O
the DT O
unresponsiveness NN O
of IN O
some DT O
types NNS O
of IN O
leukemia NN O
to TO O
steroid VB O
therapy NN O
. . O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
number NN O
and CC O
intracellular JJ O
water NN O
space NN O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
relationship NN O
between IN O
cell NN O
water NN O
content NN O
and CC O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
, , O
eleven RB O
normal JJ O
and CC O
malignant JJ O
lymphoid NN O
or CC O
myelomonocytic JJ O
cell NN O
types NNS O
originating VBG O
from IN O
mouse NN O
, , O
rat NN O
and CC O
man NN O
were VBD O
investigated VBN O
. . O

The DT O
cellular JJ O
water NN O
space NN O
was VBD O
measured VBN O
with IN O
3H2O CD O
, , O
and CC O
glucocorticoid JJ B-Gene
receptor NN I-Gene
number NN O
was VBD O
measured VBN O
in IN O
a DT O
whole JJ O
- : O
cell NN O
binding VBG O
assay NN O
with IN O
[ JJ O
3H CD O
] JJ O
dexamethasone NN O
at IN O
30 CD O
and CC O
37 CD O
degrees NNS O
C NNP O
. . O

The DT O
intracellular JJ O
water NN O
phase NN O
concentration NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
around IN O
40 CD O
nmol JJ O
/ NNP O
l NN O
cell NN O
water NN O
) ) O
, , O
and CC O
the DT O
dependence NN O
of IN O
receptor NN O
affinity NN O
on IN O
temperature NN O
were VBD O
similar JJ O
in IN O
normal JJ O
and CC O
malignant JJ O
rodent NN O
and CC O
human JJ O
cells NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
comparisons NNS O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
are VBP O
best RB O
made VBN O
on IN O
the DT O
basis NN O
of IN O
intracellular JJ B-Gene
receptor NN I-Gene
concentrations NNS O
. . O

Covalent NNP O
labeling NN O
of IN O
rat NN O
thymocyte NN O
and CC O
human JJ B-Gene
lymphoid NN I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
. . O

Lymphoid NNP O
cells NNS O
contain VBP O
specific JJ O
receptors NNS B-Gene
for IN O
glucocorticoids NNS O
. . O

We PRP O
have VBP O
used VBN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
- : O
21 CD O
- : O
mesylate NN O
to TO O
label VB O
covalently RB O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
rat NN O
thymic JJ O
lymphocytes NNS O
and CC O
in IN O
neoplastic JJ O
cells NNS O
obtained VBN O
from IN O
patients NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
and CC O
malignant JJ O
lymphoma NN O
. . O

The DT O
covalently RB O
labeled VBN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
were VBD O
identified VBN O
by IN O
polyacrylamide JJ O
gel NN O
electrophoresis NN O
( ( O
in IN O
the DT O
presence NN O
of IN O
0 CD O
. . O
1 CD O
% NN O
sodium NN O
dodecyl NN O
sulfate NN O
) ) O
. . O

In IN O
cytosolic JJ O
fractions NNS O
prepared VBD O
from IN O
rat NN O
thymic JJ O
lymphocytes NNS O
, , O
[ VBP O
3H CD O
] SYM O
- : O
dexamethasone NN O
- : O
21 CD O
- : O
mesylate NN O
labels NNS O
a DT O
protein NN O
( ( O
Mr NNP O
approximately RB O
equal JJ O
to TO O
95 CD O
, , O
0 CD O
) ) O
which WDT O
was VBD O
identified VBN O
as IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
by IN O
the DT O
following JJ O
criteria NNS O
: : O
( ( O
a DT O
) ) O
labeling NN O
of IN O
this DT O
moiety NN O
is VBZ O
inhibited VBN O
by IN O
treatment NN O
with IN O
a DT O
100 CD O
- : O
fold NN O
molar JJ O
excess NN O
of IN O
glucocorticoids NNS O
, , O
such JJ O
as IN O
dexamethasone NN O
and CC O
triamcinolone NN O
acetonide NN O
; : O
and CC O
( ( O
b NN O
) ) O
the DT O
covalently RB O
labeled VBN O
Mr NNP O
approximately RB O
equal JJ O
to TO O
95 CD O
, , O
0 CD O
protein NN O
is VBZ O
activated VBN O
( ( O
by IN O
heating VBG O
at IN O
20 CD O
degrees NNS O
for IN O
30 CD O
min NN O
) ) O
to TO O
a DT O
form NN O
that WDT O
binds VBZ O
to TO O
DNA VB O
- : O
cellulose NN O
. . O

When WRB O
intact JJ O
thymocytes NNS O
are VBP O
treated VBN O
with IN O
[ JJ O
3H CD O
] NN O
dexamethasone NN O
- : O
21 CD O
- : O
mesylate NN O
, , O
an DT O
Mr NNP O
approximately RB O
equal JJ O
to TO O
95 CD O
, , O
0 CD O
moiety NN O
is VBZ O
also RB O
labeled VBN O
covalently RB O
. . O

Approximately RB O
35 CD O
% NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
can MD O
be VB O
labeled VBN O
covalently RB O
when WRB O
intact JJ O
thymocytes NNS O
are VBP O
treated VBN O
with IN O
100 CD O
nM NNS O
[ VBD O
3H CD O
] NNP O
dexamethasone NN O
- : O
21 CD O
- : O
mesylate NN O
for IN O
30 CD O
min NN O
at IN O
4 CD O
degrees NNS O
. . O

Neoplastic JJ O
cells NNS O
from IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
and CC O
malignant JJ O
lymphoma NN O
were VBD O
treated VBN O
with IN O
[ JJ O
3H CD O
] NN O
dexamethasone NN O
- : O
21 CD O
- : O
mesylate NN O
. . O

In IN O
all DT O
samples NNS O
, , O
an DT O
Mr NNP O
approximately RB O
equal JJ O
to TO O
95 CD O
, , O
0 CD O
moiety NN O
was VBD O
labeled VBN O
covalently RB O
; : O
labeling VBG O
was VBD O
inhibited VBN O
by IN O
excess JJ O
glucocorticoid NN O
. . O

Smaller NN B-Gene
moieties NNS I-Gene
were VBD O
also RB O
identified VBN O
by IN O
competition NN O
experiments NNS O
; : O
these DT O
may MD O
represent VB O
proteolytic JJ B-Gene
fragments NNS I-Gene
of IN O
the DT O
Mr NNP O
approximately RB O
equal JJ O
to TO O
95 CD O
, , O
0 CD O
receptor NN O
. . O

Thus RB O
, , O
in IN O
rat NN O
and CC O
human JJ O
lymphoid NN O
cells NNS O
, , O
[ VBZ O
3H CD O
] NN O
dexamethasone NN O
- : O
21 CD O
- : O
mesylate NN O
can MD O
be VB O
used VBN O
to TO O
label VB O
covalently RB O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
. . O

The DT O
association NN O
of IN O
cytosol NN O
oestrogen NN B-Gene
and CC I-Gene
progesterone NN I-Gene
receptors NNS I-Gene
with IN O
histological JJ O
features NNS O
of IN O
breast NN O
cancer NN O
and CC O
early JJ O
recurrence NN O
of IN O
disease NN O
. . O

Two CD O
hundred CD O
and CC O
eighty VB O
- : O
eight CD O
primary JJ O
breast NN O
tumours NNS O
were VBD O
examined VBN O
for IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
oestrogen NN B-Gene
( ( I-Gene
REc NNP I-Gene
) ) I-Gene
and CC I-Gene
progesterone NN I-Gene
( ( I-Gene
RPc NNP I-Gene
) ) I-Gene
receptors NNS I-Gene
. . O

Analysis NN O
has VBZ O
shown VBN O
a DT O
relative JJ O
interdependence NN O
between IN O
the DT O
steroid JJ B-Gene
receptor NN I-Gene
status NN O
of IN O
primary JJ O
breast NN O
cancer NN O
and CC O
other JJ O
prognostic JJ O
variables NNS O
such JJ O
as IN O
histological JJ O
grade NN O
, , O
lymphocytic JJ O
infiltration NN O
and CC O
tumour JJ O
elastosis NN O
. . O

There EX O
were VBD O
significant JJ O
associations NNS O
between IN O
epithelial JJ O
cellularity NN O
, , O
stromal JJ O
fibrosis NN O
and CC O
the DT O
value NN O
of IN O
REc NNP B-Gene
in IN O
those DT O
tumours NNS O
in IN O
which WDT O
the DT O
receptor NN O
was VBD O
present JJ O
. . O

Cellularity NN O
and CC O
fibrosis NN O
were VBD O
unrelated JJ O
to TO O
the DT O
presence NN O
or CC O
absence NN O
of IN O
oestrogen NN B-Gene
receptor NN I-Gene
. . O

By IN O
contrast NN O
, , O
neither CC O
the DT O
presence NN O
or CC O
absence NN O
nor CC O
the DT O
value NN O
of IN O
RPc NNP B-Gene
could MD O
be VB O
related VBN O
to TO O
cellularity NN O
or CC O
fibrosis NN O
. . O

The DT O
value NN O
of IN O
REc NNP B-Gene
and CC O
RPc NNP B-Gene
analysis NN O
as IN O
an DT O
indicator NN O
of IN O
prognosis NN O
was VBD O
examined VBN O
in IN O
a DT O
sub JJ O
- : O
group NN O
of IN O
175 CD O
patients NNS O
receiving VBG O
no DT O
additional JJ O
treatment NN O
following VBG O
mastectomy NN O
. . O

Overall JJ O
relapse NN O
- : O
free JJ O
survival NN O
( ( O
RFS NNP O
) ) O
was VBD O
no DT O
different JJ O
for IN O
those DT O
patients NNS O
with IN O
receptors NNS O
compared VBN O
to TO O
those DT O
without IN O
them PRP O
( ( O
REc NNP B-Gene
P NNP O
= VBD O
0 CD O
. . O
11 CD O
, , O
RPc NNP O
P NNP O
= VBD O
0 CD O
. . O
7 CD O
) ) O
. . O

There EX O
was VBD O
no DT O
difference NN O
in IN O
RFS NNP O
of IN O
receptor NN O
positive JJ O
and CC O
negative JJ O
tumours NNS O
when WRB O
the DT O
axillary JJ O
node NN O
status NN O
was VBD O
taken VBN O
into IN O
account NN O
. . O

Clinical JJ O
implications NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
human JJ O
leukemia NN O
. . O

Normal NNP O
lymphoid JJ O
cells NNS O
contain VBP O
glucocorticoid JJ B-Gene
receptor NN I-Gene
. . O

A DT O
variety NN O
of IN O
stimuli NNS O
that WDT O
activate VBP O
these DT O
cells NNS O
also RB O
induce VBP O
increases NNS O
in IN O
receptor NN O
concentration NN O
. . O

Similar JJ O
glucocorticoid NN B-Gene
receptors NNS I-Gene
can MD O
be VB O
detected VBN O
in IN O
lymphoid JJ O
cells NNS O
from IN O
patients NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
( ( O
ALL DT O
) ) O
. . O

Absence NN O
of IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
( ( O
usually RB O
found VBN O
in IN O
treated JJ O
patients NNS O
) ) O
predicts VBZ O
lack NN O
of IN O
glucocorticoid JJ O
responsiveness NN O
. . O

Furthermore RB O
, , O
in IN O
our PRP$ O
hands NNS O
, , O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
correlate VBP O
with IN O
the DT O
duration NN O
of IN O
complete JJ O
remission NN O
in IN O
ALL NNP O
( ( O
though IN O
not RB O
in IN O
other JJ O
forms NNS O
of IN O
leukemia NN O
) ) O
. . O

This DT O
association NN O
is VBZ O
independent JJ O
of IN O
cell NN O
type NN O
, , O
age NN O
, , O
sex NN O
, , O
or CC O
initial JJ O
leukocyte NN O
count NN O
. . O

The DT O
level NN O
of IN O
receptor NN O
shows VBZ O
a DT O
negative JJ O
correlation NN O
with IN O
increasing VBG O
aggressiveness NN O
of IN O
the DT O
tumor NN O
( ( O
null JJ O
- : O
cell NN O
leukemia VBZ O
greater JJR O
than IN O
T NNP O
- : O
cell NN O
leukemia VBZ O
greater JJR O
than IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
) ) O
. . O

Corticosteroid NNP O
- : O
mediated VBN O
immunoregulation NN O
in IN O
man NN O
. . O

Glucocorticoids NNS O
have VBP O
profound VBN O
and CC O
complex JJ O
effects NNS O
on IN O
the DT O
human JJ O
immune JJ O
response NN O
. . O

However RB O
, , O
the DT O
precise JJ O
mechanisms NN O
of IN O
the DT O
corticosteroid JJ O
- : O
induced JJ O
immunoregulation NN O
in IN O
man NN O
have VBP O
not RB O
been VBN O
precisely RB O
defined VBN O
. . O

Intracytoplasmic NNP B-Gene
corticosteroid NN I-Gene
- : I-Gene
specific JJ I-Gene
receptors NNS I-Gene
appear VBP O
to TO O
be VB O
an DT O
important JJ O
common JJ O
pathway NN O
for IN O
steroid JJ O
- : O
induced JJ O
changes NNS O
, , O
but CC O
variations NNS O
of IN O
receptor NN O
parameters NNS O
do VBP O
not RB O
account VB O
for IN O
the DT O
multifaceted JJ O
effects NNS O
on IN O
the DT O
immune NN O
system NN O
. . O

Human NNP O
circulating VBG O
mononuclear JJ O
cells NNS O
redistribute VBP O
out IN O
of IN O
the DT O
intravascular JJ O
compartment NN O
following VBG O
treatment NN O
with IN O
corticosteroids NNS O
. . O

Although IN O
certain JJ O
components NNS O
at IN O
this DT O
redistribution NN O
phenomenon NN O
have VBP O
been VBN O
well RB O
- : O
characterized VBN O
, , O
the DT O
importance NN O
of IN O
this DT O
compartmental JJ O
cellular JJ O
shift NN O
with IN O
respect NN O
to TO O
the DT O
mechanisms NN O
of IN O
corticosteroid JJ O
- : O
induced JJ O
immunoregulation NN O
are VBP O
less RBR O
well RB O
- : O
defined VBN O
. . O

Recent JJ O
observations NNS O
that WDT O
activated VBD O
lymphocytes NNS O
may MD O
be VB O
sensitive JJ O
to TO O
the DT O
lytic JJ O
effects NNS O
of IN O
glucocorticoids NNS O
suggest VBP O
that IN O
under IN O
certain JJ O
situations NNS O
the DT O
elimination NN O
of IN O
selected VBN O
subsets NNS O
of IN O
cells NNS O
may MD O
be VB O
a DT O
relevant JJ O
mechanism NN O
of IN O
corticosteroid JJ O
- : O
mediated VBN O
immunoregulation NN O
in IN O
man NN O
. . O

Corticosteroid NNP O
- : O
mediated JJ O
effects NNS O
on IN O
monocyte NN O
function NN O
may MD O
be VB O
an DT O
important JJ O
mechanism NN O
of IN O
drug NN O
- : O
induced JJ O
immunoregulation NN O
in IN O
monocyte JJ O
- : O
dependent JJ O
responses NNS O
. . O

In IN O
some DT O
experimental JJ O
conditions NNS O
, , O
corticosteroids NNS O
inhibit VBP O
Interleukin JJ B-Gene
1 CD I-Gene
production NN O
by IN O
monocytes NNS O
. . O

The DT O
immunoregulatory JJ O
effects NNS O
of IN O
corticosteroids NNS O
on IN O
lymphocyte NN O
immune NN O
responses NNS O
are VBP O
complex JJ O
. . O

In IN O
vitro JJ O
corticosteroids NNS O
appear VBP O
to TO O
selectively RB O
affect VB O
early JJ O
immunoregulatory NN O
events NNS O
as IN O
opposed VBN O
to TO O
altering VBG O
an DT O
established VBN O
response NN O
. . O

Multiple NNP O
sites NNS O
of IN O
steroid JJ O
- : O
induced JJ O
modulations NNS O
of IN O
human JJ O
B NNP O
cell NN O
responses NNS O
have VBP O
been VBN O
defined VBN O
. . O

Human NNP O
lymphoid NN O
cell NN O
lines NNS O
and CC O
glucocorticoids NNS O
: : O
II NNP O
. . O

Whole NNP O
cell NN O
and CC O
cytoplasmic JJ O
binding NN O
properties NNS O
of IN O
lymphoblastoid NN O
, , O
leukaemia NN O
and CC O
lymphoma NN O
lines NNS O
. . O

The DT O
glucocorticoid NN O
binding VBG O
properties NNS O
of IN O
18 CD O
human JJ O
lymphoid NN O
cell NN O
lines NNS O
( ( O
HLCL NNP O
) ) O
have VBP O
been VBN O
investigated VBN O
. . O

The DT O
specificity NN O
of IN O
steroid JJ O
binding NN O
was VBD O
confirmed VBN O
with IN O
various JJ O
glucocorticoid JJ O
agonists NNS O
and CC O
antagonists NNS O
. . O

A DT O
gradation NN O
in IN O
whole JJ O
cell NN O
and CC O
cytoplasmic JJ O
glucocorticoid NN O
binding VBG O
capacity NN O
was VBD O
observed VBN O
in IN O
the DT O
different JJ O
cell NN O
line NN O
types NNS O
: : O
lymphoblastoid NN O
greater JJR O
than IN O
lymphoma JJR O
greater JJR O
than IN O
leukaemia NN O
. . O

The DT O
cytoplasmic JJ B-Gene
receptors NNS I-Gene
of IN O
leukaemia NN O
and CC O
lymphoblastoid JJ O
lines NNS O
appeared VBD O
to TO O
contain VB O
both DT O
proteinaceous JJ O
and CC O
phospholipid JJ O
components NNS O
. . O

Cytoplasmic NNP B-Gene
steroid SYM I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
exhibited VBD O
a DT O
wide JJ O
range NN O
of IN O
sedimentation NN O
coefficients NNS O
( ( O
8 CD O
. . O
5 CD O
- : O
11 CD O
. . O
3S CD O
) ) O
in IN O
low JJ O
ionic JJ O
strength NN O
buffer NN O
but CC O
there EX O
was VBD O
no DT O
correlation NN O
with IN O
cell NN O
line NN O
type NN O
or CC O
glucocorticoid JJ O
sensitivity NN O
. . O

Activation NN O
of IN O
these DT O
complexes NNS O
by IN O
heat NN O
( ( O
37 CD O
degrees NNS O
C NNP O
) ) O
or CC O
exposure NN O
to TO O
high VB O
ionic JJ O
strength NN O
buffer NN O
( ( O
0 CD O
. . O
3 CD O
M NNP O
NaCl NNP O
) ) O
induced VBD O
nuclear JJ O
binding NN O
of IN O
steroid NN O
but CC O
only RB O
complexes NNS O
in IN O
high JJ O
ionic JJ O
strength NN O
buffer NN O
manifested VBD O
changes NNS O
in IN O
sedimentation NN O
coefficient NN O
. . O

No DT O
correlation NN O
was VBD O
observed VBN O
between IN O
the DT O
level NN O
or CC O
nature NN O
of IN O
glucocorticoid NN O
binding NN O
and CC O
the DT O
cytolethal NN O
or CC O
cytostatic JJ O
responsiveness NN O
of IN O
HLCL NNP O
to TO O
glucocorticoid VB O
treatment NN O
in IN O
vitro NN O
. . O

The DT O
resistance NN O
to TO O
cytolethal VB O
effects NNS O
can MD O
not RB O
be VB O
ascribed VBN O
to TO O
a DT O
failure NN O
of IN O
cells NNS O
to TO O
take VB O
up RP O
and CC O
bind VB O
steroid NN O
or CC O
to TO O
significant JJ O
differences NNS O
in IN O
the DT O
molecular JJ O
species NNS O
of IN O
cytoplasmic JJ B-Gene
receptors NNS I-Gene
present JJ O
. . O

The DT O
molecular JJ O
mechanisms NNS O
by IN O
which WDT O
glucocorticoids NNS O
achieve VBP O
cytolethal JJ O
responses NNS O
in IN O
human JJ O
lymphoid NN O
cells NNS O

CD28 NNP B-Gene
- : O
mediated VBN O
activation NN O
in IN O
CD45RA NNP O
+ NNP O
and CC O
CD45RO NNP O
+ NNP O
T NNP O
cells NNS O
: : O
enhanced JJ O
levels NNS O
of IN O
reactive JJ O
oxygen NN O
intermediates NNS O
and CC O
c SYM B-Gene
- : I-Gene
Rel JJ I-Gene
nuclear JJ O
translocation NN O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
effect NN O
of IN O
complete JJ O
T NNP O
cell NN O
activation NN O
( ( O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
plus CC O
anti JJ B-Gene
- : I-Gene
CD28 NN I-Gene
) ) O
on IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
CD45RA NNP O
+ NNP O
( ( O
naive JJ O
) ) O
and CC O
CD45RO NNP O
+ NNP O
( ( O
memory NN O
/ NNP O
effector NN O
) ) O
T NNP O
cells NNS O
. . O

Long JJ O
exposure NN O
( ( O
24 CD O
h NN O
) ) O
induced VBD O
stronger JJR O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NN O
binding NN O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
than IN O
in IN O
CD45RO NNP O
+ NNP O
cells NNS O
. . O

Analysis NN O
of IN O
the DT O
nuclear JJ B-Gene
c SYM I-Gene
- : I-Gene
Rel NNP I-Gene
protein NN I-Gene
indicated VBD O
that IN O
after IN O
anti JJ O
- : O
CD3 NNP O
+ NNP O
anti SYM O
- : O
CD28 NNP O
stimulation NN O
the DT O
level NN O
of IN O
c JJ B-Gene
- : I-Gene
Rel NN I-Gene
was VBD O
higher RBR O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
. . O

Analysis NN O
of IN O
the DT O
cytoplasmic JJ O
inhibitor NN O
IkappaBalpha NNP B-Gene
indicated VBD O
that IN O
anti SYM O
- : O
CD3 NNP O
+ NNP O
anti SYM O
- : O
CD28 NNP O
stimulation NN O
induced VBD O
a DT O
long JJ O
- : O
lasting VBG O
degradation NN O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
but CC O
in IN O
CD45RO NNP O
+ NNP O
cells NNS O
the DT O
degradation NN O
process NN O
was VBD O
more RBR O
rapid JJ O
. . O

Because IN O
the DT O
CD28 NNP O
costimulus NN O
is VBZ O
known VBN O
to TO O
induce VB O
the DT O
production NN O
of IN O
reactive JJ O
oxygen NN O
intermediates NNS O
( ( O
ROIs NNP O
) ) O
, , O
the DT O
intracellular JJ O
ROI NNP O
levels NNS O
in IN O
CD45RA NNP O
+ NNP O
and CC O
CD45RO NNP O
+ NNP O
cells NNS O
were VBD O
compared VBN O
by IN O
flow JJ O
cytometry NN O
. . O

ROIs NNP O
were VBD O
produced VBN O
in IN O
both DT O
cell NN O
types NNS O
, , O
but CC O
more JJR O
strongly RB O
in IN O
CD45RA NNP O
+ NNP O
cells NNS O
. . O

The DT O
data NN O
presented VBN O
in IN O
this DT O
study NN O
further RB O
emphasize VB O
the DT O
differences NNS O
between IN O
CD45RA NNP O
+ NNP O
and CC O
CD45RO NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
in IN O
ROI NNP O
- : O
dependent NN O
signaling VBG O
pathways NNS O
. . O

Ikaros NNS B-Gene
in IN O
hemopoietic JJ O
lineage NN O
determination NN O
and CC O
homeostasis NN O
. . O

Studies NNS O
on IN O
the DT O
molecular JJ O
mechanisms NNS O
that WDT O
control VBP O
hemopoietic JJ O
differentiation NN O
have VBP O
focused VBN O
on IN O
signaling VBG O
cascades NNS O
and CC O
nuclear JJ O
effectors NNS O
that WDT O
drive VBP O
this DT O
complex JJ O
developmental NN O
system NN O
in IN O
a DT O
regulated JJ O
fashion NN O
. . O

Here RB O
we PRP O
review VBP O
the DT O
role NN O
of IN O
Ikaros NNP B-Gene
, , O
the DT O
founding JJ O
member NN O
of IN O
a DT O
unique JJ O
family NN O
of IN O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
this DT O
developmental JJ O
process NN O
. . O

Studies NNS O
on IN O
an DT O
Ikaros NNP B-Gene
null NN O
mutation NN O
have VBP O
revealed VBN O
an DT O
essential JJ O
role NN O
for IN O
this DT O
factor NN O
in IN O
lymphoid NN O
cell NN O
fate NN O
determination NN O
and CC O
at IN O
subsequent JJ O
branch NN O
points NNS O
of IN O
the DT O
T NNP O
cell NN O
differentiation NN O
pathway NN O
. . O

Differences NNS O
in IN O
the DT O
phenotypes NNS O
of IN O
a DT O
null NN O
and CC O
a DT O
dominant JJ O
negative JJ O
( ( O
DN NNP O
) ) O
Ikaros NNP O
mutation NN O
provide NN O
insight VBD O
into IN O
a DT O
regulatory JJ O
network NN O
through IN O
which WDT O
Ikaros NNP B-Gene
proteins VBZ I-Gene
exert VB O
their PRP$ O
effects NNS O
in IN O
development NN O
. . O

In IN O
addition NN O
a DT O
comparative JJ O
analysis NN O
of IN O
the DT O
hemopoietic JJ O
stem NN O
cell NN O
and CC O
precursor NN O
compartment NN O
resulting VBG O
from IN O
the DT O
two CD O
Ikaros NNP B-Gene
mutations NNS O
reveals VBZ O
a DT O
profound NN O
yet RB O
not RB O
absolute JJ O
requirement NN O
for IN O
Ikaros NNP B-Gene
in IN O
the DT O
production NN O
and CC O
differentiation NN O
of IN O
these DT O
populations NNS O
. . O

Overexpression NN O
of IN O
p65 NN O
and CC O
c SYM O
- : O
Jun NN O
substitutes NNS O
for IN O
B7 NNP O
- : O
1 CD O
costimulation NN O
by IN O
targeting VBG O
the DT O
CD28RE NNP B-Gene
within IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

The DT O
role NN O
of IN O
Rel NNP B-Gene
and CC O
activation NN B-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
B7 NNP O
- : O
1 CD O
- : O
and CC O
leukocyte JJ O
function NN O
- : O
associated VBN O
Ag NNP O
- : O
3 CD O
( ( O
LFA NNP O
. . O
3 CD O
) ) O
- : O
costimulated VBN O
T NNP O
cells NNS O
has VBZ O
been VBN O
evaluated VBN O
. . O

We PRP O
demonstrate VBP O
that DT O
overexpression NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
but CC O
not RB O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
increases NNS O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
both DT O
B7 NNP O
- : O
1 CD O
- : O
and CC O
LFA NNP O
- : O
3 CD O
- : O
costimulated VBN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Cotransfection NN O
of IN O
both DT O
c SYM O
- : O
Jun NN O
and CC O
c SYM O
- : O
Fos NN O
substitutes NNS O
for IN O
B7 NNP O
- : O
1 CD O
costimulation NN O
in IN O
driving VBG O
an DT O
activation NN B-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
response NN I-Gene
element NN I-Gene
but CC O
not RB O
for IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

Overexpression NN O
of IN O
Rel NNP B-Gene
proteins NNS I-Gene
demonstrated VBD O
that IN O
p65 NN O
- : O
expressing VBG O
Jurkat NNP O
cells NNS O
transcribed VBD O
equally RB O
well RB O
a DT O
nuclear JJ B-Gene
factor NN I-Gene
kappabeta NN I-Gene
reporter NN I-Gene
construct NN I-Gene
when WRB O
costimulated VBN O
with IN O
B7 NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
LFA NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
but CC O
transcription NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
or CC O
CD28 NNP B-Gene
response NN I-Gene
element NN I-Gene
( ( I-Gene
CD28RE NNP I-Gene
) ) I-Gene
- : I-Gene
driven NN I-Gene
reporters NNS I-Gene
was VBD O
superior JJ O
in IN O
B7 NNP O
- : O
1 CD O
- : O
costimulated VBN O
cells NNS O
. . O

Combined JJ O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
p65 NN B-Gene
induced VBD O
vigorous JJ O
transcription NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
- : I-Gene
and CC I-Gene
CD28RE NNP I-Gene
- : I-Gene
driven NN I-Gene
reporter NN I-Gene
constructs NNS I-Gene
in IN O
both DT O
LFA NNP O
- : O
3 CD O
- : O
and CC O
B7 NNP O
- : O
1 CD O
- : O
costimulated VBN O
Jurkat NNP O
cells NNS O
. . O

Mutating VBG O
the DT O
CD28RE NNP B-Gene
but CC O
not RB O
the DT O
upstream JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
kappabeta SYM I-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
reduced VBN O
B7 NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
driven VBN O
transcription NN O
> VBZ O
90 CD O
% NN O
. . O

The DT O
results NNS O
implicates VBZ O
a DT O
major JJ O
role NN O
of IN O
the DT O
CD28RE NNP B-Gene
in IN O
the DT O
integration NN O
of IN O
p65 NN B-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
- : O
mediated VBN O
transcription NN O
within IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

We PRP O
suggest VBP O
that IN O
the DT O
transition NN O
from IN O
an DT O
autocrine NN O
LFA NNP B-Gene
- : I-Gene
3 CD I-Gene
- : O
driven VBN O
immune JJ O
response NN O
to TO O
a DT O
B7 NNP O
- : O
- : O
induced JJ O
paracrine NN O
immune JJ O
response NN O
involves VBZ O
the DT O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
p65 NN B-Gene
, , O
which WDT O
target VBP O
the DT O
CD28RE NNP B-Gene
region NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

Defects NNS O
in IN O
actin JJ O
- : O
cap NN O
formation NN O
in IN O
Vav NNP O
- : O
deficient NN O
mice NN O
implicate VBP O
an DT O
actin JJ O
requirement NN O
for IN O
lymphocyte JJ O
signal JJ O
transduction NN O
. . O

BACKGROUND NN O
: : O
Antigen NNP O
- : O
receptor NN O
interactions NNS O
on IN O
lymphocytes NNS O
result VBP O
in IN O
local JJ O
clustering NN O
of IN O
actin NN B-Gene
, , O
receptors NNS O
and CC O
signaling VBG O
molecules NNS O
into IN O
an DT O
asymmetric JJ O
membrane NN O
structure NN O
termed VBD O
a DT O
cap NN O
. . O

Although IN O
actin JJ O
polymerization NN O
is VBZ O
known VBN O
to TO O
be VB O
required VBN O
, , O
the DT O
mechanisms NNS O
underlying VBG O
cap NN O
formation NN O
are VBP O
unclear JJ O
. . O

We PRP O
have VBP O
studied VBN O
the DT O
events NNS O
underlying JJ O
cap NN O
formation NN O
using VBG O
mice NNS O
bearing VBG O
a DT O
null JJ O
mutation NN O
in IN O
vav NN B-Gene
( ( O
vav JJ B-Gene
- : O
/ SYM O
- : O
) ) O
, , O
a DT O
gene NN O
that WDT O
encodes VBZ O
a DT O
guanine JJ B-Gene
- : I-Gene
nucleotide JJ I-Gene
exchange NN I-Gene
factor NN I-Gene
for IN O
the DT O
GTPase NNP B-Gene
Rac NNP I-Gene
. . O

RESULTS NN O
: : O
Lymphocytes VBZ O
from IN O
vav FW B-Gene
- : O
/ SYM O
- : O
mice NN O
failed VBD O
to TO O
form VB O
T NNP O
- : O
cell NN O
receptor NN O
caps NNS O
following VBG O
activation NN O
and CC O
had VBD O
a DT O
defective JJ O
actin NN O
cytoskeleton NN O
. . O

The DT O
vav NN O
- : O
/ SYM O
- : O
T NN O
cells NNS O
were VBD O
deficient JJ O
in IN O
interleukin JJ O
- : O
2 CD O
( ( O
IL NNP O
- : O
2 CD O
) ) O
production NN O
and CC O
proliferation NN O
, , O
and CC O
the DT O
peak NN O
of IN O
Ca2 NNP O
+ NNP O
mobilization NN O
was VBD O
reduced VBN O
although IN O
of IN O
normal JJ O
duration NN O
. . O

Activation NN O
of IN O
Jun NNP B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
or CC O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
or CC O
SAPK NNP B-Gene
) ) O
and CC O
mitogen $ B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
and CC O
the DT O
induction NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
ATc1 NNP I-Gene
and CC I-Gene
egr SYM I-Gene
- : I-Gene
1 CD I-Gene
genes NNS I-Gene
was VBD O
normal JJ O
. . O

Despite IN O
the DT O
reduced JJ O
Ca2 NNP O
+ NNP O
mobilization NN O
, , O
translocation NN O
of IN O
cytoplasmic JJ B-Gene
NF NNP I-Gene
- : I-Gene
ATc NN I-Gene
to TO O
the DT O
nucleus NN O
was VBD O
normal JJ O
, , O
reflecting VBG O
that IN O
the DT O
lower JJR O
levels NNS O
of IN O
Ca2 NNP O
+ NNP O
in IN O
vav NNP O
- : O
/ SYM O
- : O
cells NNS O
were VBD O
still RB O
sufficient JJ O
to TO O
activate VB O
calcineurin NN B-Gene
. . O

Treatment NN O
of IN O
lymphocytes NNS O
with IN O
cytochalasin NN O
D NNP O
, , O
which WDT O
blocks VBZ O
actin NN O
polymerization NN O
, , O
inhibited JJ O
cap NN O
formation NN O
and CC O
produced VBD O
defects NNS O
in IN O
signaling VBG O
and CC O
IL NNP O
- : O
2 CD O
transcriptional JJ O
induction NN O
in IN O
response NN O
to TO O
antigen VB O
- : O
receptor NN O
signaling VBG O
that WDT O
were VBD O
nearly RB O
identical JJ O
to TO O
those DT O
seen VBN O
in IN O
vav JJ O
- : O
/ SYM O
- : O
cells NNS O
. . O

In IN O
transfection NN O
studies NNS O
, , O
either CC O
constitutively RB O
active JJ O
Vav NNP B-Gene
or CC O
Rac NNP B-Gene
could MD O
complement VB O
constitutively RB O
active JJ O
calcineurin NN B-Gene
to TO O
activate VB O
NF NNP O
- : O
AT NNP O
- : O
dependent JJ O
transcription NN O
. . O

CONCLUSIONS NN O
: : O
These DT O
results NNS O
indicate VBP O
that IN O
Vav NNP B-Gene
is VBZ O
required VBN O
for IN O
cap NN O
formation NN O
in IN O
lymphocytes NNS O
. . O

Furthermore RB O
, , O
the DT O
correlation NN O
between IN O
cap NN O
formation NN O
, , O
IL NNP O
- : O
2 CD O
production NN O
and CC O
proliferation NN O
supports VBZ O
the DT O
hypothesis NN O
that IN O
an DT O
actin JJ O
- : O
dependent JJ O
pathway NN O
is VBZ O
a DT O
source NN O
of IN O
specialized JJ O
growth NN O
regulatory JJ O
signals NNS O
. . O

CD14 NNP B-Gene
- : O
dependent JJ O
activation NN O
of IN O
human JJ O
endothelial JJ O
cells NNS O
by IN O
Bacteroides NNP O
fragilis VBP O
outer RB O
membrane NN O
. . O

We PRP O
studied VBD O
the DT O
capacity NN O
of IN O
isolated JJ O
Bacteriodes NNP O
fragilis NN O
outer NN O
membrane NN O
, , O
B NNP O
. . O
fragilis NN O
NCTC9343 NNP O
lipopolysaccharide NN O
( ( O
LPS NNP O
; : O
endotoxin NN O
) ) O
, , O
and CC O
B NNP O
. . O
fragilis NN O
NCTC9343 NNP O
capsular NN O
polysaccharides NNS O
to TO O
activate VB O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cell NN O
( ( O
HUVEC NNP O
) ) O
monolayers NNS O
. . O

To TO O
assess VB O
HUVEC NNP O
activation NN O
, , O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
expression NN O
was VBD O
measured VBN O
by IN O
enzyme JJ O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
( ( O
ELISA NNP O
) ) O
, , O
Northern NNP O
blot NN O
analysis NN O
for IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
- : I-Gene
specific JJ I-Gene
mRNA NN I-Gene
, , O
and CC O
electrophoretic JJ O
gel NN O
mobility NN O
shift NN O
assay VBP O
( ( O
EMSA NNP O
) ) O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
a DT O
transcription NN B-Gene
factor NN I-Gene
necessary JJ O
for IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
gene NN I-Gene
activation NN O
. . O

Exposure NN O
of IN O
HUVECs NNP O
to TO O
B NNP O
. . O
fragilis NN O
outer NN O
membrane NN O
fractions NNS O
, , O
separated VBN O
from IN O
other JJ O
components NNS O
of IN O
the DT O
B NNP O
. . O
fragilis NN O
cell NN O
wall NN O
by IN O
isopycnic JJ O
, , O
sucrose JJ O
gradient NN O
centrifugation NN O
, , O
significantly RB O
increased VBD O
surface JJ O
expression NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
and CC O
induced JJ O
functional JJ O
endothelial NN O
cell NN O
- : O
dependent JJ O
leukocyte JJ O
adhesion NN O
. . O

B NNP O
. . O
fragilis NN O
outer NN O
membranes NNS O
induced VBD O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
to TO O
HUVEC NNP O
nuclei NN O
and CC O
accumulation NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
mRNA NN I-Gene
in IN O
HUVEC NNP O
cytoplasm NN O
. . O

E LS O
- : O
selectin NN O
expression NN O
induced VBN O
by IN O
B NNP O
. . O
fragilis NN O
outer NN O
membranes NNS O
was VBD O
not RB O
blocked VBN O
by IN O
polymixin NN O
B NNP O
. . O

In IN O
contrast NN O
, , O
E NNP O
- : O
selectin NN O
expression NN O
induced VBN O
by IN O
outer NN O
membrane NN O
fractions NNS O
purified VBD O
from IN O
E NNP O
. . O
coli NN O
was VBD O
competitively RB O
inhibited VBN O
by IN O
polymixin NN O
B NNP O
. . O

Neither DT O
purified VBD O
B NNP O
. . O
fragilis NN O
LPS NNP O
, , O
a DT O
prominent JJ O
constituent NN O
of IN O
the DT O
outer NN O
membrane NN O
, , O
nor CC O
purified JJ O
B NNP O
. . O
fragilis NN O
capsular JJ O
polysaccharides NNS O
induced VBD O
HUVEC NNP O
activation NN O
. . O

Two CD O
different JJ O
monoclonal JJ B-Gene
antibodies NNS I-Gene
directed VBN O
against IN O
human JJ B-Gene
CD14 NNP I-Gene
completely RB O
inhibited VBD O
B NNP O
. . O
fragilis NN O
outer NN O
membrane NN O
- : O
induced JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
E NNP O
- : O
selectin NN O
transcription NN O
, , O
and CC O
E NNP O
- : O
selectin NN O
surface NN O
expression NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
outer NN O
membrane NN O
component NN O
of IN O
the DT O
B NNP O
. . O
fragilis NN O
cell NN O
wall NN O
contains VBZ O
a DT O
proinflammatory JJ O
factor NN O
( ( O
s NN O
) ) O
, , O
that WDT O
is VBZ O
not RB O
LPS NNP O
, , O
which WDT O
induces VBZ O
human JJ O
endothelial JJ O
cell NN O
activation NN O
by IN O
a DT O
soluble JJ O
CD14 NNP B-Gene
- : O
dependent NN O
mechanism NN O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
protects VBZ O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
myeloid JJ O
cells NNS O
from IN O
apoptosis NN O
. . O

HIV NNP O
- : O
1 CD O
infection NN O
of IN O
primary JJ O
monocytic JJ O
cells NNS O
and CC O
myeloid NN O
cell NN O
lines NNS O
results NNS O
in IN O
sustained JJ O
NF NNP O
- : O
kappaB NN O
activation NN O
. . O

Recently RB O
, , O
NF NNP O
- : O
kappaB NN O
induction NN O
has VBZ O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
protecting VBG O
cells NNS O
from IN O
programmed VBN O
cell NN O
death NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
sought VBD O
to TO O
investigate VB O
whether IN O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
in IN O
chronically RB O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
promonocytic JJ O
U937 NNP O
( ( O
U9 NNP O
- : O
IIIB NN O
) ) O
and CC O
myeloblastic JJ O
PLB NNP O
- : O
985 CD O
( ( O
PLB NNP O
- : O
IIIB NN O
) ) O
cells NNS O
affects VBZ O
apoptotic JJ O
signaling NN O
. . O

TNFalpha NNP B-Gene
and CC O
cycloheximide NN O
caused VBD O
infected JJ O
cells NNS O
to TO O
undergo VB O
apoptosis NN O
more RBR O
rapidly RB O
than IN O
parental JJ O
U937 NNP O
and CC O
PLB NNP O
- : O
985 CD O
cells NNS O
. . O

Inhibition NN O
of IN O
TNFalpha NNP B-Gene
- : O
induced VBD O
NF NNP O
- : O
kappaB NN O
activation NN O
using VBG O
the DT O
antioxidant JJ O
N NNP O
- : O
acetylcysteine NN O
( ( O
NAC NNP O
) ) O
resulted VBD O
in IN O
increased JJ O
apoptosis NN O
in IN O
both DT O
U937 NNP O
and CC O
U9 NNP O
- : O
IIIB NNP O
cells NNS O
, , O
while IN O
preactivation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
with IN O
the DT O
non JJ B-Gene
- : I-Gene
apoptotic JJ I-Gene
inducer NN I-Gene
IL NNP I-Gene
- : I-Gene
1beta CD I-Gene
caused VBD O
a DT O
relative JJ O
decrease NN O
in IN O
apoptosis NN O
. . O

Inhibition NN O
of IN O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
in IN O
U9 NNP O
- : O
IIIB NN O
and CC O
PLB NNP O
- : O
IIIB NNP O
cells NNS O
also RB O
induced VBD O
apoptosis NN O
, , O
suggesting VBG O
that IN O
NF NNP O
- : O
kappaB NN O
protects NNS O
cells NNS O
from IN O
a DT O
persistent JJ O
apoptotic JJ O
signal NN O
. . O

TNFalpha NNP B-Gene
plus CC O
NAC NNP O
treatment NN O
resulted VBD O
in IN O
a DT O
marked JJ O
decrease NN O
in IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
levels NNS O
in IN O
HIV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
, , O
coupled VBN O
with IN O
an DT O
increase NN O
in IN O
Bax NNP B-Gene
protein NN I-Gene
compared VBN O
to TO O
uninfected JJ O
cells NNS O
, , O
suggesting VBG O
that IN O
the DT O
difference NN O
in IN O
susceptibility NN O
to TO O
TNFalpha NNP B-Gene
- : O
induced JJ O
apoptosis NN O
may MD O
relate VB O
to TO O
the DT O
differences NNS O
in IN O
relative JJ O
levels NNS O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
Bax NNP B-Gene
. . O

The DT O
protective JJ O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
blocking VBG O
TNFalpha NNP O
- : O
and CC O
HIV NNP O
- : O
1 CD O
- : O
induced JJ O
apoptosis NN O
was VBD O
supported VBN O
by IN O
studies NNS O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
engineered VBD O
to TO O
express VB O
IkappaB NNP B-Gene
alpha NN I-Gene
repressor NN I-Gene
mutants NNS I-Gene
( ( O
TD NNP B-Gene
- : I-Gene
IkappaB NN I-Gene
) ) O
under IN O
the DT O
control NN O
of IN O
a DT O
tetracycline JJ B-Gene
- : I-Gene
responsive JJ I-Gene
promoter NN I-Gene
. . O

Cells NNP O
underwent JJ O
apoptosis NN O
in IN O
response NN O
to TO O
TNFalpha NNP B-Gene
only RB O
when WRB O
NF NNP O
- : O
kappaB NN O
activation NN O
was VBD O
inhibited VBN O
by IN O
TD NNP B-Gene
- : I-Gene
IkappaB NNP I-Gene
expression NN O
. . O

As IN O
was VBD O
observed VBN O
for IN O
the DT O
U9 NNP O
- : O
IIIB NNP O
cells NNS O
, , O
TNFalpha NNP B-Gene
treatment NN O
also RB O
induced VBD O
a DT O
marked JJ O
decrease NN O
in IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
levels NNS O
in IN O
TD NNP O
- : O
IkappaB NNP O
expressing VBG O
cells NNS O
. . O

These DT O
experiments NNS O
demonstrate VBP O
that IN O
apoptotic JJ O
signaling NN O
is VBZ O
perturbed VBN O
in IN O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
U9 NNP O
- : O
IIIB NNP O
cells NNS O
and CC O
indicate VBP O
that IN O
NF NNP O
- : O
kappaB NN O
activation NN O
may MD O
play VB O
an DT O
additional JJ O
protective JJ O
role NN O
against IN O
HIV NNP O
- : O
1 CD O
- : O
induced JJ O
apoptosis NN O
in IN O
myeloid JJ O
cells NNS O
. . O

Human NNP O
normal JJ O
peripheral JJ O
blood NN O
B NNP O
- : O
lymphocytes NNS O
are VBP O
deficient JJ O
in IN O
DNA NNP O
- : O
dependent NN O
protein JJ O
kinase NN O
activity NN O
due JJ O
to TO O
the DT O
expression NN O
of IN O
a DT O
variant JJ O
form NN O
of IN O
the DT O
Ku86 NNP B-Gene
protein NN I-Gene
. . O

The DT O
heterodimeric JJ O
Ku NNP B-Gene
protein NN I-Gene
, , O
which WDT O
comprises VBZ O
a DT O
86 CD B-Gene
kDa NN I-Gene
( ( I-Gene
Ku86 NNP I-Gene
) ) I-Gene
amd VBD O
a DT O
70 CD B-Gene
kDa NN I-Gene
( ( I-Gene
Ku70 NNP I-Gene
) ) I-Gene
subunits NNS I-Gene
, , O
is VBZ O
an DT O
abundant JJ O
nuclear JJ B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
which WDT O
binds VBZ O
in IN O
vitro NN O
to TO O
DNA NNP B-Gene
termini NN I-Gene
without IN O
sequence NN O
specificity NN O
. . O

Ku NNP B-Gene
is VBZ O
the DT O
DNA NNP B-Gene
- : I-Gene
targeting VBG I-Gene
component NN I-Gene
of IN O
the DT O
large JJ O
catalytic JJ B-Gene
sub NN I-Gene
- : I-Gene
unit NN I-Gene
of IN O
the DT O
DNA NNP B-Gene
- : I-Gene
dependent NN I-Gene
protein JJ I-Gene
kinase NN I-Gene
complex NN I-Gene
( ( O
DNA NNP B-Gene
- : I-Gene
PK NNP I-Gene
[ NNP I-Gene
CS NNP I-Gene
] NNP I-Gene
) ) O
, , O
that WDT O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
mammalian JJ O
double JJ O
- : O
strand NN O
break NN O
repair NN O
and CC O
lymphoid JJ O
V NNP O
( ( O
D NNP O
) ) O
J NNP O
recombination NN O
. . O

By IN O
using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
, , O
we PRP O
demonstrated VBD O
that IN O
in IN O
addition NN O
to TO O
the DT O
major JJ B-Gene
Ku NNP I-Gene
x NNP I-Gene
DNA NNP I-Gene
complex JJ I-Gene
usually RB O
detected VBN O
in IN O
cell NN O
line NN O
extracts VBZ O
, , O
a DT O
second JJ O
complex NN O
with IN O
faster RBR O
electrophoretic JJ O
mobility NN O
was VBD O
observed VBN O
in IN O
normal JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
( ( O
PBL NNP O
) ) O
extracts VBZ O
. . O

The DT O
presence NN O
of IN O
this DT O
faster RBR B-Gene
migrating VBG I-Gene
complex NN I-Gene
was VBD O
restricted VBN O
to TO O
B NNP O
cells NNS O
among IN O
the DT O
circulating VBG O
lymphocyte JJ O
population NN O
. . O

Western JJ O
blot NN O
analysis NN O
revealed VBD O
that IN O
B NNP O
cells NNS O
express VBP O
a DT O
variant JJ O
form NN O
of IN O
the DT O
Ku86 NNP B-Gene
protein NN I-Gene
with IN O
an DT O
apparent JJ O
molecular JJ O
weight NN O
of IN O
69 CD O
kDa NNS O
, , O
and CC O
not RB O
the DT O
86 CD B-Gene
kDa SYM I-Gene
- : I-Gene
full JJ I-Gene
- : I-Gene
length NN I-Gene
protein NN I-Gene
. . O

Although IN O
the DT O
heterodimer NN B-Gene
Ku70 NNP I-Gene
/ NNP I-Gene
variant JJ I-Gene
- : I-Gene
Ku86 NNP I-Gene
binds VBZ O
to TO O
DNA VB B-Gene
- : I-Gene
ends NNS I-Gene
, , O
this DT O
altered JJ O
form NN O
of IN O
the DT O
Ku NNP B-Gene
heterodimer NN I-Gene
has VBZ O
a DT O
decreased VBN O
ability NN O
to TO O
recruit VB O
the DT O
catalytic JJ B-Gene
component NN I-Gene
of IN O
the DT O
complex JJ O
, , O
DNA NNP B-Gene
- : I-Gene
PK NNP I-Gene
( ( I-Gene
CS NNP I-Gene
) ) I-Gene
, , O
which WDT O
contributes VBZ O
to TO O
an DT O
absence NN O
of IN O
detectable JJ O
DNA NNP O
- : O
PK NN O
activity NN O
in IN O
B NNP O
cells NNS O
. . O

These DT O
data NNS O
provide VBP O
a DT O
molecular JJ O
basis NN O
for IN O
the DT O
increased JJ O
sensitivity NN O
of IN O
B NNP O
cells NNS O
to TO O
ionizing VBG O
radiation NN O
and CC O
identify VB O
a DT O
new JJ O
mechanism NN O
of IN O
regulation NN O
of IN O
DNA NNP O
- : O
PK NN O
activity NN O
that WDT O
operates VBZ O
in IN O
vivo NN O
. . O

Co NNP O
- : O
stimulation NN O
of IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
monoclonal JJ I-Gene
antibodies NNS I-Gene
induces VBZ O
phosphorylation NN O
of IN O
CREB NNP B-Gene
. . O

Phosphorylation NN O
of IN O
the DT O
cAMP NN B-Gene
- : I-Gene
response NN I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
CREB NNP I-Gene
within IN O
1 CD O
h NN O
of IN O
CD2 NNP B-Gene
but CC O
not RB O
CD3 NNP B-Gene
cross SYM O
- : O
linking NN O
of IN O
human JJ O
PBMC NNP O
was VBD O
recently RB O
demonstrated VBN O
. . O

The DT O
absence NN O
of IN O
P NNP B-Gene
- : I-Gene
CREB NN I-Gene
following VBG O
CD3 NNP O
cross SYM O
- : O
linking NN O
was VBD O
unexpected JJ O
, , O
as IN O
other JJ O
laboratories NNS O
reported VBN O
increased JJ O
phosphorylation NN O
of IN O
CREB NNP B-Gene
following VBG O
CD3 NNP O
cross SYM O
- : O
linking NN O
of IN O
the DT O
Jurkat NNP O
lymphocyte NN O
cell NN O
line NN O
. . O

Due JJ O
to TO O
Jurkat NNP O
T NNP O
- : O
cells NNS O
being VBG O
IL NNP O
- : O
2 CD O
- : O
independent JJ O
, , O
it PRP O
was VBD O
postulated VBN O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
might MD O
provide VB O
a DT O
necessary JJ O
co NN O
- : O
stimulus NN O
for IN O
phosphorylation NN O
of IN O
CREB NNP B-Gene
in IN O
primary JJ O
lymphocytes NNS O
. . O

Therefore RB O
, , O
P NNP B-Gene
- : I-Gene
CREB NN I-Gene
was VBD O
evaluated VBN O
following VBG O
co NN O
- : O
stimulation NN O
of IN O
human JJ O
PBMC NNP O
through IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC I-Gene
CD2 NNP I-Gene
or CC I-Gene
CD3 NNP I-Gene
receptors NNS I-Gene
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
did VBD O
not RB O
further RBR O
augment JJ O
phosphorylation NN O
of IN O
CREB NNP B-Gene
following VBG O
CD2 NNP O
cross SYM O
- : O
linking NN O
. . O

However RB O
, , O
while IN O
neither CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
nor CC O
CD3 NNP O
cross SYM O
- : O
linking VBG O
alone RB O
induced VBN O
P NNP B-Gene
- : I-Gene
CREB NNP I-Gene
, , O
a DT O
4 CD O
. . O
5 CD O
- : O
fold JJ O
increase NN O
in IN O
phosphorylation NN O
of IN O
CREB NNP B-Gene
within IN O
1 CD O
h NN O
of IN O
IL NNP O
- : O
2 CD O
/ JJ O
CD3 NNP O
co NN O
- : O
stimulation NN O
was VBD O
observed VBN O
. . O

Phosphorylation NN O
was VBD O
not RB O
associated VBN O
with IN O
the DT O
induction NN O
of IN O
cAMP NN O
, , O
and CC O
inhibition NN O
of IN O
PKA NNP O
signaling VBG O
had VBD O
no DT O
effect NN O
on IN O
P NNP B-Gene
- : I-Gene
CREB NN I-Gene
. . O

Consistent JJ O
with IN O
signal JJ O
transduction NN O
through IN O
p56lck NN B-Gene
or CC O
p59fyn NN B-Gene
, , O
inhibition NN O
of IN O
PTK NNP O
signaling VBG O
reduced VBN O
phosphorylation NN O
50 CD O
% NN O
. . O

Interestingly RB O
, , O
inhibiting VBG O
PKC NNP O
signaling VBG O
with IN O
calphostin NN O
C NNP O
further RB O
increased VBD O
P NNP O
- : O
CREB NN O
levels NNS O
3 CD O
- : O
fold NN O
over IN O
that DT O
observed VBN O
in IN O
IL NNP O
- : O
2 CD O
/ JJ O
CD3 NNP O
co NN O
- : O
stimulated VBN O
cells NNS O
not RB O
pretreated VBN O
with IN O
a DT O
PKC NNP O
inhibitor NN O
. . O

In IN O
contrast NN O
to TO O
previous JJ O
studies NNS O
performed VBN O
in IN O
the DT O
absence NN O
of IN O
exogenous JJ B-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
, , O
no DT O
increase NN O
in IN O
binding NN O
of IN O
CREB NNP B-Gene
to TO O
a DT O
32P CD O
- : O
labeled VBN O
oligonucleotide IN O
probe NN O
was VBD O
observed VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
CD3 NNP B-Gene
signaling VBG O
pathways NNS O
provide VBP O
a DT O
necessary JJ O
and CC O
co JJ O
- : O
operative JJ O
stimulus NN O
promoting VBG O
phosphorylation NN O
of IN O
CREB NNP B-Gene
following VBG O
receptor NN O
cross SYM O
- : O
linking NN O
. . O

HIV NNP O
- : O
1 CD O
infection NN O
induces NNS O
a DT O
selective JJ O
reduction NN O
in IN O
STAT5 NNP O
protein NN O
expression NN O
. . O

HIV NNP O
- : O
1 CD O
infection NN O
is VBZ O
accompanied VBN O
by IN O
qualitative JJ O
and CC O
quantitative JJ O
defects NNS O
in IN O
CD4 NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
. . O

Loss NNP O
of IN O
immune JJ O
function NN O
in IN O
HIV NNP O
patients NNS O
is VBZ O
usually RB O
associated VBN O
with IN O
a DT O
profound JJ O
dysregulation NN O
of IN O
cytokine NN B-Gene
production NN O
. . O

To TO O
investigate VB O
whether IN O
cytokine NN B-Gene
signaling VBG O
defects NNS O
occur VBP O
during IN O
HIV NNP O
infection NN O
, , O
PHA NNP O
blasts VBZ O
from IN O
healthy JJ O
human JJ O
donors NNS O
were VBD O
infected VBN O
with IN O
two CD O
strains NNS O
of IN O
HIV NNP O
- : O
1 CD O
and CC O
screened VBD O
for IN O
the DT O
expression NN O
of IN O
STAT NNP B-Gene
proteins NNS I-Gene
used VBN O
in IN O
cytokine NN B-Gene
signaling NN O
. . O

A DT O
selective JJ O
decrease NN O
in IN O
STAT5B NNP B-Gene
was VBD O
seen VBN O
8 CD O
days NNS O
after IN O
infection NN O
with IN O
the DT O
BZ167 NNP O
dual JJ O
- : O
tropic NN O
HIV NNP O
isolate NN O
, , O
but CC O
not RB O
with IN O
the DT O
Ba NNP O
- : O
L NNP O
, , O
M NNP O
- : O
tropic NN O
strain NN O
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
purified VBD O
T NNP O
cells NNS O
from IN O
HIV NNP O
- : O
infected JJ O
patients NNS O
in IN O
different JJ O
stages NNS O
of IN O
disease NN O
were VBD O
also RB O
tested VBN O
for IN O
STAT NNP O
expression NN O
; : O
decreases VBZ O
in IN O
STAT5A NNP B-Gene
, , O
STAT5B NNP B-Gene
, , O
and CC O
STAT1alpha NNP B-Gene
were VBD O
observed VBN O
in IN O
all DT O
patients NNS O
. . O

The DT O
reduction NN O
in IN O
STATs NNP B-Gene
seen VBN O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
after IN O
HIV NNP O
infection NN O
may MD O
contribute VB O
to TO O
the DT O
loss NN O
of IN O
T NNP O
cell NN O
function NN O
in IN O
HIV NNP O
disease NN O
. . O

Transcription NN B-Gene
factors NNS I-Gene
that WDT O
regulate VBP O
monocyte NNS O
/ JJ O
macrophage NN O
differentiation NN O
. . O

Although IN O
all PDT O
the DT O
cells NNS O
in IN O
an DT O
organism NN O
contain VBP O
the DT O
same JJ O
genetic JJ O
information NN O
, , O
differences NNS O
in IN O
the DT O
cell NN O
phenotype NN O
arise NN O
from IN O
the DT O
expression NN O
of IN O
lineage NN B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
. . O

During IN O
myelopoiesis NN O
, , O
external JJ O
differentiating NN O
signals NNS O
regulate VBP O
the DT O
expression NN O
of IN O
a DT O
set NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

The DT O
combined JJ O
action NN O
of IN O
these DT O
transcription NN B-Gene
factors NNS I-Gene
subsequently RB O
determines VBZ O
the DT O
expression NN O
of IN O
myeloid JJ B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
and CC O
the DT O
generation NN O
of IN O
monocytes NNS O
and CC O
macrophages NNS O
. . O

In IN O
particular JJ O
, , O
the DT O
transcription NN B-Gene
factor NN I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
has VBZ O
a DT O
critical JJ O
role NN O
in IN O
this DT O
process NN O
. . O

We PRP O
review VBP O
the DT O
contribution NN O
of IN O
several JJ O
transcription NN B-Gene
factors NNS I-Gene
to TO O
the DT O
control NN O
of IN O
macrophage NN O
development NN O

Transcription NNP B-Gene
factor NN I-Gene
LKLF NNP I-Gene
is VBZ O
sufficient JJ O
to TO O
program NN O
T NNP O
cell NN O
quiescence NN O
via IN O
a DT O
c JJ O
- : O
Myc NNP O
- : O
- : O
dependent JJ O
pathway NN O
. . O

T NNP O
lymphocytes VBZ O
circulate VBP O
in IN O
a DT O
quiescent JJ O
state NN O
until IN O
they PRP O
encounter VBP O
cognate JJ B-Gene
antigen NN I-Gene
bound NN O
to TO O
the DT O
surface NN O
of IN O
an DT O
antigen NN O
- : O
presenting NN O
cell NN O
. . O

The DT O
molecular JJ O
pathways NNS O
that WDT O
regulate VBP O
T NNP O
cell NN O
quiescence NN O
remain VBP O
largely RB O
unknown JJ O
. . O

Here RB O
we PRP O
show VBP O
that IN O
forced JJ O
expression NN O
of IN O
the DT O
lung NN B-Gene
Kruppel NNP I-Gene
- : I-Gene
like IN I-Gene
transcription NN I-Gene
factor NN I-Gene
( ( O
LKLF NNP B-Gene
) ) O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
is VBZ O
sufficient JJ O
to TO O
program NN O
a DT O
quiescent NN O
phenotype NN O
characterized VBN O
by IN O
decreased JJ O
proliferation NN O
, , O
reduced VBN O
cell NN O
size NN O
and CC O
protein NN O
synthesis NN O
and CC O
decreased VBD O
surface NN O
expression NN O
of IN O
activation NN O
markers NNS O
. . O

Conversely RB O
, , O
LKLF NNP O
- : O
deficient JJ O
peripheral JJ O
T NNP O
cells NNS O
produced VBN O
by IN O
gene NN O
targeting VBG O
showed VBD O
increased VBN O
proliferation NN O
, , O
increased VBN O
cell NN O
size NN O
and CC O
enhanced JJ O
expression NN O
of IN O
surface NN O
activation NN O
markers NNS O
in IN O
vivo NN O
. . O

LKLF RB B-Gene
appeared VBD O
to TO O
function VB O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
by IN O
decreasing VBG O
expression NN O
of IN O
the DT O
proto NN B-Gene
- : I-Gene
oncogene NN I-Gene
encoding VBG O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
. . O

Forced NNP O
expression NN O
of IN O
LKLF NNP B-Gene
was VBD O
associated VBN O
with IN O
markedly RB O
decreased VBN O
c SYM B-Gene
- : I-Gene
Myc JJ I-Gene
expression NN O
. . O

In IN O
addition NN O
, , O
many JJ O
effects NNS O
of IN O
LKLF NNP B-Gene
expression NN O
were VBD O
mimicked VBN O
by IN O
expression NN O
of IN O
the DT O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
MadMyc NNP I-Gene
protein NN I-Gene
and CC O
rescued VBN O
by IN O
overexpression NN O
of IN O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
. . O

Thus RB O
, , O
LKLF NNP B-Gene
is VBZ O
both DT O
necessary JJ O
and CC O
sufficient JJ O
to TO O
program NN O
quiescence NN O
in IN O
T NNP O
cells NNS O
and CC O
functions NNS O
, , O
in IN O
part NN O
, , O
by IN O
negatively RB O
regulating VBG O
a DT O
c JJ O
- : O
Myc NNP O
- : O
- : O
dependent JJ O
pathway NN O
. . O

HTLV NNP B-Gene
- : I-Gene
1 CD I-Gene
p12 NN I-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
protein NN I-Gene
enhances VBZ O
STAT5 NNP O
activation NN O
and CC O
decreases VBZ O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
requirement NN O
for IN O
proliferation NN O
of IN O
primary JJ O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

The DT O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
protein NN I-Gene
, , O
encoded VBN O
by IN O
the DT O
pX NN B-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
I PRP I-Gene
of IN O
the DT O
human JJ O
T NNP O
- : O
lymphotropic NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
, , O
is VBZ O
a DT O
hydrophobic JJ B-Gene
protein NN I-Gene
that WDT O
localizes VBZ O
to TO O
the DT O
endoplasmic JJ O
reticulum NN O
and CC O
the DT O
Golgi NNP O
. . O

Although IN O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
contains VBZ O
4 CD O
minimal JJ O
proline NN O
- : O
rich JJ O
, , O
src JJ B-Gene
homology NN I-Gene
3 CD I-Gene
- : I-Gene
binding NN I-Gene
motifs NNS I-Gene
( ( O
PXXP NNP B-Gene
) ) O
, , O
a DT O
characteristic JJ O
commonly RB O
found VBN O
in IN O
proteins NNS O
involved VBN O
in IN O
signaling VBG O
pathways NNS O
, , O
it PRP O
has VBZ O
not RB O
been VBN O
known VBN O
whether IN O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
has VBZ O
a DT O
role NN O
in IN O
modulating VBG O
intracellular JJ O
signaling NN O
pathways NNS O
. . O

This DT O
study NN O
demonstrated VBD O
that IN O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
binds VBZ O
to TO O
the DT O
cytoplasmic JJ B-Gene
domain NN I-Gene
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
) ) I-Gene
beta NN I-Gene
chain NN I-Gene
that WDT O
is VBZ O
involved VBN O
in IN O
the DT O
recruitment NN O
of IN O
the DT O
Jak1 NNP B-Gene
and CC I-Gene
Jak3 NNP I-Gene
kinases NNS I-Gene
. . O

As IN O
a DT O
result NN O
of IN O
this DT O
interaction NN O
, , O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
increases VBZ O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
5 CD I-Gene
( ( O
STAT5 NNP B-Gene
) ) O
DNA NNP O
binding NN O
and CC O
transcriptional JJ O
activity NN O
and CC O
this DT O
effect NN O
depends VBZ O
on IN O
the DT O
presence NN O
of IN O
both DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
and CC I-Gene
gamma NN I-Gene
( ( I-Gene
c NN I-Gene
) ) I-Gene
chains NNS I-Gene
and CC O
Jak3 NNP B-Gene
. . O

Transduction NN O
of IN O
primary JJ O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMCs NNP O
) ) O
with IN O
a DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
- : I-Gene
based VBN I-Gene
retroviral JJ I-Gene
vector NN I-Gene
expressing VBG O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
also RB O
resulted VBD O
in IN O
increased JJ O
STAT5 NNP B-Gene
phosphorylation NN O
and CC O
DNA NNP O
binding NN O
. . O

However RB O
, , O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
could MD O
increase VB O
proliferation NN O
of IN O
human JJ O
PBMCs NNP O
only RB O
after IN O
stimulation NN O
of IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptors NNS I-Gene
by IN O
treatment NN O
of IN O
cells NNS O
with IN O
low JJ O
concentrations NNS O
of IN O
alphaCD3 NN B-Gene
and CC I-Gene
alphaCD28 JJ I-Gene
antibodies NNS I-Gene
. . O

In IN O
addition NN O
, , O
the DT O
proliferative JJ O
advantage NN O
of IN O
p12 NN O
( ( O
I PRP O
) ) O
- : O
transduced VBD O
PBMCs NNP O
was VBD O
evident JJ O
mainly RB O
at IN O
low JJ O
concentrations NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Together RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
p12 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
may MD O
confer VB O
a DT O
proliferative JJ O
advantage NN O
on IN O
HTLV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
suboptimal JJ O
antigen NN O
stimulation NN O
and CC O
that IN O
this DT O
event NN O
may MD O
account VB O
for IN O
the DT O
clonal JJ O
proliferation NN O
of IN O
infected JJ O
T NNP O
cells NNS O
in IN O
vivo NN O
. . O

( ( O
Blood NNP O
. . O
2001 CD O
; : O
98 CD O
: : O
823 CD O
- : O
829 CD O
) ) O

Single NNP O
dose NN O
intranasal JJ O
administration NN O
of IN O
retinal JJ B-Gene
autoantigen NN I-Gene
generates VBZ O
a DT O
rapid JJ O
accumulation NN O
and CC O
cell NN O
activation NN O
in IN O
draining VBG O
lymph JJ O
node NN O
and CC O
spleen NN O
: : O
implications NNS O
for IN O
tolerance NN O
therapy NN O
. . O

BACKGROUND NNP O
/ NNP O
AIMS NNP O
: : O
A DT O
single JJ O
intranasal NN O
delivery NN O
of IN O
retinal JJ B-Gene
autoantigen NN I-Gene
suppresses NNS O
effectively RB O
experimental JJ O
autoimmune NN O
uveoretinitis NN O
( ( O
EAU NNP O
) ) O
. . O

To TO O
further RBR O
unravel JJ O
underlying VBG O
mechanisms PDT O
the DT O
authors NNS O
wished VBD O
to TO O
determine VB O
, , O
firstly RB O
, , O
the DT O
kinetics NNS O
of IN O
antigen NN O
delivery NN O
and CC O
, , O
secondly RB O
, , O
the DT O
early JJ O
cellular JJ O
responses NNS O
involved VBN O
in IN O
the DT O
initial JJ O
stages NNS O
of IN O
nasal NN O
mucosal NN O
tolerance NN O
induction NN O
. . O

METHODS NN O
: : O
Flow NNP O
cytometry NN O
, , O
cell NN O
proliferation NN O
assays NNS O
, , O
and CC O
microscopy NN O
were VBD O
used VBN O
to TO O
track VB O
antigen NN B-Gene
following VBG O
a DT O
single JJ O
, , O
intranasal JJ O
dose NN O
of IN O
Alexa NNP B-Gene
- : I-Gene
488 CD I-Gene
labelled VBD I-Gene
retinal JJ I-Gene
antigen NN I-Gene
. . O

RESULTS NN O
: : O
A DT O
rapid JJ O
accumulation NN O
of IN O
antigen NN B-Gene
within IN O
both DT O
superficial JJ O
cervical JJ O
lymph NN O
nodes NNS O
( ( O
SCLN NNP O
) ) O
and CC O
spleen NN O
was VBD O
observed VBN O
after IN O
30 CD O
minutes NNS O
. . O

Significant NNP O
proliferative JJ O
responses NNS O
to TO O
IRBP NNP O
were VBD O
elicited VBN O
by IN O
48 CD O
hours NNS O
indicating VBG O
that IN O
systemic JJ O
priming NN O
of IN O
naive JJ O
T NNP O
cells NNS O
to TO O
retinal VB B-Gene
antigen NN I-Gene
had VBD O
occurred VBN O
. . O

Cell NNP O
activation NN O
was VBD O
further RBR O
confirmed VBN O
by IN O
immunoprecipitation NN O
studies NNS O
, , O
which WDT O
demonstrated VBD O
phosphorylation NN O
of IN O
STAT4 NNP B-Gene
but CC O
not RB O
STAT6 NNP B-Gene
in IN O
both DT O
lymph JJ O
nodes NNS O
and CC O
spleen NN O
. . O

However RB O
, , O
at IN O
24 CD O
hours NNS O
, , O
STAT4 NNP O
heterodimerisation NN O
with IN O
STAT NNP B-Gene
3 CD I-Gene
was VBD O
only RB O
observed VBN O
in IN O
spleen NN O
. . O

CONCLUSIONS NN O
: : O
The DT O
results NNS O
provide VBP O
novel JJ O
evidence NN O
that IN O
following VBG O
a DT O
single JJ O
intranasal NN O
application NN O
rapid JJ O
transfer NN O
of IN O
antigen NN B-Gene
occurs NNS O
. . O

Resulting VBG O
T NNP O
cell NN O
proliferation NN O
develops VBZ O
consequent NN O
to TO O
differential VB O
cell NN O
signalling VBG O
in IN O
SCLN NNP O
and CC O
spleen NN O
. . O

Further RB O
understanding NN O
of IN O
these DT O
underlying VBG O
cellular JJ O
mechanisms NNS O
, , O
in IN O
particular JJ O
as IN O
is VBZ O
inferred VBN O
by IN O
the DT O
results NNS O
the DT O
contribution NN O
of IN O
local JJ O
versus NN O
systemic JJ O
tolerance NN O
induction NN O
, , O
may MD O
assist VB O
in IN O
strategies NNS O
to TO O
clinically RB O
apply VB O
mucosal JJ O
tolerance NN O
therapy NN O
successfully RB O
. . O

Regulation NN O
of IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
18 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
expression NN O
on IN O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
during IN O
T NNP O
helper NN O
( ( O
Th NNP O
) ) O
1 CD O
/ JJ O
Th2 NNP O
differentiation NN O
. . O

Critical JJ O
downregulatory NN O
role NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

Interleukin NNP B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
18 CD I-Gene
has VBZ O
been VBN O
well RB O
characterized VBN O
as IN O
a DT O
costimulatory NN B-Gene
factor NN I-Gene
for IN O
the DT O
induction NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
- : I-Gene
mediated VBN I-Gene
interferon NN I-Gene
( ( I-Gene
IFN NNP I-Gene
) ) I-Gene
- : I-Gene
gamma NN I-Gene
production NN O
by IN O
T NNP O
helper NN O
( ( O
Th NNP O
) ) O
1 CD O
cells NNS O
, , O
but CC O
also RB O
can MD O
induce VB O
IL NNP O
- : O
4 CD O
production NN O
and CC O
thus RB O
facilitate VB O
the DT O
differentiation NN O
of IN O
Th2 NNP O
cells NNS O
. . O

To TO O
determine VB O
the DT O
mechanisms NNS O
by IN O
which WDT O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
might MD O
regulate VB O
these DT O
diametrically RB O
distinct JJ O
immune JJ O
responses NNS O
, , O
we PRP O
have VBP O
analyzed VBN O
the DT O
role NN O
of IN O
cytokines NNS B-Gene
in IN O
the DT O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
) ) O
expression NN O
. . O

The DT O
majority NN O
of IN O
peripheral JJ O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
constitutively RB O
expressed VBD O
the DT O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
. . O

Upon IN O
antigen JJ O
stimulation NN O
in IN O
the DT O
presence NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
marked VBD O
enhancement NN O
of IN O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
expression NN O
was VBD O
observed VBN O
. . O

IL NNP B-Gene
- : I-Gene
12 CD I-Gene
- : O
mediated VBN O
upregulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
required VBN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

Activated VBN O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
that WDT O
expressed VBD O
low JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
could MD O
produce VB O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
when WRB O
stimulated VBN O
with IN O
the DT O
combination NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
, , O
while IN O
CD4 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
which WDT O
expressed VBD O
high JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
could MD O
respond VB O
to TO O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
alone RB O
. . O

In IN O
contrast NN O
, , O
T NNP O
cell NN O
stimulation NN O
in IN O
the DT O
presence NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
resulted VBD O
in IN O
a DT O
downregulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
expression NN O
. . O

Both DT O
IL NNP O
- : O
4 CD O
( ( O
- : O
/ NN O
) ) O
- : O
and CC O
signal JJ O
transducer NN O
and CC O
activator NN O
of IN O
transcription NN O
( ( O
Stat NNP O
) ) O
6 CD O
( ( O
- : O
/ NN O
) ) O
- : O
T NNP O
cells NNS O
expressed VBD O
higher JJR O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
after IN O
TCR NNP O
stimulation NN O
. . O

Furthermore RB O
, , O
activated VBD O
T NNP O
cells NNS O
from IN O
Stat6 NNP O
( ( O
- : O
/ NN O
) ) O
- : O
mice NN O
produced VBD O
more JJR O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
than IN O
wild JJ O
- : O
type NN O
controls NNS O
. . O

Thus RB O
, , O
positive JJ O
/ NNP O
negative JJ O
regulation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
18Ralpha CD I-Gene
by IN O
the DT O
major JJ O
inductive JJ O
cytokines NNS B-Gene
( ( O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
) ) O
determines VBZ O
the DT O
capacity NN O
of IN O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
to TO O
polarize VB O
an DT O
immune JJ O
response NN O
. . O

Glucocorticoid NNP B-Gene
- : I-Gene
regulated JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

Glucocorticoids NNS O
are VBP O
the DT O
most RBS O
effective JJ O
antiinflammatory NN O
drugs NNS O
used VBN O
in IN O
the DT O
treatment NN O
of IN O
asthma NN O
. . O

They PRP O
act VBP O
by IN O
binding VBG O
to TO O
a DT O
specific JJ O
receptor NN O
( ( O
GR NNP B-Gene
) ) O
that IN O
, , O
upon IN O
activation NN O
, , O
translocates VBZ O
to TO O
the DT O
nucleus NN O
and CC O
either DT O
increases NNS O
( ( O
transactivates NNS O
) ) O
or CC O
decreases VBZ O
( ( O
transrepresses NNS O
) ) O
gene NN O
expression NN O
. . O

Inhibition NN O
of IN O
pro JJ B-Gene
- : I-Gene
inflammatory JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
such JJ O
as IN O
activator NN B-Gene
protein NN I-Gene
( ( I-Gene
AP NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
, , O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
STATs NNP B-Gene
) ) O
, , O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
thought VBN O
to TO O
be VB O
a DT O
major JJ O
action NN O
of IN O
glucocorticoids NNS O
. . O

Acetylation NN O
of IN O
histones NNS B-Gene
allows NNS O
unwinding VBG O
of IN O
the DT O
local JJ B-Gene
DNA NNP I-Gene
structure NN I-Gene
and CC O
enables VBZ O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
to TO O
enhance VB O
gene NN O
transcription NN O
. . O

Histone CD O
acetylation NN O
is VBZ O
regulated VBN O
by IN O
a DT O
balance NN O
between IN O
the DT O
activity NN O
of IN O
histone NN B-Gene
acetyltransferases NNS I-Gene
( ( O
HATs NNP B-Gene
) ) O
and CC O
histone NN B-Gene
deacetylases NNS I-Gene
( ( O
HDACs NNP B-Gene
) ) O
. . O

GR NNP B-Gene
acts VBZ O
as IN O
a DT O
direct JJ O
inhibitor NN O
of IN O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
induced VBD O
HAT NNP O
activity NN O
and CC O
also RB O
by IN O
recruiting VBG O
HDAC2 NNP B-Gene
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
HAT NNP I-Gene
complex NN I-Gene
. . O

A DT O
sub JJ O
- : O
group NN O
of IN O
patients NNS O
with IN O
glucocorticoid JJ O
- : O
insensitive JJ O
asthma NN O
have VBP O
an DT O
inability NN O
to TO O
induce VB O
histone CD O
acetylation NN O
in IN O
response NN O
to TO O
dexamethasone VB O
suggesting VBG O
reduced JJ O
expression NN O
of IN O
a DT O
GR NNP B-Gene
- : I-Gene
specific JJ I-Gene
HAT NNP I-Gene
. . O

This DT O
suggests VBZ O
that IN O
pharmacological JJ O
manipulation NN O
of IN O
specific JJ O
histone NN O
acetylation NN O
status NN O
is VBZ O
a DT O
potentially RB O
useful JJ O
approach NN O
for IN O
the DT O
treatment NN O
of IN O
inflammatory JJ O
diseases NNS O
. . O

Identification NN O
of IN O
the DT O
precise JJ O
mechanism NN O
by IN O
which WDT O
activated VBD B-Gene
GR NNP I-Gene
recruits NNS O
HDAC2 NNP B-Gene
may MD O
reveal VB O
new JJ O
targets NNS O
for IN O
the DT O
development NN O
of IN O
drugs NNS O
that WDT O
may MD O
dissociate VB O
the DT O
antiinflammatory JJ O
actions NNS O
of IN O
glucocorticoids NNS O
from IN O
their PRP$ O
side NN O
effects NNS O
that WDT O
are VBP O
largely RB O
due JJ O
to TO O
gene NN O
induction NN O
. . O

Copyright NNP O
Academic NNP O
Press NNP O
. . O

Differential JJ O
ultraviolet NN O
- : O
B NNP O
- : O
induced JJ O
immunomodulation NN O
in IN O
XPA NNP O
, , O
XPC NNP O
, , O
and CC O
CSB NNP O
DNA NNP O
repair NN O
- : O
deficient NN O
mice NN O
. . O

Ultraviolet NN O
B NNP O
irradiation NN O
has VBZ O
serious JJ O
consequences NNS O
for IN O
cellular JJ O
immunity NN O
and CC O
can MD O
suppress VB O
the DT O
rejection NN O
of IN O
skin NN O
tumors NNS O
and CC O
the DT O
resistance NN O
to TO O
infectious JJ O
diseases NNS O
. . O

DNA NN O
damage NN O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
these DT O
immunomodulatory JJ O
effects NNS O
of IN O
ultraviolet NN O
B NNP O
, , O
as IN O
impaired JJ O
repair NN O
of IN O
ultraviolet JJ O
- : O
B NNP O
- : O
induced VBD O
DNA NNP O
damage NN O
has VBZ O
been VBN O
shown VBN O
to TO O
cause VB O
suppression NN O
of IN O
cellular JJ O
immunity NN O
. . O

Ultraviolet NNP O
- : O
B NNP O
- : O
induced VBD O
DNA NNP O
damage NN O
is VBZ O
repaired VBN O
by IN O
the DT O
nucleotide JJ O
excision NN O
repair NN O
mechanism NN O
very RB O
efficiently RB O
. . O

Nucleotide NNP O
excision NN O
repair NN O
comprises VBZ O
two CD O
subpathways NNS O
: : O
transcription NN O
- : O
coupled VBN O
and CC O
global JJ O
genome NN O
repair NN O
. . O

In IN O
this DT O
study NN O
the DT O
immunologic JJ O
consequences NNS O
of IN O
specific JJ O
nucleotide JJ O
excision NN O
repair NN O
defects NNS O
in IN O
three CD O
mouse NN O
models NNS O
, , O
XPA NNP O
, , O
XPC NNP O
, , O
and CC O
CSB NNP O
mutant NNP O
mice NN O
, , O
were VBD O
investigated VBN O
. . O

XPA NNP O
mice NN O
carry VBP O
a DT O
total JJ O
nucleotide JJ O
excision NN O
repair NN O
defect NN O
, , O
whereas JJ O
XPC NNP O
and CC O
CSB NNP O
mice NNP O
only RB O
lack VBP O
global JJ O
genome NN O
and CC O
transcription NN O
- : O
coupled VBN O
nucleotide JJ O
excision NN O
repair NN O
, , O
respectively RB O
. . O

Our PRP$ O
data NNS O
demonstrate NN O
that IN O
cellular JJ O
immune NN O
parameters NNS O
in IN O
XPA NNP O
, , O
XPC NNP O
, , O
and CC O
CSB NNP O
mice NNS O
are VBP O
normal JJ O
compared VBN O
with IN O
their PRP$ O
wild JJ O
- : O
type NN O
( ( O
control NN O
) ) O
littermates VBZ O
. . O

This DT O
may MD O
indicate VB O
that IN O
the DT O
reported VBN O
altered VBD O
cellular JJ O
responses NNS O
in IN O
xeroderma NNP O
pigmentosum NN O
patients NNS O
are VBP O
not RB O
constitutive JJ O
but CC O
could MD O
be VB O
due JJ O
to TO O
external JJ O
factors NNS O
, , O
such JJ O
as IN O
ultraviolet NN O
B NNP O
. . O

Upon IN O
exposure NN O
to TO O
ultraviolet VB O
B NNP O
, , O
only RB O
XPA NNP O
mice NNS O
are VBP O
very RB O
sensitive JJ O
to TO O
ultraviolet VB O
- : O
B NNP O
- : O
induced JJ O
inhibition NN O
of IN O
Th1 NNP O
- : O
mediated VBN O
contact NN O
hypersensitivity NN O
responses NNS O
and CC O
interferon VB B-Gene
- : I-Gene
gamma NN I-Gene
production NN O
in IN O
skin NN O
draining VBG O
lymph JJ O
nodes NNS O
. . O

Lipopolysaccharide NNP O
- : O
stimulated VBD O
tumor JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
and CC O
interleukin JJ B-Gene
- : I-Gene
10 CD I-Gene
production NN O
are VBP O
significantly RB O
augmented VBN O
in IN O
both DT O
XPA NNP O
and CC O
CSB NNP O
mice NN O
after IN O
ultraviolet JJ O
B NNP O
exposure NN O
. . O

Lymph NNP O
node NN O
cell NN O
numbers NNS O
were VBD O
increased VBN O
very RB O
significantly RB O
in IN O
XPA NNP O
, , O
mildly RB O
increased VBD O
in IN O
CSB NNP O
, , O
and CC O
not RB O
in IN O
XPC NNP O
mice NN O
. . O

In IN O
general JJ O
XPC NNP O
mice NN O
do VBP O
not RB O
exhibit VB O
any DT O
indication NN O
of IN O
enhanced JJ O
ultraviolet NN O
B NNP O
susceptibility NN O
with IN O
regard NN O
to TO O
the DT O
immune JJ O
parameters NNS O
analyzed VBD O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
both DT O
global JJ O
genome NN O
repair NN O
and CC O
transcription NN O
- : O
coupled VBN O
repair NN O
are VBP O
needed VBN O
to TO O
prevent VB O
immunomodulation NN O
by IN O
ultraviolet NN O
B NNP O
, , O
whereas JJ O
transcription NN O
- : O
coupled VBN O
repair NN O
is VBZ O
the DT O
major JJ O
DNA NNP O
repair NN O
subpathway NN O
of IN O
nucleotide JJ O
excision NN O
repair NN O
that WDT O
prevents VBZ O
the DT O
acute JJ O
ultraviolet NN O
- : O
B NNP O
- : O
induced JJ O
effects NNS O
such JJ O
as IN O
erythema NN O
. . O

Biomechanical JJ O
strain NN O
induces NNS O
class NN O
a DT O
scavenger NN B-Gene
receptor NN I-Gene
expression NN O
in IN O
human JJ O
monocyte NN O
/ NN O
macrophages NNS O
and CC O
THP NNP O
- : O
1 CD O
cells NNS O
: : O
a DT O
potential JJ O
mechanism NN O
of IN O
increased JJ O
atherosclerosis NN O
in IN O
hypertension NN O
. . O

BACKGROUND NN O
: : O
Although IN O
hypertension NN O
is VBZ O
an DT O
important JJ O
risk NN O
factor NN O
for IN O
the DT O
development NN O
of IN O
atherosclerosis NN O
, , O
the DT O
mechanisms NN O
for IN O
this DT O
interaction NN O
are VBP O
incompletely RB O
described VBN O
. . O

Previous JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
biomechanical JJ O
strain NN O
regulates NNS O
macrophage VBP O
phenotype NN O
. . O

We PRP O
tested VBD O
the DT O
hypothesis NN O
that WDT O
biomechanical JJ O
strain NN O
can MD O
induce VB O
expression NN O
of IN O
the DT O
class NN B-Gene
A NNP I-Gene
scavenger NN I-Gene
receptor NN I-Gene
( ( O
SRA NNP B-Gene
) ) O
, , O
an DT O
important JJ O
lipoprotein NN B-Gene
receptor NN I-Gene
in IN O
atherogenesis NN O
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
Human NNP O
monocyte VBZ O
/ JJ O
macrophages NNS O
or CC O
THP NNP O
- : O
1 CD O
cells NNS O
were VBD O
cultured VBN O
in IN O
a DT O
device NN O
that WDT O
imposes VBZ O
uniform JJ O
biaxial JJ O
cyclic NN O
1 CD O
- : O
Hz NNP O
strains NNS O
of IN O
0 CD O
% NN O
, , O
1 CD O
% NN O
, , O
2 CD O
% NN O
, , O
or CC O
3 CD O
% NN O
, , O
and CC O
SRA NNP B-Gene
expression NN O
was VBD O
analyzed VBN O
. . O

Mechanical JJ O
strains NNS O
induced VBN O
SRA NNP B-Gene
mRNA NN I-Gene
( ( O
3 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
- : O
fold NN O
at IN O
3 CD O
% NN O
strain NN O
for IN O
48 CD O
hours NNS O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
SRA NNP B-Gene
protein NN I-Gene
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
in IN O
an DT O
amplitude NN O
- : O
dependent JJ O
manner NN O
. . O

This DT O
induction NN O
was VBD O
accompanied VBN O
by IN O
augmented JJ O
expression NN O
of IN O
the DT O
class NN B-Gene
B NNP I-Gene
scavenger NN I-Gene
receptor NN I-Gene
CD36 NNP I-Gene
( ( O
2 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
- : O
fold NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
but CC O
not RB O
by IN O
increased VBN O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
- : I-Gene
gamma NN I-Gene
expression NN O
. . O

To TO O
evaluate VB O
this DT O
effect NN O
in IN O
vivo NN O
, , O
apolipoprotein RB O
E NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
were VBD O
randomly RB O
assigned VBN O
to TO O
receive VB O
standard NN O
chow NN O
, , O
a DT O
high JJ O
- : O
cholesterol NN O
diet JJ O
, , O
or CC O
a DT O
high JJ O
- : O
cholesterol NN O
diet JJ O
with IN O
hypertension NN O
induced VBN O
by IN O
angiotensin NN O
II NNP O
infusion NN O
for IN O
8 CD O
weeks NNS O
. . O

Immunohistochemistry NN O
revealed VBD O
that IN O
among IN O
macrophages NNS O
in IN O
atherosclerotic JJ O
lesions NNS O
of IN O
the DT O
aorta NN O
, , O
the DT O
proportion NN O
of IN O
macrophages NNS O
with IN O
SRA NNP B-Gene
expression NN O
was VBD O
highest JJS O
in IN O
hypertensive JJ O
animals NNS O
on IN O
a DT O
high JJ O
- : O
cholesterol NN O
diet JJ O
( ( O
43 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
% NN O
, , O
versus NN O
12 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
0 CD O
% NN O
for IN O
normotensive JJ O
animals NNS O
on IN O
a DT O
high JJ O
- : O
cholesterol NN O
diet JJ O
and CC O
4 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
7 CD O
% NN O
for IN O
animals NNS O
on IN O
standard JJ O
chow NN O
; : O
P NNP O
< VBD O
0 CD O
. . O
1 CD O
) ) O
. . O

CONCLUSIONS NN O
: : O
Biomechanical JJ O
strain NN O
induces NNS O
SRA NNP B-Gene
expression NN O
by IN O
monocyte NN O
/ NN O
macrophages NNS O
, , O
suggesting VBG O
a DT O
novel JJ O
mechanism NN O
for IN O
promotion NN O
of IN O
atherosclerosis NN O
in IN O
hypertensive JJ O
patients NNS O
. . O

High JJ O
glucose NN O
induces NNS O
MCP NNP O
- : O
1 CD O
expression NN O
partly RB O
via IN O
tyrosine NN O
kinase NN O
- : O
AP NNP O
- : O
1 CD O
pathway NN O
in IN O
peritoneal JJ O
mesothelial JJ O
cells NNS O
. . O

BACKGROUND NN O
: : O
High JJ O
glucose NN O
in IN O
peritoneal JJ O
dialysis NN O
solutions NNS O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
peritoneal JJ O
fibrosis NN O
in IN O
chronic JJ O
ambulatory NN O
peritoneal JJ O
dialysis NN O
( ( O
CAPD NNP O
) ) O
patients NNS O
. . O

However RB O
, , O
the DT O
mechanisms NNS O
are VBP O
not RB O
very RB O
clear JJ O
. . O

Peritoneal NNP O
macrophages VBZ O
seem VBP O
to TO O
participate VB O
in IN O
the DT O
process NN O
of IN O
peritoneal JJ O
fibrosis NN O
and CC O
monocyte NN B-Gene
chemoattractant NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
( ( O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
the DT O
recruitment NN O
of IN O
monocytes NNS O
toward IN O
the DT O
peritoneal JJ O
cavity NN O
. . O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
effect NN O
of IN O
high JJ O
glucose NN O
on IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
its PRP$ O
signal JJ O
transduction NN O
pathway NN O
in IN O
human JJ O
peritoneal JJ O
mesothelial JJ O
cells NNS O
. . O

METHODS NN O
: : O
Mesothelial JJ O
cells NNS O
were VBD O
cultured VBN O
with IN O
glucose NN O
( ( O
5 CD O
to TO O
100 CD O
mmol NNS O
/ NNP O
L NNP O
) ) O
or CC O
mannitol $ O
chronically RB O
for IN O
up IN O
to TO O
seven CD O
days NNS O
. . O

MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
of IN O
mRNA NN O
and CC O
protein NN O
was VBD O
measured VBN O
by IN O
Northern NNP O
blot NN O
analysis NN O
and CC O
enzyme VB O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
( ( O
ELISA NNP O
) ) O
. . O

Chemotactic JJ O
activity NN O
of IN O
high JJ O
- : O
glucose JJ O
- : O
conditioned JJ O
culture NN O
supernatant NN O
was VBD O
measured VBN O
by IN O
chemotactic JJ O
assay NN O
. . O

To TO O
examine VB O
the DT O
roles NNS O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
activator VBP B-Gene
protein JJ I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
, , O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
( ( O
EMSA NNP O
) ) O
was VBD O
performed VBN O
. . O

RESULTS NN O
: : O
Glucose NNP O
induced VBD O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ I-Gene
expression NN O
in IN O
a DT O
time NN O
- : O
and CC O
dose VB O
- : O
dependent JJ O
manner NN O
. . O

MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
in IN O
cell NN O
culture NN O
supernant NN O
was VBD O
also RB O
increased VBN O
. . O

Equivalent JJ O
concentrations NNS O
of IN O
mannitol NN O
had VBD O
no DT O
significant JJ O
effect NN O
. . O

High JJ O
- : O
glucose JJ O
- : O
conditioned VBN O
supernatant NN O
possessed VBD O
an DT O
increased VBN O
chemotactic JJ O
activity NN O
for IN O
monocytes NNS O
, , O
which WDT O
was VBD O
neutralized VBN O
by IN O
anti JJ B-Gene
- : I-Gene
MCP NNP I-Gene
- : I-Gene
1 CD I-Gene
antibody NN I-Gene
. . O

EMSA NNP O
revealed VBD O
that IN O
glucose NN O
increased VBD O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
activity NN O
in IN O
a DT O
time NN O
- : O
and CC O
dose VB O
- : O
dependent JJ O
manner NN O
, , O
but CC O
not RB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Curcumin NNP O
, , O
an DT O
inhibitor NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
dose SYM O
- : O
dependently RB O
suppressed VBD O
the DT O
induction NN O
of IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
by IN O
high JJ O
glucose NN O
. . O

Tyrosine NNP O
kinase NN O
inhibitors NNS O
such JJ O
as IN O
genistein NN O
( ( O
12 CD O
. . O
5 CD O
to TO O
50 CD O
micromol NNS O
/ NNP O
L NNP O
) ) O
and CC O
herbimycin VB O
A NNP O
( ( O
0 CD O
. . O
1 CD O
to TO O
1 CD O
micromol NNS O
/ NNP O
L NNP O
) ) O
inhibited VBD O
the DT O
high JJ O
- : O
glucose JJ O
- : O
induced JJ O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ I-Gene
expression NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
, , O
and CC O
also RB O
suppressed VBD O
the DT O
high JJ O
- : O
glucose JJ O
- : O
induced JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
activity NN O
. . O

CONCLUSIONS NN O
: : O
: : O
High JJ O
glucose NN O
induced VBD O
mesothelial JJ O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
partly RB O
via IN O
the DT O
tyrosine NN O
kinase NN O
- : O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
pathway NN O
. . O

Signal NNP O
thresholds NNS O
and CC O
modular JJ O
synergy NN O
during IN O
expression NN O
of IN O
costimulatory NN O
molecules NNS O
in IN O
B NNP O
lymphocytes NNS O
. . O

We PRP O
analyzed VBD O
intracellular JJ O
pathways NNS O
modulating VBG O
surface NN O
densities NNS O
of IN O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
in IN O
B NNP O
cells NNS O
activated VBD O
through IN O
ligation NN O
of IN O
the DT O
Ag NNP B-Gene
receptor NN I-Gene
, , O
and CC O
the DT O
adhesion NN B-Gene
molecule NN I-Gene
CD54 NNP B-Gene
. . O

Whereas NNP O
B NNP B-Gene
cell NN I-Gene
Ag NNP I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
cross NN O
- : O
linking VBG O
alone RB O
stimulated VBN O
increased JJ O
expression NN O
of IN O
CD86 NNP B-Gene
, , O
up RB O
- : O
regulation NN O
of IN O
CD80 NNP B-Gene
required VBD O
dual JJ O
stimulation NN O
with IN O
anti JJ B-Gene
- : I-Gene
IgM NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
CD54 NN I-Gene
. . O

The DT O
principal JJ O
downstream NN O
component NN O
contributed VBN O
by IN O
BCR NNP B-Gene
signaling VBG O
, , O
toward IN O
both DT O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
induction NN O
, , O
was VBD O
the DT O
elevated JJ O
concentration NN O
of IN O
free JJ O
cytoplasmic NN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
, , O
recruited VBN O
by IN O
way NN O
of IN O
capacitative JJ O
influx NN O
. . O

This DT O
alone NN O
was VBD O
sufficient JJ O
to TO O
generate VB O
an DT O
increase NN O
in IN O
CD86 NNP B-Gene
levels NNS O
. . O

However RB O
, , O
CD80 NNP B-Gene
enhancement NN O
required VBD O
the DT O
concerted JJ O
action NN O
of IN O
both DT O
intracellular JJ O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
concentration NN O
and CC O
CD54 NNP O
- : O
initiated JJ O
pathways NNS O
. . O

The DT O
nexus NN O
between IN O
anti JJ O
- : O
IgM NN O
and CC O
anti JJ O
- : O
CD54 NNP O
stimulation NN O
, , O
in IN O
the DT O
context NN O
of IN O
CD80 NNP B-Gene
regulation NN O
, , O
was VBD O
identified VBN O
to TO O
involve VB O
a DT O
self NN O
- : O
propagating VBG O
process NN O
of IN O
sequential JJ O
synergy NN O
. . O

The DT O
first JJ O
step NN O
involved VBN O
amplified JJ O
accumulation NN O
of IN O
intracellular JJ O
cAMP NN O
, , O
as IN O
a DT O
result NN O
of IN O
cross NN O
- : O
talk NN O
between IN O
BCR NNP B-Gene
- : O
mobilized VBN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
and CC O
CD54 NNP O
- : O
derived VBN O
signals NNS O
. . O

This DT O
then RB O
facilitated VBD O
a DT O
second JJ O
synergistic JJ O
interaction NN O
between IN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
and CC O
cAMP NN O
, , O
culminating VBG O
in IN O
CD80 NNP B-Gene
expression NN O
. . O

Our PRP$ O
findings NNS O
of IN O
distinct JJ O
signal JJ O
transducer NN O
requirements NNS O
, , O
with IN O
the DT O
added JJ O
consequences NNS O
of IN O
cross NN O
- : O
talk NN O
, , O
offers VBZ O
an DT O
explanation NN O
for IN O
variable JJ O
modulation NN O
of IN O
costimulatory NN O
molecule NN O
expression NN O
in IN O
response NN O
to TO O
diverse VB O
physiological JJ O
stimuli NNS O
. . O

Importantly RB O
, , O
these DT O
results NNS O
also RB O
reveal VBP O
how WRB O
concentration NN O
threshold VBD O
barriers NNS O
for IN O
recruitment NN O
of IN O
individual JJ O
second JJ O
messengers NNS O
can MD O
be VB O
overcome VBN O
by IN O
constructive JJ O
convergence NN O
of IN O
signaling VBG O
modules NNS O
. . O

The DT O
role NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
in IN O
neoplastic JJ O
transformation NN O
. . O

In IN O
this DT O
review NN O
, , O
we PRP O
focus VBP O
on IN O
new JJ O
data NNS O
from IN O
basic JJ O
, , O
translational JJ O
and CC O
clinical JJ O
research NN O
relating VBG O
to TO O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
. . O

Beside IN O
its PRP$ O
well NN O
- : O
known VBN O
tropism NN O
for IN O
B NNP O
lymphocytes NNS O
and CC O
epithelial JJ O
cells NNS O
, , O
EBV NNP O
also RB O
infects VBZ O
T NNP O
lymphocytes NNS O
, , O
monocytes NNS O
and CC O
granulocytes NNS O
. . O

After IN O
primary JJ O
infection NN O
, , O
EBV NNP O
persists VBZ O
throughout IN O
the DT O
life NN O
span NN O
in IN O
resting VBG O
memory NN O
B NNP O
cells NNS O
, , O
from IN O
where WRB O
it PRP O
is VBZ O
reactivated VBN O
upon IN O
breakdown NN O
of IN O
cellular JJ O
immunity NN O
. . O

In IN O
the DT O
process NN O
of IN O
neoplastic JJ O
transformation NN O
, , O
the DT O
EBV NNP B-Gene
- : I-Gene
encoded VBD I-Gene
latent JJ I-Gene
membrane NN I-Gene
protein NN I-Gene
1 CD I-Gene
( ( I-Gene
LMP1 NNP I-Gene
) ) I-Gene
oncogene NN I-Gene
represents VBZ O
the DT O
major JJ O
driving VBG O
force NN O
. . O

LMP1 JJ B-Gene
acts NNS O
like IN O
a DT O
constitutively RB B-Gene
activated JJ I-Gene
receptor NN I-Gene
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
family NN I-Gene
and CC O
allows VBZ O
the DT O
amplification NN O
or CC O
bypassing NN O
of IN O
physiological JJ O
regulatory JJ O
signals NNS O
through IN O
direct JJ O
and CC O
indirect JJ O
interactions NNS O
with IN O
proteins NNS O
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
( ( I-Gene
TRAF NNP I-Gene
) ) I-Gene
family NN I-Gene
. . O

TRAF2 NNP B-Gene
- : O
mediated VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
induction NN O
and CC O
JAK3 NNP B-Gene
/ NNP O
STAT NNP B-Gene
activation NN O
may MD O
result VB O
in IN O
sustained JJ O
proliferation NN O
leading VBG O
to TO O
lymphoma VB O
. . O

The DT O
ability NN O
of IN O
LMP1 NNP B-Gene
to TO O
suppress VB O
germinal JJ O
center NN O
formation NN O
and CC O
its PRP$ O
capacity NN O
to TO O
mediate VB O
its PRP$ O
own JJ O
transcriptional JJ O
activation NN O
shed VBD O
new JJ O
light NN O
on IN O
the DT O
pathogenesis NN O
of IN O
EBV NNP O
- : O
associated VBN O
latency NN O
type NN O
II NNP O
lymphoproliferations NNS O
like IN O
Hodgkin NNP O
' POS O
s JJ O
disease NN O
and CC O
angioimmunoblastic JJ O
lymphadenopathy NN O
. . O

The DT O
carboxy JJ B-Gene
terminus NN I-Gene
of IN O
LMP1 NNP B-Gene
is VBZ O
also RB O
a DT O
reliable JJ O
marker NN O
for IN O
individual JJ O
EBV NNP O
strain NN O
identification NN O
and CC O
thus RB O
offers VBZ O
new JJ O
possibilities NNS O
in IN O
tracing VBG O
the DT O
molecular JJ O
events NNS O
leading VBG O
to TO O
posttransplant VB O
lymphoproliferative JJ O
disorders NNS O
( ( O
PTLDs NNP O
) ) O
. . O

Cytotoxic NNP O
T NNP O
lymphocytes VBZ O
directed VBN O
against IN O
well RB O
- : O
characterized VBN O
epitopes NNS O
of IN O
EBV NNP B-Gene
latency NN I-Gene
genes NNS I-Gene
represent VBP O
an DT O
already RB O
successful JJ O
and CC O
promising JJ O
therapeutic JJ O
approach NN O
to TO O
EBV NNP O
- : O
associated VBN O
lymphomas NN O
, , O
in IN O
particular JJ O
PTLDs NNP O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
drives NNS O
T NNP O
cell NN O
- : O
mediated VBN O
immunopathology NN O
in IN O
the DT O
intestine NN O
. . O

The DT O
ability NN O
of IN O
interferon NN B-Gene
( ( I-Gene
IFN NNP I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
to TO O
induce VB O
autoimmunity NN O
and CC O
exacerbate VB O
Th1 NNP O
diseases NNS O
is VBZ O
well RB O
known VBN O
. . O

We PRP O
have VBP O
recently RB O
described VBN O
enhanced JJ O
expression NN O
of IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
in IN O
the DT O
mucosa NN O
of IN O
patients NNS O
with IN O
celiac JJ O
disease NN O
( ( O
CD NN O
) ) O
, , O
a DT O
gluten JJ O
- : O
sensitive JJ O
Th1 NNP O
- : O
mediated VBD O
enteropathy JJ O
, , O
characterized VBN O
by IN O
villous JJ O
atrophy NN O
and CC O
crypt NN O
cell NN O
hyperplasia NN O
. . O

Previous JJ O
studies NNS O
from IN O
this DT O
laboratory NN O
have VBP O
shown VBN O
that IN O
T NNP O
cell NN O
activation NN O
in IN O
explant JJ O
cultures NNS O
of IN O
human JJ O
fetal JJ O
gut NN O
can MD O
also RB O
result VB O
in IN O
villous JJ O
atrophy NN O
and CC O
crypt NN O
cell NN O
hyperplasia NN O
. . O

We PRP O
have VBP O
, , O
therefore RB O
, , O
examined VBD O
changes NNS O
that WDT O
take VBP O
place NN O
in IN O
explant JJ O
cultures NNS O
of IN O
human JJ O
fetal JJ O
gut NN O
after IN O
activation NN O
of IN O
T NNP O
cells NNS O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
and CC O
/ NN O
or CC O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

We PRP O
show VBP O
that DT O
activation NN O
of IN O
T NNP O
cells NNS O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
alone RB O
elicits VBZ O
a DT O
small JJ O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
response NN O
with IN O
no DT O
tissue NN O
injury NN O
. . O

Similarly RB O
, , O
no DT O
changes NNS O
are VBP O
seen VBN O
in IN O
explants NNS O
cultured VBN O
with IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
alone RB O
. . O

However RB O
, , O
addition NN O
of IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
results NNS O
in IN O
enhanced JJ O
Th1 NNP O
response NN O
and CC O
crypt NN O
cell NN O
hyperplasia NN O
. . O

This DT O
is VBZ O
associated VBN O
with IN O
enhanced JJ O
phosphorylation NN O
of IN O
STAT1 NNP B-Gene
, , O
STAT3 NNP B-Gene
, , O
and CC O
Fyn NNP B-Gene
, , I-Gene
a DT I-Gene
Src NNP I-Gene
homology NN I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
, , O
which WDT O
interacts VBZ O
with IN O
both DT O
TCR NNP O
and CC O
IFN NNP O
- : O
alpha JJ O
signal JJ O
components NNS O
. . O

Together RB O
these DT O
data NNS O
indicate VBP O
that IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
can MD O
facilitate VB O
activation NN O
of IN O
Th1 NNP O
- : O
reactive JJ O
cells NNS O
in IN O
the DT O
gut NN O
and CC O
drive JJ O
immunopathology NN O
. . O

Suppression NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha IN I-Gene
production NN O
by IN O
cAMP NN O
in IN O
human JJ O
monocytes NNS O
: : O
dissociation NN O
with IN O
mRNA JJ O
level NN O
and CC O
independent JJ O
of IN O
interleukin JJ B-Gene
- : I-Gene
10 CD I-Gene
. . O

BACKGROUND NN O
: : O
Elevation NN O
of IN O
cellular JJ O
cAMP NN O
inhibits NNS O
lipopolysaccharide VBP O
( ( O
LPS NNP O
) ) O
- : O
stimulated VBN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
production NN O
and CC O
increases VBZ O
the DT O
expression NN O
of IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
10 CD I-Gene
in IN O
mononuclear JJ O
cells NNS O
. . O

TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN I-Gene
expression NN O
obligates VBZ O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
. . O

Exogenous JJ O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
inhibits NNS O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
monocytes NNS O
and CC O
thus RB O
attenuates NNS O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
. . O

We PRP O
examined VBD O
the DT O
role NN O
of IN O
endogenous JJ O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
in IN O
the DT O
regulation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
in IN O
human JJ O
monocytes NNS O
by IN O
cAMP NN O
. . O

METHODS NN O
: : O
Human JJ O
monocytes NNS O
were VBD O
stimulated VBN O
with IN O
Escherichia NNP O
coli NNS O
LPS NNP O
( ( O
100 CD O
ng RB O
/ NNP O
ml NN O
) ) O
with IN O
and CC O
without IN O
forskolin NN O
( ( O
FSK NNP O
, , O
50 CD O
microM NN O
) ) O
or CC O
dibutyryl JJ O
cyclic JJ O
AMP NNP O
( ( O
dbcAMP NN O
, , O
100 CD O
microM NN O
) ) O
. . O

Cytokine NNP B-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
) ) O
release NN O
was VBD O
measured VBN O
by IN O
immunoassay NN O
. . O

TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
mRNA NN I-Gene
was VBD O
measured VBN O
by IN O
reverse JJ O
transcription NN O
polymerase NN O
chain NN O
reaction NN O
, , O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
binding NN O
activity NN O
was VBD O
assessed VBN O
by IN O
gel JJ O
mobility NN O
shift NN O
assay NN O
. . O

RESULTS NN O
: : O
cAMP JJ O
- : O
elevating VBG O
agents NNS O
inhibited VBN O
LPS NNP O
- : O
stimulated VBD O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
( ( O
0 CD O
. . O
77 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
13 CD O
ng JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
in IN O
LPS NNP O
+ NNP O
dbcAMP NN O
and CC O
0 CD O
. . O
68 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
19 CD O
ng JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
in IN O
LPS NNP O
+ NNP O
FSK NNP O
, , O
both DT O
P NNP O
< VBD O
0 CD O
. . O
5 CD O
vs JJ O
1 CD O
. . O
61 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
34 CD O
ng JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
in IN O
LPS NNP O
alone RB O
) ) O
. . O

Conversely RB O
, , O
cAMP NN O
enhanced VBD O
LPS NNP O
- : O
stimulated VBD O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
release NN O
( ( O
100 CD O
+ NN O
/ NNP O
- : O
21 CD O
. . O
5 CD O
pg JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
in IN O
LPS NNP O
+ NNP O
dbcAMP NN O
and CC O
110 CD O
+ NN O
/ NNP O
- : O
25 CD O
. . O
2 CD O
pg JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
in IN O
LPS NNP O
+ NNP O
FSK NNP O
, , O
both DT O
P NNP O
< VBD O
0 CD O
. . O
5 CD O
vs JJ O
53 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
12 CD O
. . O
8 CD O
pg JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
in IN O
LPS NNP O
alone RB O
) ) O
. . O

Neither DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
mRNA NN I-Gene
expression NN O
nor CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
stimulated VBN O
by IN O
LPS NNP O
was VBD O
inhibited VBN O
by IN O
the DT O
cAMP NN O
- : O
elevating VBG O
agents NNS O
. . O

Neutralization NN O
of IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
with IN O
a DT O
specific JJ O
antibody NN B-Gene
did VBD O
not RB O
attenuate VB O
the DT O
effect NN O
of IN O
cAMP NN O
- : O
elevating VBG O
agents NNS O
on IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
. . O

CONCLUSION NN O
: : O
The DT O
results NNS O
indicate VBP O
that IN O
cAMP NN O
inhibits NNS O
LPS NNP O
- : O
stimulated VBD O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
through IN O
a DT O
posttranscriptional JJ O
mechanism NN O
that WDT O
is VBZ O
independent JJ O
of IN O
endogenous JJ O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Activation NN O
of IN O
the DT O
p21 NN B-Gene
( ( I-Gene
CIP1 NNP I-Gene
/ NNP I-Gene
WAF1 NNP I-Gene
) ) I-Gene
promoter NN I-Gene
by IN O
bone NN B-Gene
morphogenetic JJ I-Gene
protein NN I-Gene
- : I-Gene
2 CD I-Gene
in IN O
mouse NN O
B NNP O
lineage NN O
cells NNS O
. . O

BMPs NNP B-Gene
exert VBZ O
a DT O
negative JJ O
growth NN O
effect NN O
on IN O
various JJ O
types NNS O
of IN O
cells NNS O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that IN O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
inhibited VBD O
the DT O
growth NN O
of IN O
HS NNP O
- : O
72 CD O
mouse NN O
hybridoma NN O
cells NNS O
by IN O
inducing VBG O
p21 NN O
( ( O
CIP1 NNP O
/ NNP O
WAF1 NNP O
) ) O
expression NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
demonstrated VBD O
that IN O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
activated VBD O
the DT O
mouse NN O
p21 NN B-Gene
( ( I-Gene
CIP1 NNP I-Gene
/ NNP I-Gene
WAF1 NNP I-Gene
) ) I-Gene
promoter NN I-Gene
in IN O
HS NNP O
- : O
72 CD O
cells NNS O
, , O
and CC O
that IN O
a DT O
29 CD B-Gene
- : I-Gene
base NN I-Gene
pair NN I-Gene
( ( I-Gene
b NN I-Gene
) ) I-Gene
region NN I-Gene
of IN O
the DT O
promoter NN O
( ( O
- : O
1928 CD O
/ SYM O
- : O
1900 CD O
relative NN O
to TO O
the DT O
TATA NNP B-Gene
box NN I-Gene
) ) O
, , O
conserved VBD O
between IN O
mice NNS O
and CC O
humans NNS O
, , O
was VBD O
responsive JJ O
to TO O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
as RB O
well RB O
as IN O
expression NN O
of IN O
Smad1 NNP B-Gene
, , O
Smad4 NNP B-Gene
, , O
and CC O
constitutively RB O
active JJ O
mutants NNS O
of IN O
BMP NNP B-Gene
type NN I-Gene
I PRP I-Gene
receptors NNS I-Gene
. . O

Furthermore RB O
, , O
an DT O
oligonucleotide NN O
containing VBG O
the DT O
29 CD B-Gene
- : I-Gene
b NN I-Gene
region NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
Smad4 NNP B-Gene
and CC O
phosphorylated VBD B-Gene
Smad1 NNP I-Gene
in IN O
the DT O
nuclear JJ O
extract NN O
of IN O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
stimulated VBN O
HS NNP O
- : O
72 CD O
cells NNS O
. . O

These DT O
results NNS O
suggested VBD O
that IN O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
might MD O
activate VB O
p21 NN O
( ( O
CIP1 NNP O
/ NNP O
WAF1 NNP O
) ) O
transcription NN O
by IN O
inducing VBG O
a DT O
binding NN O
of IN O
Smad4 NNP B-Gene
and CC O
Smad1 NNP B-Gene
to TO O
the DT O
29 CD B-Gene
- : I-Gene
b NN I-Gene
region NN I-Gene
in IN O
HS NNP O
- : O
72 CD O
cells NNS O
. . O

Dendritic NNP O
cell NN O
development NN O
from IN O
common JJ O
myeloid NN O
progenitors NNS O
. . O

Dendritic JJ O
cells NNS O
( ( O
DCs NNP O
) ) O
are VBP O
professional JJ O
antigen NN O
- : O
presenting NN O
cells NNS O
which WDT O
both DT O
initiate VBP O
adaptive JJ O
immune NN O
responses NNS O
and CC O
control VB O
tolerance NN O
to TO O
self VB B-Gene
- : I-Gene
antigens NNS I-Gene
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
these DT O
different JJ O
effects NNS O
on IN O
responder NN O
cells NNS O
depend VBP O
on IN O
subsets NNS O
of IN O
DCs NNP O
arising VBG O
from IN O
either CC O
myeloid VB O
or CC O
lymphoid VB O
hematopoietic JJ O
origins NNS O
. . O

In IN O
this DT O
model NN O
, , O
CD8 NNP O
alpha VBZ O
+ NNP O
Mac NNP O
- : O
1 CD O
- : O
DCs NN O
are VBP O
supposed VBN O
to TO O
be VB O
of IN O
lymphoid JJ O
while IN O
CD8 NNP O
alpha SYM O
- : O
Mac NNP O
- : O
1 CD O
+ JJ O
DCs NNP O
are VBP O
supposed VBN O
to TO O
be VB O
of IN O
myeloid JJ O
origin NN O
. . O

Here RB O
we PRP O
summarize VBP O
our PRP$ O
findings NNS O
that IN O
both DT O
CD8 NNP O
alpha NN O
+ NN O
and CC O
CD8 NNP O
alpha VBP O
- : O
DCs NN O
can MD O
arise VB O
from IN O
clonogenic JJ O
common JJ O
myeloid NN O
progenitors NNS O
( ( O
CMPs NNP O
) ) O
in IN O
both DT O
thymus NN O
and CC O
spleen NN O
. . O

Therefore RB O
CD8 NNP B-Gene
alpha JJ I-Gene
expression NN O
DCs NNP O
does VBZ O
not RB O
indicate VB O
a DT O
lymphoid JJ O
origin NN O
and CC O
differences NNS O
among IN O
CD8 NNP O
alpha VBP O
+ NNP O
and CC O
CD8 NNP O
alpha VBP O
- : O
DCs NN O
might MD O
rather RB O
reflect VB O
maturation NN O
status NN O
than IN O
ontogeny NN O
. . O

On IN O
the DT O
basis NN O
of IN O
transplantation NN O
studies NNS O
, , O
it PRP O
seems VBZ O
likely JJ O
that IN O
most JJS O
of IN O
the DT O
DCs NNP O
in IN O
secondary JJ O
lymphoid JJ O
organs NNS O
and CC O
a DT O
substantial JJ O
fraction NN O
of IN O
thymic JJ O
DCs NNP O
are VBP O
myeloid JJ O
- : O
derived VBN O
. . O

Macrophage NN O
stimulation NN O
with IN O
Murabutide NNP O
, , O
an DT O
HIV NNP O
- : O
suppressive JJ O
muramyl NN O
peptide NN O
derivative JJ O
, , O
selectively RB O
activates VBZ O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated VBN I-Gene
kinases NNS I-Gene
1 CD I-Gene
and CC I-Gene
2 CD I-Gene
, , O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
and CC O
STAT1 NNP B-Gene
: : O
role NN O
of IN O
CD14 NNP B-Gene
and CC O
Toll NNP B-Gene
- : I-Gene
like IN I-Gene
receptors NNS I-Gene
2 CD I-Gene
and CC I-Gene
4 CD I-Gene
. . O

The DT O
smallest JJS O
unit NN O
of IN O
bacterial JJ O
peptidoglycans NNS O
known VBN O
to TO O
be VB O
endowed VBN O
with IN O
biological JJ O
activities NNS O
is VBZ O
muramyl JJ O
dipeptide NN O
( ( O
MDP NNP O
) ) O
. . O

A DT O
clinically RB O
acceptable JJ O
synthetic JJ O
derivative NN O
of IN O
MDP NNP O
, , O
namely RB O
murabutide NN O
( ( O
MB NNP O
) ) O
, , O
has VBZ O
been VBN O
found VBN O
to TO O
present VB O
interesting JJ O
pharmacological JJ O
properties NNS O
and CC O
to TO O
suppress VB O
HIV NNP O
- : O
1 CD O
replication NN O
in IN O
monocyte JJ O
- : O
derived VBN O
macrophages NNS O
( ( O
MDM NNP O
) ) O
. . O

We PRP O
have VBP O
addressed VBN O
the DT O
signaling VBG O
events NNS O
activated VBN O
in IN O
MDM NNP O
following VBG O
stimulation NN O
with IN O
either DT O
MB NNP O
or CC O
the DT O
potent JJ O
immunostimulant JJ O
LPS NNP O
. . O

We PRP O
also RB O
examined VBD O
whether IN O
signaling VBG O
by IN O
muramyl NN O
peptides NNS O
involves VBZ O
the DT O
use NN O
of IN O
cell NN B-Gene
surface NN I-Gene
receptors NNS I-Gene
, , O
including VBG O
CD14 NNP B-Gene
and CC O
Toll NNP B-Gene
- : I-Gene
like IN I-Gene
receptor NN I-Gene
2 CD I-Gene
( ( O
TLR2 NNP B-Gene
) ) O
or CC O
TLR4 $ B-Gene
that WDT O
are VBP O
known VBN O
to TO O
be VB O
signal JJ B-Gene
- : I-Gene
transducing NN I-Gene
receptors NNS I-Gene
for IN O
other JJ O
bacterial JJ O
cell NN O
wall NN O
components NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
, , O
unlike IN O
LPS NNP O
, , O
the DT O
safe JJ O
immunomodulator NN O
MB NNP O
selectively RB O
activates VBZ O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated VBN I-Gene
kinases NNS I-Gene
( ( I-Gene
Erk NNP I-Gene
) ) I-Gene
1 CD I-Gene
/ $ I-Gene
2 CD I-Gene
, , O
in IN O
the DT O
absence NN O
of IN O
detectable JJ O
Jun NNP B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
or CC O
p38 JJ B-Gene
mitogen NN I-Gene
- : I-Gene
activated JJ I-Gene
kinase NN I-Gene
activation NN O
. . O

Furthermore RB O
, , O
STAT1 NNP B-Gene
activation NN O
but CC O
weak JJ O
or CC O
no DT O
activation NN O
of IN O
STAT3 NNP B-Gene
or CC O
STAT5 NNP B-Gene
respectively RB O
, , O
could MD O
be VB O
detected VBN O
in IN O
MB NNP O
- : O
stimulated VBD O
MDM NNP O
. . O

Using VBG O
MonoMac6 NNP O
cells NNS O
, , O
we PRP O
observed VBD O
high JJ O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
but CC O
weaker JJR O
and CC O
transient JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
by IN O
MB NNP O
. . O

Moreover RB O
, , O
the DT O
truncated JJ O
form NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
, , O
known VBN O
to TO O
repress VB O
HIV NNP O
- : O
1 CD O
transcription NN O
, , O
was VBD O
detected VBN O
in IN O
extracts NNS O
from IN O
MB NNP O
- : O
treated VBD O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Surprisingly RB O
, , O
neither DT O
MB NNP O
nor CC O
MDP NNP O
were VBD O
able JJ O
to TO O
transduce VB O
signals NNS O
via IN O
CD14 NNP B-Gene
and CC O
TLR2 NNP B-Gene
or CC I-Gene
4 CD I-Gene
. . O

These DT O
findings NNS O
present VBP O
major JJ O
differences NNS O
in IN O
the DT O
early JJ O
cell NN O
activation NN O
process NN O
between IN O
LPS NNP O
and CC O
muramyl NNP O
peptides NNS O
, , O
and CC O
strongly RB O
argue VB O
for IN O
the DT O
implication NN O
of IN O
co NN B-Gene
- : I-Gene
receptors NNS I-Gene
other JJ O
than IN O
TLR2 NNP B-Gene
and CC O
TLR4 NNP B-Gene
in IN O
mediating VBG O
the DT O
signaling VBG O
events NNS O
induced VBN O
by IN O
defined JJ O
subunits NNS O
of IN O
bacterial JJ O
peptidoglycans NNS O
. . O

Nuclear JJ B-Gene
peroxisome NN I-Gene
proliferator NN I-Gene
- : I-Gene
activated JJ I-Gene
receptors NNS I-Gene
alpha VBP I-Gene
and CC I-Gene
gamma VBP I-Gene
have VBP O
opposing VBG O
effects NNS O
on IN O
monocyte NN O
chemotaxis NN O
in IN O
endometriosis NN O
. . O

The DT O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptors NNS I-Gene
( ( I-Gene
PPARs NNP I-Gene
) ) I-Gene
alpha NN I-Gene
and CC I-Gene
gamma NN I-Gene
are VBP O
nuclear JJ B-Gene
receptors NNS I-Gene
that IN O
play VBP O
important JJ O
roles NNS O
in IN O
inflammatory JJ O
diseases NNS O
like IN O
ulcerative JJ O
colitis NN O
and CC O
arthritis NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
the DT O
possible JJ O
role NN O
of IN O
PPARs NNP B-Gene
in IN O
macrophage NN O
attraction NN O
into IN O
the DT O
peritoneal JJ O
cavity NN O
of IN O
patients NNS O
with IN O
endometriosis NN O
. . O

We PRP O
identified VBD O
PPAR NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
gamma NN I-Gene
messenger NN O
RNA NNP O
by IN O
RT NNP O
- : O
PCR NN O
and CC O
protein NN O
by IN O
immunoblotting VBG O
of IN O
lysates NNS O
of IN O
peritoneal JJ O
macrophages NNS O
and CC O
monocytic JJ O
U937 NNP O
cells NNS O
. . O

Using VBG O
immunocytochemistry NN O
, , O
we PRP O
localized VBD O
PPAR NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
gamma NN I-Gene
within IN O
the DT O
nuclei NN O
of IN O
both DT O
cell NN O
types NNS O
. . O

Monocyte NNP O
chemotactic JJ O
activity NN O
of IN O
peritoneal JJ O
fluid NN O
from IN O
patients NNS O
with IN O
endometriosis NN O
was VBD O
quantified VBN O
in IN O
Boyden NNP O
chambers NNS O
. . O

Migration NN O
of IN O
U937 NNP O
cells NNS O
was VBD O
increased VBN O
by IN O
WY NNP O
14643 CD O
and CC O
reduced VBN O
by IN O
rosiglitazone NN O
. . O

Peritoneal NNP O
fluid NN O
from IN O
patients NNS O
with IN O
endometriosis NN O
activated VBN O
U937 NNP O
cells NNS O
transiently RB O
transfected VBN O
with IN O
a DT O
PPAR NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ JJ I-Gene
GAL4 NNP I-Gene
luciferase NN I-Gene
reporter NN I-Gene
. . O

By IN O
contrast NN O
, , O
peritoneal JJ O
fluid NN O
did VBD O
not RB O
cause VB O
significant JJ O
activation NN O
of IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
/ JJ I-Gene
GAL4 NNP I-Gene
constructs NNS I-Gene
. . O

The DT O
U937 NNP O
cells NNS O
transiently RB O
transfected VBN O
with IN O
a DT O
PPAR NNP B-Gene
response NN I-Gene
element NN I-Gene
luciferase NN I-Gene
reporter NN I-Gene
showed VBD O
disease NN O
stage NN O
- : O
dependent NN O
up IN O
- : O
regulation NN O
when WRB O
treated VBN O
with IN O
peritoneal JJ O
fluid NN O
from IN O
patients NNS O
with IN O
endometriosis NN O
. . O

Treatment NN O
with IN O
peritoneal JJ O
fluid NN O
from IN O
healthy JJ O
controls NNS O
down RP O
- : O
regulated JJ O
PPAR NNP O
response NN O
element NN O
transactivation NN O
. . O

We PRP O
conclude VBP O
that DT O
peritoneal JJ O
fluid NN O
of IN O
endometriosis NN O
patients NNS O
contains VBZ O
activators NNS O
of IN O
PPAR NNP B-Gene
- : I-Gene
alpha NN I-Gene
that WDT O
stimulate JJ O
macrophage NN O
chemotaxis NN O
. . O

Inhibitors NNS O
of IN O
PPAR NNP B-Gene
- : I-Gene
alpha NN I-Gene
or CC O
activators NNS O
of IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
could MD O
be VB O
developed VBN O
for IN O
the DT O
treatment NN O
of IN O
inflammation NN O
associated VBN O
with IN O
endometriosis NN O
. . O

Long NNP O
- : O
term NN O
- : O
impaired JJ O
expression NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
in IN O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
of IN O
trauma NN O
patients NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
expression NN O
and CC O
dimer NN O
characteristics NNS O
were VBD O
studied VBN O
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMCs NNP O
) ) O
of IN O
major JJ O
- : O
trauma NN O
patients NNS O
and CC O
healthy JJ O
controls NNS O
. . O

Analysis NN O
of IN O
PBMCs NNP O
on IN O
days NNS O
1 CD O
, , O
3 CD O
, , O
5 CD O
, , O
and CC O
10 CD O
after IN O
trauma NN O
revealed VBD O
that IN O
expression NN O
of IN O
both DT O
p65p50 JJ B-Gene
heterodimers NNS I-Gene
and CC O
p50p50 NN B-Gene
homodimers NNS I-Gene
was VBD O
significantly RB O
reduced VBN O
compared VBN O
with IN O
that DT O
in IN O
controls NNS O
. . O

In IN O
vitro JJ O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
stimulation NN O
of IN O
PBMCs NNP O
induced VBD O
NF NNP O
- : O
kappa NN O
B NNP O
translocation NN O
. . O

However RB O
, , O
throughout IN O
the DT O
survey NN O
, , O
p65p50 JJ O
activation NN O
remained VBD O
significantly RB O
lower JJR O
in IN O
trauma NN O
patients NNS O
than IN O
in IN O
controls NNS O
. . O

After IN O
LPS NNP O
stimulation NN O
in IN O
vitro NN O
, , O
the DT O
p65p50 NN O
/ NNP O
p50p50 NN O
ratio NN O
was VBD O
significantly RB O
lower JJR O
in IN O
PBMCs NNP O
from IN O
trauma NN O
patients NNS O
than IN O
from IN O
healthy JJ O
controls NNS O
. . O

The DT O
ex NN O
vivo JJ O
expression NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
was VBD O
higher RBR O
in IN O
PBMCs NNP O
of IN O
controls NNS O
than IN O
of IN O
trauma JJ O
patients NNS O
. . O

LPS NNP O
did VBD O
not RB O
induce VB O
I PRP O
kappa VBP O
B NNP O
expression NN O
in IN O
PBMCs NNP O
from IN O
trauma NN O
patients NNS O
, , O
but CC O
strong JJ O
induction NN O
was VBD O
obtained VBN O
with IN O
staphylococci NN O
, , O
suggesting VBG O
that IN O
this DT O
defect NN O
is VBZ O
not RB O
universal JJ O
and CC O
depends VBZ O
on IN O
the DT O
nature NN O
of IN O
the DT O
activating VBG O
signal NN O
. . O

Although IN O
no DT O
direct JJ O
correlation NN O
was VBD O
found VBN O
between IN O
levels NNS O
of IN O
interleukin JJ B-Gene
- : I-Gene
10 CD I-Gene
or CC O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
these DT O
immunosuppressive JJ B-Gene
cytokines NNS I-Gene
were VBD O
significantly RB O
elevated VBN O
in IN O
trauma NN O
patients NNS O
by IN O
10 CD O
days NNS O
after IN O
admission NN O
. . O

The DT O
long JJ O
- : O
term NN O
low JJ O
- : O
basal NN O
and CC O
LPS NNP O
- : O
induced VBD O
nuclear JJ O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
recalled VBD O
long JJ O
- : O
term NN O
immunoparalysis NN O
observed VBN O
in IN O
patients NNS O
with IN O
severe JJ O
inflammatory JJ O
stress NN O
such JJ O
as IN O
trauma NN O
. . O

Hepatic NNP O
ischemia NN O
- : O
reperfusion NN O
injury NN O
. . O

BACKGROUND NN O
: : O
The DT O
morbidity NN O
associated VBN O
with IN O
liver JJ O
transplantation NN O
and CC O
major JJ O
hepatic JJ O
resections NNS O
is VBZ O
partly RB O
a DT O
result NN O
of IN O
ischemia NN O
- : O
reperfusion NN O
injury NN O
. . O

DATA NNP O
SOURCES NNS O
: : O
The DT O
entire JJ O
world NN O
literature NN O
on IN O
the DT O
subject NN O
was VBD O
searched VBN O
via IN O
Medline NNP O
. . O

Keywords NNS O
included VBD O
reperfusion NN O
injury NN O
, , O
transplantation NN O
, , O
liver JJ O
resection NN O
, , O
nitric JJ O
oxide NN O
, , O
endothelin NN O
, , O
cytokines NNS B-Gene
, , O
Kupffer NNP O
cells NNS O
, , O
ischemic JJ O
/ NNP O
ischaemic JJ O
preconditioning NN O
, , O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

CONCLUSIONS NN O
: : O
An DT O
imbalance NN O
between IN O
endothelin NN O
and CC O
nitric JJ O
oxide NN O
levels NNS O
results NNS O
in IN O
failure NN O
of IN O
the DT O
hepatic JJ O
microcirculation NN O
at IN O
the DT O
onset NN O
of IN O
reperfusion NN O
. . O

Activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
the DT O
liver NN O
promotes VBZ O
proinflammatory JJ B-Gene
cytokine NN I-Gene
and CC O
adhesion NN B-Gene
molecule NN I-Gene
synthesis NN O
. . O

These DT O
result NN O
in IN O
oxygen NN O
- : O
derived VBN O
free JJ O
radical JJ O
production NN O
and CC O
neutrophil JJ O
recruitment NN O
, , O
further RB O
contributing VBG O
to TO O
cellular JJ O
injury NN O
. . O

Various JJ O
therapeutic JJ O
modalities NNS O
acting VBG O
on IN O
the DT O
above JJ O
mediators NNS O
have VBP O
been VBN O
successfully RB O
used VBN O
to TO O
attenuate VB O
reperfusion NN O
injury NN O
in IN O
animal JJ O
models NNS O
of IN O
hepatic JJ O
transplantation NN O
and CC O
resection NN O
. . O

Application NN O
of IN O
the DT O
knowledge NN O
gained VBN O
from IN O
animal JJ O
models NNS O
of IN O
hepatic JJ O
ischemia NN O
- : O
reperfusion NN O
to TO O
the DT O
clinical JJ O
setting NN O
will MD O
improve VB O
the DT O
outcome NN O
of IN O
hepatic JJ O
surgery NN O
. . O

Down NNP O
- : O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
p40 JJ I-Gene
gene NN I-Gene
in IN O
Plasmodium NNP O
berghei SYM O
- : O
infected JJ O
mice NN O
. . O

We PRP O
analyzed VBD O
the DT O
mechanism NN O
that WDT O
causes VBZ O
suppression NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
p40 JJ I-Gene
gene NN I-Gene
induction NN O
during IN O
Plasmodium NNP O
berghei JJ O
infection NN O
. . O

Although IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
together RB O
with IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
protection NN O
against IN O
pathogenic JJ O
infection NN O
, , O
the DT O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
p70 NN I-Gene
protein NN I-Gene
production NN O
of IN O
infected JJ O
macrophages NNS O
is VBZ O
lower JJR O
than IN O
that DT O
by IN O
the DT O
uninfected JJ O
macrophages NNS O
. . O

We PRP O
showed VBD O
in IN O
the DT O
present JJ O
study NN O
that IN O
the DT O
induction NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
p40 JJ I-Gene
gene NN I-Gene
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
p35 JJ I-Gene
gene NN I-Gene
in IN O
macrophages NNS O
of IN O
P NNP O
. . O
berghei SYM O
- : O
infected JJ O
mice NN O
was VBD O
profoundly RB O
inhibited VBN O
. . O

The DT O
inhibition NN O
was VBD O
induced VBN O
by IN O
interaction NN O
with IN O
macrophages NNS O
that WDT O
had VBD O
contacted VBN O
with IN O
P NNP O
. . O
berghei SYM O
- : O
infected VBN O
erythrocytes NNS O
and CC O
was VBD O
mediated VBN O
by IN O
a DT O
soluble JJ O
factor NN O
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
. . O

There EX O
was VBD O
comparable JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
uninfected JJ O
and CC O
infected JJ O
cells NNS O
. . O

The DT O
induction NN O
of IN O
IFN NNP B-Gene
- : I-Gene
regulatory JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
was VBD O
comparable JJ O
in IN O
transcription NN O
level NN O
in IN O
uninfected JJ O
and CC O
infected JJ O
cells NNS O
, , O
while IN O
the DT O
unidentified JJ O
complex JJ O
formation NN O
of IN O
IFN NNP B-Gene
- : I-Gene
regulatory JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
observed VBN O
in IN O
infected JJ O
cells NNS O
. . O

Therefore RB O
, , O
the DT O
inhibition NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
p40 JJ I-Gene
gene NN I-Gene
induction NN O
appeared VBD O
to TO O
be VB O
regulated VBN O
at IN O
transcriptional JJ O
regulation NN O
level NN O
of IN O
the DT O
gene NN O
. . O

The DT O
Friend NNP B-Gene
of IN I-Gene
GATA NNP I-Gene
proteins NNS I-Gene
U NNP O
- : O
shaped VBD O
, , O
FOG NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
FOG NNP B-Gene
- : I-Gene
2 CD I-Gene
function NN O
as IN O
negative JJ O
regulators NNS O
of IN O
blood NN O
, , O
heart NN O
, , O
and CC O
eye NN O
development NN O
in IN O
Drosophila NNP O
. . O

Friend NN B-Gene
of IN I-Gene
GATA NNP I-Gene
( ( I-Gene
FOG NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
regulate JJ O
GATA NNP O
factor NN O
- : O
activated VBN O
gene NN O
transcription NN O
. . O

During IN O
vertebrate JJ O
hematopoiesis NN O
, , O
FOG NNP B-Gene
and CC I-Gene
GATA NNP I-Gene
proteins NNS I-Gene
cooperate VBP O
to TO O
promote VB O
erythrocyte NN O
and CC O
megakaryocyte JJ O
differentiation NN O
. . O

The DT O
Drosophila NNP B-Gene
FOG NNP I-Gene
homologue NN I-Gene
U NNP I-Gene
- : I-Gene
shaped VBD I-Gene
( ( O
Ush NNP B-Gene
) ) O
is VBZ O
expressed VBN O
similarly RB O
in IN O
the DT O
blood NN O
cell NN O
anlage NN O
during IN O
embryogenesis NN O
. . O

During IN O
hematopoiesis NN O
, , O
the DT O
acute NN O
myeloid NN O
leukemia NN O
1 CD O
homologue NN O
Lozenge NNP O
and CC O
Glial NNP O
cells NNS O
missing VBG O
are VBP O
required VBN O
for IN O
the DT O
production NN O
of IN O
crystal JJ O
cells NNS O
and CC O
plasmatocytes NNS O
, , O
respectively RB O
. . O

However RB O
, , O
additional JJ O
factors NNS O
have VBP O
been VBN O
predicted VBN O
to TO O
control VB O
crystal JJ O
cell NN O
proliferation NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
show VBP O
that IN O
Ush NNP B-Gene
is VBZ O
expressed VBN O
in IN O
hemocyte NN O
precursors NNS O
and CC O
plasmatocytes NNS O
throughout IN O
embryogenesis NN O
and CC O
larval NN O
development NN O
, , O
and CC O
the DT O
GATA NNP B-Gene
factor NN I-Gene
Serpent NNP I-Gene
is VBZ O
essential JJ O
for IN O
Ush NNP B-Gene
embryonic JJ O
expression NN O
. . O

Furthermore RB O
, , O
loss NN O
of IN O
ush JJ O
function NN O
results NNS O
in IN O
an DT O
overproduction NN O
of IN O
crystal JJ O
cells NNS O
, , O
whereas RB O
forced VBN O
expression NN O
of IN O
Ush NNP B-Gene
reduces VBZ O
this DT O
cell NN O
population NN O
. . O

Murine NNP B-Gene
FOG NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
FOG NNP I-Gene
- : I-Gene
2 CD I-Gene
also RB O
can MD O
repress VB O
crystal JJ O
cell NN O
production NN O
, , O
but CC O
a DT O
mutant JJ O
version NN O
of IN O
FOG NNP B-Gene
- : I-Gene
2 CD I-Gene
lacking VBG O
a DT O
conserved JJ O
motif NN O
that WDT O
binds VBZ O
the DT O
corepressor NN B-Gene
C NNP I-Gene
- : I-Gene
terminal JJ I-Gene
binding NN I-Gene
protein NN I-Gene
fails VBZ O
to TO O
affect VB O
the DT O
cell NN O
lineage NN O
. . O

The DT O
GATA NNP B-Gene
factor NN I-Gene
Pannier NNP I-Gene
( ( O
Pnr NNP B-Gene
) ) O
is VBZ O
required VBN O
for IN O
eye NN O
and CC O
heart NN O
development NN O
in IN O
Drosophila NNP O
. . O

When WRB O
Ush NNP B-Gene
, , O
FOG NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
FOG NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
or CC O
mutant JJ B-Gene
FOG NNP I-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
coexpressed VBN O
with IN O
Pnr NNP B-Gene
during IN O
these DT O
developmental JJ O
processes NNS O
, , O
severe JJ O
eye NN O
and CC O
heart NN O
phenotypes NNS O
result NN O
, , O
consistent NN O
with IN O
a DT O
conserved JJ O
negative JJ O
regulation NN O
of IN O
Pnr NNP B-Gene
function NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
fly NN O
and CC O
mouse NN O
FOG NNP B-Gene
proteins VBZ I-Gene
function NN O
similarly RB O
in IN O
three CD O
distinct JJ O
cellular JJ O
contexts NN O
in IN O
Drosophila NNP O
, , O
but CC O
may MD O
use VB O
different JJ O
mechanisms NNS O
to TO O
regulate VB O
genetic JJ O
events NNS O
in IN O
blood NN O
vs NN O
. . O
cardial NN O
or CC O
eye NN O
cell NN O
lineages NNS O

The DT O
RING NNP B-Gene
finger NN I-Gene
protein NN I-Gene
Siah NNP B-Gene
- : I-Gene
1 CD I-Gene
regulates VBZ O
the DT O
level NN O
of IN O
the DT O
transcriptional JJ B-Gene
coactivator NN I-Gene
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
transcriptional JJ B-Gene
coactivator NN I-Gene
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
which WDT O
interacts VBZ O
with IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
the DT O
octamer JJ B-Gene
site NN I-Gene
DNA NN I-Gene
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
critical JJ O
for IN O
development NN O
of IN O
a DT O
normal JJ O
immune JJ O
response NN O
and CC O
the DT O
formation NN O
of IN O
germinal JJ O
centers NNS O
in IN O
secondary JJ O
lymphoid JJ O
organs NNS O
. . O

Here RB O
we PRP O
have VBP O
identified VBN O
the DT O
RING NNP B-Gene
finger NN I-Gene
protein NN I-Gene
Siah NNP B-Gene
- : I-Gene
1 CD I-Gene
as IN O
a DT O
protein NN O
interacting VBG O
specifically RB O
with IN O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

This DT O
interaction NN O
is VBZ O
mediated VBN O
by IN O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
part NN O
of IN O
Siah NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
by IN O
residues NNS O
in IN O
the DT O
N NNP B-Gene
- : I-Gene
terminus NN I-Gene
of IN O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
partly RB O
distinct VBZ O
from IN O
the DT O
residues NNS O
required VBN O
for IN O
formation NN O
of IN O
a DT O
complex JJ O
with IN O
the DT O
Oct NNP B-Gene
POU NNP I-Gene
domains NNS I-Gene
and CC O
the DT O
DNA NN O
. . O

Interaction NN O
between IN O
Siah NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
leads NNS O
to TO O
downregulation NN O
of IN O
OBF NNP O
- : O
1 CD O
protein JJ O
level NN O
but CC O
not RB O
mRNA VB O
, , O
and CC O
to TO O
a DT O
corresponding JJ O
reduction NN O
in IN O
octamer NN O
site NN O
- : O
dependent JJ O
transcription NN O
activation NN O
. . O

Inhibition NN O
of IN O
the DT O
ubiquitin JJ O
- : O
proteasome NN O
pathway NN O
in IN O
B NNP O
cells NNS O
leads VBZ O
to TO O
elevated JJ O
levels NNS O
of IN O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
. . O

Furthermore RB O
, , O
in IN O
immunized JJ O
mice NN O
, , O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
amounts NNS O
are VBP O
dramatically RB O
increased VBN O
in IN O
primary JJ O
activated VBD O
B NNP O
cells NNS O
, , O
without IN O
concomitant JJ O
increase NN O
in IN O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
Siah NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
part NN O
of IN O
a DT O
novel JJ O
regulatory JJ O
loop NN O
controlling VBG O
the DT O
level NN O
of IN O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
in IN O
B NNP O
cells NNS O
. . O

The DT O
beta NN O
- : O
catenin NN O
- : O
- : O
TCF NNP O
- : O
1 CD O
pathway NN O
ensures NNS O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
thymocyte NN O
survival NN O
. . O

The DT O
association NN O
of IN O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
T NNP I-Gene
cell NN I-Gene
factors NNS I-Gene
( ( O
TCFs NNP B-Gene
) ) O
or CC O
lymphoid JJ B-Gene
enhancer NN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
with IN O
their PRP$ O
coactivator NN O
beta SYM O
- : O
catenin NN O
mediates VBZ O
transient JJ O
transcriptional JJ O
responses NNS O
to TO O
extracellular VB O
Wnt NNP O
signals NNS O
. . O

We PRP O
show VBP O
here RB O
that IN O
T NNP O
cell NN O
maturation NN O
depends VBZ O
on IN O
the DT O
presence NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
- : I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
in IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

This DT O
domain NN O
is VBZ O
necessary JJ O
to TO O
mediate VB O
the DT O
survival NN O
of IN O
immature NN O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
double JJ O
- : O
positive JJ O
( ( O
DP NNP O
) ) O
thymocytes VBZ O
. . O

Accelerated NNP O
spontaneous JJ O
thymocyte NN O
death NN O
in IN O
the DT O
absence NN O
of IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
correlates NNS O
with IN O
aberrantly RB O
low JJ O
expression NN O
of IN O
the DT O
anti JJ B-Gene
- : I-Gene
apoptotic JJ I-Gene
protein NN I-Gene
Bcl NNP B-Gene
- : I-Gene
x NN I-Gene
( ( I-Gene
L NNP I-Gene
) ) I-Gene
. . O

Increasing VBG O
anti SYM O
- : O
apoptotic JJ O
effectors NNS O
in IN O
thymocytes NNS O
by IN O
the DT O
use NN O
of IN O
a DT O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
transgene NN I-Gene
rescued VBN O
TCF NNP O
- : O
1 CD O
- : O
deficient NN O
DP NNP O
thymocytes VBZ O
from IN O
apoptosis NN O
. . O

Thus RB O
, , O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
upon IN O
association NN O
with IN O
beta NN O
- : O
catenin NN O
, , O
transiently RB O
ensures VBZ O
the DT O
survival NN O
of IN O
immature NN O
T NNP O
cells NNS O
, , O
which WDT O
enables VBZ O
them PRP O
to TO O
generate VB O
and CC O
edit VB O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( I-Gene
TCR NNP I-Gene
) ) I-Gene
alpha NN I-Gene
chains NNS I-Gene
and CC O
attempt NN O
TCR NNP B-Gene
- : O
mediated VBD O
positive JJ O
selection NN O
. . O

TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
ligand VBP I-Gene
selectively RB O
induces JJ O
apoptosis NN O
and CC O
overcomes NNS O
drug NN O
resistance NN O
in IN O
multiple JJ O
myeloma NN O
: : O
therapeutic JJ O
applications NNS O
. . O

Multiple JJ O
myeloma NN O
( ( O
MM NNP O
) ) O
remains VBZ O
incurable JJ O
and CC O
novel JJ O
treatments NNS O
are VBP O
urgently RB O
needed VBN O
. . O

Preclinical NNP O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
evaluations NNS O
were VBD O
performed VBN O
to TO O
assess VB O
the DT O
potential JJ O
therapeutic JJ O
applications NNS O
of IN O
human JJ O
recombinant JJ O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
- : I-Gene
related VBN I-Gene
apoptosis NN I-Gene
- : I-Gene
inducing NN I-Gene
ligand NN I-Gene
/ NNP I-Gene
Apo2 NNP I-Gene
ligand NN I-Gene
( ( O
TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
) ) O
in IN O
MM NNP O
. . O

TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
potently RB O
induced VBD O
apoptosis NN O
of IN O
MM NNP O
cells NNS O
from IN O
patients NNS O
and CC O
the DT O
majority NN O
of IN O
MM NNP O
cell NN O
lines NNS O
, , O
including VBG O
cells NNS O
sensitive JJ O
or CC O
resistant JJ O
to TO O
dexamethasone VB O
( ( O
Dex NNP O
) ) O
, , O
doxorubicin FW O
( ( O
Dox NNP O
) ) O
, , O
melphalan NN O
, , O
and CC O
mitoxantrone NN O
. . O

TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
also RB O
overcame VBP O
the DT O
survival JJ O
effect NN O
of IN O
interleukin JJ B-Gene
6 CD I-Gene
on IN O
MM NNP O
cells NNS O
and CC O
did VBD O
not RB O
affect VB O
the DT O
survival NN O
of IN O
peripheral JJ O
blood NN O
and CC O
bone NN O
marrow NN O
mononuclear JJ O
cells NNS O
and CC O
purified VBD O
B NNP O
cells NNS O
from IN O
healthy JJ O
donors NNS O
. . O

The DT O
status NN O
of IN O
the DT O
TRAIL NNP B-Gene
receptors NNS I-Gene
( ( O
assessed VBN O
by IN O
immunoblotting VBG O
and CC O
flow JJ O
cytometry NN O
) ) O
could MD O
not RB O
predict VB O
TRAIL NNP O
sensitivity NN O
of IN O
MM NNP O
cells NNS O
. . O

The DT O
anti JJ O
- : O
MM NNP O
activity NN O
of IN O
TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
was VBD O
confirmed VBN O
in IN O
nu JJ O
/ NNP O
xid NNP O
/ NNP O
bg NN O
mice NN O
xenografted VBD O
with IN O
human JJ O
MM NNP O
cells NNS O
; : O
TRAIL NNP B-Gene
( ( O
500 CD O
microg NNS O
intraperitoneally RB O
daily RB O
for IN O
14 CD O
days NNS O
) ) O
was VBD O
well RB O
tolerated VBN O
and CC O
significantly RB O
suppressed VBD O
the DT O
growth NN O
of IN O
plasmacytomas NN O
. . O

Dox NNP O
up RP O
- : O
regulated VBN O
the DT O
expression NN O
of IN O
the DT O
TRAIL NNP B-Gene
receptor NN I-Gene
death NN B-Gene
receptor NN I-Gene
5 CD I-Gene
( ( O
DR5 NNP B-Gene
) ) O
and CC O
synergistically RB O
enhanced VBD O
the DT O
effect NN O
of IN O
TRAIL NNP B-Gene
not RB O
only RB O
against IN O
MM NNP O
cells NNS O
sensitive JJ O
to TO O
, , O
but CC O
also RB O
against IN O
those DT O
resistant JJ O
to TO O
, , O
Dex NNP O
- : O
or CC O
Dox NNP O
- : O
induced JJ O
apoptosis NN O
. . O

Nuclear JJ O
factor NN O
( ( O
NF NNP O
) ) O
- : O
kappaB NN O
inhibitors NNS O
, , O
such JJ O
as IN O
SN50 NNP O
( ( O
a DT O
cell NN O
- : O
permeable JJ O
inhibitor NN O
of IN O
the DT O
nuclear JJ O
translocation NN O
and CC O
transcriptional JJ O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
or CC O
the DT O
proteasome JJ O
inhibitor NN O
PS NNP O
- : O
341 CD O
, , O
enhanced VBD O
the DT O
proapoptotic JJ O
activity NN O
of IN O
TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
against IN O
TRAIL NNP O
- : O
sensitive JJ O
MM NNP O
cells NNS O
, , O
whereas NNS O
SN50 NNP O
reversed VBD O
the DT O
TRAIL NNP O
resistance NN O
of IN O
ARH NNP O
- : O
77 CD O
and CC O
IM NNP O
- : O
9 CD O
MM NNP O
cells NNS O
. . O

Importantly RB O
, , O
normal JJ O
B NNP O
lymphocytes NNS O
were VBD O
not RB O
sensitized VBN O
to TO O
TRAIL NNP B-Gene
by IN O
either DT O
Dox NNP O
, , O
SN50 NNP O
, , O
or CC O
PS NNP O
- : O
341 CD O
. . O

These DT O
preclinical JJ O
studies NNS O
suggest VBP O
that IN O
TRAIL NNP B-Gene
/ NNP I-Gene
Apo2L NNP I-Gene
can MD O
overcome VB O
conventional JJ O
drug NN O
resistance NN O
and CC O
provide VB O
the DT O
basis NN O
for IN O
clinical JJ O
trials NNS O
of IN O
TRAIL NNP B-Gene
- : O
based VBN O
treatment NN O
regimens NNS O
to TO O
improve VB O
outcome NN O
in IN O
patients NNS O
with IN O
MM NNP O
. . O

( ( O
Blood NNP O
. . O
2001 CD O
; : O
98 CD O
: : O
795 CD O
- : O
804 CD O
) ) O

CD28 NNP B-Gene
costimulation NN O
is VBZ O
required VBN O
not RB O
only RB O
to TO O
induce VB O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
receptor NN I-Gene
but CC O
also RB O
to TO O
render VB O
janus NN B-Gene
kinases NNS I-Gene
/ VBP I-Gene
STAT4 NNP I-Gene
responsive NN O
to TO O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
stimulation NN O
in IN O
TCR NNP O
- : O
triggered VBD O
T NNP O
cells NNS O
. . O

The DT O
activation NN O
of IN O
resting VBG O
T NNP O
cells NNS O
for IN O
the DT O
acquisition NN O
of IN O
various JJ O
functions NNS O
depends VBZ O
on IN O
whether IN O
CD28 NNP O
costimulatory NN O
signals NNS O
are VBP O
provided VBN O
upon IN O
T NNP O
cell NN O
receptor NN O
stimulation NN O
. . O

Here RB O
, , O
we PRP O
investigated VBD O
how WRB O
CD28 NNP O
costimulation NN O
functions NNS O
to TO O
allow VB O
TCR NNP B-Gene
- : O
triggered VBD O
resting VBG O
T NNP O
cells NNS O
to TO O
acquire VB O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
responsiveness NN O
. . O

When WRB O
T NNP O
cells NNS O
are VBP O
stimulated VBN O
with IN O
low JJ O
doses NNS O
of IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
mAb NN I-Gene
, , O
CD28 NNP O
costimulation NN O
was VBD O
required VBN O
for IN O
the DT O
optimal JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
receptor NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
12R CD I-Gene
) ) O
expression NN O
. . O

However RB O
, , O
stimulation NN O
of IN O
T NNP O
cells NNS O
with IN O
high JJ O
doses NNS O
of IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
alone RB O
induced VBD O
comparable JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
12R CD I-Gene
expression NN O
to TO O
those DT O
induced VBN O
upon IN O
CD28 NNP O
costimulation NN O
. . O

Nevertheless RB O
, , O
there EX O
was VBD O
a DT O
substantial JJ O
difference NN O
in IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
responsiveness NN O
between IN O
these DT O
two CD O
groups NNS O
of IN O
T NNP O
cells NNS O
: : O
compared VBN O
to TO O
anti VB O
- : O
CD28 NNP O
- : O
costimulated VBD O
T NNP O
cells NNS O
, , O
T NNP O
cells NNS O
that WDT O
were VBD O
not RB O
costimulated VBN O
with IN O
anti JJ B-Gene
- : I-Gene
CD28 NN I-Gene
exhibited VBD O
decreased JJ O
levels NNS O
of IN O
Janus NNP B-Gene
kinases NNS I-Gene
( ( O
JAK NNP B-Gene
) ) O
JAK2 NNP B-Gene
/ NNP I-Gene
TYK2 NNP I-Gene
and CC O
STAT4 NNP B-Gene
phosphorylation NN O
and CC O
IFN NNP O
- : O
y NN O
production NN O
following VBG O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
stimulation NN O
. . O

Importantly RB O
, , O
STAT6 NNP O
phosphorylation NN O
following VBG O
IL NNP O
- : O
4 CD O
stimulation NN O
was VBD O
not RB O
decreased VBN O
in IN O
anti JJ O
- : O
CD28 NNP O
- : O
uncostimulated JJ O
T NNP O
cells NNS O
. . O

These DT O
resutls VB O
indicate NN O
that IN O
CD28 NNP O
costimulation NN O
not RB O
only RB O
contributes VBZ O
to TO O
up RP O
- : O
regulating NN O
IL NNP B-Gene
- : I-Gene
12R CD I-Gene
expression NN O
but CC O
is VBZ O
also RB O
required VBN O
to TO O
render VB O
JAKs NNP B-Gene
/ NNP I-Gene
STAT4 NNP I-Gene
responsive NN O
to TO O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
stimulation NN O
. . O

Constitutively RB O
activated VBN O
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
vital JJ O
for IN O
the DT O
survival NN O
of IN O
human JJ O
monocyte NN O
- : O
differentiated VBN O
macrophages NNS O
. . O

Role NNP O
of IN O
Mcl NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
independent JJ O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
, , O
Bad NNP B-Gene
, , O
or CC O
caspase NN O
activation NN O
. . O

Recent JJ O
data NNS O
from IN O
mice JJ O
deficient NN O
for IN O
phosphatase NN B-Gene
and CC O
tensin NN B-Gene
homologue NN I-Gene
deleted VBN O
from IN O
chromosome NN B-Gene
10 CD I-Gene
or CC O
src VB B-Gene
homology NN I-Gene
2 CD I-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
5 CD I-Gene
' '' I-Gene
inositol JJ I-Gene
phosphatase NN I-Gene
, , O
phosphatases VBZ B-Gene
that IN O
negatively RB O
regulate VB O
the DT O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI3K NNP B-Gene
) ) O
pathway NN O
, , O
revealed VBD O
an DT O
increased JJ O
number NN O
of IN O
macrophages NNS O
in IN O
these DT O
animals NNS O
, , O
suggesting VBG O
an DT O
essential JJ O
role NN O
for IN O
the DT O
PI3K NNP B-Gene
pathway NN O
for IN O
macro JJ O
- : O
phage NN O
survival NN O
. . O

Here RB O
, , O
we PRP O
focused VBD O
on IN O
the DT O
role NN O
of IN O
the DT O
PI3K NNP B-Gene
- : I-Gene
regulated VBD I-Gene
serine JJ I-Gene
/ NNP I-Gene
threonine NN I-Gene
kinase NN I-Gene
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
modulating VBG O
macrophage NN O
survival NN O
. . O

Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
constitutively RB O
activated VBN O
in IN O
human JJ O
macrophages NNS O
and CC O
addition NN O
of IN O
the DT O
PI3K NNP B-Gene
inhibitor NN O
, , O
LY294002 NNP O
, , O
suppressed VBD O
the DT O
activation NN O
of IN O
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
induced VBD O
cell NN O
death NN O
. . O

Furthermore RB O
, , O
suppression NN O
of IN O
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
by IN O
inhibition NN O
of IN O
PI3K NNP B-Gene
or CC O
a DT O
dominant JJ B-Gene
negative JJ I-Gene
( ( I-Gene
DN NNP I-Gene
) ) I-Gene
Akt NNP I-Gene
- : I-Gene
1 CD I-Gene
resulted VBD O
in IN O
loss NN O
of IN O
mitochondrial JJ O
transmembrane NN O
potential NN O
, , O
activation NN O
of IN O
caspases NNS B-Gene
- : I-Gene
9 CD I-Gene
and CC I-Gene
- : I-Gene
3 CD I-Gene
, , O
and CC O
DNA NNP O
fragmentation NN O
. . O

The DT O
effects NNS O
of IN O
PI3K NNP B-Gene
inhibition NN O
were VBD O
reversed VBN O
by IN O
the DT O
ectopic JJ O
expression NN O
of IN O
constitutively RB O
activated VBN O
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
Bcl NNP B-Gene
- : I-Gene
x NN I-Gene
( ( I-Gene
L NNP I-Gene
) ) I-Gene
. . O

Inhibition NN O
of IN O
PI3K NNP B-Gene
/ NNP O
Akt NNP O
- : O
1 CD O
pathway NN O
either CC O
by IN O
LY294002 NNP O
or CC O
DN NNP B-Gene
Akt NNP I-Gene
- : I-Gene
1 CD I-Gene
had VBD O
no DT O
effect NN O
on IN O
the DT O
constitutive NN O
or CC O
inducible JJ O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
human JJ O
macrophages NNS O
. . O

However RB O
, , O
after IN O
inhibition NN O
of IN O
the DT O
PI3K NNP B-Gene
/ NNP O
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
pathway NN O
, , O
a DT O
marked JJ O
decrease NN O
in IN O
the DT O
expression NN O
of IN O
the DT O
antiapoptotic JJ B-Gene
molecule NN I-Gene
Mcl NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
not RB O
other JJ O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
family NN I-Gene
members NNS I-Gene
was VBD O
observed VBN O
, , O
and CC O
Mcl NNP B-Gene
- : I-Gene
1 CD I-Gene
rescued VBN O
macrophages NNS O
from IN O
LY294002 NNP O
- : O
induced VBD O
cell NN O
death NN O
. . O

Further RB O
, , O
inhibition NN O
of IN O
Mcl NNP B-Gene
- : I-Gene
1 CD I-Gene
by IN O
antisense NN O
oligonucleotides NNS O
, , O
also RB O
resulted VBD O
in IN O
macrophage NN O
apoptosis NN O
. . O

Thus RB O
, , O
our PRP$ O
findings NNS O
demonstrate VBP O
that IN O
the DT O
constitutive JJ O
activation NN O
of IN O
Akt NNP B-Gene
- : I-Gene
1 CD I-Gene
regulates NNS O
macrophage NN O
survival NN O
through IN O
Mcl NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
which WDT O
is VBZ O
independent JJ O
of IN O
caspases NNS B-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
or CC O
Bad NNP B-Gene
. . O

GRbeta NNP O
expression NN O
in IN O
nasal JJ O
polyp JJ O
inflammatory NN O
cells NNS O
and CC O
its PRP$ O
relationship NN O
to TO O
the DT O
anti JJ O
- : O
inflammatory JJ O
effects NNS O
of IN O
intranasal NN O
fluticasone NN O
. . O

BACKGROUND NN O
: : O
Nasal JJ O
polyposis NN O
disease NN O
is VBZ O
an DT O
inflammatory JJ O
disorder NN O
with IN O
intense JJ O
eosinophilic JJ O
infiltration NN O
of IN O
respiratory NN O
mucosa NN O
that WDT O
is VBZ O
often RB O
difficult JJ O
to TO O
control VB O
with IN O
topical JJ O
steroids NNS O
. . O

Recent JJ O
evidence NN O
suggests VBZ O
that IN O
overexpression NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
splice NN I-Gene
variant NN I-Gene
GRbeta NNP B-Gene
in IN O
inflammatory JJ O
cells NNS O
might MD O
contribute VB O
to TO O
steroid VB O
insensitivity NN O
in IN O
diseases NNS O
such JJ O
as IN O
asthma NN O
. . O

OBJECTIVE NN O
: : O
The DT O
purposes NNS O
of IN O
this DT O
investigation NN O
were VBD O
to TO O
determine VB O
whether IN O
nasal JJ O
polyp NN O
( ( O
NP NNP O
) ) O
inflammatory NN O
cells NNS O
overexpress JJ O
GRbeta NNP B-Gene
and CC O
to TO O
examine VB O
whether IN O
GRbeta NNP B-Gene
overexpression NN O
is VBZ O
associated VBN O
with IN O
insensitivity NN O
to TO O
the DT O
potent JJ O
topical JJ O
steroid NN O
fluticasone NN O
propionate NN O
( ( O
FP NNP O
) ) O
. . O

METHODS NN O
: : O
Biopsies NNS O
were VBD O
obtained VBN O
from IN O
10 CD O
subjects NNS O
with IN O
NPs NNP O
before IN O
and CC O
4 CD O
weeks NNS O
after IN O
treatment NN O
with IN O
intranasal JJ O
FP NNP O
. . O

Middle NNP O
turbinates VBZ O
biopsies NNS O
from IN O
6 CD O
healthy JJ O
, , O
nonallergic JJ O
subjects NNS O
served VBD O
as IN O
normal JJ O
controls NNS O
. . O

Biopsies NNS O
were VBD O
immunostained VBN O
for IN O
inflammatory NN O
cell NN O
markers NNS O
as RB O
well RB O
as IN O
GRbeta NNP B-Gene
and CC O
probed VBN O
for IN O
various JJ O
cytokine NN B-Gene
mRNA NN I-Gene
. . O

The DT O
anti JJ O
- : O
inflammatory NN O
response NN O
to TO O
FP NNP O
was VBD O
examined VBN O
in IN O
relation NN O
to TO O
pretreatment NN O
levels NNS O
of IN O
GRbeta NNP O
expression NN O
. . O

RESULTS NN O
: : O
The DT O
total JJ O
numbers NNS O
of IN O
inflammatory JJ O
cells NNS O
were VBD O
increased VBN O
in IN O
NPs NNP O
. . O

The DT O
percentage NN O
of IN O
inflammatory JJ O
cells NNS O
expressing VBG O
GRbeta NNP B-Gene
was VBD O
also RB O
increased VBN O
( ( O
40 CD O
. . O
5 CD O
% NN O
+ NNP O
/ NNP O
- : O
19 CD O
. . O
2 CD O
% NN O
vs NN O
16 CD O
. . O
1 CD O
% NN O
+ NNP O
/ NNP O
- : O
4 CD O
. . O
0 CD O
% NN O
, , O
P NNP O
= NNP O
. . O
9 CD O
) ) O
. . O

GRbeta NNP B-Gene
expression NN O
in IN O
NPs NNP O
was VBD O
almost RB O
exclusive JJ O
to TO O
T NNP O
lymphocytes NNS O
, , O
eosinophils NNS O
, , O
and CC O
macrophages NNS O
. . O

An DT O
inverse JJ O
correlation NN O
was VBD O
observed VBN O
between IN O
the DT O
baseline NN O
inflammatory NN O
cell NN O
GRbeta NNP B-Gene
expression NN O
and CC O
the DT O
reduction NN O
after IN O
FP NNP O
treatment NN O
in IN O
EG2 NNP O
- : O
positive JJ O
eosinophils NNS O
, , O
CD4 NNP O
- : O
positive JJ O
T NNP O
lymphocytes NNS O
, , O
endothelial JJ O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
, , O
and CC O
IL NNP O
- : O
4 CD O
mRNA SYM O
- : O
positive JJ O
cells NNS O
. . O

NPs NN O
that WDT O
were VBD O
` `` O
` `` O
FP NNP O
- : O
insensitive NN O
' '' O
' '' O
in IN O
terms NNS O
of IN O
suppression NN O
of IN O
eosinophil JJ O
numbers NNS O
( ( O
major JJ B-Gene
basic NN I-Gene
protein NN I-Gene
- : O
positive JJ O
) ) O
had VBD O
a DT O
significantly RB O
greater JJR O
percentage NN O
of IN O
GRbeta NNP O
- : O
positive JJ O
inflammatory NN O
cells NNS O
, , O
a DT O
higher JJR O
ratio NN O
of IN O
GRbeta NNP O
- : O
positive JJ O
/ NN O
GRalpha NNP O
- : O
positive JJ O
cells NNS O
, , O
and CC O
increased VBD O
numbers NNS O
of IN O
GRbeta NNP O
- : O
positive JJ O
eosinophils NNS O
and CC O
macrophages NNS O
in IN O
comparison NN O
with IN O
those DT O
that WDT O
were VBD O
` `` O
` `` O
FP NNP O
- : O
sensitive JJ O
. . O
' '' O
' '' O

` `` O
` `` O
FP NNP O
- : O
insensitive NN O
' '' O
' POS O
NPs NNP O
also RB O
demonstrated VBD O
a DT O
higher JJR O
percentage NN O
of IN O
IL NNP O
- : O
5 CD O
- : O
positive JJ O
inflammatory NN O
cells NNS O
expressing VBG O
GRbeta NNP B-Gene
before IN O
and CC O
after IN O
FP NNP O
treatment NN O
. . O

CONCLUSION NN O
: : O
GRbeta NNP B-Gene
expression NN O
appears VBZ O
to TO O
be VB O
a DT O
marker NN O
of IN O
steroid JJ O
insensitivity NN O
in IN O
NPs NNP O
. . O

Expression NN O
of IN O
GRbeta NNP B-Gene
by IN O
NP NNP O
inflammatory NN O
cells NNS O
, , O
particularly RB O
T NNP O
cells NNS O
and CC O
eosinophils NNS O
, , O
might MD O
render VB O
them PRP O
resistant VB O
to TO O
suppression NN O
by IN O
topical JJ O
steroids NNS O
and CC O
thereby RB O
contribute VB O
to TO O
persistent JJ O
NP NNP O
inflammation NN O
. . O

Transcriptional JJ O
regulation NN O
of IN O
galectin NN B-Gene
- : I-Gene
10 CD I-Gene
( ( O
eosinophil NN B-Gene
Charcot NNP I-Gene
- : I-Gene
Leyden NNP I-Gene
crystal NN I-Gene
protein NN I-Gene
) ) O
: : O
a DT O
GC NNP B-Gene
box NN I-Gene
( ( O
- : O
44 CD O
to TO O
- : O
50 CD O
) ) O
controls NNS O
butyric JJ O
acid JJ O
induction NN O
of IN O
gene NN O
expression NN O
. . O

Galectin NNP B-Gene
- : I-Gene
10 CD I-Gene
( ( O
gal JJ B-Gene
- : I-Gene
10 CD I-Gene
, , O
also RB O
known VBN O
as IN O
Charcot NNP B-Gene
- : I-Gene
Leyden NNP I-Gene
crystal NN I-Gene
protein NN I-Gene
) ) O
is VBZ O
a DT O
member NN O
of IN O
the DT O
galectin JJ B-Gene
family NN I-Gene
of IN O
beta NN B-Gene
- : I-Gene
galactoside NN I-Gene
binding NN I-Gene
proteins NNS I-Gene
that WDT O
is VBZ O
expressed VBN O
uniquely RB O
in IN O
eosinophilic JJ O
and CC O
basophilic JJ O
leukocytes NNS O
. . O

To TO O
gain VB O
a DT O
better JJR O
understanding NN O
of IN O
galectin JJ O
gene NN O
expression NN O
, , O
we PRP O
present VBP O
an DT O
analysis NN O
of IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
gene NN O
encoding VBG O
gal JJ B-Gene
- : I-Gene
10 CD I-Gene
. . O

Analysis NN O
of IN O
the DT O
minimal JJ B-Gene
promoter NN I-Gene
revealed VBD O
nine CD O
consensus NN B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
for IN O
transcription NN B-Gene
factors NNS I-Gene
, , O
including VBG O
several JJ O
that WDT O
are VBP O
also RB O
found VBN O
in IN O
the DT O
minimal JJ B-Gene
promoters NNS I-Gene
of IN O
galectins NNS B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
- : I-Gene
2 CD I-Gene
, , I-Gene
and CC I-Gene
- : I-Gene
3 CD I-Gene
. . O

The DT O
decrease NN O
in IN O
gal JJ O
- : O
10 CD O
promoter NN O
activity NN O
after IN O
disruption NN O
of IN O
either CC O
the DT O
GC NNP B-Gene
box NN I-Gene
( ( O
- : O
44 CD O
to TO O
- : O
50 CD O
) ) O
or CC O
the DT O
Oct NNP B-Gene
site NN I-Gene
( ( O
- : O
255 CD O
to TO O
- : O
261 CD O
) ) O
suggests VBZ O
that IN O
these DT O
sites NNS O
, , O
along IN O
with IN O
the DT O
previously RB O
characterized VBN O
GATA NNP B-Gene
and CC I-Gene
EoTF NNP I-Gene
sites NNS I-Gene
, , O
are VBP O
necessary JJ O
for IN O
full JJ O
promoter NN O
activity NN O
. . O

By IN O
supershift NN O
analysis NN O
, , O
we PRP O
demonstrate VBP O
binding VBG O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
Sp1 NNP B-Gene
and CC O
Oct1 NNP B-Gene
to TO O
the DT O
consensus NN B-Gene
GC NNP I-Gene
box NN I-Gene
and CC O
the DT O
Oct NNP B-Gene
site NN I-Gene
, , O
respectively RB O
. . O

Similar JJ O
to TO O
gal VB B-Gene
- : I-Gene
1 CD I-Gene
, , O
gal JJ O
- : O
10 CD O
expression NN O
is VBZ O
induced VBN O
by IN O
butyric JJ O
acid NN O
, , O
an DT O
effect NN O
that WDT O
is VBZ O
lost VBN O
upon IN O
ablation NN O
of IN O
the DT O
GC NNP B-Gene
box NN I-Gene
. . O

Additionally RB O
, , O
we PRP O
demonstrate VBP O
AML3 NNP O
binding NN O
to TO O
the DT O
consensus NN B-Gene
AML NNP I-Gene
site NN I-Gene
and CC O
YY1 NNP B-Gene
binding NN I-Gene
to TO O
the DT O
Inr NNP B-Gene
sequence NN I-Gene
, , O
both DT O
elements NNS O
functioning VBG O
as IN O
silencers NNS O
in IN O
the DT O
gal JJ B-Gene
- : I-Gene
10 CD I-Gene
promoter NN I-Gene
. . O

Tumour SYM O
- : O
stromal JJ O
interactions NNS O
. . O

Role NNP O
of IN O
the DT O
stroma NN O
in IN O
mammary JJ O
development NN O
. . O

Mammary NNP O
development NN O
depends VBZ O
on IN O
branching VBG O
morphogenesis NN O
, , O
namely RB O
the DT O
bifurcation NN O
and CC O
extension NN O
of IN O
ductal JJ O
growth NN O
points NNS O
( ( O
end VB O
buds NN O
) ) O
and CC O
secretory JJ O
lobules NNS O
into IN O
a DT O
more RBR O
or CC O
less RBR O
fatty JJ O
stroma NN O
. . O

Because IN O
breast NN O
carcinomas NN O
are VBP O
overwhelmingly RB O
ductal JJ O
in IN O
origin NN O
, , O
this DT O
review NN O
focuses VBZ O
on IN O
stromal JJ O
influences NNS O
guiding VBG O
postnatal JJ O
ductal NN O
development NN O
and CC O
there EX O
is VBZ O
only RB O
the DT O
briefest JJS O
account NN O
of IN O
the DT O
role NN O
of IN O
embryonic JJ O
stroma NN O
( ( O
mesenchyme NN O
) ) O
. . O

The DT O
stroma NN O
as IN O
the DT O
necessary JJ O
target NN O
for IN O
endocrine JJ O
mammogens NNS O
and CC O
the DT O
source NN O
of IN O
stimulatory JJ O
growth NN O
factors NNS O
is VBZ O
described VBN O
and CC O
the DT O
importance NN O
of IN O
mammary JJ O
epithelium NN O
- : O
induced JJ O
modifications NNS O
of IN O
the DT O
periductal JJ O
stroma NN O
is VBZ O
emphasized VBN O
. . O

Evidence NN O
is VBZ O
presented VBN O
that IN O
if IN O
they PRP O
are VBP O
to TO O
grow VB O
, , O
end VB O
buds NN O
must MD O
condition VB O
proximal JJ O
fatty JJ O
stroma NN O
by IN O
recruiting VBG O
white JJ O
blood NN O
cells NNS O
as RB O
well RB O
as IN O
inducing VBG O
stromal NN O
cell NN O
division NN O
and CC O
, , O
possibly RB O
, , O
estrogen NN B-Gene
receptors NNS I-Gene
. . O

The DT O
induction NN O
of IN O
a DT O
fibrous JJ O
stromal JJ O
tunic NN O
around IN O
the DT O
end NN O
bud NN O
is VBZ O
described VBN O
and CC O
its PRP$ O
likely JJ O
role NN O
as IN O
a DT O
complex JJ O
ductal NN O
morphogen NN O
is VBZ O
discussed VBN O
; : O
a DT O
possible JJ O
role NN O
in IN O
growth NN O
inhibition NN O
is VBZ O
also RB O
considered VBN O
. . O

Although IN O
the DT O
signals NNS O
governing VBG O
fibrotic JJ O
induction NN O
, , O
ductal JJ O
morphogenesis NN O
, , O
and CC O
growth NN O
inhibition NN O
are VBP O
unknown JJ O
, , O
a DT O
role NN O
for IN O
transforming VBG O
growth NN B-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
is VBZ O
highly RB O
likely JJ O
and CC O
is VBZ O
discussed VBN O
. . O

Finally RB O
, , O
a DT O
need NN O
for IN O
new JJ O
conceptual JJ O
and CC O
experimental JJ O
approaches NNS O
to TO O
understanding VBG O
stromal JJ O
- : O
epithelial JJ O
signaling NN O
is VBZ O
discussed VBN O
. . O

Adipophilin NNP B-Gene
is VBZ O
a DT O
sensitive JJ O
marker NN O
for IN O
lipid JJ O
loading NN O
in IN O
human JJ O
blood NN O
monocytes NNS O
. . O

Adipophilin NNP B-Gene
, , O
a DT O
marker NN O
of IN O
lipid JJ O
accumulation NN O
initially RB O
described VBN O
in IN O
adipocytes NNS O
, , O
was VBD O
recently RB O
shown VBN O
to TO O
be VB O
induced VBN O
in IN O
macrophage NN O
foam NN O
cells NNS O
. . O

We PRP O
found VBD O
that IN O
even RB O
freshly RB O
isolated VBN O
blood NN O
monocytes NNS O
express VBP O
adipophilin NN B-Gene
and CC O
that IN O
the DT O
amount NN O
of IN O
adipophilin NN B-Gene
protein NN I-Gene
is VBZ O
variable JJ O
in IN O
monocytes NNS O
from IN O
different JJ O
healthy JJ O
individuals NNS O
. . O

However RB O
, , O
the DT O
physiological JJ O
expression NN O
of IN O
adipophilin NN B-Gene
does VBZ O
not RB O
correlate VB O
with IN O
the DT O
levels NNS O
of IN O
free JJ O
fatty JJ O
acids NNS O
, , O
cholesterylesters NNS O
or CC O
free JJ O
cholesterol NN O
. . O

Enzymatically RB B-Gene
modified VBN I-Gene
low JJ I-Gene
- : I-Gene
density NN I-Gene
lipoprotein NN I-Gene
( ( O
E NNP B-Gene
- : I-Gene
LDL NNP I-Gene
) ) O
induces VBZ O
rapid JJ O
foam NN O
cell NN O
formation NN O
in IN O
monocytes NNS O
and CC O
upregulates NNS O
adipophilin VBP B-Gene
mRNA NN O
and CC O
protein NN O
within IN O
2 CD O
h NN O
of IN O
incubation NN O
. . O

This DT O
rapid JJ O
induction NN O
of IN O
adipophilin NN B-Gene
is VBZ O
accompanied VBN O
by IN O
a DT O
significant JJ O
increase NN O
of IN O
free JJ O
fatty JJ O
acids NNS O
in IN O
monocytes NNS O
incubated VBN O
with IN O
E NNP B-Gene
- : I-Gene
LDL NN I-Gene
. . O

Adipophilin NNP B-Gene
facilitates VBZ O
the DT O
uptake NN O
of IN O
free JJ O
fatty JJ O
acids NNS O
, , O
and CC O
here RB O
we PRP O
demonstrate VBP O
that IN O
free JJ O
fatty JJ O
acids NNS O
increase NN O
is VBZ O
related VBN O
to TO O
the DT O
early JJ O
upregulation NN O
of IN O
adipophilin JJ O
expression NN O
in IN O
blood NN O
monocytes NNS O
. . O

Fatty JJ O
acids NNS O
are VBP O
ligands VBZ O
for IN O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
- : I-Gene
gamma NN I-Gene
( ( O
PPARgamma NNP B-Gene
) ) O
, , O
and CC O
the DT O
upregulation NN O
of IN O
adipophilin NN B-Gene
mRNA NN I-Gene
by IN O
PPARgamma NNP B-Gene
agonists NNS O
like IN O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
and CC O
ciglitazone NN O
indicates VBZ O
that IN O
PPARgamma NNP B-Gene
may MD O
mediate VB O
the DT O
induction NN O
of IN O
adipophilin JJ O
expression NN O
in IN O
human JJ O
blood NN O
monocytes NNS O
. . O

Constitutive JJ O
expression NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
in IN O
melanoma NN O
cell NN O
lines NNS O
results NNS O
from IN O
the DT O
transcription NN O
of IN O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
abnormally RB O
initiated VBN O
from IN O
its PRP$ O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
promoter NN I-Gene
. . O

In IN O
melanoma NN O
cell NN O
lines NNS O
, , O
two CD O
different JJ O
patterns NNS O
of IN O
MHC NNP O
class NN O
II NNP O
expression NN O
have VBP O
been VBN O
described VBN O
, , O
either DT O
an DT O
IFN NNP O
gamma NN O
- : O
inducible JJ O
expression NN O
of IN O
HLA NNP B-Gene
- : I-Gene
DR NN I-Gene
and CC O
HLA NNP B-Gene
- : I-Gene
DP NNP I-Gene
, , O
with IN O
a DT O
faint NN O
or CC O
null JJ O
expression NN O
of IN O
HLA NNP B-Gene
- : I-Gene
DQ NNP I-Gene
, , O
resembling VBG O
that IN O
described VBN O
for IN O
melanocytes NNS O
, , O
or CC O
a DT O
constitutive JJ O
expression NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
IFN NNP O
- : O
gamma NN O
independent JJ O
, , O
of IN O
all DT O
three CD O
HLA NNP B-Gene
- : I-Gene
D NNP I-Gene
isotypes NNS I-Gene
. . O

As IN O
this DT O
latter JJ O
phenotype NN O
has VBZ O
been VBN O
associated VBN O
with IN O
a DT O
more RBR O
rapid JJ O
progression NN O
of IN O
melanoma NN O
tumors NNS O
, , O
we PRP O
have VBP O
analyzed VBN O
in IN O
different JJ O
melanoma NN O
cell NN O
lines NNS O
the DT O
molecular JJ O
mechanisms NNS O
leading VBG O
to TO O
this DT O
abnormal JJ O
pattern NN O
of IN O
MHC NNP O
class NN O
II NNP O
expression NN O
. . O

In IN O
agreement NN O
with IN O
the DT O
evidence NN O
of IN O
a DT O
coordinate JJ O
transcription NN O
of IN O
the DT O
HLA NNP B-Gene
- : I-Gene
D NNP I-Gene
genes NNS I-Gene
in IN O
these DT O
cell NN O
lines NNS O
, , O
we PRP O
have VBP O
shown VBN O
the DT O
constitutive JJ O
expression NN O
of IN O
CIITA NNP B-Gene
( ( I-Gene
class NN I-Gene
II NNP I-Gene
transactivator NN I-Gene
) ) I-Gene
transcripts NNS I-Gene
, , O
CIITA NNP B-Gene
being VBG O
known VBN O
as IN O
the DT O
master NN O
switch NN O
of IN O
MHC NNP O
class NN O
II NNP O
expression NN O
. . O

Unexpectedly RB O
, , O
these DT O
transcripts NNS O
initiate VBP O
from IN O
promoter NN B-Gene
III NNP I-Gene
of IN O
the DT O
CIITA NNP B-Gene
gene NN I-Gene
, , O
a DT O
promoter NN O
that WDT O
is VBZ O
mainly RB O
used VBN O
constitutively RB O
in IN O
B NNP O
lymphocytes NNS O
. . O

This DT O
expression NN O
was VBD O
further RB O
shown VBN O
to TO O
occur VB O
through IN O
factor NN O
( ( O
s PRP O
) ) O
acting VBG O
on IN O
the DT O
enhancer NN O
located VBN O
upstream NN O
of IN O
CIITA NNP B-Gene
promoter NN I-Gene
III NNP I-Gene
, , O
which WDT O
was VBD O
previously RB O
described VBN O
in IN O
epithelioid JJ O
cells NNS O
as IN O
an DT O
IFN NNP O
- : O
gamma NN O
- : O
response NN O
sequence NN O
. . O

The DT O
hypothesis NN O
of IN O
a DT O
general JJ O
abnormality NN O
of IN O
the DT O
IFN NNP O
- : O
gamma NN O
transduction NN O
pathway NN O
was VBD O
dismissed VBN O
. . O

Constitutive JJ O
transcription NN O
of IN O
CIITA NNP B-Gene
from IN O
promoter NN B-Gene
III NNP I-Gene
having VBG O
been VBN O
observed VBN O
in IN O
unrelated JJ O
melanoma NN O
cell NN O
lines NNS O
, , O
we PRP O
propose VBP O
the DT O
hypothesis NN O
that IN O
this DT O
phenomenon NN O
might MD O
not RB O
be VB O
a DT O
random JJ O
event NN O
, , O
but CC O
could MD O
be VB O
linked VBN O
to TO O
the DT O
neoplasic JJ O
state NN O
of IN O
the DT O
melanoma NN O
cells NNS O

Caspase NNP B-Gene
- : O
mediated VBD O
calcineurin JJ O
activation NN O
contributes NNS O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
release NN O
during IN O
T NNP O
cell NN O
activation NN O
. . O

Calcineurin NNP B-Gene
, , O
a DT O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
/ VBZ I-Gene
calmodulin JJ I-Gene
- : I-Gene
dependent NN I-Gene
Ser NNP I-Gene
/ NNP I-Gene
Thr NNP I-Gene
phosphatase NN I-Gene
( ( I-Gene
protein JJ I-Gene
phosphatase NN I-Gene
2B CD I-Gene
) ) I-Gene
, , O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
IL NNP O
- : O
2 CD O
production NN O
during IN O
T NNP O
cell NN O
activation NN O
. . O

It PRP O
has VBZ O
been VBN O
previously RB O
reported VBN O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
release NN O
in IN O
activated JJ O
Jurkat NNP O
T NNP O
requires VBZ O
caspase JJ O
- : O
like IN O
activity NN O
( ( O
Posmantur NNP O
et RB O
al RB O
. . O
( ( O
1998 CD O
) ) O
Exp NNP O
. . O
Cell NNP O
. . O
Res NNP O
. . O
244 CD O
, , O
302 CD O
- : O
309 CD O
) ) O
. . O

We PRP O
report VBP O
here RB O
that IN O
the DT O
60 CD B-Gene
- : I-Gene
kDa NN I-Gene
catalytic JJ I-Gene
subunit NN I-Gene
of IN O
calcineurin NN B-Gene
A NNP I-Gene
( ( O
Cn NNP B-Gene
A NNP I-Gene
) ) O
was VBD O
partially RB O
cleaved VBN O
to TO O
a DT O
45 CD B-Gene
- : I-Gene
kDa NN I-Gene
form NN O
in IN O
phytohemagglutinin NN O
A NNP O
( ( O
PHA NNP O
) ) O
or CC O
phorbol JJ O
ester NN O
+ NNP O
ionomycin NN O
( ( O
P NNP O
+ NNP O
I PRP O
) ) O
- : O
activated VBN O
Jurkat NNP O
cells NNS O
. . O

In IN O
parallel NN O
, , O
proteolytic JJ O
activation NN O
of IN O
upstream JJ O
caspases NNS B-Gene
( ( O
caspase VB O
- : O
8 CD O
and CC O
- : O
9 CD O
) ) O
as RB O
well RB O
as IN O
effector NN B-Gene
caspase NN I-Gene
- : I-Gene
3 CD I-Gene
was VBD O
also RB O
observed VBN O
. . O

Cn VB B-Gene
A DT I-Gene
cleavage NN O
was VBD O
caspase NN O
mediated VBN O
, , O
since IN O
it PRP O
was VBD O
inhibitable JJ O
by IN O
pan JJ O
- : O
caspase NN O
inhibitor NN O
Cbz NNP O
- : O
Asp NNP O
- : O
CH NNP O
( ( O
2 CD O
) ) O
OC NNP O
( ( O
O NNP O
) ) O
- : O
2 CD O
, , O
6 CD O
- : O
dichlorobenzene NN O
( ( O
Z NNP O
- : O
D NNP O
- : O
DCB NN O
) ) O
. . O

Cn VB B-Gene
A DT I-Gene
cleavage NN O
was VBD O
also RB O
observed VBN O
when WRB O
purified JJ O
calcineurin NN B-Gene
was VBD O
digested VBN O
in IN O
vitro NN O
with IN O
caspase NN B-Gene
- : I-Gene
3 CD I-Gene
. . O

Truncated VBN B-Gene
Cn NNP I-Gene
A NNP I-Gene
was VBD O
associated VBN O
with IN O
enhanced JJ O
phosphatase NN O
activity NN O
and CC O
reduced JJ O
calmodulin NN O
sensitivity NN O
. . O

Furthermore RB O
, , O
in IN O
PHA NNP O
or CC O
P NNP O
+ VBP O
I PRP O
- : O
activated VBD O
Jurkat NNP O
cells NNS O
, , O
dephosphorylation NN O
of IN O
calcineurin NN B-Gene
substrate NN O
NFATc NNP B-Gene
( ( O
a DT O
transcription NN B-Gene
factor NN I-Gene
known VBN O
to TO O
be VB O
involved VBN O
in IN O
transactivation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
) ) O
, , O
was VBD O
also RB O
suppressed VBN O
by IN O
Z NNP O
- : O
D NNP O
- : O
DCB NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
caspase NN O
- : O
mediated JJ O
cleavage NN O
of IN O
Cn NNP B-Gene
A NNP I-Gene
contributes VBZ O
to TO O
IL NNP O
- : O
2 CD O
production NN O
during IN O
T NNP O
cell NN O
activation NN O
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Maturation NN O
of IN O
human JJ O
dendritic JJ O
cells NNS O
as IN O
sulfasalazine JJ O
target NN O
. . O

AIM NN O
: : O
Sulfasalazine NNP O
, , O
a DT O
nonsteroidal JJ O
anti NN O
- : O
inflammatory JJ O
drug NN O
, , O
is VBZ O
effective JJ O
in IN O
treating VBG O
some DT O
autoimmune NN O
diseases NNS O
, , O
but CC O
its PRP$ O
mechanism NN O
of IN O
action NN O
is VBZ O
unclear JJ O
. . O

To TO O
determine VB O
whether IN O
dendritic JJ O
cells NNS O
could MD O
be VB O
a DT O
possible JJ O
target NN O
of IN O
the DT O
drug NN O
, , O
we PRP O
studied VBD O
the DT O
effects NNS O
of IN O
sulfasalazine NN O
and CC O
its PRP$ O
metabolites NNS O
, , O
aminosalicylate NN O
and CC O
sulfapyridine NN O
, , O
on IN O
in IN O
vitro JJ O
maturation NN O
( ( O
terminal JJ O
differentiation NN O
) ) O
of IN O
human JJ O
myeloid JJ O
dendritic JJ O
cells NNS O
. . O

METHODS NNS O
: : O
We PRP O
prepared VBD O
immature JJ O
dendritic JJ O
cells NNS O
by IN O
incubating VBG O
CD14 NNP O
- : O
positive JJ O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
granulocyte JJ B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
and CC O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
4 CD I-Gene
. . O

The DT O
cells NNS O
were VBD O
matured VBN O
by IN O
addition NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
- : I-Gene
a DT I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
, , O
and CC O
prostaglandin NN B-Gene
E2 NNP I-Gene
in IN O
the DT O
presence NN O
of IN O
sulfasalazine NN O
or CC O
its PRP$ O
metabolites NNS O
- : O
- : O
aminosalicylate NN O
and CC O
sulfapyridine NN O
, , O
or CC O
their PRP$ O
combinations NNS O
. . O

We PRP O
quantified VBD O
the DT O
effect NN O
of IN O
drugs NNS O
on IN O
the DT O
dendritic JJ O
cell NN O
characteristics NNS O
, , O
such JJ O
as IN O
stimulation NN O
of IN O
autologous JJ O
and CC O
allogeneic JJ O
pan NN O
- : O
T NNP O
cell NN O
proliferation NN O
, , O
surface NN O
marker NN O
phenotype NN O
, , O
IL NNP O
- : O
12 CD O
p40 NN O
subunit NN O
secretion NN O
, , O
and CC O
activation NN O
of IN O
nuclear JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

RESULTS NN O
: : O
Dendritic JJ O
cells NNS O
treated VBN O
with IN O
sulfasalazine NN O
( ( O
1 CD O
. . O
25 CD O
micromol JJ O
/ NNP O
L NNP O
or CC O
2 CD O
. . O
5 CD O
micromol JJ O
/ NNP O
L NNP O
) ) O
could MD O
not RB O
stimulate VB O
T NNP O
cells NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
28 CD O
, , O
two CD O
- : O
sided VBD O
paired JJ O
t JJ O
- : O
test NN O
) ) O
. . O

In IN O
distinction NN O
to TO O
drug NN O
- : O
free JJ O
maturing VBG O
dendritic JJ O
cells NNS O
, , O
2 CD O
. . O
5 CD O
micromol JJ O
/ NNP O
L NNP O
sulfasalazine NN O
upregulated VBD O
the DT O
levels NNS O
of IN O
CD14 NNP B-Gene
and CC O
CD68 NNP B-Gene
and CC O
downregulated VBD O
the DT O
levels NNS O
of IN O
CD40 NNP B-Gene
, , O
CD80 NNP B-Gene
, , O
and CC O
CD83 NNP B-Gene
( ( O
for IN O
all DT O
CD NN O
markers NNS O
, , O
p VBP O
< JJ O
0 CD O
. . O
3 CD O
for IN O
difference NN O
between IN O
measurements NNS O
in IN O
the DT O
absence NN O
and CC O
the DT O
presence NN O
of IN O
sulfasalazine NN O
) ) O
. . O

From IN O
concentration NN O
- : O
dependent JJ O
changes NNS O
in IN O
CD83 NNP O
expression NN O
, , O
we PRP O
found VBD O
an DT O
apparent JJ O
ID50 NNP O
> NNP O
> VBD O
1 CD O
. . O
5 CD O
micromol JJ O
/ NNP O
L NNP O
sulfasalazine NN O
. . O

The DT O
apparent JJ O
ID50 NNP O
value NN O
for IN O
aminosalicylate JJ O
- : O
inhibited JJ O
maturation NN O
was VBD O
4 CD O
micromol NN O
/ NNP O
L NNP O
. . O

Sulfapyridine NNP O
had VBD O
no DT O
effect NN O
. . O

At IN O
1 CD O
. . O
25 CD O
micromol JJ O
/ NNP O
L NNP O
, , O
sulfasalazine NN O
largely RB O
inhibited JJ O
NF NNP O
- : O
kB NN O
activation NN O
in IN O
dendritic JJ O
cells NNS O
. . O

CONCLUSION NN O
: : O
Maturing NNP O
human JJ O
dendritic JJ O
cells NNS O
are VBP O
hundred VBN O
- : O
fold RB O
more RBR O
sensitive JJ O
to TO O
sulfasalazine VB O
than IN O
T NNP O
cells NNS O
and CC O
NK NNP O
cells NNS O
and CC O
the DT O
most RBS O
sensitive JJ O
human JJ O
cells NNS O
described VBN O
so RB O
far RB O
. . O

Thus RB O
, , O
dendritic JJ O
cell NN O
maturation NN O
is VBZ O
an DT O
important JJ O
target NN O
of IN O
sulfasalazine NN O
. . O

Because IN O
of IN O
the DT O
role NN O
of IN O
dendritic JJ O
cells NNS O
in IN O
( ( O
auto NN O
) ) O
immunity NN O
, , O
inhibition NN O
of IN O
their PRP$ O
maturation NN O
might MD O
provide VB O
a DT O
target NN O
for IN O
further JJ O
optimization NN O
of IN O
sulfasalazine JJ O
therapy NN O
. . O

Defective JJ O
function NN O
of IN O
the DT O
proteasome NN B-Gene
in IN O
autoimmunity NN O
: : O
involvement NN O
of IN O
impaired JJ O
NF NNP O
- : O
kappaB NN O
activation NN O
. . O

Type $ O
1 CD O
diabetes NNS O
( ( O
also RB O
known VBN O
as IN O
insulin NN O
- : O
dependent NN O
diabetes VBZ O
mellitus NNS O
or CC O
juvenile NN O
- : O
onset NN O
diabetes NNS O
) ) O
is VBZ O
usually RB O
caused VBN O
by IN O
T NNP O
cell NN O
- : O
mediated VBN O
autoimmunity NN O
, , O
with IN O
a DT O
prediabetic JJ O
state NN O
characterized VBN O
by IN O
the DT O
production NN O
of IN O
autoantibodies NNS B-Gene
specific JJ O
for IN O
proteins NNS O
expressed VBN O
by IN O
pancreatic JJ O
beta NN O
cells NNS O
. . O

The DT O
nonobese JJ O
patient NN O
with IN O
diabetes NNS O
( ( O
NOD NNP O
) ) O
mouse NN O
is VBZ O
a DT O
spontaneous JJ O
model NN O
of IN O
type JJ O
1 CD O
diabetes NNS O
with IN O
a DT O
strong JJ O
genetic JJ O
component NN O
that WDT O
maps VBZ O
to TO O
the DT O
major JJ B-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( I-Gene
MHC NNP I-Gene
) ) I-Gene
region NN I-Gene
of IN O
the DT O
genome NN B-Gene
. . O

A DT O
specific JJ O
proteasome NN B-Gene
defect NN O
has VBZ O
been VBN O
identified VBN O
in IN O
NOD NNP O
mouse NN O
in IN O
select JJ O
lymphocytic JJ O
and CC O
monocytic JJ O
lineages NNS O
that WDT O
results NNS O
from IN O
down IN O
- : O
regulation NN O
of IN O
expression NN O
of IN O
the DT O
proteasome JJ B-Gene
subunit NN I-Gene
LMP2 NNP I-Gene
, , O
which WDT O
is VBZ O
encoded VBN O
by IN O
a DT O
gene NN O
in IN O
the DT O
MHC NNP B-Gene
genomic JJ I-Gene
region NN I-Gene
. . O

This DT O
defect NN O
prevents VBZ O
the DT O
proteolytic JJ O
processing NN O
required VBN O
for IN O
the DT O
production NN O
and CC O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
, , O
which WDT O
plays VBZ O
important JJ O
roles NNS O
in IN O
immune NN O
and CC O
inflammatory JJ O
responses NNS O
, , O
as RB O
well RB O
as IN O
increases NNS O
the DT O
susceptibility NN O
of IN O
the DT O
affected JJ O
cells NNS O
to TO O
apoptosis VB O
induced VBN O
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
. . O

The DT O
novel JJ O
role NN O
of IN O
the DT O
proteasome NN B-Gene
in IN O
dysfunction NN O
in IN O
autoimmunity NN O
is VBZ O
presented VBN O
and CC O
documented VBN O
to TO O
be VB O
both DT O
tissue NN O
and CC O
developmental JJ O
stage NN O
specific NN O
. . O

We PRP O
propose VBP O
a DT O
role NN O
of IN O
the DT O
proteasome NN B-Gene
as IN O
a DT O
step NN O
in IN O
disease NN O
pathogenesis NN O
and CC O
tissue NN O
targeting NN O
. . O

Down NNP O
- : O
regulation NN O
of IN O
TDT NNP O
transcription NN O
in IN O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
thymocytes VBZ O
by IN O
Ikaros NNP B-Gene
proteins NNS I-Gene
in IN O
direct JJ O
competition NN O
with IN O
an DT O
Ets NNP B-Gene
activator NN I-Gene
. . O

Ikaros NNP B-Gene
is VBZ O
a DT O
unique JJ O
regulator NN O
of IN O
lymphopoiesis NN O
that WDT O
associates VBZ O
with IN O
pericentromeric JJ B-Gene
heterochromatin NN I-Gene
and CC O
has VBZ O
been VBN O
implicated VBN O
in IN O
heritable JJ O
gene NN O
inactivation NN O
. . O

Binding NNP O
and CC O
competition NN O
experiments NNS O
demonstrate VBP O
that IN O
Ikaros NNP B-Gene
dimers NNS I-Gene
compete VBP O
with IN O
an DT O
Ets NNP B-Gene
activator NN I-Gene
for IN O
occupancy NN O
of IN O
the DT O
lymphocyte NN B-Gene
- : I-Gene
specific JJ I-Gene
TdT NNP I-Gene
promoter NN I-Gene
. . O

Mutations NNS O
that WDT O
selectively RB O
disrupt VBP O
Ikaros NNP O
binding VBG O
to TO O
an DT O
integrated VBN B-Gene
TdT NNP I-Gene
promoter NN I-Gene
had VBD O
no DT O
effect NN O
on IN O
promoter NN O
function NN O
in IN O
a DT O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
thymocyte NN O
line NN O
. . O

However RB O
, , O
these DT O
mutations NNS O
abolished VBD O
down RB O
- : O
regulation NN O
on IN O
differentiation NN O
, , O
providing VBG O
evidence NN O
that IN O
Ikaros NNP B-Gene
plays VBZ O
a DT O
direct JJ O
role NN O
in IN O
repression NN O
. . O

Reduced NNP O
access NN O
to TO O
restriction VB O
enzyme JJ O
cleavage NN O
suggested VBD O
that IN O
chromatin NN O
alterations NNS O
accompany VBP O
down RP O
- : O
regulation NN O
. . O

The DT O
Ikaros NNP O
- : O
dependent NN O
down IN O
- : O
regulation NN O
event NN O
and CC O
the DT O
observed JJ O
chromatin NN O
alterations NNS O
appear VBP O
to TO O
precede VB O
pericentromeric JJ O
repositioning NN O
. . O

Current JJ O
models NNS O
propose VBP O
that IN O
the DT O
functions NNS O
of IN O
Ikaros NNP B-Gene
should MD O
be VB O
disrupted VBN O
by IN O
a DT O
small JJ O
isoform NN B-Gene
that WDT O
retains VBZ O
the DT O
dimerization NN B-Gene
domain NN I-Gene
and CC O
lacks VBZ O
the DT O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
. . O

Surprisingly RB O
, , O
in IN O
the DT O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
thymocyte NN O
line NN O
, , O
overexpression NN O
of IN O
a DT O
small JJ B-Gene
Ikaros NNP I-Gene
isoform NN I-Gene
had VBD O
no DT O
effect NN O
on IN O
differentiation NN O
or CC O
on IN O
the DT O
pericentromeric JJ O
targeting NN O
and CC O
DNA NNP O
- : O
binding NN O
properties NNS O
of IN O
Ikaros NNP B-Gene
. . O

Rather RB O
, , O
the DT O
small JJ O
isoform NN B-Gene
assembled VBN O
into IN O
multimeric JJ B-Gene
complexes NNS I-Gene
with IN O
DNA NNP B-Gene
- : I-Gene
bound NN I-Gene
Ikaros NNP I-Gene
at IN O
the DT O
pericentromeric JJ O
foci NN O
. . O

The DT O
capacity NN O
for IN O
in IN O
vivo JJ O
multimer NN O
formation NN O
suggests VBZ O
that IN O
interactions NNS O
between IN O
Ikaros NNP B-Gene
dimers NNS I-Gene
bound VBD O
to TO O
the DT O
TdT NNP B-Gene
promoter NN I-Gene
and CC O
those DT O
bound VBN O
to TO O
pericentromeric VB B-Gene
repeat NN I-Gene
sequences NNS I-Gene
may MD O
contribute VB O
to TO O
the DT O
pericentromeric JJ O
repositioning NN O
of IN O
the DT O
inactive JJ B-Gene
gene NN I-Gene
. . O

Type NN B-Gene
I PRP I-Gene
interferons NNS I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
: : O
convergence NN O
and CC O
cross NN O
- : O
regulation NN O
among IN O
mediators NNS O
of IN O
cellular JJ O
immunity NN O
. . O

Therapeutic JJ O
use NN O
of IN O
type NN B-Gene
I PRP I-Gene
IFN NNP I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ NNP I-Gene
beta NN I-Gene
) ) O
has VBZ O
become VBN O
common JJ O
. . O

Many JJ O
of IN O
the DT O
diverse NN O
diseases NNS O
targeted VBN O
are VBP O
marked VBN O
by IN O
pathogenetic JJ O
abnormalities NNS O
in IN O
cell NN O
- : O
mediated VBN O
immunity NN O
( ( O
CMI NNP O
) ) O
, , O
these DT O
cellular JJ O
immune NN O
responses NNS O
either CC O
causing VBG O
injury NN O
to TO O
the DT O
host NN O
, , O
lacking VBG O
sufficient JJ O
vigor NN O
for IN O
virus NN O
or CC O
tumor NN O
clearance NN O
, , O
or CC O
both DT O
. . O

In IN O
general JJ O
, , O
therapeutic JJ O
efficacy NN O
is VBZ O
limited VBN O
. . O

It PRP O
is VBZ O
thus RB O
notable JJ O
that IN O
the DT O
pleiotropic NN O
effects NNS O
of IN O
type NN B-Gene
I PRP I-Gene
IFN VBP I-Gene
on IN O
CMI NNP O
remain VBP O
poorly RB O
understood JJ O
. . O

We PRP O
characterized VBD O
the DT O
effects NNS O
of IN O
type NN B-Gene
I PRP I-Gene
IFN VBP I-Gene
on IN O
the DT O
production NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
the DT O
central JJ B-Gene
immunoregulatory JJ I-Gene
cytokine NN I-Gene
of IN O
the DT O
CD4 NNP B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
T NNP I-Gene
cell NN I-Gene
arm NN I-Gene
of IN O
CMI NNP O
. . O

We PRP O
show VBP O
that IN O
type NN B-Gene
I PRP I-Gene
IFN NNP I-Gene
are VBP O
potent JJ O
inhibitors NNS O
of IN O
IL NNP O
- : O
12 CD O
production NN O
by IN O
human JJ O
monocytes NNS O
/ VBP O
macrophages NNS O
. . O

The DT O
underlying VBG O
mechanism NN O
involves VBZ O
transcriptional JJ O
inhibition NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
12p40 CD I-Gene
gene NN I-Gene
, , O
marked VBN O
by IN O
down IN O
- : O
regulation NN O
of IN O
PU NNP O
. . O
1 CD O
binding NN O
activity NN O
at IN O
the DT O
upstream JJ B-Gene
Ets NNP I-Gene
site NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
12p40 CD I-Gene
promoter NN I-Gene
. . O

Type NN B-Gene
I PRP I-Gene
IFN VBP I-Gene
have VBP O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
able JJ O
to TO O
substitute VB O
for IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
in IN O
driving VBG O
IFN NNP O
- : O
gamma NN O
production NN O
from IN O
T NNP O
and CC O
NK NNP O
cells NNS O
. . O

The DT O
ability NN O
of IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ VBZ I-Gene
beta NN I-Gene
to TO O
suppress VB O
IL NNP O
- : O
12 CD O
production NN O
while IN O
up IN O
- : O
regulating NN O
IFN NNP O
- : O
gamma NN O
production NN O
suggests VBZ O
a DT O
possible JJ O
mechanistic JJ O
basis NN O
for IN O
the DT O
difficulties NNS O
of IN O
employing VBG O
these DT O
cytokines NNS B-Gene
in IN O
diseases NNS O
involving VBG O
abnormalities NNS O
of IN O
CMI NNP O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
suppressive JJ O
and CC O
inhibitor JJ B-Gene
- : I-Gene
kappaB NN I-Gene
stimulatory JJ O
effects NNS O
of IN O
troglitazone NN O
in IN O
obese JJ O
patients NNS O
with IN O
type JJ O
2 CD O
diabetes NNS O
: : O
evidence NN O
of IN O
an DT O
antiinflammatory JJ O
action NN O
? . O

It PRP O
has VBZ O
been VBN O
shown VBN O
recently RB O
that IN O
troglitazone NN O
exerts VBZ O
an DT O
anti JJ O
- : O
inflammatory JJ O
effect NN O
, , O
in IN O
vitro NN O
, , O
and CC O
in IN O
experimental JJ O
animals NNS O
. . O

To TO O
test VB O
these DT O
properties NNS O
in IN O
humans NNS O
, , O
we PRP O
investigated VBD O
the DT O
effect NN O
of IN O
troglitazone NN O
on IN O
the DT O
proinflammatory NN B-Gene
transcription NN I-Gene
factor NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
its PRP$ O
inhibitory NN B-Gene
protein NN I-Gene
IkappaB NNP I-Gene
in IN O
mononuclear JJ O
cells NNS O
( ( O
MNC NNP O
) ) O
and CC O
plasma $ B-Gene
soluble JJ I-Gene
intracellular JJ I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
monocyte NN B-Gene
chemoattractant NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
, , O
plasminogen NN B-Gene
activator NN I-Gene
inhibitor NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
C NNP B-Gene
- : I-Gene
reactive JJ I-Gene
protein NN I-Gene
. . O

We PRP O
also RB O
examined VBD O
the DT O
effect NN O
of IN O
troglitazone NN O
on IN O
reactive JJ O
oxygen NN O
species NNS O
generation NN O
, , O
p47 NN O
( ( O
phox NN O
) ) O
subunit NN O
expression NN O
, , O
9 CD O
- : O
hydroxyoctadecadieno NN O
acid NN O
( ( O
9 CD O
- : O
HODE NN O
) ) O
, , O
13 CD O
- : O
HODE NN O
, , O
o SYM O
- : O
tyrosine NN O
, , O
and CC O
m SYM O
- : O
tyrosine NN O
in IN O
obese JJ O
patients NNS O
with IN O
type JJ O
2 CD O
diabetes NNS O
. . O

Seven NNP O
obese JJ O
patients NNS O
with IN O
type JJ O
2 CD O
diabetes NNS O
were VBD O
treated VBN O
with IN O
troglitazone NN O
( ( O
400 CD O
mg NNS O
/ JJ O
day NN O
) ) O
for IN O
4 CD O
weeks NNS O
. . O

Blood NN O
samples NNS O
were VBD O
obtained VBN O
at IN O
weekly JJ O
intervals NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
activity NN O
in IN O
MNC NNP O
nuclear JJ O
extracts NNS O
was VBD O
significantly RB O
inhibited VBN O
after IN O
troglitazone NN O
treatment NN O
at IN O
week NN O
1 CD O
and CC O
continued VBD O
to TO O
be VB O
inhibited VBN O
up RP O
to TO O
week NN O
4 CD O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
IkappaB NNP O
protein NN O
levels NNS O
increased VBN O
significantly RB O
after IN O
troglitazone NN O
treatment NN O
at IN O
week NN O
1 CD O
, , O
and CC O
this DT O
increase NN O
persisted VBD O
throughout IN O
the DT O
study NN O
. . O

Plasma NNP B-Gene
monocyte NN I-Gene
chemoattractant NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
and CC O
soluble JJ B-Gene
intracellular JJ I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
concentrations NNS O
did VBD O
not RB O
decrease VB O
significantly RB O
after IN O
troglitazone NN O
treatment NN O
, , O
although IN O
there EX O
was VBD O
a DT O
trend NN O
toward IN O
inhibition NN O
. . O

Reactive JJ O
oxygen NN O
species NNS O
generation NN O
by IN O
polymorphonuclear JJ O
cells NNS O
and CC O
MNC NNP O
, , O
p47 NN B-Gene
( ( I-Gene
phox NN I-Gene
) ) I-Gene
subunit NN I-Gene
protein NN I-Gene
quantities NNS O
, , O
plasminogen NN B-Gene
activator NN I-Gene
inhibitor NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
C NNP B-Gene
- : I-Gene
reactive JJ I-Gene
protein NN I-Gene
levels NNS O
decreased VBN O
significantly RB O
after IN O
troglitazone JJ O
intake NN O
. . O

13 CD O
- : O
HODE NNP O
/ NNP O
linoleic NN O
acid NN O
and CC O
9 CD O
- : O
HODE NNP O
/ NNP O
linoleic VBZ O
acid JJ O
ratios NNS O
also RB O
decreased VBD O
after IN O
troglitazone NN O
intake NN O
. . O

However RB O
, , O
o SYM O
- : O
tyrosine NN O
/ JJ O
phenylalanine NN O
and CC O
m SYM O
- : O
tyrosine NN O
/ JJ O
phenylalanine JJ O
ratios NNS O
did VBD O
not RB O
change VB O
significantly RB O
. . O

These DT O
data NNS O
show VBP O
that IN O
troglitazone NN O
has VBZ O
profound VBN O
antiinflammatory JJ O
effects NNS O
in IN O
addition NN O
to TO O
antioxidant JJ O
effects NNS O
in IN O
obese JJ O
type NN O
2 CD O
diabetics NNS O
; : O
these DT O
effects NNS O
may MD O
be VB O
relevant JJ O
to TO O
the DT O
recently RB O
described VBN O
beneficial JJ O
antiatherosclerotic JJ O
effects NNS O
of IN O
troglitazone NN O
at IN O
the DT O
vascular JJ O
level NN O
. . O

OX40 NNP O
stimulation NN O
by IN O
gp34 NN B-Gene
/ NNP I-Gene
OX40 NNP I-Gene
ligand NN I-Gene
enhances NNS O
productive JJ O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
infection NN O
. . O

OX40 NNP B-Gene
is VBZ O
a DT O
member NN O
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
receptor NN I-Gene
superfamily RB I-Gene
and CC O
known VBN O
to TO O
be VB O
an DT O
important JJ O
costimulatory NN B-Gene
molecule NN I-Gene
expressed VBN O
on IN O
activated JJ O
T NNP O
cells NNS O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
costimulation NN O
of IN O
OX40 NNP B-Gene
in IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
infection NN O
by IN O
its PRP$ O
natural JJ O
ligand NN O
, , O
gp34 NN B-Gene
, , O
the DT O
OX40 NNP O
- : O
transfected VBD O
ACH NNP O
- : O
2 CD O
cell NN O
line NN O
, , O
ACH NNP O
- : O
2 CD O
/ NN O
OX40 NNP O
, , O
chronically RB O
infected VBN O
with IN O
HIV NNP O
- : O
1 CD O
, , O
was VBD O
cocultured VBN O
with IN O
paraformaldehyde NN O
( ( O
PFA NNP O
) ) O
- : O
fixed VBN O
gp34 SYM O
- : O
transfected VBN O
mouse NN O
cell NN O
line NN O
, , O
SV NNP O
- : O
T2 NNP O
/ NNP O
gp34 NN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
HIV NNP O
- : O
1 CD O
production NN O
was VBD O
strongly RB O
induced VBN O
. . O

This DT O
was VBD O
followed VBN O
by IN O
apparent JJ O
apoptosis NN O
, , O
and CC O
both DT O
processes NNS O
were VBD O
specifically RB O
inhibited VBN O
by IN O
the DT O
gp34 NN B-Gene
- : O
specific JJ O
neutralizing VBG B-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
5A8 CD I-Gene
. . O

Endogenous JJ O
TNF NNP B-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
and CC O
TNF NNP B-Gene
- : I-Gene
beta NN I-Gene
production NN O
were VBD O
not RB O
involved VBN O
in IN O
the DT O
enhanced JJ O
HIV NNP O
- : O
1 CD O
production NN O
. . O

Furthermore RB O
, , O
enhanced VBD O
HIV NNP O
- : O
1 CD O
transcription NN O
in IN O
gp34 JJ B-Gene
- : O
stimulated VBN O
ACH NNP O
- : O
2 CD O
/ JJ O
OX40 NNP O
cells NNS O
was VBD O
dependent JJ O
on IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
site NN I-Gene
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
, , O
and CC O
the DT O
OX40 NNP O
- : O
gp34 NN O
interaction NN O
activated VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
consisting NN O
of IN O
p50 NN B-Gene
and CC I-Gene
p65 NN I-Gene
subunits NNS I-Gene
. . O

When WRB O
primary JJ O
activated VBD O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
acutely RB O
infected VBN O
with IN O
HIV NNP O
- : O
1 CD O
( ( O
NL4 NNP O
- : O
3 CD O
) ) O
( ( O
CXCR4 NNP O
- : O
using VBG O
T NNP O
- : O
cell NN O
- : O
line NN O
- : O
tropic NN O
) ) O
were VBD O
cocultured VBN O
with IN O
PFA NNP O
- : O
fixed VBN O
gp34 NN O
( ( O
+ NNP O
) ) O
human NN O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
- : O
bearing NN O
MT NNP O
- : O
2 CD O
cells NNS O
or CC O
SV NNP O
- : O
T2 NNP O
/ NNP O
gp34 NN O
cells NNS O
, , O
HIV NNP O
- : O
1 CD O
production NN O
was VBD O
also RB O
markedly RB O
enhanced VBD O
. . O

The DT O
enhancement NN O
was VBD O
again RB O
significantly RB O
inhibited VBN O
by IN O
5A8 CD B-Gene
. . O

The DT O
present JJ O
study NN O
first RB O
shows VBZ O
that IN O
OX40 NNP O
- : O
gp34 NN O
interaction NN O
stimulates VBZ O
HIV NNP O
- : O
1 CD O
expression NN O
and CC O
suggests VBZ O
that IN O
OX40 NNP O
triggering VBG O
by IN O
gp34 NN B-Gene
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
enhancing VBG O
HIV NNP O
- : O
1 CD O
production NN O
in IN O
both DT O
acutely RB O
and CC O
latently RB O
infected VBN O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
in IN O
vivo NN O
. . O

Troglitazone NN O
, , O
a DT O
PPARgamma NNP O
ligand NN O
, , O
inhibits VBZ O
osteopontin JJ O
gene NN O
expression NN O
in IN O
human JJ O
monocytes NNS O
/ VBP O
macrophage NN O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Peroxizome NNP B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
- : I-Gene
gamma NN I-Gene
( ( O
PPARgamma NNP B-Gene
) ) O
is VBZ O
a DT O
member NN O
of IN O
the DT O
nuclear JJ B-Gene
receptor NN I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
that WDT O
regulate VBP O
adipocyte DT O
differentiation NN O
. . O

Recent JJ O
studies NNS O
indicate VBP O
that IN O
liganded VBD B-Gene
PPARgamma NNP I-Gene
not RB O
only RB O
promotes VBZ O
differentiation NN O
but CC O
also RB O
inhibits VBZ O
the DT O
activation NN O
of IN O
macrophages NNS O
. . O

Osteopontin NNP B-Gene
, , O
a DT O
component NN O
of IN O
extracellular JJ O
matrix NN O
, , O
is VBZ O
synthesized VBN O
by IN O
macrophages NNS O
in IN O
atherosclerotic JJ O
plaques NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
whether IN O
PPARgamma NNP B-Gene
ligand VBP O
regulates VBZ O
osteopontin JJ O
gene NN O
expression NN O
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
, , O
a DT O
cell NN O
line NN O
derived VBN O
from IN O
human JJ O
monocytic JJ O
leukemia NN O
cells NNS O
which WDT O
can MD O
differentiate VB O
to TO O
macrophage VB O
upon JJ O
stimulation NN O
with IN O
phorbol NN O
ester NN O
PMA NNP O
. . O

Northern NNP O
blot NN O
analysis NN O
showed VBD O
that IN O
osteopontin JJ O
expression NN O
is VBZ O
markedly RB O
induced VBN O
in IN O
response NN O
to TO O
PMA NNP O
. . O

Troglitazone NN O
, , O
a DT O
PPARgamma NNP B-Gene
ligand NN O
, , O
dramatically RB O
attenuated VBD O
the DT O
PMA NNP O
- : O
induced VBD O
osteopontin JJ O
expression NN O
. . O

Transient JJ O
transfection NN O
assays NNS O
of IN O
the DT O
human JJ B-Gene
osteopontin NN I-Gene
promoter NN I-Gene
/ NNP I-Gene
luciferase NN I-Gene
construct NN I-Gene
which WDT O
contains VBZ O
a DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
flanking VBG I-Gene
region NN I-Gene
between IN O
- : O
1500 CD O
and CC O
+ $ O
87 CD O
relative NN O
to TO O
the DT O
transcription NN B-Gene
start NN I-Gene
site NN I-Gene
demonstrate NN O
that IN O
either DT O
treatment NN O
with IN O
troglitazone NN O
or CC O
cotransfection NN O
of IN O
PPARgamma NNP B-Gene
expression NN I-Gene
vector NN I-Gene
inhibits VBZ O
osteopontin JJ O
promoter NN O
activity NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
troglitazone NN O
reduces NNS O
osteopontin VBP O
gene NN O
expression NN O
at IN O
transcriptional JJ O
level NN O
through IN O
PPARgamma NNP B-Gene
activation NN O
, , O
and CC O
suggest VBP O
the DT O
role NN O
of IN O
troglitazone NN O
in IN O
inhibiting VBG O
the DT O
ability NN O
of IN O
macrophages NNS O
to TO O
produce VB O
extracellular JJ O
matrix NN O
, , O
which WDT O
is VBZ O
particularly RB O
relevant JJ O
to TO O
atherosclerotic JJ O
plaque NN O
formation NN O
. . O

Transcription NNP B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
regulates VBZ O
Ig NNP B-Gene
lambda NN I-Gene
light NN O
chain NN O
gene NN O
rearrangement NN O
. . O

The DT O
tissue NN O
- : O
and CC O
stage VB O
- : O
specific JJ O
assembly NN O
of IN O
Ig NNP B-Gene
and CC I-Gene
TCR NNP I-Gene
genes NNS I-Gene
is VBZ O
mediated VBN O
by IN O
a DT O
common JJ O
V NNP B-Gene
( ( I-Gene
D NNP I-Gene
) ) I-Gene
J NNP I-Gene
recombinase NN I-Gene
complex NN I-Gene
in IN O
precursor NN O
lymphocytes NNS O
. . O

Directed VBN O
alterations NNS O
in IN O
the DT O
accessibility NN O
of IN O
V NNP B-Gene
, , I-Gene
D NNP I-Gene
, , I-Gene
and CC I-Gene
J NNP I-Gene
gene NN I-Gene
segments NNS I-Gene
target VBP O
the DT O
recombinase NN B-Gene
to TO O
specific JJ O
Ag NNP B-Gene
receptor NN I-Gene
loci NN I-Gene
. . O

Accessibility NNP O
within IN O
a DT O
given VBN O
locus NN B-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
functional JJ O
interaction NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
with IN O
cognate JJ B-Gene
enhancer NN I-Gene
elements NNS I-Gene
and CC O
correlates NNS O
with IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
unrearranged JJ O
gene NN B-Gene
segments NNS I-Gene
. . O

As IN O
demonstrated VBN O
in IN O
our PRP$ O
prior JJ O
studies NNS O
, , O
rearrangement NN O
of IN O
the DT O
Igkappa NNP B-Gene
locus NN I-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
inducible JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

In IN O
contrast NN O
to TO O
the DT O
Igkappa NNP B-Gene
locus NN I-Gene
, , O
known VBN O
transcriptional JJ B-Gene
control NN I-Gene
elements NNS I-Gene
in IN O
the DT O
Iglambda NNP B-Gene
locus NN I-Gene
lack NN O
functional JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Consistent JJ O
with IN O
this DT O
observation NN O
, , O
the DT O
expression NN O
of IN O
assembled JJ O
Iglambda NNP B-Gene
genes NNS I-Gene
in IN O
mature NN O
B NNP O
cells NNS O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
independent JJ O
. . O

Nonetheless RB O
, , O
we PRP O
now RB O
show VBP O
that IN O
specific JJ O
repression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
inhibits NNS O
germline VBP O
transcription NN O
and CC O
recombination NN O
of IN O
Iglambda NNP B-Gene
gene NN I-Gene
segments NNS I-Gene
in IN O
precursor NN O
B NNP O
cells NNS O
. . O

Molecular JJ O
analyses NNS O
indicate VBP O
that IN O
the DT O
block NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
impairs NNS O
Iglambda NNP O
rearrangement NN O
at IN O
the DT O
level NN O
of IN O
recombinase NN B-Gene
accessibility NN O
. . O

In IN O
contrast NN O
, , O
the DT O
activities NNS O
of IN O
known VBN O
Iglambda NNP B-Gene
promoter NN I-Gene
and CC O
enhancer NN B-Gene
elements NNS I-Gene
are VBP O
unaffected VBN O
in IN O
the DT O
same JJ O
cellular JJ O
background NN O
. . O

These DT O
findings NNS O
expand VBP O
the DT O
range NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
action NN O
in IN O
precursor NN O
B NNP O
cells NNS O
beyond IN O
Igkappa NNP B-Gene
to TO O
include VB O
the DT O
control NN O
of IN O
recombinational JJ O
accessibility NN O
at IN O
both DT O
L NNP B-Gene
chain NN I-Gene
loci NN I-Gene
. . O

Moreover RB O
, , O
our PRP$ O
results NNS O
strongly RB O
suggest VBP O
the DT O
existence NN O
of IN O
a DT O
novel JJ O
Iglambda NNP B-Gene
regulatory JJ I-Gene
element NN I-Gene
that WDT O
is VBZ O
either DT O
directly RB O
or CC O
indirectly RB O
activated VBN O
by IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
during IN O
the DT O
early JJ O
stages NNS O
of IN O
B NNP O
cell NN O
development NN O
. . O

Transcription NNP B-Gene
factor NN I-Gene
STAT5A NNP B-Gene
is VBZ O
a DT O
substrate NN O
of IN O
Bruton NNP B-Gene
' POS I-Gene
s JJ I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
in IN O
B NNP O
cells NNS O
. . O

STAT5A NNP B-Gene
is VBZ O
a DT O
molecular JJ O
regulator NN O
of IN O
proliferation NN O
, , O
differentiation NN O
, , O
and CC O
apoptosis NN O
in IN O
lymphohematopoietic JJ O
cells NNS O
. . O

Here RB O
we PRP O
show VBP O
that IN O
STAT5A NNP B-Gene
can MD O
serve VB O
as IN O
a DT O
functional JJ O
substrate NN O
of IN O
Bruton NNP B-Gene
' POS I-Gene
s JJ I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( O
BTK NNP B-Gene
) ) O
. . O

Purified NNP B-Gene
recombinant JJ I-Gene
BTK NNP I-Gene
was VBD O
capable JJ O
of IN O
directly RB O
binding VBG O
purified VBN B-Gene
recombinant JJ I-Gene
STAT5A NNP I-Gene
with IN O
high JJ O
affinity NN O
( ( O
K NNP O
( ( O
d NN O
) ) O
= VBZ O
44 CD O
nm NN O
) ) O
, , O
as IN O
determined VBN O
by IN O
surface NN O
plasmon NN O
resonance NN O
using VBG O
a DT O
BIAcore NNP O
biosensor NN O
system NN O
. . O

BTK NNP B-Gene
was VBD O
also RB O
capable JJ O
of IN O
tyrosine JJ O
- : O
phosphorylating VBG O
ectopically RB O
expressed VBN O
recombinant JJ B-Gene
STAT5A NNP I-Gene
on IN O
Tyr NNP O
( ( O
694 CD O
) ) O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
in IN O
a DT O
Janus NNP B-Gene
kinase NN I-Gene
3 CD I-Gene
- : O
independent JJ O
fashion NN O
. . O

BTK NNP B-Gene
phosphorylated VBD O
the DT O
Y665F NNP B-Gene
, , I-Gene
Y668F NNP I-Gene
, , I-Gene
and CC I-Gene
Y682F NNP I-Gene
, , I-Gene
Y683F NNP I-Gene
mutants NNS I-Gene
but CC O
not RB O
the DT O
Y694F NNP B-Gene
mutant NN I-Gene
of IN O
STAT5A NNP B-Gene
. . O

STAT5A NNP O
mutations NNS O
in IN O
the DT O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
( ( I-Gene
SH2 NNP I-Gene
) ) I-Gene
and CC I-Gene
SH3 NNP I-Gene
domains NNS I-Gene
did VBD O
not RB O
alter VB O
the DT O
BTK NNP B-Gene
- : O
mediated VBD O
tyrosine JJ O
phosphorylation NN O
. . O

Recombinant JJ B-Gene
BTK NNP I-Gene
proteins VBZ I-Gene
with IN O
mutant JJ O
pleckstrin NN O
homology NN O
, , O
SH2 NNP B-Gene
, , I-Gene
or CC I-Gene
SH3 NNP I-Gene
domains NNS I-Gene
were VBD O
capable JJ O
of IN O
phosphorylating VBG O
STAT5A NNP B-Gene
, , O
whereas JJ O
recombinant NN B-Gene
BTK NNP I-Gene
proteins VBZ I-Gene
with IN O
SH1 NNP O
/ NNP O
kinase NN O
domain NN O
mutations NNS O
were VBD O
not RB O
. . O

In IN O
pull NN O
- : O
down IN O
experiments NNS O
, , O
only RB O
full JJ B-Gene
- : I-Gene
length NN I-Gene
BTK NNP I-Gene
and CC O
its PRP$ O
SH1 NNP B-Gene
/ NNP I-Gene
kinase NN I-Gene
domain NN I-Gene
( ( O
but CC O
not RB O
the DT O
pleckstrin NN O
homology NN O
, , O
SH2 NNP B-Gene
, , I-Gene
or CC I-Gene
SH3 NNP I-Gene
domains NNS I-Gene
) ) O
were VBD O
capable JJ O
of IN O
binding VBG O
STAT5A NNP B-Gene
. . O

Ectopically RB O
expressed VBN O
BTK NNP B-Gene
kinase NN I-Gene
domain NN I-Gene
was VBD O
capable JJ O
of IN O
tyrosine JJ O
- : O
phosphorylating NN O
STAT5A NNP B-Gene
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

BTK NNP B-Gene
- : O
mediated VBD O
tyrosine JJ O
phosphorylation NN O
of IN O
ectopically RB O
expressed VBN O
wild JJ O
type NN O
( ( O
but CC O
not RB O
Tyr NNP B-Gene
( ( I-Gene
694 CD I-Gene
) ) I-Gene
mutant NN I-Gene
) ) O
STAT5A NNP B-Gene
enhanced VBD O
its PRP$ O
DNA NNP O
binding NN O
activity NN O
. . O

In IN O
BTK NNP B-Gene
- : O
competent NN O
chicken NN O
B NNP O
cells NNS O
, , O
anti SYM O
- : O
IgM NNP O
- : O
stimulated VBD O
tyrosine JJ O
phosphorylation NN O
of IN O
STAT5 NNP B-Gene
protein NN I-Gene
was VBD O
prevented VBN O
by IN O
pretreatment NN O
with IN O
the DT O
BTK NNP B-Gene
inhibitor NN O
LFM NNP O
- : O
A13 NN O
but CC O
not RB O
by IN O
pretreatment NN O
with IN O
the DT O
JAK3 NNP O
inhibitor NN O
HI NNP O
- : O
P131 NN O
. . O

B NNP O
cell NN O
antigen NN O
receptor NN O
ligation NN O
resulted VBD O
in IN O
enhanced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
STAT5 NNP B-Gene
in IN O
BTK NNP B-Gene
- : O
deficient NN O
chicken NN O
B NNP O
cells NNS O
reconstituted VBN O
with IN O
wild JJ B-Gene
type JJ I-Gene
human JJ I-Gene
BTK NNP I-Gene
but CC O
not RB O
in IN O
BTK NNP B-Gene
- : O
deficient NN O
chicken NN O
B NNP O
cells NNS O
reconstituted VBN O
with IN O
kinase NN B-Gene
- : I-Gene
inactive JJ I-Gene
mutant JJ I-Gene
BTK NNP I-Gene
. . O

Similarly RB O
, , O
anti SYM O
- : O
IgM NNP O
stimulation NN O
resulted VBD O
in IN O
enhanced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
STAT5A NNP B-Gene
in IN O
BTK NNP B-Gene
- : O
competent NN O
B NNP O
cells NNS O
from IN O
wild JJ O
type JJ O
mice NN O
but CC O
not RB O
in IN O
BTK NNP B-Gene
- : O
deficient NN O
B NNP O
cells NNS O
from IN O
XID NNP O
mice NN O
. . O

In IN O
contrast NN O
to TO O
B NNP O
cells NNS O
from IN O
XID NNP O
mice NN O
, , O
B NNP O
cells NNS O
from IN O
JAK3 NNP O
knockout NN O
mice NN O
showed VBD O
a DT O
normal JJ O
STAT5A NNP O
phosphorylation NN O
response NN O
to TO O
anti VB O
- : O
IgM NNP O
stimulation NN O
. . O

These DT O
findings NNS O
provide VBP O
unprecedented JJ O
experimental JJ O
evidence NN O
that IN O
BTK NNP B-Gene
plays VBZ O
a DT O
nonredundant JJ O
and CC O
pivotal JJ O
role NN O
in IN O
B NNP O
cell NN O
antigen NN O
receptor NN O
- : O
mediated VBN O
STAT5A NNP O
activation NN O
in IN O
B NNP O
cells NNS O

Role NNP O
of IN O
T NNP B-Gene
- : I-Gene
bet NN I-Gene
in IN O
commitment NN O
of IN O
TH1 NNP O
cells NNS O
before IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
- : O
dependent JJ O
selection NN O
. . O

How WRB O
cytokines NNS B-Gene
control VBP O
differentiation NN O
of IN O
helper NN O
T NNP O
( ( O
TH NNP O
) ) O
cells NNS O
is VBZ O
controversial JJ O
. . O

We PRP O
show VBP O
that IN O
T NNP B-Gene
- : I-Gene
bet NN I-Gene
, , O
without IN O
apparent JJ O
assistance NN O
from IN O
interleukin JJ B-Gene
12 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
12 CD I-Gene
) ) I-Gene
/ NN O
STAT4 NNP B-Gene
, , O
specifies VBZ O
TH1 NNP O
effector NN O
fate NN O
by IN O
targeting VBG O
chromatin NN O
remodeling VBG O
to TO O
individual JJ O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
( ( I-Gene
IFN NNP I-Gene
- : I-Gene
gamma NN I-Gene
) ) I-Gene
alleles NNS I-Gene
and CC O
by IN O
inducing VBG O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
receptor NN I-Gene
beta2 NN I-Gene
expression NN O
. . O

Subsequently RB O
, , O
it PRP O
appears VBZ O
that IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
/ JJ O
STAT4 NNP B-Gene
serves VBZ O
two CD O
essential JJ O
functions NNS O
in IN O
the DT O
development NN O
of IN O
TH1 NNP O
cells NNS O
: : O
as IN O
growth NN B-Gene
signal NN I-Gene
, , O
inducing VBG O
survival NN O
and CC O
cell NN O
division NN O
; : O
and CC O
as IN O
trans NNS B-Gene
- : I-Gene
activator NN I-Gene
, , O
prolonging VBG O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
synthesis NN O
through IN O
a DT O
genetic JJ O
interaction NN O
with IN O
the DT O
coactivator NN B-Gene
, , O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
a DT O
cytokine NN B-Gene
does VBZ O
not RB O
simply RB O
induce VB O
TH NNP O
fate NN O
choice NN O
but CC O
instead RB O
may MD O
act VB O
as IN O
an DT O
essential JJ O
secondary JJ O
stimulus NN O
that WDT O
mediates VBZ O
selective JJ O
survival NN O
of IN O
a DT O
lineage NN O
. . O

Stat6 NNP B-Gene
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
IL NNP O
- : O
4 CD O
' '' O
s JJ O
role NN O
in IN O
Th2 NNP O
differentiation NN O
and CC O
cell NN O
expansion NN O
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
the DT O
differentiation NN O
of IN O
T NNP O
CR NNP O
- : O
stimulated VBD O
naive JJ O
CD4 NNP O
T NNP O
cells NNS O
to TO O
the DT O
Th2 NNP O
phenotype NN O
. . O

In IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
the DT O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
activates VBZ O
a DT O
set NN O
of IN O
phosphotyrosine NN B-Gene
binding NN I-Gene
domain NN I-Gene
- : I-Gene
containing NN I-Gene
proteins NNS I-Gene
, , O
including VBG O
insulin NN B-Gene
receptor NN I-Gene
substrate VBP I-Gene
1 CD I-Gene
/ JJ I-Gene
2 CD I-Gene
, , O
Shc NNP B-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
interacting VBG I-Gene
protein NN I-Gene
, , O
as RB O
well RB O
as IN O
Stat6 NNP B-Gene
. . O

Stat6 NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
Th2 NNP O
differentiation NN O
. . O

To TO O
determine VB O
the DT O
roles NNS O
of IN O
the DT O
phosphotyrosine NN B-Gene
binding VBG I-Gene
adaptors NNS I-Gene
in IN O
Th2 NNP O
differentiation NN O
, , O
we PRP O
prepared VBD O
a DT O
retrovirus NN O
containing VBG O
a DT O
mutant NN O
of IN O
the DT O
human JJ B-Gene
( ( I-Gene
h NN I-Gene
) ) I-Gene
IL NNP I-Gene
- : I-Gene
4R CD I-Gene
alpha JJ I-Gene
- : I-Gene
chain NN I-Gene
, , O
Y497F NNP B-Gene
, , O
which WDT O
is VBZ O
unable JJ O
to TO O
recruit VB O
these DT O
adaptors NNS O
. . O

The DT O
mutant JJ B-Gene
hIL NN I-Gene
- : I-Gene
4Ralpha CD I-Gene
, , O
as RB O
well RB O
as IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
( ( I-Gene
WT NNP I-Gene
) ) I-Gene
hIL VBD I-Gene
- : I-Gene
4Ralpha CD I-Gene
, , O
was VBD O
introduced VBN O
into IN O
naive JJ O
CD4 NNP O
T NNP O
cells NNS O
. . O

Upon IN O
hIL SYM O
- : O
4 CD O
stimulation NN O
, , O
Y497F NNP B-Gene
worked VBD O
as RB O
well RB O
as IN O
the DT O
WT NNP B-Gene
hIL VBD I-Gene
- : I-Gene
4Ralpha CD I-Gene
in IN O
driving VBG O
Th2 NNP O
differentiation NN O
, , O
as IN O
measured VBN O
by IN O
Gata3 NNP O
up RP O
- : O
regulation NN O
and CC O
IL NNP O
- : O
4 CD O
production NN O
. . O

Furthermore RB O
, , O
IL NNP O
- : O
4 CD O
- : O
driven NN O
cell NN O
expansion NN O
was VBD O
also RB O
normal JJ O
in IN O
the DT O
cells NNS O
infected VBN O
with IN O
Y497F NNP B-Gene
, , O
although IN O
cells NNS O
infected VBN O
with IN O
Y497F NNP B-Gene
were VBD O
not RB O
capable JJ O
of IN O
phosphorylating VBG O
insulin NN B-Gene
receptor NN I-Gene
substrate NN I-Gene
2 CD I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
signal JJ O
pathway NN O
mediated VBN O
by IN O
Y497 NNP B-Gene
is VBZ O
dispensable JJ O
for IN O
both DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
driven VBN O
Th2 NNP O
differentiation NN O
and CC O
cell NN O
expansion NN O
. . O

Both DT O
WT NNP B-Gene
and CC I-Gene
Y497F NNP I-Gene
hIL VBD I-Gene
- : I-Gene
4Ralpha CD I-Gene
lose VBP O
the DT O
ability NN O
to TO O
drive VB O
Th2 NNP O
differentiation NN O
and CC O
cell NN O
expansion NN O
in IN O
Stat6 NNP O
- : O
knockout NN O
CD4 NNP O
T NNP O
cells NNS O
. . O

A DT O
constitutively RB O
activated JJ O
form NN O
of IN O
Stat6 NNP B-Gene
introduced VBD O
into IN O
CD4 NNP O
T NNP O
cells NNS O
resulted VBD O
in IN O
both DT O
Th2 NNP O
differentiation NN O
and CC O
enhanced VBD O
cell NN O
expansion NN O
. . O

Thus RB O
, , O
activated JJ B-Gene
Stat6 NNP I-Gene
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
to TO O
mediate VB O
both DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
driven VBN O
Th2 NNP O
differentiation NN O
and CC O
cell NN O
expansion NN O
in IN O
CD4 NNP O
T NNP O
cells NNS O
. . O

The DT O
effect NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
regulatory JJ I-Gene
proteins NNS I-Gene
on IN O
cellular JJ O
genes NNS O
: : O
derepression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
by IN O
Tat NNP B-Gene
. . O

In IN O
HIV NNP O
- : O
infected JJ O
individuals NNS O
dysregulation NN O
of IN O
the DT O
immune NN O
system NN O
is VBZ O
characterized VBN O
by IN O
severe JJ O
disorders NNS O
of IN O
the DT O
cytokine NN O
network NN O
. . O

Increase NNP O
secretion NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
the DT O
major JJ O
T NNP O
cell NN O
growth NN O
and CC O
differentiation NN O
cytokine NN B-Gene
, , O
may MD O
play VB O
a DT O
decisive JJ O
role NN O
in IN O
sensitization NN O
of IN O
T NNP O
cells NNS O
for IN O
activation NN O
induced VBN O
apoptosis NN O
and CC O
indirect JJ O
death NN O
of IN O
activated JJ O
T NNP O
cells NNS O
through IN O
augmented VBN O
virus NN O
replication NN O
. . O

We PRP O
investigated VBD O
the DT O
cause NN O
of IN O
enhanced JJ O
IL NNP O
- : O
2 CD O
secretion NN O
and CC O
found VBD O
that IN O
the DT O
HIV NNP B-Gene
Tat NNP I-Gene
induces VBZ O
this DT O
effect NN O
. . O

We PRP O
demonstrate VBP O
that IN O
increased VBD O
IL NNP O
- : O
2 CD O
secretion NN O
is VBZ O
due JJ O
to TO O
Tat NNP B-Gene
- : O
enhanced VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activation NN O
. . O

Tat NNP B-Gene
derepresses NNS O
and CC O
activates VBZ O
the DT O
distal JJ B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
( ( O
position NN B-Gene
- : I-Gene
185 CD I-Gene
to TO I-Gene
- : I-Gene
177 CD I-Gene
) ) O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

In IN O
nonstimulated JJ O
T NNP O
cells NNS O
a DT O
repressor NN O
complex JJ O
containing VBG O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
, , O
JunB NNP B-Gene
, , O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
Fra NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
formed VBN O
on IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
/ NNP I-Gene
d NN I-Gene
) ) I-Gene
site NN I-Gene
and CC O
represses VBZ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
. . O

After IN O
T NNP O
cell NN O
activation NN O
, , O
a DT O
heterodimeric JJ B-Gene
activator NN I-Gene
containing VBG O
p65 NN B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
binds VBZ O
to TO O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
/ NNP I-Gene
d NN I-Gene
) ) I-Gene
site NN I-Gene
. . O

HIV NNP B-Gene
Tat NNP I-Gene
enhances VBZ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
consequently RB O
, , O
activates VBZ O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
/ NNP I-Gene
d NN I-Gene
) ) I-Gene
site NN I-Gene
. . O

Our PRP$ O
data NNS O
provide VBP O
evidence NN O
for IN O
a DT O
novel JJ O
mechanism NN O
by IN O
which WDT O
HIV NNP B-Gene
Tat NNP I-Gene
dysregulates VBZ O
IL NNP O
- : O
2 CD O
production NN O
and CC O
therefore NN O
may MD O
contribute VB O
to TO O
the DT O
HIV NNP O
- : O
1 CD O
infection NN O
in IN O
a DT O
way NN O
yet RB O
to TO O
be VB O
clarified VBN O
. . O

Transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta1 NN I-Gene
interferes VBZ O
with IN O
thrombopoietin JJ O
- : O
induced JJ O
signal JJ O
transduction NN O
in IN O
megakaryoblastic JJ O
and CC O
erythroleukemic JJ O
cells NNS O
. . O

OBJECTIVE NN O
: : O
Thrombopoietin NNP B-Gene
( ( O
TPO NNP B-Gene
) ) O
and CC O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
( ( I-Gene
1 CD I-Gene
) ) I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
( ( I-Gene
1 CD I-Gene
) ) I-Gene
) ) O
have VBP O
been VBN O
shown VBN O
to TO O
exert VB O
opposite JJ O
effects NNS O
on IN O
proliferation NN O
and CC O
megakaryocytic JJ O
differentiation NN O
of IN O
hematopoietic JJ O
cells NNS O
. . O

To TO O
determine VB O
whether IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
( ( I-Gene
1 CD I-Gene
) ) I-Gene
interferes VBZ O
directly RB O
with IN O
TPO NNP B-Gene
- : O
induced VBD O
signal JJ O
transduction NN O
in IN O
hematopoietic JJ O
cells NNS O
, , O
we PRP O
compared VBN O
the DT O
regulatory JJ O
effects NNS O
in IN O
the DT O
TPO NNP B-Gene
- : O
responsive NN O
cell NN O
lines NNS O
Mo NNP O
- : O
7e CD O
and CC O
HEL NNP O
. . O

MATERIALS NNP O
AND CC O
METHODS NNP O
: : O
The DT O
cells NNS O
were VBD O
stimulated VBN O
by IN O
100 CD O
ng JJ O
/ NNP O
mL NN O
TPO NNP B-Gene
and CC O
/ NNP O
or CC O
100 CD O
ng JJ O
/ NNP O
mL NN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
and CC O
analyzed VBN O
for IN O
proliferation NN O
( ( O
3H CD O
thymidine NN O
incorporation NN O
) ) O
, , O
viability NN O
( ( O
trypan JJ O
blue NN O
exclusion NN O
) ) O
, , O
and CC O
protein JJ O
expression NN O
and CC O
phosphorylation NN O
( ( O
Western JJ O
blot NN O
) ) O
. . O

RESULTS NN O
: : O
TPO NNP B-Gene
enhanced VBD O
the DT O
proliferation NN O
of IN O
Mo NNP O
- : O
7e CD O
cells NNS O
as IN O
determined VBN O
by IN O
3H CD O
- : O
thymidine NN O
incorporation NN O
, , O
whereas WP O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
suppressed VBD O
baseline NN O
cell NN O
growth NN O
and CC O
antagonized VBD O
the DT O
proliferative JJ O
effect NN O
of IN O
TPO NNP B-Gene
. . O

TPO NNP B-Gene
- : O
induced JJ O
proliferation NN O
also RB O
was VBD O
reduced VBN O
by IN O
a DT O
specific JJ O
inhibitor NN O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
pathway NN O
( ( O
PD098059 NNP O
) ) O
, , O
which WDT O
inhibits VBZ O
activation NN O
of IN O
the DT O
MAPK NNP B-Gene
extracellular JJ I-Gene
signal NN I-Gene
- : I-Gene
regulated VBN I-Gene
kinases NNS I-Gene
( ( O
ERK NNP B-Gene
) ) O
ERK1 NNP B-Gene
and CC O
ERK2 NNP B-Gene
, , O
and CC O
AG490 NNP O
, , O
an DT O
inhibitor NN O
of IN O
Janus NNP B-Gene
kinase NNP I-Gene
- : I-Gene
2 CD I-Gene
, , O
which WDT O
completely RB O
blocked VBD O
TPO NNP B-Gene
- : O
induced JJ O
proliferation NN O
. . O

As IN O
demonstrated VBN O
by IN O
Western JJ O
blotting NN O
, , O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
reduced VBD O
the DT O
TPO NNP B-Gene
- : O
stimulated VBD O
ERK1 NNP B-Gene
/ NNP O
ERK2 NNP B-Gene
and CC O
STAT5 NNP O
phosphorylation NN O
in IN O
Mo NNP O
- : O
7e CD O
and CC O
HEL NNP O
cells NNS O
. . O

This DT O
effect NN O
was VBD O
completely RB O
reversed VBN O
by IN O
preincubation NN O
with IN O
a DT O
tyrosine JJ O
phosphatase NN O
inhibitor NN O
( ( O
Na3VO4 NNP O
) ) O
, , O
which WDT O
suggests VBZ O
that IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
activated VBD O
a DT O
phosphatase NN B-Gene
. . O

Although IN O
STAT3 NNP B-Gene
also RB O
was VBD O
activated VBN O
by IN O
TPO NNP B-Gene
, , O
STAT3 NNP B-Gene
activation NN O
remained VBD O
unaltered JJ O
by IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
. . O

CONCLUSION NN O
: : O
Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
modulates VBZ O
TPO NNP B-Gene
- : O
mediated JJ O
effects NNS O
on IN O
megakaryocytic JJ O
proliferation NN O
by IN O
interfering VBG O
with IN O
TPO NNP B-Gene
- : O
induced VBD O
signal JJ O
transduction NN O
, , O
particularly RB O
by IN O
reducing VBG O
the DT O
activities NNS O
of IN O
MAPK NNP B-Gene
ERK1 NNP I-Gene
/ NNP I-Gene
ERK2 NNP I-Gene
and CC I-Gene
STAT5 NNP I-Gene
. . O

Invariant NNP B-Gene
chain NN I-Gene
induces NNS O
B NNP O
cell NN O
maturation NN O
by IN O
activating VBG O
a DT O
TAF NNP B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
105 CD I-Gene
- : I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
- : O
dependent JJ O
transcription NN O
program NN O
. . O

Early JJ O
stages NNS O
of IN O
B NNP O
cell NN O
development NN O
occur NN O
in IN O
the DT O
bone NN O
marrow NN O
, , O
resulting VBG O
in IN O
formation NN O
of IN O
immature NN O
B NNP O
cells NNS O
. . O

From IN O
there EX O
these DT O
immature NN O
cells NNS O
migrate VBP O
to TO O
the DT O
spleen NN O
where WRB O
they PRP O
differentiate VBP O
to TO O
mature VB O
cells NNS O
. . O

This DT O
final JJ O
maturation NN O
step NN O
is VBZ O
crucial JJ O
for IN O
the DT O
B NNP O
cells NNS O
to TO O
become VB O
responsive JJ O
to TO O
antigens NNS B-Gene
and CC O
to TO O
participate VB O
in IN O
the DT O
immune JJ O
response NN O
. . O

Recently RB O
, , O
invariant NN B-Gene
chain NN I-Gene
( ( O
Ii NNP B-Gene
) ) O
, , O
a DT O
major JJ B-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
class NN I-Gene
II NNP I-Gene
chaperone NN I-Gene
, , O
as RB O
well RB O
as IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
c VBP B-Gene
- : I-Gene
Rel NN I-Gene
and CC O
p65 NN B-Gene
/ NNP I-Gene
RelA NNP I-Gene
, , O
were VBD O
found VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
the DT O
final JJ O
antigen NN O
- : O
independent JJ O
differentiation NN O
stage NN O
of IN O
B NNP O
cells NNS O
in IN O
the DT O
spleen NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
a DT O
possible JJ O
link NN O
between IN O
Ii NNP B-Gene
- : O
dependent NN O
B NNP O
cell NN O
maturation NN O
and CC O
the DT O
NF NNP O
- : O
kappaB NN O
pathway NN O
. . O

Our PRP$ O
studies NNS O
indicate VBP O
that IN O
Ii NNP B-Gene
- : O
induced VBD O
B NNP O
cell NN O
maturation NN O
involves VBZ O
activation NN O
of IN O
transcription NN O
mediated VBN O
by IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
p65 NN I-Gene
/ NNP I-Gene
RelA NNP I-Gene
homodimer NN I-Gene
and CC O
requires VBZ O
the DT O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
enriched VBN I-Gene
coactivator NN I-Gene
TBP NNP B-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
105 CD I-Gene
. . O

Androgens NNS O
indirectly RB O
accelerate VBP O
thymocyte JJ O
apoptosis NN O
. . O

Apoptotic JJ O
processes NNS O
, , O
or CC O
the DT O
disturbance NN O
of IN O
the DT O
natural JJ O
regulation NN O
of IN O
these DT O
processes NNS O
, , O
may MD O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
autoimmune NN O
diseases NNS O
( ( O
AID NNP O
) ) O
. . O

Women NNS O
are VBP O
, , O
in IN O
general JJ O
, , O
more RBR O
susceptible JJ O
than IN O
men NNS O
to TO O
develop VB O
AID NNP O
like IN O
rheumatoid JJ O
arthritis NN O
. . O

Androgens NNS O
and CC O
glucocorticoids NNS O
, , O
in IN O
contrast NN O
to TO O
oestrogens NNS O
, , O
have VBP O
favourable JJ O
effects NNS O
in IN O
AID NNP O
models NNS O
as RB O
well RB O
as IN O
in IN O
human JJ O
AID NN O
. . O

It PRP O
is VBZ O
known VBN O
that IN O
glucocorticoids NNS O
( ( O
GC NNP O
) ) O
, , O
used VBD O
for IN O
treatment NN O
of IN O
AID NNP O
, , O
increase NN O
apoptosis NN O
in IN O
the DT O
thymus NN O
resulting VBG O
in IN O
decreased JJ O
numbers NNS O
of IN O
CD4 NNP O
+ NNP O
CD8 NNP O
+ NNP O
thymocytes NNS O
. . O

It PRP O
was VBD O
asked VBN O
whether IN O
androgens NNS O
, , O
in IN O
contrast NN O
to TO O
oestrogens NNS O
, , O
exert VBP O
their PRP$ O
favourable JJ O
effects NNS O
in IN O
the DT O
treatment NN O
of IN O
AID NNP O
by IN O
a DT O
mechanism NN O
comparable JJ O
to TO O
that DT O
described VBN O
for IN O
GC NNP O
by IN O
eliminating VBG O
the DT O
apoptosis NN O
prone NN O
CD4 NNP O
+ NNP O
CD8 NNP O
+ NNP O
population NN O
in IN O
the DT O
thymus NN O
. . O

Although IN O
both DT O
androgens NNS O
and CC O
oestrogens NNS O
proved VBD O
thymolytic JJ O
, , O
a DT O
significantly RB O
decreased VBN O
percentage NN O
of IN O
CD4 NNP O
+ NNP O
CD8 NNP O
+ NNP O
thymocytes VBZ O
was VBD O
observed VBN O
by IN O
flow JJ O
cytometry NN O
after IN O
treatment NN O
of IN O
mice NN O
with IN O
the DT O
androgen NN O
methyltestosterone NN O
, , O
but CC O
not RB O
with IN O
the DT O
oestrogen NN O
ethinylestradiol NN O
. . O

To TO O
investigate VB O
whether IN O
the DT O
observed JJ O
thymolytic JJ O
effects NNS O
were VBD O
due JJ O
to TO O
the DT O
presence NN O
of IN O
hormone NN B-Gene
receptors NNS I-Gene
on IN O
thymocytes NNS O
, , O
cells NNS O
were VBD O
isolated VBN O
from IN O
the DT O
thymus NN O
and CC O
incubated VBN O
with IN O
androgens NNS O
or CC O
oestrogens NNS O
to TO O
measure VB O
apoptosis NN O
. . O

Several JJ O
techniques NNS O
were VBD O
used VBN O
to TO O
determine VB O
thymocyte JJ O
apoptosis NN O
in IN O
vitro NN O
, , O
but CC O
no DT O
enhanced JJ O
apoptotic JJ O
signal NN O
was VBD O
observed VBN O
. . O

Using VBG O
the DT O
very RB O
sensitive JJ O
TUNEL NNP O
assay NN O
, , O
no DT O
direct JJ O
effect NN O
of IN O
androgens NNS O
on IN O
thymocytes NNS O
in IN O
vitro NN O
could MD O
be VB O
observed VBN O
. . O

This DT O
is VBZ O
in IN O
sharp JJ O
contrast NN O
to TO O
the DT O
high JJ O
signal NN O
observed VBD O
with IN O
GC NNP O
. . O

Therefore RB O
, , O
upon IN O
in IN O
vivo JJ O
androgen NN O
treatment NN O
, , O
other JJ O
cells NNS O
containing VBG O
androgen NN B-Gene
receptors NNS I-Gene
than IN O
thymocytes NNS O
are VBP O
probably RB O
involved VBN O
in IN O
inducing VBG O
the DT O
increase NN O
in IN O
thymic JJ O
apoptosis NN O
. . O

To TO O
study VB O
the DT O
role NN O
of IN O
the DT O
androgen NN B-Gene
receptor NN I-Gene
on IN O
thymocyte JJ O
apoptosis NN O
, , O
androgen NN B-Gene
receptor NN I-Gene
mutant NN O
( ( O
Tfm NNP O
/ NNP O
Y NNP O
) ) O
mice NN O
were VBD O
treated VBN O
with IN O
androgens NNS O
. . O

No DT O
alterations NNS O
of IN O
thymocyte JJ O
subpopulations NNS O
were VBD O
seen VBN O
, , O
suggesting VBG O
that IN O
changes NNS O
in IN O
the DT O
percentage NN O
of IN O
CD4 NNP O
+ NNP O
CD8 NNP O
+ NNP O
thymocytes VBZ O
after IN O
administration NN O
of IN O
androgens NNS O
depend VBP O
on IN O
the DT O
presence NN O
of IN O
functional JJ O
androgen NN B-Gene
receptors NNS I-Gene
. . O

Thus RB O
, , O
it PRP O
is VBZ O
concluded VBN O
that IN O
androgens VBZ O
indirectly RB O
accelerate JJ O
thymocyte NN O
apoptosis NN O
in IN O
vivo NN O
. . O

Inhibition NN O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
CD4 NNP O
T NNP O
cells NNS O
by IN O
peroxisome JJ B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
gamma NN I-Gene
ligands NNS I-Gene
. . O

The DT O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
gamma NN I-Gene
( ( O
PPARgamma NNP B-Gene
) ) O
, , O
a DT O
member NN O
of IN O
the DT O
nuclear JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
superfamily RB I-Gene
, , O
is VBZ O
essential JJ O
for IN O
adipocyte JJ O
differentiation NN O
and CC O
glucose JJ O
homeostasis NN O
. . O

PPARgamma NNP B-Gene
has VBZ O
been VBN O
found VBN O
recently RB O
to TO O
regulate VB O
macrophage NN O
activation NN O
in IN O
response NN O
to TO O
mitogens NNS B-Gene
and CC O
inflammation NN O
. . O

Our PRP$ O
study NN O
shows VBZ O
PPARgamma NNP B-Gene
to TO O
be VB O
preferentially RB O
expressed VBN O
in IN O
the DT O
nuclei NN O
of IN O
resting VBG O
T NNP O
cells NNS O
and CC O
to TO O
increase VB O
upon JJ O
activation NN O
of IN O
T NNP O
cells NNS O
by IN O
either DT O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
CD28 NN I-Gene
or CC O
phorbol NN O
myristyl NN O
acetate NN O
( ( O
PMA NNP O
) ) O
. . O

We PRP O
also RB O
found VBD O
the DT O
PPARgamma NNP B-Gene
ligand NN I-Gene
ciglitizone NN O
to TO O
attenuate VB O
the DT O
activation NN O
of IN O
T NNP O
cells NNS O
by IN O
inhibiting VBG O
cytokine JJ O
gene NN O
expression NN O
and CC O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
CD28 NN I-Gene
or CC O
PMA NNP O
- : O
induced VBD O
proliferative JJ O
responses NNS O
. . O

Inhibition NN O
of IN O
both CC O
the DT O
proliferative JJ O
response NN O
and CC O
inflammatory JJ O
cytokine NN O
expression NN O
in IN O
CD4 NNP O
T NNP O
cells NNS O
was VBD O
correlated VBN O
with IN O
suppression NN O
of IN O
the DT O
activated JJ O
transcription NN B-Gene
factors NNS I-Gene
AP1 NNP B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

PPARgamma NNP B-Gene
ligands VBZ I-Gene
also RB O
strongly RB O
inhibited VBN O
SEA NNP O
- : O
induced VBD O
Vbeta3 NNP O
T NNP O
cell NN O
activation NN O
in IN O
vivo NN O
. . O

These DT O
results NNS O
, , O
together RB O
with IN O
previous JJ O
findings NNS O
of IN O
the DT O
inhibitory JJ O
effect NN O
of IN O
PPARgamma NNP B-Gene
ligands VBZ I-Gene
on IN O
activated JJ O
macrophages NNS O
, , O
provide VBP O
clear JJ O
evidence NN O
for IN O
PPARgamma NNP B-Gene
as IN O
a DT O
negative JJ B-Gene
regulator NN I-Gene
of IN O
the DT O
inflammatory JJ O
activation NN O
of IN O
both DT O
macrophage NN O
and CC O
T NNP O
cells NNS O
. . O

PPARgamma NNP B-Gene
may MD O
thus RB O
be VB O
a DT O
potential JJ O
therapeutic JJ O
target NN O
for IN O
the DT O
treatment NN O
of IN O
autoimmunity NN O
. . O

A DT O
prominent JJ O
role NN O
for IN O
activator NN B-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
in IN O
the DT O
transcription NN O
of IN O
the DT O
human JJ B-Gene
2B4 CD I-Gene
( ( I-Gene
CD244 NNP I-Gene
) ) I-Gene
gene NN I-Gene
in IN O
NK NNP O
cells NNS O
. . O

The DT O
cell NN B-Gene
surface NN I-Gene
glycoprotein NN I-Gene
2B4 CD I-Gene
( ( O
CD244 NNP B-Gene
) ) O
of IN O
the DT O
Ig NNP B-Gene
superfamily NN I-Gene
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
NK NNP O
and CC O
T NNP O
lymphocyte JJ O
functions NNS O
. . O

We PRP O
have VBP O
recently RB O
identified VBN O
CD48 NNP B-Gene
as IN O
the DT O
high JJ B-Gene
affinity NN I-Gene
counterreceptor NN I-Gene
for IN O
2B4 CD B-Gene
in IN O
both DT O
mice NNS O
and CC O
humans NNS O
. . O

The DT O
cytoplasmic JJ B-Gene
domain NN I-Gene
of IN O
2B4 CD B-Gene
associates NNS O
with IN O
src JJ B-Gene
homology NN I-Gene
2 CD I-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
protein NN I-Gene
or CC O
signaling VBG B-Gene
lymphocyte JJ I-Gene
activation NN I-Gene
molecule NN I-Gene
- : I-Gene
associated VBN I-Gene
protein NN I-Gene
, , O
whose WP$ O
mutation NN O
is VBZ O
the DT O
underlying JJ O
genetic JJ O
defect NN O
in IN O
the DT O
X NNP O
- : O
linked VBD O
lymphoproliferative JJ O
syndrome NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
report VBP O
the DT O
molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
the DT O
human JJ B-Gene
2B4 CD I-Gene
( ( I-Gene
h2B4 NN I-Gene
) ) I-Gene
promoter NN I-Gene
. . O

Through IN O
primer JJ O
extension NN O
analysis NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
transcription NN O
of IN O
the DT O
h2B4 NN B-Gene
gene NN I-Gene
initiates NNS O
at IN O
multiple JJ O
start NN O
sites NNS O
. . O

We PRP O
isolated VBD O
h2B4 JJ B-Gene
genomic JJ I-Gene
clones NNS I-Gene
and CC O
PCR NNP O
amplified VBD O
the DT O
5 CD B-Gene
' POS I-Gene
untranslated JJ I-Gene
region NN I-Gene
containing VBG O
the DT O
promoter NN B-Gene
elements NNS I-Gene
. . O

We PRP O
have VBP O
identified VBN O
a DT O
functional JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
that WDT O
lies VBZ O
between IN O
( ( O
- : O
106 CD O
to TO O
- : O
100 CD O
) ) O
through IN O
transient NN O
transfection NN O
analysis NN O
in IN O
YT NNP O
cells NNS O
, , O
a DT O
human JJ O
NK NNP O
cell NN O
line NN O
. . O

EMSAs NN O
with IN O
Abs NNP B-Gene
specific NN O
for IN O
various JJ O
protein JJ B-Gene
factors NNS I-Gene
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
family NN I-Gene
revealed VBD O
that IN O
multiple JJ O
members NNS O
of IN O
the DT O
Jun NNP B-Gene
family NN I-Gene
are VBP O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
the DT O
h2B4 JJ B-Gene
gene NN I-Gene
. . O

Mutation NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
not RB O
only RB O
abolishes VBZ O
protein JJ O
/ NNP O
DNA NNP O
interactions NNS O
but CC O
also RB O
promoter NN O
activity NN O
. . O

These DT O
results NNS O
demonstrate VBP O
a DT O
significant JJ O
role NN O
for IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
h2B4 JJ B-Gene
gene NN I-Gene
. . O

Functional JJ O
correction NN O
of IN O
FA NNP O
- : O
C NNP O
cells NNS O
with IN O
FANCC NNP B-Gene
suppresses VBZ O
the DT O
expression NN O
of IN O
interferon NN B-Gene
gamma NN I-Gene
- : I-Gene
inducible JJ I-Gene
genes NNS I-Gene
. . O

Because IN O
hematopoietic JJ O
cells NNS O
derived VBN O
from IN O
Fanconi NNP O
anemia NN O
( ( O
FA NNP O
) ) O
patients NNS O
of IN O
the DT O
C NNP O
- : O
complementation NN O
group NN O
( ( O
FA NNP O
- : O
C NN O
) ) O
are VBP O
hypersensitive JJ O
to TO O
the DT O
inhibitory JJ O
effects NNS O
of IN O
interferon NN B-Gene
gamma NN I-Gene
( ( O
IFNgamma NNP B-Gene
) ) O
, , O
the DT O
products NNS O
of IN O
certain JJ O
IFNgamma NNP B-Gene
- : I-Gene
inducible JJ I-Gene
genes NNS I-Gene
known VBN O
to TO O
influence VB O
hematopoietic JJ O
cell NN O
survival NN O
were VBD O
quantified VBN O
. . O

High JJ O
constitutive JJ O
expression NN O
of IN O
the DT O
IFNgamma NNP B-Gene
- : I-Gene
inducible JJ I-Gene
genes NNS I-Gene
, , O
IFN NNP B-Gene
- : I-Gene
stimulated VBD I-Gene
gene NN I-Gene
factor NN I-Gene
3 CD I-Gene
gamma NN I-Gene
subunit NN I-Gene
( ( O
ISGF3gamma NNP B-Gene
) ) O
, , O
IFN NNP B-Gene
regulatory JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
and CC O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN I-Gene
p21 NN I-Gene
( ( O
WAF1 NNP B-Gene
) ) O
was VBD O
found VBN O
in IN O
FANCC NNP B-Gene
mutant NN O
B NNP O
lymphoblasts VBZ O
, , O
low JJ O
- : O
density NN O
bone NN O
marrow NN O
cells NNS O
, , O
and CC O
murine VB O
embryonic JJ O
fibroblasts NNS O
. . O

Paradoxically RB O
, , O
these DT O
cells NNS O
do VBP O
not RB O
activate VB B-Gene
signal JJ I-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
1 CD I-Gene
properly RB O
. . O

In IN O
an DT O
attempt NN O
to TO O
clarify VB O
mechanisms NNS O
by IN O
which WDT O
FA NNP O
- : O
C NNP O
cells NNS O
overexpress JJ O
IFNgamma NNP B-Gene
- : I-Gene
inducible JJ I-Gene
genes NNS I-Gene
in IN O
the DT O
face NN O
of IN O
defective JJ O
STAT1 NNP O
phosphorylation NN O
, , O
it PRP O
was VBD O
reasoned VBN O
that IN O
decreased JJ O
levels NNS O
of IN O
activated VBN B-Gene
STAT1 NNP I-Gene
might MD O
result VB O
in IN O
reduced JJ O
expression NN O
of IN O
a DT O
hematopoietic JJ B-Gene
IFNgamma NNP I-Gene
- : I-Gene
responsive JJ I-Gene
protein NN I-Gene
that WDT O
normally RB O
modulates VBZ O
expression NN O
of IN O
other JJ O
IFNgamma NNP B-Gene
- : I-Gene
responsive JJ I-Gene
genes NNS I-Gene
. . O

Levels NNS O
of IN O
the DT O
IFNgamma NNP B-Gene
- : O
inducible JJ O
factor NN O
IFN NNP B-Gene
consensus NN I-Gene
sequence NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
ICSBP NNP B-Gene
) ) O
, , O
a DT O
negative JJ B-Gene
trans NNS I-Gene
- : I-Gene
acting VBG I-Gene
regulator NN I-Gene
of IN O
some DT O
IFNgamma NNP B-Gene
- : I-Gene
inducible JJ I-Gene
genes NNS I-Gene
, , O
were VBD O
quantified VBN O
. . O

ICSBP NN B-Gene
levels NNS O
were VBD O
reduced VBN O
in IN O
FA NNP O
- : O
C NNP O
B NNP O
lymphoblasts NNS O
and CC O
MEFs NNP O
. . O

However RB O
, , O
enforced JJ O
expression NN O
of IN O
ICSBP NNP B-Gene
failed VBD O
to TO O
down VB O
- : O
regulate NN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
ISGF3gamma NNP B-Gene
, , O
and CC O
p21 NN B-Gene
( ( I-Gene
WAF1 NNP I-Gene
) ) I-Gene
. . O

Thus RB O
, , O
the DT O
FANCC NNP B-Gene
protein NN I-Gene
functions NNS O
to TO O
modulate VB O
expression NN O
of IN O
a DT O
family NN O
of IN O
genes NNS O
that WDT O
in IN O
normal JJ O
cells NNS O
are VBP O
inducible JJ O
only RB O
by IN O
specific JJ O
environmental JJ O
cues NNS O
for IN O
apoptosis NN O
or CC O
mitogenic JJ O
inhibition NN O
, , O
but CC O
it PRP O
does VBZ O
so RB O
independently RB O
of IN O
the DT O
classic JJ O
IFN NNP O
- : O
STAT1 NNP O
pathway NN O
and CC O
is VBZ O
not RB O
the DT O
direct JJ O
result NN O
of IN O
reduced JJ O
ICSBP NNP B-Gene
expression NN O
. . O

A DT O
genetic JJ O
investigation NN O
of IN O
E2A NNP O
function NN O
in IN O
lymphocyte NN O
development NN O
. . O

Lymphocytes NNS O
are VBP O
derived VBN O
from IN O
hematopoietic JJ O
stem NN O
cells NNS O
( ( O
HSC NNP O
) ) O
following VBG O
a DT O
series NN O
of IN O
regulated JJ O
differentiation NN O
events NNS O
. . O

Multipotent NNP O
HSCs NNP O
become NN O
committed VBD O
to TO O
the DT O
B NNP O
cell NN O
lineage NN O
in IN O
bone NN O
marrow NN O
and CC O
the DT O
T NNP O
cell NN O
lineage NN O
in IN O
the DT O
thymus NN O
after IN O
receiving VBG O
appropriate JJ O
signals NNS O
from IN O
the DT O
corresponding JJ O
microenvironment NN O
. . O

These DT O
committed VBN O
lymphoid NN O
cells NNS O
must MD O
then RB O
undergo VB O
V NNP O
( ( O
D NNP O
) ) O
J NNP O
recombination NN O
at IN O
the DT O
immunoglobulin JJ B-Gene
gene NN I-Gene
or CC O
T NNP B-Gene
cell VBP I-Gene
receptor NN I-Gene
gene NN I-Gene
locus NN I-Gene
resulting VBG O
in IN O
clonal JJ O
production NN O
of IN O
functional JJ O
B NNP O
or CC O
T NNP O
lymphocytes NNS O
, , O
respectively RB O
. . O

Lymphocyte NNP O
commitment NN O
and CC O
differentiation NN O
are VBP O
accompanied VBN O
by IN O
programmed JJ O
gene NN O
expression NN O
or CC O
repression NN O
events NNS O
which WDT O
are VBP O
driven VBN O
by IN O
lineage NN B-Gene
and CC I-Gene
stage NN I-Gene
specific JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

The DT O
basic JJ B-Gene
- : I-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
bHLH NN I-Gene
) ) I-Gene
transcription NN I-Gene
factors NNS I-Gene
encoded VBN O
by IN O
the DT O
E2A NNP B-Gene
gene NN I-Gene
are VBP O
involved VBN O
in IN O
several JJ O
differentiation NN O
events NNS O
during IN O
B NNP O
and CC O
T NNP O
cell NN O
development NN O
, , O
including VBG O
lineage NN O
commitment NN O
, , O
initiation NN O
of IN O
V NNP O
( ( O
D NNP O
) ) O
J NNP O
recombination NN O
, , O
and CC O
antigen NN O
receptor NN O
mediated VBD O
proliferation NN O
and CC O
differentiation NN O
. . O

Several JJ O
recent JJ O
reviews NNS O
have VBP O
provided VBN O
a DT O
comprehensive JJ O
discussion NN O
of IN O
biochemical JJ O
, , O
cellular JJ O
, , O
and CC O
genetic JJ O
research NN O
on IN O
E2A NNP O
function NN O
in IN O
lymphocyte NN O
development NN O
( ( O
1 CD O
, , O
2 CD O
) ) O
. . O

Here RB O
, , O
we PRP O
only RB O
discuss VBD O
some DT O
of IN O
the DT O
genetic JJ O
approaches NNS O
our PRP$ O
laboratory NN O
( ( O
except IN O
where WRB O
it PRP O
is VBZ O
noted VBN O
) ) O
has VBZ O
undertaken VBN O
to TO O
investigate VB O
the DT O
molecular JJ O
pathways NNS O
mediated VBN O
by IN O
E2A NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
lymphocyte NN O
development NN O

D609 NNP O
inhibits VBZ O
ionizing VBG O
radiation NN O
- : O
induced JJ O
oxidative JJ O
damage NN O
by IN O
acting VBG O
as IN O
a DT O
potent NN O
antioxidant NN O
. . O

Tricyclodecan JJ O
- : O
9 CD O
- : O
yl NN O
- : O
xanthogenate NN O
( ( O
D609 NNP O
) ) O
has VBZ O
been VBN O
extensively RB O
studied VBN O
in IN O
biological JJ O
systems NNS O
and CC O
exhibits VBZ O
a DT O
variety NN O
of IN O
biological JJ O
functions NNS O
, , O
including VBG O
antiviral JJ O
, , O
antitumor NN O
, , O
and CC O
anti SYM O
- : O
inflammatory NN O
activities NNS O
. . O

Most JJS O
of IN O
these DT O
activities NNS O
have VBP O
been VBN O
largely RB O
attributed VBN O
to TO O
the DT O
inhibitory JJ O
effect NN O
of IN O
D609 NNP O
on IN O
phosphatidylcholine NN O
- : O
specific JJ O
phospholipase NN B-Gene
C NNP I-Gene
. . O

However RB O
, , O
as IN O
a DT O
xanthate JJ O
derivative NN O
, , O
D609 NNP O
is VBZ O
a DT O
strong JJ O
electrolyte NN O
and CC O
readily RB O
dissociates VBZ O
to TO O
xanthate VB O
anions NNS O
and CC O
cations NNS O
of IN O
alkali JJ O
metals NNS O
in IN O
solution NN O
. . O

Xanthate NN O
anions NNS O
and CC O
protonated VBD O
xanthic JJ O
acid NN O
contain VBP O
a DT O
free JJ O
thiol NN O
moiety NN O
and CC O
are VBP O
highly RB O
reductive JJ O
. . O

This DT O
implies VBZ O
that IN O
D609 NNP O
and CC O
other JJ O
xanthate NNP O
derivatives NNS O
may MD O
function VB O
as IN O
potent JJ O
antioxidants NNS O
. . O

Indeed RB O
, , O
we PRP O
found VBD O
that IN O
D609 NNP O
inhibited VBD O
the DT O
Fenton NNP O
reaction NN O
- : O
induced JJ O
oxidation NN O
of IN O
dihydrorhodamine NN O
123 CD O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
similar JJ O
to TO O
that DT O
of IN O
pyrrolidinedithiocar NN O
, , O
a DT O
well RB O
known VBN O
antioxidant NN O
. . O

In IN O
addition NN O
, , O
D609 NNP O
inhibited VBD O
the DT O
formation NN O
of IN O
the DT O
alpha JJ O
- : O
phenyl NN O
- : O
tert NN O
- : O
butylnitrone NN O
- : O
free JJ O
radical JJ O
spin NN O
adducts NNS O
and CC O
lipid JJ O
peroxidation NN O
of IN O
synaptosomal JJ O
membranes NNS O
by IN O
the DT O
Fenton NNP O
reagents NNS O
. . O

Furthermore RB O
, , O
preincubation NN O
of IN O
lymphocytes NNS O
with IN O
D609 NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
diminution NN O
of IN O
ionizing VBG O
radiation NN O
( ( O
IR NNP O
) ) O
- : O
induced JJ O
1 CD O
) ) O
production NN O
of IN O
reactive JJ O
oxygen NN O
species NNS O
; : O
2 CD O
) ) O
decrease NN O
in IN O
intracellular JJ O
reduced VBD O
glutathione NN O
; : O
3 CD O
) ) O
oxidative JJ O
damage NN O
to TO O
proteins NNS O
and CC O
lipids NNS O
; : O
and CC O
4 CD O
) ) O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Moreover RB O
, , O
when WRB O
D609 NNP O
( ( O
50 CD O
mg NN O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
was VBD O
administered VBN O
to TO O
mice VB O
10 CD O
min NNS O
prior RB O
to TO O
total VB O
body NN O
IR NNP O
( ( O
6 CD O
. . O
5 CD O
and CC O
8 CD O
. . O
5 CD O
Gy NNP O
) ) O
, , O
it PRP O
protected VBD O
the DT O
mice NN O
from IN O
IR NNP O
- : O
induced JJ O
lethality NN O
. . O

Thus RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
D609 NNP O
is VBZ O
a DT O
potent JJ O
antioxidant NN O
and CC O
has VBZ O
the DT O
ability NN O
to TO O
inhibit VB O
IR NNP O
- : O
induced VBD O
cellular JJ O
oxidative JJ O
stress NN O
. . O

Inhibition NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
by IN O
the DT O
glucocorticoid JJ O
- : O
inducible JJ O
protein NN B-Gene
GILZ NNP I-Gene
. . O

The DT O
immunosuppressive JJ O
effects NNS O
of IN O
glucocorticoids NNS O
arise VBP O
largely RB O
by IN O
inhibition NN O
of IN O
cytokine JJ O
gene NN O
expression NN O
, , O
which WDT O
has VBZ O
been VBN O
ascribed VBN O
to TO O
interference VB O
between IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
and CC O
transcription NN B-Gene
factors NNS I-Gene
such JJ O
as IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
as RB O
well RB O
as IN O
by IN O
competition NN O
for IN O
common JJ O
coactivators NNS O
. . O

Here RB O
we PRP O
show VBP O
that IN O
glucocorticoid JJ O
- : O
induced JJ O
inhibition NN O
of IN O
interleukin JJ O
- : O
2 CD O
mRNA JJ O
expression NN O
in IN O
activated VBN O
normal JJ O
T NNP O
cells NNS O
required VBD O
new JJ O
protein JJ O
synthesis NN O
, , O
suggesting VBG O
that IN O
this DT O
phenomenon NN O
is VBZ O
secondary JJ O
to TO O
expression NN O
of IN O
glucocorticoid JJ O
- : O
regulated VBN O
genes NNS B-Gene
. . O

One CD O
of IN O
the DT O
most RBS O
prominent JJ O
glucocorticoid NN O
- : O
induced JJ O
genes NNS B-Gene
is VBZ O
glucocorticoid JJ B-Gene
- : I-Gene
induced JJ I-Gene
leucine JJ I-Gene
zipper NN I-Gene
( ( O
GILZ NNP B-Gene
) ) O
, , O
which WDT O
has VBZ O
been VBN O
reported VBN O
to TO O
inhibit VB O
activation JJ O
- : O
induced VBN O
up RP O
- : O
regulation NN O
of IN O
Fas NNP B-Gene
ligand NN I-Gene
( ( I-Gene
FasL NNP I-Gene
) ) I-Gene
mRNA NN I-Gene
. . O

Indeed RB O
, , O
transient JJ O
expression NN O
of IN O
GILZ NNP B-Gene
in IN O
Jurkat NNP O
T NNP O
cells NNS O
blocked VBD O
induction NN O
of IN O
a DT O
reporter NN B-Gene
construct NN I-Gene
driven VBN O
by IN O
the DT O
FasL NNP B-Gene
promoter NN I-Gene
. . O

This DT O
could MD O
be VB O
accounted VBN O
for IN O
by IN O
GILZ NNP B-Gene
- : O
mediated VBD O
inhibition NN O
of IN O
Egr NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
Egr NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
NFAT NNP B-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
- : O
inducible JJ O
transcription NN B-Gene
factors NNS I-Gene
that WDT O
bind VBP O
a DT O
regulatory JJ B-Gene
element NN I-Gene
in IN O
the DT O
FasL NNP B-Gene
promoter NN I-Gene
and CC O
up RB O
- : O
regulate NN O
FasL NNP O
expression NN O
. . O

GILZ NNP B-Gene
also RB O
potently RB O
inhibited VBN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
driven NN I-Gene
and CC I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
- : I-Gene
driven NN I-Gene
reporter NN I-Gene
constructs NNS I-Gene
, , O
and CC O
recombinant JJ O
GILZ NNP B-Gene
specifically RB O
interacted VBD O
with IN O
c JJ B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
in IN O
vitro NN O
and CC O
inhibited VBD O
the DT O
binding NN O
of IN O
active JJ B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
to TO O
its PRP$ O
target NN O
DNA NN O
. . O

Whereas NNP O
homodimerization NN O
of IN O
GILZ NNP B-Gene
required VBD O
the DT O
presence NN O
of IN O
its PRP$ O
leucine NN B-Gene
zipper NN I-Gene
, , O
the DT O
interaction NN O
with IN O
c JJ B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
occurred VBD O
through IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal NN I-Gene
60 CD B-Gene
- : I-Gene
amino NN I-Gene
acid JJ I-Gene
region NN I-Gene
of IN O
GILZ NNP B-Gene
. . O

Thus RB O
, , O
GILZ NNP B-Gene
represents VBZ O
a DT O
glucocorticoid JJ O
- : O
induced JJ O
gene NN O
product NN O
that WDT O
can MD O
inhibit VB O
a DT O
variety NN O
of IN O
activation NN O
- : O
induced JJ O
events NNS O
, , O
at IN O
least JJS O
in IN O
part NN O
by IN O
direct JJ O
interference NN O
with IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
is VBZ O
therefore RB O
a DT O
candidate NN O
for IN O
a DT O
mediator NN O
of IN O
glucocorticoid JJ O
- : O
induced JJ O
immunosuppression NN O
. . O

Pharmacokinetic JJ O
differences NNS O
between IN O
a DT O
T NNP O
cell NN O
- : O
tolerizing NN O
and CC O
a DT O
T NNP O
cell NN O
- : O
activating VBG O
peptide NN O
. . O

Vaccination NN O
with IN O
a DT O
peptide NN O
representing VBG O
a DT O
CTL NNP O
epitope NN O
from IN O
the DT O
human JJ O
papillomavirus NN O
( ( O
HPV NNP O
) ) O
16 CD O
E7 NNP B-Gene
protein NN I-Gene
induces VBZ O
a DT O
specific JJ O
CTL NNP O
response NN O
that WDT O
prevents VBZ O
the DT O
outgrowth NN O
of IN O
HPV16 NNP O
E7 NNP O
- : O
expressing VBG O
tumors NNS O
. . O

In IN O
contrast NN O
, , O
vaccination NN O
with IN O
a DT O
peptide NN O
encoding VBG O
an DT O
adenovirus NN O
type NN O
5 CD O
( ( O
Ad5 NNP O
) ) O
E1A NNP O
CTL NNP O
epitope NN O
results NNS O
in IN O
CTL NNP O
tolerance NN O
and CC O
enhanced VBD O
growth NN O
of IN O
an DT O
Ad5 NNP O
E1A NNP O
- : O
expressing VBG O
tumor NN O
. . O

It PRP O
is VBZ O
unclear JJ O
why WRB O
these DT O
peptides NNS O
induce VBP O
such JJ O
opposite JJ O
effects NNS O
. . O

To TO O
determine VB O
whether IN O
a DT O
difference NN O
in IN O
pharmacokinetics NNS O
can MD O
explain VB O
the DT O
functional JJ O
contrasts NNS O
, , O
tritiated VBD O
Ad5 NNP O
E1A NNP O
and CC O
HPV16 NNP O
E7 NNP O
peptides NNS O
were VBD O
injected VBN O
into IN O
mice NN O
. . O

Results NNS O
show VBP O
that IN O
the DT O
tolerizing VBG O
peptide NN O
spread NN O
through IN O
the DT O
body NN O
16 CD O
times NNS O
faster RBR O
than IN O
the DT O
activating VBG O
peptide NN O
and CC O
was VBD O
cleared VBN O
at IN O
least JJS O
2 CD O
times NNS O
faster RBR O
. . O

The DT O
HPV16 NNP O
E7 NNP O
peptide IN O
kinetics NNS O
correlated VBN O
with IN O
the DT O
kinetics NNS O
of IN O
HPV16 NNP B-Gene
E7 NNP I-Gene
- : O
specific JJ O
CTL NNP O
induction NN O
. . O

In IN O
contrast NN O
, , O
Ad5 NNP O
E1A NNP O
peptide IN O
injection NN O
resulted VBD O
in IN O
physical JJ O
deletion NN O
of IN O
preexisting VBG O
Ad5 NNP B-Gene
E1A NNP I-Gene
- : O
specific JJ O
CTLs NNP B-Gene
within IN O
24 CD O
h NN O
after IN O
injection NN O
. . O

This DT O
tolerization NN O
occurred VBD O
at IN O
the DT O
time NN O
when WRB O
the DT O
peptide NN O
reached VBD O
its PRP$ O
maximum JJ O
peptide JJ O
concentration NN O
in IN O
the DT O
organs NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
ubiquitous JJ O
expression NN O
of IN O
the DT O
tolerizing VBG O
Ad5 NNP O
E1A NNP O
peptide NN O
within IN O
a DT O
short JJ O
period NN O
of IN O
time NN O
causes NNS O
activation VBP O
- : O
induced VBN O
cell VBP O
death NN O
of IN O
Ad5 NNP B-Gene
E1A NNP I-Gene
- : O
specific JJ O
CTLs NNP B-Gene
. . O

Therefore RB O
, , O
information NN O
on IN O
the DT O
pharmacokinetics NNS O
of IN O
peptides NNS O
is VBZ O
vital JJ O
for IN O
the DT O
safety NN O
and CC O
efficacy NN O
of IN O
peptide NN O
- : O
based VBN O
vaccines NNS O
. . O

Smad3 NNP B-Gene
and CC O
Smad4 NNP B-Gene
mediate VBP O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta1 NN I-Gene
- : O
induced JJ O
IgA NNP O
expression NN O
in IN O
murine NN O
B NNP O
lymphocytes VBZ O
. . O

Transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
( ( I-Gene
TGF NNP I-Gene
) ) I-Gene
- : I-Gene
beta1 NN I-Gene
is VBZ O
well RB O
established VBN O
as IN O
a DT O
critical JJ O
IgA NNP B-Gene
isotype NN I-Gene
switching VBG I-Gene
factor NN I-Gene
and CC O
Smad NNP B-Gene
molecules NNS I-Gene
have VBP O
been VBN O
reported VBN O
to TO O
act VB O
as IN O
transducers NNS B-Gene
and CC O
transcriptional JJ B-Gene
factors NNS I-Gene
in IN O
the DT O
expression NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
- : O
targeted VBN O
genes NNS B-Gene
. . O

We PRP O
examined VBD O
the DT O
involvement NN O
of IN O
Smad NNP B-Gene
proteins NNS I-Gene
in IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
- : O
induced JJ O
IgA NNP O
expression NN O
. . O

First RB O
, , O
we PRP O
found VBD O
that IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
significantly RB O
increases VBZ O
endogenous JJ B-Gene
germ NNS I-Gene
- : I-Gene
line NN I-Gene
( ( I-Gene
GL NNP I-Gene
) ) I-Gene
alpha NN I-Gene
transcripts NNS I-Gene
by IN O
LPS NNP O
- : O
stimulated VBD O
CH12 NNP O
. . O
LX NNP O
. . O
4933 CD O
( ( O
mu NN O
( ( O
+ NNP O
) ) O
) ) O
B NNP O
lymphoma NN O
cells NNS O
. . O

To TO O
investigate VB O
its PRP$ O
signaling VBG O
mechanisms NNS O
, , O
the DT O
lymphoma NN O
cell NN O
line NN O
was VBD O
transfected VBN O
with IN O
pFL3 NN B-Gene
that WDT O
contains VBZ O
the DT O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
of IN O
the DT O
GLalpha NNP B-Gene
promoter NN I-Gene
, , O
and CC O
stimulated VBD O
with IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
. . O

Similar JJ O
to TO O
endogenous JJ B-Gene
GLalpha NNP I-Gene
transcripts NNS I-Gene
, , O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
induces NNS O
GLalpha NNP B-Gene
promoter NN I-Gene
activity NN O
and CC O
overexpression NN O
of IN O
Smad3 NNP B-Gene
markedly RB O
enhances VBZ O
the DT O
promoter NN O
activity NN O
. . O

This DT O
activity NN O
is VBZ O
further RB O
augmented VBN O
by IN O
cotransfected JJ B-Gene
Smad4 NNP I-Gene
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
Smad7 NNP B-Gene
substantially RB O
abrogates VBZ O
the DT O
synergistic JJ O
effect NN O
of IN O
Smad3 NNP B-Gene
/ NNP I-Gene
4 CD I-Gene
on IN O
GLalpha NNP B-Gene
promoter NN I-Gene
activity NN O
. . O

In IN O
addition NN O
, , O
overexpression NN O
of IN O
Smad3 NNP B-Gene
/ NNP I-Gene
4 CD I-Gene
enhances NNS O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
- : O
induced VBN O
endogenous JJ B-Gene
GLalpha NNP I-Gene
transcripts NNS I-Gene
in IN O
normal JJ O
spleen JJ O
B NNP O
cell NN O
s NN O
. . O

Finally RB O
, , O
in IN O
the DT O
presence NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
, , O
overexpression NN O
of IN O
Smad3 NNP B-Gene
/ NNP I-Gene
4 CD I-Gene
selectively RB O
increases VBZ O
both DT O
surface NN O
IgA NNP O
expression NN O
and CC O
IgA NNP O
production NN O
. . O

The DT O
results NNS O
from IN O
the DT O
present JJ O
study NN O
indicate VBP O
that IN O
Smad3 NNP B-Gene
, , O
Smad4 NNP B-Gene
, , O
and CC O
Smad7 NNP B-Gene
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
serve VBP O
as IN O
mediators NNS O
linking VBG O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
to TO O
transcriptional JJ O
regulation NN O
of IN O
IgA NNP B-Gene
switching VBG I-Gene
related VBN I-Gene
gene NN I-Gene
and CC O
regulation NN O
of IN O
IgA NNP O
class NN O
switching NN O
. . O

The DT O
translesion NN B-Gene
DNA NNP I-Gene
polymerase NN I-Gene
zeta NNP I-Gene
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
Ig NNP O
and CC O
bcl SYM O
- : O
6 CD O
somatic JJ O
hypermutation NN O
. . O

Ig NNP O
somatic JJ O
mutations NNS O
would MD O
be VB O
introduced VBN O
by IN O
a DT O
polymerase NN B-Gene
( ( O
pol NN B-Gene
) ) O
while IN O
repairing VBG O
DNA NNP O
outside JJ O
main JJ O
DNA NNP O
replication NN O
. . O

We PRP O
show VBP O
that IN O
human JJ O
B NNP O
cells NNS O
constitutively RB O
express VBP O
the DT O
translesion NN B-Gene
pol NN I-Gene
zeta NN I-Gene
, , O
which WDT O
effectively RB O
extends VBZ O
DNA NNP O
past IN O
mismatched VBN O
bases NNS O
( ( O
mispair JJ O
extender NN O
) ) O
, , O
and CC O
pol NN B-Gene
eta NN I-Gene
, , O
which WDT O
bypasses VBZ O
DNA NNP O
lesions NNS O
in IN O
an DT O
error NN O
- : O
free JJ O
fashion NN O
. . O

Upon IN O
B NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
engagement NN O
and CC O
coculture NN O
with IN O
activated JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
, , O
these DT O
lymphocytes NNS O
upregulated VBD O
pol JJ B-Gene
zeta NN I-Gene
, , O
downregulated VBD O
pol NN B-Gene
eta NN I-Gene
, , O
and CC O
mutated VBD O
the DT O
Ig NNP B-Gene
and CC I-Gene
bcl SYM I-Gene
- : I-Gene
6 CD I-Gene
genes NNS I-Gene
. . O

Inhibition NN O
of IN O
the DT O
pol NN B-Gene
zeta NN I-Gene
REV3 NNP B-Gene
catalytic JJ I-Gene
subunit NN I-Gene
by IN O
specific JJ O
phosphorothioate NN O
- : O
modified VBN O
oligonucleotides NNS O
impaired JJ O
Ig NNP O
and CC O
bcl SYM O
- : O
6 CD O
hypermutation NN O
and CC O
UV NNP O
damage NN O
- : O
induced JJ O
DNA NNP O
mutagenesis NN O
, , O
without IN O
affecting VBG O
cell NN O
cycle NN O
or CC O
viability NN O
. . O

Thus RB O
, , O
pol JJ B-Gene
zeta NN I-Gene
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
Ig NNP O
and CC O
bcl SYM O
- : O
6 CD O
hypermutation NN O
, , O
perhaps RB O
facilitated VBN O
by IN O
the DT O
downregulation NN O
of IN O
pol NN B-Gene
eta NN I-Gene
. . O

Molecular JJ O
mechanism NN O
of IN O
cell NN O
cycle NN O
progression NN O
induced VBN O
by IN O
the DT O
oncogene JJ B-Gene
product NN I-Gene
Tax NNP I-Gene
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
. . O

The DT O
trans NNPS B-Gene
- : I-Gene
activator NN I-Gene
protein JJ I-Gene
Tax NNP I-Gene
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
development NN O
of IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
through IN O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
its PRP$ O
ability NN O
to TO O
stimulate VB O
cell NN O
growth NN O
. . O

We PRP O
previously RB O
reported VBD O
that IN O
Tax NNP B-Gene
induced VBD O
cell NN O
cycle NN O
progression NN O
from IN O
G0 NNP O
/ NNP O
G1 NNP O
phase NN O
to TO O
S NNP O
and CC O
G2 NNP O
/ NNP O
M NNP O
phases VBZ O
in IN O
human JJ O
T NNP O
- : O
cell NN O
line NN O
Kit NNP O
225 CD O
cells NNS O
. . O

To TO O
elucidate VB O
molecular JJ O
mechanism NN O
of IN O
Tax NNP B-Gene
- : O
induced VBN O
cell NN O
cycle NN O
progression NN O
, , O
we PRP O
systematically RB O
examined VBD O
the DT O
effects NNS O
of IN O
Tax NNP B-Gene
on IN O
biochemical JJ O
events NNS O
associated VBN O
with IN O
cell NN O
cycle NN O
progression NN O
. . O

Introduction NN O
of IN O
Tax NNP B-Gene
into IN O
resting VBG O
Kit NNP O
225 CD O
cells NNS O
induced JJ O
activation NN O
of IN O
the DT O
G1 NNP O
/ NNP O
S NNP O
transition NN O
regulation NN O
cascade VBD O
consisting VBG O
of IN O
activation NN O
of IN O
cyclin NN B-Gene
dependent JJ I-Gene
kinase NN I-Gene
2 CD I-Gene
( ( O
CDK2 NNP B-Gene
) ) O
and CC O
CDK4 NNP B-Gene
, , O
phosphorylation NN O
of IN O
the DT O
Rb NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
and CC O
an DT O
increase NN O
in IN O
free JJ O
E2F NNP B-Gene
. . O

The DT O
kinase NN O
activation NN O
was VBD O
found VBN O
to TO O
result VB O
from IN O
Tax NNP B-Gene
- : O
induced JJ O
expression NN O
of IN O
genes NNS O
for IN O
cell NN B-Gene
cycle NN I-Gene
regulatory JJ I-Gene
molecules NNS I-Gene
including VBG O
cyclin NN B-Gene
D2 NNP I-Gene
, , O
cyclin NN B-Gene
E NNP I-Gene
, , O
E2F1 NNP B-Gene
, , O
CDK2 NNP B-Gene
, , O
CDK4 NNP B-Gene
and CC O
CDK6 NNP B-Gene
, , O
and CC O
Tax NNP B-Gene
- : O
induced JJ O
reduction NN O
of IN O
CDK NNP B-Gene
inhibitors NNS I-Gene
p19 VBP I-Gene
( ( O
INK4d NNP B-Gene
) ) O
and CC O
p27 NN B-Gene
( ( I-Gene
Kip1 NNP I-Gene
) ) I-Gene
. . O

These DT O
modulations NNS O
by IN O
Tax NNP B-Gene
always RB O
paralleled VBD O
the DT O
ability NN O
of IN O
Tax NNP B-Gene
to TO O
activate VB O
the DT O
NF NNP O
- : O
kappaB NN O
transcription NN O
pathway NN O
. . O

These DT O
results NNS O
indicate VBP O
the DT O
important JJ O
role NN O
of IN O
Tax NNP B-Gene
- : O
mediated VBD O
trans NNS O
- : O
activation NN O
of IN O
the DT O
genes NNS O
for IN O
cell NN B-Gene
cycle NN I-Gene
regulatory JJ I-Gene
molecules NNS I-Gene
in IN O
Tax NNP B-Gene
- : O
induced VBN O
cell NN O
cycle NN O
progression NN O
. . O

Cot NNP B-Gene
kinase NN I-Gene
induces NNS O
cyclooxygenase VBP O
- : O
2 CD O
expression NN O
in IN O
T NNP O
cells NNS O
through IN O
activation NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
. . O

Cyclooxygenase NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
is VBZ O
induced VBN O
in IN O
human JJ O
T NNP O
lymphocytes VBZ O
upon IN O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
triggering VBG O
. . O

Here RB O
we PRP O
report VBP O
that IN O
Cot NNP B-Gene
kinase NNP I-Gene
, , O
a DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
kinase NN I-Gene
involved VBN O
in IN O
T NNP O
cell NN O
activation NN O
, , O
up RB O
- : O
regulates NNS O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
expression NN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Induction NN O
of IN O
COX NNP O
- : O
2 CD O
promoter NN O
activity NN O
by IN O
Cot NNP B-Gene
kinase NN I-Gene
occurred VBD O
mainly RB O
through IN O
activation NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
. . O

Mutation NN O
of IN O
the DT O
distal NN B-Gene
( ( I-Gene
- : I-Gene
105 CD I-Gene
/ SYM I-Gene
- : I-Gene
97 CD I-Gene
) ) I-Gene
and CC O
proximal JJ B-Gene
( ( I-Gene
- : I-Gene
76 CD I-Gene
/ SYM I-Gene
- : I-Gene
61 CD I-Gene
) ) I-Gene
NFAT NNP B-Gene
response NN I-Gene
elements NNS I-Gene
in IN O
the DT O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
abolished VBD O
the DT O
activation NN O
induced VBN O
by IN O
Cot NNP B-Gene
kinase NN I-Gene
. . O

Even RB O
more RBR O
, , O
coexpression NN O
of IN O
a DT O
dominant JJ O
negative JJ O
version NN O
of IN O
NFAT NNP B-Gene
inhibited VBD O
Cot NNP B-Gene
kinase NNP I-Gene
- : O
mediated VBD O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activation NN O
, , O
whereas JJ O
cotransfection NN O
of IN O
a DT O
constitutively RB O
active JJ O
version NN O
of IN O
the DT O
calcium NN B-Gene
- : I-Gene
dependent JJ I-Gene
phosphatase NN I-Gene
calcineurin NN I-Gene
synergizes VBZ O
with IN O
Cot NNP B-Gene
kinase NN I-Gene
in IN O
the DT O
up RP O
- : O
regulation NN O
of IN O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
- : O
driven JJ O
transcription NN O
. . O

Strikingly RB O
, , O
Cot NNP B-Gene
kinase NN I-Gene
increased VBD O
transactivation NN O
mediated VBN O
by IN O
a DT O
GAL4 NNP B-Gene
- : I-Gene
NFAT NNP I-Gene
fusion NN I-Gene
protein NN I-Gene
containing VBG O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
transactivation NN I-Gene
domain NN I-Gene
of IN O
NFATp NNP B-Gene
. . O

In IN O
contrast NN O
to TO O
phorbol VB O
ester JJ O
plus CC O
calcium JJ O
ionophore NN O
A23187 NNP O
, , O
Cot NNP B-Gene
kinase NN I-Gene
increases VBZ O
both DT O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
and CC O
NFAT NNP B-Gene
- : O
mediated VBN O
transactivation NN O
in IN O
a DT O
cyclosporin NN O
A NNP O
- : O
independent JJ O
manner NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
Cot NNP B-Gene
kinase VBD I-Gene
up RP O
- : O
regulates NNS O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
- : O
driven VBN O
transcription NN O
through IN O
the DT O
NFAT NNP B-Gene
response NN I-Gene
elements NNS I-Gene
, , O
being VBG O
the DT O
Cot NNP B-Gene
kinase NNP I-Gene
- : O
induced VBD O
NFAT NNP B-Gene
- : O
dependent JJ O
transactivation NN O
presumably RB O
implicated VBN O
in IN O
this DT O
up RP O
- : O
regulation NN O
. . O

Positive JJ O
and CC O
negative JJ O
roles NNS O
of IN O
the DT O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
T NNP I-Gene
cell NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
for IN O
the DT O
acquisition NN O
of IN O
distinct JJ O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
MHC NNP I-Gene
class NN I-Gene
I PRP I-Gene
receptors NNS I-Gene
by IN O
NK NNP O
cells NNS O
. . O

Members NNS O
of IN O
the DT O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
gene NN I-Gene
family NN I-Gene
code NN O
for IN O
class NN B-Gene
I PRP I-Gene
MHC NNP I-Gene
- : I-Gene
specific JJ I-Gene
receptors NNS I-Gene
that WDT O
regulate VBP O
NK NNP O
cell NN O
function NN O
. . O

Due JJ O
to TO O
a DT O
combinatorial JJ O
distribution NN O
of IN O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
receptors NNS I-Gene
, , O
NK NNP O
cells NNS O
display VBP O
considerable JJ O
clonal JJ O
heterogeneity NN O
. . O

The DT O
acquisition NN O
of IN O
one CD O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
receptor NN I-Gene
, , O
Ly NNP B-Gene
- : I-Gene
49A CD I-Gene
is VBZ O
strictly RB O
dependent JJ O
on IN O
the DT O
transcriptional JJ B-Gene
trans NNS I-Gene
- : I-Gene
acting VBG I-Gene
factor NN I-Gene
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Indeed RB O
, , O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
binds NNS O
to TO O
two CD O
sites NNS O
in IN O
the DT O
Ly NNP B-Gene
- : I-Gene
49a CD I-Gene
promoter NN I-Gene
and CC O
regulates VBZ O
its PRP$ O
activity NN O
, , O
suggesting VBG O
that IN O
the DT O
Ly NNP B-Gene
- : I-Gene
49a CD I-Gene
gene NN I-Gene
is VBZ O
a DT O
direct JJ O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
target NN O
. . O

TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
deficiency NN O
resulted VBD O
in IN O
the DT O
altered JJ O
usage NN O
of IN O
additional JJ O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
receptors NNS I-Gene
. . O

We PRP O
show VBP O
in IN O
this DT O
study NN O
, , O
using VBG O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
- : I-Gene
microglobulin NN I-Gene
double JJ O
- : O
deficient NN O
mice NN O
, , O
that IN O
these DT O
repertoire NN O
alterations NNS O
are VBP O
not RB O
due JJ O
to TO O
Ly NNP O
- : O
49 CD O
/ JJ O
MHC NNP O
class NN O
I PRP O
interactions NNS O
. . O

Our PRP$ O
findings NNS O
rather RB O
suggest VBP O
a DT O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent NN O
, , O
cell VBP O
autonomous JJ O
effect NN O
on IN O
the DT O
acquisition NN O
of IN O
multiple JJ O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
receptors NNS I-Gene
. . O

Besides IN O
reduced VBN O
receptor NN O
usage NN O
( ( O
Ly NNP B-Gene
- : I-Gene
49A CD I-Gene
and CC I-Gene
D NNP I-Gene
) ) O
, , O
we PRP O
also RB O
observed VBD O
no DT O
effect NN O
( ( O
Ly NNP B-Gene
- : I-Gene
49C CD I-Gene
) ) O
and CC O
significantly RB O
expanded VBN O
( ( O
Ly NNP B-Gene
- : I-Gene
49G CD I-Gene
and CC I-Gene
I PRP I-Gene
) ) O
receptor NN O
usage NN O
in IN O
the DT O
absence NN O
of IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

These DT O
effects NNS O
did VBD O
not RB O
in IN O
all DT O
cases NNS O
correlate VBP O
with IN O
the DT O
presence NN O
of IN O
TCF NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
respective JJ O
proximal JJ B-Gene
promoter NN I-Gene
. . O

Therefore RB O
, , O
besides IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
to TO O
the DT O
proximal JJ B-Gene
promoter NN I-Gene
, , O
Ly NNP O
- : O
49 CD O
acquisition NN O
may MD O
also RB O
be VB O
regulated VBN O
by IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
to TO O
more RBR O
distant JJ O
cis NN B-Gene
- : I-Gene
acting JJ I-Gene
elements NNS I-Gene
and CC O
/ NN O
or CC O
by IN O
regulating VBG O
the DT O
expression NN O
of IN O
additional JJ O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
factors NNS I-Gene
. . O

Consistent JJ O
with IN O
the DT O
observed JJ O
differential NN O
, , O
positive JJ O
or CC O
negative JJ O
role NN O
of IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
for IN O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
receptor NN I-Gene
acquisition NN O
, , O
reporter NN O
gene NN O
assays NNS O
revealed VBD O
the DT O
presence NN O
of IN O
an DT O
inducing NN O
as RB O
well RB O
as IN O
a DT O
repressing VBG O
TCF NNP B-Gene
site NN I-Gene
in IN O
certain JJ O
proximal JJ O
Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
promoters NNS I-Gene
. . O

These DT O
findings NNS O
reveal VBP O
an DT O
important JJ O
role NN O
of IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
for IN O
the DT O
formation NN O
of IN O
the DT O
NK NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
repertoire NN O
. . O

Ligation NN O
of IN O
CD11b NNP B-Gene
and CC O
CD11c NNP B-Gene
beta NN I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
integrins NNS B-Gene
by IN O
antibodies NNS B-Gene
or CC O
soluble JJ B-Gene
CD23 NNP I-Gene
induces NNS O
macrophage VBP B-Gene
inflammatory JJ I-Gene
protein NN I-Gene
1alpha CD I-Gene
( ( O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
) ) O
and CC O
MIP NNP B-Gene
- : I-Gene
1beta CD I-Gene
production NN O
in IN O
primary JJ O
human JJ O
monocytes VBZ O
through IN O
a DT O
pathway JJ O
dependent NN O
on IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Chemokines NNS B-Gene
and CC O
adhesion NN B-Gene
molecules NNS I-Gene
such JJ O
as IN O
integrins NNS B-Gene
play VBP O
a DT O
major JJ O
part NN O
in IN O
the DT O
trafficking NN O
, , O
extravasation NN O
, , O
and CC O
recruitment NN O
of IN O
leukocytes NNS O
to TO O
inflammatory VB O
sites NNS O
. . O

This DT O
study NN O
investigated VBD O
the DT O
effects NNS O
of IN O
beta NN O
( ( O
2 CD O
) ) O
integrin NN O
engagement NN O
on IN O
chemokine NN O
production NN O
by IN O
freshly RB O
isolated VBN O
human JJ O
monocytes NNS O
. . O

We PRP O
found VBD O
that IN O
ligation NN O
of IN O
CD11b NNP B-Gene
or CC O
CD11c NNP B-Gene
but CC O
not RB O
CD11a NNP B-Gene
alpha NN I-Gene
chains NNS I-Gene
of IN O
beta NN B-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
integrins NNS I-Gene
by IN O
antibodies NNS B-Gene
or CC O
soluble JJ B-Gene
CD23 NNP I-Gene
( ( I-Gene
sCD23 NN I-Gene
) ) I-Gene
fusion NN I-Gene
proteins NNS I-Gene
rapidly RB O
induced VBD O
transcription NN O
and CC O
secretion NN O
of IN O
interleukin JJ B-Gene
8 CD I-Gene
, , O
macrophage NN B-Gene
inflammatory NN I-Gene
protein NN I-Gene
( ( I-Gene
MIP NNP I-Gene
) ) I-Gene
1alpha CD I-Gene
, , O
and CC O
MIP NNP B-Gene
- : I-Gene
1beta CD I-Gene
. . O

Because IN O
the DT O
promoters NNS B-Gene
of IN O
these DT O
chemokine JJ B-Gene
genes NNS I-Gene
contain VBP O
kappaB JJ B-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
we PRP O
assessed VBD O
the DT O
possible JJ O
role NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
in IN O
controlling VBG O
induction NN O
of IN O
the DT O
genes NNS O
through IN O
beta NN O
( ( O
2 CD O
) ) O
integrin NN O
engagement NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
showed VBD O
that IN O
sCD23 NN B-Gene
or CC O
antibodies NNS B-Gene
to TO O
CD11b NNP B-Gene
or CC O
to TO O
CD11c NNP B-Gene
up RP O
- : O
regulated VBN O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
was VBD O
accompanied VBN O
by IN O
degradation NN O
of IN O
its PRP$ O
cytosolic JJ B-Gene
inhibitor NN I-Gene
IkappaB NNP I-Gene
- : I-Gene
alpha NN I-Gene
. . O

Blockade NN O
of IN O
depletion NN O
of IN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
by IN O
proteasome JJ O
inhibitors NNS O
( ( O
proteasome JJ O
inhibitor NN O
I PRP O
or CC O
acetyl VB O
- : O
leucinyl NN O
- : O
leucinyl NN O
- : O
norleucinal NN O
) ) O
led VBD O
to TO O
concomitant VB O
inhibition NN O
of IN O
NF NNP O
- : O
kappaB NN O
DNA NNP O
- : O
binding NN O
activity NN O
and CC O
expression NN O
of IN O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
and CC I-Gene
MIP NNP I-Gene
- : I-Gene
1beta CD I-Gene
messenger NN I-Gene
RNA NNP I-Gene
induced VBN O
by IN O
beta NN O
( ( O
2 CD O
) ) O
integrin NN O
ligation NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
triggering VBG O
of IN O
CD11b NNP B-Gene
or CC O
CD11c NNP B-Gene
beta NN I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
integrin NN O
on IN O
primary JJ O
human JJ O
monocytes NNS O
provides VBZ O
activation NN O
signals NNS O
leading VBG O
to TO O
nuclear JJ O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
subsequent JJ O
secretion NN O
of IN O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
and CC O
MIP NNP B-Gene
- : I-Gene
1beta CD I-Gene
that WDT O
may MD O
have VB O
an DT O
important JJ O
role NN O
in IN O
recruitment NN O
of IN O
other JJ O
inflammatory JJ O
cells NNS O
during IN O
initiation NN O
of IN O
an DT O
inflammatory JJ O
response NN O

Synergistic JJ O
transcriptional JJ O
activation NN O
of IN O
human JJ B-Gene
Acyl NNP I-Gene
- : I-Gene
coenzyme NN I-Gene
A DT I-Gene
: : I-Gene
cholesterol NN I-Gene
acyltransterase VBZ I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
by IN O
interferon JJ B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
all DT O
- : O
trans NNS O
- : O
retinoic NN O
acid NN O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Acyl NNP B-Gene
- : I-Gene
coenzyme NN I-Gene
A DT I-Gene
: : I-Gene
cholesterol NN I-Gene
acyltransferase NN I-Gene
( ( O
ACAT NNP B-Gene
) ) O
is VBZ O
an DT O
intracellular JJ B-Gene
enzyme NN I-Gene
involved VBN O
in IN O
cellular JJ O
cholesterol NN O
homeostasis NN O
and CC O
in IN O
atherosclerotic JJ O
foam NN O
cell NN O
formation NN O
. . O

Human NNP B-Gene
ACAT NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
contains NNS O
two CD O
promoters NNS B-Gene
( ( O
P1 NNP B-Gene
and CC O
P7 NNP B-Gene
) ) O
, , O
each DT O
located VBN O
in IN O
a DT O
different JJ O
chromosome NN B-Gene
( ( I-Gene
1 CD I-Gene
and CC I-Gene
7 CD I-Gene
) ) I-Gene
( ( O
Li NNP O
, , O
B NNP O
. . O
L NNP O
. . O
, , O
Li NNP O
, , O
X NNP O
. . O
L NNP O
. . O
, , O
Duan NNP O
, , O
Z NNP O
. . O
J NNP O
. . O
, , O
Lee NNP O
, , O
O NNP O
. . O
, , O
Lin NNP O
, , O
S NNP O
. . O
, , O
Ma NNP O
, , O
Z NNP O
. . O
M NNP O
. . O
, , O
Chang NNP O
, , O
C NNP O
. . O
C NNP O
. . O
, , O
Yang NNP O
, , O
X NNP O
. . O
Y NNP O
. . O
, , O
Park NNP O
, , O
J NNP O
. . O
P NNP O
. . O
, , O
Mohandas NNP O
, , O
T NNP O
. . O
K NNP O
. . O
, , O
Noll NNP O
, , O
W NNP O
. . O
, , O
Chan NNP O
, , O
L NNP O
. . O
, , O
and CC O
Chang NNP O
, , O
T NNP O
. . O
Y NNP O
. . O
( ( O
1999 CD O
) ) O
J NNP O
. . O
Biol NNP O
Chem NNP O
. . O
274 CD O
, , O
11060 CD O
- : O
11071 CD O
) ) O
. . O

Interferon NNP B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
, , O
a DT O
cytokine NN B-Gene
that WDT O
exerts VBZ O
many JJ O
pro JJ O
- : O
atherosclerotic JJ O
effects NNS O
in IN O
vivo NN O
, , O
causes VBZ O
up RP O
- : O
regulation NN O
of IN O
ACAT NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
in IN O
human JJ O
blood NN O
monocyte NN O
- : O
derived VBN O
macrophages NNS O
and CC O
macrophage VB O
- : O
like IN O
cells NNS O
but CC O
not RB O
in IN O
other JJ O
cell NN O
types NNS O
. . O

To TO O
examine VB O
the DT O
molecular JJ O
nature NN O
of IN O
this DT O
observation NN O
, , O
we PRP O
identified VBD O
within IN O
the DT O
ACAT NNP B-Gene
- : I-Gene
1 CD I-Gene
P1 NNP I-Gene
promoter NN I-Gene
a DT O
159 CD B-Gene
- : I-Gene
base NN I-Gene
pair NN I-Gene
core NN I-Gene
region NN I-Gene
. . O

This DT O
region NN O
contains VBZ O
4 CD O
Sp1 NNP B-Gene
elements NNS I-Gene
and CC O
an DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
activated VBD I-Gene
sequence NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
that IN O
overlaps VBZ O
with IN O
the DT O
second JJ O
Sp1 NNP B-Gene
element NN I-Gene
. . O

In IN O
the DT O
monocytic JJ O
cell NN O
line NN O
THP NNP O
- : O
1 CD O
cell NN O
, , O
the DT O
combination NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
all DT O
- : O
trans NNS O
- : O
retinoic NN O
acid NN O
( ( O
a DT O
known VBN O
differentiation NN O
agent NN O
) ) O
enhances VBZ O
the DT O
ACAT NNP B-Gene
- : I-Gene
1 CD I-Gene
P1 NNP I-Gene
promoter NN I-Gene
but CC O
not RB O
the DT O
P7 NNP B-Gene
promoter NN I-Gene
. . O

Additional JJ O
experiments NNS O
showed VBD O
that IN O
all DT O
- : O
trans NNS O
- : O
retinoic NN O
acid NN O
causes VBZ O
large JJ O
induction NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
STAT1 NNP I-Gene
, , O
while IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
causes VBZ O
activation NN O
of IN O
STAT1 NNP B-Gene
such JJ O
that IN O
it PRP O
binds VBZ O
to TO O
the DT O
GAS NNP B-Gene
/ NNP I-Gene
Sp1 NNP I-Gene
site NN I-Gene
in IN O
the DT O
ACAT NNP B-Gene
- : I-Gene
1 CD I-Gene
P1 NNP I-Gene
promoter NN I-Gene
. . O

Our PRP$ O
work NN O
provides VBZ O
a DT O
molecular JJ O
mechanism NN O
to TO O
account VB O
for IN O
the DT O
effect NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
causing VBG O
transcriptional JJ O
activation NN O
of IN O
ACAT NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
macrophage NN O
- : O
like IN O
cells NNS O
. . O

Inhaled VBN O
nitric JJ O
oxide RB O
down IN O
- : O
regulates NNS O
intrapulmonary JJ O
nitric JJ O
oxide NN O
production NN O
in IN O
lipopolysaccharide JJ O
- : O
induced JJ O
acute NN O
lung NN O
injury NN O
. . O

OBJECTIVE NN O
: : O
To TO O
examine VB O
whether IN O
inhaled JJ O
nitric JJ O
oxide NN O
( ( O
NO NNP O
) ) O
affected VBD O
the DT O
intrapulmonary JJ O
production NN O
of IN O
NO NNP O
, , O
reactive JJ O
oxygen NN O
species NNS O
, , O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
a DT O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
- : O
induced JJ O
model NN O
of IN O
acute JJ O
lung JJ O
injury NN O
. . O

DESIGN NN O
: : O
Prospective JJ O
, , O
randomized VBN O
, , O
laboratory NN O
study NN O
. . O

SETTING NN O
: : O
Experimental JJ O
laboratory NN O
at IN O
a DT O
biomedical JJ O
institute NN O
. . O

SUBJECTS NN O
: : O
Twenty NNP O
male NN O
rabbits NNS O
weighing VBG O
2 CD O
. . O
5 CD O
- : O
3 CD O
. . O
5 CD O
kg NN O
. . O

INTERVENTIONS NN O
: : O
Saline NN O
or CC O
LPS NNP O
( ( O
5 CD O
mg NN O
/ NNP O
kg NN O
of IN O
body NN O
weight NN O
) ) O
was VBD O
administered VBN O
intravenously RB O
with IN O
or CC O
without IN O
NO DT O
inhalation NN O
( ( O
10 CD O
ppm NN O
) ) O
in IN O
each DT O
group NN O
of IN O
five CD O
rabbits NNS O
. . O

MEASUREMENTS NNP O
AND CC O
MAIN NNP O
RESULTS NNP O
: : O
LPS NNP O
increased VBD O
the DT O
lung NN O
leak NN O
index NN O
, , O
the DT O
neutrophils NNS O
and CC O
NO NNP O
levels NNS O
in IN O
bronchoalveolar JJ O
lavage NN O
fluid NN O
, , O
and CC O
NO NNP O
levels NNS O
produced VBN O
by IN O
resting VBG O
and CC O
stimulated VBD O
alveolar JJ O
macrophages NNS O
. . O

Inhaled VBN O
NO DT O
decreased VBD O
the DT O
lung NN O
leak NN O
index NN O
, , O
the DT O
neutrophils NNS O
and CC O
NO NNP O
levels NNS O
as IN O
measured VBN O
by IN O
nitrite JJ O
levels NNS O
in IN O
the DT O
lavage NN O
fluid NN O
, , O
and CC O
NO NNP O
produced VBN O
by IN O
the DT O
resting NN O
and CC O
stimulated VBD O
alveolar JJ O
macrophages NNS O
. . O

Inhaled VBN O
NO NNP O
also RB O
blocked VBD O
the DT O
activities NNS O
of IN O
reactive JJ O
oxygen NN O
species NNS O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
to TO O
DNA NNP O
in IN O
lavage NN O
cells NNS O
and CC O
in IN O
alveolar JJ O
macrophages NNS O
. . O

CONCLUSION NN O
: : O
Inhaled VBN O
NO NNP O
attenuates VBZ O
LPS NNP O
- : O
induced VBD O
acute JJ O
lung NN O
injury NN O
, , O
possibly RB O
by IN O
decreasing VBG O
NO NNP O
production NN O
in IN O
the DT O
lungs NNS O
. . O

The DT O
mechanism NN O
of IN O
reducing VBG O
NO NNP O
production NN O
resulting VBG O
from IN O
inhaled VBN O
NO NNP O
may MD O
involve VB O
, , O
in IN O
part NN O
, , O
the DT O
activities NNS O
of IN O
reactive JJ O
oxygen NN O
species NNS O
and CC O
/ NN O
or CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Treatment NN O
of IN O
allergic JJ O
airway JJ O
inflammation NN O
and CC O
hyperresponsiveness NN O
by IN O
antisense JJ O
- : O
induced JJ O
local JJ O
blockade NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
. . O

Recent JJ O
studies NNS O
in IN O
transgenic JJ O
mice NNS O
have VBP O
revealed VBN O
that IN O
expression NN O
of IN O
a DT O
dominant JJ O
negative JJ O
form NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
in IN O
T NNP O
cells NNS O
can MD O
prevent VB O
T NNP O
helper NN O
cell NN O
type NN O
2 CD O
( ( O
Th2 NNP O
) ) O
- : O
mediated VBN O
allergic JJ O
airway NN O
inflammation NN O
in IN O
mice NN O
. . O

However RB O
, , O
it PRP O
remains VBZ O
unclear JJ O
whether IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
plays VBZ O
a DT O
role NN O
in IN O
the DT O
effector NN O
phase NN O
of IN O
allergic JJ O
airway JJ O
inflammation NN O
and CC O
whether IN O
antagonizing VBG O
the DT O
expression NN O
and CC O
/ NN O
or CC O
function NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
can MD O
be VB O
used VBN O
for IN O
the DT O
therapy NN O
of IN O
allergic JJ O
airway JJ O
inflammation NN O
and CC O
hyperresponsiveness NN O
. . O

Here RB O
, , O
we PRP O
analyzed VBD O
the DT O
effects NNS O
of IN O
locally RB O
antagonizing VBG O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
function NN O
in IN O
a DT O
murine JJ O
model NN O
of IN O
asthma NN O
. . O

We PRP O
could MD O
suppress VB O
GATA NNP O
- : O
3 CD O
expression NN O
in IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
4 CD I-Gene
- : O
producing VBG O
T NNP O
cells NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
by IN O
an DT O
antisense JJ O
phosphorothioate NN O
oligonucleotide IN O
overlapping VBG O
the DT O
translation NN B-Gene
start VBZ I-Gene
site NN I-Gene
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
whereas JJ O
nonsense NN O
control NN O
oligonucleotides NNS O
were VBD O
virtually RB O
inactive JJ O
. . O

In IN O
a DT O
murine JJ O
model NN O
of IN O
asthma NN O
associated VBN O
with IN O
allergic JJ O
pulmonary JJ O
inflammation NN O
and CC O
hyperresponsiveness NN O
in IN O
ovalbumin NN O
( ( O
OVA NNP O
) ) O
- : O
sensitized VBN O
mice NN O
, , O
local JJ O
intranasal NN O
administration NN O
of IN O
fluorescein JJ O
isothiocyanate JJ O
- : O
labeled VBN O
GATA NNP O
- : O
3 CD O
antisense NN O
oligonucleotides NNS O
led VBD O
to TO O
DNA NNP O
uptake NN O
in IN O
lung NN O
cells NNS O
associated VBN O
with IN O
a DT O
reduction NN O
of IN O
intracellular JJ O
GATA NNP O
- : O
3 CD O
expression NN O
. . O

Such JJ O
intrapulmonary JJ O
blockade NN O
of IN O
GATA NNP O
- : O
3 CD O
expression NN O
caused VBD O
an DT O
abrogation NN O
of IN O
signs NNS O
of IN O
lung NN O
inflammation NN O
including VBG O
infiltration NN O
of IN O
eosinophils NNS O
and CC O
Th2 NNP O
cytokine NN O
production NN O
. . O

Furthermore RB O
, , O
treatment NN O
with IN O
antisense NN O
but CC O
not RB O
nonsense JJ O
oligonucleotides NNS O
induced VBD O
a DT O
significant JJ O
reduction NN O
of IN O
airway NN O
hyperresponsiveness NN O
in IN O
OVA NNP O
- : O
sensitized JJ O
mice NN O
to TO O
levels NNS O
comparable JJ O
to TO O
saline VB O
- : O
treated VBN O
control NN O
mice NN O
, , O
as IN O
assessed VBN O
by IN O
both DT O
enhanced VBN O
pause NN O
( ( O
PenH NNP O
) ) O
responses NNS O
and CC O
pulmonary JJ O
resistance NN O
determined VBN O
by IN O
body NN O
plethysmography NN O
. . O

These DT O
data NNS O
indicate VBP O
a DT O
critical JJ O
role NN O
for IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
the DT O
effector NN O
phase NN O
of IN O
a DT O
murine NN O
asthma NN O
model NN O
and CC O
suggest VBP O
that IN O
local JJ O
delivery NN O
of IN O
GATA NNP O
- : O
3 CD O
antisense JJ O
oligonucleotides NNS O
may MD O
be VB O
a DT O
novel JJ O
approach NN O
for IN O
the DT O
treatment NN O
of IN O
airway JJ O
hyperresponsiveness NN O
such JJ O
as IN O
in IN O
asthma NN O
. . O

This DT O
approach NN O
has VBZ O
the DT O
potential JJ O
advantage NN O
of IN O
suppressing VBG O
the DT O
expression NN O
of IN O
various JJ O
proinflammatory JJ B-Gene
Th2 NNP I-Gene
cytokines NNS I-Gene
simultaneously RB O
rather RB O
than IN O
suppressing VBG O
the DT O
activity NN O
of IN O
a DT O
single JJ O
cytokine NN B-Gene
. . O

T NNP O
helper SYM O
- : O
cell NN O
phenotype NN O
regulates VBZ O
atherosclerosis NN O
in IN O
mice NN O
under IN O
conditions NNS O
of IN O
mild JJ O
hypercholesterolemia NN O
. . O

BACKGROUND NN O
: : O
T NNP O
cells NNS O
are VBP O
implicated VBN O
in IN O
atherosclerosis NN O
, , O
but CC O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
genetic JJ O
control NN O
or CC O
molecular JJ O
pathways NNS O
, , O
especially RB O
under IN O
conditions NNS O
of IN O
mild JJ O
hypercholesterolemia NN O
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
BALB NNP O
/ NNP O
c NN O
mice NN O
, , O
making VBG O
a DT O
CD4 NNP O
+ NNP O
Th2 NNP O
( ( O
IL NNP O
- : O
4 CD O
+ NN O
) ) O
cell NN O
response NN O
, , O
express VB O
both DT O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
antigens VBZ I-Gene
( ( O
IA NNP B-Gene
( ( I-Gene
d NN I-Gene
) ) I-Gene
, , O
IE NNP B-Gene
( ( I-Gene
d NN I-Gene
) ) I-Gene
) ) O
and CC O
are VBP O
atherosclerosis JJ O
- : O
resistant NN O
. . O

C57Bl NNP O
/ VBD O
6 CD O
mice NN O
produce VBP O
a DT O
CD4 NNP O
+ NNP O
Th1 NNP O
( ( O
interferon NN O
[ NNP O
IFN NNP O
] NNP O
gamma NN O
+ NNP O
) ) O
response NN O
, , O
express NN O
IA NNP B-Gene
( ( I-Gene
b NN I-Gene
) ) I-Gene
but CC O
no DT O
IE NNP B-Gene
, , O
and CC O
are VBP O
atherosclerosis JJ O
- : O
prone NN O
. . O

To TO O
evaluate VB O
T NNP O
helper SYM O
- : O
cell NN O
phenotype NN O
in IN O
fatty JJ O
streak JJ O
formation NN O
, , O
wild JJ O
- : O
type NN O
C57Bl NNP O
/ VBZ O
6 CD O
mice NN O
( ( O
IA NNP O
( ( O
b NN O
) ) O
+ NN O
IE NNP O
- : O
) ) O
and CC O
transgenic JJ O
mice NN O
, , O
either CC O
AB NNP O
( ( O
o NN O
) ) O
, , O
IA NNP O
( ( O
b NN O
) ) O
- : O
IE NNP O
- : O
; : O
ABEalpha NNP O
, , O
IA NNP O
- : O
IE NNP O
( ( O
k NN O
) ) O
+ NN O
; : O
or CC O
BL VB O
: : O
TG NN O
: : O
Ealpha NNP O
, , O
IA NNP O
( ( O
b NN O
) ) O
+ NN O
IE NNP O
( ( O
k NN O
) ) O
+ NN O
, , O
were VBD O
fed VBN O
a DT O
high JJ O
- : O
cholesterol NN O
diet NN O
for IN O
16 CD O
weeks NNS O
and CC O
evaluated VBD O
histomorphometricall NN O
for IN O
aortic JJ O
lesions NNS O
. . O

Lesion NNP O
size NN O
in IN O
AB NNP O
( ( O
o NN O
) ) O
, , O
ABEalpha NNP O
, , O
and CC O
BL NNP O
: : O
TG NN O
: : O
Ealpha NNP O
strains NNS O
was VBD O
decreased VBN O
by IN O
54 CD O
% NN O
, , O
79 CD O
% NN O
, , O
and CC O
82 CD O
% NN O
, , O
respectively RB O
, , O
compared VBN O
with IN O
wild JJ O
- : O
type NN O
, , O
correlating VBG O
with IN O
decreased VBN O
Th1 NNP O
and CC O
increased VBD O
Th2 NNP O
expression NN O
and CC O
suggesting VBG O
that IN O
T NNP O
helper SYM O
- : O
cell NN O
phenotype NN O
is VBZ O
important JJ O
in IN O
fatty JJ O
lesion NN O
development NN O
. . O

Decreasing VBG O
Th1 NNP O
cells NNS O
by IN O
antibodies NNS B-Gene
( ( O
alpha SYM B-Gene
- : I-Gene
CD4 NN I-Gene
) ) O
or CC O
cytokines NNS B-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
) ) O
also RB O
caused VBD O
> JJ O
/ NNP O
= NNP O
80 CD O
% NN O
reductions NNS O
in IN O
lesion NN O
size NN O
. . O

Immunohistology NNP O
revealed VBD O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
colocalized VBN O
with IN O
activated JJ O
macrophages NNS O
. . O

Confirming VBG O
these DT O
findings NNS O
in IN O
a DT O
different JJ O
mouse NN O
strain NN O
, , O
BALB NNP O
/ NNP O
c VBD O
Stat NNP O
6 CD O
knockout NN O
mice NN O
( ( O
Th2 NNP O
cell VBP O
- : O
deficient NN O
) ) O
developed VBD O
aortic JJ O
lesions NNS O
comparable JJ O
to TO O
C57Bl NNP O
/ NNP O
6 CD O
mice NN O
on IN O
the DT O
same JJ O
diet NN O
. . O

CONCLUSIONS NN O
: : O
In IN O
mildly RB O
hypercholesterolemic JJ O
C57Bl NNP O
/ NNP O
6 CD O
mice NN O
, , O
presence NN O
of IN O
IA NNP B-Gene
( ( I-Gene
b NN I-Gene
) ) I-Gene
and CC O
absence NN O
of IN O
IE NNP B-Gene
regulated VBD O
CD4 NNP O
+ NNP O
T NNP O
helper SYM O
- : O
cell NN O
phenotype NN O
; : O
fatty JJ O
lesions NNS O
were VBD O
proportional JJ O
to TO O
IFNgamma NNP O
+ NNP O
Th1 NNP O
cells NNS O
in IN O
both DT O
C57Bl NNP O
/ VBD O
6 CD O
and CC O
BALB NNP O
/ NNP O
c NN O
strains NNS O
. . O

IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
may MD O
participate VB O
through IN O
macrophage NN O
activation NN O
, , O
whereas WP O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
may MD O
act VB O
to TO O
limit VB O
Th1 NNP O
- : O
cell NN O
response NN O
. . O

Requirement NN O
for IN O
p38 NN B-Gene
and CC O
p44 NN B-Gene
/ NNP I-Gene
p42 NN I-Gene
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinases NNS I-Gene
in IN O
RAGE NNP B-Gene
- : O
mediated VBD O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
transcriptional JJ O
activation NN O
and CC O
cytokine JJ O
secretion NN O
. . O

Advanced NNP O
glycation NN O
end NN O
product NN O
( ( O
AGE NNP O
) ) O
activation NN O
of IN O
the DT O
signal JJ B-Gene
- : I-Gene
transducing NN I-Gene
receptor NN I-Gene
for IN I-Gene
AGE NNP I-Gene
( ( O
RAGE NNP B-Gene
) ) O
has VBZ O
been VBN O
linked VBN O
to TO O
a DT O
proinflammatory JJ O
phenotypic NN O
change NN O
within IN O
cells NNS O
. . O

However RB O
, , O
the DT O
precise JJ O
intracellular JJ O
signaling VBG O
pathways NNS O
involved VBN O
have VBP O
not RB O
been VBN O
elucidated VBN O
. . O

We PRP O
demonstrate VBP O
here RB O
that IN O
human JJ O
serum NN O
albumin NN O
modified VBN O
with IN O
N NNP O
( ( O
varepsilon NN O
) ) O
- : O
( ( O
carboxymethyl NN O
) ) O
lysine NN O
( ( O
CML NNP O
) ) O
, , O
a DT O
major JJ O
AGE NNP O
adduct NN O
that WDT O
progressively RB O
accumulates VBZ O
with IN O
aging VBG O
, , O
diabetes NNS O
, , O
and CC O
renal JJ O
failure NN O
, , O
induced JJ O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
- : O
driven VBN O
reporter JJ O
gene NN O
expression NN O
in IN O
human JJ O
monocytic JJ O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

The DT O
NF NNP O
- : O
kappaB NN O
response NN O
was VBD O
blocked VBN O
with IN O
a DT O
synthetic JJ O
peptide NN O
corresponding VBG O
to TO O
the DT O
putative JJ B-Gene
ligand NN I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
of IN O
RAGE NNP B-Gene
, , O
with IN O
anti JJ O
- : O
RAGE NN B-Gene
antiserum NN O
, , O
and CC O
by IN O
coexpression NN O
of IN O
truncated JJ B-Gene
receptors NNS I-Gene
lacking VBG O
the DT O
intracellular JJ B-Gene
domain NN I-Gene
. . O

Signal JJ O
transduction NN O
from IN O
RAGE NNP B-Gene
to TO O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
involved VBD O
the DT O
generation NN O
of IN O
reactive JJ O
oxygen NN O
species NNS O
, , O
since IN O
reporter NN O
gene NN O
expression NN O
was VBD O
blocked VBN O
with IN O
the DT O
antioxidant JJ O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
. . O

CML NNP B-Gene
- : I-Gene
modified VBD I-Gene
albumin NN I-Gene
produced VBN O
rapid JJ O
transient JJ O
activation NN O
of IN O
tyrosine JJ O
phosphorylation NN O
, , O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
and CC I-Gene
2 CD I-Gene
, , O
and CC O
p38 NN B-Gene
mitogen NN I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
, , O
but CC O
not RB O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
NH NNP I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
. . O

RAGE NNP B-Gene
- : O
mediated VBD O
NF NNP O
- : O
kappaB NN O
activation NN O
was VBD O
suppressed VBN O
by IN O
the DT O
selective JJ O
p38 NN B-Gene
MAPK NNP I-Gene
inhibitor NN O
SB203580 NNP O
and CC O
by IN O
coexpression NN O
of IN O
a DT O
kinase JJ O
- : O
dead JJ O
p38 NN O
dominant JJ O
- : O
negative JJ O
mutant NN O
. . O

Activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
by IN O
CML NNP B-Gene
- : I-Gene
modified VBD I-Gene
albumin NN I-Gene
increased VBD O
secretion NN O
of IN O
proinflammatory NN B-Gene
cytokines NNS I-Gene
( ( O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
, , O
interleukin JJ B-Gene
- : I-Gene
1beta CD I-Gene
, , O
and CC O
monocyte NN B-Gene
chemoattractant NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
) ) O
severalfold NN O
, , O
and CC O
inhibition NN O
of IN O
p38 NN B-Gene
MAPK NNP I-Gene
blocked VBD O
these DT O
increases NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
p38 NN B-Gene
MAPK NNP I-Gene
activation NN O
mediates VBZ O
RAGE NNP B-Gene
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
dependent JJ O
secretion NN O
of IN O
proinflammatory NN B-Gene
cytokines NNS I-Gene
and CC O
suggest VBP O
that IN O
accelerated JJ O
inflammation NN O
may MD O
be VB O
a DT O
consequence NN O
of IN O
cellular JJ O
activation NN O
induced VBN O
by IN O
this DT O
receptor NN O
. . O

Antigen NNP O
- : O
receptor NN O
cross NN O
- : O
linking NN O
and CC O
lipopolysaccharide JJ O
trigger NN O
distinct JJ O
phosphoinositide RB B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
- : O
dependent NN O
pathways NNS O
to TO O
NF NNP O
- : O
kappa NN O
B NNP O
activation NN O
in IN O
primary JJ O
B NNP O
cells NNS O
. . O

The DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
Rel NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
play VBP O
an DT O
important JJ O
role NN O
in IN O
the DT O
expression NN O
of IN O
genes NNS O
involved VBN O
in IN O
B NNP O
cell NN O
development NN O
, , O
differentiation NN O
and CC O
function NN O
. . O

Nuclear NNP B-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
is VBZ O
induced VBN O
in IN O
B NNP O
cells NNS O
by IN O
engagement NN O
of IN O
either CC O
the DT O
BCR NNP B-Gene
or CC O
CD40 NNP B-Gene
or CC O
by IN O
stimulation NN O
with IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
. . O

Despite IN O
the DT O
importance NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
to TO O
B NNP O
cell NN O
function NN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
signaling NN O
pathways VBZ O
leading VBG O
to TO O
NF NNP O
- : O
kappaB NN O
activation NN O
. . O

In IN O
this DT O
report NN O
we PRP O
address VBP O
the DT O
role NN O
of IN O
phosphoinositide JJ B-Gene
3 CD I-Gene
' POS I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
in IN O
BCR NNP B-Gene
- : O
and CC O
LPS NNP O
- : O
induced VBD O
NF NNP O
- : O
kappaB NN O
activation NN O
using VBG O
populations NNS O
of IN O
primary JJ O
murine NN O
resting VBG O
B NNP O
cells NNS O
. . O

Using VBG O
the DT O
specific JJ O
pharmacological JJ O
inhibitors NNS O
of IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
, , O
Wortmannin NNP O
and CC O
LY294002 NNP O
, , O
we PRP O
demonstrate VBP O
that IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
activity NN O
is VBZ O
vital JJ O
for IN O
BCR NNP B-Gene
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
- : O
binding NN O
activity NN O
. . O

Furthermore RB O
, , O
we PRP O
show VBP O
that IN O
this DT O
is VBZ O
achieved VBN O
via IN O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
- : O
dependent JJ O
degradation NN O
of IN O
IkappaBalpha NNP B-Gene
. . O

Similar JJ O
analyses NNS O
reveal VBP O
that IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
is VBZ O
also RB O
critical JJ O
in IN O
triggering VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
- : O
binding NN O
activity NN O
and CC O
IkappaBalpha NNP B-Gene
degradation NN O
following VBG O
LPS NNP O
stimulation NN O
. . O

Interestingly RB O
, , O
a DT O
PKC NNP O
inhibitor NN O
which WDT O
blocked VBD O
the DT O
BCR NNP B-Gene
- : O
induced VBD O
IkappaBalpha NNP B-Gene
degradation NN O
had VBD O
no DT O
effect NN O
on IN O
the DT O
degradation NN O
of IN O
IkappaBalpha NNP B-Gene
after IN O
LPS NNP O
stimulation NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
the DT O
involvement NN O
of IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
in IN O
at IN O
least JJS O
two CD O
distinct JJ O
signaling VBG O
pathways NNS O
leading VBG O
to TO O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
B NNP O
cells NNS O
. . O

Tetramer NNP O
- : O
guided VBD O
epitope JJ O
mapping NN O
: : O
rapid JJ O
identification NN O
and CC O
characterization NN O
of IN O
immunodominant JJ O
CD4 NNP O
+ NNP O
T NNP O
cell NN O
epitopes NNS O
from IN O
complex JJ O
antigens NNS B-Gene
. . O

T NNP O
cell NN O
responses NNS O
to TO O
Ags NNP B-Gene
involve VB O
recognition NN O
of IN O
selected VBN O
peptide NN B-Gene
epitopes NNS I-Gene
contained VBN O
within IN O
the DT O
antigenic JJ B-Gene
protein NN I-Gene
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
describe VBP O
a DT O
new JJ O
approach NN O
for IN O
direct JJ O
identification NN O
of IN O
CD4 NNP O
+ NNP O
T NNP O
cell NN O
epitopes NNS O
of IN O
complex JJ O
Ags NNP B-Gene
that WDT O
uses VBZ O
human JJ B-Gene
class NN I-Gene
II NNP I-Gene
tetramers NNS I-Gene
to TO O
identify VB O
reactive JJ O
cells NNS O
. . O

With IN O
a DT O
panel NN O
of IN O
60 CD O
overlapping VBG O
peptides NNS O
covering VBG O
the DT O
entire JJ O
sequence NN O
of IN O
the DT O
VP16 NNP B-Gene
protein NN I-Gene
, , O
a DT O
major JJ O
Ag NNP B-Gene
for IN O
HSV NNP O
- : O
2 CD O
, , O
we PRP O
generated VBD O
a DT O
panel NN O
of IN O
class NN B-Gene
II NNP I-Gene
MHC NNP I-Gene
tetramers NNS I-Gene
loaded VBD O
with IN O
peptide NN O
pools NNS O
that WDT O
were VBD O
used VBN O
to TO O
stain VB O
peripheral JJ O
lymphocytes NNS O
of IN O
an DT O
HSV NNP O
- : O
2 CD O
infected JJ O
individual NN O
. . O

With IN O
this DT O
approach NN O
, , O
we PRP O
identified VBD O
four CD O
new JJ O
DRA1 NNP O
* NN O
101 CD O
/ NNP O
DRB1 NNP O
* NN O
401 CD O
- : O
and CC O
two CD O
DRA1 NNP O
* NN O
101 CD O
/ NNP O
DRB1 NNP O
* NN O
404 CD O
- : O
restricted VBN O
, , O
VP16 NNP B-Gene
- : I-Gene
specific JJ I-Gene
epitopes NNS I-Gene
. . O

By IN O
using VBG O
tetramers NNS B-Gene
to TO O
sort VB O
individual JJ O
cells NNS O
, , O
we PRP O
easily RB O
obtained VBD O
a DT O
large JJ O
number NN O
of IN O
clones NNS O
specific JJ O
to TO O
these DT O
epitopes NNS B-Gene
. . O

Although IN O
DRA1 NNP O
* NNP O
101 CD O
/ NNP O
DRB1 NNP O
* NNP O
401 CD O
and CC O
DRA1 NNP O
* NNP O
101 CD O
/ NNP O
DRB1 NNP O
* NN O
404 CD O
are VBP O
structurally RB O
very RB O
similar JJ O
, , O
nonoverlapping JJ O
VP16 NNP B-Gene
epitopes NNS I-Gene
were VBD O
identified VBN O
, , O
illustrating VBG O
high JJ O
selectivity NN O
of IN O
individual JJ O
allele NN O
polymorphisms NN O
within IN O
common JJ O
MHC NNP O
variants NNS O
. . O

This DT O
rapid JJ O
approach NN O
to TO O
detecting VBG O
CD4 NNP O
+ NNP O
T NNP O
cell NN O
epitopes NNS O
from IN O
complex JJ O
Ags NNP B-Gene
can MD O
be VB O
applied VBN O
to TO O
any DT O
known VBN O
Ag NNP B-Gene
that WDT O
gives VBZ O
a DT O
T NNP O
cell NN O
response NN O
. . O

Localized VBN O
pancreatic JJ O
NF NNP O
- : O
kappaB NN O
activation NN O
and CC O
inflammatory JJ O
response NN O
in IN O
taurocholate JJ O
- : O
induced JJ O
pancreatitis NN O
. . O

Transcription NNP B-Gene
factor NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
is VBZ O
activated VBN O
in IN O
cerulein NN O
pancreatitis NN O
and CC O
mediates NNS O
cytokine VBP O
expression NN O
. . O

The DT O
role NN O
of IN O
transcription NN O
factor NN O
activation NN O
in IN O
other JJ O
models NNS O
of IN O
pancreatitis NN O
has VBZ O
not RB O
been VBN O
established VBN O
. . O

Here RB O
we PRP O
report VBP O
upregulation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
inflammatory JJ B-Gene
molecules NNS I-Gene
, , O
and CC O
their PRP$ O
correlation NN O
with IN O
local JJ O
pancreatic JJ O
injury NN O
, , O
in IN O
a DT O
model NN O
of IN O
severe JJ O
pancreatitis NN O
. . O

Rats NNS O
received VBD O
intraductal JJ O
infusion NN O
of IN O
taurocholate NN O
or CC O
saline NN O
, , O
and CC O
the DT O
pancreatic JJ O
head NN O
and CC O
tail NN O
were VBD O
analyzed VBN O
separately RB O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
activator NN B-Gene
protein VBP I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
activation NN O
were VBD O
assessed VBN O
by IN O
gel NN O
shift NN O
assay NN O
, , O
and CC O
mRNA JJ O
expression NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
, , O
KC NNP O
, , O
monocyte NN B-Gene
chemoattractant NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
inducible JJ B-Gene
nitric JJ I-Gene
oxide IN I-Gene
synthase NN I-Gene
was VBD O
assessed VBN O
by IN O
semiquantitative JJ O
RT NNP O
- : O
PCR NN O
. . O

Morphological JJ O
damage NN O
and CC O
trypsin NN O
activation NN O
were VBD O
much RB O
greater JJR O
in IN O
the DT O
pancreatic JJ O
head NN O
than IN O
tail NN O
, , O
in IN O
parallel NN O
with IN O
a DT O
stronger JJR O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC I-Gene
cytokine NN I-Gene
mRNA NN I-Gene
. . O

Saline NNP O
infusion NN O
mildly RB O
affected VBD O
these DT O
parameters NNS O
. . O

AP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
strongly RB O
activated VBN O
in IN O
both DT O
pancreatic JJ O
segments NNS O
after IN O
either DT O
taurocholate NN O
or CC O
saline JJ O
infusion NN O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
inhibition NN O
with IN O
N NNP O
- : O
acetylcysteine NN O
ameliorated VBD O
the DT O
local JJ O
inflammatory NN O
response NN O
. . O

Correlation NN O
between IN O
localized VBN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
, , O
cytokine JJ O
upregulation NN O
, , O
and CC O
tissue NN O
damage NN O
suggests VBZ O
a DT O
key JJ O
role NN O
for IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
the DT O
development NN O
of IN O
the DT O
inflammatory JJ O
response NN O
of IN O
acute JJ O
pancreatitis NN O
. . O

CD45 NNP B-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
controls VBZ O
common JJ O
gamma NN B-Gene
- : I-Gene
chain NN I-Gene
cytokine JJ I-Gene
- : O
mediated VBN O
STAT NNP B-Gene
and CC O
extracellular JJ O
signal NN O
- : O
related JJ O
kinase NN O
phosphorylation NN O
in IN O
activated JJ O
human JJ O
lymphoblasts NNS O
: : O
inhibition NN O
of IN O
proliferation NN O
without IN O
induction NN O
of IN O
apoptosis NN O
. . O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
test VB O
whether IN O
CD45 NNP O
signals NNS O
can MD O
influence VB O
signaling VBG O
processes NNS O
in IN O
activated JJ O
human JJ O
lymphoblasts NNS O
. . O

To TO O
this DT O
end NN O
, , O
we PRP O
generated VBD O
lymphoblasts NNS O
which WDT O
proliferate VBP O
in IN O
response NN O
to TO O
common JJ O
gamma NN B-Gene
- : I-Gene
chain NN I-Gene
cytokines NNS I-Gene
, , O
but CC O
readily RB O
undergo JJ O
apoptosis NN O
after IN O
cytokine NN O
withdrawal NN O
. . O

In IN O
experiments NNS O
with IN O
the DT O
CD45R0 NNP B-Gene
mAb NN I-Gene
UCHL NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
not RB O
control VB B-Gene
CD45 NNP I-Gene
mAbs NN I-Gene
, , O
we PRP O
found VBD O
significant JJ O
inhibition NN O
of IN O
proliferation NN O
. . O

Interestingly RB O
, , O
the DT O
pan NN B-Gene
- : I-Gene
CD45 NNP I-Gene
mAb NN I-Gene
GAP8 NNP I-Gene
. . I-Gene
3 CD I-Gene
, , O
which WDT O
is VBZ O
most RBS O
effective JJ O
in IN O
inhibition NN O
of IN O
OKT NNP O
- : O
3 CD O
- : O
mediated VBN O
proliferation NN O
in IN O
quiescent NN O
lymphocytes NNS O
, , O
was VBD O
ineffective JJ O
in IN O
lymphoblasts NNS O
. . O

Addition NN O
of IN O
CD3 NNP B-Gene
mAb FW I-Gene
OKT NNP I-Gene
- : I-Gene
3 CD I-Gene
had VBD O
no DT O
influence NN O
on IN O
IL NNP O
- : O
2 CD O
- : O
mediated VBN O
proliferation NN O
( ( O
with IN O
or CC O
without IN O
UCHL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

In IN O
contrast NN O
, , O
after IN O
addition NN O
of IN O
OKT NNP B-Gene
- : I-Gene
3 CD I-Gene
to TO O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
and CC O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
- : O
stimulated VBN O
proliferation NN O
assays NNS O
, , O
UCHL NNP B-Gene
- : I-Gene
1 CD I-Gene
signals NNS O
could MD O
not RB O
significantly RB O
alter VB O
cellular JJ O
proliferation NN O
. . O

We PRP O
did VBD O
not RB O
find VB O
induction NN O
of IN O
apoptosis NN O
following VBG O
CD45R0 NNP O
signaling VBG O
. . O

In IN O
Western JJ O
blots NNS O
using VBG O
mAbs NN B-Gene
detecting VBG O
phosphorylated VBN B-Gene
STAT NNP I-Gene
- : I-Gene
3 CD I-Gene
, , I-Gene
STAT NNP I-Gene
- : I-Gene
5 CD I-Gene
, , I-Gene
STAT NNP I-Gene
- : I-Gene
6 CD I-Gene
, , O
or CC O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
related JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
/ NN I-Gene
2 CD I-Gene
, , O
we PRP O
found VBD O
that IN O
CD45R0 NNP O
signaling VBG O
could MD O
effectively RB O
diminish VB O
phosphorylation NN O
of IN O
these DT O
intracellular JJ O
signaling NN O
components NNS O
. . O

Using VBG O
RT NNP O
- : O
PCR NN O
, , O
we PRP O
found VBD O
that IN O
CD45R0 NNP O
signaling VBG O
inhibited VBN O
IL NNP O
- : O
2 CD O
mRNA NN O
production NN O
without IN O
major JJ O
influence NN O
on IN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
, , O
or CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
mRNA NN I-Gene
levels NNS O
. . O

Costimulation NN O
with IN O
OKT NNP B-Gene
- : I-Gene
3 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
optimally RB O
induced JJ O
secretion NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
, , O
which WDT O
was VBD O
not RB O
decreased VBN O
by IN O
CD45 NNP O
signals NNS O
. . O

In IN O
conclusion NN O
, , O
we PRP O
illustrate VBP O
that IN O
CD45R0 NNP O
signals NNS O
control VBP O
early JJ O
cytokine NN O
receptor NN O
- : O
associated VBN O
signaling JJ O
processes NNS O
and CC O
mRNA NN O
and CC O
DNA NNP O
synthesis NN O
in IN O
activated JJ O
human JJ O
lymphoblasts NNS O
. . O

Furthermore RB O
, , O
we PRP O
show VBP O
the DT O
existence NN O
of IN O
CD45 NNP B-Gene
epitopes NNS I-Gene
( ( O
GAP8 NNP B-Gene
. . I-Gene
3 CD I-Gene
) ) O
, , O
which WDT O
are VBP O
active JJ O
and CC O
critical JJ O
for IN O
signaling VBG O
in IN O
quiescent NN O
lymphocytes NNS O
, , O
but CC O
are VBP O
nonfunctional JJ O
in IN O
activated JJ O
human JJ O
lymphoblasts NNS O
. . O

Pax5 NNP B-Gene
determines VBZ O
the DT O
identity NN O
of IN O
B NNP O
cells NNS O
from IN O
the DT O
beginning NN O
to TO O
the DT O
end NN O
of IN O
B NNP O
- : O
lymphopoiesis NN O
. . O

Despite IN O
being VBG O
one CD O
of IN O
the DT O
most RBS O
intensively RB O
studied VBN O
cell NN O
types NNS O
, , O
the DT O
molecular JJ O
basis NN O
of IN O
B NNP O
cell NN O
specification NN O
is VBZ O
largely RB O
unknown JJ O
. . O

The DT O
Pax5 NNP B-Gene
gene NN I-Gene
encoding VBG O
the DT O
transcription NN B-Gene
factor NN I-Gene
BSAP NNP I-Gene
is VBZ O
required VBN O
for IN O
progression NN O
of IN O
B NNP O
- : O
lymphopoiesis NN O
beyond IN O
the DT O
pro JJ O
- : O
B NN O
cell NN O
stage NN O
. . O

Pax5 NNP O
- : O
deficient NN O
pro JJ O
- : O
B NN O
cells NNS O
are VBP O
, , O
however RB O
, , O
not RB O
yet RB O
committed VBN O
to TO O
the DT O
B NNP O
- : O
lymphoid NN O
lineage NN O
, , O
but CC O
instead RB O
have VBP O
a DT O
broad JJ O
lymphomyeloid NN O
developmental JJ O
potential NN O
. . O

Pax5 NNP B-Gene
appears VBZ O
to TO O
mediate VB O
B NNP O
- : O
lineage NN O
commitment NN O
by IN O
repressing VBG O
the DT O
transcription NN O
of IN O
non JJ B-Gene
- : I-Gene
B NNP I-Gene
- : I-Gene
lymphoid NN I-Gene
genes NNS I-Gene
and CC O
by IN O
simultaneously RB O
activating VBG O
the DT O
expression NN O
of IN O
B NNP B-Gene
- : I-Gene
lineage NN I-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
. . O

Pax5 NNP B-Gene
thus RB O
functions VBZ O
both CC O
as IN O
a DT O
transcriptional JJ O
repressor NN O
and CC O
activator NN O
, , O
depending VBG O
on IN O
its PRP$ O
interactions NNS O
with IN O
corepressors NNS B-Gene
of IN O
the DT O
Groucho NNP B-Gene
protein VBP I-Gene
family NN I-Gene
or CC O
with IN O
positive JJ O
regulators NNS O
such JJ O
as IN O
the DT O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

Once RB O
committed VBN O
to TO O
the DT O
B NNP O
- : O
lineage NN O
, , O
B NNP O
cells NNS O
require VBP O
Pax5 NNP B-Gene
function NN O
to TO O
maintain VB O
their PRP$ O
B NNP O
- : O
lymphoid NN O
identity NN O
throughout IN O
B NNP O
cell NN O
development NN O

Partners NNS O
in IN O
transcription NN O
: : O
NFAT NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Combinatorial JJ O
regulation NN O
is VBZ O
a DT O
powerful JJ O
mechanism NN O
that WDT O
enables VBZ O
tight JJ O
control NN O
of IN O
gene NN O
expression NN O
, , O
via IN O
integration NN O
of IN O
multiple JJ O
signaling VBG O
pathways NNS O
that WDT O
induce VBP O
different JJ O
transcription NN B-Gene
factors NNS I-Gene
required VBD O
for IN O
enhanceosome NN O
assembly NN O
. . O

The DT O
four CD O
calcium NN O
- : O
regulated JJ O
transcription NN B-Gene
factors NNS I-Gene
of IN O
the DT O
NFAT NNP B-Gene
family NN I-Gene
act NN O
synergistically RB O
with IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
Fos NNP I-Gene
/ NNP I-Gene
Jun NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
on IN O
composite JJ O
DNA NN O
elements NNS O
which WDT O
contain VBP O
adjacent JJ O
NFAT NNP B-Gene
and CC I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
where WRB O
they PRP O
form VBP O
highly RB O
stable JJ O
ternary JJ O
complexes NNS O
to TO O
regulate VB O
the DT O
expression NN O
of IN O
diverse NN O
inducible JJ O
genes NNS O
. . O

Concomitant JJ O
induction NN O
of IN O
NFAT NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
requires VBZ O
concerted VBN O
activation NN O
of IN O
two CD O
different JJ O
signaling VBG O
pathways NNS O
: : O
calcium NN O
/ NN O
calcineurin NN O
, , O
which WDT O
promotes VBZ O
NFAT NNP O
dephosphorylation NN O
, , O
nuclear JJ O
translocation NN O
and CC O
activation NN O
; : O
and CC O
protein VB B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( I-Gene
PKC NNP I-Gene
) ) I-Gene
/ NN I-Gene
Ras NNP I-Gene
, , O
which WDT O
promotes VBZ O
the DT O
synthesis NN O
, , O
phosphorylation NN O
and CC O
activation NN O
of IN O
members NNS O
of IN O
the DT O
Fos NNP B-Gene
and CC I-Gene
Jun NNP I-Gene
families NNS I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

A DT O
fifth JJ O
member NN O
of IN O
the DT O
NFAT NNP B-Gene
family NN I-Gene
, , O
NFAT5 NNP B-Gene
, , O
controls VBZ O
the DT O
cellular JJ O
response NN O
to TO O
osmotic JJ O
stress NN O
, , O
by IN O
a DT O
mechanism NN O
that WDT O
requires VBZ O
dimer JJR O
formation NN O
and CC O
is VBZ O
independent JJ O
of IN O
calcineurin NN B-Gene
or CC O
of IN O
interaction NN O
with IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Pharmacological JJ O
interference NN O
with IN O
theNFAT NN O
: : O
AP NNP O
- : O
1 CD O
interaction NN O
may MD O
be VB O
useful JJ O
in IN O
selective JJ O
manipulation NN O
of IN O
the DT O
immune JJ O
response NN O
. . O

Balanced NNP O
activation NN O
of IN O
NFAT NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
known VBN O
to TO O
be VB O
required VBN O
for IN O
productive JJ O
immune NN O
responses NNS O
, , O
but CC O
the DT O
role NN O
of IN O
NFAT NNP O
: : O
AP NNP O
- : O
1 CD O
interactions NNS O
in IN O
other JJ O
cell NN O
types NNS O
and CC O
biological JJ O
processes NNS O
remains VBZ O
to TO O
be VB O
understood JJ O
. . O

Cytokine NNP O
production NN O
by IN O
Vgamma NNP O
( ( O
+ NNP O
) ) O
- : O
T SYM O
- : O
cell NN O
subsets NNS O
is VBZ O
an DT O
important JJ O
factor NN O
determining VBG O
CD4 NNP O
( ( O
+ NNP O
) ) O
- : O
Th SYM O
- : O
cell NN O
phenotype NN O
and CC O
susceptibility NN O
of IN O
BALB NNP O
/ NNP O
c NN O
mice NN O
to TO O
coxsackievirus VB O
B3 NNP O
- : O
induced VBD O
myocarditis NN O
. . O

Two CD O
coxsackievirus NN O
B3 NNP O
( ( O
CVB3 NNP O
) ) O
variants NNS O
( ( O
H3 NNP O
and CC O
H310A1 NNP O
) ) O
differ NN O
by IN O
a DT O
single JJ O
amino NN O
acid JJ O
mutation NN O
in IN O
the DT O
VP2 NNP B-Gene
capsid NN I-Gene
protein NN I-Gene
. . O

H3 NNP O
induces NNS O
severe JJ O
myocarditis NN O
in IN O
BALB NNP O
/ NNP O
c NN O
mice NN O
, , O
but CC O
H310A1 NNP O
is VBZ O
amyocarditic JJ O
. . O

Infection NN O
with IN O
H3 NNP O
, , O
but CC O
not RB O
H310A1 NNP O
, , O
preferentially RB O
activates VBZ O
Vgamma4 NNP O
Vdelta4 NNP O
cells NNS O
, , O
which WDT O
are VBP O
strongly RB O
positive JJ O
for IN O
gamma NN B-Gene
interferon NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
, , O
whereas JJ O
Vgamma1 NNP O
Vdelta4 NNP O
cells NNS O
are VBP O
increased VBN O
in IN O
both DT O
H3 NNP O
and CC O
H310A1 NNP O
virus NNP O
- : O
infected JJ O
animals NNS O
. . O

Depletion NN O
of IN O
Vgamma1 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
using VBG O
monoclonal JJ B-Gene
anti NN I-Gene
- : I-Gene
Vgamma1 NNP I-Gene
antibody NN I-Gene
enhanced VBD O
myocarditis NN O
and CC O
CD4 NNP O
( ( O
+ NNP O
) ) O
- : O
, , O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
+ NNP O
) ) O
- : O
cell NN O
responses NNS O
in IN O
both DT O
H3 NNP O
- : O
and CC O
H310A1 NNP O
- : O
infected JJ O
mice NN O
yet RB O
decreased VBN O
the DT O
CD4 NNP O
( ( O
+ NNP O
) ) O
- : O
, , O
IL NNP O
- : O
4 CD O
( ( O
+ NN O
) ) O
- : O
cell NN O
response NN O
. . O

Depleting VBG O
Vgamma4 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
suppressed VBN O
myocarditis NN O
and CC O
reduced JJ O
CD4 NNP O
( ( O
+ NNP O
) ) O
IFN NNP O
- : O
gamma NN O
( ( O
+ NNP O
) ) O
cells NNS O
but CC O
increased VBD O
CD4 NNP O
( ( O
+ NNP O
) ) O
IL NNP O
- : O
4 CD O
( ( O
+ NN O
) ) O
T NNP O
cells NNS O
. . O

The DT O
role NN O
of IN O
cytokine JJ O
production NN O
by IN O
Vgamma1 NNP O
( ( O
+ NNP O
) ) O
and CC O
Vgamma4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
was VBD O
investigated VBN O
by IN O
adoptively RB O
transferring VBG O
these DT O
cells NNS O
isolated VBD O
from IN O
H3 NNP O
- : O
infected VBD O
BALB NNP O
/ NNP O
c VBZ O
Stat4 NNP O
knockout NN O
( ( O
Stat4ko NNP O
) ) O
( ( O
defective JJ O
in IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
expression NN O
) ) O
or CC O
BALB NNP O
/ NNP O
c NN O
Stat6ko NNP O
( ( O
defective JJ O
in IN O
IL NNP O
- : O
4 CD O
expression NN O
) ) O
mice NN O
into IN O
H3 NNP O
virus SYM O
- : O
infected VBN O
wild JJ O
- : O
type NN O
BALB NNP O
/ NNP O
c NN O
recipients NNS O
. . O

Vgamma4 NNP O
and CC O
Vgamma1 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
from IN O
Stat4ko NNP O
mice NNS O
expressed VBD O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
but CC O
no DT O
or CC O
minimal JJ O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
whereas IN O
these DT O
cell NN O
populations NNS O
derived VBN O
from IN O
Stat6ko NNP O
mice NNS O
expressed VBD O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
but CC O
no DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

Stat4ko NNP O
Vgamma1 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
( ( O
IL NNP O
- : O
4 CD O
( ( O
+ NNP O
) ) O
) ) O
suppress NN O
myocarditis NN O
. . O

Stat6ko NNP O
Vgamma1 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
( ( O
IFN NNP O
- : O
gamma NN O
( ( O
+ NNP O
) ) O
) ) O
were VBD O
not RB O
inhibitory JJ O
. . O

Stat6ko NNP O
Vgamma4 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
( ( O
IFN NNP O
- : O
gamma NN O
( ( O
+ NNP O
) ) O
) ) O
significantly RB O
enhanced VBN O
myocarditis NN O
. . O

Stat4ko NNP O
Vgamma4 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
( ( O
IL NNP O
- : O
4 CD O
( ( O
+ NNP O
) ) O
) ) O
neither CC O
inhibited VBN O
nor CC O
enhanced JJ O
disease NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
distinct JJ O
gammadelta NN O
- : O
T NNP O
- : O
cell NN O
subsets NNS O
control VBP O
myocarditis NN O
susceptibility NN O
and CC O
bias VB O
the DT O
CD4 NNP O
( ( O
+ NNP O
) ) O
- : O
Th SYM O
- : O
cell NN O
response NN O
. . O

The DT O
cytokines NNS B-Gene
produced VBN O
by IN O
the DT O
Vgamma NNP O
subpopulation NN O
have VBP O
a DT O
significant JJ O
influence NN O
on IN O
the DT O
CD4 NNP B-Gene
( ( O
+ NNP O
) ) O
- : O
Th SYM O
- : O
cell NN O
phenotype NN O
. . O

Plasmin NNP B-Gene
- : O
induced JJ O
expression NN O
of IN O
cytokines NNS B-Gene
and CC O
tissue NN B-Gene
factor NN I-Gene
in IN O
human JJ O
monocytes NNS O
involves VBZ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
IKKbeta NNP B-Gene
- : O
mediated VBD O
NF NNP O
- : O
kappaB NN O
activation NN O
. . O

It PRP O
was VBD O
previously RB O
shown VBN O
that IN O
plasmin NN B-Gene
activates VBZ O
human JJ O
peripheral JJ O
monocytes NNS O
in IN O
terms NNS O
of IN O
lipid JJ O
mediator NN O
release NN O
and CC O
chemotactic JJ O
migration NN O
. . O

Here RB O
it PRP O
is VBZ O
demonstrated VBN O
that IN O
plasmin NN B-Gene
induces NNS O
proinflammatory JJ B-Gene
cytokine JJ I-Gene
release NN O
and CC O
tissue NN B-Gene
factor NN I-Gene
( ( O
TF NNP B-Gene
) ) O
expression NN O
by IN O
monocytes NNS O
. . O

Plasmin NNP B-Gene
0 CD O
. . O
43 CD O
to TO O
1 CD O
. . O
43 CD O
CTA NNP O
U NNP O
/ NNP O
mL NN O
, , O
but CC O
not RB O
active JJ B-Gene
site NN I-Gene
- : I-Gene
blocked JJ I-Gene
plasmin NN I-Gene
, , O
triggered VBN O
concentration NN O
- : O
dependent JJ O
expression NN O
of IN O
mRNA NN O
for IN O
interleukin JJ B-Gene
- : I-Gene
1alpha CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
) ) O
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
and CC O
TF NNP B-Gene
with IN O
maximum JJ O
responses NNS O
after IN O
4 CD O
hours NNS O
. . O

Plasmin NNP B-Gene
- : O
mediated VBD O
mRNA JJ O
expression NN O
was VBD O
inhibited VBN O
in IN O
a DT O
concentration NN O
- : O
dependent JJ O
manner NN O
by IN O
the DT O
lysine NN O
analogue NN O
trans VBZ O
- : O
4 CD O
- : O
( ( O
aminomethyl NN O
) ) O
cyclohexane NN O
- : O
1 CD O
- : O
carboxylic JJ O
acid NN O
( ( O
t JJ O
- : O
AMCA NN O
) ) O
. . O

Increases NNS O
in IN O
mRNA NN O
levels NNS O
were VBD O
followed VBN O
by IN O
concentration NN O
- : O
and CC O
time NN O
- : O
dependent JJ O
release NN O
of IN O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
by IN O
TF NNP B-Gene
expression NN O
on IN O
monocyte NN O
surfaces NNS O
. . O

Neither DT O
cytokines NNS B-Gene
nor CC O
TF NNP B-Gene
could MD O
be VB O
detected VBN O
when WRB O
monocytes NNS O
were VBD O
preincubated VBN O
with IN O
actinomycin JJ O
D NNP O
or CC O
cycloheximide NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
indicated VBD O
plasmin JJ B-Gene
- : O
induced JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
; : O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
complexes NNS I-Gene
were VBD O
composed VBN O
of IN O
p50 NN B-Gene
, , O
p65 NN B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
as IN O
shown VBN O
by IN O
supershift NN O
experiments NNS O
. . O

Nuclear JJ O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
Rel NNP I-Gene
proteins NNS I-Gene
coincided VBD O
with IN O
IkappaBalpha NNP O
degradation NN O
. . O

At IN O
variance NN O
with IN O
endotoxic JJ O
lipopolysaccharide NN O
, , O
plasmin NN B-Gene
elicited VBD O
the DT O
rapid JJ O
degradation NN O
of IN O
another DT O
cytoplasmic JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
inhibitor NN I-Gene
, , I-Gene
p105 NN I-Gene
. . O

Proteolysis NN O
of IN O
NF NNP O
- : O
kappaB NN O
inhibitors NNS O
was VBD O
apparently RB O
due JJ O
to TO O
transient JJ O
activation NN O
of IN O
IkappaB NNP B-Gene
kinase NNP I-Gene
( ( I-Gene
IKK NNP I-Gene
) ) I-Gene
beta NN I-Gene
that IN O
reached VBD O
maximum JJ O
activity NN O
at IN O
1 CD O
hour NN O
after IN O
plasmin JJ B-Gene
stimulation NN O
. . O

In IN O
addition NN O
, , O
AP NNP O
- : O
1 CD O
binding NN O
was VBD O
increased VBN O
in IN O
plasmin NN B-Gene
- : O
treated VBN O
monocytes NNS O
, , O
with IN O
most JJS O
complexes NNS O
composed VBN O
of IN O
JunD NNP B-Gene
, , O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
and CC O
FosB NNP B-Gene
. . O

These DT O
findings NNS O
further RBR O
substantiate VBP O
the DT O
role NN O
of IN O
plasmin NN B-Gene
as IN O
a DT O
proinflammatory JJ O
activator NN O
of IN O
human JJ O
monocytes NNS O
and CC O
reveal VB O
an DT O
important JJ O
new JJ O
link NN O
between IN O
the DT O
plasminogen NN O
- : O
plasmin NN O
system NN O
and CC O
inflammation NN O
. . O

( ( O
Blood NNP O
. . O
2001 CD O
; : O
97 CD O
: : O
3941 CD O
- : O
3950 CD O
) ) O

STAT3 NNP B-Gene
is VBZ O
constitutively RB O
active JJ O
in IN O
some DT O
patients NNS O
with IN O
Polycythemia NNP O
rubra NN O
vera NN O
. . O

OBJECTIVE NN O
: : O
Polycythemia NNP O
vera NN O
is VBZ O
a DT O
clonal JJ O
stem NN O
cell NN O
disorder NN O
characterized VBN O
by IN O
hyperproliferation NN O
of IN O
the DT O
erythroid NN O
, , O
myeloid NN O
, , O
and CC O
megakaryocytic JJ O
lineages NNS O
. . O

While IN O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
progenitor NN O
cells NNS O
of IN O
P NNP O
. . O
vera NN O
patients NNS O
are VBP O
hypersensitive JJ O
to TO O
several JJ O
growth NN O
factors NNS O
including VBG O
erythropoietin NN B-Gene
, , O
insulin SYM B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
thrombopoietin NN B-Gene
, , O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
, , O
and CC O
granulocyte NN B-Gene
/ NN I-Gene
monocyte NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
, , O
the DT O
molecular JJ O
pathogenesis NN O
of IN O
this DT O
disease NN O
remains VBZ O
unknown JJ O
. . O

Growth NNP O
factor NN O
hypersensitivity NN O
could MD O
be VB O
mediated VBN O
by IN O
changes NNS O
in IN O
signal JJ O
transduction NN O
pathways NNS O
. . O

We PRP O
therefore RB O
investigated VBD O
a DT O
common JJ O
downstream NN O
effector NN O
of IN O
cytokines NNS B-Gene
, , O
the DT O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
STATs NNP B-Gene
) ) O
. . O

A DT O
constitutive JJ O
activation NN O
of IN O
STAT NNP B-Gene
factors NNS I-Gene
could MD O
explain VB O
the DT O
increased JJ O
proliferation NN O
of IN O
P NNP O
. . O
vera NN O
cells NNS O
even RB O
in IN O
the DT O
absence NN O
of IN O
growth NN O
factor NN O
stimulation NN O
. . O

METHODS NN O
: : O
Peripheral JJ O
granulocytes NNS O
from IN O
patients NNS O
with IN O
P NNP O
. . O
vera NN O
and CC O
from IN O
healthy JJ O
volunteers NNS O
were VBD O
assayed VBN O
for IN O
STAT1 NNP B-Gene
, , I-Gene
3 CD I-Gene
, , I-Gene
and CC I-Gene
5 CD I-Gene
DNA NN O
binding NN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

RESULTS NNS O
: : O
Four CD O
of IN O
14 CD O
P NNP O
. . O
vera NN O
patients NNS O
analyzed VBD O
showed JJ O
constitutive JJ O
STAT3 NNP O
DNA NNP O
binding NN O
in IN O
unstimulated JJ O
peripheral JJ O
granulocytes NNS O
, , O
while IN O
none NN O
of IN O
the DT O
17 CD O
healthy JJ O
volunteers NNS O
tested VBD O
did VBD O
. . O

None NN O
of IN O
the DT O
subjects NNS O
showed VBD O
constitutive JJ O
STAT1 NNP B-Gene
or CC O
STAT5 NNP B-Gene
activity NN O
. . O

Western JJ O
blotting NN O
demonstrated VBD O
that IN O
, , O
in IN O
the DT O
three CD O
patients NNS O
, , O
STAT3 NNP B-Gene
is VBZ O
constitutively RB O
phosphorylated VBN O
on IN O
Tyr NNP O
705 CD O
, , O
whereas IN O
it PRP O
is VBZ O
unphosphorylated VBN O
in IN O
the DT O
other JJ O
patients NNS O
and CC O
in IN O
controls NNS O
. . O

Interestingly RB O
, , O
constitutive JJ O
STAT3 NNP B-Gene
activity NN O
did VBD O
not RB O
correlate VB O
with IN O
the DT O
duration NN O
of IN O
disease NN O
or CC O
the DT O
treatment NN O
regimen NNS O
. . O

It PRP O
was VBD O
observed VBN O
in IN O
a DT O
recently RB O
diagnosed VBN O
patient NN O
and CC O
in IN O
two CD O
patients NNS O
treated VBD O
only RB O
with IN O
phlebotomy NN O
. . O

CONCLUSION NN O
: : O
Our PRP$ O
data NNS O
suggest VBP O
that IN O
constitutive JJ O
phosphorylation NN O
and CC O
activation NN O
of IN O
STAT3 NNP B-Gene
is VBZ O
not RB O
a DT O
secondary JJ O
event NN O
induced VBN O
by IN O
mutagenizing VBG O
agents NNS O
or CC O
by IN O
prolonged JJ O
hyperproliferation NN O
of IN O
hematopoietic JJ O
cells NNS O
, , O
but CC O
rather RB O
represents VBZ O
a DT O
primary JJ O
molecular JJ O
aberration NN O
. . O

Constitutively RB B-Gene
active JJ I-Gene
STAT3 NNP I-Gene
may MD O
contribute VB O
to TO O
the DT O
growth NN O
factor NN O
hypersensitivity NN O
of IN O
P NNP O
. . O
vera NN O
cells NNS O
. . O

Identification NN O
of IN O
phosphorylation NN B-Gene
sites NNS I-Gene
for IN O
Bruton NNP B-Gene
' POS I-Gene
s JJ I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
within IN O
the DT O
transcriptional JJ B-Gene
regulator NN I-Gene
BAP NNP I-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
. . O

Bruton NNP B-Gene
' POS I-Gene
s JJ I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( O
Btk NNP B-Gene
) ) O
, , O
a DT O
member NN O
of IN O
the DT O
Tec NNP B-Gene
family NN I-Gene
of IN I-Gene
cytosolic JJ I-Gene
kinases NNS I-Gene
, , O
is VBZ O
essential JJ O
for IN O
B NNP O
cell NN O
development NN O
and CC O
function NN O
. . O

BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
, , O
a DT O
protein NN O
implicated VBN O
in IN O
transcriptional JJ O
regulation NN O
, , O
is VBZ O
associated VBN O
with IN O
Btk NNP B-Gene
in IN O
B NNP O
cells NNS O
and CC O
is VBZ O
transiently RB O
phosphorylated VBN O
on IN O
tyrosine NN O
following VBG O
B NNP O
cell NN O
receptor NN O
engagement NN O
. . O

BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
is VBZ O
a DT O
substrate NN O
for IN O
Btk NNP B-Gene
in IN O
vitro NN O
and CC O
is VBZ O
hyperphosphorylated VBN O
on IN O
tyrosine NN O
upon IN O
coexpression NN O
with IN O
Btk NNP B-Gene
in IN O
mammalian JJ O
cells NNS O
. . O

In IN O
an DT O
effort NN O
to TO O
understand VB O
the DT O
physiologic JJ O
consequences NNS O
of IN O
BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
tyrosine VBP O
phosphorylation NN O
following VBG O
B NNP O
cell NN O
receptor NN O
stimulation NN O
, , O
site NN O
- : O
directed VBN O
mutagenesis NN O
and CC O
phosphopeptide NN O
mapping NN O
were VBD O
used VBN O
to TO O
locate VB O
the DT O
predominant NN O
sites NNS O
of IN O
BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
phosphorylation VBP O
by IN O
Btk NNP B-Gene
in IN O
vitro NN O
. . O

These DT O
residues NNS O
, , O
Tyr248 NNP O
, , O
Tyr357 NNP O
, , O
and CC O
Tyr462 NNP O
, , O
were VBD O
also RB O
found VBN O
to TO O
be VB O
the DT O
major JJ O
sites NNS O
for IN O
Btk NNP B-Gene
- : O
dependent JJ O
phosphorylation NN O
of IN O
BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
in IN O
vivo NN O
. . O

Residues NNP O
Tyr357 NNP O
and CC O
Tyr462 NNP O
are VBP O
contained VBN O
within IN O
the DT O
loop JJ B-Gene
regions NNS I-Gene
of IN O
adjacent JJ O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
- : I-Gene
like IN I-Gene
repeats NNS I-Gene
within IN O
BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
. . O

Mutation NN O
of IN O
either DT O
Tyr248 NNP O
, , O
Tyr357 NNP O
, , O
or CC O
Tyr462 NNP O
to TO O
phenylalanine VB O
reduced VBN O
transcription NN O
from IN O
a DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
promoter NN I-Gene
relative NN O
to TO O
wild VB B-Gene
- : I-Gene
type NN I-Gene
BAP NNP I-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
in IN O
transfected VBN O
COS NNP O
- : O
7 CD O
cells NNS O
, , O
consistent NN O
with IN O
the DT O
interpretation NN O
that IN O
phosphorylation NN O
at IN O
these DT O
sites NNS O
contributes NNS O
to TO O
transcriptional JJ O
activation NN O
. . O

Phosphorylation NN O
of IN O
BAP NNP B-Gene
/ NNP I-Gene
TFII NNP I-Gene
- : I-Gene
I PRP I-Gene
by IN O
Btk NNP B-Gene
may MD O
link VB O
engagement NN O
of IN O
receptors NNS O
such JJ O
as IN O
surface NN O
immunoglobulin NN B-Gene
to TO O
modulation NN O
of IN O
gene NN O
expression NN O
. . O

Expression NN O
of IN O
interferon NN B-Gene
consensus NN I-Gene
sequence NN I-Gene
binding VBG I-Gene
protein JJ I-Gene
induces NNS O
potent JJ O
immunity NN O
against IN O
BCR NNP O
/ NNP O
ABL NNP O
- : O
induced VBD O
leukemia NN O
. . O

Mice NNP O
deficient NN O
in IN O
the DT O
interferon NN B-Gene
consensus NN I-Gene
sequence NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
ICSBP NNP B-Gene
) ) O
develop VB O
a DT O
disease NN O
resembling VBG O
chronic JJ O
myeloid NN O
leukemia NN O
( ( O
CML NNP O
) ) O
, , O
which WDT O
in IN O
humans NNS O
is VBZ O
caused VBN O
by IN O
the DT O
BCR NNP B-Gene
/ NNP I-Gene
ABL NNP I-Gene
oncoprotein NN I-Gene
. . O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
induces VBZ O
ICSBP NNP B-Gene
expression NN O
and CC O
is VBZ O
an DT O
effective JJ O
therapy NN O
for IN O
CML NNP O
. . O

This DT O
study NN O
examined VBD O
whether IN O
enforced JJ O
expression NN O
of IN O
ICSBP NNP B-Gene
might MD O
antagonize VB O
BCR NNP O
/ NNP O
ABL NNP O
- : O
induced JJ O
leukemia NN O
; : O
results NNS O
demonstrated VBD O
that IN O
ICSBP NNP O
- : O
modified VBD O
cells NNS O
generated VBD O
a DT O
protective JJ O
CD8 NNP O
( ( O
+ NNP O
) ) O
cytotoxic NN O
T NNP O
- : O
cell NN O
response NN O
against IN O
BCR NNP O
/ NNP O
ABL NNP O
- : O
transformed VBD O
BaF3 NNP O
cells NNS O
in IN O
a DT O
murine NN O
leukemia NN O
model NN O
. . O

ICSBP NNP B-Gene
expression NN O
represents VBZ O
a DT O
novel JJ O
means NNS O
of IN O
stimulating VBG O
a DT O
host NN O
immune JJ O
response NN O
to TO O
BCR NNP O
/ NNP O
ABL NNP O
( ( O
+ NNP O
) ) O
leukemia NN O
cells NNS O
and CC O
a DT O
potential JJ O
strategy NN O
for IN O
immunotherapy NN O
of IN O
CML NNP O
. . O

( ( O
Blood NNP O
. . O
2001 CD O
; : O
97 CD O
: : O
3491 CD O
- : O
3497 CD O
) ) O

A DT O
transcriptional JJ O
block NN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
at IN O
the DT O
- : B-Gene
150 CD I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
effector NN O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
. . O

Both DT O
CD4 NNP O
+ NN O
and CC O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
that WDT O
produce VBP O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
response NN O
to TO O
Ag NNP O
recognition NN O
have VBP O
been VBN O
isolated VBN O
. . O

However RB O
, , O
most JJS O
effector NN O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
recovered VBD O
after IN O
exposure NN O
to TO O
Ag NNP B-Gene
do VB O
not RB O
produce VB O
sufficient JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
to TO O
sustain VB O
growth NN O
, , O
and CC O
depend VB O
on IN O
CD4 NNP O
+ NNP O
T NNP O
helper NN O
cells NNS O
for IN O
this DT O
obligate JJ O
growth NN O
factor NN O
. . O

IL NNP O
- : O
2 CD O
expression NN O
in IN O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
is VBZ O
primarily RB O
controlled VBN O
at IN O
the DT O
level NN O
of IN O
transcription NN O
, , O
but CC O
mechanisms NNS O
restricting VBG O
IL NNP O
- : O
2 CD O
production NN O
in IN O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
have VBP O
not RB O
been VBN O
elucidated VBN O
. . O

To TO O
evaluate VB O
transcriptional JJ O
regulation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
, , O
we PRP O
stably RB O
transfected VBD O
reporter NN B-Gene
genes NNS I-Gene
into IN O
Ag NNP B-Gene
- : O
specific JJ O
CD8 NNP O
+ NNP O
T NNP O
cell NN O
clones NNS O
. . O

CD28 NNP O
+ NNP O
CD8 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
unable JJ O
to TO O
transcribe VB O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
response NN O
to TO O
antigenic JJ O
stimulation NN O
had VBD O
a DT O
block NN O
in IN O
transactivation NN O
of IN O
the DT O
- : B-Gene
150 CD I-Gene
CD28 NNP I-Gene
response NN I-Gene
element NN I-Gene
( ( I-Gene
CD28RE NNP I-Gene
) ) I-Gene
/ VBP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
, , O
but CC O
did VBD O
transactivate VB O
the DT O
composite JJ O
NFAT NNP B-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
OCT NNP I-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
sites NNS I-Gene
, , O
and CC O
a DT O
consensus NN B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
motif NN I-Gene
. . O

Mutation NN O
of IN O
the DT O
nonconsensus NN B-Gene
- : I-Gene
150 CD I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
to TO O
a DT O
consensus NN B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
, , O
or CC O
insertion NN O
of IN O
a DT O
CD28RE NNP B-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
consensus NN I-Gene
site NN I-Gene
upstream NN O
of IN O
the DT O
native JJ O
- : B-Gene
150 CD I-Gene
CD28RE NNP I-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
restored VBN O
transactivation NN O
of IN O
the DT O
altered JJ O
promoter NN B-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
defect NN O
at IN O
the DT O
- : B-Gene
150 CD I-Gene
site NN I-Gene
may MD O
reflect VB O
the DT O
absence NN O
or CC O
inactivity NN O
of IN O
a DT O
required JJ O
factor NN O
rather RB O
than IN O
repression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

Stem NNP B-Gene
cell NN I-Gene
factor NN I-Gene
and CC O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
induce NN O
stepwise NN O
generation NN O
of IN O
erythroid JJ O
precursor NN O
cells NNS O
from IN O
a DT O
basic JJ O
fibroblast NN B-Gene
growth NN I-Gene
factor NN I-Gene
- : O
dependent JJ O
hematopoietic JJ O
stem NN O
cell NN O
line NN O
, , O
A NNP O
- : O
6 CD O
. . O

A DT O
m JJ O
ultipotent JJ O
immature NN O
myeloid NN O
cell NN O
population NN O
was VBD O
produced VBN O
from IN O
a DT O
basic JJ B-Gene
fibroblast NN I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
bFGF NN B-Gene
) ) O
- : O
dependent JJ O
hematopoietic JJ O
stem NN O
cell NN O
line NN O
, , O
A NNP O
- : O
6 CD O
, , O
when WRB O
cultured VBN O
with IN O
stem NN B-Gene
cell NN I-Gene
factor NN I-Gene
( ( O
SCF NNP B-Gene
) ) O
replacing VBG O
bFGF NN B-Gene
. . O

Those DT O
cells NNS O
were VBD O
positive JJ O
for IN O
stem NN B-Gene
cell NN I-Gene
markers NNS I-Gene
, , O
c SYM B-Gene
- : I-Gene
kit NN I-Gene
and CC O
CD34 NNP B-Gene
, , O
and CC O
a DT O
myeloid NN B-Gene
cell NN I-Gene
marker NN I-Gene
, , I-Gene
F4 NNP I-Gene
/ VBZ I-Gene
80 CD I-Gene
. . O

Some DT O
cell NN O
fractions NNS O
were VBD O
also RB O
positive JJ O
for IN O
Mac NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
a DT I-Gene
macrophage NN I-Gene
marker NN I-Gene
or CC O
Gr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
a DT I-Gene
granulocytic JJ I-Gene
maker NN I-Gene
, , O
but CC O
negative JJ O
for IN O
an DT O
erythroid JJ B-Gene
marker NN I-Gene
TER119 NNP I-Gene
. . O

They PRP O
also RB O
showed VBD O
the DT O
expression NN O
of IN O
mRNA NN O
for IN O
the DT O
myeloid NN B-Gene
- : I-Gene
specific JJ I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
but CC O
did VBD O
not RB O
that IN O
for IN O
the DT O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
GATA NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Among IN O
various JJ O
cytokines NNS B-Gene
, , O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
induced VBN O
erythroid JJ O
precursor NN O
cells NNS O
that WDT O
expressed VBD O
the DT O
erythroid NN B-Gene
- : I-Gene
specific JJ I-Gene
GATA NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
beta SYM B-Gene
- : I-Gene
major JJ I-Gene
globin NN I-Gene
. . O

The DT O
quantitative JJ O
analysis NN O
showed VBD O
that IN O
erythroid NN O
precursor NN O
cells NNS O
were VBD O
newly RB O
produced VBN O
from IN O
the DT O
immature NN O
myeloid NN O
cells NNS O
by IN O
cultivation NN O
with IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

SCF NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
induced JJ O
stepwise NN O
generation NN O
of IN O
erythroid JJ O
precursor NN O
cells NNS O
from IN O
an DT O
A NNP O
- : O
6 CD O
hematopoietic JJ O
stem NN O
cell NN O
line NN O
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Distinct NNP O
BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
EZH2 NNP B-Gene
expression NN O
patterns NNS O
in IN O
thymocytes NNS O
and CC O
mature NN O
T NNP O
cells NNS O
suggest VBP O
a DT O
role NN O
for IN O
Polycomb NNP B-Gene
genes NNS I-Gene
in IN O
human JJ O
T NNP O
cell NN O
differentiation NN O
. . O

BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
EZH2 NNP B-Gene
Polycomb NNP B-Gene
- : I-Gene
group NN I-Gene
( ( I-Gene
PcG NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
belong JJ O
to TO O
two CD O
distinct JJ O
protein NN O
complexes NNS O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
hematopoiesis NN O
. . O

Using VBG O
unique JJ O
PcG NNP O
- : O
specific JJ O
antisera NN O
and CC O
triple JJ O
immunofluorescence NN O
, , O
we PRP O
found VBD O
that IN O
mature NN O
resting VBG O
peripheral JJ O
T NNP O
cells NNS O
expressed VBD O
BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
whereas NNS O
dividing VBG O
blasts NNS O
were VBD O
EZH2 NNP O
( ( O
+ NNP O
) ) O
. . O

By IN O
contrast NN O
, , O
subcapsular JJ O
immature NN O
double JJ O
- : O
negative JJ O
( ( O
DN NNP O
) ) O
( ( O
CD4 NNP O
( ( O
- : O
) ) O
/ FW O
CD8 NNP O
( ( O
- : O
) ) O
) ) O
T NNP O
cells NNS O
in IN O
the DT O
thymus NN O
coexpressed VBD O
BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
EZH2 NNP B-Gene
or CC O
were VBD O
BMI NNP O
- : O
1 CD O
single JJ O
positive JJ O
. . O

Their PRP$ O
descendants NNS O
, , O
double JJ O
- : O
positive JJ O
( ( O
DP NNP O
; : O
CD4 NNP O
( ( O
+ NNP O
) ) O
/ VBP O
CD8 NNP O
( ( O
+ NNP O
) ) O
) ) O
cortical JJ O
thymocytes NNS O
, , O
expressed VBD O
EZH2 NNP B-Gene
without IN O
BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Most JJS O
EZH2 NNP O
( ( O
+ NNP O
) ) O
DN NNP O
and CC O
DP NNP O
thymocytes NNS O
were VBD O
dividing VBG O
, , O
while IN O
DN NNP O
BMI NNP O
- : O
1 CD O
( ( O
+ NN O
) ) O
/ NN O
EZH2 NNP O
( ( O
- : O
) ) O
thymocytes NNS O
were VBD O
resting VBG O
and CC O
proliferation NN O
was VBD O
occasionally RB O
noted VBN O
in IN O
DN NNP O
BMI NNP O
- : O
1 CD O
( ( O
+ NN O
) ) O
/ NN O
EZH2 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
. . O

Maturation NN O
of IN O
DP NNP O
cortical JJ O
thymocytes NNS O
to TO O
single JJ O
- : O
positive JJ O
( ( O
CD4 NNP O
( ( O
+ NNP O
) ) O
/ VBP O
CD8 NNP O
( ( O
- : O
) ) O
or CC O
CD8 NNP O
( ( O
+ NNP O
) ) O
/ VBP O
CD4 NNP O
( ( O
- : O
) ) O
) ) O
medullar NN O
thymocytes NNS O
correlated VBD O
with IN O
decreased JJ O
detectability NN O
of IN O
EZH2 NNP B-Gene
and CC O
continued VBD O
relative JJ O
absence NN O
of IN O
BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Our PRP$ O
data NNS O
show VBP O
that IN O
BMI NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
EZH2 NNP B-Gene
expression NN O
in IN O
mature JJ O
peripheral JJ O
T NNP O
cells NNS O
is VBZ O
mutually RB O
exclusive JJ O
and CC O
linked VBN O
to TO O
proliferation NN O
status NN O
, , O
and CC O
that IN O
this DT O
pattern NN O
is VBZ O
not RB O
yet RB O
established VBN O
in IN O
thymocytes NNS O
of IN O
the DT O
cortex NN O
and CC O
medulla NN O
. . O

T NNP O
cell NN O
stage NN O
- : O
specific JJ O
PcG NNP O
expression NN O
profiles NNS O
suggest VBP O
that IN O
PcG NNP B-Gene
genes NNS I-Gene
contribute VBP O
to TO O
regulation NN O
of IN O
T NNP O
cell NN O
differentiation NN O
. . O

They PRP O
probably RB O
reflect VBP O
stabilization NN O
of IN O
cell NN O
type NN O
- : O
specific JJ O
gene NN O
expression NN O
and CC O
irreversibility NN O
of IN O
lineage NN O
choice NN O
. . O

The DT O
difference NN O
in IN O
PcG NNP O
expression NN O
between IN O
medullar JJ O
thymocytes NNS O
and CC O
mature NN O
interfollicular JJ O
T NNP O
cells NNS O
indicates VBZ O
that IN O
additional JJ O
maturation NN O
processes VBZ O
occur VBP O
after IN O
thymocyte JJ O
transportation NN O
from IN O
the DT O
thymus NN O
. . O

Stepwise NNP O
lineage NN O
restriction NN O
of IN O
progenitors NNS O
in IN O
lympho JJ O
- : O
myelopoiesis NN O
. . O

It PRP O
has VBZ O
long RB O
been VBN O
controversial JJ O
whether IN O
hematopoiesis NN O
progresses VBZ O
through IN O
ordered JJ O
stages NNS O
of IN O
determination NN O
as IN O
in IN O
embryonic JJ O
development NN O
. . O

This DT O
is VBZ O
due JJ O
to TO O
the DT O
absence NN O
of IN O
a DT O
methodology NN O
capable JJ O
of IN O
exactly RB O
determining VBG O
the DT O
developmental JJ O
potential NN O
of IN O
hematopoietic JJ O
stem NN O
/ NNP O
progenitor NN O
cells NNS O
. . O

The DT O
multilineage NN O
progenitor NN O
( ( O
MLP NNP O
) ) O
assay VBP O
enabled VBN O
us PRP O
to TO O
discriminate VB O
among IN O
seven CD O
types NNS O
of IN O
hematopoietic JJ O
progenitors NNS O
, , O
which WDT O
are VBP O
multipotent JJ O
progenitor NN O
p SYM O
- : O
MTB NNP O
( ( O
capable JJ O
of IN O
generating VBG O
myeloid NN O
, , O
T NNP O
and CC O
B NNP O
cells NNS O
) ) O
, , O
bipotent JJ O
progenitors NNS O
p VBP O
- : O
MT NNP O
, , O
p SYM O
- : O
MB NN O
and CC O
p NN O
- : O
TB NN O
, , O
and CC O
unipotent JJ O
progenitors NNS O
p VBP O
- : O
M NNP O
, , O
p SYM O
- : O
T NN O
and CC O
p NN O
- : O
B NN O
. . O

Among IN O
these DT O
seven CD O
types NNS O
, , O
the DT O
p NN O
- : O
TB NN O
type NN O
progenitor NN O
was VBD O
found VBN O
to TO O
be VB O
absent JJ O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
the DT O
process NN O
of IN O
lineage NN O
commitment NN O
proceeds NNS O
through IN O
an DT O
ordered VBN O
but CC O
not RB O
random JJ O
process NN O
. . O

By IN O
extending VBG O
the DT O
area NN O
of IN O
investigation NN O
to TO O
include VB O
the DT O
erythroid JJ O
lineage NN O
, , O
more RBR O
convincing JJ O
evidence NN O
for IN O
the DT O
ordered JJ O
process NN O
was VBD O
obtained VBN O
. . O

Detailed VBN O
and CC O
exact JJ O
illustration NN O
of IN O
the DT O
process NN O
of IN O
hematopoiesis NN O
will MD O
provide VB O
an DT O
opportunity NN O
to TO O
revive VB O
hematopoiesis NN O
as IN O
one CD O
of IN O
the DT O
most RBS O
fascinating JJ O
targets NNS O
of IN O
research NN O
in IN O
developmental JJ O
biology NN O

Epstein NNP O
- : O
Barr NNP O
Virus NNP O
and CC O
its PRP$ O
glycoprotein NN B-Gene
- : I-Gene
350 CD I-Gene
upregulate JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
in IN O
human NN O
B NNP O
- : O
lymphocytes VBZ O
via IN O
CD21 NNP B-Gene
, , O
involving VBG O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
different JJ O
signaling NN O
pathways NNS O
. . O

Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
is VBZ O
a DT O
ubiquitous JJ O
and CC O
highly RB O
immunotropic JJ O
gamma NN O
herpesvirus NN O
that WDT O
infects VBZ O
more JJR O
than IN O
90 CD O
% NN O
of IN O
humans NNS O
worldwide VBP O
. . O

Its PRP$ O
pathogenicity NN O
leads VBZ O
to TO O
a DT O
number NN O
of IN O
diseases NNS O
including VBG O
tumors NNS O
that WDT O
result VBP O
from IN O
EBV NNP O
' POS O
s NN O
ability NN O
to TO O
readily RB O
transform VB O
B NNP O
- : O
lymphocytes NNS O
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
epithelial JJ O
cells NNS O
. . O

EBV NNP O
utilizes VBZ O
CD21 NNP B-Gene
/ NNP I-Gene
CR2 NNP I-Gene
as IN O
its PRP$ O
receptor NN O
on IN O
B NNP O
cells NNS O
to TO O
initiate VB O
the DT O
infection NN O
process NN O
. . O

EBV NNP O
binds VBZ O
to TO O
CR2 NNP B-Gene
through IN O
its PRP$ O
major JJ B-Gene
envelope NN I-Gene
glycoprotein SYM I-Gene
- : I-Gene
350 CD I-Gene
( ( O
gp350 NN B-Gene
) ) O
and CC O
is VBZ O
also RB O
a DT O
remarkable JJ O
immunomodulating NN O
agent NN O
. . O

We PRP O
had VBD O
previously RB O
shown VBN O
that IN O
EBV NNP O
is VBZ O
capable JJ O
of IN O
modulating VBG O
the DT O
synthesis NN O
of IN O
a DT O
number NN O
of IN O
cytokines NNS B-Gene
. . O

We PRP O
now RB O
show VBP O
that IN O
while IN O
both DT O
purified JJ O
recombinant NN B-Gene
gp350 NN I-Gene
( ( O
rgp350 NN B-Gene
) ) O
and CC O
EBV NNP O
upregulate VBP O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA JJ I-Gene
synthesis NN O
in IN O
B NNP O
cells NNS O
, , O
EBV NNP O
- : O
induced VBD O
IL NNP O
- : O
6 CD O
gene NN O
activation NN O
occurs VBZ O
for IN O
a DT O
significantly RB O
longer JJR O
period NN O
of IN O
time NN O
( ( O
i JJ O
. . O
e NN O
. . O
12 CD O
hours NNS O
for IN O
EBV NNP O
as IN O
compared VBN O
to TO O
6 CD O
hours NNS O
for IN O
rgp350 NN B-Gene
) ) O
. . O

Moreover RB O
, , O
the DT O
half NN O
- : O
life NN O
of IN O
EBV NNP O
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
was VBD O
also RB O
significantly RB O
longer JJR O
( ( O
10 CD O
hours NNS O
) ) O
than IN O
that DT O
of IN O
mRNA NN O
induced VBN O
by IN O
rgp350 NN B-Gene
( ( O
about IN O
6 CD O
hours NNS O
) ) O
. . O

Both DT O
EBV NNP O
and CC O
gp350 JJ B-Gene
enhance NN O
the DT O
binding NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
as IN O
determined VBN O
by IN O
band NN O
- : O
shift NN O
and CC O
augment JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
mediated VBN O
activation NN O
of IN O
a DT O
CAT NNP B-Gene
reporter NN I-Gene
plasmid NN I-Gene
. . O

Furthermore RB O
, , O
we PRP O
demonstrate VBP O
that IN O
while IN O
the DT O
activation NN O
of IN O
IL NNP O
- : O
6 CD O
gene NN O
expression NN O
by IN O
gp350 NN B-Gene
is VBZ O
mediated VBN O
primarily RB O
by IN O
the DT O
protein NN O
kinase VBD O
C NNP O
pathway NN O
, , O
EBV NNP O
can MD O
mediate VB O
its PRP$ O
effects NNS O
through IN O
multiple JJ O
signaling NN O
pathways NNS O
. . O

To TO O
our PRP$ O
knowledge NN O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
showing VBG O
that IN O
the DT O
binding NN O
of IN O
a DT O
herpesvirus NN B-Gene
envelope NN I-Gene
glycoprotein NN I-Gene
to TO O
CR2 NNP B-Gene
on IN O
human JJ O
B NNP O
cells NNS O
results NNS O
in IN O
the DT O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN I-Gene
factor NN I-Gene
leading VBG O
to TO O
the DT O
upregulation NN O
of IN O
IL NNP O
- : O
6 CD O
gene NN O
expression NN O
in IN O
these DT O
lymphocytes NNS O
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Gene NNP O
- : O
and CC O
tissue VB O
- : O
specificity NN O
of IN O
mutation NN O
in IN O
Big NNP O
Blue NNP O
rats NNS O
treated VBD O
with IN O
the DT O
hepatocarcinogen NN O
N NNP O
- : O
hydroxy NN O
- : O
2 CD O
- : O
acetylaminofluorene NN O
. . O

In IN O
a DT O
previous JJ O
study NN O
, , O
we PRP O
found VBD O
that IN O
treating VBG O
transgenic JJ O
Big NNP O
Blue NNP O
rats VBZ O
with IN O
the DT O
hepatocarcinogen NN O
N NNP O
- : O
hydroxy NN O
- : O
2 CD O
- : O
acetylaminofluorene NN O
( ( O
N NNP O
- : O
OH NNP O
- : O
AAF NN O
) ) O
produced VBD O
the DT O
same JJ O
major JJ O
DNA NN O
adduct NN O
in IN O
the DT O
target NN O
liver NN O
and CC O
the DT O
nontarget NN O
spleen JJ O
lymphocytes NNS O
and CC O
bone NN O
marrow NN O
cells NNS O
, , O
induced VBD O
lacI JJ O
mutants NNS O
in IN O
the DT O
liver NN O
, , O
and CC O
induced VBD O
much RB O
lower JJR O
frequencies NNS O
of IN O
l NN O
acI NN O
and CC O
hprt NN O
mutants NNS O
in IN O
spleen JJ O
lymphocytes NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
sequence NN O
analysis NN O
was VBD O
conducted VBN O
on IN O
lacI NN B-Gene
DNA NN I-Gene
and CC O
hprt NN B-Gene
cDNA NN I-Gene
from IN O
the DT O
mutants NNS O
, , O
to TO O
determine VB O
the DT O
mutational JJ O
specificity NN O
of IN O
N NNP O
- : O
OH NNP O
- : O
AAF NN O
in IN O
the DT O
rat NN O
. . O

All PDT O
the DT O
mutation NN O
spectra NN O
from IN O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
- : O
treated VBD O
rats NNS O
differed VBN O
significantly RB O
from IN O
corresponding VBG O
mutation NN O
profiles NNS O
from IN O
untreated JJ O
animals NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
2 CD O
to TO O
P NNP O
< NNP O
0 CD O
. . O
1 CD O
) ) O
. . O

Although IN O
there EX O
were VBD O
similarities NNS O
among IN O
the DT O
mutational JJ O
patterns NNS O
derived VBN O
from IN O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
- : O
treated VBD O
rats NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
G NNP O
: : O
C NNP O
- : O
- : O
> NN O
T NN O
: : O
A DT O
transversion NN O
was VBD O
the DT O
most RBS O
common JJ O
mutation NN O
in IN O
all DT O
mutation NN O
sets NNS O
) ) O
, , O
there EX O
were VBD O
significant JJ O
differences NNS O
in IN O
the DT O
patterns NNS O
of IN O
basepair NN O
substitution NN O
and CC O
frameshift VB O
mutation NN O
between IN O
the DT O
liver NN O
and CC O
spleen JJ O
lymphocyte NN O
lacI NN O
mutants NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
2 CD O
) ) O
and CC O
between IN O
the DT O
spleen JJ O
lymphocyte NN O
lacI NN O
and CC O
hprt NN O
mutants NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
4 CD O
) ) O
. . O

Also RB O
, , O
multiplex JJ O
PCR NNP O
analysis NN O
of IN O
genomic JJ B-Gene
DNA NN I-Gene
from IN O
the DT O
hprt NN O
mutants NNS O
indicated VBD O
that IN O
12 CD O
% NN O
of IN O
mutants NNS O
from IN O
treated VBN O
rats NNS O
had VBD O
major JJ O
deletions NNS O
in IN O
the DT O
hprt JJ B-Gene
gene NN I-Gene
; : O
no DT O
corresponding JJ O
incidence NN O
of IN O
large JJ O
deletions NNS O
was VBD O
evident JJ O
among IN O
lacI JJ O
mutations NNS O
. . O

All PDT O
the DT O
mutation NN O
profiles NNS O
reflect VBP O
the DT O
general JJ O
mutational JJ O
specificity NN O
of IN O
the DT O
major JJ O
DNA NNP O
adduct NN O
formed VBN O
by IN O
N NNP O
- : O
OH NNP O
- : O
AAF NN O
. . O

The DT O
differences NNS O
between IN O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
mutation NN O
in IN O
the DT O
endogenous JJ B-Gene
gene NN I-Gene
and CC O
transgene NN B-Gene
can MD O
be VB O
partially RB O
explained VBN O
by IN O
the DT O
structures NNS O
of IN O
the DT O
two CD O
genes NNS O
. . O

The DT O
tissue NN O
- : O
specificity NN O
of IN O
the DT O
mutation NN O
spectra NN O
may MD O
contribute VB O
to TO O
targeting VBG O
tumor NN O
formation NN O
to TO O
the DT O
liver NN O
. . O

Environ NNP O
. . O
Mol NNP O
. . O
Mutagen NNP O
. . O
37 CD O
: : O
203 CD O
- : O
214 CD O
, , O
2001 CD O
. . O

Published VBN O
2001 CD O
Wiley NNP O
- : O
Liss NNP O
, , O
Inc NNP O
. . O

Caspase NNP B-Gene
- : O
dependent JJ O
cleavage NN O
of IN O
the DT O
hematopoietic JJ B-Gene
specific JJ I-Gene
adaptor NN I-Gene
protein NN I-Gene
Gads NNP I-Gene
alters NNS O
signalling VBG O
from IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
. . O

Gads NNP B-Gene
is VBZ O
a DT O
SH2 NNP B-Gene
and CC I-Gene
SH3 NNP I-Gene
domain VBP I-Gene
- : O
containing NN O
, , O
hematopoietic JJ B-Gene
- : I-Gene
specific JJ I-Gene
adaptor NN I-Gene
protein NN I-Gene
that WDT O
functions NNS O
in IN O
signalling VBG O
from IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
. . O

Gads NNS B-Gene
acts NNS O
by IN O
linking VBG O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
, , O
bound VBN O
by IN O
the DT O
carboxy JJ B-Gene
- : I-Gene
terminal JJ I-Gene
Gads NNP I-Gene
SH3 NNP I-Gene
domain NN I-Gene
, , O
to TO O
tyrosine VB B-Gene
phosphorylated VBN I-Gene
LAT NNP I-Gene
which WDT O
contains VBZ O
binding VBG O
sites NNS O
for IN O
the DT O
Gads NNP B-Gene
SH2 NNP I-Gene
domain NN I-Gene
. . O

Gads NNP B-Gene
is VBZ O
distinguished VBN O
from IN O
Grb2 NNP B-Gene
and CC O
the DT O
closely RB O
related JJ O
Grap NNP B-Gene
protein NN I-Gene
by IN O
the DT O
presence NN O
of IN O
a DT O
120 CD B-Gene
amino NN I-Gene
acid NN I-Gene
unique JJ I-Gene
region NN I-Gene
between IN O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
and CC O
the DT O
carboxy JJ B-Gene
terminal NN I-Gene
SH3 NNP I-Gene
domain NN I-Gene
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
unique JJ O
region NN O
of IN O
Gads NNP B-Gene
contains VBZ O
a DT O
capase NN B-Gene
cleavage NN I-Gene
site NN I-Gene
. . O

Induction NN O
of IN O
apoptosis NN O
in IN O
lymphocytes NNS O
results NNS O
in IN O
detectable JJ O
Gads NNP B-Gene
cleavage NN O
by IN O
60 CD O
min NNS O
. . O

Gads NNP B-Gene
cleavage NN O
is VBZ O
blocked VBN O
in IN O
vivo NN O
by IN O
treating VBG O
cells NNS O
with IN O
a DT O
caspase NN O
3 CD O
inhibitor NN O
. . O

A DT O
putative JJ B-Gene
caspase NN I-Gene
3 CD I-Gene
cleavage NN I-Gene
site NN I-Gene
was VBD O
identified VBN O
within IN O
the DT O
unique JJ O
region NN O
and CC O
mutation NN O
of IN O
this DT O
site NN O
prevented VBD O
Gads NNP B-Gene
cleavage NN O
in IN O
vitro NN O
, , O
and CC O
in IN O
vivo NN O
. . O

The DT O
Gads NNP B-Gene
cleavage NN O
products NNS O
retained VBD O
the DT O
predicted JJ O
binding NN O
specificity NN O
for IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
and CC O
LAT NNP B-Gene
. . O

Expression NN O
of IN O
the DT O
Gads NNP B-Gene
cleavage NN O
products NNS O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
inhibited VBD O
NFAT NNP O
activation NN O
following VBG O
TCR NNP O
cross NN O
linking NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
cleavage NN O
of IN O
Gads NNP B-Gene
in IN O
vivo NN O
could MD O
function VB O
to TO O
alter VB O
signalling VBG O
downstream NN O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
by IN O
disrupting VBG O
cross NN O
talk NN O
between IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
and CC O
LAT NNP B-Gene
. . O

Targeting VBG O
of IN O
p300 NN B-Gene
to TO O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
via IN O
CREB NNP O
- : O
Rel NNP O
cross SYM O
- : O
talk NN O
during IN O
mitogen NN B-Gene
and CC O
oncogenic JJ O
molecular JJ O
signaling NN O
in IN O
activated JJ O
T NNP O
- : O
cells NNS O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
explore VBP O
the DT O
mechanisms NN O
of IN O
targeting VBG O
of IN O
p300 NN B-Gene
to TO O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
promoter NN I-Gene
in IN O
response NN O
to TO O
mitogenic VB O
and CC O
oncogenic JJ O
molecular JJ O
signals NNS O
. . O

Recruitment NN O
of IN O
p300 NN B-Gene
by IN O
cAMP JJ B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
- : I-Gene
Rel NNP I-Gene
cross SYM O
- : O
talk NN O
at IN O
the DT O
composite JJ B-Gene
CD28 NNP I-Gene
response NN I-Gene
element NN I-Gene
( ( O
CD28RE NNP B-Gene
) ) O
- : O
TRE NNP B-Gene
element NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
is VBZ O
essential JJ O
for IN O
promoter NN O
inducibility NN O
during IN O
T NNP O
- : O
cell NN O
activation NN O
, , O
and CC O
CD28RE NNP B-Gene
- : I-Gene
TRE NN I-Gene
is VBZ O
the DT O
exclusive JJ O
target NN O
of IN O
the DT O
human JJ O
T NNP O
- : O
cell NN O
lymphotropic VBZ O
virus IN O
type NN O
I PRP O
oncoprotein VBP B-Gene
Tax NNP I-Gene
. . O

The DT O
intrinsic JJ O
histone NN O
acetyltransferase NN O
activity NN O
of IN O
p300 NN B-Gene
is VBZ O
dispensable JJ O
for IN O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
, , O
and CC O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
743 CD I-Gene
residues NNS I-Gene
contain VBP O
the DT O
minimal JJ O
structural JJ O
requirements NNS O
for IN O
synergistic JJ O
transactivation NN O
of IN O
the DT O
CD28RE NNP B-Gene
- : I-Gene
TRE NN I-Gene
, , O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
, , O
and CC O
endogenous JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
expression NN O
. . O

Mutational JJ O
analysis NN O
of IN O
p300 NN B-Gene
reveals NNS O
differential JJ O
structural JJ O
requirements NNS O
for IN O
the DT O
N NNP O
- : O
terminal JJ O
p300 NN O
module NN O
by IN O
individual JJ O
cis NN B-Gene
- : I-Gene
elements NNS I-Gene
within IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

These DT O
findings NNS O
provide VBP O
evidence NN O
that IN O
p300 NN B-Gene
assembles NNS O
at IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
to TO O
form VB O
an DT O
enhanceosome JJ O
- : O
like IN O
signal JJ O
transduction NN O
target NN O
that WDT O
is VBZ O
centrally RB O
integrated VBN O
at IN O
the DT O
CD28RE NNP B-Gene
- : I-Gene
TRE NNP I-Gene
element NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
through IN O
specific JJ O
protein NN O
module NN O
- : O
targeted JJ O
associations NNS O
in IN O
activated JJ O
T NNP O
- : O
cells NNS O
. . O

Regulation NN O
of IN O
cytokine NN O
production NN O
in IN O
T NNP O
- : O
cell NN O
responses NNS O
to TO O
inhalant VB O
allergen NN O
: : O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
distinguishes NNS O
between IN O
Th1 NNP O
- : O
and CC O
Th2 NNP O
- : O
polarized VBN O
immunity NN O
. . O

BACKGROUND NN O
: : O
The DT O
precise JJ O
nature NN O
of IN O
allergen NN O
- : O
specific JJ O
cytokine NN O
responses NNS O
in IN O
atopics NNS O
versus VBP O
non JJ O
- : O
atopics NNS O
, , O
in IN O
particular JJ O
the DT O
' POS O
Th1 NNP O
polarity NN O
' '' O
of IN O
responses NNS O
in IN O
non JJ O
- : O
atopics NNS O
, , O
remains VBZ O
controversial JJ O
. . O

This DT O
is VBZ O
due JJ O
in IN O
part NN O
to TO O
the DT O
relative JJ O
insensitivity NN O
of IN O
cytokine JJ O
detection NN O
systems NNS O
, , O
and CC O
associated JJ O
variations NNS O
in IN O
kinetics NNS O
of IN O
cytokine NN O
production NN O
and CC O
catabolism NN O
in IN O
in IN O
vitro JJ O
culture NN O
systems NNS O
. . O

As IN O
an DT O
alternative NN O
to TO O
cytokine VB O
measurement NN O
, , O
this DT O
study NN O
focuses VBZ O
on IN O
expression NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
for IN O
analysis NN O
of IN O
allergen NN O
- : O
specific JJ O
Th NNP O
cell NN O
responses NNS O
. . O

METHODS NN O
: : O
Cord NNP O
blood NN O
mononuclear NN O
cells NNS O
were VBD O
Th1 NNP O
- : O
or CC O
Th2 NNP O
- : O
polarized VBN O
by IN O
culture NN O
in IN O
IL NNP O
- : O
12 CD O
- : O
or CC O
IL NNP O
- : O
4 CD O
- : O
employing VBG O
established VBN O
methods NNS O
; : O
PBMC NNP O
from IN O
house NN O
dust NN O
mite NN O
( ( O
HDM NNP O
) ) O
- : O
sensitive JJ O
atopics NNS O
and CC O
controls NNS O
were VBD O
stimulated VBN O
overnight JJ O
with IN O
HDM NNP O
; : O
cytokine JJ O
production NN O
was VBD O
measured VBN O
by IN O
ELISA NNP O
and CC O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
mRNA JJ I-Gene
expression NN O
by IN O
PCR NNP O
. . O

RESULTS NN O
: : O
Cytokine NNP B-Gene
- : O
driven NN O
Th2 NNP O
polarization NN O
of IN O
naive JJ O
T NNP O
cells NNS O
is VBZ O
associated VBN O
with IN O
marked JJ O
upregulation NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
, , O
whereas IN O
a DT O
reciprocal JJ O
expression NN O
pattern NN O
accompanies VBZ O
differentiation NN O
towards IN O
the DT O
Th1 NNP O
cytokine NN O
phenotype NN O
. . O

In IN O
T NNP O
cells NNS O
from IN O
HDM NNP O
skin FW O
prick NN O
test NN O
- : O
positive JJ O
( ( O
HDM NNP O
- : O
SPT NNP O
+ NNP O
/ NNP O
HDM NNP O
- : O
IgE NNP O
+ NNP O
) ) O
volunteers NNS O
, , O
overnight JJ O
stimulation NN O
results NNS O
in IN O
marked JJ O
upregulation NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
, , O
compared VBN O
to TO O
an DT O
equally RB O
marked JJ O
downregulation NN O
of IN O
expression NN O
in IN O
T NNP O
cells NNS O
from IN O
SPT NNP O
- : O
/ NN O
IgE NNP O
- : O
subjects NNS O
. . O

In IN O
subjects NNS O
who WP O
are VBP O
HDM NNP O
- : O
SPT NNP O
+ NNP O
but CC O
IgE NNP O
- : O
, , O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
levels NNS O
remained VBD O
relatively RB O
stable JJ O
during IN O
culture NN O
with IN O
HDM NNP O
. . O

CONCLUSIONS NN O
: : O
Upregulation NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
in IN O
PBMC NNP O
is VBZ O
a DT O
hallmark NN O
of IN O
the DT O
early JJ O
phase NN O
of IN O
Th2 NNP O
recall NN O
responses NNS O
to TO O
specific JJ O
allergen NN O
in IN O
atopics NNS O
. . O

The DT O
reciprocal JJ O
expression NN O
pattern NN O
observed VBN O
in IN O
HDM NNP O
- : O
specific JJ O
recall JJ O
responses NNS O
of IN O
non JJ O
- : O
atopics NNS O
provides VBZ O
independent JJ O
confirmation NN O
of IN O
the DT O
presence NN O
of IN O
underlying VBG O
Th1 NNP O
- : O
like IN O
immunity NN O
in IN O
these DT O
subjects NNS O
. . O

The DT O
parallel JJ O
findings NNS O
in IN O
neonatal JJ O
T NNP O
cells NNS O
suggest VBP O
that IN O
the DT O
same JJ O
approach NN O
may MD O
be VB O
utilized VBN O
for IN O
monitoring VBG O
the DT O
progress NN O
of IN O
allergen NN O
- : O
specific JJ O
Th1 NNP O
/ NNP O
Th2 NNP O
memory NN O
development NN O
during IN O
early JJ O
childhood NN O
, , O
and CC O
hence RB O
in IN O
assessment NN O
of IN O
risk NN O
for IN O
future JJ O
allergic JJ O
disease NN O
. . O

Copyright JJ O
2001 CD O
S NNP O
. . O
Karger NNP O
AG NNP O
, , O
Basel NNP O

The DT O
heat NN O
shock NN O
response NN O
reduces VBZ O
myelin JJ B-Gene
oligodendrocyte NN I-Gene
glycoprotein NN I-Gene
- : O
induced JJ O
experimental JJ O
autoimmune NN O
encephalomyelitis NN O
in IN O
mice NN O
. . O

The DT O
stress NN O
response NN O
( ( O
SR NNP O
) ) O
can MD O
block VB O
inflammatory JJ O
gene NN O
expression NN O
by IN O
preventing VBG O
activation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
. . O

As IN O
inflammatory JJ O
gene NN O
expression NN O
contributes VBZ O
to TO O
the DT O
pathogenesis NN O
of IN O
demyelinating VBG O
diseases NNS O
, , O
we PRP O
tested VBD O
the DT O
effects NNS O
of IN O
the DT O
SR NNP O
on IN O
the DT O
progression NN O
of IN O
the DT O
demyelinating VBG O
disease NN O
experimental JJ O
autoimmune NN O
encephalomyelitis NN O
( ( O
EAE NNP O
) ) O
. . O

EAE NNP O
was VBD O
actively RB O
induced VBN O
in IN O
C57BL NNP O
/ NNP O
6 CD O
mice NN O
using VBG O
an DT O
encephalitogenic JJ O
myelin NN B-Gene
oligodendrocyte NN I-Gene
glycoprotein NN I-Gene
( ( O
MOG NNP B-Gene
( ( I-Gene
35 CD I-Gene
- : I-Gene
55 CD I-Gene
) ) I-Gene
) ) O
peptide NN O
. . O

Whole JJ O
body NN O
hyperthermia NN O
was VBD O
used VBN O
to TO O
induce VB O
a DT O
heat NN O
shock NN O
response NN O
( ( O
HSR NNP O
) ) O
in IN O
immunized JJ O
mice NN O
2 CD O
days NNS O
after IN O
the DT O
booster NN O
MOG NNP O
( ( O
35 CD O
- : O
55 CD O
) ) O
peptide NN O
injection NN O
. . O

The DT O
HSR NNP O
reduced VBD O
the DT O
incidence NN O
of IN O
EAE NNP O
by IN O
70 CD O
% NN O
, , O
delayed JJ O
disease NN O
onset VBN O
by IN O
6 CD O
days NNS O
, , O
and CC O
attenuated VBD O
disease NN O
severity NN O
. . O

The DT O
HSR NNP O
attenuated VBD O
leukocyte JJ O
infiltration NN O
into IN O
CNS NNP O
assessed VBN O
by IN O
quantitation NN O
of IN O
perivascular JJ O
infiltrates NNS O
, , O
and CC O
by IN O
reduced JJ O
staining NN O
for IN O
CD4 NNP B-Gene
and CC O
CD25 NNP B-Gene
immunopositive VBP O
T NNP O
- : O
cells NNS O
. . O

T NNP O
- : O
cell NN O
activation NN O
, , O
assessed VBN O
by IN O
the DT O
production NN O
of IN O
interferon NN B-Gene
gamma NN I-Gene
( ( O
IFNgamma NNP B-Gene
) ) O
in IN O
response NN O
to TO O
MOG NNP B-Gene
( ( I-Gene
35 CD I-Gene
- : I-Gene
55 CD I-Gene
) ) I-Gene
, , O
was VBD O
also RB O
decreased VBN O
by IN O
the DT O
HSR NNP O
. . O

The DT O
HSR NNP O
reduced VBD O
inflammatory JJ O
gene NN O
expression NN O
in IN O
the DT O
brain NN O
that WDT O
normally RB O
occurs VBZ O
during IN O
EAE NNP O
, , O
including VBG O
the DT O
early JJ O
increase NN O
in IN O
RANTES NNP B-Gene
( ( O
regulated VBN B-Gene
on IN I-Gene
activation NN I-Gene
of IN I-Gene
normal JJ I-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
expressed VBN I-Gene
and CC I-Gene
secreted VBN I-Gene
) ) O
expression NN O
, , O
and CC O
the DT O
later JJ O
expression NN O
of IN O
the DT O
inducible JJ O
form NN O
of IN O
nitric JJ B-Gene
oxide JJ I-Gene
synthase NN I-Gene
. . O

The DT O
early JJ O
activation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
was VBD O
also RB O
blocked VBN O
by IN O
the DT O
HSR NNP O
. . O

The DT O
finding NN O
that IN O
the DT O
SR NNP O
reduces NNS O
inflammation NN O
in IN O
the DT O
brain NN O
and CC O
the DT O
clinical JJ O
severity NN O
of IN O
EAE NNP O
opens VBZ O
a DT O
novel JJ O
therapeutic JJ O
approach NN O
for IN O
prevention NN O
of IN O
autoimmune NN O
diseases NNS O
. . O

In IN O
vivo JJ O
detection NN O
of IN O
intracellular JJ O
signaling VBG O
pathways NNS O
in IN O
developing VBG O
thymocytes NNS O
. . O

Information NN O
regarding VBG O
the DT O
intracellular JJ O
signaling NN O
processes VBZ O
that IN O
occur NN O
during IN O
the DT O
development NN O
of IN O
T NNP O
cells NNS O
has VBZ O
largely RB O
been VBN O
obtained VBN O
with IN O
the DT O
use NN O
of IN O
transgenic JJ O
mouse NN O
models NNS O
, , O
which WDT O
although IN O
providing VBG O
invaluable JJ O
information NN O
are VBP O
time NN O
consuming VBG O
and CC O
costly JJ O
. . O

To TO O
this DT O
end NN O
, , O
we PRP O
have VBP O
developed VBN O
a DT O
novel NN O
system NN O
that WDT O
facilitates VBZ O
the DT O
in IN O
vivo JJ O
analysis NN O
of IN O
signal JJ O
transduction NN O
pathways NNS O
during IN O
T NNP O
- : O
lymphocyte NN O
development NN O
. . O

This DT O
approach NN O
uses VBZ O
reporter JJR B-Gene
- : I-Gene
plasmids NN I-Gene
for IN O
the DT O
detection NN O
of IN O
intracellular JJ O
signals NNS O
mediated VBN O
by IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
or CC O
cyclic JJ B-Gene
AMP NNP I-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinase NN I-Gene
. . O

Reporter NNP B-Gene
- : I-Gene
plasmids NNS I-Gene
are VBP O
transfected VBN O
into IN O
thymocytes NNS O
in IN O
fetal JJ O
thymic JJ O
organ JJ O
culture NN O
by IN O
accelerated JJ O
DNA NNP O
/ NNP O
particle NN O
bombardment NN O
( ( O
gene NN O
gun NN O
) ) O
, , O
and CC O
the DT O
activation NN O
of IN O
a DT O
signaling VBG O
pathway NN O
is VBZ O
determined VBN O
in IN O
the DT O
form NN O
of IN O
a DT O
standard JJ O
luciferase NN O
assay NN O
. . O

Importantly RB O
, , O
this DT O
powerful JJ O
technique NN O
preserves VBZ O
the DT O
structural JJ O
integrity NN O
of IN O
the DT O
thymus NN O
, , O
and CC O
will MD O
provide VB O
an DT O
invaluable JJ O
tool NN O
to TO O
study VB O
how WRB O
thymocytes NNS O
respond VBP O
to TO O
normal JJ O
environmental JJ O
stimuli NNS O
encountered VBD O
during IN O
differentiation NN O
within IN O
the DT O
thymic JJ O
milieu NN O
. . O

Thus RB O
, , O
this DT O
method NN O
allows VBZ O
for IN O
the DT O
monitoring NN O
of IN O
signals NNS O
that WDT O
occur VBP O
in IN O
a DT O
biological JJ O
time NN O
frame NN O
, , O
such JJ O
as IN O
during IN O
differentiation NN O
, , O
and CC O
within IN O
the DT O
natural JJ O
environment NN O
of IN O
differentiating VBG O
cells NNS O
. . O

Core NNP B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
beta NN I-Gene
( ( O
CBFbeta NNP B-Gene
) ) O
, , O
but CC O
not RB O
CBFbeta NNP B-Gene
- : I-Gene
smooth JJ I-Gene
muscle NN I-Gene
myosin NN I-Gene
heavy NN I-Gene
chain NN I-Gene
, , O
rescues VBZ O
definitive JJ O
hematopoiesis NN O
in IN O
CBFbeta NNP B-Gene
- : O
deficient NN O
embryonic JJ O
stem NN O
cells NNS O
. . O

Core NNP B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
beta NN I-Gene
( ( O
CBFbeta NNP B-Gene
) ) O
is VBZ O
the DT O
non JJ B-Gene
- : I-Gene
DNA NN I-Gene
- : I-Gene
binding VBG I-Gene
subunit NN I-Gene
of IN O
the DT O
heterodimeric JJ B-Gene
CBFs NNP I-Gene
. . O

Genes NNS B-Gene
encoding VBG I-Gene
CBFbeta NNP I-Gene
( ( O
CBFB NNP B-Gene
) ) O
, , O
and CC O
one CD O
of IN O
the DT O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
CBFalpha NNP I-Gene
subunits NNS I-Gene
, , I-Gene
Runx1 NNP I-Gene
( ( O
also RB O
known VBN O
as IN O
CBFalpha2 NNP B-Gene
, , O
AML1 NNP B-Gene
, , O
and CC O
PEBP2alphaB NNP B-Gene
) ) O
, , O
are VBP O
required VBN O
for IN O
normal JJ O
hematopoiesis NN O
and CC O
are VBP O
also RB O
frequent JJ O
targets NNS O
of IN O
chromosomal JJ O
translocations NNS O
in IN O
acute JJ O
leukemias NN O
in IN O
humans NNS O
. . O

Homozygous JJ O
disruption NN O
of IN O
either CC O
the DT O
Runx1 NNP B-Gene
or CC I-Gene
Cbfb NNP I-Gene
gene NN I-Gene
in IN O
mice JJ O
results NNS O
in IN O
embryonic JJ O
lethality NN O
at IN O
midgestation NN O
due JJ O
to TO O
hemorrhaging VBG O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
and CC O
severely RB O
impairs JJ O
fetal JJ O
liver NN O
hematopoiesis NN O
. . O

Results NNS O
of IN O
this DT O
study NN O
show NN O
that IN O
Cbfb NNP O
- : O
deficient NN O
mouse NN O
embryonic JJ O
stem NN O
( ( O
ES NNP O
) ) O
cells NNS O
can MD O
differentiate VB O
into IN O
primitive JJ O
erythroid NN O
colonies NNS O
in IN O
vitro NN O
, , O
but CC O
are VBP O
impaired VBN O
in IN O
their PRP$ O
ability NN O
to TO O
produce VB O
definitive JJ O
erythroid NN O
and CC O
myeloid NN O
colonies NNS O
, , O
mimicking VBG O
the DT O
in IN O
vivo NN O
defect NN O
. . O

Definitive JJ O
hematopoiesis NN O
is VBZ O
restored VBN O
by IN O
ectopic JJ O
expression NN O
of IN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
Cbfb NNP I-Gene
transgenes NNS I-Gene
, , O
as RB O
well RB O
as IN O
by IN O
a DT O
transgene NN O
encoding VBG O
only RB O
the DT O
heterodimerization NN B-Gene
domain NN I-Gene
of IN O
CBFbeta NNP B-Gene
. . O

In IN O
contrast NN O
, , O
the DT O
CBFbeta NNP B-Gene
- : O
smooth JJ B-Gene
muscle NN I-Gene
myosin NN I-Gene
heavy NN I-Gene
chain NN I-Gene
( ( I-Gene
SMMHC NNP I-Gene
) ) I-Gene
fusion NN I-Gene
protein NN I-Gene
generated VBN O
by IN O
the DT O
inv NN B-Gene
( ( I-Gene
16 CD I-Gene
) ) I-Gene
associated VBN O
with IN O
acute JJ O
myeloid NN O
leukemias NN O
( ( O
M4Eo NNP O
) ) O
can MD O
not RB O
rescue VB O
definitive JJ O
hematopoiesis NN O
by IN O
Cbfb NNP O
- : O
deficient NN O
ES NNP O
cells NNS O
. . O

Sequences NNS O
responsible JJ O
for IN O
the DT O
inability NN O
of IN O
CBFbeta NNP B-Gene
- : O
SMMHC NN O
to TO O
rescue VB O
definitive JJ O
hematopoiesis NN O
reside NN O
in IN O
the DT O
SMMHC NNP B-Gene
portion NN I-Gene
of IN O
the DT O
fusion NN B-Gene
protein NN I-Gene
. . O

Results NNS O
also RB O
show VBP O
that IN O
the DT O
CBFbeta NNP B-Gene
- : I-Gene
SMMHC NNP I-Gene
fusion NN I-Gene
protein NN I-Gene
transdominantly RB O
inhibits VBZ O
definitive JJ O
hematopoiesis NN O
, , O
but CC O
not RB O
to TO O
the DT O
same JJ O
extent NN O
as IN O
homozygous JJ O
loss NN O
of IN O
Runx1 NNP B-Gene
or CC O
Cbfb NNP B-Gene
. . O

CBFbeta NNP B-Gene
- : I-Gene
SMMHC NNP I-Gene
preferentially RB O
inhibits VBZ O
the DT O
differentiation NN O
of IN O
myeloid JJ O
lineage NN O
cells NNS O
, , O
while IN O
increasing VBG O
the DT O
number NN O
of IN O
blastlike JJ O
cells NNS O
in IN O
culture NN O
. . O

The DT O
latency NN O
pattern NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
infection NN O
and CC O
viral JJ O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
expression NN O
in IN O
cutaneous JJ O
natural JJ O
killer NN O
/ NN O
T NNP O
- : O
cell NN O
lymphomas NN O
. . O

The DT O
nasal NN O
type NN O
, , O
extranodal JJ O
natural JJ O
killer NN O
or CC O
T NNP O
( ( O
NK NNP O
/ NNP O
T NNP O
) ) O
- : O
cell NN O
lymphoma NN O
is VBZ O
usually RB O
associated VBN O
with IN O
latent NN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
infection NN O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
EBV NNP O
gene NN O
expression NN O
patterns NNS O
in IN O
vivo NN O
, , O
we PRP O
examined VBD O
eight CD O
patients NNS O
with IN O
cutaneous JJ O
EBV NNP O
- : O
related JJ O
NK NNP O
/ NNP O
T NNP O
- : O
cell NN O
lymphomas NN O
, , O
including VBG O
six CD O
patients NNS O
with IN O
a DT O
NK NNP O
- : O
cell NN O
phenotype NN O
and CC O
two CD O
patients NNS O
with IN O
a DT O
T NNP O
- : O
cell NN O
phenotype NN O
. . O

The DT O
implication NN O
of IN O
EBV NNP O
in IN O
the DT O
skin NN O
lesions NNS O
was VBD O
determined VBN O
by IN O
the DT O
presence NN O
of IN O
EBV NNP B-Gene
- : I-Gene
DNA NN I-Gene
, , O
EBV NNP B-Gene
- : I-Gene
encoded VBD I-Gene
nuclear JJ I-Gene
RNA NNP I-Gene
( ( O
EBER NNP B-Gene
) ) O
and CC O
a DT O
clonality NN O
of IN O
EBV NNP B-Gene
- : I-Gene
DNA NN I-Gene
fragments NNS I-Gene
containing VBG O
the DT O
terminal JJ B-Gene
repeats NNS I-Gene
. . O

Transcripts NNS O
of IN O
EBV NNP B-Gene
- : I-Gene
encoded VBD I-Gene
genes NNS I-Gene
were VBD O
screened VBN O
by IN O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
, , O
and CC O
confirmed VBN O
by IN O
Southern NNP O
blot NN O
hybridization NN O
. . O

The DT O
expression NN O
of IN O
EBV NNP B-Gene
- : I-Gene
related JJ I-Gene
antigens NNS I-Gene
was VBD O
examined VBN O
by IN O
immunostaining VBG O
using VBG O
paraffin JJ O
- : O
embedded JJ O
tissue NN O
sections NNS O
and CC O
cell NN O
pellets NNS O
of IN O
EBV NNP O
- : O
positive JJ O
cell NN O
lines NNS O
. . O

Our PRP$ O
study NN O
demonstrated VBD O
that IN O
all DT O
samples NNS O
from IN O
the DT O
patients NNS O
contained VBD O
EBV NNP B-Gene
nuclear JJ I-Gene
antigen NN I-Gene
( ( I-Gene
EBNA NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
which WDT O
was VBD O
transcribed VBN O
using VBG O
the DT O
Q NNP B-Gene
promoter NN I-Gene
, , O
whereas IN O
both DT O
the DT O
Q NNP B-Gene
promoter NN I-Gene
and CC O
another DT O
upstream JJ B-Gene
promoter NN I-Gene
( ( O
Cp NNP B-Gene
/ NNP I-Gene
Wp NNP I-Gene
) ) O
were VBD O
used VBN O
in IN O
EBV NNP O
- : O
positive JJ O
cell NN O
lines NNS O
, , O
B95 NNP O
. . O
8 CD O
, , O
Raji NNP O
and CC O
Jiyoye NNP O
. . O

Latent NNP B-Gene
membrane NN I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
LMP NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
in IN O
seven CD O
of IN O
eight CD O
patients NNS O
and CC O
all DT O
cell NN O
lines NNS O
, , O
whereas NNS O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
transcripts NNS I-Gene
were VBD O
found VBN O
only RB O
in IN O
the DT O
cell NN O
lines NNS O
. . O

Immunostaining VBG O
showed VBD O
no DT O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
EBNA NNP I-Gene
- : I-Gene
2 CD I-Gene
or CC I-Gene
ZEBRA NNP I-Gene
antigens NNS I-Gene
in IN O
the DT O
paraffin NN O
- : O
embedded VBN O
tissue NN O
sections NNS O
, , O
although IN O
they PRP O
were VBD O
positive JJ O
in IN O
the DT O
cell NN O
line NN O
cells NNS O
. . O

Latent NNP B-Gene
BHRF1 NNP I-Gene
transcripts NNS I-Gene
encoding VBG O
bcl SYM B-Gene
- : I-Gene
2 CD I-Gene
homologue NN I-Gene
and CC O
BCRF1 NNP B-Gene
transcripts NNS I-Gene
encoding VBG O
viral JJ B-Gene
interleukin NN I-Gene
( ( I-Gene
vIL NN I-Gene
) ) I-Gene
- : I-Gene
10 CD I-Gene
were VBD O
detected VBN O
in IN O
one CD O
and CC O
two CD O
of IN O
eight CD O
patients NNS O
, , O
respectively RB O
. . O

A DT O
patient NN O
with IN O
NK NNP O
- : O
cell NN O
lymphoma NN O
expressing VBG O
both DT O
transcripts NNS O
died VBD O
of IN O
rapid JJ O
progression NN O
of IN O
the DT O
illness NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
restricted JJ O
expression NN O
of IN O
the DT O
latency NN B-Gene
- : I-Gene
associated VBN I-Gene
EBV NNP I-Gene
genes NNS I-Gene
and CC O
the DT O
production NN O
of IN O
vIL JJ B-Gene
- : I-Gene
10 CD I-Gene
and CC I-Gene
bcl VB I-Gene
- : I-Gene
2 CD I-Gene
homologue NN I-Gene
may MD O
favour VB O
tumour NN O
growth NN O
, , O
evading VBG O
the DT O
host NN O
immune JJ O
surveillance NN O
. . O

Copyright JJ O
2001 CD O
Cancer NNP O
Research NNP O
Campaign NNP O
. . O

Oxidized VBN O
alkyl JJ O
phospholipids NNS O
are VBP O
specific JJ O
, , O
high JJ O
affinity NN O
peroxisome VBP O
proliferator NN O
- : O
activated VBN O
receptor NN O
gamma NN O
ligands NNS O
and CC O
agonists NNS O
. . O

Synthetic JJ O
high JJ O
affinity NN O
peroxisome VBP O
proliferator NN O
- : O
activated VBN O
receptor NN O
( ( O
PPAR NNP O
) ) O
agonists NNS O
are VBP O
known VBN O
, , O
but CC O
biologic JJ O
ligands NNS O
are VBP O
of IN O
low JJ O
affinity NN O
. . O

Oxidized VBN B-Gene
low JJ I-Gene
density NN I-Gene
lipoprotein NN I-Gene
( ( O
oxLDL NN B-Gene
) ) O
is VBZ O
inflammatory JJ O
and CC O
signals NNS O
through IN O
PPARs NNP B-Gene
. . O

We PRP O
showed VBD O
, , O
by IN O
phospholipase NN O
A NNP O
( ( O
1 CD O
) ) O
digestion NN O
, , O
that IN O
PPARgamma NNP O
agonists NNS O
in IN O
oxLDL JJ B-Gene
arise NN O
from IN O
the DT O
small JJ O
pool NN O
of IN O
alkyl JJ O
phosphatidylcholines NNS O
in IN O
LDL NNP B-Gene
. . O

We PRP O
identified VBD O
an DT O
abundant JJ O
oxidatively RB O
fragmented JJ O
alkyl NN O
phospholipid NN O
in IN O
oxLDL NN B-Gene
, , O
hexadecyl NN O
azelaoyl NN O
phosphatidylcholine NN O
( ( O
azPC NN O
) ) O
, , O
as IN O
a DT O
high JJ O
affinity NN O
ligand NN O
and CC O
agonist NN O
for IN O
PPARgamma NNP B-Gene
. . O

[ NN O
( ( O
3 CD O
) ) O
H NNP O
] NNP O
azPC NN O
bound NN O
recombinant JJ B-Gene
PPARgamma NNP I-Gene
with IN O
an DT O
affinity NN O
( ( O
K NNP O
( ( O
d NN O
) ) O
( ( O
( ( O
app RB O
) ) O
) ) O
approximately RB O
40 CD O
nm NNS O
) ) O
that WDT O
was VBD O
equivalent JJ O
to TO O
rosiglitazone VB O
( ( O
BRL49653 NNP O
) ) O
, , O
and CC O
competition NN O
with IN O
rosiglitazone NN O
showed VBD O
that IN O
binding VBG O
occurred VBD O
in IN O
the DT O
ligand NN B-Gene
- : I-Gene
binding NN I-Gene
pocket NN I-Gene
. . O

azPC NN O
induced VBD O
PPRE NNP O
reporter NN O
gene NN O
expression NN O
, , O
as IN O
did VBD O
rosiglitazone NN O
, , O
with IN O
a DT O
half JJ O
- : O
maximal JJ O
effect NN O
at IN O
100 CD O
nm NNS O
. . O

Overexpression NN O
of IN O
PPARalpha NNP B-Gene
or CC O
PPARgamma NNP B-Gene
revealed VBD O
that IN O
azPC NN O
was VBD O
a DT O
specific JJ O
PPARgamma NNP O
agonist NN O
. . O

The DT O
scavenger NN B-Gene
receptor NN I-Gene
CD36 NNP I-Gene
is VBZ O
encoded VBN O
by IN O
a DT O
PPRE NNP B-Gene
- : I-Gene
responsive JJ I-Gene
gene NN I-Gene
, , O
and CC O
azPC RB O
enhanced JJ O
expression NN O
of IN O
CD36 NNP B-Gene
in IN O
primary JJ O
human JJ O
monocytes NNS O
. . O

We PRP O
found VBD O
that IN O
anti JJ B-Gene
- : I-Gene
CD36 NN I-Gene
inhibited VBD O
azPC JJ O
uptake NN O
, , O
and CC O
it PRP O
inhibited VBD O
PPRE NNP O
reporter NN O
induction NN O
. . O

Results NNS O
with IN O
a DT O
small JJ O
molecule NN O
phospholipid JJ B-Gene
flippase NN I-Gene
mimetic JJ I-Gene
suggest NN O
azPC NN O
acts VBZ O
intracellularly RB O
and CC O
that IN O
cellular JJ O
azPC NN O
accumulation NN O
was VBD O
efficient JJ O
. . O

Thus RB O
, , O
certain JJ O
alkyl NN O
phospholipid JJ O
oxidation NN O
products NNS O
in IN O
oxLDL NN B-Gene
are VBP O
specific JJ O
, , O
high JJ O
affinity NN O
extracellular JJ O
ligands NNS O
and CC O
agonists NNS O
for IN O
PPARgamma NNP B-Gene
that WDT O
induce VBP O
PPAR NNP B-Gene
- : I-Gene
responsive NN I-Gene
genes NNS I-Gene

Regulation NN O
of IN O
the DT O
human JJ B-Gene
MAT2B NNP I-Gene
gene NN I-Gene
encoding VBG O
the DT O
regulatory JJ B-Gene
beta NN I-Gene
subunit NN I-Gene
of IN O
methionine JJ B-Gene
adenosyltransferase NN I-Gene
, , O
MAT NNP B-Gene
II NNP I-Gene
. . O

Methionine NNP B-Gene
adenosyltransferase NN I-Gene
( ( O
MAT NNP B-Gene
) ) O
catalyzes VBZ O
the DT O
biosynthesis NN O
of IN O
S NNP B-Gene
- : I-Gene
adenosylmethionine NN I-Gene
( ( O
AdoMet NNP B-Gene
) ) O
, , O
a DT O
key JJ O
molecule NN O
in IN O
transmethylation NN O
reactions NNS O
and CC O
polyamine JJ O
biosynthesis NN O
. . O

The DT O
MAT NNP B-Gene
II NNP I-Gene
isozyme NN I-Gene
consists VBZ O
of IN O
a DT O
catalytic JJ B-Gene
alpha2 NN I-Gene
and CC I-Gene
a DT I-Gene
regulatory JJ I-Gene
beta NN I-Gene
subunit NN I-Gene
. . O

Down NNP O
- : O
regulation NN O
of IN O
the DT O
MAT NNP B-Gene
II NNP I-Gene
beta NN I-Gene
subunit NN I-Gene
expression NN O
causes VBZ O
a DT O
6 CD O
- : O
10 CD O
- : O
fold JJ O
increase NN O
in IN O
intracellular JJ O
AdoMet NNP B-Gene
levels NNS O
. . O

To TO O
understand VB O
the DT O
mechanism NN O
by IN O
which WDT O
the DT O
beta NN B-Gene
subunit NN I-Gene
expression NN O
is VBZ O
regulated VBN O
, , O
we PRP O
cloned VBD O
the DT O
MAT2B NNP B-Gene
gene NN I-Gene
, , O
determined VBD O
its PRP$ O
organization NN O
, , O
characterized VBD O
its PRP$ O
5 CD B-Gene
' '' I-Gene
- : I-Gene
flanking NN I-Gene
sequences NNS I-Gene
, , O
and CC O
elucidated VBD O
the DT O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
regulation NN O
of IN O
its PRP$ O
promoter NN B-Gene
. . O

Transcription NN O
of IN O
the DT O
MAT2B NNP B-Gene
gene NN I-Gene
initiates NNS O
at IN O
position NN O
- : O
203 CD O
relative NN O
to TO O
the DT O
translation NN B-Gene
start NN I-Gene
site NN I-Gene
. . O

Promoter NNP B-Gene
deletion NN I-Gene
analysis NN I-Gene
defined VBD O
a DT O
minimal JJ B-Gene
promoter NN I-Gene
between IN O
positions NNS B-Gene
+ VBP I-Gene
52 CD I-Gene
and CC I-Gene
+ $ I-Gene
93 CD I-Gene
base NN O
pairs NN O
, , O
a DT O
GC NNP B-Gene
- : I-Gene
rich JJ I-Gene
region NN I-Gene
. . O

Inclusion NN O
of IN O
the DT O
sequences NNS O
between IN O
- : O
4 CD O
and CC O
+ $ O
52 CD O
enhanced JJ O
promoter NN O
activity NN O
; : O
this DT O
was VBD O
primarily RB O
because IN O
of IN O
an DT O
Sp1 NNP B-Gene
recognition NN I-Gene
site NN I-Gene
at IN O
+ $ O
9 CD O
/ NNP O
+ VBD O
15 CD O
. . O

The DT O
inclusion NN O
of IN O
sequences NNS O
up RB O
to TO O
position NN O
- : O
115 CD O
provided JJ O
full JJ O
activity NN O
; : O
this DT O
was VBD O
attributed VBN O
to TO O
a DT O
TATA NNP B-Gene
at IN O
- : O
32 CD O
. . O

The DT O
Sp1 NNP B-Gene
site NN I-Gene
at IN O
position NN O
+ FW O
9 CD O
was VBD O
key NN O
for IN O
the DT O
formation NN O
of IN O
protein NN O
. . O
DNA NN O
complexes NNS O
. . O

Mutation NN O
of IN O
both CC O
the DT O
Sp1 NNP B-Gene
site NN I-Gene
at IN O
+ $ O
9 CD O
and CC O
the DT O
TATA NNP B-Gene
at IN O
- : O
32 CD O
reduced JJ O
promoter NN O
activity NN O
to TO O
its PRP$ O
minimal JJ O
level NN O
. . O

Supershift NNP O
assays NNS O
showed VBD O
no DT O
effect NN O
of IN O
the DT O
anti JJ B-Gene
- : I-Gene
Sp1 NNP I-Gene
antibody NN I-Gene
on IN O
complex JJ O
formation NN O
, , O
whereas IN O
the DT O
anti JJ B-Gene
- : I-Gene
Sp3 NN I-Gene
antibody NN I-Gene
had VBD O
a DT O
strong JJ O
effect NN O
on IN O
protein NN O
. . O
DNA NN O
complex JJ O
formation NN O
, , O
suggesting VBG O
that IN O
Sp3 NNP B-Gene
is VBZ O
one CD O
of IN O
the DT O
main JJ O
factors NNS O
binding VBG O
to TO O
this DT O
Sp1 NNP B-Gene
site NN I-Gene
. . O

Chromatin NNP O
immunoprecipitation NN O
assays NNS O
supported VBD O
the DT O
involvement NN O
of IN O
both DT O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
in IN O
complexes NNS O
formed VBN O
on IN O
the DT O
MAT2B NNP B-Gene
promoter NN I-Gene
. . O

The DT O
data NN O
show NN O
that IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
untranslated JJ I-Gene
sequences NNS I-Gene
play VBP O
an DT O
important JJ O
role NN O
in IN O
regulating VBG O
the DT O
MAT2B NNP B-Gene
gene NN I-Gene
and CC O
identifies VBZ O
the DT O
Sp1 NNP B-Gene
site NN I-Gene
at IN O
+ JJ O
9 CD O
as IN O
a DT O
potential JJ O
target NN O
for IN O
modulating VBG O
MAT2B NNP O
expression NN O
, , O
a DT O
process NN O
that WDT O
can MD O
have VB O
a DT O
major JJ O
effect NN O
on IN O
intracellular JJ O
AdoMet NNP B-Gene
levels NNS O
. . O

Molecular JJ O
pathogenesis NN O
of IN O
influenza NN O
A NNP O
virus NN O
infection NN O
and CC O
virus NN O
- : O
induced JJ O
regulation NN O
of IN O
cytokine JJ B-Gene
gene NN I-Gene
expression NN O
. . O

Despite IN O
vaccines NNS O
and CC O
antiviral JJ O
substances NNS O
influenza VBP O
still RB O
causes VBZ O
significant JJ O
morbidity NN O
and CC O
mortality NN O
world NN O
wide JJ O
. . O

Better RBR O
understanding NN O
of IN O
the DT O
molecular JJ O
mechanisms NN O
of IN O
influenza JJ O
virus NN O
replication NN O
, , O
pathogenesis NN O
and CC O
host NN O
immune JJ O
responses NNS O
is VBZ O
required VBN O
for IN O
the DT O
development NN O
of IN O
more RBR O
efficient JJ O
means NNS O
of IN O
prevention NN O
and CC O
treatment NN O
of IN O
influenza NN O
. . O

Influenza NNP O
A NNP O
virus NN O
, , O
which WDT O
replicates VBZ O
in IN O
epithelial JJ O
cells NNS O
and CC O
leukocytes NNS O
, , O
regulates VBZ O
host NN O
cell NN O
transcriptional JJ O
and CC O
translational JJ O
systems NNS O
and CC O
activates NNS O
, , O
as RB O
well RB O
as IN O
downregulates NNS O
apoptotic JJ O
pathways NNS O
. . O

Influenza NNP O
A NNP O
virus NN O
infection NN O
results NNS O
in IN O
the DT O
production NN O
of IN O
chemotactic JJ O
( ( O
RANTES NNP B-Gene
, , O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
, , O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
MCP NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
and CC O
IP NNP B-Gene
- : I-Gene
10 CD I-Gene
) ) O
, , O
pro JJ O
- : O
inflammatory NN O
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
, , O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
and CC O
antiviral JJ B-Gene
( ( I-Gene
IFN NNP I-Gene
- : I-Gene
alpha NN I-Gene
/ NNP I-Gene
beta NN I-Gene
) ) I-Gene
cytokines NNS I-Gene
. . O

Cytokine NNP O
gene NN O
expression NN O
is VBZ O
associated VBN O
with IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
STAT NNP B-Gene
and CC O
IRF NNP B-Gene
signal JJ I-Gene
transducing NN I-Gene
molecules NNS I-Gene
in IN O
influenza NN O
A NNP O
virus NN O
- : O
infected JJ O
cells NNS O
. . O

In IN O
addition NN O
of IN O
upregulating VBG O
cytokine JJ B-Gene
gene NN I-Gene
expression NN O
, , O
influenza VB O
A NNP O
virus NN O
infection NN O
activates VBZ O
caspase SYM B-Gene
- : I-Gene
1 CD I-Gene
enzyme NN I-Gene
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
proteolytic JJ O
processing NN O
of IN O
proIL NN B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
and CC O
proIL VB B-Gene
- : I-Gene
18 CD I-Gene
into IN O
their PRP$ O
biologically RB O
active JJ O
forms NNS O
. . O

Influenza NNP O
A NNP O
virus NN O
- : O
induced JJ O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ NN I-Gene
beta NN I-Gene
is VBZ O
essential JJ O
in IN O
host NN O
' POS O
s JJ O
antiviral JJ O
defence NN O
by IN O
activating VBG O
the DT O
expression NN O
of IN O
antiviral JJ B-Gene
Mx NNP I-Gene
, , O
PKR NNP B-Gene
and CC I-Gene
oligoadenylate JJ I-Gene
synthetase NN I-Gene
genes NNS I-Gene
. . O

IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ NN I-Gene
beta NN I-Gene
also RB O
prolongs VBZ O
T NNP O
cell NN O
survival NN O
, , O
upregulates VBZ O
IL NNP O
- : O
12 CD O
and CC O
IL NNP O
- : O
18 CD O
receptor NN O
gene NN O
expression NN O
and CC O
together RB O
with IN O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
stimulates NNS O
NK NNP O
and CC O
T NNP O
cell NN O
IFN NNP O
- : O
gamma NN O
production NN O
and CC O
the DT O
development NN O
of IN O
Th1 NNP O
- : O
type NN O
immune JJ O
response NN O
. . O

Comparison NNP O
of IN O
hprt NN O
and CC O
lacI NN O
mutant JJ O
frequency NN O
with IN O
DNA NNP O
adduct NN O
formation NN O
in IN O
N NNP O
- : O
hydroxy NN O
- : O
2 CD O
- : O
acetylaminofluorene NN O
- : O
treated VBN O
Big NNP O
Blue NNP O
rats NNS O
. . O

N NNP O
- : O
Hydroxy NNP O
- : O
2 CD O
- : O
acetylaminofluorene NN O
( ( O
N NNP O
- : O
OH NNP O
- : O
AAF NN O
) ) O
is VBZ O
the DT O
proximate NN O
carcinogenic JJ O
metabolite NN O
of IN O
the DT O
powerful JJ O
rat NN O
liver NN O
carcinogen NN O
2 CD O
- : O
acetylaminofluorene NN O
. . O

In IN O
this DT O
study NN O
, , O
transgenic JJ O
Big NNP O
Blue NNP O
( ( O
R NNP O
) ) O
rats NNS O
were VBD O
used VBN O
to TO O
examine VB O
the DT O
relationship NN O
between IN O
in IN O
vivo JJ O
mutagenicity NN O
and CC O
DNA NNP O
adduct NN O
formation NN O
by IN O
N NNP O
- : O
OH NNP O
- : O
AAF NN O
in IN O
the DT O
target NN O
liver NN O
compared VBN O
with IN O
that DT O
in IN O
nontarget DT O
tissues NNS O
. . O

Male JJ O
rats NNS O
were VBD O
given VBN O
one CD O
, , O
two CD O
, , O
or CC O
four CD O
doses NNS O
of IN O
25 CD O
mg NNS O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
/ NNP O
kg VB O
body NN O
weight NN O
by IN O
i NN O
. . O
p NN O
. . O
injection NN O
at IN O
4 CD O
- : O
day NN O
intervals NNS O
, , O
and CC O
groups NNS O
of IN O
treated JJ O
and CC O
control NN O
rats NNS O
were VBD O
euthanized VBN O
up RB O
to TO O
10 CD O
weeks NNS O
after IN O
beginning VBG O
the DT O
dosing NN O
. . O

Mutant JJ O
frequencies NNS O
were VBD O
measured VBN O
in IN O
the DT O
spleen JJ B-Gene
lymphocyte NN I-Gene
hprt NN I-Gene
gene NN I-Gene
, , O
and CC O
lacI JJ O
mutant JJ O
frequencies NNS O
were VBD O
determined VBN O
in IN O
the DT O
liver NN O
and CC O
spleen JJ O
lymphocytes NNS O
. . O

At IN O
6 CD O
weeks NNS O
after IN O
beginning VBG O
the DT O
dosing NN O
, , O
the DT O
hprt NN O
mutant JJ O
frequency NN O
in IN O
spleen JJ O
lymphocytes NNS O
from IN O
the DT O
four CD O
- : O
dose NN O
group NN O
was VBD O
16 CD O
. . O
5 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
compared VBN O
with IN O
3 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
in IN O
control NN O
animals NNS O
. . O

Also RB O
at IN O
6 CD O
weeks NNS O
, , O
rats NNS O
given VBN O
one CD O
, , O
two CD O
, , O
or CC O
four CD O
doses NNS O
of IN O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
had VBD O
lacI VBN O
mutant JJ O
frequencies NNS O
in IN O
the DT O
liver NN O
of IN O
97 CD O
. . O
6 CD O
, , O
155 CD O
. . O
6 CD O
, , O
and CC O
406 CD O
. . O
8 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
, , O
respectively RB O
, , O
compared VBN O
with IN O
a DT O
control NN O
frequency NN O
of IN O
25 CD O
. . O
7 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
; : O
rats NNS O
given VBN O
four CD O
doses NNS O
had VBD O
lacI VBN O
mutant JJ O
frequencies NNS O
in IN O
spleen JJ O
lymphocytes NNS O
of IN O
55 CD O
. . O
8 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
compared VBN O
with IN O
a DT O
control NN O
frequency NN O
of IN O
20 CD O
. . O
4 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
. . O

Additional JJ O
rats NNS O
were VBD O
evaluated VBN O
for IN O
DNA NNP O
adduct NN O
formation NN O
in IN O
the DT O
liver NN O
, , O
spleen JJ O
lymphocytes NNS O
, , O
and CC O
bone NN O
marrow NN O
by IN O
( ( O
32 CD O
) ) O
P NNP O
- : O
postlabeling NN O
. . O

Adduct NN O
analysis NN O
was VBD O
conducted VBN O
1 CD O
day NN O
after IN O
one CD O
, , O
two CD O
, , O
and CC O
four CD O
treatments NNS O
with IN O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
, , O
5 CD O
days NNS O
after IN O
one CD O
treatment NN O
, , O
and CC O
9 CD O
days NNS O
after IN O
two CD O
treatments NNS O
. . O

N NNP O
- : O
( ( O
Deoxyguanosin NNP O
- : O
8 CD O
- : O
yl NN O
) ) O
- : O
2 CD O
- : O
aminofluorene NN O
was VBD O
the DT O
major JJ O
DNA NNP O
adduct NN O
identified VBN O
in IN O
all PDT O
the DT O
tissues NNS O
examined VBN O
. . O

Adduct NNP O
concentrations NNS O
increased VBD O
with IN O
total JJ O
dose NN O
to TO O
maximum VB O
values NNS O
in IN O
samples NNS O
taken VBN O
1 CD O
day NN O
after IN O
two CD O
doses NNS O
, , O
and CC O
remained VBD O
essentially RB O
the DT O
same JJ O
after IN O
four CD O
doses NNS O
. . O

In IN O
samples NNS O
taken VBN O
after IN O
four CD O
doses NNS O
, , O
adduct NN O
levels NNS O
were VBD O
103 CD O
, , O
28 CD O
, , O
and CC O
7 CD O
fmol NN O
/ NNP O
microg NN O
of IN O
DNA NNP O
in IN O
liver NN O
, , O
spleen JJ O
lymphocytes NNS O
, , O
and CC O
bone NN O
marrow NN O
, , O
respectively RB O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
extent NN O
of IN O
both DT O
DNA NNP O
adduct NN O
formation NN O
and CC O
mutant JJ O
induction NN O
correlates NNS O
with IN O
the DT O
organ JJ O
specificity NN O
for IN O
N NNP O
- : O
OH NNP O
- : O
AAF NNP O
carcinogenesis NN O
in IN O
the DT O
rat NN O
. . O

Environ NNP O
. . O
Mol NNP O
. . O
Mutagen NNP O
. . O
37 CD O
: : O
195 CD O
- : O
202 CD O
, , O
2001 CD O
. . O

Published VBN O
2001 CD O
Wiley NNP O
- : O
Liss NNP O
, , O
Inc NNP O
. . O

Expression NN O
of IN O
Mad1 NNP B-Gene
in IN O
T NNP O
cells NNS O
leads VBZ O
to TO O
reduced VB O
thymic JJ O
cellularity NN O
and CC O
impaired JJ O
mitogen NN O
- : O
induced JJ O
proliferation NN O
. . O

To TO O
investigate VB O
Mad1 NNP B-Gene
function NN O
in IN O
vivo NN O
, , O
transgenic JJ O
mice NN O
were VBD O
generated VBN O
that IN O
express NN O
a DT O
Mad1 NNP B-Gene
transgene NN I-Gene
in IN O
T NNP O
lineage NN O
cells NNS O
under IN O
the DT O
control NN O
of IN O
the DT O
proximal JJ B-Gene
lck NN I-Gene
promoter NN I-Gene
. . O

Thymus NNP O
size NN O
in IN O
lck JJ O
- : O
Mad1 NNP O
transgenic JJ O
mice NN O
is VBZ O
drastically RB O
reduced VBN O
although IN O
representation NN O
of IN O
the DT O
various JJ O
thymocyte NN O
sub NN O
populations NNS O
appears VBZ O
normal JJ O
. . O

To TO O
investigate VB O
more RBR O
closely RB O
any DT O
effects NNS O
of IN O
Mad1 NNP O
expression NN O
on IN O
thymocytes NNS O
, , O
we PRP O
examined VBD O
thymic JJ O
selection NN O
using VBG O
MHC NNP O
class NN O
I PRP O
- : O
restricted VBN O
H NNP O
- : O
Y SYM O
- : O
TCR NNP O
transgenic JJ O
mice NN O
. . O

Mad1 NNP O
expression NN O
in IN O
vivo NN O
reduces VBZ O
the DT O
efficiency NN O
of IN O
positive JJ O
selection NN O
. . O

Furthermore RB O
, , O
thymocytes NNS O
and CC O
splenic JJ O
T NNP O
cells NNS O
from IN O
lck JJ O
- : O
Mad1 NNP O
transgenic JJ O
mice NN O
display VBD O
a DT O
profound JJ O
proliferative JJ O
defect NN O
in IN O
response NN O
to TO O
activation NN O
with IN O
either DT O
PMA NNP O
/ NNP O
Ionomycin NNP O
or CC O
immobilized VBN B-Gene
anti JJ I-Gene
- : I-Gene
CD3 NNP I-Gene
/ NNP I-Gene
CD28 NNP I-Gene
antibody NN I-Gene
. . O

This DT O
proliferative JJ O
defect NN O
is VBZ O
not RB O
reversed VBN O
by IN O
addition NN O
of IN O
exogenous JJ B-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
and CC O
is VBZ O
p53 JJ O
- : O
independent JJ O
. . O

The DT O
growth NN O
inhibition NN O
caused VBN O
by IN O
Mad1 NNP B-Gene
is VBZ O
overcome VBN O
by IN O
expression NN O
of IN O
active JJ B-Gene
c SYM I-Gene
- : I-Gene
Myc NN I-Gene
. . O

Differential JJ O
requirement NN O
for IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
in IN O
the DT O
generation NN O
of IN O
natural JJ O
killer NN O
cells NNS O
versus NN O
B NNP O
and CC O
T NNP O
cells NNS O
. . O

PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
a DT O
member NN O
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
required VBN O
for IN O
the DT O
development NN O
of IN O
various JJ O
lymphoid NN O
and CC O
myeloid NN O
cell NN O
lineages NNS O
, , O
but CC O
its PRP$ O
role NN O
in IN O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
cell NN O
development NN O
is VBZ O
not RB O
known VBN O
. . O

The DT O
study NN O
shows VBZ O
that IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
expressed VBN O
in IN O
NK NNP O
cells NNS O
and CC O
that DT O
, , O
on IN O
cell NN O
transfer NN O
into IN O
alymphoid JJ O
Rag2 NNP O
/ NNP O
gammac NN O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
, , O
hematopoietic JJ O
progenitors NNS O
of IN O
PU NNP O
. . O
1 CD O
( ( O
- : O
/ SYM O
- : O
) ) O
fetal VBP O
liver JJ O
cells NNS O
could MD O
generate VB O
functional JJ O
NK NNP O
cells NNS O
but CC O
not RB O
B NNP O
or CC O
T NNP O
cells NNS O
. . O

Nevertheless RB O
, , O
the DT O
numbers NNS O
of IN O
bone NN O
marrow NN O
NK NNP O
cell NN O
precursors NNS O
and CC O
splenic JJ O
mature NN O
NK NNP O
cells NNS O
were VBD O
reduced VBN O
compared VBN O
to TO O
controls NNS O
. . O

Moreover RB O
, , O
PU NNP O
. . O
1 CD O
( ( O
- : O
/ SYM O
- : O
) ) O
NK NNP O
cells NNS O
displayed VBD O
reduced JJ O
expression NN O
of IN O
the DT O
receptors NNS O
for IN O
stem NN B-Gene
cell NN I-Gene
factor NN I-Gene
and CC O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
7 CD I-Gene
, , O
suggesting VBG O
a DT O
nonredundant JJ O
role NN O
for IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
in IN O
regulating VBG O
the DT O
expression NN O
of IN O
these DT O
cytokine JJ B-Gene
receptor NN I-Gene
genes NNS I-Gene
during IN O
NK NNP O
cell NN O
development NN O
. . O

PU NNP O
. . O
1 CD O
( ( O
- : O
/ SYM O
- : O
) ) O
NK NNP O
cells NNS O
also RB O
showed VBD O
defective JJ O
expression NN O
of IN O
inhibitory NN O
and CC O
activating VBG O
members NNS O
of IN O
the DT O
Ly49 NNP B-Gene
family NN I-Gene
and CC O
failed VBD O
to TO O
proliferate VB O
in IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
. . O

Thus RB O
, , O
despite IN O
the DT O
less RBR O
stringent JJ O
requirement NN O
for IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
in IN O
NK NNP O
cell NN O
development NN O
compared VBN O
to TO O
B NNP O
and CC O
T NNP O
cells NNS O
, , O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
regulates NNS O
NK NNP O
cell NN O
differentiation NN O
and CC O
homeostasis NN O
. . O

Benzene NNP O
- : O
extracted JJ O
components NNS O
are VBP O
important JJ O
for IN O
the DT O
major JJ O
activity NN O
of IN O
diesel NN O
exhaust JJ O
particles NNS O
: : O
effect NN O
on IN O
interleukin JJ B-Gene
- : I-Gene
8 CD I-Gene
gene NN I-Gene
expression NN O
in IN O
human JJ O
bronchial JJ O
epithelial JJ O
cells NNS O
. . O

Epidemiologic NNP O
and CC O
experimental JJ O
studies NNS O
suggest VBP O
that IN O
diesel NN O
exhaust NN O
particles NNS O
( ( O
DEPs NNP O
) ) O
may MD O
be VB O
related VBN O
to TO O
increasing VBG O
respiratory JJ O
mortality NN O
and CC O
morbidity NN O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
DEPs NNP O
augmented VBD O
the DT O
production NN O
of IN O
inflammatory JJ B-Gene
cytokines NNS I-Gene
by IN O
human JJ O
airway RB O
epithelial JJ O
cells NNS O
in IN O
vitro NN O
. . O

To TO O
better RBR O
understand VB O
the DT O
mechanisms NN O
of IN O
their PRP$ O
proinflammatory NN O
activities NNS O
, , O
we PRP O
studied VBD O
the DT O
effects NNS O
of IN O
several JJ O
components NNS O
extracted VBN O
from IN O
DEPs NNP O
on IN O
interleukin NN O
( ( O
IL NNP O
) ) O
- : O
8 CD O
expression NN O
in IN O
human JJ O
bronchial JJ O
epithelial NN O
cell NN O
line NN O
BEAS NNP O
- : O
2B CD O
and CC O
normal JJ O
human JJ O
airway RB O
epithelial JJ O
cells NNS O
obtained VBN O
from IN O
very RB O
peripheral JJ O
airways NNS O
by IN O
an DT O
ultrathin JJ O
bronchoscope NN O
. . O

We PRP O
used VBD O
several JJ O
agents NNS O
active JJ O
on IN O
signal JJ O
transduction NN O
pathways NNS O
in IN O
cytokine JJ O
expression NN O
, , O
such JJ O
as IN O
the DT O
protein NN O
kinase VBD O
C NNP O
inhibitor NN O
staurosporin NN O
, , O
antioxidant JJ O
agents NNS O
including VBG O
N NNP O
- : O
acetyl NN O
cysteine NN O
( ( O
NAC NNP O
) ) O
and CC O
pyrrolidine JJ O
dithiocarbamate NN O
( ( O
PDTC NNP O
) ) O
, , O
and CC O
p38 NN B-Gene
mitogen NN I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
inhibitor NN O
SB203580 NNP O
. . O

Benzene NNP O
- : O
extracted VBD O
components NNS O
showed VBD O
effects NNS O
mimicking VBG O
DEPs NNP O
on IN O
IL NNP O
- : O
8 CD O
gene NN O
expression NN O
, , O
release NN O
of IN O
several JJ O
cytokines NNS B-Gene
( ( O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
; : O
granulocyte JJ B-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating JJ I-Gene
factor NN I-Gene
; : O
and CC O
regulated VBN O
on IN O
activation NN O
, , O
normal JJ O
T NNP O
cells NNS O
expressed VBD O
and CC O
secreted VBD O
) ) O
and CC O
nuclear JJ O
factor NN O
( ( O
NF NNP O
) ) O
- : O
kappa NN O
B NNP O
activation NN O
. . O

We PRP O
also RB O
found VBD O
that IN O
NAC NNP O
, , O
PDTC NNP O
, , O
and CC O
SB203580 NNP O
suppressed VBD O
the DT O
activities NNS O
of IN O
DEPs NNP O
and CC O
their PRP$ O
benzene NN O
extracts NNS O
, , O
suggesting VBG O
the DT O
roles NNS O
of IN O
oxidants NNS O
- : O
mediated VBN O
NF NNP O
- : O
kappa NN O
B NNP O
activation NN O
and CC O
p38MAPK NN B-Gene
pathways NNS O
. . O

Finally RB O
, , O
benzo NN O
[ VBD O
a DT O
] JJ O
pyrene NN O
, , O
one CD O
of IN O
the DT O
important JJ O
compounds NNS O
included VBN O
in IN O
the DT O
benzene NN O
component NN O
, , O
replicated VBD O
the DT O
activities NNS O
shown VBN O
by IN O
DEPs NNP O
. . O

The DT O
nuclear JJ B-Gene
receptor NN I-Gene
PPAR NNP I-Gene
gamma NN I-Gene
is VBZ O
expressed VBN O
by IN O
mouse NN O
T NNP O
lymphocytes VBZ O
and CC O
PPAR NNP O
gamma VBP O
agonists NNS O
induce VBP O
apoptosis NN O
. . O

Peroxisome NNP B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
( ( I-Gene
PPAR NNP I-Gene
) ) I-Gene
- : I-Gene
gamma NN I-Gene
is VBZ O
a DT O
nuclear JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
that WDT O
serves VBZ O
as IN O
a DT O
trans NNS O
factor NN O
to TO O
regulate VB O
lipid JJ O
metabolism NN O
. . O

Intense JJ O
interest NN O
is VBZ O
focused VBN O
on IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
its PRP$ O
ligands NNS O
owing VBG O
to TO O
its PRP$ O
putative JJ O
role NN O
in IN O
adipocyte JJ O
differentiation NN O
. . O

Little JJ O
is VBZ O
known VBN O
, , O
however RB O
, , O
about IN O
the DT O
functions NNS O
of IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
the DT O
immune NN O
system NN O
, , O
especially RB O
in IN O
T NNP O
lymphocytes NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
both DT O
naive JJ O
and CC O
activated VBD O
ovalbumin SYM O
- : O
specific JJ O
T NNP O
cells NNS O
from IN O
DO11 NNP O
. . O
10 CD O
- : O
transgenic JJ O
mice NN O
express NN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
mRNA NN O
and CC O
protein NN O
. . O

In IN O
order NN O
to TO O
determine VB O
the DT O
function NN O
of IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
T NNP O
cells NNS O
were VBD O
stimulated VBN O
with IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
and CC O
ionomycin NN O
or CC O
antigen NN O
and CC O
antigen NN O
- : O
presenting NN O
cells NNS O
. . O

Simultaneous JJ O
exposure NN O
to TO O
PPAR NNP O
- : O
gamma NN O
ligands NNS O
( ( O
e NN O
. . O
g NN O
. . O
15 CD O
- : O
deoxy NN O
- : O
Delta NNP O
( ( O
12 CD O
, , O
14 CD O
) ) O
- : O
prostaglandin NN O
J NNP O
( ( O
2 CD O
) ) O
, , O
troglitazone NN O
) ) O
showed VBD O
drastic JJ O
inhibition NN O
of IN O
proliferation NN O
and CC O
significant JJ O
decreases NNS O
in IN O
cell NN O
viability NN O
. . O

The DT O
decrease NN O
in IN O
cell NN O
viability NN O
was VBD O
due JJ O
to TO O
apoptosis NN O
of IN O
the DT O
T NNP O
lymphocytes NNS O
, , O
and CC O
occurred VBD O
only RB O
when WRB O
cells NNS O
were VBD O
treated VBN O
with IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
and CC O
not RB O
PPAR NNP O
- : O
alpha NN O
agonists NNS O
, , O
revealing VBG O
specificity NN O
of IN O
this DT O
response NN O
for IN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

These DT O
observations NNS O
suggest VBP O
that IN O
PPAR NNP O
- : O
gamma NN O
agonists NNS O
play VBP O
an DT O
important JJ O
role NN O
in IN O
regulating VBG O
T NNP O
cell NN O
- : O
mediated VBN O
immune JJ O
responses NNS O
by IN O
inducing VBG O
apoptosis NN O
. . O

T NNP O
cell NN O
death NN O
via IN O
PPAR NNP O
- : O
gamma NN O
ligation NN O
may MD O
act VB O
as IN O
a DT O
potent NN O
anti SYM O
- : O
inflammatory JJ O
signal NN O
in IN O
the DT O
immune NN O
system NN O
, , O
and CC O
ligands NNS O
could MD O
possibly RB O
be VB O
used VBN O
to TO O
control VB O
disorders NNS O
in IN O
which WDT O
excessive JJ O
inflammation NN O
occurs NNS O
. . O

Suppression NN O
of IN O
lung NN O
inflammation NN O
in IN O
rats NNS O
by IN O
prevention NN O
of IN O
NF NNP O
- : O
kappaB NN O
activation NN O
in IN O
the DT O
liver NN O
. . O

Activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
production NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
dependent JJ O
chemokines NNS B-Gene
are VBP O
thought VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
neutrophilic JJ O
lung NN O
inflammation NN O
. . O

Calpain NNP O
- : O
1 CD O
inhibitor NN O
( ( O
CI NNP O
- : O
1 CD O
) ) O
blocks NNS O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
by IN O
preventing VBG O
proteolysis NN O
of IN O
the DT O
inhibitory NN O
protein NN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
by IN O
the DT O
ubiquitin JJ O
/ JJ O
proteasome NN O
pathway NN O
. . O

We PRP O
hypothesized VBD O
that IN O
inhibition NN O
of IN O
proteasome JJ O
function NN O
with IN O
CI NNP O
- : O
1 CD O
would MD O
block VB O
NF NNP O
- : O
kappaB NN O
activation NN O
in IN O
vivo NN O
after IN O
intraperitoneal NN O
( ( O
i JJ O
. . O
p NN O
. . O
) ) O
treatment NN O
with IN O
bacterial JJ O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
, , O
and CC O
that IN O
NF NNP O
- : O
kappaB NN O
inhibition NN O
would MD O
be VB O
associated VBN O
with IN O
suppression NN O
of IN O
chemokine JJ O
gene NN O
expression NN O
and CC O
attenuation NN O
of IN O
neutrophilic JJ O
alveolitis NN O
. . O

We PRP O
treated VBD O
rats NNS O
with IN O
a DT O
single JJ O
i NN O
. . O
p NN O
. . O
injection NN O
of IN O
CI NNP O
- : O
1 CD O
( ( O
10 CD O
mg NN O
/ NNP O
kg NN O
) ) O
two CD O
hours NNS O
prior RB O
to TO O
i VB O
. . O
p NN O
. . O
LPS NNP O
( ( O
7 CD O
mg NN O
/ NNP O
kg NN O
) ) O
. . O

Treatment NN O
with IN O
Cl NNP O
- : O
1 CD O
prevented JJ O
degradation NN O
of IN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
the DT O
liver NN O
in IN O
response NN O
to TO O
LPS NNP O
; : O
however RB O
, , O
Cl NNP O
- : O
1 CD O
treatment NN O
had VBD O
no DT O
detected JJ O
effect NN O
on IN O
NF NNP O
- : O
kappaB NN O
activation NN O
in IN O
lung NN O
tissue NN O
. . O

CI NNP O
- : O
1 CD O
treatment NN O
prior RB O
to TO O
LPS NNP O
resulted VBD O
in IN O
40 CD O
% NN O
lower JJR O
MIP NNP O
- : O
2 CD O
concentration NN O
in IN O
lung NN O
lavage NN O
fluid NN O
compared VBN O
to TO O
rats NNS O
treated VBN O
with IN O
vehicle NN O
prior RB O
to TO O
LPS NNP O
( ( O
502 CD O
+ NN O
/ NNP O
- : O
112 CD O
pg NN O
/ NNP O
ml NN O
vs NN O
. . O
859 CD O
+ JJ O
/ NNP O
- : O
144 CD O
pg NN O
/ NNP O
ml NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

In IN O
addition NN O
, , O
CI NNP O
- : O
1 CD O
treatment NN O
substantially RB O
inhibited VBN O
LPS NNP O
- : O
induced VBD O
neutrophilic JJ O
alveolitis NN O
( ( O
2 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
5 CD O
) ) O
vs NN O
. . O
43 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
12 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
5 CD O
) ) O
lung NN O
lavage NN O
neutrophils NNS O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
NF NNP O
- : O
kappaB NN O
inhibition NN O
in IN O
the DT O
liver NN O
can MD O
alter VB O
lung JJ O
inflammation NN O
induced VBN O
by IN O
systemic JJ O
LPS NNP O
treatment NN O
and CC O
suggest VBP O
that IN O
a DT O
liver NN O
- : O
lung NN O
interaction NN O
contributes VBZ O
to TO O
the DT O
inflammatory JJ O
response NN O
of IN O
the DT O
lung NN O
. . O

Notch1 NNP B-Gene
regulates VBZ O
maturation NN O
of IN O
CD4 NNP O
+ NNP O
and CC O
CD8 NNP O
+ NNP O
thymocytes NNS O
by IN O
modulating VBG O
TCR NNP O
signal JJ O
strength NN O
. . O

Notch NNP O
signaling VBG O
regulates NNS O
cell VBP O
fate JJ O
decisions NNS O
in IN O
multiple JJ O
lineages NNS O
. . O

We PRP O
demonstrate VBP O
in IN O
this DT O
report NN O
that IN O
retroviral JJ O
expression NN O
of IN O
activated JJ O
Notch1 NNP B-Gene
in IN O
mouse NN O
thymocytes NNS O
abrogates VBZ O
differentiation NN O
of IN O
immature NN O
CD4 NNP O
+ NNP O
CD8 NNP O
+ NNP O
thymocytes VBZ O
into IN O
both DT O
CD4 NNP O
and CC O
CD8 NNP O
mature VBP O
single JJ O
- : O
positive JJ O
T NNP O
cells NNS O
. . O

The DT O
ability NN O
of IN O
Notch1 NNP B-Gene
to TO O
inhibit VB O
T NNP O
cell NN O
development NN O
was VBD O
observed VBN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
with IN O
both DT O
normal JJ O
and CC O
TCR NNP O
transgenic JJ O
thymocytes NNS O
. . O

Notch1 NNP B-Gene
- : O
mediated VBD O
developmental JJ O
arrest NN O
was VBD O
dose JJ O
dependent JJ O
and CC O
was VBD O
associated VBN O
with IN O
impaired JJ O
thymocyte NN O
responses NNS O
to TO O
TCR NNP O
stimulation NN O
. . O

Notch1 NNP B-Gene
also RB O
inhibited VBD O
TCR NNP O
- : O
mediated VBD O
signaling VBG O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
constitutively RB O
active JJ O
Notch1 NNP B-Gene
abrogates VBZ O
CD4 NNP O
+ NNP O
and CC O
CD8 NNP O
+ NNP O
maturation NN O
by IN O
interfering VBG O
with IN O
TCR NNP O
signal JJ O
strength NN O
and CC O
provide VB O
an DT O
explanation NN O
for IN O
the DT O
physiological JJ O
regulation NN O
of IN O
Notch NNP O
expression NN O
during IN O
thymocyte NN O
development NN O
. . O

Expression NN O
of IN O
SART3 NNP B-Gene
antigen NN I-Gene
and CC O
induction NN O
of IN O
CTLs NNP O
by IN O
SART3 NNP O
- : O
derived VBD O
peptides NNS O
in IN O
breast NN O
cancer NN O
patients NNS O
. . O

We PRP O
recently RB O
reported VBD O
the DT O
SART3 NNP B-Gene
tumour SYM I-Gene
- : I-Gene
rejection NN I-Gene
antigen NN I-Gene
as IN O
possessing VBG O
tumour JJ O
epitopes NNS O
capable JJ O
of IN O
inducing VBG O
HLA NNP O
- : O
class NN O
I PRP O
- : O
restricted VBN O
cytotoxic JJ O
T NNP O
lymphocytes NNS O
( ( O
CTLs NNP O
) ) O
. . O

This DT O
study NN O
investigated VBD O
expression NN O
of IN O
the DT O
SART3 NNP B-Gene
antigen NN I-Gene
in IN O
breast NN O
cancer NN O
to TO O
explore VB O
an DT O
appropriate JJ O
molecule NN O
for IN O
use NN O
in IN O
specific JJ O
immunotherapy NN O
of IN O
breast NN O
cancer NN O
patients NNS O
. . O

The DT O
SART3 NNP B-Gene
antigen NN I-Gene
was VBD O
detected VBN O
in IN O
all DT O
of IN O
the DT O
breast NN O
cancer NN O
cell NN O
lines NNS O
tested VBD O
, , O
30 CD O
of IN O
40 CD O
( ( O
75 CD O
% NN O
) ) O
breast NN O
cancer NN O
tissue NN O
samples NNS O
, , O
and CC O
0 CD O
of IN O
3 CD O
non JJ O
- : O
tumourous JJ O
breast NN O
tissue NN O
samples NNS O
. . O

SART3 NNP O
derived VBD O
peptides NNS O
at IN O
positions NNS B-Gene
109 CD I-Gene
- : I-Gene
118 CD I-Gene
and CC I-Gene
315 CD I-Gene
- : I-Gene
323 CD I-Gene
induced JJ O
HLA NNP O
- : O
A24 NNP O
restricted VBD O
CTLs NNP O
that WDT O
reacted VBD O
to TO O
breast VB O
cancer NN O
cells NNS O
from IN O
the DT O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMCs NNP O
) ) O
of IN O
breast NN O
cancer NN O
patients NNS O
. . O

Therefore RB O
, , O
the DT O
SART3 NNP B-Gene
antigen NN I-Gene
and CC O
its PRP$ O
peptides NNS O
could MD O
be VB O
an DT O
appropriate JJ O
molecule NN O
for IN O
use NN O
in IN O
specific JJ O
immunotherapy NN O
of IN O
the DT O
majority NN O
of IN O
HLA NNP O
- : O
A24 NNP O
- : O
positive JJ O
breast NN O
cancer NN O
patients NNS O

Autostimulation NN O
of IN O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
BRLF1 NNP B-Gene
promoter NN I-Gene
is VBZ O
mediated VBN O
through IN O
consensus NN O
Sp1 NNP B-Gene
and CC I-Gene
Sp3 NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

As IN O
an DT O
essential JJ O
step NN O
in IN O
the DT O
lytic JJ O
cascade NN O
, , O
the DT O
Rta NNP O
homologues NNS O
of IN O
gammaherpesviruses NNS O
all DT O
activate VBP O
their PRP$ O
own JJ O
expression NN O
. . O

Consistent JJ O
with IN O
this DT O
biologic JJ O
function NN O
, , O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
Rta NNP B-Gene
protein NN I-Gene
powerfully RB O
stimulates VBZ O
the DT O
promoter NN B-Gene
of IN O
its PRP$ O
own JJ O
gene NN O
, , O
Rp NNP B-Gene
, , O
in IN O
EBV NNP O
- : O
positive JJ O
B NNP O
cells NNS O
in IN O
transient JJ O
- : O
transfection NN O
reporter NN O
- : O
based VBN O
assays NNS O
. . O

We PRP O
analyzed VBD O
the DT O
activity NN O
of IN O
RpCAT NNP B-Gene
in IN O
response NN O
to TO O
Rta NNP B-Gene
by IN O
deletional JJ O
and CC O
site NN O
- : O
directed JJ O
mutagenesis NN O
. . O

Two CD O
cognate NN B-Gene
Sp1 NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
located VBN O
at IN O
- : O
279 CD O
and CC O
- : O
45 CD O
relative NN O
to TO O
the DT O
transcriptional JJ B-Gene
start NN I-Gene
site NN I-Gene
proved VBD O
crucial JJ O
for IN O
Rta NNP O
- : O
mediated VBN O
activation NN O
. . O

Previously RB O
described VBN O
binding NN O
sites NNS O
for IN O
the DT O
cellular JJ O
transcription NN B-Gene
factor NN I-Gene
Zif268 NNP I-Gene
and CC O
the DT O
viral JJ B-Gene
transactivator NN I-Gene
ZEBRA NNP I-Gene
were VBD O
found VBN O
to TO O
be VB O
dispensable JJ O
for IN O
activation NN O
of IN O
RpCAT NNP B-Gene
by IN O
Rta NNP B-Gene
. . O

Gel NNP O
shift NN O
analysis NN O
, , O
using VBG O
extracts NNS O
of IN O
B NNP O
cells NNS O
in IN O
latency NN O
or CC O
induced VBN O
into IN O
the DT O
lytic JJ O
cycle NN O
, , O
identified VBN O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
as IN O
the DT O
predominant NN O
cellular JJ B-Gene
proteins NNS I-Gene
bound VBN O
to TO O
Rp NNP B-Gene
near IN O
- : O
45 CD O
. . O

During IN O
the DT O
lytic JJ O
cycle NN O
, , O
ZEBRA NNP B-Gene
bound VBD O
Rp NNP B-Gene
near IN O
the DT O
Sp1 NNP B-Gene
/ NNP I-Gene
Sp3 NNP I-Gene
site NN I-Gene
. . O

The DT O
binding NN O
of IN O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
to TO O
Rp NNP B-Gene
correlated VBN O
with IN O
the DT O
reporter NN O
activities NNS O
in IN O
the DT O
mutagenesis NN O
study NN O
, , O
establishing VBG O
a DT O
direct JJ O
link NN O
between IN O
transcriptional JJ O
activation NN O
of IN O
Rp NNP B-Gene
by IN O
Rta NNP B-Gene
and CC O
DNA NNP O
binding NN O
by IN O
Sp1 NNP B-Gene
and CC O
/ NNP O
or CC O
Sp3 NNP B-Gene
. . O

The DT O
relative JJ O
abundance NN O
or CC O
functional JJ O
state NN O
of IN O
the DT O
cellular JJ O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
transcription NN B-Gene
factors NNS I-Gene
may MD O
be VB O
altered VBN O
in IN O
response NN O
to TO O
stimuli VB O
that DT O
induce VB O
the DT O
BRLF1 NNP B-Gene
promoter NN I-Gene
and CC O
thereby RB O
contribute VB O
to TO O
the DT O
activation NN O
of IN O
the DT O
viral JJ O
lytic JJ O
cycle NN O
. . O

Gene NNP O
transfer NN O
of IN O
antisense JJ O
hypoxia NN B-Gene
inducible JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
enhances VBZ O
the DT O
therapeutic JJ O
efficacy NN O
of IN O
cancer NN O
immunotherapy NN O
. . O

Solid JJ O
tumors NNS O
meet VBP O
their PRP$ O
demands NNS O
for IN O
nascent JJ O
blood NN O
vessels NNS O
and CC O
increased JJ O
glycolysis NN O
, , O
to TO O
combat VB O
hypoxia NN O
, , O
by IN O
activating VBG O
multiple JJ O
genes NNS O
involved VBN O
in IN O
angiogenesis NN O
and CC O
glucose JJ O
metabolism NN O
. . O

Hypoxia NNP B-Gene
inducible JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
HIF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
a DT O
constitutively RB O
expressed VBN O
basic JJ O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
formed VBN O
by IN O
the DT O
assembly NN O
of IN O
HIF NNP B-Gene
- : I-Gene
1alpha CD I-Gene
and CC O
HIF NNP B-Gene
- : I-Gene
1beta CD I-Gene
( ( O
Arnt NNP B-Gene
) ) O
, , O
that WDT O
is VBZ O
stablized VBN O
in IN O
response NN O
to TO O
hypoxia VB O
, , O
and CC O
rapidly RB O
degraded VBD O
under IN O
normoxic JJ O
conditions NNS O
. . O

It PRP O
activates VBZ O
the DT O
transcription NN O
of IN O
genes NNS O
important JJ O
for IN O
maintaining VBG O
oxygen NN O
homeostasis NN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
engineered VBD O
down IN O
- : O
regulation NN O
of IN O
HIF NNP B-Gene
- : I-Gene
1alpha CD I-Gene
by IN O
intratumoral JJ O
gene NN O
transfer NN O
of IN O
an DT O
antisense NN B-Gene
HIF NNP I-Gene
- : I-Gene
1alpha CD I-Gene
plasmid JJ I-Gene
leads NNS O
to TO O
the DT O
down RP O
- : O
regulation NN O
of IN O
VEGF NNP B-Gene
, , O
and CC O
decreased VBD O
tumor NN O
microvessel NN O
density NN O
. . O

Antisense NNP O
HIF NNP O
- : O
1alpha CD O
monotherapy NN O
resulted VBD O
in IN O
the DT O
complete JJ O
and CC O
permanent JJ O
rejection NN O
of IN O
small JJ O
( ( O
0 CD O
. . O
1 CD O
cm NN O
in IN O
diameter NN O
) ) O
EL NNP O
- : O
4 CD O
tumors NNS O
, , O
which WDT O
is VBZ O
unusual JJ O
for IN O
an DT O
anti JJ O
- : O
angiogenic JJ O
agent NN O
where WRB O
transient JJ O
suppression NN O
of IN O
tumor NN O
growth NN O
is VBZ O
the DT O
norm NN O
. . O

It PRP O
induced VBD O
NK NNP O
cell NN O
- : O
dependent JJ O
rejection NN O
of IN O
tumors NNS O
, , O
but CC O
failed VBD O
to TO O
stimulate VB O
systemic JJ O
T NNP O
cell NN O
- : O
mediated VBN O
anti IN O
- : O
tumor NN O
immunity NN O
, , O
and CC O
synergized VBN O
with IN O
B7 NNP O
- : O
1 CD O
- : O
mediated VBN O
immunotherapy NN O
to TO O
cause VB O
the DT O
NK NNP O
cell NN O
and CC O
CD8 NNP O
T NNP O
cell NN O
- : O
dependent JJ O
rejection NN O
of IN O
larger JJR O
EL NNP O
- : O
4 CD O
tumors NNS O
( ( O
0 CD O
. . O
4 CD O
cm NN O
in IN O
diameter NN O
) ) O
that WDT O
were VBD O
refractory JJ O
to TO O
monotherapies NNS O
. . O

Mice NNP O
cured VBD O
of IN O
their PRP$ O
tumors NNS O
by IN O
combination NN O
therapy NN O
resisted VBD O
a DT O
rechallenge NN O
with IN O
parental JJ O
tumor NN O
cells NNS O
, , O
indicating VBG O
systemic JJ O
antitumor NN O
immunity NN O
had VBD O
been VBN O
achieved VBN O
. . O

In IN O
summary JJ O
, , O
whilst JJ O
intensive JJ O
investigations NNS O
are VBP O
in IN O
progress NN O
to TO O
target VB O
the DT O
many JJ O
HIF NNP B-Gene
- : I-Gene
1 CD I-Gene
effectors NNS O
, , O
the DT O
results NNS O
herein VBP O
indicate VBP O
that IN O
blocking VBG O
hypoxia SYM O
- : O
inducible JJ O
pathways NNS O
and CC O
enhancing VBG O
NK NNP O
- : O
mediated VBD O
antitumor JJ O
immunity NN O
by IN O
targeting VBG O
HIF NNP B-Gene
- : I-Gene
1 CD I-Gene
itself PRP O
may MD O
be VB O
advantageous JJ O
, , O
especially RB O
when WRB O
combined VBN O
with IN O
cancer NN O
immunotherapy NN O
. . O

Runx2 NN B-Gene
: : O
a DT O
novel JJ O
oncogenic JJ O
effector NN O
revealed VBN O
by IN O
in IN O
vivo JJ O
complementation NN O
and CC O
retroviral JJ O
tagging NN O
. . O

The DT O
Runx2 NNP B-Gene
( ( O
Cbfa1 NNP B-Gene
, , O
Pebp2alphaA NNP B-Gene
, , O
Aml3 NNP B-Gene
) ) O
gene NN O
was VBD O
previously RB O
identified VBN O
as IN O
a DT O
frequent JJ O
target NN O
for IN O
transcriptional JJ O
activation NN O
by IN O
proviral JJ O
insertion NN O
in IN O
T NNP O
- : O
cell NN O
lymphomas NN O
of IN O
CD2 NNP O
- : O
MYC NNP O
transgenic JJ O
mice NN O
. . O

We PRP O
have VBP O
recently RB O
shown VBN O
that IN O
over IN O
- : O
expression NN O
of IN O
the DT O
full JJ O
- : O
length NN O
, , O
most JJS O
highly RB O
expressed VBN O
Runx2 NNP B-Gene
isoform NN O
in IN O
the DT O
thymus NN O
perturbs NN O
T NNP O
- : O
cell NN O
development NN O
, , O
leads VBZ O
to TO O
development NN O
of IN O
spontaneous JJ O
lymphomas NNS O
at IN O
low JJ O
frequency NN O
and CC O
is VBZ O
strongly RB O
synergistic JJ O
with IN O
Myc NNP B-Gene
. . O

To TO O
gain VB O
further JJ O
insight NN O
into IN O
the DT O
relationship NN O
of IN O
Runx2 NNP B-Gene
to TO O
other JJ O
lymphomagenic JJ O
pathways NNS O
, , O
we PRP O
tested VBD O
the DT O
effect NN O
of IN O
combining VBG O
the DT O
CD2 NNP B-Gene
- : I-Gene
Runx2 NNP I-Gene
transgene NN I-Gene
either RB O
with IN O
a DT O
Pim1 NNP B-Gene
transgene NN I-Gene
( ( O
E NNP B-Gene
( ( I-Gene
mu NN I-Gene
) ) I-Gene
- : I-Gene
Pim1 NN I-Gene
) ) O
or CC O
with IN O
the DT O
p53 NN B-Gene
null JJ O
genotype NN O
, , O
as IN O
each DT O
of IN O
these DT O
displays NNS O
independent JJ O
synergy NN O
with IN O
Myc NNP B-Gene
. . O

In IN O
both DT O
cases NNS O
we PRP O
observed VBD O
synergistic JJ O
tumour NN O
development NN O
. . O

However RB O
, , O
Runx2 NNP B-Gene
appeared VBD O
to TO O
have VB O
a DT O
dominant JJ O
effect NN O
on IN O
the DT O
tumour NN O
phenotype NN O
in IN O
each DT O
case NN O
, , O
with IN O
most JJS O
tumours NNS O
conforming VBG O
to TO O
the DT O
CD3 NNP O
( ( O
+ NNP O
) ) O
, , O
CD8 NNP O
( ( O
+ NNP O
) ) O
, , O
CD4 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
phenotype NN O
seen VBN O
in IN O
CD2 NNP O
- : O
Runx2 NNP O
mice NN O
. . O

Neonatal JJ O
infection NN O
of IN O
CD2 NNP O
- : O
Runx2 NNP O
mice NN O
with IN O
Moloney NNP O
murine NN O
leukaemia NN O
virus NN O
( ( O
Moloney NNP O
MLV NNP O
) ) O
also RB O
led VBN O
to TO O
a DT O
dramatic JJ O
acceleration NN O
of IN O
tumour JJ O
onset NN O
. . O

Analysis NN O
of IN O
known VBN O
Moloney NNP B-Gene
MLV NNP I-Gene
target NN I-Gene
genes NNS I-Gene
in IN O
these DT O
lymphomas NN O
showed VBD O
a DT O
high JJ O
frequency NN O
of IN O
rearrangement NN O
at IN O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
or CC O
N NNP B-Gene
- : I-Gene
Myc NNP I-Gene
( ( O
82 CD O
% NN O
) ) O
, , O
and CC O
a DT O
significant JJ O
number NN O
at IN O
Pim1 NNP B-Gene
or CC O
Pim2 NNP B-Gene
( ( O
23 CD O
% NN O
) ) O
, , O
and CC O
at IN O
Pal1 NNP B-Gene
/ NNP I-Gene
Gfi1 NNP I-Gene
( ( O
18 CD O
% NN O
) ) O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
Runx2 NNP B-Gene
makes VBZ O
a DT O
distinct JJ O
contribution NN O
to TO O
T NNP O
- : O
cell NN O
lymphoma NN O
development NN O
which WDT O
does VBZ O
not RB O
coincide VB O
with IN O
any DT O
of IN O
the DT O
oncogene JJ O
complementation NN O
groups NNS O
previously RB O
identified VBN O
by IN O
retroviral JJ O
tagging NN O
. . O

The DT O
involvement NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
related JJ O
apoptosis NN O
- : O
inducing NN O
ligand NN O
in IN O
the DT O
enhanced JJ O
cytotoxicity NN O
of IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
stimulated VBN O
human JJ O
dendritic JJ O
cells NNS O
to TO O
tumor VB O
cells NNS O
. . O

TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
related JJ O
apoptosis NN O
- : O
inducing NN O
ligand NN O
( ( O
TRAIL NNP O
) ) O
is VBZ O
characterized VBN O
by IN O
its PRP$ O
preferential JJ O
induction NN O
of IN O
apoptosis NN O
of IN O
tumor NN O
cells NNS O
but CC O
not RB O
normal JJ O
cells NNS O
. . O

Dendritic JJ O
cells NNS O
( ( O
DCs NNP O
) ) O
, , O
besides IN O
their PRP$ O
role NN O
as IN O
APCs NNP O
, , O
now RB O
have VBP O
been VBN O
demonstrated VBN O
to TO O
exert VB O
cytotoxicity NN O
or CC O
cytostasis NN O
on IN O
some DT O
tumor NN O
cells NNS O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
both DT O
human JJ O
CD34 NNP O
( ( O
+ NNP O
) ) O
stem NN O
cell SYM O
- : O
derived VBN O
DCs NNP O
( ( O
CD34DCs NNP O
) ) O
and CC O
human JJ O
CD14 NNP O
( ( O
+ NNP O
) ) O
monocyte SYM O
- : O
derived VBN O
DCs NNP O
( ( O
MoDCs NNP O
) ) O
express NN O
TRAIL NNP O
and CC O
exhibit NN O
cytotoxicity NN O
to TO O
some DT O
types NNS O
of IN O
tumor NN O
cells NNS O
partially RB O
through IN O
TRAIL NNP O
. . O

Moderate JJ O
expression NN O
of IN O
TRAIL NNP O
appeared VBD O
on IN O
CD34DCs NNP O
from IN O
the DT O
8th CD O
day NN O
of IN O
culture NN O
and CC O
was VBD O
also RB O
seen VBN O
on IN O
freshly RB O
isolated VBN O
monocytes NNS O
. . O

The DT O
level NN O
of IN O
TRAIL NNP O
expression NN O
remained VBD O
constant JJ O
until IN O
DC NNP O
maturation NN O
. . O

TRAIL NNP O
expression NN O
on IN O
immature NN O
CD34DCs NNP O
or CC O
MoDCs NNP O
was VBD O
greatly RB O
up IN O
- : O
regulated VBN O
after IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
stimulation NN O
. . O

Moreover RB O
, , O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
could MD O
strikingly VB O
enhance VB O
the DT O
ability NN O
of IN O
CD34DCs NNP O
or CC O
MoDCs NNP O
to TO O
kill VB O
TRAIL NNP O
- : O
sensitive JJ O
tumor NN O
cells NNS O
, , O
but CC O
LPS NNP O
did VBD O
not RB O
have VB O
such JJ O
an DT O
effect NN O
. . O

The DT O
up RP O
- : O
regulation NN O
of IN O
TRAIL NNP O
on IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
stimulated VBN O
DCs NNP O
partially RB O
contributed VBD O
to TO O
the DT O
increased VBN O
cytotoxicity NN O
of IN O
DCS NNP O
: : O
Pretreatment NN O
of IN O
TRAIL NNP O
- : O
sensitive JJ O
tumor NN O
cells NNS O
with IN O
caspase NN O
- : O
3 CD O
inhibitor NN O
could MD O
significantly RB O
increase VB O
their PRP$ O
resistance NN O
to TO O
the DT O
cytotoxicity NN O
of IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
stimulated VBN O
DCS NNP O
: : O
In IN O
contrast NN O
, , O
NF NNP O
- : O
kappaB NN O
inhibitor NN O
could MD O
significantly RB O
increase VB O
the DT O
sensitivity NN O
of IN O
tumor NN O
cells NNS O
to TO O
the DT O
killing NN O
by IN O
nonstimulated JJ O
or CC O
LPS NNP O
- : O
stimulated VBD O
DCS NNP O
: : O
Our PRP$ O
studies NNS O
demonstrate VBP O
that IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
stimulated VBN O
DCs NNP O
are VBP O
functionally RB O
cytotoxic JJ O
. . O

Thus RB O
, , O
an DT O
innate NN O
mechanism NN O
of IN O
DC NNP O
- : O
mediated VBD O
antitumor JJ O
immunity NN O
might MD O
exist VB O
in IN O
vivo NN O
in IN O
which WDT O
DCs NNP O
act NN O
as IN O
effectors NNS O
to TO O
directly RB O
kill VB O
tumor NN O
cells NNS O
partially RB O
via IN O
TRAIL NNP O
. . O

Subsequently RB O
, , O
DCs NNP O
act NN O
as IN O
APCs NNP O
involved VBD O
in IN O
the DT O
uptake NN O
, , O
processing NN O
, , O
and CC O
presentation NN O
of IN O
apoptotic JJ B-Gene
tumor NN I-Gene
Ags NNP I-Gene
to TO O
cross VB O
- : O
prime JJ O
CD8 NNP O
( ( O
+ NNP O
) ) O
CTL NNP O
cells NNS O
. . O

Tumor NNP O
cells NNS O
regulate VBP O
the DT O
lytic JJ O
activity NN O
of IN O
tumor NN O
- : O
specific JJ O
cytotoxic NN O
t NN O
lymphocytes NNS O
by IN O
modulating VBG O
the DT O
inhibitory JJ O
natural JJ O
killer NN O
receptor NN O
function NN O
. . O

Tumor NNP O
- : O
infiltrating VBG O
p58 JJ O
+ NNP O
T NNP O
cells NNS O
from IN O
a DT O
renal JJ O
tumor NN O
were VBD O
specifically RB O
expanded VBN O
in IN O
response NN O
to TO O
tumor VB O
cell NN O
stimulation NN O
and CC O
cloned VBN O
. . O

These DT O
p58 JJ O
+ NN O
T NNP O
cells NNS O
were VBD O
found VBN O
to TO O
express VB O
a DT O
memory NN O
phenotype NN O
and CC O
corresponded VBD O
to TO O
clonal JJ O
TCRBV3 NNP O
T NNP O
- : O
cell NN O
expansion NN O
. . O

Functionally RB O
, , O
p58 NN O
( ( O
+ NNP O
) ) O
CTLs NNP O
displayed VBD O
a DT O
low JJ O
lytic JJ O
activity NN O
for IN O
HLA NNP O
- : O
A2 NNP O
tumor NN O
and CC O
normal JJ O
cells NNS O
. . O

However RB O
, , O
this DT O
lytic JJ O
activity NN O
was VBD O
significantly RB O
increased VBN O
after IN O
blockade NN O
of IN O
p58 NN B-Gene
with IN O
specific JJ O
monoclonal JJ B-Gene
antibodies NNS I-Gene
. . O

Interestingly RB O
, , O
we PRP O
demonstrated VBD O
that IN O
stimulation NN O
by IN O
tumor NN O
cells NNS O
was VBD O
required VBN O
to TO O
trigger VB O
the DT O
inhibitory JJ O
effect NN O
of IN O
p58 NN B-Gene
on IN O
the DT O
lytic JJ O
activity NN O
of IN O
antigen NN O
- : O
specific JJ O
CTLs NNP O
and CC O
that DT O
stimulation NN O
of IN O
the DT O
inhibitory JJ O
function NN O
of IN O
p58 NN B-Gene
by IN O
tumor NN O
cells NNS O
correlated VBN O
with IN O
an DT O
inhibition NN O
of IN O
nuclear JJ O
factor NN O
- : O
kappaB NN O
activation NN O
in IN O
p58 NN O
+ NNP O
tumor NN O
- : O
specific JJ O
CTLS NNP O
. . O

T NNP B-Gene
- : I-Gene
cell NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
expression NN O
during IN O
human JJ O
natural JJ O
killer NN O
cell NN O
development NN O
and CC O
in IN O
circulating VBG O
CD56 NNP B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
bright VBD O
natural JJ O
killer NN O
cells NNS O
. . O

Transcription NN B-Gene
factors NNS I-Gene
are VBP O
essential JJ O
to TO O
govern VB O
differentiation NN O
along IN O
the DT O
lymphoid JJ O
lineage NN O
from IN O
uncommitted JJ O
hematopoietic JJ O
stem NN O
cells NNS O
. . O

Although IN O
many JJ O
of IN O
these DT O
transcription NN B-Gene
factors NNS I-Gene
have VBP O
putative JJ O
roles NNS O
based VBN O
on IN O
murine NN O
knockout NN O
experiments NNS O
, , O
their PRP$ O
function NN O
in IN O
human JJ O
lymphoid NN O
development NN O
is VBZ O
less RBR O
known JJ O
and CC O
was VBD O
studied VBN O
further RB O
. . O

Transcription NNP O
factor NN O
expression NN O
in IN O
fresh JJ O
and CC O
cultured JJ O
adult NN O
human JJ O
bone NN O
marrow NN O
and CC O
umbilical JJ O
cord NN O
blood NN O
progenitors NNS O
was VBD O
evaluated VBN O
. . O

We PRP O
found VBD O
that IN O
fresh JJ O
CD34 NNP O
( ( O
+ NNP O
) ) O
Lin NNP O
( ( O
- : O
) ) O
cells NNS O
that WDT O
are VBP O
human JJ O
leukocyte JJ O
antigen NN O
( ( O
HLA NNP O
) ) O
- : O
DR NN O
( ( O
- : O
) ) O
or CC O
CD38 NNP O
( ( O
- : O
) ) O
constitutively RB O
express JJ O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
but CC O
not RB O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
or CC O
Id NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

Culture NN O
with IN O
the DT O
murine NN O
fetal JJ O
liver RB O
cell VBP O
line NN O
AFT024 NNP O
and CC O
defined VBD O
cytokines NNS B-Gene
was VBD O
capable JJ O
of IN O
inducing VBG O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

However RB O
, , O
no DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
gene NN I-Gene
rearrangement NN O
was VBD O
identified VBN O
in IN O
cultured JJ O
progeny NN O
. . O

Id NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
a DT O
basic JJ B-Gene
helix NN I-Gene
loop NN I-Gene
helix NN I-Gene
factor NN I-Gene
with IN O
dominant JJ O
negative JJ O
function NN O
for IN O
T NNP O
- : O
cell NN O
differentiation NN O
transcription NN B-Gene
factors NNS I-Gene
, , O
also RB O
was VBD O
upregulated JJ O
and CC O
may MD O
explain VB O
unsuccessful JJ O
T NNP O
- : O
cell NN O
maturation NN O
. . O

To TO O
better RBR O
understand VB O
the DT O
developmental JJ O
link NN O
between IN O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
cells NNS O
derived VBN O
from IN O
progenitors NNS O
, , O
we PRP O
studied VBD O
NK NNP O
cell NN O
subsets NNS O
circulating VBG O
in IN O
blood NN O
. . O

CD56 NNP O
( ( O
+ NNP O
bright RB O
) ) O
, , O
but CC O
not RB O
CD56 NNP O
( ( O
+ NNP O
dim NN O
) ) O
, , O
NK NNP O
cells NNS O
constitutively RB O
express VBP O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
by IN O
reverse NN O
transcriptase NN O
polymerase NN O
chain NN O
reaction NN O
and CC O
Western JJ O
blot NN O
analysis NN O
. . O

The DT O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
isoform NN I-Gene
found VBN O
in IN O
CD56 NNP O
( ( O
+ NNP O
bright RB O
) ) O
cells NNS O
, , O
which WDT O
express VBP O
lectin NNS B-Gene
but CC O
not RB O
immunoglobulin JJ B-Gene
class NN I-Gene
I PRP I-Gene
recognizing VBG O
inhibitory JJ B-Gene
receptors NNS I-Gene
, , O
was VBD O
identical JJ O
to TO O
that DT O
induced VBN O
in IN O
NK NNP O
cell NN O
differentiation NN O
culture NN O
and CC O
was VBD O
distinctly RB O
different JJ O
from IN O
isoforms NNS O
in IN O
T NNP O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
does VBZ O
not RB O
target VB O
human JJ B-Gene
killer NN I-Gene
immunoglobulin NN I-Gene
receptor NN I-Gene
genes NNS I-Gene
, , O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
uniquely RB O
expressed VBN O
in IN O
circulating VBG O
CD56 NNP O
( ( O
+ NNP O
bright RB O
) ) O
NK NNP O
cells NNS O
, , O
and CC O
specific JJ O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
isoforms NNS I-Gene
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
regulating VBG O
NK NNP O
differentiation NN O
from IN O
a DT O
common JJ O
NK NNP O
/ NNP O
T NNP O
- : O
cell NN O
progenitor NN O
. . O

Transcriptional JJ O
activation NN O
by IN O
a DT O
matrix NN B-Gene
associating VBG I-Gene
region NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

contextual JJ O
requirements NNS O
for IN O
the DT O
function NN O
of IN O
bright NN B-Gene
. . O

Bright NNP B-Gene
( ( O
B NNP B-Gene
cell NN I-Gene
regulator NN I-Gene
of IN I-Gene
IgH NNP I-Gene
transcription NN I-Gene
) ) O
is VBZ O
a DT O
B NNP O
cell NN O
- : O
specific NN O
, , O
matrix JJ B-Gene
associating VBG I-Gene
region NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
that WDT O
transactivates VBZ O
gene NN O
expression NN O
from IN O
the DT O
IgH NNP B-Gene
intronic JJ I-Gene
enhancer NN I-Gene
( ( O
E NNP B-Gene
mu NN I-Gene
) ) O
. . O

We PRP O
show VBP O
here RB O
that DT O
Bright NNP B-Gene
has VBZ O
multiple VBN O
contextual JJ O
requirements NNS O
to TO O
function VB O
as IN O
a DT O
transcriptional JJ B-Gene
activator NN I-Gene
. . O

Bright NNP B-Gene
can MD O
not RB O
transactivate VB O
via IN O
out IN O
of IN O
context NN O
, , O
concatenated VBD B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Transactivation NN O
is VBZ O
maximal JJ O
on IN O
integrated JJ O
substrates NNS O
. . O

Two CD O
of IN O
the DT O
three CD O
previously RB O
identified VBN O
binding NN B-Gene
sites NNS I-Gene
in IN O
E NNP B-Gene
mu NNS I-Gene
are VBP O
required VBN O
for IN O
full JJ O
Bright NNP B-Gene
transactivation NN O
. . O

The DT O
Bright NNP B-Gene
DNA NNP I-Gene
binding VBG I-Gene
domain NN I-Gene
defined VBD O
a DT O
new JJ O
family NN O
, , O
which WDT O
includes VBZ O
SWI1 NNP B-Gene
, , O
a DT O
component NN O
of IN O
the DT O
SWI NNP B-Gene
. . I-Gene
SNF NNP I-Gene
complex JJ I-Gene
shown VBN O
to TO O
have VB O
high JJ O
mobility NN O
group NN O
- : O
like IN O
DNA NNP O
binding VBG O
characteristics NNS O
. . O

Similar JJ O
to TO O
one CD O
group NN O
of IN O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
box NN I-Gene
proteins NNS I-Gene
, , O
Bright NNP B-Gene
distorts VBZ O
E NNP B-Gene
mu NN I-Gene
binding VBG I-Gene
site NN I-Gene
- : O
containing VBG O
DNA NN O
on IN O
binding NN O
, , O
supporting VBG O
the DT O
concept NN O
that IN O
it PRP O
mediates VBZ O
E NNP B-Gene
mu NN I-Gene
remodeling NN O
. . O

Transfection NN O
studies NNS O
further RBR O
implicate NN O
Bright NNP B-Gene
in IN O
facilitating VBG O
spatially RB O
separated VBN O
promoter NN O
- : O
enhancer NN O
interactions NNS O
in IN O
both DT O
transient NN O
and CC O
stable JJ O
assays NNS O
. . O

Finally RB O
, , O
we PRP O
show VBP O
that DT O
overexpression NN O
of IN O
Bright NNP B-Gene
leads VBZ O
to TO O
enhanced VB O
DNase NNP O
I PRP O
sensitivity NN O
of IN O
the DT O
endogenous JJ O
E NNP B-Gene
mu NN I-Gene
matrix NN O
associating VBG O
regions NNS O
. . O

These DT O
data NNS O
further RB O
suggest VBP O
that IN O
Bright NNP B-Gene
may MD O
contribute VB O
to TO O
increased VBN O
gene NN O
expression NN O
by IN O
remodeling VBG O
the DT O
immunoglobulin NN B-Gene
locus NN I-Gene
during IN O
B NNP O
cell NN O
development NN O
. . O

Analysis NN O
of IN O
BCL NNP O
- : O
6 CD O
mutations NNS O
in IN O
classic JJ O
Hodgkin NNP O
disease NN O
of IN O
the DT O
B NNP O
- : O
and CC O
T NNP O
- : O
cell NN O
type NN O
. . O

BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
is VBZ O
essential JJ O
for IN O
germinal JJ O
center NN O
formation NN O
and CC O
thus RB O
for IN O
affinity NN O
maturation NN O
of IN O
immunoglobulin NN B-Gene
( ( I-Gene
Ig NNP I-Gene
) ) I-Gene
genes NNS I-Gene
by IN O
somatic JJ O
mutations NNS O
. . O

The DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
noncoding VBG I-Gene
region NN I-Gene
of IN O
the DT O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
is VBZ O
even RB O
a DT O
target NN O
for IN O
the DT O
mutation NN O
machinery NN O
. . O

Translocations NNS O
of IN O
the DT O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
to TO O
heterologous JJ B-Gene
promoters NNS I-Gene
and CC O
mutations NNS O
of IN O
its PRP$ O
5 CD B-Gene
' '' I-Gene
- : I-Gene
noncoding VBG I-Gene
regulatory JJ I-Gene
region NN I-Gene
were VBD O
reported VBN O
to TO O
be VB O
potential JJ O
mechanisms NNS O
for IN O
deregulating VBG O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
and CC O
for IN O
playing VBG O
a DT O
role NN O
in IN O
the DT O
genesis NN O
of IN O
non JJ O
- : O
Hodgkin NNP O
lymphoma NN O
. . O

In IN O
line NN O
with IN O
this DT O
hypothesis NN O
is VBZ O
the DT O
observation NN O
that IN O
B NNP O
- : O
cell NN O
lymphoma NN O
with IN O
somatic JJ O
mutations NNS O
, , O
such JJ O
as IN O
diffuse NN O
large JJ O
B NNP O
- : O
cell NN O
lymphoma NN O
and CC O
follicular JJ O
lymphoma NN O
, , O
also RB O
carry VBP O
BCL NNP O
- : O
6 CD O
mutations NNS O
, , O
some DT O
of IN O
which WDT O
are VBP O
recurrently RB O
detectable JJ O
. . O

Classic JJ O
Hodgkin NNP O
disease NN O
( ( O
cHD NN O
) ) O
is VBZ O
also RB O
derived VBN O
from IN O
B NNP O
cells NNS O
with IN O
high JJ O
loads NNS O
of IN O
somatic JJ O
mutations NNS O
and CC O
thus RB O
a DT O
further JJ O
candidate NN O
for IN O
BCL NNP O
- : O
6 CD O
mutations NNS O
. . O

To TO O
determine VB O
the DT O
presence NN O
and CC O
potential JJ O
role NN O
of IN O
BCL NNP O
- : O
6 CD O
mutations NNS O
in IN O
cHD NN O
, , O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
noncoding NN I-Gene
BCL NNP I-Gene
- : I-Gene
6 CD I-Gene
proportion NN O
of IN O
single JJ O
Hodgkin NNP O
and CC O
Reed NNP O
- : O
Sternberg NNP O
( ( O
HRS NNP O
) ) O
cells NNS O
from IN O
6 CD O
cases NNS O
of IN O
cHD NN O
and CC O
6 CD O
cases NNS O
of IN O
HD NNP O
- : O
derived VBN O
cell NN O
lines NNS O
was VBD O
analyzed VBN O
. . O

All DT O
B NNP O
- : O
cell NN O
- : O
derived VBN O
HD NNP O
cases NNS O
and CC O
cell NN O
lines NNS O
harbored VBD O
BCL NNP O
- : O
6 CD O
mutations NNS O
. . O

In IN O
contrast NN O
, , O
both DT O
T NNP O
- : O
cell NN O
- : O
derived VBN O
HD NNP O
cases NNS O
and CC O
cell NN O
lines NNS O
were VBD O
devoid NN O
of IN O
BCL NNP O
- : O
6 CD O
mutations NNS O
. . O

With IN O
only RB O
one CD O
exception NN O
, , O
there EX O
were VBD O
no DT O
lymphoma NN O
- : O
specific JJ O
recurrent NN O
BCL NNP O
- : O
6 CD O
mutations NNS O
detected VBN O
, , O
and CC O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
protein NN I-Gene
was VBD O
absent JJ O
from IN O
the DT O
HRS NNP O
cells NNS O
of IN O
most JJS O
cases NNS O
. . O

In IN O
conclusion NN O
, , O
( ( O
1 CD O
) ) O
somatic JJ O
BCL NNP O
- : O
6 CD O
mutations NNS O
are VBP O
restricted VBN O
to TO O
cHD VB O
cases NNS O
of IN O
B NNP O
- : O
cell NN O
origin NN O
, , O
and CC O
( ( O
2 CD O
) ) O
the DT O
BCL NNP O
- : O
6 CD O
mutations NNS O
represent VBP O
mostly RB O
irrelevant JJ O
somatic JJ O
base NN O
substitutions NNS O
without IN O
consequences NNS O
for IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
protein NN I-Gene
expression NN O
and CC O
the DT O
pathogenesis NN O
of IN O
cHD NN O
. . O

Gadd45gamma NNP B-Gene
is VBZ O
dispensable JJ O
for IN O
normal JJ O
mouse NN O
development NN O
and CC O
T NNP O
- : O
cell NN O
proliferation NN O
. . O

Gadd45gamma NNP B-Gene
, , O
a DT O
family NN O
member NN O
of IN O
the DT O
growth NN B-Gene
arrest NN I-Gene
and CC I-Gene
DNA NNP I-Gene
damage NN I-Gene
- : I-Gene
inducible JJ I-Gene
gene NN I-Gene
family NN I-Gene
45 CD I-Gene
( ( O
Gadd45 NNP B-Gene
) ) O
, , O
is VBZ O
strongly RB O
induced VBN O
by IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
in IN O
peripheral JJ O
T NNP O
cells NNS O
. . O

While IN O
in IN O
most JJS O
tissues NNS O
all DT O
Gadd45 NNP B-Gene
family NN I-Gene
members NNS I-Gene
are VBP O
expressed VBN O
, , O
Gadd45gamma NNP B-Gene
is VBZ O
the DT O
only JJ O
member NN O
that WDT O
is VBZ O
induced VBN O
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
induced JJ O
expression NN O
of IN O
Gadd45gamma NNP B-Gene
is VBZ O
dependent JJ O
on IN O
a DT O
signaling VBG O
pathway NN O
mediated VBN O
by IN O
the DT O
tyrosine NN B-Gene
kinase NN I-Gene
Jak3 NNP I-Gene
and CC O
the DT O
transcription NN B-Gene
factors NNS I-Gene
Stat5a NNP B-Gene
and CC O
Stat5b NNP B-Gene
( ( O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
) ) O
. . O

Previous JJ O
studies NNS O
with IN O
ectopically RB O
overexpressed VBN O
Gadd45gamma NNP B-Gene
in IN O
various JJ O
cell NN O
lines NNS O
implicated VBD O
its PRP$ O
function NN O
in IN O
negative JJ O
growth NN O
control NN O
. . O

To TO O
analyze VB O
the DT O
physiological JJ O
role NN O
of IN O
Gadd45gamma NNP B-Gene
we PRP O
used VBD O
homologous JJ O
recombination NN O
to TO O
generate VB O
mice NN O
lacking VBG O
Gadd45gamma NNP B-Gene
. . O

Gadd45gamma NNP B-Gene
- : O
deficient NN O
mice NN O
develop VB O
normally RB O
, , O
are VBP O
indistinguishable JJ O
from IN O
their PRP$ O
littermates NNS O
, , O
and CC O
are VBP O
fertile JJ O
. . O

Furthermore RB O
, , O
hematopoiesis NN O
in IN O
mice NN O
lacking VBG O
Gadd45gamma NNP B-Gene
is VBZ O
not RB O
impaired JJ O
and CC O
Gadd45gamma NNP B-Gene
- : O
deficient NN O
T NNP O
lymphocytes VBZ O
show VBP O
normal JJ O
responses NNS O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
Gadd45gamma NNP B-Gene
is VBZ O
not RB O
essential JJ O
for IN O
normal JJ O
mouse NN O
development NN O
and CC O
hematopoiesis NN O
, , O
possibly RB O
due JJ O
to TO O
functional JJ O
redundancy NN O
among IN O
the DT O
Gadd45 NNP B-Gene
family NN I-Gene
members NNS I-Gene
. . O

Gadd45gamma NNP B-Gene
is VBZ O
also RB O
dispensable JJ O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
induced VBN O
T NNP O
- : O
cell NN O
proliferation NN O
. . O

Decreased VBN O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
myc JJ I-Gene
family NN I-Gene
genes NNS I-Gene
in IN O
thymuses NNS O
from IN O
myasthenia NN O
gravis NN O
patients NNS O
. . O

The DT O
thymus NN O
is VBZ O
a DT O
critical JJ O
organ NN O
for IN O
the DT O
elimination NN O
of IN O
autoreactive JJ O
T NNP O
cells NNS O
by IN O
apoptosis NN O
. . O

We PRP O
studied VBD O
the DT O
expression NN O
of IN O
apoptosis NN O
- : O
associated VBN O
genes NNS O
, , O
bcl SYM B-Gene
- : I-Gene
xL NN I-Gene
, , O
bad JJ B-Gene
, , O
caspase VB B-Gene
- : I-Gene
3 CD I-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
myc JJ I-Gene
family NN I-Gene
genes NNS I-Gene
in IN O
myasthenia NN O
gravis NN O
( ( O
MG NNP O
) ) O
thymuses VBZ O
. . O

We PRP O
observed VBD O
that IN O
the DT O
mRNA NN O
levels NNS O
of IN O
myc NNS B-Gene
family NN I-Gene
genes NNS I-Gene
, , O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
and CC O
max NN B-Gene
, , O
were VBD O
markedly RB O
reduced VBN O
in IN O
MG NNP O
thymuses NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
- : O
mediated VBN O
signaling NN O
is VBZ O
abnormal JJ O
in IN O
MG NNP O
thymuses NNS O
. . O

The DT O
levels NNS O
of IN O
molecules NNS O
whose WP$ O
expressions NNS O
are VBP O
associated VBN O
with IN O
myc NN B-Gene
, , O
such JJ O
as IN O
STAM NNP B-Gene
, , O
prothymosin NN B-Gene
- : I-Gene
alpha NN I-Gene
, , O
and CC O
NFkappaB NNP B-Gene

Immunohistochemical JJ O
detection NN O
of IN O
interferon NN O
- : O
gamma NN O
- : O
producing VBG O
cells NNS O
in IN O
dermatophytosis NN O
. . O

Skin NNP O
lesions NNS O
of IN O
dermatophytosis NN O
are VBP O
thought VBN O
to TO O
be VB O
a DT O
result NN O
of IN O
a DT O
T NNP O
cell NN O
- : O
dependent JJ O
inflammatory JJ O
response NN O
that WDT O
is VBZ O
mediated VBN O
by IN O
various JJ O
cytokines NNS B-Gene
. . O

We PRP O
examined VBD O
whether IN O
IFN NNP O
- : O
gamma NN O
- : O
positive JJ O
cells NNS O
( ( O
as IN O
expression NN O
of IN O
Th1 NNP O
response NN O
) ) O
were VBD O
present JJ O
in IN O
the DT O
skin JJ O
lesions NNS O
of IN O
dermatophytosis NN O
in IN O
situ NN O
by IN O
immunohistochemical JJ O
techniques NNS O
. . O

Mixtures NNS O
of IN O
CD4 NNP O
- : O
positive JJ O
T NNP O
cells NNS O
and CC O
CD8 NNP O
- : O
positive JJ O
T NNP O
cells NNS O
were VBD O
found VBN O
to TO O
be VB O
present JJ O
in IN O
the DT O
dermal JJ O
infiltrates NNS O
of IN O
the DT O
lesions NNS O
. . O

Considerable JJ O
numbers NNS O
of IN O
CD1a NNP O
- : O
positive JJ O
cells NNS O
were VBD O
detected VBN O
in IN O
the DT O
upper JJ O
dermis NN O
and CC O
epidermis NN O
. . O

A DT O
marked JJ O
accumulation NN O
of IN O
CD68 NNP O
- : O
positive JJ O
cells NNS O
was VBD O
found VBN O
in IN O
the DT O
upper JJ O
dermis NN O
. . O

IFN NNP O
- : O
gamma NN O
- : O
positive JJ O
cells NNS O
were VBD O
present JJ O
in IN O
the DT O
upper JJ O
dermis NN O
of IN O
the DT O
lesions NNS O
. . O

The DT O
pattern NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
staining NN O
appeared VBD O
to TO O
be VB O
intracellular JJ O
in IN O
mononuclear JJ O
lymphoid JJ O
cells NNS O
. . O

The DT O
staining NN O
was VBD O
considered VBN O
to TO O
be VB O
highly RB O
specific JJ O
because IN O
it PRP O
could MD O
be VB O
completely RB O
blocked VBN O
by IN O
preabsorption NN O
with IN O
recombinant JJ B-Gene
IFN NNP I-Gene
- : I-Gene
gamma NN I-Gene
. . O

Our PRP$ O
data NNS O
support NN O
the DT O
hypothesis NN O
that IN O
the DT O
skin JJ O
lesions NNS O
of IN O
dermatophytosis NN O
may MD O
be VB O
associated VBN O
with IN O
a DT O
Th1 NNP O
response NN O
. . O

Th1 NNP O
response NN O
, , O
which WDT O
is VBZ O
characterized VBN O
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
release NN O
, , O
is VBZ O
thought VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
host NN O
defense NN O
against IN O
dermatophytes NNS O
and CC O
to TO O
reflect VB O
cutaneous JJ O
reaction NN O
in IN O
dermatophytosis NN O
. . O

Regulation NN O
of IN O
the DT O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
proteins NNS I-Gene
, , O
E2A NNP B-Gene
and CC O
Id3 NNP B-Gene
, , O
by IN O
the DT O
Ras NNP B-Gene
- : O
ERK NNP B-Gene
MAPK NNP B-Gene
cascade NN O
. . O

Activation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
pathways VBZ O
leads VBZ O
to TO O
cellular JJ O
differentiation NN O
and CC O
/ NN O
or CC O
proliferation NN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
cell NN O
types NNS O
, , O
including VBG O
developing VBG O
thymocytes NNS O
. . O

The DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
bHLH NN I-Gene
) ) I-Gene
proteins VBZ I-Gene
E12 NNP B-Gene
and CC O
E47 NNP B-Gene
and CC O
an DT O
inhibitor NN B-Gene
HLH NNP I-Gene
protein NN I-Gene
, , O
Id3 NNP B-Gene
, , O
play NN O
key JJ O
roles NNS O
in IN O
thymocyte JJ O
differentiation NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
E2A NNP B-Gene
DNA NNP O
binding NN O
is VBZ O
lowered VBN O
in IN O
primary JJ O
immature NN O
thymocytes VBZ O
consequent JJ O
to TO O
T NNP O
cell NN O
receptor NN O
( ( O
TCR NNP O
) ) O
- : O
mediated VBN O
ligation NN O
. . O

Whereas NNP O
expression NN O
of IN O
E2A NNP O
mRNA NN O
and CC O
protein NN O
are VBP O
unaltered JJ O
, , O
Id3 NNP B-Gene
transcripts NNS I-Gene
are VBP O
rapidly RB O
induced VBN O
upon IN O
signaling VBG O
from IN O
the DT O
TCR NNP B-Gene
. . O

Activation NN O
of IN O
Id3 NNP O
transcription NN O
is VBZ O
regulated VBN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
by IN O
the DT O
extracellular JJ O
signal NN O
- : O
regulated VBN O
kinase NN O
( ( O
ERK NNP B-Gene
) ) O
MAPK NNP B-Gene
module NN O
. . O

These DT O
observations NNS O
directly RB O
connect VBP O
the DT O
ERK NNP B-Gene
MAPK NNP B-Gene
cascade NN O
and CC O
HLH NNP B-Gene
proteins NNS I-Gene
in IN O
a DT O
linear JJ O
pathway NN O
. . O

Retinoic NNP O
acid VBZ O
up RP O
- : O
regulates NNS O
myeloid VBP O
ICAM NNP O
- : O
3 CD O
expression NN O
and CC O
function NN O
in IN O
a DT O
cell NN O
- : O
specific JJ O
fashion NN O
- : O
- : O
evidence NN O
for IN O
retinoid JJ O
signaling VBG O
pathways NNS O
in IN O
the DT O
mast NN O
cell NN O
lineage NN O
. . O

Investigation NN O
of IN O
mast NN O
cell NN O
responsiveness NN O
toward IN O
retinoic JJ O
acid NN O
( ( O
RA NNP O
) ) O
revealed VBD O
selective JJ O
promotion NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
in IN O
the DT O
human JJ O
mast NN O
cell NN O
line NN O
HMC NNP O
- : O
1 CD O
. . O

This DT O
process NN O
was VBD O
dose JJ O
- : O
and CC O
time NN O
- : O
dependent NN O
and CC O
detectable JJ O
by IN O
flow JJ O
cytometry NN O
, , O
Western JJ O
blot NN O
analysis NN O
, , O
ELISA NNP O
, , O
and CC O
Northern NNP O
blot NN O
analysis NN O
. . O

ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
modulation NN O
was VBD O
found VBN O
to TO O
be VB O
cell VBN O
- : O
type NN O
dependent NN O
, , O
detectable JJ O
also RB O
for IN O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
monocytes NNS O
but CC O
not RB O
U NNP O
- : O
937 CD O
and CC O
only RB O
weakly RB O
for IN O
KU812 NNP O
cells NNS O
. . O

Terminally RB O
differentiated VBN O
skin NN O
mast NN O
cells NNS O
also RB O
failed VBD O
to TO O
up RP O
- : O
modulate VB O
their PRP$ O
ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
suggesting VBG O
the DT O
requirement NN O
for IN O
some DT O
degree NN O
of IN O
immaturity NN O
for IN O
the DT O
process NN O
. . O

RA NNP O
- : O
mediated JJ O
effects NNS O
on IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
, , O
studied VBN O
in IN O
parallel NN O
, , O
were VBD O
clearly RB O
distinct JJ O
from IN O
those DT O
on IN O
ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

Investigation NN O
of IN O
retinoid JJ B-Gene
receptor NN I-Gene
expression NN O
, , O
known VBN O
to TO O
mediate VB O
intracellular JJ O
RA NNP O
signaling NN O
, , O
revealed VBD O
presence NN O
of IN O
RAR NNP B-Gene
alpha NN I-Gene
, , I-Gene
RAR NNP I-Gene
gamma NN I-Gene
, , I-Gene
RXR NNP I-Gene
beta NN I-Gene
, , I-Gene
and CC I-Gene
RXR NNP I-Gene
gamma NN I-Gene
transcripts NNS I-Gene
in IN O
all DT O
cell NN O
lines NNS O
studied VBN O
, , O
and CC O
HMC NNP O
- : O
1 CD O
cells NNS O
were VBD O
the DT O
only JJ O
line NN O
lacking VBG O
RXR NNP B-Gene
alpha NN I-Gene
. . O

RAR NNP B-Gene
beta NN I-Gene
, , O
not RB O
expressed VBN O
at IN O
baseline NN O
, , O
was VBD O
induced VBN O
by IN O
RA NNP O
in IN O
a DT O
fashion NN O
obviously RB O
correlating VBG O
with IN O
ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
up IN O
- : O
regulation NN O
. . O

Increased VBN O
ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
was VBD O
of IN O
functional JJ O
significance NN O
, , O
such JJ O
that IN O
processes VBZ O
stimulated VBD O
or CC O
co SYM O
- : O
stimulated VBN O
via IN O
ICAM NNP B-Gene
- : I-Gene
3 CD I-Gene
( ( O
homotypic NN O
aggregation NN O
, , O
IL NNP O
- : O
8 CD O
secretion NN O
) ) O
were VBD O
clearly RB O
enhanced VBN O
upon IN O
RA NNP O
pretreatment NN O
, , O
suggesting VBG O
that IN O
RA NNP O
may MD O
contribute VB O
via IN O
hitherto NN O
unrecognized JJ O
pathways NNS O
to TO O
immune VB O
function NN O
and CC O
host NN O
defense NN O
. . O

CD28 NNP B-Gene
and CC O
T NNP O
cell VBP O
co SYM O
- : O
stimulation NN O
. . O

Over IN O
the DT O
last JJ O
decade NN O
the DT O
concept NN O
of IN O
T NNP O
cell NN O
co SYM O
- : O
stimulation NN O
has VBZ O
emerged VBN O
to TO O
take VB O
a DT O
central JJ O
role NN O
in IN O
the DT O
process NN O
of IN O
T NNP O
cell NN O
activation NN O
. . O

However RB O
, , O
the DT O
exact JJ O
definition NN O
of IN O
co NN O
- : O
stimulation NN O
is VBZ O
still RB O
unclear JJ O
. . O

In IN O
this DT O
review NN O
, , O
we PRP O
re VBP O
- : O
examine VB O
the DT O
concept NN O
of IN O
co JJ O
- : O
stimulation NN O
. . O

We PRP O
suggest VBP O
that IN O
while IN O
co JJ O
- : O
stimulation NN O
is VBZ O
important JJ O
, , O
there EX O
is VBZ O
little JJ O
evidence NN O
to TO O
link VB O
co JJ O
- : O
stimulation NN O
with IN O
T NNP O
cell NN O
anergy NN O
. . O

We PRP O
then RB O
suggest VBP O
a DT O
framework NN O
for IN O
studying VBG O
co JJ O
- : O
stimulation NN O
. . O

Focusing VBG O
on IN O
recent JJ O
advances NNS O
in IN O
our PRP$ O
understanding NN O
of IN O
CD28 NNP B-Gene
, , O
we PRP O
discuss VBP O
four CD O
areas NNS O
of IN O
T NNP O
cell NN O
activation NN O
where WRB O
co NN O
- : O
stimulation NN O
may MD O
play VB O
a DT O
role NN O
. . O

Regulation NN O
of IN O
activator NN B-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
exposed VBD O
to TO O
peripheral VB B-Gene
self PRP I-Gene
- : I-Gene
antigens NNS I-Gene
. . O

The DT O
transcriptional JJ O
events NNS O
that WDT O
control VBP O
T NNP O
cell NN O
tolerance NN O
to TO O
peripheral VB B-Gene
self NN I-Gene
Ags NNP I-Gene
are VBP O
still RB O
unknown JJ O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
analyzed VBD O
the DT O
regulation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
mediated JJ O
transcription NN O
during IN O
in IN O
vivo JJ O
induction NN O
of IN O
tolerance NN O
to TO O
a DT O
self NN B-Gene
Ag NNP I-Gene
expressed VBD O
exclusively RB O
on IN O
hepatocytes NNS O
. . O

Naive JJ O
CD8 NNP O
( ( O
+ NNP O
) ) O
Desire NNP O
( ( O
Des NNP O
) ) O
( ( O
+ $ O
) ) O
T NNP O
cells NNS O
isolated VBN O
from IN O
the DT O
Des NNP O
TCR NNP O
- : O
transgenic JJ O
mice NN O
that WDT O
are VBP O
specific JJ O
for IN O
the DT O
H NNP B-Gene
- : I-Gene
2K CD I-Gene
( ( I-Gene
b NN I-Gene
) ) I-Gene
class NN I-Gene
I PRP I-Gene
Ag VBP I-Gene
were VBD O
transferred VBN O
into IN O
Alb NNP O
- : O
K NNP O
( ( O
b NN O
) ) O
- : O
transgenic JJ O
mice NN O
that WDT O
express VBZ O
the DT O
H NNP B-Gene
- : I-Gene
2K CD I-Gene
( ( I-Gene
b NN I-Gene
) ) I-Gene
Ag NNP I-Gene
on IN O
hepatocytes NNS O
only RB O
. . O

Tolerance NN O
develops VBZ O
in IN O
these DT O
mice NNS O
. . O

We PRP O
found VBD O
that IN O
the DT O
self NN O
- : O
reactive JJ O
CD8 NNP O
( ( O
+ NNP O
) ) O
Des NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
were VBD O
transiently RB O
activated VBN O
, , O
then RB O
became VBD O
unresponsive JJ O
and CC O
were VBD O
further RB O
deleted VBN O
. . O

In IN O
contrast NN O
to TO O
CD8 NNP O
( ( O
+ NNP O
) ) O
Des NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
activated VBN O
in IN O
vivo NN O
with IN O
APCs NNP O
, , O
which WDT O
express RB O
high JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
high JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcriptional JJ O
activity NN O
, , O
the DT O
unresponsive JJ O
CD8 NNP O
( ( O
+ NNP O
) ) O
Des NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
expressed VBD O
no DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
only RB O
weak JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcriptional JJ O
activity NN O
. . O

The DT O
differences NNS O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcriptional JJ O
activity NN O
correlated VBN O
with IN O
the DT O
generation NN O
of IN O
distinct JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complexes NN I-Gene
. . O

Indeed RB O
, , O
in IN O
vivo NN O
primed VBN O
T NNP O
cells NNS O
predominantly RB O
express VBP O
p50 JJ B-Gene
/ NNP I-Gene
p50 NN I-Gene
and CC I-Gene
p65 NN I-Gene
/ NNP I-Gene
p50 NN I-Gene
dimers NNS I-Gene
, , O
whereas IN O
these DT O
p50 SYM B-Gene
- : I-Gene
containing NN I-Gene
complexes NNS I-Gene
are VBP O
barely RB O
detectable JJ O
in IN O
tolerant JJ O
T NNP O
cells NNS O
that WDT O
express VBP O
p65 SYM B-Gene
- : I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Rel NNP I-Gene
- : I-Gene
containing NN I-Gene
complexes NNS I-Gene
. . O

These DT O
observations NNS O
suggest VBP O
that IN O
fine JJ O
regulation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex JJ I-Gene
formation NN O
may MD O
determine VB O
T NNP O
cell NN O
fate NN O
. . O

Transcriptional JJ O
regulation NN O
in IN O
lymphocytes NNS O
. . O

Lymphocytes NNS O
have VBP O
been VBN O
used VBN O
to TO O
investigate VB O
many JJ O
cellular JJ O
processes NNS O
, , O
including VBG O
lineage NN O
commitment NN O
, , O
differentiation NN O
, , O
proliferation NN O
and CC O
apoptosis NN O
. . O

The DT O
transcription NN B-Gene
factors NNS I-Gene
that WDT O
mediate VBP O
these DT O
processes NNS O
are VBP O
often RB O
expressed VBN O
broadly RB O
in IN O
many JJ O
cell NN O
types NNS O
. . O

The DT O
emerging VBG O
theme NN O
is VBZ O
one CD O
of IN O
cell NN O
- : O
type NN O
- : O
specific JJ O
regulation NN O
, , O
affecting VBG O
not RB O
only RB O
the DT O
functional JJ O
activation NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
but CC O
also RB O
their PRP$ O
access NN O
to TO O
appropriate VB O
regions NNS O
of IN O
DNA NNP O
. . O

Existence NN O
of IN O
retinoic NN B-Gene
acid SYM I-Gene
- : I-Gene
receptor NN I-Gene
- : O
independent JJ O
retinoid NN B-Gene
X NNP I-Gene
- : I-Gene
receptor NN I-Gene
- : O
dependent JJ O
pathway NN O
in IN O
myeloid NN O
cell NN O
function NN O
. . O

We PRP O
previously RB O
reported VBD O
that IN O
ER NNP O
- : O
27191 CD O
( ( O
4 CD O
- : O
[ NN O
4 CD O
, , O
5 CD O
, , O
7 CD O
, , O
8 CD O
, , O
9 CD O
, , O
10 CD O
- : O
hexahydro NN O
- : O
7 CD O
, , O
7 CD O
, , O
10 CD O
, , O
10 CD O
- : O
tetramethyl NN O
- : O
1 CD O
- : O
( ( O
3 CD O
- : O
pyridylmethyl NN O
) ) O
anthra NN O
[ $ O
1 CD O
, , O
2 CD O
- : O
b NN O
] NN O
pyrrol NN O
- : O
3 CD O
- : O
yl NN O
] JJ O
benzoic NN O
acid NN O
) ) O
is VBZ O
a DT O
potent JJ O
antagonist NN O
of IN O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
( ( O
RAR NNP B-Gene
) ) O
, , O
and CC O
ER NNP O
- : O
35795 CD O
( ( O
( ( O
2E CD O
, , O
4E CD O
, , O
6E CD O
) ) O
- : O
7 CD O
- : O
[ NN O
1 CD O
- : O
( ( O
1 CD O
- : O
methylethyl NN O
) ) O
- : O
8 CD O
- : O
chloro NN O
- : O
1 CD O
, , O
2 CD O
, , O
3 CD O
, , O
4 CD O
- : O
tetrahydroquinolin NN O
- : O
6 CD O
- : O
yl NN O
] SYM O
- : O
6 CD O
- : O
fluoro NN O
- : O
3 CD O
- : O
methyl NN O
- : O
2 CD O
, , O
4 CD O
, , O
6 CD O
- : O
nonatrienoic JJ O
acid NN O
) ) O
is VBZ O
a DT O
novel JJ O
retinoid NN B-Gene
X NNP I-Gene
receptor NN I-Gene
( ( O
RXR NNP B-Gene
) ) O
- : O
specific JJ O
agonist NN O
. . O

By IN O
using VBG O
these DT O
compounds NNS O
, , O
we PRP O
investigated VBD O
whether IN O
distinct JJ O
RAR NNP B-Gene
- : O
dependent NN O
and CC O
RXR NNP B-Gene
- : O
dependent NN O
pathways NNS O
operate VBP O
to TO O
mediate VB O
the DT O
diverse JJ O
activities NNS O
of IN O
retinoids NNS O
, , O
particularly RB O
, , O
the DT O
effects NNS O
of IN O
the DT O
RXR NNP B-Gene
pathway NN O
on IN O
cellular JJ O
function NN O
. . O

ER NNP O
- : O
27191 CD O
completely RB O
antagonized JJ O
HL60 NNP O
cell NN O
differentiation NN O
induced VBN O
by IN O
all DT O
- : O
trans NNS O
- : O
retinoic NN O
acid NN O
( ( O
atRA NN O
) ) O
. . O

However RB O
, , O
the DT O
differentiation NN O
induced VBN O
by IN O
the DT O
ER NNP O
- : O
35795 CD O
was VBD O
not RB O
antagonized VBN O
at IN O
all DT O
by IN O
the DT O
RAR NNP B-Gene
antagonist NN O
, , O
but CC O
was VBD O
inhibited VBN O
by IN O
an DT O
RXR NNP B-Gene
homodimer NN I-Gene
antagonist NN O
( ( O
LGD100754 NNP O
, , O
( ( O
2E CD O
, , O
4E CD O
, , O
6Z CD O
) ) O
- : O
7 CD O
- : O
( ( O
3 CD O
- : O
n JJ O
- : O
propoxy JJ O
- : O
5 CD O
, , O
6 CD O
, , O
7 CD O
, , O
8 CD O
- : O
tetrahydro NN O
- : O
5 CD O
, , O
5 CD O
, , O
8 CD O
, , O
8 CD O
- : O
tetramethylnaphthale NN O
- : O
2 CD O
- : O
yl NN O
) ) O
- : O
3 CD O
- : O
methylocta NN O
- : O
2 CD O
, , O
4 CD O
, , O
6 CD O
- : O
trienoic NN O
acid NN O
) ) O
. . O

Its PRP$ O
agonistic JJ O
action NN O
on IN O
RXR NNP B-Gene
/ NNP I-Gene
RAR NNP I-Gene
heterodimer NN I-Gene
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
was VBD O
neutralized VBN O
by IN O
the DT O
RAR NNP B-Gene
antagonist NN O
. . O

During IN O
HL60 NNP O
cell NN O
differentiation NN O
, , O
atRA RB O
induced JJ O
RARbeta NNP B-Gene
mRNA NN I-Gene
, , O
while IN O
the DT O
RXR NNP B-Gene
had VBD O
no DT O
effect NN O
. . O

Interestingly RB O
, , O
a DT O
functional JJ O
RXR NNP B-Gene
- : O
pathway NN O
was VBD O
also RB O
seen VBN O
in IN O
lipopolysaccharide JJ O
- : O
induced JJ O
inhibition NN O
of IN O
mouse NN O
splenocyte NN O
proliferation NN O
. . O

These DT O
results NNS O
strongly RB O
suggest VBP O
the DT O
existence NN O
of IN O
a DT O
pharmacological JJ O
RXR NNP B-Gene
- : O
dependent JJ O
pathway NN O
that WDT O
is VBZ O
activated VBN O
by IN O
a DT O
ligand NN O
that WDT O
can MD O
bind VB O
to TO O
RXR NNP B-Gene
. . O

Targeting VBG O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
tyrosine JJ I-Gene
phosphatase NN I-Gene
( ( O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
into IN O
lipid JJ O
rafts NNS O
inhibits NNS O
CD3 NNP B-Gene
- : O
induced VBD O
T NNP O
cell NN O
activation NN O
. . O

To TO O
study VB O
the DT O
mechanism NN O
by IN O
which WDT O
protein NN B-Gene
tyrosine NN I-Gene
phosphatases NNS I-Gene
( ( O
PTPs NNP B-Gene
) ) O
regulate VBP O
CD3 NNP B-Gene
- : O
induced JJ O
tyrosine NN O
phosphorylation NN O
, , O
we PRP O
investigated VBD O
the DT O
distribution NN O
of IN O
PTPs NNP B-Gene
in IN O
subdomains NNS O
of IN O
plasma NN O
membrane NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
the DT O
bulk NN O
PTP NNP B-Gene
activity NN O
associated VBN O
with IN O
T NNP O
cell NN O
membrane NN O
is VBZ O
present JJ O
outside IN O
the DT O
lipid JJ O
rafts NNS O
, , O
as IN O
determined VBN O
by IN O
sucrose JJ O
density NN O
gradient NN O
sedimentation NN O
. . O

In IN O
Jurkat NNP O
T NNP O
cells NNS O
, , O
approximately RB O
5 CD O
- : O
- : O
10 CD O
% NN O
of IN O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
tyrosine JJ I-Gene
phosphatase NN I-Gene
( ( O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
constitutively RB O
associated VBN O
with IN O
plasma NN O
membrane NN O
, , O
and CC O
nearly RB O
50 CD O
% NN O
of IN O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
translocated VBN O
to TO O
plasma VB O
membrane NN O
after IN O
vanadate JJ O
treatment NN O
. . O

Similar JJ O
to TO O
transmembrane VB B-Gene
PTP NNP I-Gene
, , O
CD45 NNP B-Gene
, , O
the DT O
membrane NN O
- : O
associated JJ O
populations NNS O
of IN O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
are VBP O
essentially RB O
excluded VBN O
from IN O
lipid JJ O
rafts NNS O
, , O
where WRB O
other JJ O
signaling VBG B-Gene
molecules NNS I-Gene
such JJ O
as IN O
Lck NNP B-Gene
, , I-Gene
linker NN I-Gene
for IN I-Gene
activation NN I-Gene
of IN I-Gene
T NNP I-Gene
cells NNS I-Gene
, , O
and CC O
CD3 NNP B-Gene
zeta NN I-Gene
are VBP O
enriched VBN O
. . O

We PRP O
further RB O
demonstrated VBD O
that IN O
CD3 NNP B-Gene
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
these DT O
substrates NNS O
is VBZ O
largely RB O
restricted VBN O
to TO O
lipid VB O
rafts NNS O
, , O
unless IN O
PTPs NNP B-Gene
are VBP O
inhibited VBN O
. . O

It PRP O
suggests VBZ O
that IN O
a DT O
restricted JJ O
partition NN O
of IN O
PTPs NNP B-Gene
among IN O
membrane JJ O
subdomains NNS O
may MD O
regulate VB O
protein NNS O
tyrosine JJ O
phosphorylation NN O
in IN O
T NNP O
cell NN O
membrane NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
targeted VBD O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
into IN O
lipid JJ O
rafts NNS O
by IN O
using VBG O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
of IN I-Gene
Lck NNP I-Gene
( ( O
residues VBZ B-Gene
1 CD I-Gene
- : I-Gene
- : I-Gene
14 CD I-Gene
) ) O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
expression NN O
of IN O
Lck NNP B-Gene
/ NNP I-Gene
SHP NNP I-Gene
- : I-Gene
1 CD I-Gene
chimera NN I-Gene
inside IN O
lipid JJ O
rafts NNS O
profoundly RB O
inhibits VBZ O
CD3 NNP B-Gene
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
CD3 NNP B-Gene
zeta NNP I-Gene
/ NNP I-Gene
epsilon NN I-Gene
, , O
IL NNP O
- : O
2 CD O
generation NN O
, , O
and CC O
nuclear JJ O
mobilization NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
. . O

Collectively RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
the DT O
exclusion NN O
of IN O
PTPs NNP B-Gene
from IN O
lipid JJ O
rafts NNS O
may MD O
be VB O
a DT O
mechanism NN O
that WDT O
potentiates VBZ O
TCR NNP B-Gene
/ NNP O
CD3 NNP B-Gene
activation NN O

An DT O
instructive JJ O
component NN O
in IN O
T NNP O
helper NN O
cell NN O
type NN O
2 CD O
( ( O
Th2 NNP O
) ) O
development NN O
mediated VBN O
by IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

Although IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
12 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
polarize NN O
naive JJ O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
toward IN O
T NNP O
helper NN O
cell NN O
type NN O
1 CD O
( ( O
Th1 NNP O
) ) O
or CC O
Th2 NNP O
phenotypes NNS O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
cytokines NNS B-Gene
instruct VBP O
the DT O
developmental JJ O
fate NN O
in IN O
uncommitted JJ O
progenitors NNS O
or CC O
select NN O
for IN O
outgrowth NN O
of IN O
cells NNS O
that WDT O
have VBP O
stochastically RB O
committed VBN O
to TO O
a DT O
particular JJ O
fate NN O
. . O

To TO O
distinguish VB O
these DT O
instructive JJ O
and CC O
selective JJ O
models NNS O
, , O
we PRP O
used VBD O
surface NN O
affinity NN O
matrix NNP O
technology NN O
to TO O
isolate VB O
committed JJ O
progenitors NNS O
based VBN O
on IN O
cytokine JJ O
secretion NN O
phenotype NN O
and CC O
developed VBD O
retroviral JJ O
- : O
based VBN O
tagging VBG O
approaches NNS O
to TO O
directly RB O
monitor VB O
individual JJ O
progenitor NN O
fate NN O
decisions NNS O
at IN O
the DT O
clonal JJ O
and CC O
population NN O
levels NNS O
. . O

We PRP O
observe VBP O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
dependent JJ O
redirection NN O
of IN O
phenotype NN O
in IN O
cells NNS O
that WDT O
have VBP O
already RB O
committed VBN O
to TO O
a DT O
non JJ O
- : O
IL NNP O
- : O
4 CD O
- : O
producing VBG O
fate NN O
, , O
inconsistent NN O
with IN O
predictions NNS O
of IN O
the DT O
selective JJ O
model NN O
. . O

Further RB O
, , O
retroviral JJ O
tagging NN O
of IN O
naive JJ O
progenitors NNS O
with IN O
the DT O
Th2 NNP B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
provided VBD O
direct JJ O
evidence NN O
for IN O
instructive JJ O
differentiation NN O
, , O
and CC O
no DT O
evidence NN O
for IN O
the DT O
selective JJ O
outgrowth NN O
of IN O
cells NNS O
committed VBN O
to TO O
either CC O
the DT O
Th1 NNP O
or CC O
Th2 NNP O
fate NN O
. . O

These DT O
data NNS O
would MD O
seem VB O
to TO O
exclude VB O
selection NN O
as IN O
an DT O
exclusive JJ O
mechanism NN O
in IN O
Th1 NNP O
/ NNP O
Th2 NNP O
differentiation NN O
, , O
and CC O
support VB O
an DT O
instructive JJ O
model NN O
of IN O
cytokine NN O
- : O
driven JJ O
transcriptional JJ O
programming NN O
of IN O
cell NN O
fate NN O
decisions NNS O
. . O

In IN O
vitro JJ O
- : O
activated VBN O
human JJ O
lupus NN O
T NNP O
cells NNS O
express RB O
normal JJ O
estrogen NN B-Gene
receptor NN I-Gene
proteins NNS I-Gene
which WDT O
bind VBP O
to TO O
the DT O
estrogen NN B-Gene
response NN I-Gene
element NN I-Gene
. . O

We PRP O
have VBP O
shown VBN O
that IN O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ERalpha NNP B-Gene
, , O
ERbeta NNP B-Gene
) ) O
transcripts NNS O
are VBP O
expressed VBN O
in IN O
SLE NNP O
and CC O
normal JJ O
T NNP O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
T NNP O
cell NN O
nuclear JJ O
extracts NNS O
from IN O
female JJ O
lupus NN O
patients NNS O
and CC O
normal JJ O
donors NNS O
were VBD O
tested VBN O
for IN O
biologically RB O
active JJ O
ER NNP B-Gene
proteins VBZ I-Gene
capable JJ O
of IN O
binding VBG O
to TO O
the DT O
human JJ B-Gene
estrogen NN I-Gene
response NN I-Gene
element NN I-Gene
( ( O
hERE NN B-Gene
) ) O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
. . O

When WRB O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
were VBD O
stimulated VBN O
with IN O
17beta CD O
- : O
estradiol NN O
( ( O
E2 NNP O
) ) O
, , O
PMA NNP O
and CC O
ionomycin RB O
, , O
two CD O
major JJ O
retarded VBD O
bands NNS O
in IN O
T NNP O
cell NN O
nuclear JJ O
extracts NNS O
exhibited VBD O
a DT O
migration NN O
pattern NN O
similar JJ O
to TO O
slow VB O
migrating VBG O
protein SYM B-Gene
- : I-Gene
ERE NN I-Gene
complexes NNS I-Gene
in IN O
human JJ O
breast NN O
cancer NN O
cell NN O
extracts NNS O
. . O

T NNP O
cells NNS O
cultured VBD O
only RB O
with IN O
E2 NNP O
did VBD O
not RB O
have VB O
these DT O
complexes NNS O
. . O

The DT O
formation NN O
of IN O
the DT O
complexes NN O
was VBD O
inhibited VBN O
by IN O
competition NN O
with IN O
the DT O
hERE NN O
cold JJ O
oligonucleotide NN O
and CC O
partially RB O
with IN O
anti JJ B-Gene
- : I-Gene
ERalpha NN I-Gene
antibodies NNS I-Gene
. . O

There EX O
was VBD O
no DT O
notable JJ O
difference NN O
in IN O
the DT O
migration NN O
pattern NN O
of IN O
ERE NNP B-Gene
- : I-Gene
binding VBG I-Gene
proteins NNS I-Gene
between IN O
the DT O
SLE NNP O
and CC O
normal JJ O
T NNP O
cell NN O
extracts NNS O
. . O

Together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
activated VBD O
human JJ O
T NNP O
cells NNS O
, , O
whether IN O
lupus SYM O
- : O
derived VBN O
or CC O
normal JJ O
- : O
derived VBN O
, , O
contain VBP O
biologically RB O
active JJ O
ERalpha NNP B-Gene
proteins NNS I-Gene
. . O

Other JJ O
factors NNS O
may MD O
be VB O
responsible JJ O
for IN O
differential JJ O
sensitivity NN O
of IN O
lupus NN O
T NNP O
cells NNS O
to TO O
estrogen VB O
. . O

Mechanism NN O
of IN O
the DT O
inhibitory JJ O
effect NN O
of IN O
protease NN O
inhibitor NN O
on IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha JJ I-Gene
production NN O
of IN O
monocytes NNS O
. . O

If IN O
the DT O
inflammatory NN O
response NN O
becomes VBZ O
excessive JJ O
or CC O
uncontrolled VBN O
by IN O
some DT O
stimuli NNS O
, , O
inappropriate JJ O
inflammatory NN O
responses NNS O
occur VBP O
. . O

Monocytes NNS O
are VBP O
extremely RB O
important JJ O
cells NNS O
for IN O
regulating VBG O
the DT O
cytokine NN O
network NN O
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNFalpha NNP B-Gene
) ) O
and CC O
interleukin JJ B-Gene
- : I-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
10 CD I-Gene
, , O
which WDT O
are VBP O
mainly RB O
synthesized VBN O
by IN O
monocytes NNS O
, , O
are VBP O
representative JJ O
cytokines NNS B-Gene
that WDT O
play VBP O
a DT O
central JJ O
role NN O
in IN O
the DT O
cytokine NN O
network NN O
. . O

Protease NNP O
inhibitors NNS O
such JJ O
as IN O
gabexate NN O
mesilate NN O
( ( O
GM NNP O
) ) O
and CC O
ulinastatin JJ O
( ( O
UTI NNP O
) ) O
have VBP O
been VBN O
shown VBN O
to TO O
have VB O
various JJ O
beneficial JJ O
effects NNS O
by IN O
inhibiting VBG O
the DT O
activation NN O
of IN O
leukocytes NNS O
, , O
but CC O
the DT O
mechanism NN O
for IN O
this DT O
has VBZ O
yet RB O
to TO O
be VB O
fully RB O
elucidated VBN O
. . O

In IN O
this DT O
study NN O
we PRP O
investigated VBD O
the DT O
mechanism NN O
of IN O
the DT O
inhibitory JJ O
effect NN O
of IN O
protease NN O
inhibitors NNS O
on IN O
the DT O
proinflammatory NN O
cytokine JJ O
production NN O
of IN O
lipopolysaccharide JJ O
- : O
( ( O
LPS NNP O
) ) O
stimulated VBD O
monocytes NNS O
. . O

LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
were VBD O
treated VBN O
with IN O
GM NNP O
or CC O
UTI NNP O
. . O

The DT O
value NN O
of IN O
TNFalpha NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
in IN O
the DT O
culture NN O
medium NN O
of IN O
monocytes NNS O
was VBD O
measured VBN O
and CC O
each DT O
mRNA NN O
expression NN O
was VBD O
assayed VBN O
. . O

The DT O
inhibitory JJ O
effect NN O
of IN O
protease NN O
inhibitors NNS O
on IN O
the DT O
activity NN O
of IN O
intracellular JJ O
signal JJ O
transduction NN O
pathways NNS O
such JJ O
as IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NFkappaB NNP B-Gene
) ) O
were VBD O
also RB O
evaluated VBN O
. . O

GM NNP O
decreased VBD O
the DT O
TNFalpha NNP B-Gene
production NN O
of IN O
LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
as IN O
shown VBN O
by IN O
the DT O
inhibition NN O
of IN O
mRNA JJ O
expression NN O
and CC O
increased VBD O
the DT O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
production NN O
of IN O
LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
. . O

GM NNP O
also RB O
suppressed VBD O
the DT O
NFkappaB NNP B-Gene
activity NN O
of IN O
LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
. . O

UTI NNP O
decreased VBD O
the DT O
TNFalpha NNP B-Gene
production NN O
of IN O
LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
, , O
but CC O
did VBD O
not RB O
inhibit VB O
the DT O
TNFalpha NNP B-Gene
mRNA NN I-Gene
expression NN O
. . O

The DT O
present JJ O
study NN O
shows VBZ O
that IN O
the DT O
inhibitory JJ O
effect NN O
of IN O
GM NNP O
on IN O
the DT O
TNFalpha NNP B-Gene
production NN O
of IN O
activated JJ O
human JJ O
monocytes NNS O
is VBZ O
mediated VBN O
by IN O
the DT O
suppression NN O
of IN O
NFkappaB NNP B-Gene
activation NN O
, , O
while IN O
the DT O
mechanism NN O
of IN O
UTI NNP O
inhibiting VBG O
TNFalpha NNP B-Gene
production NN O
of IN O
human JJ O
monocytes NNS O
may MD O
be VB O
due JJ O
to TO O
the DT O
inhibition NN O
of IN O
either CC O
the DT O
translation NN O
or CC O
secretion NN O
of IN O
TNFalpha NNP B-Gene
. . O

Homocysteine NNP O
stimulates VBZ O
the DT O
expression NN O
of IN O
monocyte NN B-Gene
chemoattractant NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
in IN O
endothelial JJ O
cells NNS O
leading VBG O
to TO O
enhanced VB O
monocyte JJ O
chemotaxis NN O
. . O

Hyperhomocysteinemia NNP O
has VBZ O
been VBN O
identified VBN O
as IN O
an DT O
independent JJ O
risk NN O
factor NN O
for IN O
atherosclerosis NN O
. . O

The DT O
infiltration NN O
of IN O
monocytes NNS O
into IN O
the DT O
arterial JJ O
wall NN O
is VBZ O
one CD O
of IN O
the DT O
key JJ O
events NNS O
during IN O
atherogenesis NN O
. . O

Monocyte NNP B-Gene
chemoattractant NN I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
a DT O
potent JJ O
chemokine NN B-Gene
that WDT O
stimulates VBZ O
the DT O
migration NN O
of IN O
monocytes NNS O
into IN O
the DT O
intima NN O
of IN O
the DT O
arterial JJ O
wall NN O
. . O

The DT O
mechanism NN O
by IN O
which WDT O
increased VBD O
monocyte NN O
infiltration NN O
occurs VBZ O
in IN O
atherosclerotic JJ O
lesions NNS O
in IN O
patients NNS O
with IN O
hyperhomocysteinemia NN O
has VBZ O
not RB O
been VBN O
delineated VBN O
. . O

The DT O
objective NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
effect NN O
of IN O
homocysteine NN O
on IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
production NN O
in IN O
endothelial JJ O
cells NNS O
. . O

Cells NNS O
were VBD O
incubated VBN O
with IN O
homocysteine NN O
. . O

The DT O
secretion NN O
of IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
was VBD O
significantly RB O
increased VBN O
( ( O
195 CD O
% NN O
as IN O
compared VBN O
to TO O
the DT O
control NN O
) ) O
in IN O
cells NNS O
treated VBN O
with IN O
pathological JJ O
concentrations NNS O
of IN O
homocysteine NN O
. . O

Such JJ O
effect NN O
was VBD O
accompanied VBN O
by IN O
an DT O
increased JJ O
expression NN O
of IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
( ( O
176 CD O
% NN O
as IN O
compared VBN O
to TO O
the DT O
control NN O
) ) O
in IN O
endothelial JJ O
cells NNS O
which WDT O
resulted VBD O
in IN O
enhanced JJ O
monocyte NN O
chemotaxis NN O
. . O

The DT O
p38 NN B-Gene
MAP NNP I-Gene
kinase NN I-Gene
as RB O
well RB O
as IN O
other JJ O
members NNS O
of IN O
the DT O
p38 NN O
MAP NNP O
kinase NNP O
pathway NN O
, , O
including VBG O
MKK3 NNP B-Gene
, , O
MKK6 NNP B-Gene
, , O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
were VBD O
activated VBN O
in IN O
homocysteine NN O
- : O
treated JJ O
cells NNS O
. . O

Homocysteine NNP O
- : O
induced VBD O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
subsequent JJ O
monocyte NN O
chemotaxis NN O
were VBD O
blocked VBN O
by IN O
a DT O
p38 NN B-Gene
MAP NNP I-Gene
kinase NN I-Gene
inhibitor NN O
( ( O
SB203580 NNP O
) ) O
suggesting VBG O
that IN O
the DT O
p38 NN B-Gene
MAP NNP I-Gene
kinase NNP I-Gene
pathway NN O
might MD O
be VB O
involved VBN O
in IN O
homocysteine NN O
- : O
induced JJ O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
in IN O
endothelial JJ O
cells NNS O
. . O

In IN O
contrast NN O
, , O
staurosporine NN O
, , O
a DT O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
inhibitor NN O
, , O
had VBD O
no DT O
effect NN O
on IN O
homocysteine NN O
- : O
induced JJ O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
homocysteine NN O
stimulates NNS O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
in IN O
endothelial JJ O
cells NNS O
leading VBG O
to TO O
enhanced VB O
monocyte JJ O
chemotaxis NN O
. . O

Inducible JJ O
resistance NN O
to TO O
Fas NNP O
- : O
mediated VBD O
apoptosis NN O
in IN O
B NNP O
cells NNS O
. . O

Apoptosis NN O
produced VBN O
in IN O
B NNP O
cells NNS O
through IN O
Fas NNP B-Gene
( ( O
APO NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
CD95 NNP B-Gene
) ) O
triggering NN O
is VBZ O
regulated VBN O
by IN O
signals NNS O
derived VBN O
from IN O
other JJ O
surface NN O
receptors NNS O
: : O
CD40 NNP O
engagement NN O
produces VBZ O
upregulation NN O
of IN O
Fas NNP B-Gene
expression NN O
and CC O
marked JJ O
susceptibility NN O
to TO O
Fas NNP B-Gene
- : O
induced VBD O
cell NN O
death NN O
, , O
whereas WP O
antigen NN O
receptor NN O
engagement NN O
, , O
or CC O
IL NNP O
- : O
4R CD O
engagement NN O
, , O
inhibits VBZ O
Fas NNP B-Gene
killing VBG O
and CC O
in IN O
so RB O
doing VBG O
induces NNS O
a DT O
state NN O
of IN O
Fas NNP B-Gene
- : O
resistance NN O
, , O
even RB O
in IN O
otherwise RB O
sensitive JJ O
, , O
CD40 NNP B-Gene
- : O
stimulated VBD O
targets NNS O
. . O

Surface NNP B-Gene
immunoglobulin NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
utilize NN O
at IN O
least JJS O
partially RB O
distinct JJ O
pathways NNS O
to TO O
produce VB O
Fas NNP B-Gene
- : O
resistance NN O
that IN O
differentially RB O
depend VB O
on IN O
PKC NNP B-Gene
and CC O
STAT6 NNP B-Gene
, , O
respectively RB O
. . O

Further RB O
, , O
surface NN O
immunoglobulin NN O
signaling VBG O
for IN O
inducible JJ O
Fas NNP B-Gene
- : O
resistance NN O
bypasses NNS O
Btk NNP B-Gene
, , O
requires VBZ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
and CC O
entails VBZ O
new JJ O
macromolecular JJ O
synthesis NN O
. . O

Terminal JJ O
effectors NNS O
of IN O
B NNP O
cell NN O
Fas NNP B-Gene
- : O
resistance NN O
include VBP O
the DT O
known JJ O
anti NN B-Gene
- : I-Gene
apoptotic JJ I-Gene
gene NN I-Gene
products NNS I-Gene
, , O
Bcl NNP B-Gene
- : I-Gene
xL NN I-Gene
and CC O
FLIP NNP B-Gene
, , O
and CC O
a DT O
novel JJ O
anti NN B-Gene
- : I-Gene
apoptotic JJ I-Gene
gene NN I-Gene
that WDT O
encodes VBZ O
FAIM NNP B-Gene
( ( O
Fas NNP B-Gene
Apoptosis NNP I-Gene
Inhibitory NNP I-Gene
Molecule NNP I-Gene
) ) O
. . O

faim NN B-Gene
was VBD O
identified VBN O
by IN O
differential JJ O
display NN O
and CC O
exists NNS O
in IN O
two CD O
alternatively RB O
spliced VBD O
forms NNS O
; : O
faim SYM B-Gene
- : I-Gene
S NN I-Gene
is VBZ O
broadly RB O
expressed VBN O
, , O
but CC O
faim SYM O
- : O
L JJ O
expression NN O
is VBZ O
tissue JJ O
- : O
specific NN O
. . O

The DT O
FAIM NNP B-Gene
sequence NN I-Gene
is VBZ O
highly RB O
evolu JJ O
- : O
tionarily RB O
conserved VBN O
, , O
suggesting VBG O
an DT O
important JJ O
role NN O
for IN O
this DT O
molecule NN O
throughout IN O
phylogeny NN O
. . O

Inducible JJ O
resistance NN O
to TO O
Fas NNP B-Gene
killing NN O
is VBZ O
hypothesized VBN O
to TO O
protect VB O
foreign JJ O
antigen NN O
- : O
specific JJ O
B NNP O
cells NNS O
during IN O
potentially RB O
hazardous JJ O
interactions NNS O
with IN O
FasL NNP O
- : O
bearing NN O
T NNP O
cells NNS O
, , O
whereas NNS O
autoreactive VBP O
B NNP O
cells NNS O
fail VBP O
to TO O
become VB O
Fas NNP B-Gene
- : O
resistant NN O
and CC O
are VBP O
deleted VBN O
via IN O
Fas NNP B-Gene
- : O
dependent JJ O
cytotoxicity NN O
. . O

Inadvertent NN O
or CC O
aberrant JJ O
acquisition NN O
of IN O
Fas NNP B-Gene
- : O
resistance NN O
may MD O
permit VB O
autoreactive JJ O
B NNP O
cells NNS O
to TO O
escape VB O
Fas NNP B-Gene
deletion NN O
, , O
and CC O
malignant JJ O
lymphocytes NNS O
to TO O
impede VB O
anti JJ O
- : O
tumor NN O
immunity NN O
. . O

Stromal NNP B-Gene
cell NN I-Gene
- : I-Gene
derived VBN I-Gene
factor NN I-Gene
1 CD I-Gene
alpha NN I-Gene
- : O
induced JJ O
chemotaxis NN O
in IN O
T NNP O
cells NNS O
is VBZ O
mediated VBN O
by IN O
nitric JJ O
oxide IN O
signaling VBG O
pathways NNS O
. . O

Stromal NNP B-Gene
cell NN I-Gene
- : I-Gene
derived VBN I-Gene
factor NN I-Gene
1 CD I-Gene
alpha NN I-Gene
( ( O
SDF1 NNP B-Gene
alpha NN I-Gene
) ) O
and CC O
its PRP$ O
cognate NN O
chemokine NN B-Gene
receptor NN I-Gene
CXCR4 NNP I-Gene
act NN O
as IN O
potent JJ O
chemoattractants NNS O
and CC O
regulate VB O
trafficking NN O
and CC O
homing NN O
of IN O
hematopoietic JJ O
progenitor NN O
cells NNS O
and CC O
lymphocytes NNS O
. . O

However RB O
, , O
the DT O
molecular JJ O
mechanisms NNS O
regulating VBG O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
driven VBN O
cell NN O
migration NN O
are VBP O
not RB O
well RB O
defined VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
explored VBN O
the DT O
roles NNS O
of IN O
the DT O
second JJ O
messenger NN O
NO NNP O
and CC O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
induced JJ O
T NNP O
cell NN O
migration NN O
. . O

SDF1 NNP B-Gene
alpha JJ I-Gene
treatment NN O
of IN O
Jurkat NNP O
T NNP O
cells NNS O
increased VBD O
the DT O
activity NN O
of IN O
NO NNP B-Gene
synthase NN I-Gene
, , O
which WDT O
catalyzes VBZ O
the DT O
generation NN O
of IN O
NO NNP O
. . O

We PRP O
observed VBD O
that IN O
pretreatment NN O
of IN O
Jurkat NNP O
cells NNS O
or CC O
activated VBN O
PBLs NNP O
with IN O
several JJ O
NO NNP O
donors NNS O
significantly RB O
enhanced VBD O
the DT O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
induced JJ O
migration NN O
, , O
whereas VBP O
various JJ O
inhibitors NNS O
of IN O
NO NNP B-Gene
synthase NN I-Gene
markedly RB O
abrogated VBD O
the DT O
chemotactic JJ O
response NN O
in IN O
a DT O
concentration NN O
- : O
dependent JJ O
manner NN O
. . O

Furthermore RB O
, , O
we PRP O
observed VBD O
that IN O
inhibitors NNS O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
which WDT O
is VBZ O
linked VBN O
to TO O
NO NNP O
signaling VBG O
pathways NNS O
, , O
also RB O
significantly RB O
blocked VBD O
the DT O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
induced VBN O
chemotactic JJ O
response NN O
. . O

However RB O
, , O
these DT O
compounds NNS O
did VBD O
not RB O
have VB O
a DT O
significant JJ O
effect NN O
on IN O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
induced VBN O
mitogen NN O
- : O
activated VBN O
protein JJ O
kinase NN O
activity NN O
. . O

In IN O
addition NN O
, , O
the DT O
MAP NNP O
/ NNP O
Erk NNP O
kinase VB O
kinase NNP O
inhibitor NN O
PD98059 NNP O
did VBD O
not RB O
abrogate VB O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
induced JJ O
chemotaxis NN O
. . O

AKT NNP B-Gene
, , O
which WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
mediate VB O
NO NNP O
production NN O
, , O
was VBD O
also RB O
phosphorylated VBN O
upon IN O
SDF1 NNP B-Gene
alpha JJ I-Gene
stimulation NN O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
NO NNP O
- : O
related VBD O
signaling JJ O
pathways NNS O
may MD O
mediate VB O
SDF1 NNP B-Gene
alpha SYM I-Gene
- : O
induced JJ O
chemotaxis NN O
, , O
but CC O
not RB O
mitogen VB B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
activation NN O
. . O

The DT O
lack NN O
of IN O
NF NNP O
- : O
kappa NN O
B NNP O
transactivation NN O
and CC O
PKC NNP O
epsilon VBP O
expression NN O
in IN O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
thymocytes VBZ O
correlates NNS O
with IN O
negative JJ O
selection NN O
. . O

Deletion NN O
of IN O
autoreactive JJ O
thymocytes NNS O
at IN O
the DT O
DP NNP O
stage NN O
is VBZ O
the DT O
basis NN O
for IN O
tolerance NN O
to TO O
thymus VB B-Gene
- : I-Gene
expressed VBN I-Gene
self NN I-Gene
antigens NNS I-Gene
. . O

In IN O
this DT O
study NN O
we PRP O
investigated VBD O
whether IN O
distinct JJ O
signalling NN O
pathways NNS O
are VBP O
induced VBN O
in IN O
DP NNP O
thymocytes NNS O
as IN O
compared VBN O
to TO O
mature VB O
T NNP O
cells NNS O
upon IN O
stimulation NN O
with IN O
antigen NN O
. . O

Using VBG O
triple JJ O
transgenic JJ O
mice NN O
expressing VBG O
a DT O
TCR NNP B-Gene
transgene NN I-Gene
, , O
dominant JJ B-Gene
negative JJ I-Gene
ras NNS I-Gene
/ VBP I-Gene
Mek NNP I-Gene
proteins NNS I-Gene
and CC O
a DT O
reporter NN B-Gene
gene NN I-Gene
construct NN I-Gene
with IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
we PRP O
showed VBD O
a DT O
complete JJ O
lack NN O
of IN O
transcriptional JJ O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
but CC O
not RB O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
DP NNP O
thymocytes NNS O
, , O
whereas IN O
both DT O
were VBD O
transcriptionally RB O
active JJ O
in IN O
mature NN O
T NNP O
cells NNS O
after IN O
antigenic JJ O
stimulation NN O
. . O

Lack NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
induction NN O
correlated VBD O
with IN O
increased VBN O
death NN O
in IN O
response NN O
to TO O
antigen NN B-Gene
. . O

AP NNP B-Gene
- : I-Gene
1 CD I-Gene
induction NN O
was VBD O
dependent JJ O
on IN O
the DT O
integrity NN O
of IN O
the DT O
ras NNS O
/ VBP O
Mek NNP O
pathway RB O
indicating VBG O
that IN O
this DT O
pathway NN O
was VBD O
activated VBN O
in IN O
the DT O
DP NNP O
thymocytes NNS O
. . O

In IN O
contrast NN O
, , O
we PRP O
found VBD O
a DT O
complete JJ O
lack NN O
of IN O
constitutive JJ O
expression NN O
of IN O
the DT O
epsilon NN B-Gene
isoform NN I-Gene
of IN I-Gene
Protein NNP I-Gene
Kinase NNP I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
in IN O
DP NNP O
thymocytes NNS O
, , O
although IN O
it PRP O
was VBD O
present JJ O
in IN O
mature NN O
thymocytes NNS O
and CC O
peripheral JJ O
T NNP O
cells NNS O
. . O

Taken VBN O
together RB O
the DT O
results NNS O
suggest VBP O
that IN O
the DT O
lack NN O
of IN O
PKC NNP B-Gene
epsilon NN I-Gene
in IN O
DP NNP O
thymocytes NNS O
could MD O
lead VB O
to TO O
the DT O
absence NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
after IN O
antigenic JJ O
stimulation NN O
contributing VBG O
to TO O
negative JJ O
selection NN O
. . O

Cell NNP O
Death NNP O
and CC O
Differentiation NNP O
( ( O
2000 CD O
) ) O
7 CD O
, , O
1253 CD O
- : O
1262 CD O
. . O

CD2 NNP O
stimulation NN O
leads VBZ O
to TO O
the DT O
delayed VBN O
and CC O
prolonged JJ O
activation NN O
of IN O
STAT1 NNP B-Gene
in IN O
T NNP O
cells NNS O
but CC O
not RB O
NK NNP O
cells NNS O
. . O

OBJECTIVE NN O
: : O
T NNP O
lymphocytes VBZ O
can MD O
be VB O
activated VBN O
by IN O
soluble JJ O
factors NNS O
such JJ O
as IN O
cytokines NNS B-Gene
or CC O
through IN O
direct JJ O
cell NN O
- : O
cell NN O
interactions NNS O
. . O

Although IN O
cytokine JJ B-Gene
receptors NNS I-Gene
are VBP O
known VBN O
to TO O
signal VB O
through IN O
STAT NNP B-Gene
family NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
the DT O
mechanisms NNS O
by IN O
which WDT O
other JJ O
cell NN B-Gene
- : I-Gene
surface NN I-Gene
molecules NNS I-Gene
, , O
such JJ O
as IN O
CD2 NNP B-Gene
, , O
transduce NN O
signals NNS O
is VBZ O
unclear JJ O
. . O

The DT O
goal NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
whether IN O
stimulation NN O
of IN O
T NNP O
cells NNS O
through IN O
CD2 NNP B-Gene
recapitulates VBZ O
aspects NNS O
of IN O
cytokine NN B-Gene
- : O
induced JJ O
T NNP O
- : O
cell NN O
activation NN O
by IN O
use NN O
of IN O
STAT NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

MATERIALS NNP O
AND CC O
METHODS NNP O
: : O
T NNP O
cells NNS O
were VBD O
treated VBN O
with IN O
anti JJ B-Gene
- : I-Gene
CD2 NN I-Gene
antibodies NNS I-Gene
or CC O
cells NNS O
bearing VBG O
the DT O
natural JJ O
CD2 NNP B-Gene
ligand NN I-Gene
CD58 NNP I-Gene
, , O
after IN O
which WDT O
signaling VBG O
through IN O
STAT NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
was VBD O
assessed VBN O
. . O

RESULTS NN O
: : O
Stimulation NN O
of IN O
CD2 NNP B-Gene
on IN O
primary JJ O
T NNP O
lymphocytes VBZ O
leads VBZ O
to TO O
the DT O
tyrosine NN O
phosphorylation NN O
, , O
nuclear JJ O
translocation NN O
, , O
and CC O
DNA NNP O
binding NN O
of IN O
STAT1 NNP B-Gene
. . O

In IN O
contrast NN O
to TO O
stimulation NN O
by IN O
cytokines NNS B-Gene
, , O
the DT O
activation NN O
of IN O
STAT1 NNP B-Gene
in IN O
response NN O
to TO O
CD2 NNP O
ligation NN O
is VBZ O
delayed VBN O
and CC O
does VBZ O
not RB O
involve VB O
Jak NNP B-Gene
kinases NNS I-Gene
. . O

Furthermore RB O
, , O
while IN O
STAT NNP O
phosphorylation NN O
induced VBN O
by IN O
cytokines NNS B-Gene
is VBZ O
generally RB O
transient JJ O
, , O
STAT1 NNP O
phosphorylation NN O
following VBG O
CD2 NNP O
stimulation NN O
persists VBZ O
for IN O
a DT O
period NN O
of IN O
days NNS O
. . O

Transcription NN O
of IN O
key JJ O
target NN O
genes NNS O
such JJ O
as IN O
IRF1 NNP B-Gene
and CC O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
proceeds NNS O
with IN O
delayed JJ O
kinetics NNS O
following VBG O
CD2 NNP O
stimulation NN O
, , O
suggesting VBG O
that IN O
this DT O
unique JJ O
pattern NN O
of IN O
STAT NNP O
activation NN O
may MD O
lead VB O
to TO O
a DT O
distinct JJ O
cellular JJ O
response NN O
following VBG O
CD2 NNP O
ligation NN O
. . O

This DT O
pathway NN O
appears VBZ O
to TO O
be VB O
restricted VBN O
to TO O
T NNP O
cells NNS O
, , O
as IN O
stimulation NN O
of IN O
CD2 NNP B-Gene
on IN O
NK NNP O
cells NNS O
does VBZ O
not RB O
lead VB O
to TO O
STAT1 NNP O
activation NN O
. . O

CONCLUSION NN O
: : O
Stimulation NN O
of IN O
T NNP O
cells NNS O
through IN O
cell NN B-Gene
- : I-Gene
surface NN I-Gene
molecules NNS I-Gene
such JJ O
as IN O
CD2 NNP B-Gene
involves VBZ O
activation NN O
of IN O
STAT NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
thus RB O
recapitulating VBG O
elements NNS O
of IN O
cytokine NN O
signaling NN O
. . O

NFATc1 NNP B-Gene
and CC O
NFATc2 NNP B-Gene
together RB O
control VB O
both DT O
T NNP O
and CC O
B NNP O
cell NN O
activation NN O
and CC O
differentiation NN O
. . O

NFAT NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
play VBP O
critical JJ O
roles NNS O
in IN O
gene NN O
transcription NN O
during IN O
immune JJ O
responses NNS O
. . O

To TO O
investigate VB O
further RB O
the DT O
two CD O
most JJS O
prominent JJ O
NFAT NNP B-Gene
family NN I-Gene
members NNS I-Gene
, , O
NFATc1 NNP B-Gene
and CC O
NFATc2 NNP B-Gene
, , O
we PRP O
generated VBD O
mice JJ O
bearing NN O
lymphoid JJ O
systems NNS O
devoid NN O
of IN O
both DT O
. . O

Doubly RB O
deficient JJ O
T NNP O
cells NNS O
displayed VBD O
cell NN O
surface NN O
markers NNS O
of IN O
activation NN O
yet RB O
were VBD O
significantly RB O
deficient VBN O
in IN O
the DT O
development NN O
of IN O
multiple JJ O
effector NN O
functions NNS O
, , O
including VBG O
Th NNP B-Gene
cytokine NN I-Gene
production NN O
, , O
surface NN B-Gene
effector NN I-Gene
molecule NN I-Gene
expression NN O
, , O
and CC O
cytolytic JJ O
activity NN O
. . O

Nevertheless RB O
, , O
doubly RB O
deficient NN O
B NNP O
cells NNS O
were VBD O
hyperactivated VBN O
, , O
as IN O
evidenced VBN O
by IN O
extremely RB O
elevated VBN O
serum NN O
IgG1 NNP B-Gene
and CC O
IgE NNP B-Gene
, , O
as RB O
well RB O
as IN O
plasma NN O
cell NN O
expansion NN O
and CC O
infiltration NN O
of IN O
end NN O
organs NNS O
. . O

Thus RB O
, , O
in IN O
T NNP O
cells NNS O
, , O
NFATc1 NNP B-Gene
and CC O
NFATc2 NNP B-Gene
are VBP O
dispensable JJ O
for IN O
inflammatory JJ O
reactivity NN O
but CC O
are VBP O
required VBN O
for IN O
effector NN O
differentiation NN O
, , O
while IN O
in IN O
B NNP O
cells NNS O
, , O
NFATs NNP B-Gene
regulate VBP O
both DT O
normal JJ O
homeostasis NN O
and CC O
differentiation NN O
. . O

Epstein NNP O
- : O
barr NN O
virus NN O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
protein NN I-Gene
BZLF1 NNP I-Gene
is VBZ O
SUMO NNP O
- : O
1 CD O
modified VBN O
and CC O
disrupts NNS O
promyelocytic JJ O
leukemia NN O
bodies NNS O
. . O

Although IN O
the DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
proteins NNS I-Gene
of IN O
both DT O
herpes NNS O
simplex VBP O
virus NN O
( ( O
HSV NNP O
) ) O
and CC O
cytomegalovirus NN O
( ( O
CMV NNP O
) ) O
are VBP O
known VBN O
to TO O
modify VB O
promyelocytic JJ O
leukemia NN O
( ( O
PML NNP O
) ) O
( ( O
ND10 NNP O
) ) O
bodies NNS O
in IN O
the DT O
nucleus NN O
of IN O
the DT O
host NN O
cell NN O
, , O
it PRP O
has VBZ O
been VBN O
unclear JJ O
whether IN O
lytic JJ O
infection NN O
with IN O
gamma NN O
herpesviruses NNS O
induces VBZ O
a DT O
similar JJ O
effect NN O
. . O

The DT O
PML NNP B-Gene
protein NN I-Gene
is VBZ O
induced VBN O
by IN O
interferon NN B-Gene
, , O
involved VBN O
in IN O
major JJ B-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
class NN I-Gene
I PRP I-Gene
presentation VBP O
, , O
and CC O
necessary JJ O
for IN O
certain JJ O
types NNS O
of IN O
apoptosis NN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
PML NNP O
bodies NNS O
function NN O
in IN O
an DT O
antiviral JJ O
capacity NN O
. . O

SUMO NNP O
- : O
1 CD O
modification NN O
of IN O
PML NNP B-Gene
is VBZ O
known VBN O
to TO O
be VB O
required VBN O
for IN O
the DT O
formation NN O
of IN O
PML NNP O
bodies NNS O
. . O

To TO O
examine VB O
whether IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
lytic JJ O
replication NN O
interferes NNS O
with IN O
PML NNP O
bodies NNS O
, , O
we PRP O
expressed VBD O
the DT O
EBV NNP B-Gene
immediate JJ I-Gene
- : I-Gene
early JJ I-Gene
genes NNS I-Gene
BZLF1 NNP B-Gene
( ( I-Gene
Z NNP I-Gene
) ) I-Gene
and CC O
BRLF1 NNP B-Gene
( ( I-Gene
R NNP I-Gene
) ) I-Gene
in IN O
EBV NNP O
- : O
positive JJ O
cell NN O
lines NNS O
and CC O
examined VBD O
PML NNP B-Gene
localization NN O
. . O

Both DT O
Z NNP O
and CC O
R NNP O
expression NN O
resulted VBD O
in IN O
PML NNP B-Gene
dispersion NN O
in IN O
EBV NNP O
- : O
positive JJ O
cells NNS O
. . O

Z NNS O
but CC O
not RB O
R NNP O
expression NN O
is VBZ O
sufficient JJ O
to TO O
disrupt VB O
PML NNP O
bodies NNS O
in IN O
EBV NNP O
- : O
negative JJ O
cell NN O
lines NNS O
. . O

We PRP O
show VBP O
that DT O
dispersion NN O
of IN O
PML NNP O
bodies NNS O
by IN O
Z NNP B-Gene
requires VBZ O
a DT O
portion NN O
of IN O
the DT O
transcriptional JJ B-Gene
activation NN I-Gene
domain NN I-Gene
of IN O
Z NNP B-Gene
but CC O
not RB O
the DT O
DNA NNP O
- : O
binding NN O
function NN O
. . O

As IN O
was VBD O
previously RB O
reported VBN O
for IN O
the DT O
HSV NNP B-Gene
- : I-Gene
1 CD I-Gene
ICP0 NNP I-Gene
and CC I-Gene
CMV NNP I-Gene
IE1 NNP I-Gene
proteins VBZ I-Gene
, , O
Z NNP B-Gene
reduces VBZ O
the DT O
amount NN O
of IN O
SUMO NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
modified VBN I-Gene
PML NNP I-Gene
. . O

We PRP O
also RB O
found VBD O
that IN O
Z NNP B-Gene
itself PRP O
is VBZ O
SUMO NNP O
- : O
1 CD O
modified VBN O
( ( O
through IN O
amino NN O
acid VBP O
12 CD O
) ) O
and CC O
that IN O
Z NNP B-Gene
competes VBZ O
with IN O
PML NNP B-Gene
for IN O
limiting VBG O
amounts NNS O
of IN O
SUMO NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
disruption NN O
of IN O
PML NNP O
bodies NNS O
is VBZ O
important JJ O
for IN O
efficient JJ O
lytic JJ O
replication NN O
of IN O
EBV NNP O
. . O

Furthermore RB O
, , O
Z NNP B-Gene
may MD O
potentially RB O
alter VB O
the DT O
function NN O
of IN O
a DT O
variety NN O
of IN O
cellular JJ O
proteins NNS O
by IN O
inhibiting VBG O
SUMO NNP O
- : O
1 CD O
modification NN O

Suppression NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
stimulation NN O
of IN O
inhibitor NN B-Gene
kappaB NN I-Gene
by IN O
troglitazone NN O
: : O
evidence NN O
for IN O
an DT O
anti JJ O
- : O
inflammatory JJ O
effect NN O
and CC O
a DT O
potential JJ O
antiatherosclerotic JJ O
effect NN O
in IN O
the DT O
obese JJ O
. . O

To TO O
elucidate VB O
whether IN O
troglitazone NN O
exerts VBZ O
an DT O
antiinflammatory JJ O
effect NN O
in IN O
humans NNS O
, , O
in IN O
vivo NN O
, , O
we PRP O
investigated VBD O
the DT O
suppression NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
( ( O
NFkappaB NNP B-Gene
) ) O
in IN O
mononuclear JJ O
cells NNS O
( ( O
MNC NNP O
) ) O
by IN O
this DT O
drug NN O
. . O

We PRP O
measured VBD O
intranuclear JJ B-Gene
NFkappaB NNP I-Gene
, , O
total JJ O
cellular JJ B-Gene
NFkappaB NNP I-Gene
, , O
inhibitor NN B-Gene
kappaB NN I-Gene
( ( I-Gene
IkappaB NNP I-Gene
) ) I-Gene
alpha NN I-Gene
, , O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
generation NN O
, , O
and CC O
p47 NN B-Gene
( ( I-Gene
phox NN I-Gene
) ) I-Gene
subunit NN I-Gene
( ( O
a DT O
key NN O
component NN O
protein NN O
of IN O
nicotinamide JJ B-Gene
adenine JJ I-Gene
dinucleotide NN I-Gene
phosphate NN I-Gene
oxidase NN I-Gene
) ) O
in IN O
MNC NNP O
. . O

Plasma NNP B-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
, , O
soluble JJ B-Gene
intercellular JJ I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
sICAM JJ B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
monocyte JJ B-Gene
chemoattractant NN I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
MCP NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
, , O
plasminogen JJ B-Gene
activator NN I-Gene
inhibitor NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
C NNP B-Gene
- : I-Gene
reactive JJ I-Gene
protein NN I-Gene
( ( I-Gene
CRP NNP I-Gene
) ) I-Gene
, , O
and CC O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
10 CD I-Gene
( ( O
antiinflammatory JJ B-Gene
cytokine NN I-Gene
) ) O
concentrations NNS O
were VBD O
also RB O
measured VBN O
as IN O
mediators NNS O
of IN O
inflammatory JJ O
activity NN O
that WDT O
are VBP O
regulated VBN O
by IN O
the DT O
proinflammatory NN B-Gene
transcription NN I-Gene
factor NN I-Gene
NFkappaB NNP I-Gene
. . O

Seven NNP O
nondiabetic JJ O
obese JJ O
patients NNS O
were VBD O
given VBN O
400 CD O
mg JJ O
troglitazone NN O
daily NN O
for IN O
4 CD O
weeks NNS O
. . O

Blood NN O
samples NNS O
were VBD O
collected VBN O
before RB O
and CC O
at IN O
weekly JJ O
intervals NNS O
thereafter RB O
. . O

MNC NNP O
were VBD O
separated VBN O
; : O
and CC O
the DT O
levels NNS O
of IN O
intranuclear JJ B-Gene
NFkappaB NNP I-Gene
, , O
total JJ O
cellular JJ B-Gene
NFkappaB NNP I-Gene
, , O
IkappaBalpha NNP B-Gene
, , O
and CC O
p47 NN B-Gene
( ( I-Gene
phox NN I-Gene
) ) I-Gene
subunit NN I-Gene
and CC O
ROS NNP O
generation NN O
were VBD O
determined VBN O
. . O

Plasma NNP O
was VBD O
used VBN O
to TO O
measure VB O
insulin NN O
glucose NN O
, , O
TNFalpha NNP B-Gene
, , O
sICAM NN B-Gene
, , O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
CRP NNP B-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
. . O

Plasma NNP O
insulin NN O
concentrations NNS O
fell VBD O
significantly RB O
at IN O
week NN O
1 CD O
, , O
from IN O
31 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
29 CD O
. . O
1 CD O
to TO O
14 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
11 CD O
. . O
4 CD O
mU JJ O
/ NN O
L NNP O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
remained VBD O
low JJ O
throughout IN O
4 CD O
weeks NNS O
. . O

Plasma NNP O
glucose JJ O
concentrations NNS O
did VBD O
not RB O
alter VB O
significantly RB O
. . O

There EX O
was VBD O
a DT O
fall NN O
in IN O
intranuclear JJ B-Gene
NFkappaB NNP I-Gene
, , O
total JJ O
cellular JJ B-Gene
NFkappaB NNP I-Gene
, , O
and CC O
p47 NN B-Gene
( ( I-Gene
phox NN I-Gene
) ) I-Gene
subunit NN I-Gene
, , O
with IN O
an DT O
increase NN O
in IN O
cellular JJ O
IkappaBalpha NNP B-Gene
at IN O
week NN O
2 CD O
, , O
which WDT O
persisted VBD O
until IN O
week NN O
4 CD O
. . O

There EX O
was VBD O
a DT O
parallel JJ O
fall NN O
in IN O
ROS NNP O
generation NN O
by IN O
MNC NNP O
at IN O
week NN O
1 CD O
; : O
this DT O
progressed VBN O
and CC O
persisted VBN O
until IN O
week NN O
4 CD O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Plasma NNP O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
sICAM SYM B-Gene
- : I-Gene
1 CD I-Gene
, , O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
concentrations NNS O
fell VBD O
significantly RB O
at IN O
week NN O
4 CD O
. . O

Plasma NNP O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
concentration NN O
increased VBD O
significantly RB O
, , O
whereas NNS O
plasma VBP B-Gene
CRP NNP I-Gene
concentrations NNS O
decreased VBD O
. . O

We PRP O
conclude VBP O
that IN O
troglitazone NN O
has VBZ O
an DT O
antiinflammatory JJ O
action NN O
that WDT O
may MD O
contribute VB O
to TO O
its PRP$ O
putative JJ O
antiatherosclerotic JJ O
effects NNS O
. . O

Tyrosine NNP O
phosphorylation NN O
- : O
dependent JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Requirement NN O
for IN O
p56 NN B-Gene
LCK NNP I-Gene
and CC I-Gene
ZAP NNP I-Gene
- : I-Gene
70 CD I-Gene
protein NN I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
. . O

Phosphorylation NN O
of IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
domain NN I-Gene
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
inhibitory NN I-Gene
subunits NNS I-Gene
induces NNS O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Although IN O
serine JJ O
phosphorylation NN O
has VBZ O
been VBN O
shown VBN O
to TO O
induce VB O
ubiquitination NN O
and CC O
subsequent JJ O
proteasome NN O
- : O
mediated VBN O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
mechanisms NNS O
that WDT O
lead VBP O
to TO O
release VB O
of IN O
active JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
T NNP O
cells NNS O
as IN O
a DT O
consequence NN O
of IN O
tyrosine JJ O
phosphorylation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
[ NN O
Imbert NNP O
, , O
V NNP O
. . O
, , O
Rupec NNP O
, , O
R NNP O
. . O
A NNP O
. . O
, , O
Livolsi NNP O
, , O
A NNP O
. . O
, , O
Pahl NNP O
, , O
H NNP O
. . O
L NNP O
. . O
, , O
Traenckner NNP O
, , O
B NNP O
. . O
M NNP O
. . O
, , O
Mueller NNP O
- : O
Dieckmann NNP O
, , O
C NNP O
. . O
, , O
Farahifar NNP O
, , O
D NNP O
. . O
, , O
Rossi NNP O
, , O
B NNP O
. . O
, , O
Auberger NNP O
, , O
P NNP O
. . O
, , O
Baeuerle NNP O
, , O
P NNP O
. . O
& CC O
Peyron NNP O
, , O
J NNP O
. . O
F NNP O
. . O
( ( O
1996 CD O
) ) O
Cell NNP O
86 CD O
, , O
787 CD O
- : O
- : O
798 CD O
] NN O
. . O

The DT O
involvement NN O
of IN O
the DT O
tyrosine NN B-Gene
kinases VBZ I-Gene
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
and CC O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
in IN O
this DT O
reaction NN O
is VBZ O
demonstrated VBN O
here RB O
using VBG O
specific JJ O
pharmacological JJ O
inhibitors NNS O
and CC O
Jurkat NNP O
mutants NNS O
unable JJ O
to TO O
express VB O
these DT O
kinases NNS B-Gene
. . O

Although IN O
the DT O
inhibitors NNS O
prevented VBD O
both DT O
pervanadate JJ O
- : O
induced JJ O
phosphorylation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
on IN O
Tyr42 NNP O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
we PRP O
observed VBD O
that IN O
, , O
in IN O
p56 NN O
( ( O
lck NN O
) ) O
- : O
deficient NN O
Jurkat NNP O
mutants NNS O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
could MD O
still RB O
associate VB O
with IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
despite IN O
phosphorylation NN O
on IN O
Tyr42 NNP O
. . O

Furthermore RB O
, , O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
of IN O
p56 NN B-Gene
( ( I-Gene
lck JJ I-Gene
) ) I-Gene
appeared VBD O
to TO O
be VB O
required VBN O
for IN O
pervanadate JJ O
- : O
induced JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
but CC O
not RB O
for IN O
Tyr42 NNP O
phosphorylation NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
and CC O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
are VBP O
key JJ O
components NNS O
of IN O
the DT O
signaling VBG O
pathway NN O
that WDT O
leads VBZ O
to TO O
phosphotyrosine VB O
- : O
dependent NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
in IN O
T NNP O
cells NNS O
and CC O
confirm NN O
that WDT O
tyrosine VBP B-Gene
kinases NNS I-Gene
must MD O
control VB O
at IN O
least JJS O
two CD O
different JJ O
steps NNS O
to TO O
induce VB O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
H NNP O
( ( O
2 CD O
) ) O
O NNP O
( ( O
2 CD O
) ) O
, , O
which WDT O
stimulates VBZ O
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
and CC O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
in IN O
T NNP O
cells NNS O
, , O
is VBZ O
an DT O
activator NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
through IN O
tyrosine JJ O
phosphorylation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
. . O

Specific JJ O
missense NN O
mutations NNS O
in IN O
NEMO NNP B-Gene
result NN O
in IN O
hyper JJR O
- : O
IgM NNP O
syndrome NN O
with IN O
hypohydrotic JJ O
ectodermal JJ O
dysplasia NN O
. . O

The DT O
gene NN O
that WDT O
encodes VBZ O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
) ) I-Gene
essential JJ I-Gene
modulator NN I-Gene
( ( O
or CC O
NEMO NNP B-Gene
, , O
also RB O
known VBN O
as IN O
IKKgamma NNP B-Gene
) ) O
is VBZ O
required VBN O
for IN O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
. . O

We PRP O
describe VBP O
mutations NNS O
in IN O
the DT O
putative JJ B-Gene
zinc NN I-Gene
- : I-Gene
finger NN I-Gene
domain NN I-Gene
of IN O
NEMO NNP B-Gene
that WDT O
result NN O
in IN O
an DT O
X NNP O
- : O
linked VBD O
primary JJ O
immunodeficiency NN O
characterized VBN O
by IN O
hyper JJR O
- : O
IgM NNP O
syndrome NN O
and CC O
hypohydrotic JJ O
ectodermal JJ O
dysplasia NN O
( ( O
XHM NNP O
- : O
ED NN O
) ) O
. . O

These DT O
mutations NNS O
prevent VBP O
CD40 NNP B-Gene
ligand NN I-Gene
( ( O
CD40L NNP B-Gene
) ) O
- : O
mediated VBN O
degradation NN O
of IN O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
alpha NN I-Gene
( ( O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
and CC O
account NN O
for IN O
the DT O
following JJ O
observations NNS O
: : O
B NNP O
cells NNS O
from IN O
XHM NNP O
- : O
ED NN O
patients NNS O
are VBP O
unable JJ O
to TO O
undergo VB O
immunoglobulin JJ O
class NN O
- : O
switch NN O
recombination NN O
and CC O
antigen NN O
- : O
presenting NN O
cells NNS O
( ( O
APCs NNP O
) ) O
are VBP O
unable JJ O
to TO O
synthesize VB O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
regulated VBN I-Gene
cytokines NNS I-Gene
interleukin FW B-Gene
12 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
) ) O
or CC O
tumor JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
when WRB O
stimulated VBN O
with IN O
CD40L NNP B-Gene
. . O

Nevertheless RB O
, , O
innate JJ O
immunity NN O
is VBZ O
preserved VBN O
in IN O
XHM NNP O
- : O
ED NN O
patients NNS O
because IN O
APCs NNP O
retain VBP O
the DT O
capacity NN O
to TO O
respond VB O
to TO O
stimulation VB O
by IN O
lipopolysaccharide NN O
or CC O
Staphylococcus NNP B-Gene
aureus VBP I-Gene
Cowan NNP I-Gene
' POS I-Gene
s NN I-Gene
antigen NN I-Gene
( ( O
SAC NNP B-Gene
) ) O
. . O

Overall JJ O
, , O
the DT O
phenotype NN O
observed VBD O
in IN O
XHM NNP O
- : O
ED NN O
patients NNS O
shows VBZ O
that IN O
the DT O
putative JJ B-Gene
zinc NN I-Gene
- : I-Gene
finger NN I-Gene
domain NN I-Gene
of IN O
NEMO NNP B-Gene
has VBZ O
a DT O
regulatory JJ O
function NN O
and CC O
demonstrates VBZ O
the DT O
definite JJ O
requirement NN O
of IN O
CD40 NNP B-Gene
- : O
mediated VBD O
NF NNP O
- : O
kappaB NN O
activation NN O
for IN O
B NNP O
cell NN O
immunoglobulin NN O
class NN O
- : O
switching NN O
. . O

Granulocytic JJ O
differentiation NN O
of IN O
human JJ O
NB4 NNP O
promyelocytic JJ O
leukemia NN O
cells NNS O
induced VBN O
by IN O
all DT O
- : O
trans NNS O
retinoic VBP O
acid JJ O
metabolites NNS O
. . O

The DT O
metabolism NN O
of IN O
all DT O
- : O
trans NNS O
retinoic VBP O
acid NN O
( ( O
ATRA NNP O
) ) O
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
partly RB O
responsible JJ O
for IN O
the DT O
in IN O
vivo NN O
resistance NN O
to TO O
ATRA NNP O
seen VBN O
in IN O
the DT O
treatment NN O
of IN O
human JJ O
acute JJ O
promyelocytic JJ O
leukemia NN O
( ( O
APL NNP O
) ) O
. . O

However RB O
, , O
ATRA NNP O
metabolism NN O
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
the DT O
growth NN O
inhibition NN O
of IN O
several JJ O
cancer NN O
cell NN O
lines NNS O
in IN O
vitro NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
in IN O
vitro JJ O
activity NN O
of IN O
the DT O
principal JJ O
metabolites NNS O
of IN O
ATRA NNP O
[ NNP O
4 CD O
- : O
hydroxy NN O
- : O
retinoic NN O
acid NN O
( ( O
4 CD O
- : O
OH NNP O
- : O
RA NNP O
) ) O
, , O
18 CD O
- : O
hydroxy NN O
- : O
retinoic NN O
acid NN O
( ( O
18 CD O
- : O
OH NNP O
- : O
RA NNP O
) ) O
, , O
4 CD O
- : O
oxo NN O
- : O
retinoic NN O
acid NN O
( ( O
4 CD O
- : O
oxo NN O
- : O
RA NNP O
) ) O
, , O
and CC O
5 CD O
, , O
6 CD O
- : O
epoxy JJ O
- : O
retinoic NN O
acid NN O
( ( O
5 CD O
, , O
6 CD O
- : O
epoxy JJ O
- : O
RA NNP O
) ) O
] NN O
in IN O
NB4 NNP O
, , O
a DT O
human JJ O
promyelocytic JJ O
leukemia NN O
cell NN O
line NN O
that IN O
exhibits VBZ O
the DT O
APL NNP O
diagnostic JJ O
t NN O
( ( O
15 CD O
; : O
17 CD O
) ) O
chromosomal NN O
translocation NN O
and CC O
expresses VBZ O
the DT O
PML NNP B-Gene
- : I-Gene
RAR NNP I-Gene
alpha VBZ I-Gene
fusion NN I-Gene
protein NN I-Gene
. . O

We PRP O
established VBD O
that IN O
the DT O
four CD O
ATRA NNP O
metabolites NNS O
were VBD O
indeed RB O
formed VBN O
by IN O
the DT O
NB4 NNP O
cells NNS O
in IN O
vitro NN O
. . O

NB4 NNP O
cell NN O
growth NN O
was VBD O
inhibited VBN O
( ( O
69 CD O
- : O
78 CD O
% NN O
at IN O
120 CD O
h NN O
) ) O
and CC O
cell NN O
cycle NN O
progression NN O
in IN O
the DT O
G1 NNP O
phase NN O
( ( O
82 CD O
- : O
85 CD O
% NN O
at IN O
120 CD O
h NN O
) ) O
was VBD O
blocked VBN O
by IN O
ATRA NNP O
and CC O
all DT O
of IN O
the DT O
metabolites NNS O
at IN O
1 CD O
microM JJ O
concentration NN O
. . O

ATRA NNP O
and CC O
its PRP$ O
metabolites NNS O
could MD O
induce VB O
NB4 NNP O
cells NNS O
differentiation NN O
with IN O
similar JJ O
activity NN O
, , O
as IN O
evaluated VBN O
by IN O
cell NN O
morphology NN O
, , O
by IN O
the DT O
nitroblue JJ O
tetrazolium NN O
reduction NN O
test NN O
( ( O
82 CD O
- : O
88 CD O
% NN O
at IN O
120 CD O
h NN O
) ) O
or CC O
by IN O
the DT O
expression NN O
of IN O
the DT O
maturation NN B-Gene
specific NN I-Gene
cell NN I-Gene
surface NN I-Gene
marker NN I-Gene
CD11c NNP I-Gene
. . O

In IN O
addition NN O
, , O
nuclear JJ O
body NN O
reorganization NN O
to TO O
macropunctated VBN O
structures NNS O
, , O
as RB O
well RB O
as IN O
the DT O
degradation NN O
of IN O
PML NNP B-Gene
- : I-Gene
RAR NNP I-Gene
alpha NN I-Gene
, , O
was VBD O
found VBN O
to TO O
be VB O
similar JJ O
for IN O
ATRA NNP O
and CC O
all DT O
of IN O
its PRP$ O
metabolites NNS O
. . O

Comparison NNP O
of IN O
the DT O
relative JJ O
potency NN O
of IN O
the DT O
retinoids NNS O
using VBG O
the DT O
nitroblue JJ O
tetrazolium NN O
reduction NN O
test NN O
showed VBD O
effective JJ O
concentrations NNS O
required VBN O
to TO O
differentiate VB O
50 CD O
% NN O
of IN O
cells NNS O
in IN O
72 CD O
h NN O
as IN O
follows VBZ O
: : O
ATRA NNP O
, , O
15 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
7 CD O
nM NN O
; : O
4 CD O
- : O
oxo NN O
- : O
RA NNP O
, , O
38 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
3 CD O
nM NN O
; : O
18 CD O
- : O
OH NNP O
- : O
RA NNP O
, , O
55 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
8 CD O
nM NN O
; : O
4 CD O
- : O
OH NNP O
- : O
RA NNP O
, , O
79 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
8 CD O
nM NN O
; : O
and CC O
5 CD O
, , O
6 CD O
- : O
epoxy JJ O
- : O
RA NNP O
, , O
99 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
5 CD O
nM NN O
. . O

The DT O
ATRA NNP O
metabolites NNS O
were VBD O
found VBN O
to TO O
exert VB O
their PRP$ O
differentiation NN O
effects NNS O
via IN O
the DT O
RAR NNP B-Gene
alpha NN I-Gene
nuclear JJ I-Gene
receptors NNS I-Gene
, , O
because IN O
the DT O
RAR NNP O
alpha SYM O
- : O
specific JJ O
antagonist NN O
BMS614 NNP O
blocked VBD O
metabolite JJ O
- : O
induced JJ O
CD11c NNP O
expression NN O
in IN O
NB4 NNP O
cells NNS O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
the DT O
principal JJ O
ATRA NNP O
Phase NNP O
1 CD O
metabolites NNS O
can MD O
elicit VB O
leukemia NN O
cell NN O
growth NN O
inhibition NN O
and CC O
differentiation NN O
in IN O
vitro NN O
through IN O
the DT O
RAR NNP O
alpha NN O
signaling VBG O
pathway NN O
, , O
and CC O
they PRP O
suggest VBP O
that IN O
these DT O
metabolites NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
ATRA NNP O
antileukemic JJ O
activity NN O
in IN O
vivo NN O
. . O

Expression NN O
of IN O
oestrogen NN B-Gene
and CC I-Gene
progesterone NN I-Gene
receptors NNS I-Gene
by IN O
mast JJ O
cells NNS O
alone RB O
, , O
but CC O
not RB O
lymphocytes NNS O
, , O
macrophages NNS O
or CC O
other JJ O
immune JJ O
cells NNS O
in IN O
human JJ O
upper JJ O
airways NNS O
. . O

BACKGROUND NN O
: : O
Nasal JJ O
polyposis NN O
often RB O
coexists VBZ O
with IN O
asthma NN O
in IN O
airway JJ O
inflammatory JJ O
conditions NNS O
characterised VBN O
by IN O
the DT O
infiltration NN O
of IN O
a DT O
range NN O
of IN O
immune JJ O
cells NNS O
. . O

A DT O
potentially RB O
important JJ O
role NN O
for IN O
ovarian JJ O
hormones NNS O
has VBZ O
been VBN O
implicated VBN O
in IN O
airway JJ O
inflammation NN O
but CC O
the DT O
cellular JJ O
target NN O
for IN O
such JJ O
action NN O
is VBZ O
not RB O
known VBN O
. . O

METHODS NN O
: : O
Expression NN O
of IN O
oestrogen NN B-Gene
receptors NNS I-Gene
( ( O
ER NNP B-Gene
) ) O
and CC O
progesterone NN B-Gene
receptors NNS I-Gene
( ( O
PR NNP B-Gene
) ) O
was VBD O
examined VBN O
using VBG O
immunohistochemistry NN O
in IN O
formalin NN O
fixed VBN O
nasal JJ O
polyp NN O
tissues NNS O
from IN O
47 CD O
subjects NNS O
. . O

The DT O
cells NNS O
positive JJ O
for IN O
ER NNP B-Gene
or CC O
PR NNP B-Gene
were VBD O
confirmed VBN O
by IN O
spatial JJ O
location NN O
, , O
dual JJ O
immunolabelling NN O
, , O
and CC O
histochemical JJ O
staining NN O
. . O

RESULTS NN O
: : O
Consistent JJ O
with IN O
the DT O
known JJ O
features NNS O
of IN O
nasal JJ O
polyps NNS O
, , O
CD4 NNP O
+ NNP O
( ( O
T NNP O
helper VBZ O
/ NNP O
inducer NN O
) ) O
, , O
CD8 NNP O
+ NNP O
( ( O
cytotoxic JJ O
/ NNP O
suppressor NN O
) ) O
, , O
CD68 NNP O
+ NNP O
( ( O
macrophages NNS O
) ) O
, , O
mast JJ O
cells NNS O
, , O
eosinophils NNS O
and CC O
neutrophils NNS O
were VBD O
all DT O
clearly RB O
detected VBN O
by IN O
their PRP$ O
relevant JJ O
monoclonal JJ B-Gene
antibodies NNS I-Gene
or CC O
appropriate JJ O
histochemical JJ O
staining NN O
, , O
but CC O
only RB O
mast JJ O
cells NNS O
tested VBN O
positive JJ O
for IN O
ER NNP B-Gene
/ NNP O
PR NNP O
labelling VBG O
with IN O
their PRP$ O
polyclonal JJ B-Gene
and CC I-Gene
monoclonal JJ I-Gene
antibodies NNS I-Gene
. . O

The DT O
frequencies NNS O
for IN O
expression NN O
were VBD O
61 CD O
. . O
7 CD O
% NN O
for IN O
ER NNP O
positive JJ O
and CC O
59 CD O
. . O
6 CD O
% NN O
for IN O
PR NNP O
positive JJ O
cells NNS O
. . O

The DT O
expression NN O
of IN O
ER NNP B-Gene
/ NNP O
PR NNP B-Gene
was VBD O
independent JJ O
of IN O
patient JJ O
sex NN O
and CC O
age NN O
but CC O
was VBD O
highly RB O
correlated VBN O
with IN O
the DT O
numbers NNS O
of IN O
mast NN O
cells NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
973 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
for IN O
ER NNP B-Gene
; : O
r NN O
= VBZ O
0 CD O
. . O
955 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
for IN O
PR NNP B-Gene
) ) O
. . O

Fewer JJR O
than IN O
5 CD O
% NN O
of IN O
mast NN O
cells NNS O
were VBD O
found VBN O
to TO O
be VB O
negative JJ O
for IN O
ER NNP B-Gene
/ NNP O
PR NNP B-Gene
expression NN O
. . O

CONCLUSIONS NN O
: : O
Mast NNP O
cells NNS O
alone RB O
, , O
but CC O
not RB O
lymphocytes NNS O
, , O
macrophages NNS O
, , O
or CC O
other JJ O
immune JJ O
cells NNS O
, , O
express NN O
ER NNP B-Gene
/ NNP O
PR NNP B-Gene
in IN O
human JJ O
upper JJ O
airways NNS O
. . O

Numerous JJ O
ER NNP O
/ NNP O
PR NNP O
positive JJ O
mast NN O
cells NNS O
exist VBP O
in IN O
nasal JJ O
polyps NNS O
, , O
indicating VBG O
that IN O
this DT O
may MD O
be VB O
a DT O
major JJ O
route NN O
for IN O
the DT O
involvement NN O
of IN O
sex NN O
hormones NNS O
in IN O
airway JJ O
inflammation NN O
when WRB O
exposed VBN O
to TO O
the DT O
higher JJR O
and CC O
varying VBG O
concentration NN O
of IN O
oestrogen NN O
and CC O
progesterone NN O
characteristic NN O
of IN O
females NNS O
. . O

NF NNP O
kappa NN O
b NN O
signaling VBG O
in IN O
posthypoxic JJ O
endothelial JJ O
cells NNS O
: : O
relevance NN O
to TO O
E NNP O
- : O
selectin NN O
expression NN O
and CC O
neutrophil JJ O
adhesion NN O
. . O

Our PRP$ O
previous JJ O
studies NNS O
have VBP O
implicated VBN O
the DT O
nuclear JJ O
transcription NN O
factor NN O
kappa NN O
B NNP O
( ( O
NF NNP B-Gene
kappa NNP I-Gene
B NNP I-Gene
) ) O
in IN O
the DT O
regulation NN O
of IN O
adhesion NN B-Gene
molecule NN I-Gene
expression NN O
in IN O
endothelial JJ O
cells NNS O
exposed VBN O
to TO O
anoxia VB O
- : O
reoxygenation NN O
( ( O
A DT O
/ NNP O
R NNP O
) ) O
or CC O
a DT O
redox JJ O
imbalance NN O
. . O

The DT O
objectives NNS O
of IN O
this DT O
study NN O
were VBD O
( ( O
1 CD O
) ) O
to TO O
define VB O
the DT O
kinetics NNS O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
by IN O
examining VBG O
I PRP O
kappa VBP O
B NNP O
alpha NN O
degradation NN O
and CC O
the DT O
nuclear JJ O
translocation NN O
of IN O
p65 NN B-Gene
in IN O
response NN O
to TO O
A NNP O
/ NNP O
R NNP O
or CC O
redox VB O
imbalance NN O
( ( O
induced VBN O
by IN O
treatment NN O
of IN O
cells NNS O
with IN O
diamide NN O
and CC O
buthionine VB O
sulfoximine NN O
) ) O
and CC O
( ( O
2 CD O
) ) O
to TO O
determine VB O
whether IN O
the DT O
signal NN O
for IN O
I PRP O
kappa VBP O
B NNP O
alpha NN O
degradation NN O
, , O
nuclear JJ O
translocation NN O
of IN O
p65 NN B-Gene
, , O
and CC O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
- : O
mediated VBN O
neutrophil JJ O
adhesion NN O
is VBZ O
related VBN O
to TO O
the DT O
activity NN O
of IN O
protein NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( O
PTK NNP B-Gene
) ) O
, , O
protein JJ B-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
( ( O
PTPase NNP B-Gene
) ) O
and CC O
/ $ O
or CC O
protein VB B-Gene
kinase JJ I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
. . O

The DT O
results NNS O
demonstrate VBP O
that IN O
both DT O
A NNP O
/ NN O
R NNP O
and CC O
redox JJ O
imbalance NN O
led VBD O
to TO O
I PRP O
kappa VB O
B NNP O
alpha NN O
degradation NN O
within IN O
30 CD O
min NNS O
and CC O
the DT O
concomitant JJ O
appearance NN O
of IN O
p65 NN B-Gene
in IN O
the DT O
nucleus NN O
, , O
consistent JJ O
with IN O
rapid JJ O
cytosolic JJ O
activation NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
subsequent JJ O
nuclear JJ O
translocation NN O
of IN O
the DT O
activated JJ B-Gene
p65 NN I-Gene
subunit NN I-Gene
. . O

Inhibition NN O
of IN O
PKC NNP B-Gene
blocked VBD O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
degradation NN O
and CC O
p65 JJ B-Gene
translocation NN O
in IN O
A NNP O
/ NNP O
R NNP O
- : O
challenged NN O
, , O
but CC O
not RB O
redox VB O
- : O
altered VBN O
, , O
endothelial JJ O
cells NNS O
. . O

However RB O
, , O
both DT O
A NNP O
/ NN O
R NNP O
- : O
and CC O
redox VB O
- : O
induced JJ O
NF NNP O
kappa NN O
B NNP O
activation NN O
was VBD O
blocked VBN O
by IN O
inhibition NN O
of IN O
PTK NNP B-Gene
. . O

Similarly RB O
, , O
A NNP O
/ NNP O
R NNP O
- : O
induced VBD O
E NNP O
- : O
selectin NN O
expression NN O
and CC O
neutrophil JJ O
- : O
endothelial JJ O
cell NN O
adhesion NN O
were VBD O
blocked VBN O
by IN O
inhibition NN O
of IN O
PKC NNP B-Gene
or CC O
PTK NNP B-Gene
, , O
while IN O
only RB O
PTK NNP B-Gene
inhibited VBD O
the DT O
redox NN O
- : O
induced JJ O
adhesion NN O
response NN O
. . O

Pretreatment NN O
of IN O
cells NNS O
with IN O
N NNP O
- : O
acetyl NN O
cysteine NN O
effectively RB O
blocked VBD O
A NNP O
/ NNP O
R NNP O
- : O
or CC O
redox VB O
- : O
induced VBN O
I PRP O
kappa VBP O
B NNP O
degradation NN O
and CC O
significantly RB O
attenuated VBD O
the DT O
respective JJ O
neutrophil JJ O
adhesion NN O
responses NNS O
. . O

Collectively RB O
, , O
these DT O
findings NNS O
indicate VBP O
that IN O
A NNP O
/ NNP O
R NNP O
- : O
induced VBD O
E NNP O
- : O
selectin NN O
expression NN O
and CC O
neutrophil JJ O
- : O
endothelial JJ O
cell NN O
adhesion NN O
are VBP O
mediated VBN O
by IN O
both DT O
PKC NNP B-Gene
and CC O
PTK NNP B-Gene
, , O
which WDT O
signal VBP O
rapid JJ O
activation NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

This DT O
A NNP O
/ NNP O
R NNP O
- : O
induced VBD O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
signaling VBG O
response NN O
appears VBZ O
to TO O
be VB O
mediated VBN O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
by IN O
intracellular JJ O
redox NN O
imbalance NN O
. . O

Copyright JJ O
2001 CD O
S NNP O
. . O
Karger NNP O
AG NNP O
, , O
Basel NNP O

Induction NN O
of IN O
apoptosis NN O
in IN O
human JJ O
lymphocytes NNS O
by IN O
the DT O
herbicide NN O
2 CD O
, , O
4 CD O
- : O
dichlorophenoxyaceti NN O
acid NN O
. . O

Dimethylammonium NNP O
salt NN O
of IN O
2 CD O
, , O
4 CD O
- : O
dichlorophenoxyaceti NN O
acid NN O
( ( O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NN O
) ) O
is VBZ O
a DT O
widely RB O
used VBN O
herbicide NN O
that WDT O
is VBZ O
considered VBN O
moderately RB O
toxic JJ O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
found VBD O
that IN O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NN O
is VBZ O
able JJ O
to TO O
cause VB O
apoptosis NN O
in IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
healthy JJ O
individuals NNS O
and CC O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Apoptosis NN O
induced VBN O
by IN O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NN O
was VBD O
dose JJ O
and CC O
time NN O
dependent JJ O
, , O
independent JJ O
of IN O
Fas NNP B-Gene
, , O
TNF NNP B-Gene
receptor NN I-Gene
1 CD I-Gene
or CC O
the DT O
aromatic JJ B-Gene
hydrocarbon NN I-Gene
receptor NN I-Gene
, , O
and CC O
involved JJ O
disruption NN O
of IN O
the DT O
mitochondrial JJ O
transmembrane NN O
potential NN O
and CC O
activation NN O
of IN O
caspase NN B-Gene
- : I-Gene
9 CD I-Gene
. . O

ZVAD NNP O
- : O
FMK NNP O
, , O
a DT O
broad JJ O
- : O
spectrum NN O
inhibitor NN O
of IN O
caspases NNS B-Gene
, , O
blocked VBD O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NNP O
- : O
induced JJ O
apoptosis NN O
completely RB O
. . O

While IN O
an DT O
inhibitor NN O
of IN O
caspase NN B-Gene
- : I-Gene
9 CD I-Gene
, , O
as RB O
well RB O
as IN O
caspase NN B-Gene
- : I-Gene
9 CD I-Gene
and CC O
caspase VB O
- : O
3 CD O
inhibitors NNS O
in IN O
combination NN O
, , O
strongly RB O
blocked VBD O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NNP O
- : O
induced JJ O
apoptosis NN O
, , O
an DT O
inhibitor NN O
of IN O
caspase NN B-Gene
- : I-Gene
3 CD I-Gene
had VBD O
a DT O
moderate JJ O
inhibitory NN O
effect NN O
. . O

Unlike IN O
Fas NNP B-Gene
- : O
mediated VBD O
apoptosis NN O
, , O
the DT O
initiator NN B-Gene
caspase NN I-Gene
, , O
caspase VB B-Gene
- : I-Gene
8 CD I-Gene
, , O
was VBD O
not RB O
involved VBN O
in IN O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NNP O
- : O
induced JJ O
apoptosis NN O
. . O

Transfection NN O
of IN O
Jurkat NNP O
cells NNS O
with IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
prevented VBD O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NNP O
- : O
induced JJ O
disruption NN O
of IN O
the DT O
mitochondrial JJ O
transmembrane NN O
potential NN O
and CC O
led VBN O
to TO O
a DT O
complete JJ O
blockage NN O
of IN O
apoptosis NN O
. . O

Our PRP$ O
data NNS O
indicate VBP O
that IN O
DMA NNP O
- : O
2 CD O
, , O
4 CD O
- : O
D NNP O
kills VBZ O
human JJ O
lymphocytes NNS O
by IN O
initiating VBG O
apoptosis NN O
via IN O
a DT O
direct JJ O
effect NN O
on IN O
mitochondria NN O
. . O

The DT O
activation NN O
of IN O
caspases NNS B-Gene
occurs VBP O
downstream NN O
of IN O
mitochondrial JJ O
damage NN O
, , O
and CC O
the DT O
dysfunction NN O
of IN O
mitochondria NN O
appears VBZ O
to TO O
be VB O
sufficient JJ O
for IN O
triggering VBG O
all DT O
downstream NN O
events NNS O
leading VBG O
to TO O
apoptosis NN O
. . O

Inhibition NN O
of IN O
Th1 NNP O
differentiation NN O
by IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
is VBZ O
mediated VBN O
by IN O
SOCS1 NNP B-Gene
. . O

Interleukin NNP B-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
is VBZ O
a DT O
cytokine NN B-Gene
produced VBN O
by IN O
immune NN O
and CC O
nonimmune JJ O
cells NNS O
and CC O
exhibits VBZ O
functional JJ O
pleiotropy NN O
and CC O
redundancy NN O
. . O

IL NNP B-Gene
- : I-Gene
6 CD I-Gene
plays NNS O
an DT O
important JJ O
role NN O
in IN O
the DT O
differentiation NN O
of IN O
several JJ O
cell NN O
types NNS O
. . O

Here RB O
, , O
we PRP O
describe VBP O
a DT O
novel JJ O
function NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
: : O
the DT O
negative JJ O
regulation NN O
of IN O
CD4 NNP B-Gene
+ NNP O
Th1 NNP O
cell NN O
differentiation NN O
. . O

While IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : O
directed VBN O
CD4 NNP B-Gene
+ NNP O
Th2 NNP O
differentiation NN O
is VBZ O
mediated VBN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
inhibition NN O
of IN O
Th1 NNP O
differentiation NN O
by IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
is VBZ O
independent JJ O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

IL NNP B-Gene
- : I-Gene
6 CD I-Gene
upregulates NNS O
suppressor NN B-Gene
of IN I-Gene
cytokine NN I-Gene
signaling VBG I-Gene
1 CD I-Gene
( ( O
SOCS1 NNP B-Gene
) ) O
expression NN O
in IN O
activated JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
, , O
thereby RB O
interfering VBG O
with IN O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
1 CD I-Gene
( ( O
STAT1 NNP B-Gene
) ) O
phosphorylation NN O
induced VBN O
by IN O
interferon NN B-Gene
gamma NN I-Gene
( ( O
IFNgamma NNP B-Gene
) ) O
. . O

Inhibition NN O
of IN O
IFNgamma NNP B-Gene
receptor NN O
- : O
mediated VBN O
signals NNS O
by IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
prevents NNS O
autoregulation NN O
of IN O
IFNgamma NNP B-Gene
gene NN I-Gene
expression NN O
by IN O
IFNgamma NNP B-Gene
during IN O
CD4 NNP O
+ NNP O
T NNP O
cell NN O
activation NN O
, , O
thereby RB O
preventing VBG O
Th1 NNP O
differentiation NN O
. . O

Thus RB O
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
promotes NNS O
CD4 NNP B-Gene
+ NNP O
Th2 NNP O
differentiation NN O
and CC O
inhibits NNS O
Th1 NNP O
differentiation NN O
by IN O
two CD O
independent JJ O
molecular JJ O
mechanisms NNS O
. . O

Interaction NN O
between IN O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
and CC O
cyclic JJ B-Gene
AMP NNP I-Gene
response NN I-Gene
element NN I-Gene
binding VBG I-Gene
protein RB I-Gene
1 CD I-Gene
regulates NNS O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
transcription NN O
in IN O
cells NNS O
of IN O
the DT O
monocyte NN O
/ NNP O
macrophage NN O
lineage NN O
. . O

Recent JJ O
observations NNS O
have VBP O
shown VBN O
two CD O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) I-Gene
binding VBG I-Gene
sites NNS I-Gene
to TO O
be VB O
critically RB O
important JJ O
for IN O
efficient JJ O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
replication NN O
within IN O
cells NNS O
of IN O
the DT O
monocyte NN O
/ NNP O
macrophage NN O
lineage NN O
, , O
a DT O
cell NN O
type NN O
likely RB O
involved VBN O
in IN O
transport NN O
of IN O
the DT O
virus NN O
to TO O
the DT O
brain NN O
. . O

Additionally RB O
, , O
sequence NN O
variation NN O
at IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
site NN I-Gene
I PRP I-Gene
, , O
which WDT O
lies VBZ O
immediately RB O
upstream JJ O
of IN O
the DT O
distal JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
and CC O
immediately RB O
downstream NN O
of IN O
a DT O
binding NN O
site NN O
for IN O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
( ( O
ATF NNP B-Gene
) ) O
/ VBZ O
cyclic JJ B-Gene
AMP NNP I-Gene
response NN I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
affect VB O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
activity NN O
. . O

Given VBN O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
proteins NNS I-Gene
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
many JJ O
other JJ O
transcription NN B-Gene
factors NNS I-Gene
including VBG O
members NNS O
of IN O
the DT O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
family NN I-Gene
, , O
we PRP O
proceeded VBD O
to TO O
determine VB O
whether IN O
an DT O
adjacent JJ O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
binding VBG I-Gene
site NN I-Gene
could MD O
affect VB O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
protein NN I-Gene
binding VBG O
to TO O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
site NN I-Gene
I PRP I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
analyses NNS O
indicated VBD O
that IN O
selected VBN O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
site NN I-Gene
variants NNS I-Gene
assisted VBN O
in IN O
the DT O
recruitment NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
proteins VBZ I-Gene
to TO O
an DT O
adjacent JJ O
, , O
naturally RB O
occurring VBG O
, , O
low JJ O
- : O
affinity NN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
site NN I-Gene
. . O

This DT O
biophysical JJ O
interaction NN O
appears VBZ O
to TO O
occur VB O
via IN O
at IN O
least JJS O
two CD O
mechanisms NNS O
. . O

First RB O
, , O
low JJ O
amounts NNS O
of IN O
CREB NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
appear VBP O
to TO O
heterodimerize VB O
and CC O
bind VB O
to TO O
a DT O
site NN O
consisting NN O
of IN O
a DT O
half JJ O
site NN O
from IN O
both CC O
the DT O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
and CC I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
. . O

In IN O
addition NN O
, , O
CREB NNP B-Gene
- : I-Gene
1 CD I-Gene
homodimers NNS I-Gene
bind VBP O
to TO O
the DT O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
site NN I-Gene
and CC O
recruit NN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
dimers NNS I-Gene
to TO O
their PRP$ O
cognate NN O
weak JJ B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

This DT O
interaction NN O
is VBZ O
reciprocal JJ O
, , O
since IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
dimer NN I-Gene
binding NN O
to TO O
a DT O
strong JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
site NN I-Gene
leads VBZ O
to TO O
enhanced VB O
CREB NNP B-Gene
- : I-Gene
1 CD I-Gene
recruitment NN O
to TO O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
sites VBZ I-Gene
that WDT O
are VBP O
weakly JJ O
bound IN O
by IN O
CREB NNP B-Gene
. . O

Sequence NN O
variation NN O
at IN O
both DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
and CC I-Gene
ATF NNP I-Gene
/ NNP I-Gene
CREB NNP I-Gene
sites VBZ I-Gene
affects VBZ O
the DT O
molecular JJ O
interactions NNS O
involved VBN O
in IN O
mediating VBG O
both DT O
of IN O
these DT O
mechanisms NNS O
. . O

Most JJS O
importantly RB O
, , O
sequence NN O
variation NN O
at IN O
the DT O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
binding VBG I-Gene
site NN I-Gene
affected VBD O
basal JJ O
LTR NNP B-Gene
activity NN O
as RB O
well RB O
as IN O
LTR NNP B-Gene
function NN O
following VBG O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
stimulation NN O
, , O
a DT O
treatment NN O
that WDT O
leads VBZ O
to TO O
increases NNS O
in IN O
C NNP O
/ NNP O
EBP NNP O
activation NN O
. . O

Thus RB O
, , O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
binding VBG I-Gene
site NN I-Gene
sequence NN O
variation NN O
may MD O
modulate VB O
cellular JJ O
signaling VBG O
at IN O
the DT O
viral JJ B-Gene
promoter NN I-Gene
through IN O
the DT O
C NNP O
/ NNP O
EBP NNP O
pathway NN O

Selective JJ O
inhibition NN O
of IN O
interleukin JJ O
- : O
4 CD O
gene NN O
expression NN O
in IN O
human JJ O
T NNP O
cells NNS O
by IN O
aspirin NN O
. . O

Previous JJ O
studies NNS O
indicated VBD O
that IN O
aspirin NN O
( ( O
acetylsalicylic JJ O
acid NN O
[ NNP O
ASA NNP O
] NNP O
) ) O
can MD O
have VB O
profound JJ O
immunomodulatory JJ O
effects NNS O
by IN O
regulating VBG O
cytokine JJ O
gene NN O
expression NN O
in IN O
several JJ O
types NNS O
of IN O
cells NNS O
. . O

This DT O
study NN O
is VBZ O
the DT O
first JJ O
in IN O
which WDT O
concentrations NNS O
of IN O
ASA NNP O
in IN O
the DT O
therapeutic JJ O
range NN O
were VBD O
found VBN O
to TO O
significantly RB O
reduce VB O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
4 CD I-Gene
secretion NN O
and CC O
RNA NNP O
expression NN O
in IN O
freshly RB O
isolated VBN O
and CC O
mitogen SYM O
- : O
primed VBN O
human JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
. . O

In IN O
contrast NN O
, , O
ASA NNP O
did VBD O
not RB O
affect VB O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
interferon SYM B-Gene
- : I-Gene
gamma NN I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
. . O

ASA NNP O
inhibited VBD O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
promoter NN O
- : O
driven VBN O
chloramphenicol JJ O
acetyltransferase NN O
expression NN O
in IN O
transiently RB O
transfected VBN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

The DT O
structurally RB O
unrelated JJ O
nonsteroidal JJ O
anti NN O
- : O
inflammatory NN O
drugs NNS O
indomethacin NN O
and CC O
flurbiprofen NN O
did VBD O
not RB O
affect VB O
cytokine NN O
gene NN O
expression NN O
in IN O
T NNP O
cells NNS O
, , O
whereas IN O
the DT O
weak JJ O
cyclo NN O
- : O
oxygenase NN O
inhibitor NN O
salicylic JJ O
acid NN O
was VBD O
at IN O
least JJS O
as RB O
effective JJ O
as IN O
ASA NNP O
in IN O
inhibiting VBG O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
expression NN O
and CC O
promoter NN O
activity NN O
. . O

The DT O
inhibitory JJ O
effect NN O
of IN O
ASA NNP O
on IN O
IL NNP O
- : O
4 CD O
transcription NN O
was VBD O
not RB O
mediated VBN O
by IN O
decreased JJ O
nuclear JJ O
expression NN O
of IN O
the DT O
known JJ O
salicylate NN B-Gene
target NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
was VBD O
accompanied VBN O
by IN O
reduced JJ O
binding NN O
of IN O
an DT O
inducible JJ O
factor NN O
to TO O
an DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
region NN I-Gene
upstream NN O
of IN O
, , O
but CC O
not RB O
overlapping JJ O
, , O
the DT O
NF NNP B-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
- : I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
binding NN I-Gene
P1 NNP I-Gene
element NN I-Gene
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
anti SYM O
- : O
inflammatory NN O
salicylates NNS O
, , O
by IN O
means NNS O
of IN O
a DT O
previously RB O
unrecognized JJ O
mechanism NN O
of IN O
action NN O
, , O
can MD O
influence VB O
the DT O
nature NN O
of IN O
adaptive JJ O
immune NN O
responses NNS O
by IN O
selectively RB O
inhibiting VBG O
the DT O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
a DT O
critical JJ O
effector NN O
of IN O
these DT O
responses NNS O
, , O
in IN O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
. . O

Molecular JJ O
and CC O
cellular JJ O
mediators NNS O
of IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
acute JJ O
inflammatory NN O
arthritis NN O
. . O

OBJECTIVE NN O
: : O
To TO O
examine VB O
the DT O
molecular JJ O
and CC O
cellular JJ O
mechanisms NNS O
in IN O
a DT O
model NN O
of IN O
acute JJ O
inflammatory JJ O
monarticular JJ O
arthritis NN O
induced VBN O
by IN O
methylated JJ B-Gene
bovine NN I-Gene
serum NN I-Gene
albumin NN I-Gene
( ( O
mBSA NN B-Gene
) ) O
and CC O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

METHODS NN O
: : O
Mice NNP O
were VBD O
injected VBN O
intraarticularly RB O
with IN O
mBSA NNS B-Gene
on IN O
day NN O
0 CD O
and CC O
subcutaneously RB O
with IN O
recombinant JJ B-Gene
human JJ I-Gene
IL NNP I-Gene
- : I-Gene
1beta CD I-Gene
on IN O
days NNS O
0 CD O
- : O
2 CD O
. . O

At IN O
day NN O
7 CD O
, , O
knee NN O
joints NNS O
were VBD O
removed VBN O
and CC O
assessed VBN O
histologically RB O
. . O

Flow NNP O
cytometry NN O
and CC O
RNase NNP O
protection NN O
were VBD O
used VBN O
to TO O
analyze VB O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
events NNS O
. . O

RESULTS NN O
: : O
C57BL NNP O
/ VBZ O
6 CD O
( ( O
B6 NNP O
) ) O
, , O
129 CD O
/ NN O
Sv NNP O
, , O
and CC O
( ( O
B6 NNP O
x VBZ O
129 CD O
/ NNP O
Sv NNP O
) ) O
F1 NNP O
hybrid JJ O
mice NNS O
, , O
all DT O
H NNP O
- : O
2b CD O
strains NNS O
, , O
were VBD O
susceptible JJ O
to TO O
mBSA VB B-Gene
/ NNP O
IL NNP O
- : O
1 CD O
- : O
induced JJ O
arthritis NN O
, , O
whereas WP O
C3H NNP O
/ NNP O
HeJ NNP O
( ( O
H NNP O
- : O
2k CD O
) ) O
mice NN O
were VBD O
not RB O
. . O

B6 NNP O
mice NN O
lacking VBG O
T NNP O
and CC O
B NNP O
cells NNS O
( ( O
RAG1 NNP O
- : O
/ SYM O
- : O
) ) O
or CC O
major JJ B-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( I-Gene
MHC NNP I-Gene
) ) I-Gene
class NN I-Gene
II NNP I-Gene
antigens VBZ I-Gene
( ( O
MHCII NNP O
- : O
/ SYM O
- : O
) ) O
, , O
and CC O
B6 NNP O
mice NNP O
treated VBD O
with IN O
a DT O
CD4 NNP B-Gene
+ NNP I-Gene
T NNP I-Gene
cell NN I-Gene
- : I-Gene
depleting VBG I-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
, , O
were VBD O
resistant JJ O
to TO O
disease VB O
. . O

In IN O
contrast NN O
, , O
B NNP O
cell NN O
- : O
deficient NN O
( ( O
muMT JJ O
/ NNP O
muMT NN O
) ) O
mice NN O
developed VBD O
arthritis NN O
at IN O
an DT O
incidence NN O
and CC O
severity NN O
similar JJ O
to TO O
that DT O
of IN O
controls NNS O
. . O

RelB NNP O
- : O
deficient NN O
( ( O
RelB NNP O
- : O
/ SYM O
- : O
) ) O
bone NN O
marrow NN O
chimeric JJ O
mice NN O
had VBD O
arthritis NN O
that WDT O
was VBD O
significantly RB O
reduced VBN O
in IN O
incidence NN O
and CC O
severity NN O
. . O

In IN O
B6 NNP O
mice NN O
, , O
flow JJ O
cytometry NN O
demonstrated VBD O
an DT O
IL NNP O
- : O
1 CD O
- : O
dependent NN O
leukocyte JJ O
infiltration NN O
into IN O
the DT O
synovial JJ O
compartment NN O
and CC O
RNase NNP O
protection NN O
assays NNS O
revealed VBD O
induction NN O
of IN O
messenger NN B-Gene
RNA NNP I-Gene
( ( O
mRNA NN B-Gene
) ) O
for IN O
the DT O
chemokines NNS B-Gene
monocyte NN B-Gene
chemoattractant NN I-Gene
protein NN I-Gene
1 CD I-Gene
, , O
macrophage NN B-Gene
inhibitory NN I-Gene
protein NN I-Gene
2 CD I-Gene
( ( O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
, , O
RANTES NNP B-Gene
, , O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
and CC O
MIP NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
. . O

CONCLUSION NN O
: : O
Arthritis NN O
induced VBN O
by IN O
mBSA NN B-Gene
/ NNP O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
strain VBN O
specific JJ O
and CC O
dependent JJ O
on IN O
CD4 NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
and CC O
at IN O
least JJS O
partially RB O
on IN O
RelB NNP B-Gene
, , O
but CC O
not RB O
on IN O
B NNP O
lymphocytes VBZ O
or CC O
antibody NN B-Gene
. . O

IL NNP B-Gene
- : I-Gene
1 CD I-Gene
contributes NNS O
to TO O
leukocyte VB O
recruitment NN O
to TO O
the DT O
synovium NN O
and CC O
directly RB O
induces NNS O
chemokine VBP O
mRNA JJ O
production NN O
by IN O
synovial JJ O
cells NNS O
. . O

This DT O
model NN O
of IN O
acute JJ O
monarticular JJ O
arthritis NN O
is VBZ O
particularly RB O
suitable JJ O
for IN O
further JJ O
investigations NNS O
into IN O
cell NN O
- : O
mediated VBN O
immunity NN O
in IN O
arthritis NN O
and CC O
the DT O
role NN O
of IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Positive JJ O
and CC O
negative JJ O
regulation NN O
of IN O
granulopoiesis NN O
by IN O
endogenous JJ B-Gene
RARalpha NNP I-Gene
. . O

Acute NNP O
promyelocytic JJ O
leukemia NN O
( ( O
APL NNP O
) ) O
is VBZ O
always RB O
associated VBN O
with IN O
chromosomal JJ O
translocations NNS O
that WDT O
disrupt VBP O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
RARalpha NNP I-Gene
) ) I-Gene
gene NN I-Gene
. . O

Whether IN O
these DT O
translocations NNS O
relate VBP O
to TO O
a DT O
role NN O
for IN O
endogenous JJ B-Gene
RARalpha NNP I-Gene
in IN O
normal JJ O
granulopoiesis NN O
remains VBZ O
uncertain JJ O
because IN O
most JJS O
studies NNS O
addressing VBG O
this DT O
question NN O
have VBP O
used VBN O
non SYM O
- : O
physiological JJ O
overexpression NN O
systems NNS O
. . O

Granulocyte NNP O
differentiation NN O
in IN O
cells NNS O
derived VBN O
from IN O
RARalpha NNP O
- : O
deficient NN O
( ( O
RARalpha NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
) ) O
mice NN O
was VBD O
studied VBN O
and CC O
evaluated VBN O
in IN O
the DT O
context NN O
of IN O
agonist JJ B-Gene
- : I-Gene
bound NN I-Gene
and CC I-Gene
ligand VB I-Gene
- : I-Gene
free JJ I-Gene
RARalpha NNP I-Gene
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
RARalpha NNP B-Gene
is VBZ O
dispensable JJ O
for IN O
granulopoiesis NN O
, , O
as IN O
RARalpha NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
have VBP O
a DT O
normal JJ O
granulocyte NN O
population NN O
despite IN O
an DT O
impaired JJ O
ability NN O
to TO O
respond VB O
to TO O
retinoids NNS O
. . O

However RB O
, , O
although IN O
it PRP O
is VBZ O
not RB O
absolutely RB O
required VBN O
, , O
RARalpha NNP B-Gene
can MD O
bidirectionally RB O
modulate VB O
granulopoiesis NN O
. . O

RARalpha NNP B-Gene
stimulates VBZ O
differentiation NN O
in IN O
response NN O
to TO O
exogenous JJ O
retinoic NN O
acid NN O
. . O

Furthermore RB O
, , O
endogenous JJ O
retinoids NNS O
control NN O
granulopoiesis NN O
in IN O
vivo NN O
, , O
as IN O
either DT O
vitamin NN O
A NNP O
- : O
deficient NN O
mice NN O
or CC O
animals NNS O
treated VBN O
with IN O
an DT O
RAR NNP O
antagonist NN O
accumulate NN O
more RBR O
immature JJ O
granulocytes NNS O
in IN O
their PRP$ O
bone NN O
marrow NN O
. . O

Conversely RB O
, , O
RARalpha NNP B-Gene
acts VBZ O
to TO O
limit VB O
differentiation NN O
in IN O
the DT O
absence NN O
of IN O
ligand NN B-Gene
because IN O
granulocyte JJ O
precursors NNS O
from IN O
RARalpha NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
differentiate NN O
earlier RBR O
in IN O
culture NN O
. . O

Thus RB O
, , O
the DT O
block NN O
in IN O
granulopoiesis NN O
exerted VBN O
by IN O
RARalpha NNP B-Gene
fusion NN B-Gene
proteins NNS I-Gene
expressed VBN O
in IN O
APL NNP O
cells NNS O
may MD O
correspond VB O
to TO O
an DT O
amplification NN O
of IN O
a DT O
normal JJ O
function NN O
of IN O
unliganded JJ B-Gene
RARalpha NNP I-Gene
. . O

Expression NN O
and CC O
function NN O
of IN O
a DT O
stem NN B-Gene
cell NN I-Gene
promoter NN I-Gene
for IN O
the DT O
murine NN B-Gene
CBFalpha2 NNP I-Gene
gene NN I-Gene
: : O
distinct JJ O
roles NNS O
and CC O
regulation NN O
in IN O
natural JJ O
killer NN O
and CC O
T NNP O
cell NN O
development NN O
. . O

The DT O
Runt NNP B-Gene
family NN I-Gene
transcription NN I-Gene
factor NN I-Gene
CBFalpha2 NNP B-Gene
( ( O
AML1 NNP B-Gene
, , O
PEBP2alphaB NNP B-Gene
, , O
or CC O
Runx1 NNP B-Gene
) ) O
is VBZ O
required VBN O
by IN O
hematopoietic JJ O
stem NN O
cells NNS O
and CC O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
T NNP O
- : O
lineage NN O
cells NNS O
. . O

In IN O
human JJ O
T NNP O
cells NNS O
CBFalpha2 NNP B-Gene
is VBZ O
usually RB O
transcribed VBN O
from IN O
a DT O
different JJ B-Gene
promoter NN I-Gene
( ( O
distal JJ B-Gene
promoter NN I-Gene
) ) O
than IN O
in IN O
myeloid JJ O
cells NNS O
( ( O
proximal JJ B-Gene
promoter NN I-Gene
) ) O
, , O
but CC O
the DT O
developmental JJ O
and CC O
functional JJ O
significance NN O
of IN O
this DT O
promoter NN O
switch NN O
has VBZ O
not RB O
been VBN O
known VBN O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
both DT O
coding VBG B-Gene
and CC I-Gene
noncoding JJ I-Gene
sequences NNS I-Gene
of IN O
the DT O
distal JJ B-Gene
5 CD I-Gene
' POS I-Gene
end NN I-Gene
are VBP O
highly RB O
conserved VBN O
between IN O
the DT O
human JJ B-Gene
and CC I-Gene
the DT I-Gene
murine NN I-Gene
genes NNS I-Gene
, , O
and CC O
the DT O
distal JJ B-Gene
promoter NN I-Gene
is VBZ O
responsible JJ O
for IN O
the DT O
overwhelming JJ O
majority NN O
of IN O
CBFalpha2 NNP O
expression NN O
in IN O
murine JJ O
hematopoietic JJ O
stem NN O
cells NNS O
as RB O
well RB O
as IN O
in IN O
T NNP O
cells NNS O
. . O

Distal JJ O
promoter NN O
activity NN O
is VBZ O
maintained VBN O
throughout IN O
T NNP O
cell NN O
development NN O
and CC O
at IN O
lower JJR O
levels NNS O
in IN O
B NNP O
cell NN O
development NN O
, , O
but CC O
downregulated VBD O
in IN O
natural JJ O
killer NN O
cell NN O
development NN O
. . O

The DT O
distal JJ B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
isoform NN I-Gene
binds VBZ O
to TO O
functionally RB O
important JJ O
regulatory JJ B-Gene
sites NNS I-Gene
from IN O
known VBN O
target NN B-Gene
genes NNS I-Gene
with IN O
two CD O
- : O
to TO O
threefold VB O
higher JJR O
affinity NN O
than IN O
the DT O
proximal JJ B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
isoform NN I-Gene
. . O

Neither CC O
full JJ B-Gene
- : I-Gene
length NN I-Gene
isoform NN I-Gene
alters NNS O
growth NN O
of IN O
a DT O
myeloid NN O
cell NN O
line NN O
under IN O
nondifferentiating VBG O
conditions NNS O
, , O
but CC O
the DT O
proximal JJ B-Gene
isoform NN I-Gene
selectively RB O
delays VBZ O
mitotic JJ O
arrest NN O
of IN O
the DT O
cell NN O
line NN O
under IN O
differentiating VBG O
conditions NNS O
, , O
resulting VBG O
in IN O
the DT O
generation NN O
of IN O
greater JJR O
numbers NNS O
of IN O
neutrophils NNS O
. . O

Constitutive JJ O
PI3 NNP O
- : O
K NNP O
activity NN O
is VBZ O
essential JJ O
for IN O
proliferation NN O
, , O
but CC O
not RB O
survival JJ O
, , O
of IN O
Theileria NNP O
parva FW O
- : O
transformed VBN O
B NNP O
cells NNS O
. . O

Theileria NNP O
is VBZ O
an DT O
intracellular JJ O
parasite NN O
that WDT O
causes VBZ O
lymphoproliferative JJ O
disorders NNS O
in IN O
cattle NNS O
, , O
and CC O
infection NN O
of IN O
leucocytes NNS O
induces NNS O
a DT O
transformed JJ O
phenotype NN O
similar JJ O
to TO O
tumour VB O
cells NNS O
, , O
but CC O
the DT O
mechanisms NNS O
by IN O
which WDT O
the DT O
parasite NN O
induces VBZ O
this DT O
phenotype NN O
are VBP O
not RB O
understood JJ O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
infected VBD O
B NNP O
lymphocytes NNS O
display VBP O
constitutive JJ O
phosphoinositide NN O
3 CD O
- : O
kinase NN O
( ( O
PI3 NNP O
- : O
K NNP O
) ) O
activity NN O
, , O
which WDT O
appears VBZ O
to TO O
be VB O
necessary JJ O
for IN O
proliferation NN O
, , O
but CC O
not RB O
survival JJ O
. . O

Importantly RB O
, , O
we PRP O
demonstrate VBP O
that IN O
one CD O
mechanism NN O
by IN O
which WDT O
PI3 NNP B-Gene
- : I-Gene
K NNP I-Gene
mediates VBZ O
the DT O
proliferation NN O
of IN O
infected JJ O
B NNP O
lymphocytes NN O
is VBZ O
through IN O
the DT O
induction NN O
of IN O
a DT O
granulocyte JJ B-Gene
- : I-Gene
monocyte NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
- : O
dependent JJ O
autocrine NN O
loop NN O
. . O

PI3 NNP B-Gene
- : I-Gene
K NNP I-Gene
induction NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
appears VBZ O
to TO O
be VB O
at IN O
the DT O
transcriptional JJ O
level NN O
and CC O
, , O
consistently RB O
, , O
we PRP O
demonstrate VBP O
that IN O
PI3 NNP B-Gene
- : I-Gene
K NNP I-Gene
is VBZ O
also RB O
involved VBN O
in IN O
the DT O
constitutive JJ O
induction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
which WDT O
characterizes VBZ O
Theileria NNP O
- : O
infected JJ O
leucocytes NNS O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
highlight VBD O
a DT O
novel JJ O
strategy NN O
exploited VBN O
by IN O
the DT O
intracellular JJ O
parasite NN O
Theileria NNP O
to TO O
induce VB O
continued JJ O
proliferation NN O
of IN O
its PRP$ O
host NN O
leucocyte NN O
. . O

Lymphokine NNP B-Gene
dependence NN O
of IN O
STAT3 NNP O
activation NN O
produced VBN O
by IN O
surface NN O
immunoglobulin NN O
cross SYM O
- : O
linking NN O
and CC O
by IN O
phorbol NN O
ester NN O
plus CC O
calcium NN O
ionophore NN O
treatment NN O
in IN O
B NNP O
cells NNS O
. . O

Stimulation NN O
of IN O
B NNP O
cells NNS O
by IN O
surface NN B-Gene
immunoglobulin NN I-Gene
( ( O
sIg NN B-Gene
) ) O
triggering NN O
, , O
or CC O
through IN O
the DT O
mitogenic JJ O
combination NN O
of IN O
phorbol NN O
ester NN O
and CC O
calcium NN O
ionophore NN O
, , O
is VBZ O
accompanied VBN O
by IN O
activation NN O
of IN O
STAT NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

The DT O
mechanism NN O
responsible JJ O
for IN O
the DT O
delayed JJ O
nuclear JJ O
accumulation NN O
of IN O
phosphorylated JJ B-Gene
STAT3 NNP I-Gene
was VBD O
examined VBN O
in IN O
detail NN O
, , O
focusing VBG O
on IN O
the DT O
role NN O
of IN O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
derived VBN I-Gene
lymphokines NNS I-Gene
. . O

sIg SYM B-Gene
- : O
induced JJ O
activation NN O
of IN O
STAT3 NNP B-Gene
was VBD O
partially RB O
inhibited VBN O
in IN O
B NNP O
cells NNS O
obtained VBN O
from IN O
IL NNP O
- : O
6 CD O
- : O
or CC O
IL NNP O
- : O
10 CD O
- : O
deficient NN O
mice NN O
, , O
and CC O
was VBD O
partially RB O
blocked VBN O
by IN O
neutralizing VBG B-Gene
antibodies NNS I-Gene
directed VBN O
against IN O
either DT O
of IN O
these DT O
lymphokines NNS B-Gene
. . O

sIg SYM B-Gene
- : O
induced JJ O
STAT3 NNP O
activation NN O
was VBD O
completely RB O
inhibited VBN O
by IN O
combining VBG O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
and CC I-Gene
IL NNP I-Gene
- : I-Gene
10 CD I-Gene
- : I-Gene
specific JJ I-Gene
neutralizing VBG I-Gene
antibodies NNS I-Gene
, , O
or CC O
by IN O
adding VBG O
individual JJ O
neutralizing NN B-Gene
antibodies NNS I-Gene
to TO O
B NNP O
cells NNS O
obtained VBN O
from IN O
lymphokine JJ O
- : O
deficient NN O
animals NNS O
. . O

In IN O
contrast NN O
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
alone RB O
appeared VBD O
to TO O
account VB O
for IN O
STAT3 NNP O
activation NN O
resulting VBG O
from IN O
B NNP O
cell NN O
stimulation NN O
with IN O
phorbol NN O
ester NN O
and CC O
calcium NN O
ionophore NN O
. . O

In IN O
keeping VBG O
with IN O
these DT O
results NNS O
, , O
soluble JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
were VBD O
found VBN O
in IN O
supernatant JJ O
fluid NN O
obtained VBN O
from IN O
stimulated VBN O
B NNP O
cells NNS O
. . O

This DT O
work NN O
indicates VBZ O
that IN O
a DT O
lymphokine JJ O
pathway NN O
is VBZ O
responsible JJ O
for IN O
STAT3 NNP O
activation NN O
that WDT O
occurs VBZ O
late RB O
after IN O
B NNP O
cell NN O
stimulation NN O
, , O
and CC O
points NNS O
out RP O
differences NNS O
in IN O
B NNP O
cell NN O
activation NN O
that WDT O
result NN O
from IN O
stimulation NN O
through IN O
the DT O
antigen NN B-Gene
receptor NN I-Gene
and CC O
through IN O
pharmacological JJ O
mimicry NN O
of IN O
signaling VBG B-Gene
mediators NNS I-Gene
. . O

Transcription NNP B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
a DT O
ligand NN B-Gene
for IN O
immunoglobulin JJ B-Gene
- : I-Gene
kappa NN I-Gene
promoter NN I-Gene
E NNP I-Gene
- : I-Gene
box NN I-Gene
elements NNS I-Gene
. . O

Immunoglobulin NNP B-Gene
( ( I-Gene
Ig NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
promoters NNS I-Gene
from IN O
humans NNS O
and CC O
mice NNS O
share NN O
conserved VBN B-Gene
sequences NNS I-Gene
. . O

The DT O
octamer JJ B-Gene
element NN I-Gene
is VBZ O
common JJ O
to TO O
all DT O
Ig NNP B-Gene
promoters NNS I-Gene
and CC O
pivotal NN O
for IN O
their PRP$ O
function NN O
. . O

However RB O
, , O
other JJ O
conserved VBD B-Gene
sequence NN I-Gene
motifs NNS I-Gene
, , O
that WDT O
differ VBP O
between IN O
Ig NNP B-Gene
variable JJ I-Gene
gene NN I-Gene
families NNS I-Gene
, , O
are VBP O
required VBN O
for IN O
normal JJ O
promoter NN O
function NN O
. . O

These DT O
conserved VBD O
motifs NNS O
do VBP O
not RB O
stimulate VB O
transcription NN O
in IN O
the DT O
absence NN O
of IN O
an DT O
octamer NN B-Gene
. . O

One CD O
example NN O
is VBZ O
an DT O
E NNP B-Gene
- : I-Gene
box NN I-Gene
of IN O
the DT O
E47 NNP B-Gene
/ NNP I-Gene
E12 NNP I-Gene
type NN I-Gene
( ( I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
CAGCTG NNP I-Gene
- : I-Gene
3 CD I-Gene
' '' I-Gene
) ) I-Gene
, , O
which WDT O
is VBZ O
found VBN O
in IN O
all DT O
promoters NNS O
of IN O
the DT O
human JJ B-Gene
and CC I-Gene
murine JJ I-Gene
Ig NNP I-Gene
- : I-Gene
kappa NN I-Gene
gene NN I-Gene
subgroups NNS I-Gene
/ JJ I-Gene
families NNS I-Gene
, , O
with IN O
the DT O
exception NN O
of IN O
subgroups NNS O
II NNP O
and CC O
VI NNP O
and CC O
their PRP$ O
related JJ O
murine NN B-Gene
families NNS I-Gene
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
show VBP O
that IN O
the DT O
ubiquitously RB O
expressed VBN O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
4 CD I-Gene
, , O
and CC O
not RB O
E47 NNP B-Gene
, , O
interacts VBZ O
specifically RB O
with IN O
the DT O
kappa NN B-Gene
promoter NN I-Gene
E NNP I-Gene
- : I-Gene
boxes NNS I-Gene
when WRB O
tested VBN O
in IN O
electrophoretic JJ O
mobility NN O
- : O
shift NN O
assays NNS O
using VBG O
nuclear JJ O
extracts NNS O
derived VBN O
from IN O
human JJ O
and CC O
murine NN O
B NNP O
- : O
cell NN O
lines NNS O
. . O

Furthermore RB O
, , O
AP NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
unlike IN O
E47 NNP B-Gene
, , O
did VBD O
not RB O
act VB O
as IN O
a DT O
transactivator NN B-Gene
, , O
which WDT O
is VBZ O
in IN O
agreement NN O
with IN O
previous JJ O
studies NNS O
on IN O
intact JJ O
kappa NN B-Gene
promoters NNS I-Gene
, , O
showing VBG O
that IN O
transcription NN O
is VBZ O
absent JJ O
when WRB O
the DT O
octamer NN B-Gene
element NN I-Gene
has VBZ O
been VBN O
mutated VBN O
. . O

Based VBN O
on IN O
these DT O
data NNS O
, , O
and CC O
the DT O
conservation NN O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
CAGCTG NNP I-Gene
- : I-Gene
3 CD I-Gene
' '' I-Gene
motif NN I-Gene
among IN O
human JJ B-Gene
and CC I-Gene
murine JJ I-Gene
kappa NN I-Gene
promoters NNS I-Gene
, , O
we PRP O
propose VBP O
that IN O
AP NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
the DT O
major JJ B-Gene
ligand NN I-Gene
for IN O
Ig NNP B-Gene
- : I-Gene
kappa NN I-Gene
promoter NN I-Gene
E NNP I-Gene
- : I-Gene
boxes NNS I-Gene
. . O

A DT O
16 CD O
- : O
mer NN O
peptide NN O
( ( O
RQIKIWFQNRRMKWKK NNP O
) ) O
from IN O
antennapedia VBN O
preferentially RB O
targets VBZ O
the DT O
Class NN O
I PRP O
pathway VBP O
. . O

Translocation NN O
of IN O
antigenic JJ O
peptides NNS O
into IN O
the DT O
cytosol NN O
of IN O
antigen NN O
presenting VBG O
cells NNS O
facilitates VBZ O
proteosomal JJ O
processing NN O
and CC O
loading VBG O
into IN O
Class NNP B-Gene
I PRP I-Gene
molecules VBP I-Gene
for IN O
MHC NNP O
presentation NN O
on IN O
the DT O
cell NN O
surface NN O
. . O

The DT O
DNA NN B-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
the DT O
Drosophila NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
( ( O
Antennapedia NNP B-Gene
) ) O
, , O
a DT O
60 CD B-Gene
amino NN I-Gene
acid NN I-Gene
protein NN I-Gene
, , O
is VBZ O
rapidly RB O
taken VBN O
up RP O
by IN O
cells NNS O
and CC O
has VBZ O
been VBN O
fused VBN O
to TO O
selected VBN O
antigens NNS B-Gene
to TO O
enhance VB O
their PRP$ O
immunogenicity NN O
. . O

We PRP O
now RB O
demonstrate VBP O
that IN O
a DT O
16 CD O
amino NN O
acid NNS O
peptide VBP O
from IN O
antennapedia NN O
can MD O
facilitate VB O
the DT O
cytoplasmic JJ O
uptake NN O
of IN O
CTL NNP O
epitope VBP O
9 CD O
- : O
mer NN O
peptides NNS O
. . O

Synthetic JJ O
peptides NNS O
were VBD O
made VBN O
containing VBG O
the DT O
16 CD O
- : O
mer NN O
antennapedia IN O
peptide NN O
linked VBN O
in IN O
tandem NN O
to TO O
the DT O
ovalbumin NN O
SIINFEKL NNP O
CTL NNP O
peptide NN O
. . O

The DT O
peptide NN O
complex NN O
was VBD O
shown VBN O
to TO O
rapidly RB O
internalise VB O
into IN O
APCs NNP O
by IN O
confocal JJ O
microscopy NN O
. . O

This DT O
peptide NN O
induced VBD O
CTL NNP O
in IN O
C57BL NNP O
/ NNP O
6 CD O
mice NN O
and CC O
protected VBD O
them PRP O
against IN O
growth NN O
of IN O
an DT O
ovalbumin NN O
expressing VBG O
tumour NNS O
cell NN O
line NN O
( ( O
E NNP O
. . O
G7 NNP O
- : O
OVA NN O
) ) O
. . O

The DT O
ability NN O
of IN O
the DT O
hybrid JJ O
peptide NN O
to TO O
be VB O
processed VBN O
and CC O
presented VBN O
by IN O
APCs NNP O
was VBD O
similar JJ O
, , O
whether IN O
the DT O
SIINFEKL NNP O
sequence NN O
was VBD O
appended VBN O
at IN O
the DT O
C NNP B-Gene
- : I-Gene
terminus NN I-Gene
or CC O
N NNP B-Gene
- : I-Gene
terminus NN I-Gene
of IN O
the DT O
Antennapedia NNP O
peptide NN O
. . O

The DT O
production NN O
of IN O
synthetic JJ O
peptides NNS O
containing VBG O
other JJ O
CTL NNP O
peptide IN O
epitopes NNS O
may MD O
be VB O
useful JJ O
for IN O
priming VBG O
CTLs NNP O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O

Bone NNP O
marrow NN O
cells NNS O
promote VBP O
TH2 NNP O
polarization NN O
and CC O
inhibit NN O
virus NN O
- : O
specific JJ O
CTL NNP O
generation NN O
. . O

This DT O
laboratory NN O
recently RB O
reported VBD O
that IN O
human JJ O
bone NN O
marrow NN O
cells NNS O
( ( O
BMC NNP O
) ) O
inhibit VBP O
the DT O
generation NN O
of IN O
virus NN O
- : O
specific JJ O
CTL NNP O
in IN O
culture NN O
. . O

The DT O
culture NN O
supernatants NNS O
contained VBD O
increased JJ O
levels NNS O
of IN O
prostaglandin NN B-Gene
E NNP I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
( ( I-Gene
PGE NNP I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
) ) I-Gene
( ( O
shown VBN O
to TO O
favor VB O
TH2 NNP O
cell NN O
development NN O
) ) O
and CC O
also RB O
inhibited VBD O
EBV NNP O
- : O
CTL NNP O
effector NN O
cell NN O
development NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
obtained VBD O
PBL NNP O
from IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
IgG NNP B-Gene
antibody NN I-Gene
positive JJ O
kidney NN O
transplant NN O
recipients NNS O
( ( O
R NNP O
) ) O
and CC O
their PRP$ O
living NN O
- : O
related JJ O
donors NNS O
( ( O
LRD NNP O
) ) O
one CD O
year NN O
after IN O
renal JJ O
transplantation NN O
. . O

EBV NNP O
- : O
specific JJ O
CTL NNP O
were VBD O
then RB O
generated VBN O
in IN O
vitro NN O
by IN O
stimulating VBG O
PBL NNP O
with IN O
autologous JJ O
EBV NNP O
- : O
transformed VBD O
B NNP O
cells NNS O
( ( O
EBV NNP O
- : O
B NN O
) ) O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
autologous JJ O
BMC NNP O
. . O

The DT O
addition NN O
of IN O
BMC NNP O
to TO O
the DT O
EBV NNP O
- : O
CTL NNP O
generation NN O
cultures NNS O
increased VBD O
the DT O
intracellular JJ O
expression NN O
in IN O
CD3 NNP O
+ NNP O
cells NNS O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , I-Gene
- : I-Gene
5 CD I-Gene
, , I-Gene
- : I-Gene
6 CD I-Gene
, , I-Gene
- : I-Gene
10 CD I-Gene
, , I-Gene
and CC I-Gene
- : I-Gene
13 CD I-Gene
. . O

These DT O
CD3 NNP O
+ NNP O
cells NNS O
also RB O
expressed VBD O
increased JJ O
levels NNS O
of IN O
the DT O
TH2 NNP B-Gene
associated VBD I-Gene
receptor NN I-Gene
CCR3 NNP I-Gene
. . O

Inhibition NN O
was VBD O
even RB O
observed VBN O
by IN O
preparing VBG O
EBV NNP O
- : O
CTL NNP O
generating VBG O
cultures NNS O
in IN O
trans NNS O
- : O
wells NNS O
that WDT O
separated VBD O
the DT O
autologous JJ O
BMC NNP O
from IN O
the DT O
PBL NNP O
+ NNP O
EBV NNP O
- : O
B NN O
. . O

It PRP O
was VBD O
then RB O
observed VBN O
that IN O
CD3 NNP O
+ NNP O
cells NNS O
obtained VBD O
after IN O
7 CD O
days NNS O
of IN O
culture NN O
in IN O
the DT O
presence NN O
of IN O
autologous JJ O
BMC NNP O
could MD O
be VB O
used VBN O
as IN O
inhibitors NNS O
of IN O
EBV NNP O
- : O
CTL NNP O
generation NN O
. . O

Protein NNP B-Gene
Kinase NNP I-Gene
A NNP I-Gene
( ( O
PKA NNP B-Gene
) ) O
, , O
a DT O
cAMP NN B-Gene
kinase NN I-Gene
that WDT O
is VBZ O
involved VBN O
in IN O
the DT O
upregulation NN O
of IN O
TH2 NNP B-Gene
cytokine NN I-Gene
activity NN O
, , O
was VBD O
increased VBN O
in IN O
EBV NNP O
- : O
CTL NN O
cultures NNS O
by IN O
the DT O
presence NN O
of IN O
BMC NNP O
. . O

Additionally RB O
, , O
IL NNP O
- : O
4 CD O
- : O
mediated VBN O
signal JJ O
transduction NN O
and CC O
activation NN O
of IN O
transcription NN O
( ( O
STAT NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
phosphorylation NN O
was VBD O
slightly RB O
increased VBN O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
BMC NNP O
inhibition NN O
is VBZ O
mediated VBN O
by IN O
soluble JJ B-Gene
factors NNS I-Gene
( ( O
cytokines NNS B-Gene
) ) O
and CC O
that DT O
cell NN O
- : O
cell NN O
contact NN O
in IN O
this DT O
autologous JJ O
system NN O
is VBZ O
not RB O
required VBN O
, , O
so IN O
that DT O
BMC NNP O
( ( O
at IN O
least JJS O
partially RB O
, , O
via IN O
cytokine JJ O
production NN O
) ) O
promote NN O
TH2 NNP O
polarization NN O
in IN O
culture NN O
. . O

Moreover RB O
, , O
TH2 NNP O
cells NNS O
induced VBN O
by IN O
culturing VBG O
with IN O
autologous JJ O
BMC NNP O
directly RB O
inhibit VBZ O
EBV NNP O
- : O
CTL NNP O
generation NN O
, , O
and CC O
TH2 NNP B-Gene
associated VBD O
PKA NNP B-Gene
, , O
CCR3 NNP B-Gene
, , O
and CC O
STAT NNP B-Gene
- : I-Gene
6 CD I-Gene
phosphorylation NN O
are VBP O
enhanced VBN O
by IN O
BMC NNP O
. . O

Reduction NN O
in IN O
DNA NNP O
binding VBG O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
in IN O
B NNP O
lymphocytes NNS O
of IN O
aged JJ O
mice NN O
. . O

Aging NNP O
has VBZ O
been VBN O
associated VBN O
with IN O
intrinsic JJ O
changes NNS O
of IN O
the DT O
humoral JJ O
immune NN O
response NN O
, , O
which WDT O
may MD O
lead VB O
to TO O
an DT O
increased VBN O
occurrence NN O
of IN O
autoimmune NN O
disorders NNS O
and CC O
pathogenic JJ O
susceptibility NN O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
Pax NNP B-Gene
- : I-Gene
5 CD I-Gene
is VBZ O
a DT O
key JJ O
regulator NN O
of IN O
B NNP O
cell NN O
development NN O
. . O

Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
/ NN I-Gene
B NNP I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
and CC O
an DT O
alternatively RB B-Gene
spliced JJ I-Gene
isoform NN I-Gene
, , I-Gene
Pax NNP I-Gene
- : I-Gene
5d CD I-Gene
, , O
may MD O
have VB O
opposing VBG O
functions NNS O
in IN O
transcriptional JJ O
regulation NN O
due JJ O
to TO O
the DT O
lack NN O
of IN O
a DT O
transactivation NN B-Gene
domain NN I-Gene
in IN O
Pax NNP B-Gene
- : I-Gene
5d CD I-Gene
. . O

To TO O
study VB O
B NNP O
cell NN O
- : O
specific JJ O
changes NNS O
that WDT O
occur VBP O
during IN O
the DT O
aging VBG O
process NN O
, , O
we PRP O
investigated VBD O
expression NN O
patterns NNS O
of IN O
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
and CC I-Gene
5d CD I-Gene
in IN O
mature NN O
B NNP O
cells NNS O
of IN O
young JJ O
and CC O
aged JJ O
mice NN O
. . O

RNase NNP O
protection NN O
assays NNS O
showed VBD O
a DT O
similar JJ O
transcriptional JJ O
pattern NN O
for IN O
both DT O
age NN O
groups NNS O
that WDT O
indicates VBZ O
that IN O
aging VBG O
has VBZ O
no DT O
affect NN O
on IN O
transcription NN O
initiation NN O
or CC O
alternative JJ O
splicing NN O
for IN O
either DT O
isoform NN B-Gene
. . O

In IN O
contrast NN O
, , O
a DT O
significant JJ O
reduction NN O
in IN O
the DT O
DNA NNP O
binding NN O
activity NN O
of IN O
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
but CC O
not RB O
Pax NNP B-Gene
- : I-Gene
5d CD I-Gene
protein NN O
was VBD O
observed VBN O
in IN O
aged JJ O
B NNP O
cells NNS O
in IN O
vitro NN O
, , O
while IN O
Western JJ O
blot NN O
analyses NNS O
showed VBD O
that IN O
similar JJ O
levels NNS O
of IN O
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
and CC I-Gene
5d CD I-Gene
proteins NNS O
were VBD O
present JJ O
in IN O
both DT O
age NN O
groups NNS O
. . O

The DT O
observed JJ O
decrease NN O
in IN O
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
binding NN O
activity NN O
correlated VBN O
with IN O
changes NNS O
in IN O
expression NN O
of IN O
two CD O
Pax NNP B-Gene
- : I-Gene
5 CD I-Gene
target NN I-Gene
genes NNS I-Gene
in IN O
aged VBN O
B NNP O
cells NNS O
. . O

Expression NN O
of IN O
the DT O
Ig NNP B-Gene
J NNP I-Gene
chain NN I-Gene
and CC O
the DT O
secreted JJ O
form NN O
of IN O
Ig NNP B-Gene
mu NN I-Gene
, , O
which WDT O
are VBP O
both DT O
known VBN O
to TO O
be VB O
suppressed VBN O
by IN O
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
in IN O
mature NN O
B NNP O
cells NNS O
, , O
were VBD O
increased VBN O
in IN O
B NNP O
cells NNS O
of IN O
aged JJ O
mice NN O
. . O

Together RB O
, , O
our PRP$ O
studies NNS O
suggest VBP O
that IN O
changes NNS O
associated VBN O
with IN O
the DT O
aging VBG O
phenotype NN O
cause NN O
posttranslational JJ O
modification NN O
( ( O
s JJ O
) ) O
of IN O
Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
but CC O
not RB O
Pax NNP B-Gene
- : I-Gene
5d CD I-Gene
, , O
which WDT O
may MD O
lead VB O
to TO O
an DT O
abnormal JJ O
B NNP O
cell NN O
phenotype NN O
in IN O
aged JJ O
mice NN O
, , O
associated VBN O
with IN O
elevated JJ O
levels NNS O
of IN O
J NNP B-Gene
chain NN I-Gene
, , O
and CC O
secretion NN O
of IN O
IgM NNP B-Gene

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
participation NN O
in IN O
the DT O
lymphokine NN O
- : O
dependent JJ O
proliferation NN O
of IN O
T NNP O
lymphoid JJ O
cells NNS O
. . O

Proliferative JJ O
responses NNS O
of IN O
lymphoid JJ O
cells NNS O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
depend NN O
on IN O
activation NN O
of IN O
the DT O
cells NNS O
, , O
but CC O
the DT O
mechanism NN O
( ( O
s PRP O
) ) O
by IN O
which WDT O
activation NN O
enhances NNS O
cellular JJ O
competence NN O
to TO O
respond VB O
to TO O
cytokines NNS B-Gene
is VBZ O
not RB O
fully RB O
understood JJ O
. . O

The DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
Rel NNP I-Gene
family NN I-Gene
represents VBZ O
one CD O
signal NN O
transduction NN O
pathway RB O
induced VBD O
during IN O
such JJ O
activation NN O
. . O

We PRP O
show VBP O
in IN O
this DT O
study NN O
that IN O
inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
through IN O
the DT O
expression NN O
of IN O
an DT O
IkappaBalpha NNP B-Gene
( ( O
inhibitory JJ B-Gene
protein NN I-Gene
that WDT O
dissociates VBZ O
from IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
mutant NN O
refractory NN O
to TO O
signal VB O
- : O
induced VBN O
degradation NN O
( ( O
IkappaBalpha NNP B-Gene
( ( I-Gene
DeltaN NNP I-Gene
) ) I-Gene
) ) O
interfered VBN O
with IN O
the DT O
acquisition NN O
of IN O
competence NN O
to TO O
proliferate VB O
in IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
as RB O
well RB O
as IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Thymocytes NNS O
and CC O
T NNP O
cells NNS O
from IN O
IkappaBalpha NNP B-Gene
( ( I-Gene
DeltaN NNP I-Gene
) ) I-Gene
transgenic JJ O
mice NN O
expressed VBD O
normal JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
subunits NNS I-Gene
. . O

However RB O
, , O
transgenic JJ O
cells NNS O
exhibited VBD O
a DT O
dramatic JJ O
defect NN O
in IN O
Stat5A NNP O
activation NN O
treatment NN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
and CC O
a DT O
similar JJ O
defect NN O
was VBD O
observed VBN O
for IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced VBN O
Stat5 NNP B-Gene
. . O

In IN O
contrast NN O
, , O
T NNP O
lymphoid VBZ O
cells NNS O
with IN O
inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
showed VBD O
normal JJ O
insulin NN O
receptor NN O
substrate VBP O
- : O
2 CD O
phosphorylation NN O
and CC O
only RB O
a DT O
modest JJ O
decrease NN O
in IN O
Stat6 NNP O
activation NN O
and CC O
insulin NN O
receptor NN O
substrate VBP O
- : O
1 CD O
phosphorylation NN O
after IN O
IL NNP O
- : O
4 CD O
stimulation NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
NF NNP O
- : O
kappaB NN O
/ JJ O
Rel NNP O
/ NNP O
IkappaBalpha NNP O
system NN O
can MD O
regulate VB O
cytokine JJ B-Gene
receptor NN I-Gene
capacitation NN O
through IN O
effects NNS O
on IN O
the DT O
induction NN O
of IN O
downstream NN O
signaling NN O
by IN O
the DT O
Stat NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

BMS NNP O
- : O
189453 CD O
, , O
a DT O
novel JJ O
retinoid NN O
receptor NN O
antagonist NN O
, , O
is VBZ O
a DT O
potent JJ O
testicular JJ O
toxin NN O
. . O

BMS NNP O
- : O
189453 CD O
is VBZ O
a DT O
synthetic JJ O
retinoid NN O
that WDT O
acts VBZ O
as IN O
an DT O
antagonist NN O
at IN O
retinoic JJ B-Gene
acid JJ I-Gene
receptors NNS I-Gene
alpha VBP I-Gene
, , I-Gene
beta NN I-Gene
, , I-Gene
and CC I-Gene
gamma NN I-Gene
. . O

In IN O
Sprague NNP O
Dawley NNP O
rats NNS O
at IN O
daily JJ O
oral JJ O
doses NNS O
of IN O
15 CD O
, , O
60 CD O
, , O
or CC O
240 CD O
mg NNS O
/ JJ O
kg NN O
for IN O
1 CD O
month NN O
, , O
BMS NNP O
- : O
189453 CD O
produced JJ O
increases NNS O
in IN O
leukocyte NN O
counts NNS O
, , O
alkaline JJ B-Gene
phosphatase NN I-Gene
and CC O
alanine JJ B-Gene
aminotransferase NN I-Gene
levels NNS O
, , O
and CC O
marked VBD O
testicular JJ O
degeneration NN O
and CC O
atrophy NN O
at IN O
all DT O
doses NNS O
. . O

Significant NNP O
overt JJ O
signs NNS O
of IN O
toxicity NN O
and CC O
deaths NNS O
occurred VBD O
at IN O
240 CD O
mg NN O
/ NNP O
kg NN O
, , O
whereas IN O
body NN O
- : O
weight NN O
and CC O
food NN O
- : O
consumption NN O
decreases VBZ O
occurred VBD O
at IN O
60 CD O
and CC O
240 CD O
mg NN O
/ NNP O
kg NN O
. . O

When WRB O
BMS NNP O
- : O
189453 CD O
was VBD O
administered VBN O
to TO O
male VB O
rats NNS O
at IN O
daily JJ O
doses NNS O
ranging VBG O
from IN O
12 CD O
. . O
5 CD O
to TO O
100 CD O
mg NNS O
/ JJ O
kg NN O
for IN O
1 CD O
week NN O
, , O
only RB O
minimal JJ O
testicular JJ O
changes NNS O
occurred VBD O
at IN O
all DT O
doses NNS O
, , O
shortly RB O
after IN O
the DT O
dosing JJ O
period NN O
. . O

However RB O
, , O
after IN O
a DT O
1 CD O
- : O
month NN O
drug NN O
- : O
free JJ O
observation NN O
period NN O
, , O
marked VBD O
testicular JJ O
atrophy NN O
was VBD O
evident JJ O
at IN O
all DT O
doses NNS O
. . O

BMS NNP O
- : O
189453 CD O
was VBD O
then RB O
administered VBN O
at IN O
doses NNS O
of IN O
2 CD O
, , O
10 CD O
, , O
or CC O
50 CD O
mg NNS O
/ JJ O
kg NN O
to TO O
male VB O
rats NNS O
for IN O
1 CD O
, , O
3 CD O
, , O
or CC O
7 CD O
consecutive JJ O
days NNS O
. . O

Dose NNP O
- : O
and CC O
duration NN O
- : O
dependent JJ O
testicular JJ O
toxicity NN O
that WDT O
occurred VBD O
after IN O
a DT O
1 CD O
- : O
month NN O
observation NN O
period NN O
did VBD O
not RB O
recover VB O
, , O
and CC O
, , O
in IN O
some DT O
cases NNS O
, , O
was VBD O
more RBR O
severe JJ O
4 CD O
months NNS O
after IN O
the DT O
last JJ O
dose NN O
. . O

In IN O
rabbits NNS O
administered VBN O
BMS NNP O
- : O
189453 CD O
at IN O
oral JJ O
doses NNS O
of IN O
2 CD O
, , O
10 CD O
, , O
or CC O
50 CD O
mg NNS O
/ JJ O
kg NN O
for IN O
1 CD O
week NN O
, , O
testicular JJ O
degeneration NN O
and CC O
atrophy NN O
were VBD O
evident JJ O
in IN O
the DT O
high JJ O
- : O
dose NN O
group NN O
at IN O
1 CD O
month NN O
following VBG O
treatment NN O
. . O

These DT O
studies NNS O
indicate VBP O
that IN O
retinoid JJ O
antagonists NNS O
can MD O
selectively RB O
produce VB O
progressive JJ O
and CC O
prolonged JJ O
testicular NN O
toxicity NN O
after IN O
single JJ O
or CC O
repeated JJ O
oral JJ O
doses NNS O
that WDT O
are VBP O
otherwise RB O
well RB O
tolerated VBN O
. . O

Sequential JJ O
involvement NN O
of IN O
NFAT NNP B-Gene
and CC O
Egr NNP B-Gene
transcription NN B-Gene
factors NNS I-Gene
in IN O
FasL NNP O
regulation NN O
. . O

The DT O
critical JJ O
function NN O
of IN O
NFAT NNP B-Gene
proteins NNS I-Gene
in IN O
maintaining VBG O
lymphoid JJ O
homeostasis NN O
was VBD O
revealed VBN O
in IN O
mice NN O
lacking VBG O
both DT O
NFATp NNP B-Gene
and CC O
NFAT4 NNP B-Gene
( ( O
DKO NNP O
) ) O
. . O

DKO NNP O
mice JJ O
exhibit NN O
increased JJ O
lymphoproliferation NN O
, , O
decreased VBN O
activation NN O
- : O
induced VBN O
cell NN O
death NN O
, , O
and CC O
impaired JJ O
induction NN O
of IN O
FasL NNP B-Gene
. . O

The DT O
transcription NN B-Gene
factors NNS I-Gene
Egr2 NNP B-Gene
and CC O
Egr3 NNP B-Gene
are VBP O
potent JJ O
activators NNS O
of IN O
FasL NNP O
expression NN O
. . O

Here RB O
we PRP O
find VBP O
that IN O
Egr2 NNP B-Gene
and CC O
Egr3 NNP B-Gene
are VBP O
NFAT NNP B-Gene
target NN I-Gene
genes NNS I-Gene
. . O

Activation NN O
of IN O
FasL NNP B-Gene
occurs VBZ O
via IN O
the DT O
NFAT NNP B-Gene
- : O
dependent JJ O
induction NN O
of IN O
Egr3 NNP B-Gene
, , O
as IN O
demonstrated VBN O
by IN O
the DT O
ability NN O
of IN O
exogenously RB O
provided VBN O
NFATp NNP B-Gene
to TO O
restore VB O
Egr NNP B-Gene
- : O
dependent NN O
FasL NNP O
promoter NN O
activity NN O
in IN O
DKO NNP O
lymph NN O
node NN O
cells NNS O
. . O

Further RB O
, , O
Egr3 NNP B-Gene
expression NN O
is VBZ O
enriched VBN O
in IN O
Th1 NNP O
cells NNS O
, , O
suggesting VBG O
a DT O
molecular JJ O
basis NN O
for IN O
the DT O
known VBN O
preferential JJ O
expression NN O
of IN O
FasL NNP B-Gene
in IN O
the DT O
Th1 NNP O
versus NN O
Th2 NNP O
subset NN O
. . O

Mechanisms NNP O
and CC O
clinical JJ O
relevance NN O
of IN O
nongenomic JJ O
glucocorticoid JJ O
actions NNS O
. . O

Glucocorticoids NNS O
have VBP O
profound VBN O
anti SYM O
- : O
inflammatory NN O
and CC O
immunosuppressive JJ O
actions NNS O
when WRB O
used VBN O
therapeutically RB O
. . O

The DT O
therapeutic JJ O
dose NN O
is VBZ O
quite RB O
variable JJ O
and CC O
depends VBZ O
on IN O
the DT O
disease NN O
, , O
but CC O
ranges VBZ O
from IN O
very RB O
low JJ O
to TO O
extremely RB O
high JJ O
. . O

The DT O
rationale NN O
for IN O
the DT O
use NN O
of IN O
various JJ O
dosage NN O
regimens NNS O
for IN O
specific JJ O
clinical JJ O
indications NNS O
is VBZ O
the DT O
existence NN O
of IN O
three CD O
distinct NNS O
, , O
therapeutically RB O
relevant JJ O
effects NNS O
: : O
genomic NN O
, , O
specific JJ O
nongenomic JJ O
and CC O
unspecific JJ O
nongenomic NN O
. . O

Genomic JJ O
effects NNS O
are VBP O
mediated VBN O
by IN O
cytosolic JJ B-Gene
receptors NNS I-Gene
that IN O
alter JJ O
expression NN O
of IN O
specific JJ O
genes NNS O
. . O

Specific JJ O
nongenomic JJ O
effects NNS O
occur VBP O
within IN O
a DT O
few JJ O
minutes NNS O
and CC O
are VBP O
mediated VBN O
by IN O
steroid JJ B-Gene
- : I-Gene
selective JJ I-Gene
membrane NN I-Gene
receptors NNS I-Gene
. . O

Unspecific JJ O
nongenomic JJ O
effects NNS O
occur VBP O
within IN O
seconds NNS O
, , O
but CC O
only RB O
at IN O
high JJ O
glucocorticoid NN O
dosages NNS O
, , O
and CC O
seem VBP O
to TO O
result VB O
from IN O
direct JJ O
interactions NNS O
with IN O
biological JJ O
membranes NNS O
. . O

For IN O
unspecific JJ O
nongenomic JJ O
effects NNS O
, , O
methylprednisolone NN O
and CC O
other JJ O
glucocorticoids NNS O
have VBP O
been VBN O
shown VBN O
to TO O
inhibit VB O
cation NN O
cycling NN O
across IN O
the DT O
plasma NN O
membrane NN O
, , O
but CC O
to TO O
have VB O
little JJ O
effect NN O
on IN O
protein NN O
synthesis NN O
. . O

Thus RB O
, , O
glucocorticoids NNS O
could MD O
diminish VB O
or CC O
prevent VB O
the DT O
acute NN O
immune JJ O
response NN O
by IN O
interfering VBG O
with IN O
processes NNS O
such JJ O
as IN O
the DT O
rise NN O
in IN O
intracellular JJ O
Ca2 NNP O
+ NNP O
concentration NN O
. . O

It PRP O
is VBZ O
proposed VBN O
that IN O
the DT O
additional JJ O
therapeutic JJ O
benefit NN O
of IN O
higher JJR O
doses NNS O
is VBZ O
obtained VBN O
via IN O
these DT O
nongenomic JJ O
effects NNS O
. . O

High JJ O
glucose SYM O
- : O
induced JJ O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
expression NN O
through IN O
an DT O
osmotic JJ O
effect NN O
in IN O
rat NN O
mesangial JJ O
cells NNS O
is VBZ O
PKC NNP O
- : O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
dependent NN O
. . O

AIMS NNP O
/ NNP O
HYPOTHESIS NNP O
: : O
Infiltration NN O
of IN O
mononuclear JJ O
cells NNS O
and CC O
glomerular JJ O
enlargement NN O
accompanied VBN O
by IN O
glomerular JJ O
cell NN O
proliferation NN O
are VBP O
very RB O
early JJ O
characteristics NNS O
of IN O
the DT O
pathophysiology NN O
of IN O
diabetes NNS O
. . O

To TO O
clarify VB O
the DT O
mechanism NN O
of IN O
early JJ O
diabetic JJ O
nephropathy NN O
, , O
we PRP O
measured VBD O
[ $ O
3H CD O
] NNP O
- : O
thymidine NN O
incorporation NN O
and CC O
cell NN O
numbers NNS O
to TO O
show VB O
the DT O
influence NN O
of IN O
a DT O
high JJ O
ambient NN O
glucose JJ O
concentration NN O
and CC O
the DT O
osmotic JJ O
effect NN O
on IN O
rat NN O
mesangial JJ O
cell NN O
proliferation NN O
. . O

We PRP O
also RB O
measured VBD O
the DT O
effect NN O
of IN O
high JJ O
glucose NN O
on IN O
the DT O
expression NN O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
vascular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
by IN O
flow JJ O
cytometry NN O
and CC O
semiquantitative JJ O
RT NNP O
- : O
PCR NN O
in IN O
mesangial JJ O
cells NNS O
and CC O
the DT O
adhesion NN O
of IN O
leukocytes NNS O
to TO O
mesangial JJ O
cells NNS O
. . O

METHODS NNP O
/ JJ O
RESULTS NNP O
: : O
Cells NNS O
exposed VBN O
to TO O
high JJ O
D NNP O
- : O
glucose NN O
( ( O
30 CD O
mmol NN O
/ NNP O
l NN O
) ) O
caused VBD O
an DT O
increase NN O
in IN O
[ JJ O
3H CD O
] SYM O
- : O
thymidine NN O
incorporation NN O
and CC O
cell NN O
numbers NNS O
at IN O
24 CD O
and CC O
48 CD O
h NN O
and CC O
normalized VBN O
at IN O
72 CD O
h NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
, , O
whereas IN O
these DT O
changes NNS O
were VBD O
not RB O
found VBN O
in IN O
high JJ O
mannitol NN O
( ( O
30 CD O
mmol NN O
/ NNP O
l NN O
) ) O
, , O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
, , O
or CC O
TNF NNP B-Gene
alpha SYM I-Gene
- : O
stimulated VBN O
mesangial JJ O
cells NNS O
. . O

Cells NNS O
exposed VBN O
to TO O
high JJ O
- : O
glucose NN O
( ( O
15 CD O
, , O
30 CD O
, , O
or CC O
60 CD O
mmol NNS O
/ NNP O
l NN O
) ) O
or CC O
osmotic JJ O
agents NNS O
( ( O
L NNP O
- : O
glucose NN O
, , O
raffinose NN O
and CC O
mannitol NN O
) ) O
showed VBD O
that IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
expression NN O
began VBD O
to TO O
increase VB O
after IN O
24 CD O
h NN O
, , O
reached VBD O
its PRP$ O
maximum NN O
at IN O
24 CD O
and CC O
48 CD O
h NN O
and CC O
gradually RB O
decreased JJ O
afterwards NNS O
. . O

The DT O
stimulatory JJ O
effects NNS O
of IN O
high JJ O
glucose NN O
and CC O
high JJ O
mannitol NN O
on IN O
mRNA JJ O
expression NN O
were VBD O
observed VBN O
as RB O
early JJ O
as IN O
6 CD O
h NN O
and CC O
reached VBD O
its PRP$ O
maximum NN O
at IN O
12 CD O
h NN O
. . O

Up IN O
- : O
regulation NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN O
and CC O
mRNA NN O
was VBD O
also RB O
found VBN O
in IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
beta NN I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
stimulated VBN O
mesangial JJ O
cells NNS O
. . O

Neither DT O
vascular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
protein NNS O
nor CC O
mRNA JJ O
expression NN O
was VBD O
, , O
however RB O
, , O
affected VBN O
by IN O
high JJ O
glucose NN O
and CC O
high JJ O
mannitol NN O
. . O

Notably RB O
, , O
the DT O
protein NN O
kinase VBD O
C NNP O
inhibitors NNS O
calphostin VBP O
C NNP O
and CC O
staurosporine VB O
reduced VBN O
high JJ O
glucose JJ O
- : O
or CC O
high JJ O
mannitol NN O
- : O
induced JJ O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ O
expression NN O
and CC O
high JJ O
glucose NN O
- : O
induced JJ O
proliferation NN O
. . O

Furthermore RB O
, , O
the DT O
NF NNP O
- : O
kappa NN O
B NNP O
inhibitor NN O
N NNP O
- : O
tosyl NN O
- : O
L NNP O
- : O
phenylalanine NN O
chloromethyl NN O
ketone NN O
reduced VBD O
high JJ O
glucose JJ O
- : O
or CC O
high JJ O
mannitol NN O
- : O
induced JJ O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ O
expression NN O
and CC O
high JJ O
glucose NN O
- : O
induced JJ O
proliferation NN O
. . O

Results NNS O
showed VBD O
that IN O
high JJ O
glucose NN O
( ( O
15 CD O
, , O
30 CD O
mmol NN O
/ NNP O
l NN O
) ) O
or CC O
high JJ O
concentrations NNS O
of IN O
osmotic JJ O
agents NNS O
remarkably RB O
increased VBD O
the DT O
number NN O
of IN O
adherent JJ O
leukocytes NNS O
to TO O
mesangial JJ O
cells NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
compared VBN O
with IN O
control NN O
cells NNS O
( ( O
5 CD O
mmol NN O
/ NNP O
l NN O
D NNP O
- : O
glucose NN O
) ) O
. . O

Functional JJ O
blocking NN O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
on IN O
mesangial JJ O
cells NNS O
with IN O
rat NN B-Gene
intercellular JJ I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
, , O
calphostin NN O
C NNP O
, , O
staurosporine NN O
, , O
or CC O
N NNP O
- : O
tosyl NN O
- : O
L NNP O
- : O
phenylalanine NN O
chloromethyl NN O
ketone NN O
significantly RB O
inhibited VBN O
high JJ O
glucose JJ O
- : O
or CC O
high JJ O
mannitol NN O
- : O
induced JJ O
increase NN O
in IN O
leukocyte JJ O
adhesion NN O
( ( O
p JJ O
< NNP O
< NNP O
0 CD O
. . O
5 CD O
) ) O
. . O

CONCLUSION NNP O
/ NNP O
INTERPRETATION NNP O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
high JJ O
glucose NN O
can MD O
upregulate VB O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
protein NN O
and CC O
mRNA JJ O
expression NN O
but CC O
not RB O
vascular JJ O
adhesion NN O
molecule NN O
- : O
1 CD O
expression NN O
in IN O
mesangial JJ O
cells NNS O
and CC O
promote VB O
leukocyte JJ O
adhesion NN O
through IN O
up IN O
- : O
regulation NN O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
through IN O
osmotic JJ O
effect NN O
, , O
possibly RB O
depending VBG O
on IN O
the DT O
protein NN B-Gene
kinase VBD I-Gene
C NNP I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
PKC NNP B-Gene
- : O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
pathway NN O
. . O

High NNP O
glucose VBD O
itself PRP O
can MD O
also RB O
promote VB O
mesangial JJ O
cell NN O
proliferation NN O
through IN O
the DT O
PKC NNP O
- : O
NF NNP O
- : O
kappa NN O
B NNP O
pathways NNS O
. . O

We PRP O
conclude VBP O
that DT O
hyperglycaemia NN O
in IN O
itself PRP O
seems VBZ O
to TO O
be VB O
an DT O
important JJ O
factor NN O
in IN O
the DT O
development NN O
of IN O
early JJ O
diabetic JJ O
nephropathy NN O
. . O

Combined VBN O
corticosteroid JJ O
/ NNP O
granulocyte NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
therapy NN O
in IN O
the DT O
treatment NN O
of IN O
severe JJ O
congenital JJ O
neutropenia NN O
unresponsive JJ O
to TO O
G NNP B-Gene
- : I-Gene
CSF NN I-Gene
: : O
Activated VBN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
synergize VBP O
with IN O
G NNP B-Gene
- : I-Gene
CSF NN I-Gene
signals NNS O
. . O

More JJR O
than IN O
90 CD O
% NN O
of IN O
patients NNS O
with IN O
severe JJ O
congenital JJ O
neutropenia NN O
( ( O
SCN NNP O
) ) O
respond NN O
to TO O
granulocyte VB B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
therapy NN O
. . O

The DT O
basis NN O
for IN O
the DT O
refractory NN O
state NN O
in IN O
the DT O
remaining VBG O
patients NNS O
is VBZ O
unknown JJ O
. . O

To TO O
address VB O
this DT O
issue NN O
, , O
we PRP O
studied VBD O
a DT O
child NN O
with IN O
SCN NNP O
who WP O
was VBD O
totally RB O
unresponsive JJ O
to TO O
G NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
had VBD O
a DT O
novel JJ O
point NN O
mutation NN O
in IN O
the DT O
extracellular JJ B-Gene
domain NN I-Gene
of IN O
the DT O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
( ( O
GCSF NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
. . O

Marrow NNP O
stromal JJ O
support NN O
of IN O
granulopoiesis NN O
was VBD O
evaluated VBN O
by IN O
plating VBG O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
on IN O
preformed JJ O
stromal JJ O
layers NNS O
. . O

Nonadherent JJ O
cells NNS O
were VBD O
harvested VBN O
and CC O
assayed VBN O
in IN O
clonogenic JJ O
assays NNS O
for IN O
granulocytic JJ O
colony NN O
production NN O
. . O

The DT O
in IN O
vitro JJ O
effect NN O
of IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
and CC O
corticosteroids NNS O
on IN O
granulopoiesis NN O
was VBD O
evaluated VBN O
in IN O
clonogenic JJ O
assays NNS O
of IN O
marrow NN O
mononuclear NN O
cells NNS O
, , O
by IN O
proliferation NN O
studies NNS O
of IN O
the DT O
murine NN O
myeloid NN O
cell NN O
line NN O
32D CD O
expressing VBG O
the DT O
patient NN O
' POS O
s NN O
mutated VBD B-Gene
G NNP I-Gene
- : I-Gene
CSFR NNP I-Gene
, , O
and CC O
by IN O
measuring VBG O
STAT5 NNP O
activation NN O
in IN O
nuclear JJ O
extracts NNS O
from IN O
stimulated JJ O
cells NNS O
. . O

Patient NNP O
' POS O
s NN O
stroma NN O
supported VBD O
granulopoiesis NN O
derived VBN O
from IN O
control NN O
marrow NN O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
in IN O
a DT O
normal JJ O
manner NN O
. . O

Normal NNP O
stroma NN O
, , O
however RB O
, , O
failed VBD O
to TO O
induce VB O
granulopoiesis NN O
from IN O
patient NN O
' POS O
s NN O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
. . O

Clonogenic NNP O
assays NNS O
of IN O
the DT O
patient NN O
' POS O
s NN O
marrow NN O
mononuclear VBP O
cells NNS O
incorporating VBG O
either CC O
G NNP B-Gene
- : I-Gene
CSF NN I-Gene
or CC O
hydrocortisone NN O
produced VBN O
little JJ O
neutrophil JJ O
growth NN O
. . O

In IN O
contrast NN O
, , O
inclusion NN O
of IN O
both DT O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
and CC O
hydrocortisone NN O
in IN O
the DT O
cytokine NN B-Gene
` `` I-Gene
` `` I-Gene
cocktail NN I-Gene
' '' I-Gene
' '' I-Gene
markedly RB O
increased VBD O
the DT O
neutrophil JJ O
numbers NNS O
. . O

Proliferation NN O
of IN O
32D CD O
cells NNS O
expressing VBG O
the DT O
mutated VBN B-Gene
receptor NN I-Gene
and CC O
STAT5 NNP O
activation NN O
were VBD O
improved VBN O
by IN O
a DT O
combination NN O
of IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
and CC O
dexamethasone NN O
. . O

When WRB O
small JJ O
daily JJ O
doses NNS O
of IN O
oral JJ O
prednisone NN O
were VBD O
then RB O
administered VBN O
to TO O
the DT O
patient NN O
with IN O
conventional JJ O
doses NNS O
of IN O
subcutaneous JJ B-Gene
G NNP I-Gene
- : I-Gene
CSF NNP I-Gene
, , O
the DT O
patient NN O
responded VBD O
with IN O
increased JJ O
neutrophil JJ O
numbers NNS O
and CC O
with IN O
a DT O
complete JJ O
reversal NN O
of IN O
the DT O
infectious JJ O
problems NNS O
. . O

These DT O
data NNS O
provide VBP O
insight NN O
into IN O
SCN NNP O
unresponsive JJ O
to TO O
standard VB O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
treatment NN O
and CC O
to TO O
the DT O
potential JJ O
corrective JJ O
action NN O
of IN O
combined JJ O
treatment NN O
with IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
and CC O
corticosteroids NNS O
through IN O
synergistic JJ O
activation NN O
of IN O
STAT5 NNP B-Gene
. . O

Human NNP O
renal JJ O
mesangial NN O
cells NNS O
are VBP O
a DT O
target NN O
for IN O
the DT O
anti JJ O
- : O
inflammatory JJ O
action NN O
of IN O
9 CD O
- : O
cis NN O
retinoic NN O
acid NN O
. . O

Mesangial NNP O
cells NNS O
play VBP O
an DT O
active JJ O
role NN O
in IN O
the DT O
inflammatory JJ O
response NN O
to TO O
glomerular JJ O
injury NN O
. . O

We PRP O
have VBP O
studied VBN O
in IN O
cultured JJ O
human JJ O
mesangial NN O
cells NNS O
( ( O
CHMC NNP O
) ) O
several JJ O
effects NNS O
of IN O
9 CD O
- : O
cis NN O
retinoic NN O
acid NN O
( ( O
9 CD O
- : O
cRA NN O
) ) O
, , O
an DT O
activator NN O
of IN O
both DT O
retinoic JJ B-Gene
acid NN I-Gene
receptors NNS I-Gene
( ( O
RARs NNP B-Gene
) ) O
and CC O
retinoid JJ B-Gene
X NN I-Gene
receptors NNS I-Gene
( ( O
RXRs NNP B-Gene
) ) O
. . O

9 CD O
- : O
cRA NN O
inhibited JJ O
foetal JJ O
calf NN O
serum SYM O
- : O
induced JJ O
CHMC NNP O
proliferation NN O
. . O

It PRP O
also RB O
prevented VBD O
CHMC NNP O
death NN O
induced VBN O
by IN O
the DT O
inflammatory JJ O
mediator NN O
H NNP O
( ( O
2 CD O
) ) O
O NNP O
( ( O
2 CD O
) ) O
. . O

This DT O
preventive JJ O
effect NN O
was VBD O
not RB O
due JJ O
to TO O
any DT O
increase NN O
in IN O
H NNP O
( ( O
2 CD O
) ) O
O NNP O
( ( O
2 CD O
) ) O
catabolism NN O
and CC O
it PRP O
persisted VBD O
even RB O
when WRB O
both DT O
catalase NN O
and CC O
glutathione NN O
synthesis NN O
were VBD O
inhibited VBN O
. . O

Finally RB O
, , O
9 CD O
- : O
cRA NN O
diminished VBD O
monocyte JJ O
adhesion NN O
to TO O
FCS NNP O
- : O
stimulated VBD O
CHMC NNP O
. . O

Interestingly RB O
, , O
the DT O
retinoid NN O
also RB O
inhibited VBN O
in IN O
FCS NNP O
- : O
stimulated VBD O
cells NNS O
the DT O
protein JJ O
expression NN O
of IN O
two CD O
mesangial JJ B-Gene
adhesion NN I-Gene
molecules NNS I-Gene
, , O
fibronectin NN B-Gene
and CC O
osteopontin NN B-Gene
, , O
but CC O
it PRP O
did VBD O
not RB O
modify VB O
the DT O
protein NN O
expression NN O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
vascular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

All DT O
major JJ O
RARs NNP B-Gene
and CC I-Gene
RXRs NNP I-Gene
isotypes NNS I-Gene
were VBD O
expressed VBN O
in IN O
CHMC NNP O
regardless NN O
of IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
9 CD O
- : O
cRA NN O
. . O

Transcripts NNS O
to TO O
RAR NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
RAR NNP B-Gene
- : I-Gene
beta NN I-Gene
and CC O
RXR NNP B-Gene
- : I-Gene
alpha NN I-Gene
increased VBD O
after IN O
incubation NN O
with IN O
9 CD O
- : O
cRA NN O
whereas IN O
RXR NNP B-Gene
- : I-Gene
gamma NN I-Gene
was VBD O
inhibited VBN O
, , O
suggesting VBG O
a DT O
major JJ O
role NN O
for IN O
RARs NNP B-Gene
and CC O
RXRs NNP B-Gene
in IN O
9 CD O
- : O
cRA NN O
- : O
anti NN O
- : O
inflammatory JJ O
effects NNS O
. . O

9 CD O
- : O
cRA NN O
was VBD O
toxic JJ O
only RB O
at IN O
50 CD O
microM NN O
( ( O
a DT O
concentration NN O
50 CD O
- : O
5000 CD O
times NNS O
higher RBR O
than IN O
required VBN O
for IN O
the DT O
effects NNS O
above IN O
) ) O
. . O

Cell NNP O
death NN O
occurred VBN O
by IN O
apoptosis NN O
, , O
whose WP$ O
onset NN O
was VBD O
associated VBN O
with IN O
a DT O
pronounced JJ O
increase NN O
in IN O
catalase NN O
activity NN O
and CC O
reduced VBD O
glutathione NN O
content NN O
, , O
being VBG O
more RBR O
effectively RB O
induced VBN O
by IN O
all DT O
- : O
trans NNS O
retinoic VBP O
acid NN O
. . O

Modulation NN O
of IN O
the DT O
oxidant JJ O
/ NNP O
antioxidant JJ O
balance NN O
failed VBD O
to TO O
inhibit VB O
apoptosis NN O
. . O

We PRP O
conclude VBP O
that IN O
mesangial JJ O
cells NNS O
might MD O
be VB O
a DT O
target NN O
for IN O
the DT O
treatment NN O
of IN O
inflammatory JJ O
glomerulopathies NNS O
with IN O
9 CD O
- : O
cRA NN O
. . O

Expression NN O
of IN O
mammalian JJ B-Gene
defensin NN I-Gene
genes NNS I-Gene
. . O

Antimicrobial NNP O
peptides NNS O
are VBP O
a DT O
prevalent JJ O
mechanism NN O
of IN O
host NN O
defense NN O
found VBD O
throughout IN O
nature NN O
. . O

In IN O
mammals NNS O
, , O
defensins NNS B-Gene
are VBP O
among IN O
the DT O
most RBS O
abundant JJ O
of IN O
these DT O
broad JJ O
- : O
spectrum NN O
antibiotics NNS O
, , O
and CC O
are VBP O
expressed VBN O
in IN O
epithelial JJ O
and CC O
hematopoietic JJ O
cells NNS O
. . O

The DT O
defensin NN O
peptides NNS O
are VBP O
especially RB O
abundant JJ O
in IN O
neutrophils NNS O
; : O
however RB O
, , O
gene NN O
expression NN O
is VBZ O
limited VBN O
to TO O
the DT O
promyelocyte NN O
stage NN O
. . O

In IN O
epithelial JJ O
cells NNS O
, , O
defensin NN B-Gene
genes NNS I-Gene
are VBP O
found VBN O
as IN O
both DT O
constitutively RB O
expressed VBN O
and CC O
inducible JJ O
. . O

Induction NN O
has VBZ O
been VBN O
observed VBN O
in IN O
vitro NN O
by IN O
stimulation NN O
with IN O
bacterial JJ O
lipopolysaccharide NN O
as RB O
well RB O
as IN O
inflammatory JJ O
mediators NNS O
. . O

In IN O
vivo NN O
, , O
up RB O
- : O
regulation NN O
of IN O
several JJ O
defensin NN B-Gene
genes NNS I-Gene
occurs VBZ O
in IN O
both DT O
infectious JJ O
and CC O
inflammatory JJ O
states NNS O
. . O

Gene NNP O
regulation NN O
occurs VBZ O
via IN O
signal JJ O
transduction NN O
pathways NNS O
common JJ O
to TO O
other JJ O
innate NN O
immune JJ O
responses NNS O
, , O
utilizing JJ O
transcription NN B-Gene
factors NNS I-Gene
such JJ O
as IN O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
NF NNP B-Gene
interleukin VBP I-Gene
- : I-Gene
6 CD I-Gene
. . O

Together RB O
, , O
the DT O
data NNS O
suggest VBP O
a DT O
broad JJ O
- : O
based VBN O
innate NN O
host NN O
defense NN O
whereby WRB O
potent JJ O
antimicrobial JJ O
peptides NNS O
are VBP O
present JJ O
to TO O
prevent VB O
initial JJ O
colonization NN O
by IN O
pathogenic JJ O
microorganisms NNS O
. . O

In IN O
addition NN O
, , O
the DT O
recognition NN O
of IN O
bacteria NNS O
coupled VBN O
with IN O
a DT O
nascent JJ O
inflammatory NN O
response NN O
can MD O
bolster VB O
this DT O
defense NN O
by IN O
a DT O
coordinated VBN O
up RP O
- : O
regulation NN O
of IN O
the DT O
peptides NNS O
. . O

Multiple JJ O
signals NNS O
required VBN O
for IN O
cyclic JJ B-Gene
AMP NNP I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
binding VBG O
protein JJ O
interaction NN O
induced VBN O
by IN O
CD3 NNP O
/ NNP O
CD28 NNP O
costimulation NN O
. . O

The DT O
optimal JJ O
activation NN O
of IN O
cAMP NN B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
, , O
similar JJ O
to TO O
the DT O
full JJ O
activation NN O
of IN O
T NNP O
lymphocytes NNS O
, , O
requires VBZ O
the DT O
stimulation NN O
of IN O
both DT O
CD3 NNP B-Gene
and CC O
CD28 NNP B-Gene
. . O

Using VBG O
a DT O
reporter NN O
system NN O
to TO O
detect VB O
interaction NN O
of IN O
CREB NNP B-Gene
and CC O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
CBP NNP B-Gene
) ) O
, , O
in IN O
this DT O
study NN O
we PRP O
found VBD O
that IN O
CREB NNP B-Gene
binds VBZ O
to TO O
CBP NNP B-Gene
only RB O
by IN O
engagement NN O
of IN O
both DT O
CD3 NNP B-Gene
and CC O
CD28 NNP B-Gene
. . O

CD3 NNP B-Gene
/ NNP I-Gene
CD28 NNP I-Gene
- : O
promoted VBD O
CREB NNP B-Gene
- : O
CBP NNP B-Gene
interaction NN O
was VBD O
dependent JJ O
on IN O
p38 NN B-Gene
mitogen NN I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
and CC O
calcium NN B-Gene
/ NNP I-Gene
calmodulin NN I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( I-Gene
CaMK NNP I-Gene
) ) I-Gene
IV NNP I-Gene
in IN O
addition NN O
to TO O
the DT O
previously RB O
identified VBN O
extracellular JJ O
signal JJ O
- : O
regulated JJ O
kinase NN O
pathway NN O
. . O

Extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
, , I-Gene
CaMKIV NNP I-Gene
, , O
and CC O
p38 JJ B-Gene
MAPK NNP I-Gene
were VBD O
also RB O
the DT O
kinases NNS O
involved VBN O
in IN O
CREB NNP B-Gene
Ser NNP O
( ( O
133 CD O
) ) O
phosphorylation NN O
induced VBN O
by IN O
CD3 NNP B-Gene
/ NNP I-Gene
CD28 NNP I-Gene
. . O

A DT O
reconstitution NN O
experiment NN O
illustrated VBD O
that IN O
optimum JJ O
CREB NNP B-Gene
- : O
CBP NNP B-Gene
interaction NN O
and CC O
CREB NNP B-Gene
trans VBZ O
- : O
activation NN O
were VBD O
attained VBN O
when WRB O
these DT O
three CD O
kinase NN O
pathways NNS O
were VBD O
simultaneously RB O
activated VBN O
in IN O
T NNP O
cells NNS O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
coordinated VBD O
activation NN O
of IN O
different JJ O
kinases NNS B-Gene
leads VBZ O
to TO O
full JJ O
activation NN O
of IN O
CREB NNP B-Gene
. . O

Notably RB O
, , O
CD28 NNP O
ligation NN O
activated VBD O
p38 JJ B-Gene
MAPK NNP I-Gene
and CC O
CaMKIV NNP B-Gene
, , O
the DT O
kinases NNS B-Gene
stimulated VBN O
by IN O
CD3 NNP O
engagement NN O
, , O
suggesting VBG O
that IN O
CD28 NNP B-Gene
acts NNS O
by IN O
increasing VBG O
the DT O
activation NN O
extent NN O
of IN O
p38 NN B-Gene
MAPK NNP I-Gene
and CC O
CaMKIV NNP B-Gene
. . O

These DT O
results NNS O
support VBD O
the DT O
model NN O
of IN O
a DT O
minimum JJ O
activation NN O
threshold NN O
for IN O
CREB NNP B-Gene
- : O
CBP NNP B-Gene
interaction NN O
that WDT O
can MD O
be VB O
reached VBN O
only RB O
when WRB O
both DT O
CD3 NNP B-Gene
and CC O
CD28 NNP B-Gene
are VBP O
stimulated VBN O
. . O

The DT O
murine NN B-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
contains NNS O
distal JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
responsive VBP O
to TO O
the DT O
Ah NNP B-Gene
receptor NN I-Gene
, , O
a DT O
member NN O
of IN O
the DT O
evolutionarily RB O
conserved VBN O
bHLH SYM B-Gene
- : I-Gene
PAS NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

Signaling VBG O
through IN O
the DT O
TCR NNP B-Gene
and CC O
costimulatory JJ O
signals NNS O
primarily RB O
control VBP O
transcription NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
naive JJ O
T NNP O
cells NNS O
. . O

The DT O
minimal JJ B-Gene
promoter NN I-Gene
necessary JJ O
for IN O
this DT O
expression NN O
lies VBZ O
proximal JJ O
, , O
between IN O
- : O
300 CD O
and CC O
the DT O
transcription NN B-Gene
start NN I-Gene
site NN I-Gene
. . O

We PRP O
had VBD O
previously RB O
shown VBN O
that DT O
activation NN O
of IN O
the DT O
arylhydrocarbon NN B-Gene
receptor NN I-Gene
( ( O
AHR NNP B-Gene
) ) O
, , O
a DT O
member NN O
of IN O
the DT O
bHLH NN B-Gene
- : I-Gene
PAS NNP I-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
leads VBZ O
to TO O
increased VBN O
mRNA JJ O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
murine NN O
fetal JJ O
thymocytes NNS O
. . O

The DT O
AHR NNP B-Gene
is VBZ O
abundant JJ O
in IN O
the DT O
thymus NN O
and CC O
may MD O
play VB O
a DT O
role NN O
for IN O
the DT O
development NN O
of IN O
the DT O
immune NN O
system NN O
. . O

Moreover RB O
, , O
its PRP$ O
overactivation NN O
by IN O
chemicals NNS O
such JJ O
as IN O
dioxins NNS O
leads VBZ O
to TO O
immunosuppression NN O
and CC O
thymic JJ O
involution NN O
. . O

Binding VBG O
motifs NNS O
for IN O
the DT O
liganded JJ B-Gene
AHR NNP I-Gene
can MD O
be VB O
identified VBN O
in IN O
the DT O
distal JJ B-Gene
region NN I-Gene
- : I-Gene
1300 CD I-Gene
to TO I-Gene
- : I-Gene
800 CD I-Gene
of IN O
the DT O
mouse NN B-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

We PRP O
show VBP O
here RB O
that IN O
these DT O
DNA NNP B-Gene
motifs NNS I-Gene
, , O
the DT O
so RB O
- : O
called VBD O
dioxin NN B-Gene
response NN I-Gene
elements NNS I-Gene
, , O
after IN O
binding VBG O
to TO O
the DT O
liganded VBN B-Gene
AHR NNP I-Gene
are VBP O
sufficient JJ O
to TO O
transactivate VB O
luciferase JJ O
expression NN O
in IN O
a DT O
reporter NN O
gene NN O
system NN O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
can MD O
be VB O
induced VBN O
by IN O
the DT O
AHR NNP B-Gene
also RB O
in IN O
thymocytes NNS O
in IN O
vivo NN O
after IN O
injection NN O
of IN O
2 CD O
, , O
3 CD O
, , O
7 CD O
, , O
8 CD O
- : O
tetrachlorodibenzo NN O
- : O
p NN O
- : O
dioxin NN O
, , O
a DT O
potent JJ O
ligand NN O
of IN O
the DT O
AHR NNP B-Gene
. . O

The DT O
AHR NNP B-Gene
mediates VBZ O
the DT O
IL NNP O
- : O
2 CD O
induction NN O
as IN O
shown VBN O
with IN O
AHR NNP B-Gene
- : O
deficient NN O
mice NN O
. . O

However RB O
, , O
in IN O
spleen JJ O
cells NNS O
in IN O
vitro JJ O
costimulation NN O
via IN O
the DT O
TCR NNP B-Gene
is VBZ O
necessary JJ O
for IN O
optimal JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
induction NN O
. . O

Thus RB O
, , O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
region NN I-Gene
contains VBZ O
novel JJ O
distal JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
that WDT O
can MD O
be VB O
addressed VBN O
by IN O
the DT O
AHR NNP B-Gene
to TO O
induce VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
can MD O
cooperate VB O
with IN O
the DT O
proximal JJ B-Gene
promoter NN I-Gene

Visualization NN O
of IN O
Syk NNP B-Gene
- : I-Gene
antigen NN I-Gene
receptor NN I-Gene
interactions NNS O
using VBG O
green JJ B-Gene
fluorescent JJ I-Gene
protein NN I-Gene
: : O
differential JJ O
roles NNS O
for IN O
Syk NNP B-Gene
and CC O
Lyn NNP B-Gene
in IN O
the DT O
regulation NN O
of IN O
receptor NN O
capping NN O
and CC O
internalization NN O
. . O

The DT O
cross NN O
- : O
linking NN O
of IN O
the DT O
B NNP B-Gene
cell NN I-Gene
Ag NNP I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
is VBZ O
coupled VBN O
to TO O
the DT O
stimulation NN O
of IN O
multiple JJ O
intracellular JJ O
signal NN O
transduction NN O
cascades NNS O
via IN O
receptor NN O
- : O
associated VBN O
, , O
protein FW B-Gene
tyrosine JJ I-Gene
kinases NNS I-Gene
of IN O
both DT O
the DT O
Src NNP B-Gene
and CC I-Gene
Syk NNP I-Gene
families NNS I-Gene
. . O

To TO O
monitor VB O
changes NNS O
in IN O
the DT O
subcellular JJ O
distribution NN O
of IN O
Syk NNP B-Gene
in IN O
B NNP O
cells NNS O
responding VBG O
to TO O
BCR NNP B-Gene
cross NN O
- : O
linking NN O
, , O
we PRP O
expressed VBD O
in IN O
Syk NNP B-Gene
- : O
deficient NN O
DT40 NNP O
B NNP O
cells NNS O
a DT O
fusion NN B-Gene
protein NN I-Gene
consisting VBG O
of IN O
Syk NNP B-Gene
coupled VBD O
to TO O
green JJ B-Gene
fluorescent NN I-Gene
protein NN I-Gene
. . O

Treatment NN O
of IN O
these DT O
cells NNS O
with IN O
anti JJ B-Gene
- : I-Gene
IgM NNP I-Gene
Abs NNP I-Gene
leads VBZ O
to TO O
the DT O
recruitment NN O
of IN O
the DT O
kinase NN B-Gene
from IN O
cytoplasmic JJ O
and CC O
nuclear JJ O
compartments NNS O
to TO O
the DT O
site NN O
of IN O
the DT O
cross NN B-Gene
- : I-Gene
linked VBN I-Gene
receptor NN I-Gene
at IN O
the DT O
plasma NN O
membrane NN O
. . O

The DT O
Syk NNP B-Gene
- : I-Gene
receptor NN I-Gene
complexes JJ I-Gene
aggregate NN O
into IN O
membrane NN O
patches NNS O
that WDT O
redistribute VBP O
to TO O
form VB O
a DT O
cap NN O
at IN O
one CD O
pole NN O
of IN O
the DT O
cell NN O
. . O

Syk NNP B-Gene
is VBZ O
not RB O
demonstrably RB O
associated VBN O
with IN O
the DT O
internalized JJ B-Gene
receptor NN I-Gene
. . O

Catalytically RB O
active JJ O
Syk NNP B-Gene
promotes NNS O
and CC O
stabilizes VBZ O
the DT O
formation NN O
of IN O
tightly RB B-Gene
capped VBN I-Gene
BCR NNP I-Gene
complexes NNS I-Gene
at IN O
the DT O
plasma NN O
membrane NN O
. . O

Lyn NNP B-Gene
is VBZ O
not RB O
required VBN O
for IN O
the DT O
recruitment NN O
of IN O
Syk NNP B-Gene
to TO O
the DT O
cross NN B-Gene
- : I-Gene
linked VBN I-Gene
receptor NN I-Gene
, , O
but CC O
is VBZ O
required VBN O
for IN O
the DT O
internalization NN O
of IN O
the DT O
clustered JJ O
BCR NNP B-Gene
complexes NNS I-Gene
. . O

In IN O
the DT O
absence NN O
of IN O
Lyn NNP B-Gene
, , O
receptor NN B-Gene
- : I-Gene
Syk NN I-Gene
complexes NNS I-Gene
at IN O
the DT O
plasma NN O
membrane NN O
are VBP O
long RB O
lived JJ O
, , O
and CC O
the DT O
receptor NN O
- : O
mediated VBN O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
is VBZ O
enhanced VBN O
. . O

Thus RB O
, , O
Lyn NNP B-Gene
appears VBZ O
to TO O
function VB O
to TO O
negatively RB O
regulate VB O
aspects NNS O
of IN O
BCR NNP B-Gene
- : O
dependent NN O
signaling NN O
by IN O
stimulating VBG O
receptor NN O
internalization NN O
and CC O
down IN O
- : O
regulation NN O
. . O

Renal JJ O
interstitial JJ O
fibrosis NN O
is VBZ O
reduced VBN O
in IN O
angiotensin NN B-Gene
II NNP I-Gene
type NN I-Gene
1a CD I-Gene
receptor NN I-Gene
- : O
deficient NN O
mice NN O
. . O

Unilateral JJ O
ureteral JJ O
obstruction NN O
( ( O
UUO NNP O
) ) O
results NNS O
in IN O
tubulointerstitial JJ O
fibrosis NN O
of IN O
the DT O
affected JJ O
kidney NN O
by IN O
stimulating VBG O
the DT O
renin NN O
- : O
angiotensin NN O
system NN O
. . O

This DT O
study NN O
established VBD O
a DT O
UUO NNP O
model NN O
in IN O
angiotensin JJ B-Gene
type NN I-Gene
1a CD I-Gene
receptor NN I-Gene
( ( O
AT1a NNP B-Gene
) ) O
deficient NN O
( ( O
mutant JJ O
) ) O
mice NN O
to TO O
elucidate VB O
the DT O
role NN O
of IN O
angiotensin NN B-Gene
II NNP I-Gene
through IN O
AT1a NNP B-Gene
on IN O
the DT O
fibrosis NN O
of IN O
the DT O
obstructed JJ O
kidney NN O
( ( O
OBK NNP O
) ) O
. . O

The DT O
relative JJ O
volume NN O
of IN O
the DT O
tubulointerstitium NN O
was VBD O
measured VBN O
by IN O
an DT O
image NN O
analyzer NN O
; : O
deposition NN O
of IN O
collagen NN B-Gene
types NNS I-Gene
III NNP I-Gene
and CC I-Gene
IV NNP I-Gene
and CC O
monocyte JJ O
/ NNP O
macrophage NN O
infiltration NN O
were VBD O
histologically RB O
examined VBN O
using VBG O
specific JJ B-Gene
antibodies NNS I-Gene
. . O

Also RB O
determined VBN O
were VBD O
the DT O
mRNA NN O
levels NNS O
of IN O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
by IN O
Northern NNP O
blot NN O
analysis NN O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
was VBD O
assessed VBN O
by IN O
gel NN O
shift NN O
assay NN O
. . O

UUO NNP O
in IN O
wild JJ O
mice NN O
resulted VBD O
in IN O
a DT O
marked JJ O
expansion NN O
of IN O
relative JJ O
volume NN O
of IN O
the DT O
tubulointerstitium NN O
, , O
together RB O
with IN O
increased JJ O
deposition NN O
of IN O
collagen NN B-Gene
types NNS I-Gene
III NNP I-Gene
and CC I-Gene
IV NNP I-Gene
and CC O
number NN O
of IN O
infiltrated JJ O
monocytes NNS O
/ VBP O
macrophages NNS O
in IN O
the DT O
interstitium NN O
, , O
relative JJ O
to TO O
sham VB O
- : O
operated JJ O
mice NN O
. . O

In IN O
comparison NN O
, , O
these DT O
changes NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
mutant JJ O
mice NN O
with IN O
UUO NNP O
. . O

The DT O
mRNA JJ O
level NN O
of IN O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
was VBD O
significantly RB O
higher JJR O
in IN O
the DT O
OBK NNP O
of IN O
wild JJ O
mice NNS O
with IN O
UUO NNP O
compared VBN O
with IN O
sham JJ O
- : O
operated JJ O
mice NN O
. . O

In IN O
contrast NN O
, , O
the DT O
increase NN O
in IN O
mRNA JJ O
level NN O
in IN O
the DT O
OBK NNP O
of IN O
mutant JJ O
mice NN O
was VBD O
significantly RB O
less JJR O
than IN O
in IN O
wild JJ O
mice NNS O
. . O

Finally RB O
, , O
UUO NNP O
resulted VBD O
in IN O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
wild JJ O
mice NNS O
but CC O
was VBD O
inhibited VBN O
in IN O
the DT O
OBK NNP O
of IN O
mutant JJ O
mice NN O
. . O

The DT O
results NNS O
provide VBP O
direct JJ O
evidence NN O
that IN O
angiotensin NN B-Gene
II NNP I-Gene
acting VBG O
via IN O
the DT O
AT1a NNP B-Gene
plays VBZ O
a DT O
pivotal JJ O
role NN O
in IN O
the DT O
development NN O
of IN O
tubulointerstitial JJ O
fibrosis NN O
in IN O
UUO NNP O
. . O

HLA NNP B-Gene
- : I-Gene
DQ NNP I-Gene
tetramers NNS I-Gene
identify VBP O
epitope SYM O
- : O
specific JJ O
T NNP O
cells NNS O
in IN O
peripheral JJ O
blood NN O
of IN O
herpes NNS O
simplex JJ O
virus NN O
type NN O
2 CD O
- : O
infected JJ O
individuals NNS O
: : O
direct JJ O
detection NN O
of IN O
immunodominant JJ O
antigen NN O
- : O
responsive JJ O
cells NNS O
. . O

Ag NNP O
- : O
specific JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
are VBP O
present JJ O
in IN O
peripheral JJ O
blood NN O
in IN O
low JJ O
frequency NN O
, , O
where WRB O
they PRP O
undergo VBP O
recruitment NN O
and CC O
expansion NN O
during IN O
immune JJ O
responses NNS O
and CC O
in IN O
the DT O
pathogenesis NN O
of IN O
numerous JJ O
autoimmune NN O
diseases NNS O
. . O

MHC NNP B-Gene
tetramers NNS I-Gene
, , O
which WDT O
constitute VBP O
a DT O
labeled JJ B-Gene
MHC NNP I-Gene
- : I-Gene
peptide NN I-Gene
ligand NN I-Gene
suitable JJ O
for IN O
binding VBG O
to TO O
the DT O
Ag NNP B-Gene
- : I-Gene
specific JJ I-Gene
receptor NN I-Gene
on IN O
T NNP O
cells NNS O
, , O
provide VB O
a DT O
novel JJ O
approach NN O
for IN O
the DT O
detection NN O
and CC O
characterization NN O
of IN O
such JJ O
rare JJ O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
utilized VBD O
this DT O
technology NN O
to TO O
identify VB O
HLA NNP B-Gene
DQ NNP I-Gene
- : O
restricted VBD O
Ag NNP O
- : O
specific JJ O
T NNP O
cells NNS O
in IN O
the DT O
peripheral JJ O
blood NN O
of IN O
human JJ O
subjects NNS O
and CC O
to TO O
identify VB O
immunodominant JJ O
epitopes NNS O
associated VBN O
with IN O
viral JJ O
infection NN O
. . O

Peptides NNS O
representing VBG O
potential JJ O
epitope NN B-Gene
regions NNS I-Gene
of IN O
the DT O
VP16 NNP B-Gene
protein NN I-Gene
from IN O
HSV NNP O
- : O
2 CD O
were VBD O
loaded VBN O
onto IN O
recombinant JJ B-Gene
DQ0602 NNP I-Gene
molecules NNS I-Gene
to TO O
generate VB O
a DT O
panel NN O
of IN O
Ag NNP B-Gene
- : I-Gene
specific JJ I-Gene
DQ0602 NNP I-Gene
tetramers NNS I-Gene
. . O

VP16 NNP B-Gene
Ag NNP I-Gene
- : O
specific JJ O
DQ NNP O
- : O
restricted VBD O
T NNP O
cells NNS O
were VBD O
identified VBN O
and CC O
expanded VBN O
from IN O
the DT O
peripheral JJ O
blood NN O
of IN O
HSV NNP O
- : O
2 CD O
- : O
infected JJ O
individuals NNS O
, , O
representing VBG O
two CD O
predominant JJ O
epitope NN O
specificities NNS O
. . O

Although IN O
the DT O
VP16 NNP O
369 CD O
- : O
380 CD O
peptide NN O
has VBZ O
a DT O
lower JJR O
binding NN O
affinity NN O
for IN O
DQ0602 NNP B-Gene
molecules NNS I-Gene
than IN O
the DT O
VP16 NNP O
33 CD O
- : O
52 CD O
peptide NN O
, , O
T NNP O
cells NNS O
that WDT O
recognized VBD O
the DT O
VP16 NNP O
369 CD O
- : O
380 CD O
peptide NN O
occurred VBD O
at IN O
a DT O
much RB O
higher JJR O
frequency NN O
than IN O
those DT O
that WDT O
were VBD O
specific JJ O
for IN O
the DT O
VP16 NNP O
33 CD O
- : O
52 CD O
peptide NN O
. . O

Down NNP O
- : O
regulation NN O
of IN O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
and CC O
Oct2 NNP B-Gene
in IN O
classical JJ O
Hodgkin NNP O
disease NN O
but CC O
not RB O
in IN O
lymphocyte NN O
predominant NN O
Hodgkin NNP O
disease NN O
correlates VBZ O
with IN O
immunoglobulin JJ O
transcription NN O
. . O

In IN O
contrast NN O
to TO O
the DT O
tumor NN O
cells NNS O
( ( O
L NNP O
& CC O
H NNP O
cells NNS O
) ) O
of IN O
lymphocyte NN O
predominant NN O
Hodgkin NNP O
disease NN O
( ( O
LPHD NNP O
) ) O
, , O
Hodgkin NNP O
and CC O
Reed NNP O
- : O
Sternberg NNP O
( ( O
HRS NNP O
) ) O
cells NNS O
of IN O
classical JJ O
Hodgkin NNP O
disease NN O
( ( O
cHD NN O
) ) O
are VBP O
unable JJ O
to TO O
transcribe VB O
immunoglobulin NN B-Gene
, , O
despite IN O
the DT O
presence NN O
of IN O
rearranged JJ B-Gene
immunoglobulin NN I-Gene
genes NNS I-Gene
. . O

Although IN O
initial JJ O
studies NNS O
have VBP O
suggested VBN O
crippling JJ O
immunoglobulin NN O
gene NN O
mutations NNS O
to TO O
be VB O
the DT O
cause NN O
of IN O
absent JJ O
immunoglobulin NN O
expression NN O
in IN O
cHD NN O
, , O
recent JJ O
work NN O
of IN O
our PRP$ O
group NN O
has VBZ O
demonstrated VBN O
an DT O
impaired JJ O
activation NN O
of IN O
the DT O
immunoglobulin NN B-Gene
promoter NN I-Gene
as IN O
a DT O
superior JJ O
mechanism NN O
. . O

As IN O
immunoglobulin JJ O
transcription NN O
is VBZ O
mainly RB O
regulated VBN O
by IN O
the DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
Oct2 NNP B-Gene
and CC O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
, , O
we PRP O
analyzed VBD O
35 CD O
cases NNS O
of IN O
LPHD NNP O
, , O
32 CD O
cases NNS O
of IN O
cHD NN O
, , O
and CC O
2 CD O
Hodgkin NNP O
disease NN O
cell NN O
lines NNS O
for IN O
the DT O
expression NN O
of IN O
these DT O
transcription NN B-Gene
factors NNS I-Gene
and CC O
also RB O
in IN O
parallel NN O
for IN O
immunoglobulin JJ O
expression NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
an DT O
absence NN O
of IN O
Oct2 NNP B-Gene
and CC O
/ NNP O
or CC O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
in IN O
cHD NN O
and CC O
a DT O
striking JJ O
overexpression NN O
of IN O
Oct2 NNP B-Gene
in IN O
LPHD NNP O
. . O

Immunoglobulin NNP O
expression NN O
was VBD O
lacking VBG O
in IN O
cHD NN O
but CC O
present JJ O
in IN O
LPHD NNP O
. . O

Furthermore RB O
, , O
the DT O
reintroduction NN O
of IN O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
and CC O
Oct2 NNP B-Gene
into IN O
cultured VBN O
HRS NNP O
cells NNS O
restored VBD O
the DT O
activity NN O
of IN O
cotransduced JJ O
immunoglobulin NN B-Gene
promoter NN I-Gene
constructs NNS I-Gene
. . O

Our PRP$ O
findings NNS O
dismiss VBP O
the DT O
concept NN O
that IN O
the DT O
different JJ O
immunoglobulin NN O
expression NN O
in IN O
cHD NN O
and CC O
LPHD NNP O
is VBZ O
due JJ O
to TO O
disrupting VBG O
mutations NNS O
of IN O
immunoglobulin NN B-Gene
V NNP I-Gene
genes NNS I-Gene
in IN O
cHD NN O
but CC O
is VBZ O
most JJS O
likely JJ O
due JJ O
to TO O
a DT O
down RP O
- : O
regulation NN O
of IN O
Oct2 NNP B-Gene
and CC O
/ NNP O
or CC O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
. . O

This DT O
study NN O
further RB O
revealed VBD O
Oct2 NNP B-Gene
as IN O
a DT O
new JJ O
and CC O
valuable JJ O
marker NN O
for IN O
the DT O
identification NN O
of IN O
L NNP O
& CC O
H NNP O
cells NNS O
and CC O
their PRP$ O
distinction NN O
from IN O
HRS NNP O
cells NNS O
. . O

The DT O
impairment NN O
of IN O
immunoglobulin JJ O
transcription NN O
with IN O
a DT O
down JJ O
- : O
regulated JJ O
synthesis NN O
of IN O
Oct2 NNP B-Gene
and CC O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
the DT O
first JJ O
established VBN O
general JJ O
recurrent NN O
defect NN O
found VBN O
in IN O
HRS NNP O
cells NNS O
. . O

Constitutive JJ O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
characteristic JJ O
feature NN O
of IN O
mycosis NN O
fungoides NNS O
: : O
implications NNS O
for IN O
apoptosis NN O
resistance NN O
and CC O
pathogenesis NN O
. . O

The DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
is VBZ O
an DT O
important JJ O
regulator NN O
of IN O
genes NNS O
expressed VBN O
during IN O
inflammatory JJ O
responses NNS O
, , O
immunoglobulin NN O
( ( O
Ig NNP O
) ) O
class NN O
switching NN O
, , O
cellular JJ O
differentiation NN O
, , O
and CC O
apoptosis NN O
. . O

Recently RB O
, , O
members NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
family NN I-Gene
, , O
including VBG O
p65 NN B-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
, , O
have VBP O
been VBN O
implicated VBN O
in IN O
promoting VBG O
survival NN O
of IN O
various JJ O
hematopoeitic JJ O
neoplasms NNS O
, , O
including VBG O
T NNP O
cell NN O
malignancies NNS O
such JJ O
as IN O
adult NN O
T NNP O
cell NN O
leukemia SYM O
- : O
lymphoma NN O
. . O

We PRP O
investigated VBD O
the DT O
expression NN O
of IN O
active JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p65 NN I-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
in IN O
cases NNS O
of IN O
mycosis NN O
fungoides NNS O
( ( O
MF NNP O
) ) O
and CC O
the DT O
effect NN O
of IN O
chemical NN O
inhibitors NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
on IN O
apoptosis NN O
in IN O
cutaneous JJ O
T NNP O
cell NN O
lymphoma NN O
( ( O
CTCL NNP O
) ) O
cell NN O
lines NNS O
. . O

Paraffin NNP O
- : O
embedded VBD O
tissues NNS O
from IN O
23 CD O
cutaneous JJ O
lesions NNS O
and CC O
a DT O
single JJ O
lymph NN O
node NN O
biopsy NN O
from IN O
patients NNS O
diagnosed VBN O
with IN O
MF NNP O
were VBD O
evaluated VBN O
for IN O
p65 NN O
( ( O
Rel NNP O
A NNP O
) ) O
expression NN O
by IN O
using VBG O
a DT O
monoclonal JJ B-Gene
mouse NN I-Gene
antibody NN I-Gene
that WDT O
detects VBZ O
the DT O
activated JJ O
form NN O
of IN O
p65 NN B-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
. . O

Apoptosis NN O
after IN O
treatment NN O
with IN O
the DT O
NF NNP O
- : O
kappa NN O
B NNP O
inhibitors NNS O
gliotoxin NN O
, , O
MG132 NNP O
, , O
BAY NNP O
11 CD O
- : O
7082 CD O
, , O
and CC O
BAY NNP O
11 CD O
- : O
7085 CD O
was VBD O
quantitatively RB O
measured VBN O
in IN O
the DT O
CTCL NNP O
cell NN O
lines NNS O
HuT NNP O
- : O
78 CD O
and CC O
HH NNP O
by IN O
propidium NN O
iodide NN O
( ( O
PI NNP O
) ) O
/ VBP O
cell NN O
cycle NN O
analysis NN O
for IN O
detection NN O
of IN O
a DT O
hypodiploid NN O
( ( O
sub JJ O
- : O
G NNP O
( ( O
0 CD O
) ) O
) ) O
population NN O
and CC O
by IN O
determination NN O
of IN O
increased JJ O
Annexin NNP O
V NNP O
/ VBD O
7 CD O
- : O
amino NN O
- : O
actinomycin NN O
D NNP O
( ( O
7 CD O
- : O
AAD NN O
) ) O
expression NN O
. . O

Nuclear JJ O
extracts NNS O
from IN O
CTCL NNP O
cells NNS O
before IN O
and CC O
after IN O
chemical JJ O
inhibition NN O
were VBD O
analyzed VBN O
for IN O
NF NNP O
- : O
kappa NN O
B NNP O
nuclear JJ O
DNA NNP O
- : O
binding NN O
activity NN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
( ( O
EMSA NNP O
) ) O
with IN O
quantitative JJ O
densitometry NN O
. . O

Nuclear JJ O
expression NN O
of IN O
p65 NN B-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
before IN O
and CC O
after IN O
treatment NN O
with IN O
the DT O
various JJ O
inhibitory JJ O
compounds NNS O
was VBD O
measured VBN O
by IN O
immunofluorescence NN O
staining NN O
in IN O
each DT O
CTCL NNP O
cell NN O
line NN O
. . O

Neoplastic JJ O
T NNP O
lymphocytes VBZ O
from IN O
22 CD O
of IN O
24 CD O
cases NNS O
of IN O
MF NNP O
showed VBD O
strong JJ O
nuclear JJ O
and CC O
cytoplasmic JJ O
expression NN O
of IN O
active JJ B-Gene
p65 NN I-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
. . O

Compared VBN O
with IN O
untreated JJ O
control NN O
cells NNS O
, , O
a DT O
marked JJ O
increase NN O
in IN O
apoptosis NN O
, , O
a DT O
significant JJ O
decrease NN O
in IN O
NF NNP O
- : O
kappa NN O
B NNP O
DNA NNP O
- : O
binding NN O
activity NN O
, , O
and CC O
a DT O
marked JJ O
decrease NN O
in IN O
nuclear JJ O
p65 NN O
( ( O
Rel NNP O
A NNP O
) ) O
expression NN O
were VBD O
seen VBN O
in IN O
cells NNS O
from IN O
both DT O
CTCL NNP O
cell NN O
lines NNS O
after IN O
chemical NN O
NF NNP O
- : O
kappa NN O
B NNP O
inhibition NN O
. . O

These DT O
data NNS O
show VBP O
that IN O
the DT O
active JJ O
form NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p65 NN I-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
is VBZ O
commonly RB O
expressed VBN O
in IN O
neoplastic JJ O
T NNP O
lymphocytes NNS O
in IN O
patients NNS O
with IN O
MF NNP O
. . O

In IN O
CTCL NNP O
cell NN O
lines NNS O
, , O
the DT O
significant JJ O
decrease NN O
in IN O
nuclear JJ O
NF NNP O
- : O
kappa NN O
B NNP O
expression NN O
and CC O
the DT O
marked JJ O
increase NN O
in IN O
spontaneous JJ O
apoptosis NN O
caused VBN O
by IN O
chemical NN O
NF NNP O
- : O
kappa NN O
B NNP O
inhibition NN O
suggest VBP O
a DT O
critical JJ O
role NN O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
the DT O
pathogenesis NN O
and CC O
tumor NN O
cell NN O
maintenance NN O
of IN O
CTCLs NNP O
. . O

HUM NNP O
PATHOL NNP O
31 CD O
: : O
1482 CD O
- : O
1490 CD O
. . O

Human NNP O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type VBD O
1 CD O
tax NN B-Gene
protein NN I-Gene
activates VBZ O
transcription NN O
through IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
by IN O
inducing VBG O
DNA NNP O
binding VBG O
activity NN O
in IN O
T NNP O
cells NNS O
. . O

Human NNP O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
Tax NNP B-Gene
protein NN I-Gene
induces VBZ O
the DT O
expression NN O
of IN O
various JJ O
family NN O
members NNS O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
such JJ O
as IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
JunD NNP B-Gene
, , O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
and CC O
Fra NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
at IN O
the DT O
level NN O
of IN O
RNA NNP O
expression NN O
in IN O
T NNP O
cells NNS O
. . O

We PRP O
examined VBD O
the DT O
activity NN O
of IN O
Tax NNP B-Gene
in IN O
transcription NN O
through IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
) ) O
in IN O
T NNP O
cells NNS O
. . O

Transient JJ O
transfection NN O
studies NNS O
showed VBD O
that IN O
Tax NNP B-Gene
activated VBD O
the DT O
expression NN O
of IN O
a DT O
luciferase JJ B-Gene
gene NN I-Gene
regulated VBN O
by IN O
two CD O
copies NNS O
of IN O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
the DT O
human JJ O
Jurkat NNP O
T NNP O
- : O
cell NN O
line NN O
. . O

Tax NN B-Gene
activates VBZ O
the DT O
expression NN O
of IN O
viral JJ B-Gene
and CC I-Gene
cellular JJ I-Gene
genes NNS I-Gene
through IN O
two CD O
different JJ O
enhancers NNS O
: : O
a DT O
cAMP NN B-Gene
- : I-Gene
responsive NN I-Gene
( ( I-Gene
CRE NNP I-Gene
) ) I-Gene
- : I-Gene
like IN I-Gene
element NN I-Gene
and CC O
a DT O
kappaB JJ B-Gene
element NN I-Gene
. . O

Two CD O
Tax NNP B-Gene
mutants NNS I-Gene
differentially RB O
activated JJ O
expression NN O
of IN O
these DT O
two CD O
elements NNS O
. . O

Tax703 NNP B-Gene
preferentially RB O
activated VBD O
the DT O
kappaB JJ B-Gene
element NN I-Gene
but CC O
not RB O
the DT O
CRE NNP O
- : O
like IN O
one CD O
, , O
whereas VBZ O
TaxM22 NNP B-Gene
showed VBD O
the DT O
reverse NN O
. . O

In IN O
addition NN O
, , O
Tax703 NNP B-Gene
and CC O
Tax NNP B-Gene
, , O
but CC O
not RB O
TaxM22 NNP B-Gene
, , O
converted VBD O
cell NN O
growth NN O
of IN O
a DT O
mouse NN O
T NNP O
- : O
cell NN O
line NN O
from IN O
being VBG O
interleukin JJ O
( ( O
IL NNP O
) ) O
- : O
2 CD O
- : O
dependent NN O
to TO O
being VBG O
IL NNP O
- : O
2 CD O
- : O
independent JJ O
. . O

Unlike IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Tax NNP I-Gene
, , O
Tax703 NNP B-Gene
and CC O
TaxM22 NNP B-Gene
only RB O
weakly RB O
activated VBD O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
the DT O
T NNP O
- : O
cell NN O
line NN O
. . O

Thus RB O
, , O
Tax NNP B-Gene
seems VBZ O
to TO O
activate VB O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
via IN O
mechanisms NNS O
distinct VBP O
from IN O
those DT O
of IN O
kappaB NNS B-Gene
or CC I-Gene
CRE NNP I-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
, , O
and CC O
the DT O
activation NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
is VBZ O
dispensable JJ O
for IN O
IL NNP O
- : O
2 CD O
- : O
independent JJ O
growth NN O
of IN O
CTLL NNP O
- : O
2 CD O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
showed VBD O
that IN O
Tax NNP B-Gene
induced VBD O
strong JJ O
binding NN O
activity NN O
to TO O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
CTLL NNP O
- : O
2 CD O
, , O
whereas NNS O
Tax703 VBP B-Gene
did VBD O
not RB O
, , O
indicating VBG O
that IN O
the DT O
induction NN O
of IN O
binding VBG O
activity NN O
to TO O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
is VBZ O
essential JJ O
for IN O
the DT O
transcriptional JJ O
activation NN O
by IN O
Tax NNP B-Gene
. . O

The DT O
binding NN B-Gene
complex NN I-Gene
induced VBN O
by IN O
Tax NNP B-Gene
in IN O
CTLL NNP O
- : O
2 CD O
contained VBN O
JunD NNP B-Gene
and CC O
Fra NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Other JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
were VBD O
undetectable JJ O
. . O

Activation NN O
of IN O
transcription NN O
through IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
Jurkat NNP O
cells NNS O
by IN O
JunD NNP B-Gene
and CC O
/ NNP O
or CC O
Fra NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
weak JJ O
. . O

c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
JunB NNP B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
activation NN O
was VBD O
greater JJR O
, , O
although IN O
the DT O
level NN O
was VBD O
still RB O
less JJR O
than IN O
that DT O
with IN O
Tax NNP B-Gene
. . O

Thus RB O
, , O
the DT O
induction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
by IN O
Tax NNP B-Gene
may MD O
not RB O
be VB O
sufficient JJ O
for IN O
a DT O
complete JJ O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
by IN O
Tax NNP B-Gene
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Tax NNP B-Gene
activates VBZ O
the DT O
transcription NN O
of IN O
cellular JJ B-Gene
genes NNS I-Gene
with IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
sites NNS I-Gene
by IN O
inducing VBG O
the DT O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
in IN O
T NNP O
cells NNS O
, , O
a DT O
mechanism NN O
distinct NN O
from IN O
those DT O
of IN O
CRE NNP B-Gene
- : I-Gene
like IN I-Gene
and CC I-Gene
kappaB VB I-Gene
elements NNS I-Gene
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Strict NNP O
control NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
replication NN O
by IN O
a DT O
genetic JJ O
switch NN O
: : O
Tet NN O
for IN O
Tat NNP O
. . O

Live NNP O
- : O
attenuated VBD O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
variants NNS O
have VBP O
shown VBN O
great JJ O
promise NN O
as IN O
AIDS NNP O
vaccines NNS O
, , O
but CC O
continued JJ O
replication NN O
can MD O
lead VB O
to TO O
the DT O
selection NN O
of IN O
faster JJR O
- : O
replicating NN O
variants NNS O
that WDT O
are VBP O
pathogenic JJ O
. . O

We PRP O
therefore VBP O
designed VBN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
genomes NNS I-Gene
that WDT O
replicate VBP O
exclusively RB O
upon IN O
addition NN O
of IN O
the DT O
nontoxic JJ O
effector NN O
doxycycline NN O
( ( O
dox NN O
) ) O
. . O

This DT O
was VBD O
achieved VBN O
by IN O
replacement NN O
of IN O
the DT O
viral JJ O
TAR NNP O
- : O
Tat NN O
system NN O
for IN O
transcriptional JJ O
activation NN O
by IN O
the DT O
Escherichia NNP O
coli SYM O
- : O
derived VBN O
Tet NNP O
system NN O
for IN O
inducible JJ O
gene NN O
expression NN O
. . O

These DT O
designer NN O
` `` O
` `` O
HIV SYM O
- : O
rtTA NN O
' '' O
' POS O
viruses NNS O
replicate VBP O
in IN O
a DT O
strictly RB O
dox JJ O
- : O
dependent NN O
manner NN O
both DT O
in IN O
a DT O
T NNP O
- : O
cell NN O
line NN O
and CC O
in IN O
primary JJ O
blood NN O
cells NNS O
, , O
and CC O
the DT O
rate NN O
of IN O
replication NN O
can MD O
be VB O
fine JJ O
- : O
tuned VBN O
by IN O
simple JJ O
variation NN O
of IN O
the DT O
dox JJ O
concentration NN O
. . O

These DT O
HIV NNP O
- : O
rtTA NN O
viruses NNS O
provide VBP O
a DT O
tool NN O
to TO O
perform VB O
genetics NNS O
, , O
e NN O
. . O
g NN O
. . O
, , O
selection NN O
and CC O
optimization NN O
experiments NNS O
, , O
with IN O
the DT O
E NNP O
. . O
coli SYM O
- : O
derived VBN O
Tet NNP O
reagents NNS O
in IN O
a DT O
eukaryotic JJ O
background NN O
. . O

Furthermore RB O
, , O
such JJ O
viruses NNS O
may MD O
represent VB O
improved JJ O
vaccine NN O
candidates NNS O
because IN O
their PRP$ O
replication NN O
can MD O
be VB O
turned VBN O
on IN O
and CC O
off RP O
at IN O
will MD O
. . O

Synovial JJ O
fluid NN O
induced VBD O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
DNA NN O
binding NN O
in IN O
a DT O
monocytic JJ O
cell NN O
line NN O
. . O

OBJECTIVE NN O
: : O
To TO O
determine VB O
the DT O
effects NNS O
of IN O
synovial JJ O
fluids NNS O
( ( O
SF NNP O
) ) O
on IN O
DNA NN O
binding VBG O
activity NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
in IN O
the DT O
Mono NNP O
Mac NNP O
6 CD O
monocytic JJ O
/ NNP O
macrophage NN O
cell NN O
line NN O
as IN O
a DT O
model NN O
for IN O
the DT O
interaction NN O
between IN O
SF NNP O
and CC O
synovial JJ O
tissue NN O
macrophages NNS O
in IN O
arthritis NN O
. . O

METHODS NN O
: : O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
were VBD O
incubated VBN O
with IN O
SF NNP O
from IN O
the DT O
knee NN O
joints NNS O
of IN O
human JJ O
subjects NNS O
with IN O
rheumatoid JJ O
arthritis NN O
( ( O
RA NNP O
) ) O
, , O
undifferentiated JJ O
seronegative JJ O
oligoarthritis NN O
, , O
and CC O
osteoarthritis NN O
( ( O
OA NNP O
) ) O
. . O

Nuclear JJ O
extracts NNS O
prepared VBN O
from IN O
the DT O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
and CC O
RA NNP O
synovial JJ O
tissue NN O
were VBD O
analyzed VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
analysis NN O
( ( O
EMSA NNP O
) ) O
for IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

RESULTS NN O
: : O
Induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NN O
binding NN O
by IN O
the DT O
p65 NN B-Gene
( ( I-Gene
RelA NNP I-Gene
) ) I-Gene
/ VBP I-Gene
p50 JJ I-Gene
heterodimer NN I-Gene
was VBD O
observed VBN O
in IN O
response NN O
to TO O
incubation NN O
of IN O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
with IN O
SF NNP O
( ( O
20 CD O
% NN O
in IN O
culture NN O
medium NN O
) ) O
from IN O
5 CD O
of IN O
8 CD O
subjects NNS O
with IN O
RA NNP O
, , O
4 CD O
of IN O
5 CD O
with IN O
OA NNP O
, , O
and CC O
none NN O
of IN O
3 CD O
with IN O
undifferentiated JJ O
seronegative JJ O
oligoarthritis NN O
. . O

Incubation NN O
of IN O
SF NNP O
with IN O
neutralizing VBG B-Gene
antibodies NNS I-Gene
against IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( I-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
) ) I-Gene
, , O
but CC O
not RB O
antibodies NNS B-Gene
against IN O
interleukin JJ B-Gene
6 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
) ) I-Gene
, , O
significantly RB O
reduced VBD O
the DT O
induction NN O
of IN O
p65 NN O
/ NNP O
p50 NN O
binding VBG O
activity NN O
in IN O
SF NNP O
from IN O
subjects NNS O
with IN O
RA NNP O
and CC O
OA NNP O
. . O

Unexpectedly RB O
, , O
a DT O
slowly RB O
migrating JJ O
SF NNP O
inducible JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
binding NN O
complex NN O
was VBD O
observed VBN O
in IN O
EMSA NNP O
of IN O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
after IN O
incubation NN O
with IN O
SF NNP O
from IN O
5 CD O
of IN O
8 CD O
RA NNP O
and CC O
2 CD O
of IN O
5 CD O
OA NNP O
subjects NNS O
. . O

The DT O
induction NN O
of IN O
this DT O
complex JJ O
by IN O
SF NNP O
was VBD O
not RB O
affected VBN O
by IN O
neutralization NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
or CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
in IN O
SF NNP O
, , O
and CC O
the DT O
complex NN O
was VBD O
not RB O
inducible JJ O
by IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP O
- : O
1beta CD O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ NN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
platelet NN B-Gene
derived VBD I-Gene
growth NN I-Gene
factor NN I-Gene
, , O
lipopolysaccharide NN O
, , O
or CC O
tetradecanoyl VB O
phorbol NN O
acetate NN O
. . O

The DT O
slowly RB O
migrating NN B-Gene
complex NN I-Gene
could MD O
not RB O
be VB O
supershifted VBN O
with IN O
antibodies NNS B-Gene
against IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
Jun NNP B-Gene
, , O
or CC O
the DT O
transcriptional JJ O
coactivators NNS O
p300 VBP B-Gene
or CC O
CBP NNP B-Gene
. . O

A DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
binding NN I-Gene
complex NN I-Gene
with IN O
similar JJ O
slow JJ O
mobility NN O
was VBD O
observed VBN O
in IN O
nuclear JJ O
extracts NNS O
prepared VBN O
from IN O
fresh JJ O
human JJ O
RA NNP O
synovial JJ O
tissue NN O
. . O

CONCLUSION NN O
: : O
Biological JJ O
activity NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
in IN O
SF NNP O
from IN O
RA NNP O
and CC O
OA NNP O
subjects NNS O
is VBZ O
capable JJ O
of IN O
inducing VBG O
p65 JJ B-Gene
/ NNP I-Gene
p50 NN I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
binding NN O
activity NN O
in IN O
macrophages NNS O
. . O

A DT O
property NN O
of IN O
SF NNP O
that WDT O
is VBZ O
independent JJ O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
other JJ O
cytokines NNS B-Gene
is VBZ O
responsible JJ O
for IN O
the DT O
induction NN O
of IN O
a DT O
novel JJ O
slowly RB O
migrating VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
binding NN I-Gene
complex NN I-Gene
. . O

Soluble JJ O
mediators NNS O
in IN O
SF NNP O
of IN O
subjects NNS O
with IN O
RA NNP O
and CC O
OA NNP O
can MD O
therefore VB O
modulate JJ O
binding NN O
of IN O
nuclear JJ B-Gene
proteins NNS I-Gene
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
macrophages NNS O
and CC O
may MD O
play VB O
a DT O
role NN O
in IN O
inflammatory JJ O
gene NN O
expression NN O
in IN O
arthritis NN O
. . O

Peroxisome NNP B-Gene
proliferator NN I-Gene
activator NN I-Gene
receptor NN I-Gene
- : I-Gene
gamma NN I-Gene
agonists NNS O
and CC O
15 CD O
- : O
deoxy NN O
- : O
Delta NNP O
( ( O
12 CD O
, , O
14 CD O
) ) O
( ( O
12 CD O
, , O
14 CD O
) ) O
- : O
PGJ NNP O
( ( O
2 CD O
) ) O
induce NN O
apoptosis NN O
in IN O
normal JJ O
and CC O
malignant JJ O
B NNP O
- : O
lineage NN O
cells NNS O
. . O

The DT O
research NN O
described VBD O
herein JJ O
evaluates VBZ O
the DT O
expression NN O
and CC O
functional JJ O
significance NN O
of IN O
peroxisome JJ B-Gene
proliferator NN I-Gene
activator NN I-Gene
receptor NN I-Gene
- : I-Gene
gamma NN I-Gene
( ( I-Gene
PPAR NNP I-Gene
- : I-Gene
gamma NN I-Gene
) ) I-Gene
on IN O
B NNP O
- : O
lineage NN O
cells NNS O
. . O

Normal NNP O
mouse NN O
B NNP O
cells NNS O
and CC O
a DT O
variety NN O
of IN O
B NNP O
lymphoma NN O
cells NNS O
reflective NN O
of IN O
stages NNS O
of IN O
B NNP O
cell NN O
differentiation NN O
( ( O
e NN O
. . O
g NN O
. . O
, , O
70Z CD O
/ NN O
3 CD O
, , O
CH31 NNP O
, , O
WEHI NNP O
- : O
231 CD O
, , O
CH12 NNP O
, , O
and CC O
J558 NNP O
) ) O
express NN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
mRNA NN I-Gene
and CC O
, , O
by IN O
Western JJ O
blot NN O
analysis NN O
, , O
the DT O
67 CD B-Gene
- : I-Gene
kDa NN I-Gene
PPAR NNP I-Gene
- : I-Gene
gamma NN I-Gene
protein NN I-Gene
. . O

15 CD O
- : O
Deoxy NNP O
- : O
Delta NNP O
( ( O
12 CD O
, , O
14 CD O
) ) O
- : O
PGJ NNP O
( ( O
2 CD O
) ) O
( ( O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
) ) O
, , O
a DT O
PPAR NNP O
- : O
gamma NN O
agonist NN O
, , O
has VBZ O
a DT O
dose JJ O
- : O
dependent JJ O
antiproliferative JJ O
and CC O
cytotoxic JJ O
effect NN O
on IN O
normal JJ O
and CC O
malignant JJ O
B NNP O
cells NNS O
as IN O
shown VBN O
by IN O
[ NNP O
( ( O
3 CD O
) ) O
H NNP O
] NNP O
thymidine NN O
and CC O
3 CD O
- : O
[ NN O
4 CD O
, , O
5 CD O
- : O
dimethylthiazol NN O
- : O
2 CD O
- : O
yl NN O
] SYM O
- : O
2 CD O
, , O
5 CD O
- : O
diphenyltetrazolium NN O
bromide NN O
assays NNS O
. . O

Only RB O
PPAR NNP O
- : O
gamma NN O
agonists NNS O
( ( O
thiazolidinediones NNS O
) ) O
, , O
and CC O
not RB O
PPAR NNP O
- : O
alpha NN O
agonists NNS O
, , O
mimicked VBD O
the DT O
effect NN O
of IN O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
on IN O
B NNP O
- : O
lineage NN O
cells NNS O
, , O
indicating VBG O
that IN O
the DT O
mechanism NN O
by IN O
which WDT O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
negatively RB O
affects VBZ O
B NNP O
- : O
lineage NN O
cells NNS O
involves VBZ O
in IN O
part NN O
PPAR NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

The DT O
mechanism NN O
by IN O
which WDT O
PPAR NNP O
- : O
gamma NN O
agonists NNS O
induce VBP O
cytotoxicity NN O
is VBZ O
via IN O
apoptosis NN O
, , O
as IN O
shown VBN O
by IN O
annexin NN O
V NNP O
staining NN O
and CC O
as IN O
confirmed VBN O
by IN O
DNA NNP O
fragmentation NN O
detected VBD O
using VBG O
the DT O
TUNEL NNP O
assay NN O
. . O

Interestingly RB O
, , O
addition NN O
of IN O
PGF NNP O
( ( O
2alpha CD O
) ) O
, , O
which WDT O
was VBD O
not RB O
known VBN O
to TO O
affect VB O
lymphocytes NNS O
, , O
dramatically RB O
attenuated VBD O
the DT O
deleterious JJ O
effects NNS O
of IN O
PPAR NNP O
- : O
gamma NN O
agonists NNS O
on IN O
B NNP O
lymphomas NN O
. . O

Surprisingly RB O
, , O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
induced VBD O
a DT O
massive JJ O
increase NN O
in IN O
nuclear JJ O
mitogen NN O
- : O
activated VBN O
protein JJ O
kinase NN O
activation NN O
, , O
and CC O
pretreatment NN O
with IN O
PGF NNP O
( ( O
2alpha CD O
) ) O
blunted VBD O
the DT O
mitogen NN O
- : O
activated VBN O
protein JJ O
kinase NN O
activation NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
study NN O
evaluating VBG O
PPAR NNP O
- : O
gamma NN O
expression NN O
and CC O
its PRP$ O
significance NN O
on IN O
B NNP O
lymphocytes NNS O
. . O

PPAR NNP O
- : O
gamma NN O
agonists NNS O
may MD O
serve VB O
as IN O
a DT O
counterbalance NN O
to TO O
the DT O
stimulating JJ O
effects NNS O
of IN O
other JJ O
PGs NNP O
, , O
namely RB O
PGE NNP O
( ( O
2 CD O
) ) O
, , O
which WDT O
promotes VBZ O
B NNP O
cell NN O
differentiation NN O
. . O

Finally RB O
, , O
the DT O
use NN O
of IN O
PGs NNP O
, , O
such JJ O
as IN O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
, , O
and CC O
synthetic JJ O
PPAR NNP O
- : O
gamma NN O
agonists NNS O
to TO O
induce VB O
apoptosis NN O
in IN O
B NNP O
- : O
lineage NN O
cells NNS O
may MD O
lead VB O
to TO O
the DT O
development NN O
of IN O
novel JJ O
therapies NNS O
for IN O
fatal JJ O
B NNP O
lymphomas NN O

Inhibition NN O
of IN O
STAT3 NNP O
signaling VBG O
leads NNS O
to TO O
apoptosis NN O
of IN O
leukemic JJ O
large JJ O
granular JJ O
lymphocytes NNS O
and CC O
decreased VBD O
Mcl NNP O
- : O
1 CD O
expression NN O
. . O

Large JJ O
granular JJ O
lymphocyte NN O
( ( O
LGL NNP O
) ) O
leukemia NN O
is VBZ O
characterized VBN O
by IN O
the DT O
expansion NN O
of IN O
antigen NN O
- : O
activated VBN O
cytotoxic NN O
T NNP O
lymphocytes VBZ O
. . O

These DT O
leukemic JJ O
cells NNS O
are VBP O
resistant JJ O
to TO O
Fas NNP O
- : O
mediated VBD O
apoptosis NN O
despite IN O
expressing VBG O
high JJ O
levels NNS O
of IN O
Fas NNP B-Gene
. . O

We PRP O
found VBD O
that IN O
leukemic JJ O
LGL NNP O
from IN O
19 CD O
patients NNS O
displayed JJ O
high JJ O
levels NNS O
of IN O
activated JJ B-Gene
STAT3 NNP I-Gene
. . O

Treatment NN O
of IN O
leukemic JJ O
LGL NNP O
with IN O
the DT O
JAK NNP O
- : O
selective JJ O
tyrosine NN O
kinase NN O
inhibitor NN O
AG NNP O
- : O
490 CD O
induced JJ O
apoptosis NN O
with IN O
a DT O
corresponding JJ O
decrease NN O
in IN O
STAT NNP B-Gene
- : O
DNA NN O
binding NN O
activity NN O
. . O

Moreover RB O
, , O
using VBG O
an DT O
antisense NN O
oligonucleotide RB O
approach NN O
to TO O
diminish VB O
STAT3 NNP O
expression NN O
, , O
we PRP O
found VBD O
that IN O
Fas NNP O
sensitivity NN O
was VBD O
restored VBN O
in IN O
leukemic JJ O
LGL NNP O
. . O

AG NNP O
- : O
490 CD O
- : O
induced JJ O
apoptosis NN O
in IN O
leukemic JJ O
LGL NNP O
was VBD O
independent JJ O
of IN O
Bcl NNP O
- : O
xL NN O
or CC O
Bcl NNP O
- : O
2 CD O
expression NN O
. . O

However RB O
, , O
we PRP O
found VBD O
that IN O
the DT O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
family NN I-Gene
protein NN I-Gene
Mcl NNP I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
significantly RB O
reduced VBN O
by IN O
AG NNP O
- : O
490 CD O
treatment NN O
. . O

Activated NNP B-Gene
STAT3 NNP I-Gene
was VBD O
shown VBN O
to TO O
bind VB O
an DT O
SIE NNP B-Gene
- : I-Gene
related JJ I-Gene
element NN I-Gene
in IN O
the DT O
murine NN B-Gene
mcl SYM I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
. . O

Using VBG O
a DT O
luciferase NN O
reporter NN O
assay VBP O
, , O
we PRP O
demonstrated VBD O
that IN O
v FW O
- : O
src NN O
overexpression NN O
in IN O
NIH3T3 NNP O
induced VBD O
STAT3 NNP B-Gene
- : O
dependent JJ O
transcriptional JJ O
activity NN O
from IN O
the DT O
mcl NN B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
and CC O
increased VBD O
endogenous JJ O
Mcl NNP O
- : O
1 CD O
protein NN O
levels NNS O
. . O

We PRP O
conclude VBP O
that IN O
STAT3 NNP B-Gene
activation NN O
contributed VBD O
to TO O
accumulation NN O
of IN O
the DT O
leukemic JJ O
LGL NNP O
clones NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
investigation NN O
should MD O
focus VB O
on IN O
novel JJ O
strategies NNS O
targeting VBG O
STAT3 NNP B-Gene
in IN O
the DT O
treatment NN O
of IN O
LGL NNP O
leukemia NN O
. . O

Decreased VBN O
immediate JJ O
inflammatory JJ B-Gene
gene NN I-Gene
induction NN O
in IN O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
- : I-Gene
2 CD I-Gene
mutant JJ O
mice NN O
. . O

Transcription NNP B-Gene
factor NN I-Gene
activating VBG I-Gene
transcription NN I-Gene
factor NN I-Gene
( ( I-Gene
ATF NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
activated VBN O
by IN O
inflammatory JJ O
signals NNS O
transduced VBN O
by IN O
the DT O
JNK NNP O
and CC O
p38 VB O
MAP NNP O
kinase NNP O
pathways NNS O
. . O

To TO O
better JJR O
define VB O
the DT O
role NN O
of IN O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
inflammation NN O
, , O
adult NN O
mice NN O
expressing VBG O
small JJ O
amounts NNS O
of IN O
a DT O
mutant JJ B-Gene
ATF NNP I-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
were VBD O
challenged VBN O
with IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
, , O
anti SYM B-Gene
- : I-Gene
CD3 NNPS I-Gene
antibody NN I-Gene
or CC O
virus NN O
. . O

Within IN O
3 CD O
h NN O
of IN O
challenge NN O
by IN O
LPS NNP O
, , O
ATF NNP O
- : O
2 CD O
mutant JJ O
mice NN O
had VBD O
decreased VBN O
induction NN O
of IN O
the DT O
adhesion NN B-Gene
molecules VBZ I-Gene
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
P NNP B-Gene
- : I-Gene
selectin NN I-Gene
and CC O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
as RB O
well RB O
as IN O
the DT O
cytokines NNS B-Gene
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
compared VBN O
with IN O
control NN O
mice NN O
. . O

Stimulation NN O
of IN O
T NNP O
lymphocytes NNS O
by IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
antibody NN I-Gene
also RB O
showed VBD O
less JJR O
induction NN O
of IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
in IN O
ATF NNP O
- : O
2 CD O
mutant JJ O
tissues NNS O
. . O

ATF NNP O
- : O
2 CD O
mutant JJ O
thymocytes NNS O
treated VBN O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
antibody NN I-Gene
in IN O
vitro NN O
demonstrated VBD O
reduced JJ O
induction NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
JunB NNP B-Gene
, , O
JunD NNP B-Gene
and CC O
Fra NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

However RB O
, , O
similar JJ O
to TO O
what WP O
was VBD O
observed VBN O
after IN O
p38 JJ O
kinase NN O
inhibition NN O
in IN O
normal JJ O
mice NN O
, , O
relative JJ O
ATF NNP O
- : O
2 CD O
deficiency NN O
did VBD O
not RB O
prevent VB O
the DT O
development NN O
of IN O
a DT O
mononuclear NN O
cell NN O
infiltrate NN O
in IN O
the DT O
week NN O
following VBG O
an DT O
inflammatory JJ O
stimulus NN O
. . O

ATF NNP O
- : O
2 CD O
mutant JJ O
mice NN O
proved VBD O
more RBR O
susceptible JJ O
to TO O
death NN O
than IN O
control NN O
mice NN O
from IN O
LPS NNP O
plus CC O
D NNP O
- : O
galactosamine NN O
injection NN O
or CC O
Coxsackievirus NNP O
B3 NNP O
infection NN O
and CC O
had VBD O
a DT O
higher JJR O
incidence NN O
of IN O
mononuclear JJ O
pulmonary JJ O
infiltrates NNS O
after IN O
exposure NN O
to TO O
Herpes NNP O
simplex NNP O
virus NN O
- : O
1 CD O
. . O

ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
essential JJ O
for IN O
maximal JJ O
immediate JJ O
induction NN O
of IN O
adhesion NN B-Gene
molecules NNS I-Gene
and CC O
cytokine NN B-Gene
genes NNS I-Gene
, , O
but CC O
at IN O
later RB O
time NN O
points NNS O
may MD O
even RB O
protect VB O
against IN O
overactive JJ O
immune JJ O
responses NNS O
. . O

LIGHT NNP B-Gene
, , O
a DT O
TNF NNP B-Gene
- : I-Gene
like IN I-Gene
molecule NN I-Gene
, , O
costimulates VBZ O
T NNP O
cell NN O
proliferation NN O
and CC O
is VBZ O
required VBN O
for IN O
dendritic JJ O
cell NN O
- : O
mediated VBN O
allogeneic JJ O
T NNP O
cell NN O
response NN O
. . O

LIGHT NNP B-Gene
is VBZ O
a DT O
recently RB O
identified VBN O
member NN O
of IN O
the DT O
TNF NNP B-Gene
superfamily RB I-Gene
and CC O
its PRP$ O
receptors NNS O
, , O
herpesvirus NN B-Gene
entry NN I-Gene
mediator NN I-Gene
and CC O
lymphotoxin NN B-Gene
beta NN I-Gene
receptor NN I-Gene
, , O
are VBP O
found VBN O
in IN O
T NNP O
cells NNS O
and CC O
stromal JJ O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
demonstrate VBP O
that DT O
LIGHT NNP B-Gene
is VBZ O
selectively RB O
expressed VBN O
on IN O
immature NN O
dendritic JJ O
cells NNS O
( ( O
DCs NNP O
) ) O
generated VBD O
from IN O
human JJ O
PBMCs NNP O
. . O

In IN O
contrast NN O
, , O
LIGHT NNP B-Gene
is VBZ O
not RB O
detectable JJ O
in IN O
DCs NNP O
either CC O
freshly RB O
isolated VBN O
from IN O
PBMCs NNP O
or CC O
rendered VBN O
mature NN O
in IN O
vitro NN O
by IN O
LPS NNP O
treatment NN O
. . O

Blockade NN O
of IN O
LIGHT NNP B-Gene
by IN O
its PRP$ O
soluble JJ B-Gene
receptors NNS I-Gene
, , O
lymphotoxin NN B-Gene
beta NN I-Gene
receptor NN I-Gene
- : I-Gene
Ig NN I-Gene
or CC O
HVEM NNP B-Gene
- : I-Gene
Ig NNP I-Gene
, , O
inhibits VBZ O
the DT O
induction NN O
of IN O
DC NNP O
- : O
mediated VBD O
primary JJ O
allogeneic JJ O
T NNP O
cell NN O
response NN O
. . O

Furthermore RB O
, , O
engagement NN O
of IN O
LIGHT NNP B-Gene
costimulates NNS O
human JJ O
T NNP O
cell NN O
proliferation NN O
, , O
amplifies VBZ O
the DT O
NF NNP O
- : O
kappaB NN O
signaling VBG O
pathway NN O
, , O
and CC O
preferentially RB O
induces VBZ O
the DT O
production NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
in IN O
the DT O
presence NN O
of IN O
an DT O
antigenic JJ O
signal NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
LIGHT NNP B-Gene
is VBZ O
a DT O
costimulatory JJ B-Gene
molecule NN I-Gene
involved VBN O
in IN O
DC NNP O
- : O
mediated VBD O
cellular JJ O
immune JJ O
responses NNS O
. . O

Suppression NN O
of IN O
HIV NNP O
type NN O
1 CD O
replication NN O
by IN O
a DT O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
Ets NNP I-Gene
- : I-Gene
1 CD I-Gene
mutant NN I-Gene
. . O

Activity NN O
of IN O
the DT O
distal JJ B-Gene
region NN I-Gene
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
, , O
which WDT O
contains VBZ O
binding VBG B-Gene
sites NNS I-Gene
for IN O
the DT O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
USF NNP I-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
, , O
is VBZ O
integral JJ O
for IN O
HIV NNP O
- : O
1 CD O
replication NN O
. . O

The DT O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
USF NNP I-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
play VBP O
a DT O
critical JJ O
role NN O
in IN O
the DT O
activity NN O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
distal JJ I-Gene
enhancer NN I-Gene
region NN I-Gene
, , O
as IN O
indicated VBN O
by IN O
the DT O
potent JJ O
dominant JJ O
negative JJ O
effect NN O
of IN O
a DT O
mutant JJ B-Gene
Ets NNP I-Gene
- : I-Gene
1 CD I-Gene
lacking NN I-Gene
trans NNS I-Gene
- : I-Gene
activation NN I-Gene
domains NNS I-Gene
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
LTR NNP B-Gene
. . O

To TO O
determine VB O
the DT O
biological JJ O
relevance NN O
of IN O
the DT O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
USF NNP I-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
in IN O
HIV NNP O
- : O
1 CD O
replication NN O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
expression NN O
of IN O
the DT O
dominant JJ O
- : O
negative JJ O
mutant NN O
of IN O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
dnEts SYM B-Gene
- : I-Gene
1 CD I-Gene
) ) O
on IN O
HIV NNP O
- : O
1 CD O
infection NN O
of IN O
T NNP O
cells NNS O
. . O

We PRP O
demonstrated VBD O
that DT O
expression NN O
of IN O
dnEts NN B-Gene
markedly RB O
suppressed VBD O
HIV NNP O
- : O
1 CD O
infection NN O
of IN O
a DT O
T NNP O
cell NN O
line NN O
. . O

This DT O
finding NN O
indicates VBZ O
that IN O
formation NN O
of IN O
a DT O
transcriptionaly JJ B-Gene
active JJ I-Gene
USF NNP I-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
Ets NNP I-Gene
- : I-Gene
1 CD I-Gene
complex NN I-Gene
is VBZ O
important JJ O
in IN O
the DT O
productive JJ O
infection NN O
of IN O
cells NNS O
by IN O
HIV NNP O
- : O
1 CD O
, , O
and CC O
suggests VBZ O
that DT O
inhibition NN O
of IN O
the DT O
interaction NN O
between IN O
USF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
with IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
may MD O
provide VB O
a DT O
new JJ O
target NN O
for IN O
anti JJ O
- : O
HIV NNP O
- : O
1 CD O
gene NN O
therapy NN O
. . O

Human NNP O
eosinophils VBZ O
constitutively RB O
express JJ O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
p NN I-Gene
and CC I-Gene
c NN I-Gene
. . O

BACKGROUND NN O
: : O
Eosinophils NNS O
are VBP O
now RB O
known VBN O
to TO O
produce VB O
a DT O
variety NN O
of IN O
proinflammatory JJ B-Gene
cytokines NNS I-Gene
, , O
although IN O
the DT O
molecular JJ O
factors NNS O
that WDT O
regulate VBP O
their PRP$ O
production NN O
are VBP O
poorly RB O
understood JJ O
. . O

The DT O
expression NN O
of IN O
almost RB O
all DT O
of IN O
the DT O
cytokines NNS B-Gene
produced VBN O
by IN O
eosinophils NNS O
, , O
including VBG O
the DT O
proallergic JJ B-Gene
cytokine NN I-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
, , O
is VBZ O
now RB O
known VBN O
to TO O
be VB O
regulated VBN O
at IN O
the DT O
level NN O
of IN O
transcription NN O
by IN O
members NNS O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
family NN O
of IN O
transcription NN O
factors NNS O
. . O

OBJECTIVE NN O
: : O
We PRP O
sought VBD O
to TO O
characterize VB O
the DT O
expression NN O
of IN O
different JJ O
NFAT NNP B-Gene
proteins NNS I-Gene
in IN O
resting VBG O
and CC O
activated VBN O
eosinophils NNS O
. . O

METHODS NN O
: : O
Nuclear NN O
and CC O
whole JJ O
cell NN O
extracts NNS O
were VBD O
obtained VBN O
from IN O
both DT O
peripheral JJ O
blood NN O
eosinophils NNS O
and CC O
those DT O
obtained VBN O
from IN O
bronchoalveolar JJ O
lavage NN O
fluid NN O
of IN O
asthmatic JJ O
subjects NNS O
after IN O
endobronchial JJ O
allergen NN O
challenge NN O
. . O

NFAT NNP B-Gene
expression NN O
was VBD O
determined VBN O
by IN O
using VBG O
immunoprecipitation NN O
and CC O
Western JJ O
blot NN O
analysis NN O
, , O
DNA NNP O
- : O
binding NN O
assays NNS O
, , O
and CC O
RT NNP O
- : O
PCR NNP O
analysis NN O
of IN O
eosinophil JJ B-Gene
mRNA NN I-Gene
. . O

RESULTS NN O
: : O
Both DT O
peripheral JJ O
blood NN O
and CC O
bronchoalveolar JJ O
lavage NN O
fluid NN O
eosinophils NNS O
expressed VBD O
NFATp NNP B-Gene
and CC I-Gene
NFATc NNP I-Gene
protein NN I-Gene
. . O

Unlike IN O
activated VBN O
T NNP O
cells NNS O
, , O
which WDT O
express VBP O
multiple JJ O
NFATc NNP O
isoforms NNS O
, , O
eosinophils NNS O
preferentially RB O
express VBP O
the DT O
approximately RB O
85 CD O
- : O
kd NN O
isoform NN O
. . O

In IN O
addition NN O
, , O
eosinophils NNS O
were VBD O
found VBN O
to TO O
constitutively RB O
express VB O
NFATc NNP B-Gene
mRNA NN I-Gene
. . O

A DT O
brief JJ O
incubation NN O
with IN O
the DT O
T NNP B-Gene
( ( I-Gene
H NNP I-Gene
) ) I-Gene
2 CD I-Gene
cytokines NNS I-Gene
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
was VBD O
sufficient JJ O
to TO O
induce VB O
the DT O
nuclear JJ O
translocation NN O
of IN O
NFATc NNP B-Gene
. . O

Eosinophil NNP O
nuclear JJ O
extracts NNS O
contain VBP O
multiple JJ O
factors NNS O
that WDT O
can MD O
specifically RB O
recognize VB O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
P1 NNP I-Gene
NFAT NNP I-Gene
site NN I-Gene
in IN O
DNA NNP O
- : O
binding NN O
assays NNS O
, , O
including VBG O
NFATp NNP B-Gene
. . O

CONCLUSION NN O
: : O
NFATp NN B-Gene
and CC O
NFATc NNP B-Gene
can MD O
regulate VB O
the DT O
expression NN O
of IN O
cytokines NNS B-Gene
and CC O
other JJ O
genes NNS O
in IN O
eosinophils NNS O
but CC O
appear VBP O
to TO O
be VB O
regulated VBN O
by IN O
a DT O
novel JJ O
signal JJ O
transduction NN O
mechanism NN O
in IN O
these DT O
cells NNS O
. . O

BLyS NNP B-Gene
BINDS NNP O
TO NNP O
B NNP O
CELLS NNP O
WITH NNP O
HIGH NNP O
AFFINITY NNP O
AND NNP O
INDUCES NNP O
ACTIVATION NNP O
OF IN O
THE NNP O
TRANSCRIPTION NNP B-Gene
FACTORS NNP I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
AND CC O
ELF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

B NNP B-Gene
lymphocyte NN I-Gene
stimulator NN I-Gene
( ( O
BLyS NNP B-Gene
) ) O
is VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
TNF NNP B-Gene
family NN I-Gene
of IN I-Gene
proteins NNS I-Gene
expressed VBN O
by IN O
myeloid NN O
cells NNS O
as IN O
membrane NN O
- : O
bound NN O
and CC O
soluble JJ O
forms NNS O
. . O

BLyS NNP B-Gene
was VBD O
shown VBN O
to TO O
act VB O
specifically RB O
on IN O
B NNP O
cells NNS O
, , O
inducing VBG O
proliferation NN O
and CC O
immunoglobulin NN O
production NN O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

The DT O
present JJ O
study NN O
was VBD O
undertaken VBN O
to TO O
characterize VB O
binding NN O
of IN O
radiolabeled JJ B-Gene
BLyS NNP I-Gene
to TO O
its PRP$ O
cognate NN B-Gene
receptor NN I-Gene
on IN O
human JJ O
B NNP O
lymphocytes NNS O
and CC O
examine VB O
intracellular JJ O
events NNS O
initiated VBN O
by IN O
BLyS NNP B-Gene
binding NN O
. . O

Similar JJ O
to TO O
other JJ O
TNF NNP B-Gene
family NN I-Gene
members NNS I-Gene
, , O
BLyS NNP B-Gene
is VBZ O
present JJ O
in IN O
solution NN O
as IN O
a DT O
homotrimer NN B-Gene
as IN O
determined VBN O
by IN O
gel JJ O
filtration NN O
chromatography NN O
and CC O
light JJ O
scattering VBG O
analysis NN O
. . O

BLyS NNP B-Gene
binding NN O
to TO O
B NNP O
cells NNS O
is VBZ O
specific JJ O
as IN O
other JJ O
TNF NNP B-Gene
family NN I-Gene
members NNS I-Gene
tested VBD O
did VBD O
not RB O
compete VB O
for IN O
( ( O
125 CD O
) ) O
I PRP O
- : O
BLyS NN B-Gene
binding NN O
. . O

Analysis NN O
of IN O
equilibrium NN O
binding NN O
of IN O
( ( B-Gene
125 CD I-Gene
) ) I-Gene
I PRP I-Gene
- : I-Gene
labeled VBD I-Gene
BLyS NNP I-Gene
to TO O
purified VB O
human JJ O
tonsillar NN O
B NNP O
cells NNS O
demonstrated VBD O
saturable JJ O
binding NN O
. . O

Scatchard NNP O
analysis NN O
of IN O
the DT O
binding NN O
data NNS O
revealed VBD O
a DT O
single JJ O
class NN O
of IN O
high JJ O
- : O
affinity NN O
binding VBG O
on IN O
human JJ O
B NNP O
cells NNS O
with IN O
approximately RB O
2600 CD O
binding VBG O
sites NNS O
per IN O
cell NN O
and CC O
an DT O
apparent JJ O
dissociation NN O
constant NN O
( ( O
K NNP O
( ( O
D NNP O
) ) O
) ) O
of IN O
about RB O
0 CD O
. . O
1 CD O
nM NN O
. . O

In IN O
addition NN O
we PRP O
report VBP O
that IN O
BLyS NNP B-Gene
binding VBG O
to TO O
B NNP O
cells NNS O
results NNS O
in IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
the DT O
Ets NNP B-Gene
family NN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
ELF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
in IN O
the DT O
induction NN O
of IN O
mRNA NN O
for IN O
Polo NNP B-Gene
- : I-Gene
like IN I-Gene
kinase NN I-Gene
( ( O
PLK NNP B-Gene
) ) O
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Design NN O
and CC O
use NN O
of IN O
an DT O
inducibly RB O
activated VBN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
Nef NNP B-Gene
to TO O
study VB O
immune JJ O
modulation NN O
. . O

The DT O
Nef NNP B-Gene
protein NN I-Gene
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
enhance VB O
the DT O
infectivity NN O
of IN O
virus NN O
particles NNS O
, , O
downmodulate NN O
cell NN B-Gene
surface NN I-Gene
proteins NNS I-Gene
, , O
and CC O
associate JJ O
with IN O
many JJ O
intracellular JJ B-Gene
proteins NNS I-Gene
that WDT O
are VBP O
thought VBN O
to TO O
facilitate VB O
HIV NNP O
infection NN O
. . O

One CD O
of IN O
the DT O
challenges NNS O
in IN O
defining VBG O
the DT O
molecular JJ O
events NNS O
regulated VBN O
by IN O
Nef NNP B-Gene
has VBZ O
been VBN O
obtaining VBG O
good JJ O
expression NN O
of IN O
Nef NNP B-Gene
protein NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

This DT O
has VBZ O
been VBN O
attributed VBN O
to TO O
effects NNS O
of IN O
Nef NNP B-Gene
on IN O
cell NN O
proliferation NN O
and CC O
apoptosis NN O
. . O

We PRP O
have VBP O
designed VBN O
a DT O
Nef NNP B-Gene
protein NN I-Gene
that WDT O
is VBZ O
readily RB O
expressed VBN O
in IN O
T NNP O
- : O
cell NN O
lines NNS O
and CC O
whose WP$ O
function NN O
is VBZ O
inducibly RB O
activated VBN O
. . O

It PRP O
is VBZ O
composed VBN O
of IN O
a DT O
fusion NN O
between IN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
Nef NNP I-Gene
and CC O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
hormone NN I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
( ( O
Nef NNP B-Gene
- : I-Gene
ER NN I-Gene
) ) O
. . O

The DT O
Nef NNP B-Gene
- : I-Gene
ER NN I-Gene
is VBZ O
kept VBN O
in IN O
an DT O
inactive JJ O
state NN O
due JJ O
to TO O
steric JJ O
hindrance NN O
, , O
and CC O
addition NN O
of IN O
the DT O
membrane NN O
- : O
permeable JJ O
drug NN O
4 CD O
- : O
hydroxytamoxifen NN O
( ( O
4 CD O
- : O
HT NN O
) ) O
, , O
which WDT O
binds VBZ O
to TO O
the DT O
ER NNP B-Gene
domain NN I-Gene
, , O
leads VBZ O
to TO O
inducible JJ O
activation NN O
of IN O
Nef NNP B-Gene
- : I-Gene
ER NN I-Gene
within IN O
cells NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
Nef NNP B-Gene
- : I-Gene
ER NN I-Gene
inducibly RB O
associates VBZ O
with IN O
the DT O
62 CD B-Gene
- : I-Gene
kDa NN I-Gene
Ser NNP I-Gene
/ NNP I-Gene
Thr NNP I-Gene
kinase NN I-Gene
and CC O
is VBZ O
localized VBN O
to TO O
specific JJ O
membrane NN O
microdomains NNS O
( ( O
lipid JJ O
rafts NN O
) ) O
only RB O
after IN O
activation NN O
. . O

Using VBG O
this DT O
inducible JJ O
Nef NNP B-Gene
, , O
we PRP O
also RB O
compared VBN O
the DT O
specific NN O
requirements NNS O
for IN O
CD4 NNP B-Gene
and CC O
HLA NNP B-Gene
- : I-Gene
A2 NNP I-Gene
downmodulation NN O
in IN O
a DT O
SupT1 NNP O
T NNP O
- : O
cell NN O
line NN O
. . O

Half NNP O
- : O
maximal JJ O
downmodulation NN O
of IN O
cell NN B-Gene
surface NN I-Gene
CD4 NNP I-Gene
required VBD O
very RB O
little JJ O
active JJ O
Nef NNP B-Gene
- : I-Gene
ER NN I-Gene
and CC O
occurred VBD O
as RB O
early RB O
as IN O
4 CD O
h NN O
after IN O
addition NN O
of IN O
4 CD O
- : O
HT NN O
. . O

In IN O
contrast NN O
, , O
50 CD O
% NN O
downmodulation NN O
of IN O
HLA NNP B-Gene
- : I-Gene
A2 NN I-Gene
by IN O
Nef NNP B-Gene
required VBD O
16 CD O
to TO O
24 CD O
h NN O
and CC O
about IN O
50 CD O
- : O
to TO O
100 CD O
- : O
fold NN O
- : O
greater JJR O
concentrations NNS O
of IN O
4 CD O
- : O
HT NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
HLA NNP B-Gene
- : I-Gene
A2 NNP I-Gene
downmodulation NN O
may MD O
require VB O
certain JJ O
threshold JJ O
levels NNS O
of IN O
active JJ O
Nef NNP B-Gene
. . O

The DT O
differential JJ O
timing NN O
of IN O
CD4 NNP B-Gene
and CC O
HLA NNP B-Gene
- : I-Gene
A2 NNP I-Gene
downmodulation NN O
may MD O
have VB O
implications NNS O
for IN O
HIV NNP O
pathogenesis NN O
and CC O
immune JJ O
evasion NN O
. . O

Regulation NN O
of IN O
chemokine NN O
mRNA NN O
expression NN O
in IN O
a DT O
rat NN O
model NN O
of IN O
vanadium NN O
- : O
induced JJ O
pulmonary JJ O
inflammation NN O
. . O

Environmental JJ O
and CC O
occupational JJ O
exposure NN O
to TO O
vanadium NN O
dusts NNS O
results NNS O
in IN O
toxic JJ O
effects NNS O
mainly RB O
confined VBD O
to TO O
the DT O
respiratory NN O
system NN O
. . O

Using VBG O
a DT O
rat NN O
model NN O
of IN O
acute JJ O
lung NN O
inflammation NN O
induced VBN O
by IN O
intratracheal JJ O
instillation NN O
of IN O
sodium NN O
metavanadate NN O
( ( O
NaVO3 NNP O
) ) O
at IN O
the DT O
dose NN O
of IN O
200 CD O
microg NNS O
V NNP O
/ NNP O
kg NN O
, , O
we PRP O
investigated VBD O
the DT O
relationship NN O
between IN O
the DT O
cytologic JJ O
characterization NN O
of IN O
pulmonary JJ O
inflammation NN O
and CC O
the DT O
expression NN O
of IN O
chemokine NN B-Gene
mRNA NN I-Gene
. . O

Significant JJ O
polymorphonuclear JJ O
leukocyte NN O
( ( O
PMN NNP O
) ) O
influx NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
into IN O
the DT O
lung NN O
was VBD O
noted VBN O
4 CD O
h NNS O
after IN O
NaVO3 NNP O
instillation NN O
, , O
whereas IN O
alveolar JJ O
macrophages NNS O
( ( O
AMs NNP O
) ) O
in IN O
bronchoalveolar JJ O
lavage NN O
( ( O
BAL NNP O
) ) O
cells NNS O
appeared VBD O
to TO O
decrease VB O
significantly RB O
. . O

In IN O
contrast NN O
, , O
neither CC O
PMNs NNP O
nor CC O
AMs NNP O
changed VBD O
substantially RB O
1 CD O
h NN O
after IN O
NaVO3 NNP O
instillation NN O
. . O

By IN O
Northern NNP O
analysis NN O
, , O
macrophage NN B-Gene
inflammatory NN I-Gene
protein NN I-Gene
( ( I-Gene
MIP NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
in IN O
BAL NNP O
cells NNS O
increased VBD O
markedly RB O
1 CD O
h NN O
after IN O
NaVO3 NNP O
instillation NN O
and CC O
reduced VBD O
a DT O
little JJ O
bit NN O
at IN O
4 CD O
h NN O
, , O
whereas WP O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
mRNA NN I-Gene
in IN O
BAL NNP O
cells NNS O
was VBD O
expressed VBN O
relatively RB O
high JJ O
1 CD O
h NN O
after IN O
NaVO3 NNP O
instillation NN O
, , O
although IN O
a DT O
basal JJ O
expression NN O
was VBD O
detected VBN O
in IN O
control NN O
group NN O
, , O
and CC O
returned VBD O
rapidly RB O
nearly RB O
to TO O
control VB O
level NN O
at IN O
4 CD O
h NN O
. . O

Since IN O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
a DT O
potent JJ O
PMN NNP O
chemoattractant NN O
and CC O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
is VBZ O
a DT O
potent JJ O
macrophage NN O
/ NNP O
monocyte NN O
chemoattractant NN O
has VBZ O
been VBN O
well RB O
known VBN O
. . O

The DT O
facts NNS O
that WDT O
PMN NNP O
influx NN O
was VBD O
preceded VBN O
by IN O
increased JJ O
MIP NNP O
- : O
2 CD O
mRNA NN O
expression NN O
, , O
suggesting VBG O
that IN O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
involved VBN O
in IN O
the DT O
development NN O
of IN O
NaVO3 NNP O
- : O
induced VBD O
pulmonary JJ O
inflammation NN O
, , O
whereas NNS O
increased VBD O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
mRNA JJ I-Gene
expression NN O
was VBD O
followed VBN O
by IN O
decreased JJ O
AMs NNP O
in IN O
BAL NNP O
cells NNS O
, , O
suggesting VBG O
AMs NNP O
might MD O
be VB O
activated VBN O
by IN O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
adherent NN O
to TO O
the DT O
lining VBG O
surface NN O
of IN O
the DT O
airways NNS O
and CC O
then RB O
resistant VB O
to TO O
be VB O
washed VBN O
out RP O
. . O

To TO O
delineate VB O
the DT O
mechanisms NN O
of IN O
transcriptional JJ O
activation NN O
, , O
we PRP O
recently RB O
cloned VBD O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
flanking VBG I-Gene
region NN I-Gene
of IN O
the DT O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

The DT O
promotor NN B-Gene
region NN I-Gene
contains VBZ O
consensus NN B-Gene
binding VBG I-Gene
sites NNS I-Gene
for IN O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
and CC O
activator NN B-Gene
protein VBP I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
, , O
increased VBD O
nuclear JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
not RB O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
binding VBG O
activity NN O
was VBD O
detected VBN O
1 CD O
h NN O
after IN O
NaVO3 NNP O
instillation NN O
, , O
which WDT O
correlated VBD O
with IN O
the DT O
induction NN O
of IN O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
. . O

p65 NN B-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
and CC O
p50 $ B-Gene
protein NN I-Gene
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
MIP NNP O
- : O
2 CD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
studies NNS O
suggest VBP O
that IN O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
an DT O
important JJ O
mediator NN O
of IN O
NaVO3 NNP O
- : O
induced VBD O
pulmonary JJ O
inflammation NN O
in IN O
the DT O
rat NN O
model NN O
. . O

In IN O
addition NN O
, , O
elevated VBD O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
levels NNS O
are VBP O
accompanied VBN O
by IN O
increased JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
activity NN O
in IN O
BAL NNP O
cells NNS O
, , O
suggesting VBG O
possible JJ O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
transcriptional JJ O
regulation NN O
through IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Activation NN O
of IN O
signal JJ O
transduction NN O
and CC O
apoptosis NN O
in IN O
healthy JJ O
lymphomonocytes NNS O
exposed VBD O
to TO O
bystander VB O
HIV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
. . O

Persistent JJ O
activation NN O
of IN O
the DT O
immune NN O
system NN O
is VBZ O
one CD O
of IN O
the DT O
hallmarks NNS O
of IN O
HIV NNP O
- : O
1 CD O
infection NN O
. . O

In IN O
this DT O
study NN O
we PRP O
analysed VBD O
the DT O
induction NN O
of IN O
factors NNS O
involved VBN O
in IN O
cytokine JJ O
signal JJ O
transduction NN O
, , O
such JJ O
as IN O
STAT NNP B-Gene
1 CD I-Gene
proteins NNS I-Gene
and CC O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
, , O
in IN O
normal JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
exposed VBD O
to TO O
HIV NNP O
- : O
infected JJ O
cells NNS O
, , O
and CC O
the DT O
induction NN O
of IN O
apoptosis NN O
. . O

Western JJ O
blot NN O
analyses NNS O
and CC O
reverse VB O
transcriptase NN O
- : O
polymerase NN O
chain NN O
reaction NN O
results NNS O
indicate VBP O
that IN O
both DT O
cells NNS O
infected VBN O
with IN O
a DT O
X4 NN O
strain NN O
and CC O
cells NNS O
infected VBN O
with IN O
a DT O
R5 NNP O
strain NN O
are VBP O
able JJ O
to TO O
increase VB O
intracellular JJ O
levels NNS O
of IN O
STAT NNP B-Gene
1alpha CD I-Gene
and CC I-Gene
beta JJ I-Gene
proteins NNS O
as RB O
well RB O
as IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

This DT O
effect NN O
was VBD O
prevented VBN O
by IN O
neutralizing VBG O
antibodies NNS O
against IN O
interferon NN B-Gene
- : I-Gene
alpha NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
. . O

HIV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
dose JJ O
- : O
dependently RB O
induced VBN O
apoptotic JJ O
commitment NN O
in IN O
normal JJ O
PBMC NNP O
, , O
as IN O
revealed VBN O
by IN O
DNA NNP O
fragmentation NN O
analysis NN O
, , O
but CC O
this DT O
was VBD O
not RB O
accompanied VBN O
by IN O
an DT O
increase NN O
of IN O
caspase JJ O
- : O
3 CD O
activity NN O
, , O
even RB O
if IN O
a DT O
slight NN O
up RP O
- : O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
- : I-Gene
converting VBG I-Gene
enzyme JJ I-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
. . O

Apoptosis NNP O
induction NN O
could MD O
be VB O
abrogated VBN O
mainly RB O
by IN O
antibodies NNS B-Gene
against IN O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
by IN O
antibodies NNS B-Gene
against IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

All PDT O
these DT O
findings NNS O
suggest VBP O
that IN O
uninfected JJ O
PBMC NNP O
can MD O
undergo VB O
activation NN O
of IN O
signal JJ O
transduction NN O
and CC O
apoptosis NN O
after IN O
exposure NN O
to TO O
bystander VB O
HIV NNP O
- : O
infected JJ O
cells NNS O
, , O
subsequent NN O
to TO O
the DT O
induction NN O
of IN O
cytokines NNS B-Gene
such JJ O
as IN O
IFNs NNP B-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

The DT O
physical JJ O
association NN O
of IN O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
theta NN I-Gene
with IN O
a DT O
lipid JJ O
raft NN O
- : O
associated VBN O
inhibitor NN O
of IN O
kappa NN B-Gene
B NNP I-Gene
factor NN I-Gene
kinase NN I-Gene
( ( I-Gene
IKK NNP I-Gene
) ) I-Gene
complex VBP I-Gene
plays VBZ O
a DT O
role NN O
in IN O
the DT O
activation NN O
of IN O
the DT O
NF NNP O
- : O
kappa NN O
B NNP O
cascade NN O
by IN O
TCR NNP B-Gene
and CC O
CD28 NNP B-Gene
. . O

We PRP O
investigated VBD O
the DT O
role NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
theta NN I-Gene
( ( O
PKCtheta NNP B-Gene
) ) O
in IN O
the DT O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
cascade NN O
in IN O
primary JJ O
human JJ O
CD4 NNP O
( ( O
+ NNP O
) ) O
lymphocytes VBZ O
. . O

Among IN O
six CD O
or CC O
so RB O
PKC JJ B-Gene
isoforms NNS I-Gene
expressed VBN O
in IN O
T NNP O
cells NNS O
, , O
only RB O
PKCtheta NNP B-Gene
participates NNS O
in IN O
the DT O
assembly NN O
of IN O
the DT O
supramolecular JJ O
activation NN O
clusters NNS O
at IN O
the DT O
contact NN O
site NN O
of IN O
the DT O
TCR NNP B-Gene
with IN O
Ag NNP B-Gene
. . O

Signaling VBG O
via IN O
both DT O
the DT O
TCR NNP B-Gene
and CC O
CD28 NNP B-Gene
is VBZ O
required VBN O
for IN O
optimal JJ O
activation NN O
of IN O
the DT O
multisubunit NN B-Gene
IkappaB NNP I-Gene
kinase NN I-Gene
( ( I-Gene
IKK NNP I-Gene
) ) I-Gene
complex NN I-Gene
in IN O
primary JJ O
human JJ O
T NNP O
lymphocytes VBZ O
; : O
this DT O
activation NN O
could MD O
be VB O
inhibited VBN O
by IN O
a DT O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
independent JJ O
PKC NNP O
isoform NN O
inhibitor NN O
, , O
rottlerin NN O
. . O

Moreover RB O
, , O
endogenous JJ O
PKCtheta NNP B-Gene
physically RB O
associates VBZ O
with IN O
activated JJ O
IKK NNP B-Gene
complexes NNS I-Gene
in IN O
CD3 NNP O
/ NNP O
CD28 NNP O
- : O
costimulated VBD O
primary JJ O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
. . O

The DT O
same JJ O
set NN O
of IN O
stimuli NNS O
also RB O
induced VBD O
relocation NN O
of IN O
endogenous JJ O
PKCtheta NNP B-Gene
and CC O
IKKs NNP B-Gene
to TO O
a DT O
GM1 NNP O
ganglioside NN O
- : O
enriched VBN O
, , O
detergent JJ O
- : O
insoluble JJ O
membrane NN O
compartment NN O
in IN O
primary JJ O
T NNP O
cells NNS O
. . O

IKKs NNP B-Gene
recruited VBD O
to TO O
these DT O
lipid JJ O
rafts NNS O
were VBD O
capable JJ O
of IN O
phosphorylating VBG O
a DT O
recombinant JJ O
IkappaBalpha NNP O
sustrate NN O
. . O

Confocal JJ O
microscopy NN O
further RBR O
demonstrated VBD O
that IN O
exogenously RB O
expressed VBN O
PKCtheta NNP B-Gene
and CC O
IKKss NNP B-Gene
colocalize VB O
in IN O
the DT O
membrane NN O
of IN O
CD3 NNP O
/ NNP O
CD28 NNP O
- : O
costimulated VBD O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Constitutively RB O
active JJ O
but CC O
not RB O
kinase VB B-Gene
- : I-Gene
inactive JJ I-Gene
PKCtheta NNP I-Gene
activated VBD O
IKKbeta NNP B-Gene
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Expression NN O
of IN O
dominant JJ B-Gene
- : I-Gene
active JJ I-Gene
PKCtheta NNP I-Gene
also RB O
had VBD O
stimulatory JJ O
effects NNS O
on IN O
the DT O
CD28 NNP B-Gene
response NN I-Gene
element NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
show VBP O
that IN O
the DT O
activation NN O
of IN O
PKCtheta NNP B-Gene
by IN O
the DT O
TCR NNP B-Gene
and CC O
CD28 NNP B-Gene
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
assembly NN O
and CC O
activation NN O
of IN O
IKK NNP B-Gene
complexes NNS I-Gene
in IN O
the DT O
T NNP O
cell NN O
membrane NN O

T NNP O
- : O
cell NN O
- : O
mediated VBN O
regulation NN O
of IN O
osteoclastogenesis NN O
by IN O
signalling VBG O
cross NN O
- : O
talk NN O
between IN O
RANKL NNP B-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

Bone NNP O
resorption NN O
is VBZ O
regulated VBN O
by IN O
the DT O
immune NN O
system NN O
, , O
where WRB O
T NNP O
- : O
cell NN O
expression NN O
of IN O
RANKL NNP B-Gene
( ( O
receptor NN B-Gene
activator NN I-Gene
of IN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
ligand NN I-Gene
) ) O
, , O
a DT O
member NN O
of IN O
the DT O
tumour NN B-Gene
- : I-Gene
necrosis NN I-Gene
factor NN I-Gene
family NN I-Gene
that WDT O
is VBZ O
essential JJ O
for IN O
osteoclastogenesis NN O
, , O
may MD O
contribute VB O
to TO O
pathological JJ O
conditions NNS O
, , O
such JJ O
as IN O
autoimmune JJ O
arthritis NN O
. . O

However RB O
, , O
whether IN O
activated VBN O
T NNP O
cells NNS O
maintain VBP O
bone JJ O
homeostasis NN O
by IN O
counterbalancing VBG O
the DT O
action NN O
of IN O
RANKL NNP B-Gene
remains VBZ O
unknown JJ O
. . O

Here RB O
we PRP O
show VBP O
that IN O
T NNP O
- : O
cell NN O
production NN O
of IN O
interferon NN B-Gene
( ( I-Gene
IFN NNP I-Gene
) ) I-Gene
- : I-Gene
gamma NN I-Gene
strongly RB O
suppresses VBZ O
osteoclastogenesis NN O
by IN O
interfering VBG O
with IN O
the DT O
RANKL NNP B-Gene
- : O
RANK NN O
signalling VBG O
pathway NN O
. . O

IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
induces NNS O
rapid JJ O
degradation NN O
of IN O
the DT O
RANK NNP B-Gene
adapter NN I-Gene
protein NN I-Gene
, , O
TRAF6 NNP B-Gene
( ( O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
6 CD I-Gene
) ) O
, , O
which WDT O
results NNS O
in IN O
strong JJ O
inhibition NN O
of IN O
the DT O
RANKL NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
JNK NNP B-Gene
. . O

This DT O
inhibition NN O
of IN O
osteoclastogenesis NN O
is VBZ O
rescued VBN O
by IN O
overexpressing VBG O
TRAF6 NNP B-Gene
in IN O
precursor NN O
cells NNS O
, , O
which WDT O
indicates VBZ O
that IN O
TRAF6 NNP B-Gene
is VBZ O
the DT O
target NN O
critical JJ O
for IN O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
action NN O
. . O

Furthermore RB O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
the DT O
accelerated JJ O
degradation NN O
of IN O
TRAF6 NNP B-Gene
requires VBZ O
both DT O
its PRP$ O
ubiquitination NN O
, , O
which WDT O
is VBZ O
initiated VBN O
by IN O
RANKL NNP B-Gene
, , O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : O
induced JJ O
activation NN O
of IN O
the DT O
ubiquitin JJ O
- : O
proteasome NN O
system NN O
. . O

Our PRP$ O
study NN O
shows VBZ O
that IN O
there EX O
is VBZ O
cross JJ O
- : O
talk NN O
between IN O
the DT O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
and CC O
IFN NNP B-Gene
families NNS I-Gene
of IN O
cytokines NNS B-Gene
, , O
through IN O
which WDT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
provides VBZ O
a DT O
negative JJ O
link NN O
between IN O
T NNP O
- : O
cell NN O
activation NN O
and CC O
bone NN O
resorption NN O
. . O

Our PRP$ O
results NNS O
may MD O
offer VB O
a DT O
therapeutic JJ O
approach NN O
to TO O
treat VB O
the DT O
inflammation NN O
- : O
induced JJ O
tissue NN O
breakdown NN O
. . O

Stromal NNP B-Gene
- : I-Gene
derived VBD I-Gene
factor NN I-Gene
1 CD I-Gene
and CC O
thrombopoietin JJ B-Gene
regulate NN O
distinct JJ O
aspects NNS O
of IN O
human JJ O
megakaryopoiesis NN O
. . O

The DT O
role NN O
of IN O
the DT O
chemokine NN B-Gene
binding VBG O
stromal JJ B-Gene
- : I-Gene
derived VBN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
in IN O
normal JJ O
human JJ O
megakaryopoiesis NN O
at IN O
the DT O
cellular JJ O
and CC O
molecular JJ O
levels NNS O
and CC O
its PRP$ O
comparison NN O
with IN O
that DT O
of IN O
thrombopoietin NN B-Gene
( ( O
TPO NNP B-Gene
) ) O
have VBP O
not RB O
been VBN O
determined VBN O
. . O

In IN O
this DT O
study NN O
it PRP O
was VBD O
found VBN O
that IN O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
unlike IN O
TPO NNP B-Gene
, , O
does VBZ O
not RB O
stimulate VB O
alpha NN O
( ( O
IIb NNP O
) ) O
beta NN O
( ( O
3 CD O
) ) O
( ( O
+ $ O
) ) O
cell NN O
proliferation NN O
or CC O
differentiation NN O
or CC O
have VBP O
an DT O
antiapoptotic JJ O
effect NN O
. . O

However RB O
, , O
it PRP O
does VBZ O
induce VB O
chemotaxis NN O
, , O
trans VBZ O
- : O
Matrigel NNP O
migration NN O
, , O
and CC O
secretion NN O
of IN O
matrix JJ O
metalloproteinase NN B-Gene
9 CD I-Gene
( ( O
MMP NNP B-Gene
- : I-Gene
9 CD I-Gene
) ) O
and CC O
vascular JJ B-Gene
endothelial JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
VEGF NNP B-Gene
) ) O
by IN O
these DT O
cells NNS O
, , O
and CC O
both DT O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
TPO NNP B-Gene
increase VB O
the DT O
adhesion NN O
of IN O
alpha NN O
( ( O
IIb NNP O
) ) O
beta NN O
( ( O
3 CD O
) ) O
( ( O
+ $ O
) ) O
cells NNS O
to TO O
fibrinogen VB B-Gene
and CC O
vitronectin VB B-Gene
. . O

Investigating VBG O
the DT O
intracellular JJ O
signaling NN O
pathways NNS O
induced VBN O
by IN O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
TPO NNP B-Gene
revealed VBD O
some DT O
overlapping VBG O
patterns NNS O
of IN O
protein JJ O
phosphorylation NN O
/ NNP O
activation NN O
( ( O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
[ NNP I-Gene
MAPK NNP I-Gene
] NNP I-Gene
p42 NN I-Gene
/ NN I-Gene
44 CD I-Gene
, , O
MAPK NNP B-Gene
p38 NN I-Gene
, , O
and CC O
AKT NNP B-Gene
[ NNP I-Gene
protein NN I-Gene
kinase NN I-Gene
B NNP I-Gene
] NNP I-Gene
) ) O
and CC O
some DT O
that WDT O
were VBD O
distinct JJ O
for IN O
TPO NNP B-Gene
( ( O
eg NN O
, , O
JAK NNP B-Gene
- : I-Gene
STAT NN I-Gene
) ) O
and CC O
for IN O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
eg NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
. . O

It PRP O
was VBD O
also RB O
found VBN O
that IN O
though IN O
inhibition NN O
of IN O
phosphatidyl JJ B-Gene
- : I-Gene
inositol NN I-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
- : I-Gene
3K CD I-Gene
) ) O
by IN O
LY294002 NNP O
in IN O
alpha NN O
( ( O
IIb NNP O
) ) O
beta NN O
( ( O
3 CD O
) ) O
( ( O
+ $ O
) ) O
cells NNS O
induced VBN O
apoptosis NN O
and CC O
inhibited JJ O
chemotaxis NN O
adhesion NN O
and CC O
the DT O
secretion NN O
of IN O
MMP NNP B-Gene
- : I-Gene
9 CD I-Gene
and CC O
VEGF NNP B-Gene
, , O
the DT O
inhibition NN O
of IN O
MAPK NNP B-Gene
p42 NN I-Gene
/ NN I-Gene
44 CD I-Gene
( ( O
by IN O
the DT O
MEK NNP O
inhibitor NN O
U0126 NNP O
) ) O
had VBD O
no DT O
effect NN O
on IN O
the DT O
survival NN O
, , O
proliferation NN O
, , O
and CC O
migration NN O
of IN O
these DT O
cells NNS O
. . O

Hence RB O
, , O
it PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
proliferative JJ O
effect NN O
of IN O
TPO NNP B-Gene
is VBZ O
more RBR O
related JJ O
to TO O
activation NN O
of IN O
the DT O
JAK NNP O
- : O
STAT NNP O
pathway NN O
( ( O
unique JJ O
to TO O
TPO NNP B-Gene
) ) O
, , O
and CC O
the DT O
PI NNP O
- : O
3K CD O
- : O
AKT NNP O
axis NN O
is VBZ O
differentially RB O
involved VBN O
in IN O
TPO NNP O
- : O
and CC O
SDF NNP O
- : O
1 CD O
- : O
dependent NN O
signaling NN O
. . O

Accordingly RB O
, , O
PI NNP B-Gene
- : I-Gene
3K CD I-Gene
is VBZ O
involved VBN O
in IN O
TPO NNP B-Gene
- : O
mediated VBD O
inhibition NN O
of IN O
apoptosis NN O
, , O
TPO NNP O
- : O
and CC O
SDF NNP O
- : O
1 CD O
- : O
regulated VBN O
adhesion NN O
to TO O
fibrinogen VB B-Gene
and CC O
vitronectin VB B-Gene
, , O
and CC O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
mediated VBN O
migration NN O
. . O

This DT O
study NN O
expands VBZ O
the DT O
understanding NN O
of IN O
the DT O
role NN O
of IN O
SDF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
TPO NNP B-Gene
in IN O
normal JJ O
human JJ O
megakaryopoiesis NN O
and CC O
indicates VBZ O
the DT O
molecular JJ O
basis NN O
of IN O
the DT O
observed JJ O
differences NNS O
in IN O
cellular JJ O
responses NNS O
. . O

( ( O
Blood NNP O
. . O
2000 CD O
; : O
96 CD O
: : O
4142 CD O
- : O
4151 CD O
) ) O

Adhesion NN O
of IN O
immature NN O
and CC O
mature NN O
T NNP O
cells NNS O
induces NNS O
in IN O
human JJ O
thymic JJ O
epithelial NN O
cells NNS O
( ( O
TEC NNP O
) ) O
activation NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
trascription NN I-Gene
factors NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
) ) O
and CC O
IL NNP O
- : O
6 CD O
gene NN O
expression NN O
: : O
role NN O
of IN O
alpha3beta1 NN B-Gene
and CC I-Gene
alpha6beta4 NN I-Gene
integrins NNS I-Gene
. . O

T NNP O
cell NN O
precursors NNS O
homed VBD O
to TO O
thymus VB O
develop VB O
in IN O
close JJ O
contact NN O
with IN O
stromal JJ O
cells NNS O
. . O

Among IN O
them PRP O
, , O
thymic JJ O
epithelial JJ O
cells NNS O
( ( O
TEC NNP O
) ) O
are VBP O
known VBN O
to TO O
exert VB O
dominant JJ O
roles NNS O
in IN O
their PRP$ O
survival NN O
and CC O
functional JJ O
shaping NN O
. . O

Key NNP O
molecules NNS O
mediating VBG O
TEC NNP O
/ NNP O
thymocytes VBZ O
interactions NNS O
include VBP O
cytokines NNS B-Gene
and CC O
growth NN B-Gene
factors NNS I-Gene
secreted VBN O
by IN O
the DT O
two CD O
cell NN O
types NNS O
and CC O
adhesion NN B-Gene
receptors NNS I-Gene
mediating VBG O
cell NN O
contact NN O
. . O

Signaling VBG O
events NNS O
triggered VBN O
in IN O
thymocytes NNS O
by IN O
adhesion NN O
to TO O
epithelial JJ O
cells NNS O
have VBP O
been VBN O
extensively RB O
investigated VBN O
, , O
whereas JJ O
little JJ O
is VBZ O
known VBN O
on IN O
the DT O
opposite JJ O
phenomenon NN O
. . O

We PRP O
have VBP O
previously RB O
investigated VBN O
this DT O
issue NN O
in IN O
a DT O
co NN O
- : O
culture NN O
system NN O
composed VBN O
of IN O
TEC NNP O
cultures NNS O
derived VBD O
from IN O
human JJ O
normal JJ O
thymus NN O
and CC O
heterologous JJ O
thymocytes NNS O
. . O

We PRP O
demonstrated VBD O
that IN O
thymocytes NNS O
adhere RB O
to TO O
TEC NNP O
involving VBG O
beta1 NN B-Gene
and CC I-Gene
beta4 NN I-Gene
integrins NNS I-Gene
and CC O
induce VB O
the DT O
clustering NN O
of IN O
alpha3beta1 NN B-Gene
and CC I-Gene
alpha6beta4 JJ I-Gene
heterodimers NNS I-Gene
at IN O
the DT O
TEC NNP O
surface NN O
. . O

In IN O
addition NN O
thymocyte NN O
adhesion NN O
was VBD O
followed VBN O
by IN O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
gene NN B-Gene
transcription NN I-Gene
factors NNS I-Gene
and CC O
enhanced VBD O
IL NNP O
- : O
6 CD O
production NN O
. . O

The DT O
two CD O
latter JJ O
phenomena NNS O
were VBD O
reproduced VBN O
by IN O
the DT O
cross NN O
- : O
linking NN O
of IN O
the DT O
alpha3 NN B-Gene
, , O
alpha6 NN B-Gene
, , O
beta1 NN B-Gene
and CC I-Gene
beta4 NN I-Gene
integrins NNS I-Gene
, , O
thus RB O
implying VBG O
that IN O
the DT O
alpha3beta1 NN B-Gene
and CC I-Gene
alpha6beta4 JJ I-Gene
heterodimers NNS I-Gene
can MD O
signal VB O
during IN O
thymocyte JJ O
adhesion NN O
. . O

We PRP O
have VBP O
extended VBN O
our PRP$ O
previous JJ O
work NN O
investigating NN O
in IN O
the DT O
same JJ O
experimental JJ O
setting VBG O
the DT O
inducing JJ O
activity NN O
of IN O
non NN O
stimulated VBD O
or CC O
activated JJ O
policlonal NN O
or CC O
clonal JJ O
mature NN O
T NNP O
cells NNS O
as IN O
representative NN O
of IN O
the DT O
more RBR O
mature JJ O
thymocyte NN O
subset NN O
. . O

We PRP O
found VBD O
that IN O
adhesion NN O
of IN O
unstimulated JJ O
T NNP O
cell NN O
i NN O
) ) O
involved VBD O
beta1 NN O
, , O
but CC O
not RB O
beta4 JJ O
integrin JJ O
functions NNS O
at IN O
the DT O
surface NN O
ii NN O
) ) O
induced VBD O
the DT O
clustering NN O
of IN O
alpha3beta1 NN B-Gene
, , O
but CC O
not RB O
alpha2beta1 JJ B-Gene
heterodimers NNS I-Gene
at IN O
the DT O
TEC NNP O
surface NN O
and CC O
iii NN O
) ) O
up RP O
- : O
regulated VBN O
the DT O
nuclear JJ O
binding NN O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN I-Gene
factor NN I-Gene
and CC O
the DT O
IL NNP O
- : O
6 CD O
secretion NN O
. . O

We PRP O
propose VBP O
that IN O
alpha3beta1 NN B-Gene
and CC I-Gene
alpha6beta4 NN I-Gene
heterodimers NNS I-Gene
are VBP O
induced VBN O
to TO O
cluster VB O
at IN O
the DT O
TEC NNP O
surface NN O
recognizing VBG O
yet RB O
unknown JJ O
cellular JJ B-Gene
ligands NNS I-Gene
differentially RB O
expressed VBD O
during IN O
T NNP O
cell NN O
development NN O
. . O

Identification NN O
and CC O
characterization NN O
of IN O
SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
a DT O
novel JJ O
Th2 NNP B-Gene
- : I-Gene
specific JJ I-Gene
zinc NN I-Gene
finger NN I-Gene
gene NN I-Gene
. . O

We PRP O
have VBP O
identified VBN O
a DT O
novel NN O
Kruppel NNP B-Gene
- : I-Gene
type NN I-Gene
zinc NN I-Gene
finger NN I-Gene
( ( I-Gene
ZF NNP I-Gene
) ) I-Gene
gene NN I-Gene
, , O
SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
which WDT O
is VBZ O
selectively RB O
expressed VBN O
by IN O
murine NN O
Th2 NNP O
cells NNS O
. . O

The DT O
protein NN O
encoded VBN O
by IN O
this DT O
gene NN O
has VBZ O
14 CD O
C2H2 NNP O
- : O
type NN O
ZF NNP O
tandemly RB O
arrayed VBD O
at IN O
its PRP$ O
C NNP B-Gene
terminus NN I-Gene
and CC O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
SCAN NNP B-Gene
box NN I-Gene
and CC O
KRAB NNP B-Gene
domains NNS I-Gene
. . O

SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
tissue NN O
restricted VBN O
in IN O
expression NN O
at IN O
the DT O
RNA NNP O
level NN O
, , O
detectable JJ O
only RB O
in IN O
brain NN O
and CC O
at IN O
low JJ O
levels NNS O
in IN O
kidney NN O
and CC O
spleen NN O
and CC O
few JJ O
hematopoietic JJ O
cell NN O
lines NNS O
. . O

By IN O
in IN O
situ JJ O
hybridization NN O
, , O
SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
was VBD O
found VBN O
to TO O
peak VB O
in IN O
antigen NN O
- : O
stimulated VBN O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
after IN O
2 CD O
- : O
3 CD O
days NNS O
of IN O
culture NN O
under IN O
Th2 NNP O
but CC O
not RB O
Th1 NNP O
biasing VBG O
conditions NNS O
. . O

This DT O
pattern NN O
of IN O
expression NN O
closely RB O
mirrored VBD O
that IN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
the DT O
same JJ O
cells NNS O
. . O

In IN O
transient JJ O
transfection NN O
experiments NNS O
in IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
/ NN O
ionomycin SYM O
- : O
stimulated VBN O
EL4 NNP O
cells NNS O
, , O
SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
found VBN O
to TO O
up RB O
- : O
regulate VB O
the DT O
activity NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
but CC I-Gene
not RB I-Gene
the DT I-Gene
IL NNP I-Gene
- : I-Gene
5 CD I-Gene
promoter NN I-Gene
, , O
contrasting VBG O
with IN O
the DT O
ability NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
to TO O
activate VB O
both DT O
promoters NNS B-Gene
. . O

This DT O
result NN O
was VBD O
confirmed VBN O
using VBG O
clones NNS O
of IN O
EL4 NNP O
cells NNS O
stably RB O
expressing VBG O
an DT O
inducible JJ O
form NN O
of IN O
SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
thus RB O
SKAT NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
a DT O
novel JJ O
Th2 NNP B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
that WDT O
may MD O
play VB O
a DT O
role NN O
in IN O
selective JJ O
regulation NN O
of IN O
cytokine NN B-Gene
genes NNS I-Gene
in IN O
T NNP O
cells NNS O
. . O

hsp70 NN B-Gene
interacting VBG I-Gene
protein JJ I-Gene
Hip NNP I-Gene
does VBZ O
not RB O
affect VB O
glucocorticoid JJ B-Gene
receptor NN I-Gene
folding NN O
by IN O
the DT O
hsp90 NN O
- : O
based VBN O
chaperone NN O
machinery NN O
except IN O
to TO O
oppose VB O
the DT O
effect NN O
of IN O
BAG NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Reticulocyte NNP O
lysate NN O
contains VBZ O
a DT O
chaperone NN O
system NN O
that WDT O
assembles VBZ O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( I-Gene
GR NNP I-Gene
) ) I-Gene
. . I-Gene
hsp90 NN I-Gene
heterocomplexes NNS I-Gene
. . O

Using VBG O
purified JJ B-Gene
proteins NNS I-Gene
, , O
we PRP O
have VBP O
prepared VBN O
a DT O
five CD O
- : O
protein NN O
heterocomplex NN O
assembly NN O
system NN O
consisting VBG O
of IN O
two CD O
proteins NNS O
essential JJ O
for IN O
heterocomplex NN O
assembly NN O
- : O
hsp90 NN B-Gene
and CC O
hsp70 NN B-Gene
- : O
and CC O
three CD O
proteins NNS O
that WDT O
act VBP O
as IN O
co JJ O
- : O
chaperones NNS O
to TO O
enhance VB O
assembly RB O
- : O
Hop NNP B-Gene
, , O
hsp40 NN B-Gene
, , O
p23 NN B-Gene
[ NNP O
Morishima NNP O
, , O
Y NNP O
. . O
, , O
Kanelakis NNP O
, , O
K NNP O
. . O
C NNP O
. . O
, , O
Silverstein NNP O
, , O
A NNP O
. . O
M NNP O
. . O
, , O
Dittmar NNP O
, , O
K NNP O
. . O
D NNP O
. . O
, , O
Estrada NNP O
, , O
L NNP O
. . O
, , O
and CC O
Pratt NNP O
, , O
W NNP O
. . O
B NNP O
. . O
( ( O
2000 CD O
) ) O
J NNP O
. . O
Biol NNP O
. . O
Chem NNP O
. . O
275 CD O
, , O
6894 CD O
- : O
6900 CD O
] NN O
. . O

The DT O
hsp70 NN B-Gene
co SYM I-Gene
- : I-Gene
chaperone NN I-Gene
Hip NNP I-Gene
has VBZ O
been VBN O
recovered VBN O
in IN O
receptor NN B-Gene
. . I-Gene
hsp90 NN I-Gene
heterocomplexes NNS I-Gene
at IN O
an DT O
intermediate JJ O
stage NN O
of IN O
assembly NN O
in IN O
reticulocyte NN O
lysate NN O
, , O
and CC O
Hip NNP B-Gene
is VBZ O
also RB O
thought VBN O
to TO O
be VB O
an DT O
intrinsic JJ O
component NN O
of IN O
the DT O
assembly NN O
machinery NN O
. . O

Here RB O
we PRP O
show VBP O
that DT O
immunodepletion NN O
of IN O
Hip NNP B-Gene
from IN O
reticulocyte JJ O
lysate NN O
or CC O
addition NN O
of IN O
high JJ O
levels NNS O
of IN O
Hip NNP B-Gene
to TO O
the DT O
purified JJ O
five CD O
- : O
protein NN O
system NN O
does VBZ O
not RB O
affect VB O
GR NNP O
. . O
hsp90 NN O
heterocomplex NN O
assembly NN O
or CC O
the DT O
activation NN O
of IN O
steroid JJ O
binding NN O
activity NN O
that WDT O
occurs VBZ O
with IN O
assembly NN O
. . O

Despite IN O
the DT O
fact NN O
that IN O
Hip NNP B-Gene
does VBZ O
not RB O
affect VB O
assembly RB O
, , O
it PRP O
is VBZ O
recovered VBN O
in IN O
GR NNP B-Gene
. . I-Gene
hsp90 NN I-Gene
heterocomplexes NNS I-Gene
assembled VBN O
by IN O
both DT O
systems NNS O
. . O

In IN O
the DT O
five CD O
- : O
protein NN O
system NN O
, , O
Hip NNP B-Gene
prevents VBZ O
inhibition NN O
of IN O
assembly NN O
by IN O
the DT O
hsp70 NN B-Gene
co SYM I-Gene
- : I-Gene
chaperone NN I-Gene
BAG NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
cotransfection NN O
of IN O
Hip NNP B-Gene
with IN O
BAG NNP B-Gene
- : I-Gene
1 CD I-Gene
opposes NNS O
BAG NNP B-Gene
- : I-Gene
1 CD I-Gene
reduction NN O
of IN O
steroid JJ O
binding NN O
activity NN O
in IN O
COS NNP O
cells NNS O
. . O

We PRP O
conclude VBP O
that DT O
Hip NNP B-Gene
is VBZ O
not RB O
a DT O
component NN O
of IN O
the DT O
assembly NN O
machinery NN O
but CC O
that IN O
it PRP O
could MD O
play VB O
a DT O
regulatory JJ O
role NN O
in IN O
opposition NN O
to TO O
BAG NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Cutting VBG O
edge NN O
: : O
STAT6 NNP O
- : O
deficient NN O
mice NNS O
have VBP O
enhanced VBN O
tumor NN O
immunity NN O
to TO O
primary JJ O
and CC O
metastatic JJ O
mammary JJ O
carcinoma NN O
. . O

STAT4 NNP B-Gene
and CC O
STAT6 NNP B-Gene
are VBP O
essential JJ O
for IN O
the DT O
development NN O
of IN O
CD4 NNP O
( ( O
+ NNP O
) ) O
Th1 NNP O
and CC O
Th2 NNP O
development NN O
, , O
respectively RB O
. . O

Tumor NN O
immunologists NNS O
have VBP O
hypothesized VBN O
that IN O
Th1 NNP O
cells NNS O
are VBP O
critical JJ O
in IN O
tumor NN O
immunity NN O
because IN O
they PRP O
facilitate VBP O
differentiation NN O
of IN O
CD8 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
, , O
which WDT O
are VBP O
potent JJ O
anti IN O
- : O
tumor NN O
effectors NNS O
. . O

We PRP O
have VBP O
used VBN O
STAT4 NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
and CC O
STAT6 NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
to TO O
test VB O
this DT O
hypothesis NN O
. . O

BALB NNP O
/ NNP O
c NN O
and CC O
knockout NN O
mice NNS O
were VBD O
challenged VBN O
in IN O
the DT O
mammary JJ O
gland NN O
with IN O
the DT O
highly RB O
malignant JJ O
and CC O
spontaneously RB O
metastatic JJ O
BALB NNP O
/ NNP O
c SYM O
- : O
derived VBN O
4T1 CD O
mammary JJ O
carcinoma NN O
. . O

Primary JJ O
tumor NN O
growth NN O
and CC O
metastatic JJ O
disease NN O
are VBP O
reduced VBN O
in IN O
STAT6 NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice RB O
relative JJ O
to TO O
BALB NNP O
/ NNP O
c NN O
and CC O
STAT4 NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
. . O

Ab NNP O
depletions NNS O
demonstrate VBP O
that IN O
the DT O
effect NN O
is VBZ O
mediated VBN O
by IN O
CD8 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
, , O
and CC O
immunized JJ O
STAT6 NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
have VBP O
higher JJR O
levels NNS O
of IN O
4T1 CD O
- : O
specific NN O
CTL NNP O
than IN O
BALB NNP O
/ NNP O
c VBD O
or CC O
STAT4 NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
. . O

Surprisingly RB O
, , O
Th1 NNP O
or CC O
Th2 NNP O
cells NNS O
are VBP O
not RB O
involved VBN O
, , O
because IN O
CD4 NNP O
depletion NN O
does VBZ O
not RB O
diminish VB O
the DT O
anti JJ O
- : O
tumor NN O
effect NN O
. . O

Therefore RB O
, , O
deletion NN O
of IN O
the DT O
STAT6 NNP B-Gene
gene NN I-Gene
facilitates NNS O
development NN O
of IN O
potent NN O
anti SYM O
- : O
tumor NN O
immunity NN O
via IN O
a DT O
CD4 NNP O
( ( O
+ NNP O
) ) O
- : O
independent JJ O
pathway NN O
. . O

Activation NN O
of IN O
oncogenic JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
in IN O
T NNP O
cells NNS O
infected VBN O
with IN O
human JJ O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
. . O

Human NNP O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
Tax NNP B-Gene
protein NN I-Gene
transforms NNS O
primary JJ O
human JJ O
T NNP O
cells NNS O
in IN O
vitro NN O
. . O

We PRP O
previously RB O
showed VBD O
that IN O
Tax NNP B-Gene
induces VBZ O
the DT O
expression NN O
of IN O
various JJ O
family NN O
members NNS O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
such JJ O
as IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
JunD NNP B-Gene
, , O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
and CC O
Fra NNP B-Gene
- : I-Gene
1 CD I-Gene
at IN O
the DT O
mRNA NN O
level NN O
in IN O
T NNP O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
ability NN O
of IN O
Tax NNP B-Gene
to TO O
activate VB O
transcription NN O
through IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
) ) O
. . O

A DT O
transient JJ O
transfection NN O
study NN O
showed VBD O
that IN O
Tax NNP B-Gene
can MD O
activate VB O
transcription NN O
through IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
in IN O
a DT O
human JJ O
T NNP O
cell NN O
line NN O
, , O
whereas IN O
any DT O
combination NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
did VBD O
so RB O
much RB O
less JJR O
than IN O
Tax NNP B-Gene
, , O
indicating VBG O
that IN O
the DT O
activation NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
by IN O
Tax NNP B-Gene
may MD O
require VB O
a DT O
mechanism NN O
other JJ O
than IN O
the DT O
induction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

Fresh JJ O
peripheral JJ O
blood NN O
leukemia NN O
cells NNS O
of IN O
all DT O
surveyed VBN O
ATL NNP O
patients NNS O
displayed VBD O
constitutive JJ O
AP NNP O
- : O
1 CD O
DNA NNP O
- : O
binding NN O
activity NN O
, , O
whereas IN O
no DT O
normal JJ O
individuals NNS O
did VBD O
. . O

However RB O
, , O
the DT O
HTLV NNP B-Gene
- : I-Gene
1 CD I-Gene
genes NNS I-Gene
, , O
including VBG O
tax NN B-Gene
, , O
are VBP O
not RB O
significantly RB O
expressed VBN O
in IN O
fresh JJ O
leukemia NN O
cells NNS O
from IN O
ATL NNP O
patients NNS O
. . O

Our PRP$ O
present JJ O
results NNS O
suggest VBP O
that IN O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
occurs NNS O
through IN O
Tax NNP O
- : O
dependent NN O
and CC O
- : O
independent JJ O
mechanisms NNS O
in IN O
HTLV NNP O
- : O
1 CD O
- : O
infected VBN O
T NNP O
cells NNS O
, , O
which WDT O
may MD O
play VB O
some DT O
roles NNS O
in IN O
dysregulated JJ O
phenotypes NNS O
of IN O
HTLV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
. . O

2 CD O
, , O
2 CD O
' '' O
, , O
4 CD O
, , O
6 CD O
, , O
6 CD O
' POS O
- : O
pentachlorobiphenyl NN O
induces NNS O
apoptosis NN O
in IN O
human JJ O
monocytic JJ O
cells NNS O
. . O

Polychlorinatedbiphe NNP O
( ( O
PCBs NNP O
) ) O
are VBP O
a DT O
group NN O
of IN O
persistent NN O
and CC O
widely RB O
dispersed VBD O
environmental JJ O
pollutants NNS O
, , O
some DT O
of IN O
which WDT O
may MD O
be VB O
immunotoxic NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
effect NN O
of IN O
PCBs NNP O
on IN O
immune NN O
system NN O
by IN O
assessing VBG O
apoptotic JJ O
cell NN O
death NN O
in IN O
human JJ O
monocytic JJ O
U937 NNP O
cells NNS O
. . O

Among IN O
the DT O
various JJ O
congeners NNS O
tested VBD O
, , O
2 CD O
, , O
2 CD O
' '' O
, , O
4 CD O
, , O
6 CD O
, , O
6 CD O
' POS O
- : O
pentachlorobiphenyl NN O
( ( O
PeCB NNP O
) ) O
, , O
a DT O
highly RB O
ortho JJ O
- : O
substituted JJ O
congener NN O
, , O
specifically RB O
induced JJ O
DNA NNP O
fragmentation NN O
, , O
a DT O
hallmark NN O
of IN O
apoptosis NN O
, , O
while IN O
the DT O
other JJ O
examined VBD O
di JJ O
- : O
, , O
tri SYM O
- : O
, , O
tetra JJ O
- : O
, , O
and CC O
pentachlorobiphenyls NN O
did VBD O
not RB O
. . O

To TO O
further RBR O
study VB O
the DT O
2 CD O
, , O
2 CD O
' '' O
, , O
4 CD O
, , O
6 CD O
, , O
6 CD O
' POS O
- : O
PeCB NNP O
- : O
induced VBD O
cell NN O
death NN O
, , O
various JJ O
features NNS O
of IN O
apoptosis NN O
were VBD O
examined VBN O
. . O

2 CD O
, , O
2 CD O
' '' O
, , O
4 CD O
, , O
6 CD O
, , O
6 CD O
' POS O
- : O
PeCB NN O
caused VBD O
a DT O
decrease NN O
in IN O
cell NN O
viability NN O
and CC O
induced VBD O
cellular JJ O
morphologic NN O
features NNS O
characteristic JJ O
of IN O
apoptosis NN O
such JJ O
as IN O
chromatin JJ O
aggregation NN O
and CC O
apoptotic JJ O
bodies NNS O
. . O

In IN O
addition NN O
, , O
caspase NN B-Gene
- : I-Gene
3 CD I-Gene
, , O
an DT O
executioner NN O
of IN O
apoptosis NN O
, , O
was VBD O
activated VBN O
and CC O
its PRP$ O
substrate NN O
, , O
poly NN B-Gene
( ( I-Gene
ADP NNP I-Gene
- : I-Gene
ribose NN I-Gene
) ) I-Gene
polymerase NN I-Gene
( ( O
PARP NNP B-Gene
) ) O
, , O
was VBD O
cleaved VBN O
during IN O
2 CD O
, , O
2 CD O
' '' O
, , O
4 CD O
, , O
6 CD O
, , O
6 CD O
' POS O
- : O
PeCB NNP O
- : O
induced JJ O
apoptosis NN O
. . O

In IN O
contrast NN O
, , O
3 CD O
, , O
3 CD O
' '' O
, , O
4 CD O
, , O
4 CD O
' '' O
, , O
5 CD O
- : O
PeCB NN O
, , O
a DT O
congener NN O
of IN O
coplanar NN O
structure NN O
, , O
as RB O
well RB O
as IN O
2 CD O
, , O
3 CD O
, , O
7 CD O
, , O
8 CD O
- : O
TCDD NN O
did VBD O
not RB O
induce VB O
apoptosis NN O
in IN O
these DT O
human JJ O
monocytic NN O
cells NNS O
, , O
although IN O
they PRP O
potently RB O
induced VBD O
CYP NNP B-Gene
1A1 CD I-Gene
in IN O
human JJ O
hepatoma NN O
Hep NNP O
G2 NNP O
cells NNS O
. . O

Taken VBN O
together RB O
, , O
the DT O
data NNS O
indicate VBP O
that IN O
2 CD O
, , O
2 CD O
' '' O
, , O
4 CD O
, , O
6 CD O
, , O
6 CD O
' POS O
- : O
PeCB NN O
induces NNS O
apoptosis NN O
in IN O
human JJ O
monocytic JJ O
cells NNS O
through IN O
a DT O
mechanism NN O
that WDT O
is VBZ O
independent JJ O
of IN O
the DT O
arylhydrocarbon NN B-Gene
receptor NN I-Gene
. . O

This DT O
suggests VBZ O
a DT O
possibly RB O
separate JJ O
mechanism NN O
by IN O
which WDT O
PCBs NNP O
cause NN O
immunosuppression NN O
. . O

Effects NNS O
of IN O
deregulated JJ O
Raf NNP O
activation NN O
on IN O
integrin NN B-Gene
, , O
cytokine VB O
- : O
receptor NN O
expression NN O
and CC O
the DT O
induction NN O
of IN O
apoptosis NN O
in IN O
hematopoietic JJ O
cells NNS O
. . O

The DT O
effects NNS O
of IN O
deregulated JJ O
Raf NNP O
activation NN O
on IN O
the DT O
growth NN O
and CC O
differentiation NN O
of IN O
hematopoietic JJ O
cells NNS O
were VBD O
investigated VBN O
. . O

The DT O
cytokine NN O
- : O
dependent JJ O
murine NN O
myeloid NN O
FDC NNP O
- : O
P1 NN O
and CC O
human JJ O
erythroleukemic JJ O
TF NNP O
- : O
1 CD O
cell NN O
lines NNS O
were VBD O
transformed VBN O
to TO O
grow VB O
in IN O
response NN O
to TO O
deregulated VBN O
Raf NNP O
expression NN O
in IN O
the DT O
absence NN O
of IN O
exogenous JJ B-Gene
cytokines NNS I-Gene
. . O

The DT O
conditionally RB O
active JJ O
Raf NNP B-Gene
proteins NNS I-Gene
were VBD O
regulated VBN O
by IN O
beta NN O
- : O
estradiol NN O
as IN O
cDNAs NN B-Gene
containing VBG O
the DT O
Raf NNP B-Gene
catalytic JJ I-Gene
, , O
but CC O
lacking VBG O
negative JJ B-Gene
- : I-Gene
regulatory JJ I-Gene
domains NNS I-Gene
, , O
were VBD O
ligated VBN O
to TO O
the DT O
hormone NN B-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
deltaRaf NN B-Gene
: : I-Gene
ER NN I-Gene
) ) O
. . O

Continuous JJ O
deltaRaf NN B-Gene
expression NN O
prevented VBD O
apoptosis NN O
in IN O
the DT O
absence NN O
of IN O
exogenous JJ B-Gene
cytokines NNS I-Gene
and CC O
altered VBD O
the DT O
morphology NN O
of IN O
the DT O
FD NNP O
/ NNP O
deltaRaf NN O
: : O
ER NNP O
cells NNS O
as IN O
they PRP O
grew VBD O
in IN O
large JJ O
aggregated JJ O
masses NNS O
( ( O
> JJ O
100 CD O
cells NNS O
) ) O
whereas VBP O
the DT O
parental JJ O
cytokine NN O
- : O
dependent NN O
FDC NNP O
- : O
P1 NNP O
cells NNS O
grew VBD O
in IN O
smaller JJR O
grape NN O
- : O
like IN O
clusters NNS O
( ( O
< $ O
10 CD O
cells NNS O
) ) O
. . O

FD NNP O
/ NNP O
deltaRaf VBD O
- : O
1 CD O
: : O
ER NN O
cells NNS O
growing VBG O
in IN O
response NN O
to TO O
Raf NNP O
activation NN O
displayed VBD O
decreased JJ O
levels NNS O
of IN O
the DT O
Mac NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC I-Gene
Mac NNP I-Gene
- : I-Gene
3 CD I-Gene
molecules NNS I-Gene
on IN O
their PRP$ O
cell NN O
surface NN O
. . O

In IN O
contrast NN O
, , O
when WRB O
these DT O
cells NNS O
were VBD O
cultured VBN O
in IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
higher JJR O
levels NNS O
of IN O
these DT O
adhesion NN B-Gene
molecules NNS I-Gene
were VBD O
detected VBN O
. . O

Expression NN O
of IN O
activated JJ O
Raf NNP B-Gene
oncoproteins NNS I-Gene
also RB O
abrogated VBD O
cytokine JJ O
dependency NN O
and CC O
prevented JJ O
apoptosis NN O
of IN O
TF NNP O
- : O
1 CD O
cells NNS O
. . O

Moreover RB O
, , O
the DT O
differentiation NN O
status NN O
of IN O
these DT O
Raf NNP O
- : O
responsive JJ O
cells NNS O
was VBD O
more RBR O
immature JJ O
upon IN O
Raf NNP O
activation NN O
as IN O
culture NN O
with IN O
the DT O
differentiation NN O
- : O
inducing NN O
agent NN O
phorbol NN O
12 CD O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
beta $ O
- : O
estradiol NN O
resulted VBD O
in IN O
decreased JJ O
levels NNS O
of IN O
the DT O
CD11b NNP B-Gene
and CC I-Gene
CD18 NNP I-Gene
integrin VBP I-Gene
molecules NNS I-Gene
on IN O
the DT O
cell NN O
surface NN O
. . O

In IN O
contrast NN O
when WRB O
the DT O
Raf NNP O
- : O
responsive JJ O
cells NNS O
were VBD O
induced VBN O
to TO O
differentiate VB O
with IN O
PMA NNP O
and CC O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
, , O
in IN O
the DT O
absence NN O
of IN O
deltaRaf NN B-Gene
: : I-Gene
ER NNP I-Gene
activation NN O
, , O
increased JJ O
levels NNS O
of IN O
the DT O
CD11b NNP B-Gene
and CC I-Gene
CD18 NNP I-Gene
molecules NNS I-Gene
were VBD O
detected VBN O
. . O

Retinoic NNP O
acid NN O
( ( O
RA NNP O
) ) O
inhibited VBD O
3H CD O
- : O
thymidine NN O
incorporation NN O
in IN O
response NN O
to TO O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

Interestingly RB O
, , O
Raf NNP O
activation NN O
counterbalanced VBD O
the DT O
inhibition NN O
of IN O
DNA NNP O
synthesis NN O
caused VBN O
by IN O
RA NNP O
but CC O
not RB O
PMA NNP O
. . O

Thus RB O
deregulated VBN O
Raf NNP O
expression NN O
can MD O
alter VB O
cytokine JJ O
dependency NN O
, , O
integrin JJ O
expression NN O
and CC O
the DT O
stage NN O
of IN O
differentiation NN O
. . O

These DT O
Raf NNP O
- : O
responsive NN O
cell NN O
lines NNS O
will MD O
be VB O
useful JJ O
in IN O
elucidating VBG O
the DT O
roles NNS O
of IN O
the DT O
MAP NNP O
kinase NN O
cascade NN O
on IN O
hematopoietic JJ O
cell NN O
differentiation NN O
and CC O
malignant JJ O
transformation NN O

Cyclic NNP O
AMP NNP O
activates VBZ O
p38 VBP B-Gene
mitogen SYM I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
in IN O
Th2 NNP O
cells NNS O
: : O
phosphorylation NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
and CC O
stimulation NN O
of IN O
Th2 NNP O
cytokine NN O
gene NN O
expression NN O
. . O

cAMP NN O
is VBZ O
an DT O
important JJ O
second JJ O
messenger NN O
with IN O
immunomodulatory JJ O
properties NNS O
. . O

Elevation NN O
of IN O
intracellular JJ O
cAMP NN O
in IN O
T NNP O
cells NNS O
, , O
induced VBN O
by IN O
agents NNS O
such JJ O
as IN O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
or CC O
PGs NNP B-Gene
, , O
inhibits VBZ O
T NNP O
cell NN O
activation NN O
. . O

In IN O
effector NN O
T NNP O
cells NNS O
, , O
an DT O
increase NN O
in IN O
the DT O
level NN O
of IN O
intracellular JJ O
cAMP NN O
inhibits NNS O
cytokine VBP B-Gene
production NN O
in IN O
Th1 NNP O
cells NNS O
but CC O
stimulates VBZ O
cytokine JJ B-Gene
production NN O
in IN O
Th2 NNP O
cells NNS O
. . O

Here RB O
we PRP O
report VBP O
that IN O
cAMP SYM O
- : O
induced JJ O
effects NNS O
in IN O
Th2 NNP O
cells NNS O
occur VBP O
independently RB O
of IN O
the DT O
protein NN B-Gene
kinase VBD I-Gene
A DT I-Gene
pathway NN O
, , O
which WDT O
is VBZ O
the DT O
major JJ O
mediator NN O
of IN O
cAMP NN O
- : O
induced JJ O
signaling VBG O
events NNS O
in IN O
most JJS O
cell NN O
types NNS O
. . O

Instead RB O
, , O
cAMP JJ O
stimulates NNS O
activation NN O
of IN O
p38 NN B-Gene
mitogen NN I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
in IN O
Th2 NNP O
cells NNS O
. . O

This DT O
appears VBZ O
to TO O
be VB O
a DT O
Th2 NNP O
- : O
selective JJ O
event NN O
because IN O
cAMP NN O
barely RB O
increased VBD O
p38 JJ B-Gene
phosphorylation NN O
in IN O
Th1 NNP O
cells NNS O
. . O

We PRP O
show VBP O
that IN O
in IN O
Th2 NNP O
cells NNS O
, , O
cAMP NN O
promotes VBZ O
the DT O
production NN O
of IN O
both DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
which WDT O
play VBP O
distinct NNS O
but CC O
critical JJ O
roles NNS O
in IN O
asthma JJ O
pathogenesis NN O
. . O

Our PRP$ O
data NNS O
also RB O
show VBP O
that IN O
cAMP JJ O
causes NNS O
increased VBD O
phosphorylation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
, , O
which WDT O
we PRP O
have VBP O
shown VBN O
is VBZ O
a DT O
critical JJ O
regulator NN O
of IN O
Th2 NNP O
cytokine NN O
gene NN O
expression NN O
and CC O
, , O
in IN O
turn NN O
, , O
of IN O
airway JJ O
inflammation NN O
in IN O
mice NN O
. . O

Thus RB O
, , O
Th2 NNP O
- : O
specific JJ O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
expression NN O
and CC O
p38 NN B-Gene
mitogen NN I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
activation NN O
together RB O
provide VB O
a DT O
molecular JJ O
basis NN O
for IN O
the DT O
differential JJ O
effects NNS O
of IN O
cAMP NN O
in IN O
the DT O
two CD O
T NNP O
helper NN O
cell NN O
subsets NNS O
. . O

Characterization NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
signals NNS O
dependent JJ O
on IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
13 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
1 CD I-Gene
: : O
redundancy NN O
of IN O
requirement NN O
of IN O
tyrosine NN O
residue NN O
for IN O
STAT3 NNP O
activation NN O
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
are VBP O
pleiotropic JJ B-Gene
cytokines NNS I-Gene
whose WP$ O
biological JJ O
activities NNS O
overlap VBP O
with IN O
each DT O
other JJ O
. . O

IL NNP B-Gene
- : I-Gene
13 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha IN I-Gene
1 CD I-Gene
) ) O
is VBZ O
necessary JJ O
for IN O
binding VBG O
to TO O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
and CC O
the DT O
heterodimer NN O
composed VBD O
of IN O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
alpha NN I-Gene
chain NN I-Gene
transduces NNS O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
signals NNS O
; : O
however RB O
, , O
the DT O
functional JJ O
mapping NN O
of IN O
the DT O
intracellular JJ B-Gene
domain NN I-Gene
of IN O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
is VBZ O
not RB O
fully RB O
understood JJ O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
constructed VBD O
wild JJ O
and CC O
mutated VBD O
types NNS O
of IN O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
, , O
and CC O
analyzed VBD O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
signals NNS O
using VBG O
an DT O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
- : O
transfected VBN O
human JJ O
B NNP O
cell NN O
line NN O
. . O

Expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
evoked VBD O
STAT3 NNP B-Gene
activation NN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
and CC O
in IN O
stimulated JJ O
human JJ O
B NNP O
cells NNS O
, , O
on IN O
which WDT O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
was VBD O
highly RB O
expressed VBN O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
induced JJ O
STAT3 NNP B-Gene
activation NN O
. . O

Replacement NN O
of IN O
the DT O
two CD O
tyrosine NN O
residues NNS O
completely RB O
abolished VBD O
STAT3 NNP B-Gene
activation NN O
, , O
although IN O
replacing VBG O
either CC O
tyrosine JJ O
residue JJ O
alone RB O
retained VBD O
it PRP O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
that IN O
the DT O
Box1 NNP B-Gene
region NN I-Gene
and CC O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
tail NN I-Gene
of IN O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha JJ I-Gene
1 CD I-Gene
were VBD O
critical JJ O
for IN O
binding VBG O
to TO O
Tyk2 NNP B-Gene
, , O
and CC O
activation NN O
of IN O
Jak1 NNP B-Gene
, , O
Tyk2 NNP B-Gene
, , O
the DT O
insulin NN B-Gene
receptor NN I-Gene
substrate VBP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
STAT6 NNP B-Gene
respectively RB O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
STAT3 NNP B-Gene
activation NN O
is VBZ O
involved VBN O
with IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
signals NNS O
in IN O
human JJ O
B NNP O
cells NNS O
along IN O
with IN O
the DT O
activation NN O
of IN O
STAT6 NNP B-Gene
, , O
and CC O
that IN O
there EX O
is VBZ O
a DT O
unique JJ O
sequence NN O
in IN O
IL NNP B-Gene
- : I-Gene
13R CD I-Gene
alpha NN I-Gene
1 CD I-Gene
to TO O
activate VB O
STAT3 NNP B-Gene
. . O

Functional JJ O
uncoupling NN O
of IN O
the DT O
Janus NNP O
kinase NN O
3 CD O
- : O
Stat5 NNP O
pathway NN O
in IN O
malignant JJ O
growth NN O
of IN O
human JJ O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
- : O
transformed VBN O
human JJ O
T NNP O
cells NNS O
. . O

Human NNP O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
transforms NNS O
cytokine VBP B-Gene
- : O
dependent NN O
T NNP O
lymphocytes VBZ O
and CC O
causes VBZ O
adult NN O
T NNP O
cell NN O
leukemia NN O
. . O

Janus NNP B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( I-Gene
Jak NNP I-Gene
) ) I-Gene
3 CD I-Gene
and CC O
transcription NN B-Gene
factors NNS I-Gene
Stat5a NNP B-Gene
and CC O
Stat5b NNP B-Gene
are VBP O
essential JJ O
for IN O
the DT O
proliferation NN O
of IN O
normal JJ O
T NNP O
cells NNS O
and CC O
are VBP O
constitutively RB O
hyperactivated VBN O
in IN O
both DT O
HTLV NNP O
- : O
1 CD O
- : O
transformed VBN O
human JJ O
T NNP O
cell NN O
lines NNS O
and CC O
lymphocytes NNS O
isolated VBN O
from IN O
HTLV NNP O
- : O
1 CD O
- : O
infected JJ O
patients NNS O
; : O
therefore RB O
, , O
a DT O
critical JJ O
role NN O
for IN O
the DT O
Jak3 NNP O
- : O
Stat5 NNP O
pathway NN O
in IN O
the DT O
progression NN O
of IN O
this DT O
disease NN O
has VBZ O
been VBN O
postulated VBN O
. . O

We PRP O
recently RB O
reported VBD O
that IN O
tyrphostin NN O
AG NNP O
- : O
490 CD O
selectively RB O
blocked VBN O
IL NNP O
- : O
2 CD O
activation NN O
of IN O
Jak3 NNP B-Gene
/ NNP I-Gene
Stat5 NNP I-Gene
and CC O
growth NN O
of IN O
murine NN O
T NNP O
cell NN O
lines NNS O
. . O

Here RB O
we PRP O
demonstrate VBP O
that DT O
disruption NN O
of IN O
Jak3 NNP O
/ NNP O
Stat5a NNP O
/ NNP O
b NN O
signaling VBG O
with IN O
AG NNP O
- : O
490 CD O
( ( O
50 CD O
& CC O
mgr NN O
; : O
M NNP O
) ) O
blocked VBD O
the DT O
proliferation NN O
of IN O
primary JJ O
human JJ O
T NNP O
lymphocytes NNS O
, , O
but CC O
paradoxically RB O
failed VBD O
to TO O
inhibit VB O
the DT O
proliferation NN O
of IN O
HTLV NNP O
- : O
1 CD O
- : O
transformed VBN O
human JJ O
T NNP O
cell NN O
lines NNS O
, , O
HuT NNP O
- : O
102 CD O
and CC O
MT NNP O
- : O
2 CD O
. . O

Structural JJ O
homologues NNS O
of IN O
AG NNP O
- : O
490 CD O
also RB O
inhibited VBD O
the DT O
proliferation NN O
of IN O
primary JJ O
human JJ O
T NNP O
cells NNS O
, , O
but CC O
not RB O
HTLV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
. . O

Disruption NN O
of IN O
constitutive JJ O
Jak3 NNP O
/ NNP O
Stat5 NNP O
activation NN O
by IN O
AG NNP O
- : O
490 CD O
was VBD O
demonstrated VBN O
by IN O
inhibition NN O
of IN O
1 CD O
) ) O
tyrosine NN O
phosphorylation NN O
of IN O
Jak3 NNP B-Gene
, , O
Stat5a NNP B-Gene
( ( O
Tyr NNP O
( ( O
694 CD O
) ) O
) ) O
, , O
and CC O
Stat5b NNP B-Gene
( ( O
Tyr NNP O
( ( O
699 CD O
) ) O
) ) O
; : O
2 CD O
) ) O
serine NN O
phosphorylation NN O
of IN O
Stat5a NNP B-Gene
( ( O
Ser NNP O
( ( O
726 CD O
) ) O
) ) O
as IN O
determined VBN O
by IN O
a DT O
novel NN O
phosphospecific NN B-Gene
Ab NNP I-Gene
; : O
and CC O
3 CD O
) ) O
Stat5a NNP O
/ NNP O
b NN O
DNA NNP O
binding NN O
to TO O
the DT O
Stat5 NNP B-Gene
- : I-Gene
responsive NN I-Gene
beta NN I-Gene
- : I-Gene
casein NN I-Gene
promoter NN I-Gene
. . O

In IN O
contrast NN O
, , O
AG NNP O
- : O
490 CD O
had VBD O
no DT O
effect NN O
on IN O
DNA NN O
binding NN O
by IN O
p50 NN B-Gene
/ NNP I-Gene
p65 NN I-Gene
components NNS I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
a DT O
transcription NN B-Gene
factor NN I-Gene
activated VBN O
by IN O
the DT O
HTLV NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
encoded VBN I-Gene
phosphoprotein NN I-Gene
, , I-Gene
Tax NNP I-Gene
. . O

Collectively RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
the DT O
Jak3 NNP O
- : O
Stat5 NNP O
pathway NN O
in IN O
HTLV NNP O
- : O
1 CD O
- : O
transformed VBN O
T NNP O
cells NNS O
has VBZ O
become VBN O
functionally RB O
redundant JJ O
for IN O
proliferation NN O
. . O

Reversal NN O
of IN O
this DT O
functional JJ O
uncoupling NN O
may MD O
be VB O
required VBN O
before IN O
Jak3 NNP O
/ NNP O
Stat5 NNP O
inhibitors NNS O
will MD O
be VB O
useful JJ O
in IN O
the DT O
treatment NN O
of IN O
this DT O
malignancy NN O
. . O

The DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
promoter NN I-Gene
initiating VBG O
B NNP O
- : O
cell NN O
transformation NN O
is VBZ O
activated VBN O
by IN O
RFX NNP B-Gene
proteins NNS I-Gene
and CC O
the DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
BSAP NNP I-Gene
/ NNP I-Gene
Pax5 NNP I-Gene
. . O

Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
- : O
induced VBN O
B NNP O
- : O
cell NN O
growth NN O
transformation NN O
, , O
a DT O
central JJ O
feature NN O
of IN O
the DT O
virus NN O
' POS O
strategy NN O
for IN O
colonizing VBG O
the DT O
human JJ O
B NNP O
- : O
cell NN O
system NN O
, , O
requires VBZ O
full JJ O
virus NN O
latent JJ O
gene NN O
expression NN O
and CC O
is VBZ O
initiated VBN O
by IN O
transcription NN O
from IN O
the DT O
viral JJ B-Gene
promoter NN I-Gene
Wp NNP I-Gene
. . O

Interestingly RB O
, , O
when WRB O
EBV NNP O
accesses VBZ O
other JJ O
cell NN O
types NNS O
, , O
this DT O
growth NN O
- : O
transforming NN O
program NN O
is VBZ O
not RB O
activated VBN O
. . O

The DT O
present JJ O
work NN O
focuses VBZ O
on IN O
a DT O
region NN O
of IN O
Wp NNP B-Gene
which WDT O
in IN O
reporter NN O
assays NNS O
confers NNS O
B NNP O
- : O
cell NN O
- : O
specific JJ O
activity NN O
. . O

Bandshift NNP O
studies NNS O
indicate VBP O
that IN O
this DT O
region NN O
contains VBZ O
three CD O
factor NN O
binding VBG O
sites NNS O
, , O
termed VBD O
sites NNS B-Gene
B NNP I-Gene
, , I-Gene
C NNP I-Gene
, , I-Gene
and CC I-Gene
D NNP I-Gene
, , O
in IN O
addition NN O
to TO O
a DT O
previously RB O
characterized VBN O
CREB NNP B-Gene
site NN I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
site NN B-Gene
C NNP I-Gene
binds VBZ O
members NNS O
of IN O
the DT O
ubiquitously RB O
expressed VBN O
RFX NNP B-Gene
family NN I-Gene
of IN I-Gene
proteins NNS I-Gene
, , O
notably RB O
RFX1 NNP B-Gene
, , O
RFX3 NNP B-Gene
, , O
and CC O
the DT O
associated JJ O
factor NN O
MIBP1 NNP B-Gene
, , O
whereas WP O
sites VBZ B-Gene
B NNP I-Gene
and CC I-Gene
D NNP I-Gene
both DT O
bind IN O
the DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
BSAP NNP I-Gene
/ NNP I-Gene
Pax5 NNP I-Gene
. . O

In IN O
reporter NN O
assays NNS O
with IN O
mutant JJ B-Gene
Wp NNP I-Gene
constructs NNS I-Gene
, , O
the DT O
loss NN O
of IN O
factor NN O
binding VBG O
to TO O
any DT O
one CD O
of IN O
these DT O
sites NNS O
severely RB O
impaired JJ O
promoter NN O
activity NN O
in IN O
B NNP O
cells NNS O
, , O
while IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
promoter NN I-Gene
could MD O
be VB O
activated VBN O
in IN O
non JJ O
- : O
B NNP O
cells NNS O
by IN O
ectopic NN O
BSAP NNP O
expression NN O
. . O

We PRP O
suggest VBP O
that IN O
Wp NNP B-Gene
regulation NN O
by IN O
BSAP NNP B-Gene
helps VBZ O
to TO O
ensure VB O
the DT O
B NNP O
- : O
cell NN O
specificity NN O
of IN O
EBV NNP O
' POS O
s NN O
growth NN O
- : O
transforming NN O
function NN O
. . O

Activation NN O
of IN O
the DT O
Lck NNP B-Gene
tyrosine NN I-Gene
protein NN I-Gene
kinase NN I-Gene
by IN O
the DT O
Herpesvirus NNP O
saimiri NN O
tip NN B-Gene
protein VBP I-Gene
involves VBZ O
two CD O
binding NN O
interactions NNS O
. . O

The DT O
Tip NNP B-Gene
protein NN I-Gene
of IN O
Herpesvirus NNP O
saimiri NN O
strain NN O
484C CD O
binds NNS O
to TO O
and CC O
activates VBZ O
the DT O
Lck NNP B-Gene
tyrosine NN I-Gene
protein NN I-Gene
kinase NN I-Gene
. . O

Two CD O
sequences NNS O
in IN O
the DT O
Tip NNP B-Gene
protein NN I-Gene
were VBD O
previously RB O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
binding VBG O
to TO O
Lck NNP B-Gene
. . O

A DT O
proline NN B-Gene
- : I-Gene
rich JJ I-Gene
region NN I-Gene
, , O
residues VBZ O
132 CD O
- : O
141 CD O
, , O
binds NNS O
to TO O
the DT O
SH3 NNP B-Gene
domain NN I-Gene
of IN O
the DT O
Lck NNP B-Gene
protein NN I-Gene
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
other JJ O
Lck NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
, , O
residues VBZ O
104 CD O
- : O
113 CD O
, , O
binds NNS O
to TO O
the DT O
carboxyl NN B-Gene
- : I-Gene
terminal JJ I-Gene
half NN I-Gene
of IN O
Lck NNP B-Gene
and CC O
that IN O
this DT O
binding NN O
does VBZ O
not RB O
require VB O
the DT O
Lck NNP B-Gene
SH3 NNP I-Gene
domain NN I-Gene
. . O

Mutated VBN O
Tip NNP B-Gene
containing VBG O
only RB O
one CD O
functional JJ O
Lck NNP B-Gene
- : I-Gene
binding VBG I-Gene
domain NN I-Gene
can MD O
bind VB O
stably RB O
to TO O
Lck NNP B-Gene
, , O
although IN O
not RB O
as RB O
strongly RB O
as IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Tip NNP I-Gene
. . O

Interaction NN O
of IN O
Tip NNP B-Gene
with IN O
Lck NNP B-Gene
through IN O
either DT O
Lck NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
increases VBZ O
the DT O
activity NN O
of IN O
Lck NNP B-Gene
in IN O
vivo NN O
. . O

Simultaneous JJ O
binding NN O
of IN O
both DT O
domains NNS O
is VBZ O
required VBN O
for IN O
maximal JJ O
activation NN O
of IN O
Lck NNP B-Gene
. . O

The DT O
transient JJ O
expression NN O
of IN O
Tip NNP B-Gene
in IN O
T NNP O
cells NNS O
was VBD O
found VBN O
to TO O
stimulate VB O
both DT O
Stat3 NNP B-Gene
- : O
dependent NN O
and CC O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : O
dependent JJ O
transcription NN O
. . O

Mutant JJ O
forms NNS O
of IN O
Tip NNP B-Gene
lacking VBG O
one CD O
or CC O
the DT O
other JJ O
of IN O
the DT O
two CD O
Lck NNP B-Gene
- : I-Gene
binding NN I-Gene
domains NNS I-Gene
retained VBD O
the DT O
ability NN O
to TO O
stimulate VB O
Stat3 NNP B-Gene
- : O
dependent JJ O
transcription NN O
. . O

Tip NNP B-Gene
lacking VBG O
the DT O
proline NN O
- : O
rich JJ O
Lck NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
exhibited VBD O
almost RB O
wild JJ O
- : O
type NN O
activity NN O
in IN O
this DT O
assay NN O
. . O

In IN O
contrast NN O
, , O
ablation NN O
of IN O
either DT O
Lck NNP B-Gene
- : I-Gene
binding VBG I-Gene
domain NN I-Gene
abolished VBD O
the DT O
ability NN O
of IN O
Tip NNP B-Gene
to TO O
stimulate VB O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : O
dependent JJ O
transcription NN O
. . O

Full NNP O
biological JJ O
activity NN O
of IN O
Tip NNP B-Gene
, , O
therefore RB O
, , O
appears VBZ O
to TO O
require VB O
both DT O
Lck NNP B-Gene
- : I-Gene
binding NN I-Gene
domains NNS I-Gene
. . O

Accumulation NN O
of IN O
RXR NNP B-Gene
alpha NN I-Gene
during IN O
activation NN O
of IN O
cycling VBG O
human JJ O
T NNP O
lymphocytes NNS O
: : O
modulation NN O
of IN O
RXRE NNP O
transactivation NN O
function NN O
by IN O
mitogen NN O
- : O
activated VBN O
protein JJ O
kinase NN O
pathways NNS O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that IN O
the DT O
activation NN O
of IN O
resting VBG O
human JJ O
immature NN O
peripheral JJ O
blood NN O
T NNP O
( ( O
PBT NNP O
) ) O
lymphocytes VBZ O
is VBZ O
associated VBN O
with IN O
the DT O
loss NN O
of IN O
retinoid JJ B-Gene
X NNP I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( O
RXRalpha NNP B-Gene
) ) O
expression NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
demonstrated VBN O
that IN O
, , O
unlike IN O
resting VBG O
cells NNS O
, , O
activation NN O
of IN O
cycling VBG O
human JJ O
mature NN O
PBT NNP O
lymphocytes VBZ O
, , O
and CC O
T NNP O
lymphocyte VBP O
leukemia NN O
cell NN O
lines NNS O
is VBZ O
accompanied VBN O
by IN O
the DT O
accumulation NN O
of IN O
RXRalpha NNP B-Gene
mRNA NN O
and CC O
protein NN O
. . O

Interestingly RB O
, , O
cyclosporin VB O
A NNP O
further RB O
augmented VBD O
RXRalpha NNP B-Gene
expression NN O
, , O
indicating VBG O
the DT O
involvement NN O
of IN O
calcineurin NN O
pathways NNS O
in IN O
the DT O
process NN O
. . O

9 CD O
- : O
cis NN O
retinoic NN O
acid NN O
inhibited VBD O
the DT O
accumulation NN O
, , O
suggesting VBG O
that IN O
retinoids NNS O
can MD O
regulate VB O
the DT O
synthesis NN O
of IN O
their PRP$ O
own JJ O
receptors NNS O
during IN O
T NNP O
cell NN O
activation NN O
. . O

Transfection NN O
analysis NN O
in IN O
Jurkat NNP O
cells NNS O
, , O
using VBG O
RXRE NNP O
- : O
dependent NN O
reporter NN O
assays NNS O
, , O
showed VBD O
that IN O
RXRalpha NNP B-Gene
accumulated VBD O
during IN O
T NNP O
cell NN O
activation NN O
was VBD O
transcriptionally RB O
inactive JJ O
. . O

To TO O
investigate VB O
the DT O
mechanism NN O
of IN O
such JJ O
inhibition NN O
, , O
the DT O
role NN O
of IN O
two CD O
mitogen NN O
- : O
activated VBN O
protein JJ O
kinase NN O
pathways NNS O
, , O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
and CC O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated VBN I-Gene
kinase NN I-Gene
( ( O
ERK NNP B-Gene
) ) O
, , O
in IN O
modulating VBG O
RXRE NNP O
- : O
dependent JJ O
transcription NN O
, , O
was VBD O
explored VBN O
. . O

The DT O
expression NN O
of IN O
constitutively RB O
active JJ O
MAP NNP B-Gene
/ NNP I-Gene
ERK NNP I-Gene
kinase VBD I-Gene
kinase VB I-Gene
1 CD I-Gene
( ( O
MEKK1 NNP B-Gene
) ) O
inhibited VBD O
RXRE NNP O
- : O
dependent JJ O
transcription NN O
, , O
whereas JJ O
dominant JJ B-Gene
negative JJ I-Gene
MEKK1 NNP I-Gene
increased VBD O
the DT O
transcription NN O
, , O
indicating VBG O
the DT O
involvement NN O
of IN O
JNK NNP B-Gene
signaling VBG O
pathways NNS O
in IN O
the DT O
process NN O
. . O

In IN O
contrast NN O
, , O
expression NN O
of IN O
constitutively RB B-Gene
active JJ I-Gene
MEK1 NNP I-Gene
, , O
which WDT O
activates VBZ O
ERK NNP B-Gene
pathway NN O
, , O
enhanced VBD O
RXRE NNP O
- : O
dependent JJ O
activation NN O
. . O

When WRB O
both DT O
were VBD O
activated VBN O
simultaneously RB O
, , O
JNK NNP B-Gene
pathway NN O
was VBD O
dominant JJ O
over IN O
ERK NNP B-Gene
pathway NN O
and CC O
resulted VBD O
in IN O
inhibition NN O
of IN O
RXRE NNP O
- : O
mediated VBN O
transcription NN O
. . O

These DT O
data NNS O
demonstrate VBP O
a DT O
dual JJ O
regulatory JJ O
control NN O
of IN O
RXRalpha NNP B-Gene
expression NN O
during IN O
the DT O
activation NN O
of IN O
resting NN O
and CC O
cycling NN O
T NNP O
lymphocytes VBZ O
and CC O
indicate VB O
a DT O
dynamic JJ O
balance NN O
between IN O
JNK NNP O
and CC O
ERK NNP O
pathways NNS O
in IN O
modulating VBG O
RXRE NNP O
- : O
mediated VBN O
transactivation NN O
. . O

The DT O
proteasome NN B-Gene
regulates VBZ O
receptor VBP O
- : O
mediated VBN O
endocytosis NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
. . O

Recent JJ O
studies NNS O
have VBP O
increasingly RB O
implicated VBN O
the DT O
proteasome NN B-Gene
in IN O
the DT O
regulation NN O
of IN O
cell NN B-Gene
surface NN I-Gene
receptors NNS I-Gene
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
role NN O
of IN O
the DT O
proteasome NN B-Gene
for IN O
ligand NN O
- : O
dependent JJ O
endocytosis NN O
and CC O
degradation NN O
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
- : I-Gene
interleukin JJ I-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
) ) I-Gene
complex NN I-Gene
. . O

Proteasome NNP O
inhibitors NNS O
impaired VBD O
internalization NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
and CC O
prevented VBD O
the DT O
lysosomal JJ O
degradation NN O
of IN O
this DT O
cytokine NN B-Gene
. . O

Based VBN O
on IN O
time NN O
- : O
course NN O
studies NNS O
, , O
proteasome JJ B-Gene
activity NN O
is VBZ O
primarily RB O
required VBN O
after IN O
initial JJ O
endocytosis NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
. . O

Proteasome NNP O
function NN O
was VBD O
also RB O
necessary JJ O
for IN O
the DT O
lysosomal JJ O
degradation NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
internalized VBN O
by IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
that WDT O
were VBD O
comprised VBN O
of IN O
cytoplasmic JJ B-Gene
tailless NN I-Gene
beta SYM B-Gene
- : I-Gene
or CC I-Gene
gamma VB I-Gene
c SYM I-Gene
- : I-Gene
subunits NNS I-Gene
, , O
suggesting VBG O
that IN O
the DT O
target NN O
protein NN O
for IN O
the DT O
proteasome NN B-Gene
is VBZ O
independent JJ O
of IN O
either CC O
the DT O
cytoplasmic JJ B-Gene
tail NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta SYM B-Gene
- : I-Gene
or CC I-Gene
gamma VB I-Gene
c SYM I-Gene
- : I-Gene
subunits NNS I-Gene
and CC O
their PRP$ O
associated VBN O
signaling VBG O
components NNS O
. . O

Therefore RB O
, , O
a DT O
functional JJ O
proteasome NN B-Gene
is VBZ O
required VBN O
for IN O
optimal JJ O
endocytosis NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
/ JJ I-Gene
ligand NN I-Gene
complex NN I-Gene
and CC O
is VBZ O
essential JJ O
for IN O
the DT O
subsequent JJ O
lysosomal JJ O
degradation NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
possibly RB O
by IN O
regulating VBG O
trafficking VBG O
to TO O
the DT O
lysosome NN O
. . O

Functional JJ O
characterization NN O
of IN O
the DT O
two CD O
alternative JJ O
promoters NNS O
of IN O
human JJ B-Gene
p45 NN I-Gene
NF NNP I-Gene
- : I-Gene
E2 NNP I-Gene
gene NN I-Gene
. . O

OBJECTIVE NN O
: : O
The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
E2 NNP I-Gene
, , O
a DT O
heterodimeric JJ B-Gene
protein NN I-Gene
complex NN I-Gene
composed VBD O
of IN O
p45 NN B-Gene
and CC O
small JJ O
Maf NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
, , O
is VBZ O
considered VBN O
crucial JJ O
for IN O
the DT O
proper JJ O
differentiation NN O
of IN O
erythrocytes NNS O
and CC O
megakaryocytes NNS O
in IN O
vivo NN O
. . O

We PRP O
report VBP O
the DT O
results NNS O
of IN O
studies NNS O
aimed VBN O
at IN O
understanding VBG O
the DT O
regulatory JJ O
mechanisms NNS O
controlling VBG O
p45 JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
erythroid JJ O
cells NNS O
. . O

MATERIALS NNP O
AND CC O
METHODS NNP O
: : O
Human NNP B-Gene
p45 VBP I-Gene
mRNAs NNS I-Gene
have VBP O
two CD O
alternative JJ O
isoforms NNS O
, , O
aNF SYM B-Gene
- : I-Gene
E2 NN I-Gene
and CC O
fNF JJ B-Gene
- : I-Gene
E2 NN I-Gene
, , O
and CC O
these DT O
isoforms NNS O
are VBP O
transcribed VBN O
from IN O
the DT O
alternative JJ B-Gene
promoters NNS I-Gene
. . O

We PRP O
investigated VBD O
lineage NN O
- : O
specific JJ O
expression NN O
of IN O
both DT O
isomers NNS O
in IN O
human JJ O
erythroid NN O
and CC O
megakaryocytic JJ O
cells NNS O
by IN O
reverse JJ O
transcriptase NN O
polymerase NN O
chain NN O
reaction NN O
or CC O
Northern NNP O
blot NN O
analysis NN O
. . O

For IN O
functional JJ O
characterization NN O
of IN O
both DT O
promoters NNS O
, , O
plasmids NNS O
in IN O
which WDT O
reporter NN B-Gene
genes NNS I-Gene
were VBD O
placed VBN O
under IN O
the DT O
control NN O
of IN O
a DT O
series NN O
of IN O
truncated JJ O
or CC O
mutated VBN O
promoter NN B-Gene
fragments NNS I-Gene
were VBD O
transfected VBN O
to TO O
human JJ O
hematopoietic JJ O
cell NN O
lines NNS O
. . O

RESULTS NNS O
: : O
When WRB O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
isolated VBN O
from IN O
human JJ O
cord NN O
blood NN O
were VBD O
induced VBN O
to TO O
unilineage VB O
erythroid NN O
or CC O
megakaryocytic JJ O
differentiation NN O
in IN O
liquid JJ O
suspension NN O
culture NN O
, , O
both DT O
transcripts NNS O
, , O
although IN O
barely RB O
detected VBN O
at IN O
day NN O
0 CD O
, , O
were VBD O
induced VBN O
in IN O
both DT O
erythroid JJ O
and CC O
megakaryocytic JJ O
cultures NNS O
. . O

fNF SYM B-Gene
- : I-Gene
E2 NN I-Gene
mRNA NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
more RBR O
abundant JJ O
in IN O
erythroid NN O
cells NNS O
than IN O
megakaryocytic JJ O
cells NNS O
at IN O
day NN O
7 CD O
of IN O
culture NN O
. . O

Although IN O
both DT O
isomers NNS O
were VBD O
expressed VBN O
in IN O
human JJ O
erythroid JJ O
- : O
megakaryocytic JJ O
cell NN O
lines NNS O
, , O
megakaryocytic JJ O
maturation NN O
with IN O
loss NN O
of IN O
erythroid JJ O
phenotype NN O
induced VBN O
by IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
resulted VBD O
in IN O
exclusive JJ O
downregulation NN O
of IN O
fNF JJ B-Gene
- : I-Gene
E2 NN I-Gene
, , O
suggesting VBG O
that IN O
fNF JJ B-Gene
- : I-Gene
E2 NN I-Gene
promoter NN I-Gene
is VBZ O
more RBR O
erythroid JJ O
specific NN O
. . O

Functional JJ O
analysis NN O
of IN O
fNF JJ B-Gene
- : I-Gene
E2 NN I-Gene
promoter NN I-Gene
showed VBD O
that IN O
the DT O
promoter NN O
is VBZ O
active JJ O
only RB O
in IN O
erythroid JJ O
- : O
megakaryocytic JJ O
cells NNS O
and CC O
that IN O
the DT O
double JJ B-Gene
GATA NNP I-Gene
sit NN I-Gene
e NN O
in IN O
the DT O
proximal JJ O
region NN O
is VBZ O
necessary JJ O
for IN O
its PRP$ O
efficient JJ O
activity NN O
. . O

CONCLUSION NN O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
GATA NNP B-Gene
proteins NNS I-Gene
, , O
which WDT O
govern VBP O
the DT O
differentiation NN O
of IN O
erythroid JJ O
lineage NN O
cells NNS O
, , O
are VBP O
required VBN O
for IN O
full JJ O
promoter NN O
activity NN O
of IN O
the DT O
p45 JJ B-Gene
gene NN I-Gene
. . O

Transcriptional JJ O
activation NN O
of IN O
heme NN B-Gene
oxygenase NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
its PRP$ O
functional JJ O
significance NN O
in IN O
acetaminophen JJ O
- : O
induced JJ O
hepatitis NN O
and CC O
hepatocellular JJ O
injury NN O
in IN O
the DT O
rat NN O
. . O

BACKGROUND NNP O
/ NNP O
AIM NNP O
: : O
Glutathione CD O
depletion NN O
contributes NNS O
to TO O
acetaminophen VB O
hepatotoxicity NN O
and CC O
is VBZ O
known VBN O
to TO O
induce VB O
the DT O
oxidative JJ O
stress NN O
reactant JJ O
heme NN B-Gene
oxygenase SYM I-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
metabolites NNS O
of IN O
the DT O
heme NN O
oxygenase NN O
pathway NN O
, , O
biliverdin NN O
, , O
carbon NN O
monoxide NN O
, , O
and CC O
iron NN O
may MD O
modulate VB O
acetaminophen NN O
toxicity NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
assess VB O
cell NN O
- : O
type NN O
specific JJ O
expression NN O
of IN O
heme NN B-Gene
oxygenase NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
its PRP$ O
impact NN O
on IN O
liver JJ O
injury NN O
and CC O
microcirculatory NN O
disturbances NNS O
in IN O
a DT O
model NN O
of IN O
acetaminophen JJ O
- : O
induced JJ O
hepatitis NN O
. . O

METHODS NN O
: : O
Gene NNP O
expression NN O
of IN O
heme NN B-Gene
oxygenase NN I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
studied VBN O
by IN O
Northern NNP O
- : O
and CC O
Western JJ O
analysis NN O
as RB O
well RB O
as IN O
immunohistochemistry NN O
. . O

The DT O
time NN O
course NN O
of IN O
heme JJ B-Gene
oxygenase NN I-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
- : I-Gene
2 CD I-Gene
, , O
cytokine NN B-Gene
- : I-Gene
induced JJ I-Gene
neutrophil NN I-Gene
chemoattractant NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
studied VBN O
by IN O
Northern NNP O
analysis NN O
. . O

DNA NNP O
- : O
binding NN O
activity NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
was VBD O
determined VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

Sinusoidal NNP O
perfusion NN O
and CC O
leukocyte JJ O
- : O
endothelial JJ O
interactions NNS O
were VBD O
assessed VBN O
by IN O
intravital JJ O
microscopy NN O
. . O

RESULTS NN O
: : O
Acetaminophen NNP O
caused VBD O
a DT O
moderate JJ O
sinusoidal NN O
perfusion NN O
failure NN O
( ( O
- : O
15 CD O
% NN O
) ) O
and CC O
infiltration NN O
of IN O
neutrophils NNS O
along IN O
with IN O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
cytokine VB B-Gene
- : I-Gene
induced JJ I-Gene
neutrophil NN I-Gene
chemoattractant NN I-Gene
- : I-Gene
1 CD I-Gene
mRNAs NN O
. . O

Induction NN O
of IN O
heme NN B-Gene
oxygenase NN I-Gene
- : I-Gene
1 CD I-Gene
mRNA NN O
and CC O
protein NN O
( ( O
approximately RB O
30 CD O
- : O
fold NN O
) ) O
in IN O
hepatocytes NNS O
and CC O
non JJ O
- : O
parenchymal JJ O
cells NNS O
paralleled VBD O
the DT O
inflammatory JJ O
response NN O
. . O

Blockade NN O
of IN O
heme JJ O
oxygenase NN O
activity NN O
with IN O
tin NN O
- : O
protoporphyrin NN O
- : O
IX NNP O
abrogated VBD O
acetaminophen SYM O
- : O
induced VBN O
hepatic JJ O
neutrophil JJ O
accumulation NN O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
, , O
but CC O
failed VBD O
to TO O
affect VB O
sinusoidal JJ O
perfusion NN O
and CC O
liver JJ O
injury NN O
. . O

CONCLUSIONS NN O
: : O
The DT O
inflammatory JJ O
response NN O
associated VBN O
with IN O
acetaminophen JJ O
hepatotoxicity NN O
is VBZ O
modulated VBN O
by IN O
the DT O
parallel JJ O
induction NN O
of IN O
the DT O
heme NN B-Gene
oxygenase SYM I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
. . O

However RB O
, , O
heme JJ B-Gene
oxygenase SYM I-Gene
- : I-Gene
1 CD I-Gene
has VBZ O
no DT O
permissive JJ O
effect NN O
on IN O
sinusoidal JJ O
perfusion NN O
and CC O
does VBZ O
not RB O
affect VB O
liver JJ O
injury NN O
in IN O
this DT O
model NN O
. . O

These DT O
data NNS O
argue NN O
against IN O
a DT O
central JJ O
role NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
neutrophil JJ O
infiltration NN O
as IN O
perpetuating VBG O
factors NNS O
of IN O
liver JJ O
injury NN O
in IN O
acetaminophen JJ O
toxicity NN O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
proliferation NN O
requires VBZ O
synthesis NN O
of IN O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
. . O

OBJECTIVE NN O
: : O
Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
induces VBZ O
a DT O
variety NN O
of IN O
cellular JJ O
responses NNS O
, , O
some DT O
of IN O
them PRP O
being VBG O
at IN O
least JJS O
seemingly RB O
contradictory JJ O
. . O

Thus RB O
, , O
we PRP O
set VBP O
out RP O
to TO O
find VB O
differences NNS O
in IN O
the DT O
modes NNS O
of IN O
proliferative JJ O
and CC O
apoptotic JJ O
responses NNS O
to TO O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

MATERIALS NNP O
AND CC O
METHODS NNP O
: : O
We PRP O
screened VBD O
a DT O
panel NN O
of IN O
acute JJ O
myeloid NN O
leukemia NN O
- : O
derived VBN O
cell NN O
lines NNS O
for IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
responsiveness NN O
. . O

In IN O
two CD O
lines NNS O
( ( O
OCI NNP O
- : O
AML NNP O
- : O
1 CD O
, , O
OCI NNP O
- : O
AML NNP O
- : O
11 CD O
) ) O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
acted VBD O
as IN O
an DT O
apoptotic JJ O
agent NN O
; : O
in IN O
others NNS O
( ( O
HU NNP O
- : O
3 CD O
, , O
M NNP O
- : O
07e CD O
, , O
TF NNP O
- : O
1 CD O
) ) O
, , O
it PRP O
had VBD O
the DT O
opposite JJ O
effect NN O
, , O
preventing VBG O
apoptosis NN O
and CC O
inducing VBG O
proliferation NN O
. . O

Direct JJ O
and CC O
indirect JJ O
signaling VBG O
mechanisms NNS O
, , O
including VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
cytokine NN O
synthesis NN O
, , O
were VBD O
analyzed VBN O
. . O

RESULTS NNS O
: : O
All DT O
cell NN O
lines NNS O
tested VBD O
expressed VBN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
receptors NNS I-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
and CC O
responded VBD O
to TO O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
by IN O
upregulation NN O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

In IN O
contrast NN O
to TO O
granulocyte VB B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
did VBD O
not RB O
activate VB O
the DT O
MAP NNP B-Gene
kinase NN I-Gene
and CC O
p70S6 JJ O
kinase NN O
pathways NNS O
. . O

Nevertheless RB O
, , O
inhibitors NNS O
of IN O
these DT O
pathways NNS O
clearly RB O
reduced VBD O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced VBN O
cell NN O
growth NN O
, , O
indicating VBG O
that IN O
TNF NNP O
- : O
alpha NN O
- : O
proliferative JJ O
cells NNS O
produced VBD O
a DT O
growth NN O
factor NN O
that WDT O
induced VBD O
proliferation NN O
upon IN O
stimulation NN O
of IN O
the DT O
above JJ O
pathways NNS O
. . O

Anti NNP B-Gene
- : I-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
antibodies NNS I-Gene
inhibited VBD O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
growth NN O
, , O
suggesting VBG O
the DT O
presence NN O
of IN O
an DT O
autocrine NN O
loop NN O
for IN O
cell NN O
proliferation NN O
mediated VBN O
by IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

Supporting VBG O
this DT O
notion NN O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
upregulation NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
mRNA NN I-Gene
levels NNS O
and CC O
protein NN O
secretion NN O
in IN O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
proliferative NN O
, , O
but CC O
not RB O
in IN O
the DT O
TNF NNP O
- : O
alpha NN O
- : O
apoptotic JJ O
cell NN O
lines NNS O
. . O

CONCLUSION NN O
: : O
These DT O
data NNS O
identify VBP O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
synthesis NN O
as IN O
an DT O
early JJ O
and CC O
essential JJ O
step NN O
in IN O
TNF NNP O
- : O
alpha NN O
- : O
induced JJ O
proliferation NN O
. . O

We PRP O
show VBP O
for IN O
the DT O
first JJ O
time NN O
that WDT O
TNF NNP O
- : O
alpha NN O
- : O
treated VBN O
cell NN O
lines NNS O
producing VBG O
no DT O
or CC O
only RB O
minimal JJ O
amounts NNS O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
demonstrate VBP O
an DT O
apoptotic JJ O
phenotype NN O
, , O
while IN O
cell NN O
lines NNS O
with IN O
high JJ O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
expression NN O
rates NNS O
can MD O
escape VB O
from IN O
growth NN O
arrest NN O
or CC O
even RB O
apoptosis NN O
. . O

In IN O
this DT O
context NN O
, , O
we PRP O
discuss VBP O
arguments NNS O
pointing VBG O
at IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
as IN O
regulator NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
synthesis NN O
and CC O
thus RB O
indirectly RB O
as IN O
regulator NN O
for IN O
the DT O
escape NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
apoptosis NN O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
content NN O
of IN O
T NNP O
lymphocytes NNS O
: : O
evidence NN O
for IN O
heterogeneity NN O
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
were VBD O
measured VBN O
in IN O
T NNP O
lymphocytes NNS O
that WDT O
were VBD O
isolated VBN O
from IN O
peripheral JJ O
blood NN O
by IN O
either DT O
nylon JJ O
wool NN O
filtration NN O
or CC O
E NNP O
- : O
rosette NN O
sedimentation NN O
. . O

T NNP O
cells NNS O
isolated VBN O
by IN O
nylon JJ O
wool NN O
filtration NN O
specifically RB O
bind VBZ O
6 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
2 CD O
fmol NN O
of IN O
dexamethasone NN O
per IN O
million CD O
cells NNS O
( ( O
equivalent NN O
to TO O
4000 CD O
+ NNP O
/ NNP O
- : O
200 CD O
receptors NNS O
per IN O
cell NN O
) ) O
, , O
whereas JJ O
T NNP O
cells NNS O
isolated VBN O
by IN O
E NNP O
- : O
rosette NN O
sedimentation NN O
bind IN O
12 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
fmol NN O
of IN O
dexamethasone NN O
per IN O
million CD O
cells NNS O
( ( O
equivalent NN O
to TO O
7200 CD O
+ NNP O
/ NNP O
- : O
400 CD O
receptors NNS O
per IN O
cell NN O
) ) O
. . O

This DT O
difference NN O
in IN O
the DT O
amount NN O
of IN O
dexamethasone NN O
bound NN O
by IN O
the DT O
two CD O
T NNP O
cell NN O
preparations NNS O
was VBD O
significant JJ O
( ( O
p NN O
less JJR O
than IN O
. . O
1 CD O
) ) O
and CC O
was VBD O
present JJ O
immediately RB O
after IN O
cell NN O
isolation NN O
. . O

The DT O
binding NN O
affinities NNS O
of IN O
the DT O
different JJ O
T NNP O
cell NN O
preparations NNS O
for IN O
dexamethasone NN O
were VBD O
similar JJ O
. . O

T NNP O
cells NNS O
that WDT O
are VBP O
isolated VBN O
by IN O
a DT O
combination NN O
of IN O
nylon JJ O
wool NN O
filtration NN O
followed VBN O
by IN O
E NNP O
- : O
rosette NN O
sedimentation NN O
bind IN O
the DT O
same JJ O
amount NN O
of IN O
dexamethasone NN O
as IN O
T NNP O
cells NNS O
isolated VBN O
by IN O
nylon JJ O
wool JJ O
filtration NN O
alone RB O
. . O

T NNP O
cells NNS O
isolated VBN O
by IN O
a DT O
combination NN O
of IN O
E NNP O
- : O
rosette NN O
sedimentation NN O
following VBG O
by IN O
nylon JJ O
wool NN O
filtration NN O
bind NN O
less JJR O
dexamethasone NN O
than IN O
do VBP O
T NNP O
cells NNS O
isolated VBN O
by IN O
E NNP O
- : O
rosette NN O
sedimentation NN O
alone RB O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
T NNP O
cells NNS O
are VBP O
heterogeneous JJ O
with IN O
respect NN O
to TO O
their PRP$ O
quantity NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
. . O

Isolation NN O
of IN O
T NNP O
cells NNS O
by IN O
E NNP O
- : O
rosette NN O
sedimentation NN O
enriches NNS O
for IN O
T NNP O
cells NNS O
that WDT O
have VBP O
a DT O
greater JJR O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
, , O
and CC O
isolation NN O
of IN O
T NNP O
cells NNS O
by IN O
nylon JJ O
wool NN O
filtration NN O
enriches NNS O
for IN O
T NNP O
cells NNS O
that WDT O
have VBP O
a DT O
lesser JJR O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
. . O

Glucocorticoid NNP B-Gene
receptors NNS I-Gene
and CC O
glucocorticoid JJ O
sensitivity NN O
of IN O
human JJ O
leukemic JJ O
cells NNS O
. . O

We PRP O
have VBP O
established VBN O
optimal JJ O
conditions NNS O
for IN O
the DT O
measurement NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
in IN O
human JJ O
white JJ O
cells NNS O
using VBG O
a DT O
whole JJ O
- : O
cell NN O
binding VBG O
assay NN O
with IN O
[ JJ O
3H CD O
] JJ O
dexamethasone NN O
as IN O
the DT O
ligand NN O
, , O
and CC O
the DT O
subsequent JJ O
determination NN O
of IN O
the DT O
GR NNP B-Gene
content NN O
in IN O
normal JJ O
human JJ O
lymphocytes NNS O
and CC O
in IN O
leukemic JJ O
cells NNS O
of IN O
patients NNS O
with IN O
various JJ O
forms NNS O
of IN O
acute NN O
and CC O
chronic JJ O
leukemia NN O
. . O

A DT O
number NN O
of IN O
leukemia NN O
cell NN O
lines NNS O
in IN O
continuous JJ O
culture NN O
were VBD O
also RB O
subjected VBN O
to TO O
the DT O
GR NNP B-Gene
assay NN O
, , O
and CC O
the DT O
results NNS O
were VBD O
correlated VBN O
with IN O
the DT O
sensitivity NN O
of IN O
these DT O
cell NN O
lines NNS O
to TO O
glucocorticoid VB O
steroids NNS O
in IN O
vitro NN O
. . O

The DT O
GR NNP B-Gene
content NN O
of IN O
normal JJ O
human JJ O
lymphocytes NNS O
amounted VBD O
to TO O
4 CD O
, , O
850 CD O
+ NN O
/ NNP O
- : O
1 CD O
, , O
340 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
receptors NNS O
/ VBP O
cell NN O
. . O

The DT O
mean JJ O
equilibrium NN O
dissociation NN O
constant NN O
( ( O
KD NNP O
) ) O
of IN O
the DT O
interaction NN O
of IN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
with IN O
the DT O
GR NNP B-Gene
was VBD O
1 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
- : O
8 CD O
) ) O
M NNP O
. . O

Steroidal NNP O
compounds VBZ O
with IN O
a DT O
known VBN O
glucocorticoid NN O
potency NN O
effectively RB O
competed VBN O
for IN O
the DT O
binding NN O
, , O
whereas JJ O
steroids NNS O
devoid NN O
of IN O
glucocorticoid JJ O
activity NN O
( ( O
e NN O
. . O
g NN O
. . O
estradiol CC O
- : O
17 CD O
beta NN O
and CC O
testosterone NN O
) ) O
were VBD O
ineffective JJ O
. . O

The DT O
GR NNP B-Gene
content NN O
of IN O
the DT O
blast NN O
cells NNS O
obtained VBN O
from IN O
eight CD O
patients NNS O
suffering VBG O
from IN O
acute JJ O
leukemia NN O
and CC O
four CD O
patients NNS O
with IN O
a DT O
blast NN O
crisis NN O
of IN O
chronic JJ O
myelocytic JJ O
leukemia NN O
was VBD O
found VBN O
to TO O
be VB O
highly RB O
variable JJ O
( ( O
3 CD O
, , O
230 CD O
- : O
29 CD O
, , O
900 CD O
receptors NNS O
/ NNP O
cell NN O
) ) O
, , O
while IN O
the DT O
lymphocytes NNS O
of IN O
six CD O
patients NNS O
with IN O
chronic JJ O
lymphatic JJ O
leukemia NN O
contained VBD O
a DT O
rather RB O
stable JJ O
GR NNP B-Gene
content NN O
( ( O
2 CD O
, , O
930 CD O
- : O
5 CD O
, , O
120 CD O
receptors NNS O
/ NNP O
cell NN O
) ) O
, , O
which WDT O
was VBD O
comparable JJ O
with IN O
that DT O
of IN O
normal JJ O
lymphocytes NNS O
. . O

GR NNP B-Gene
was VBD O
identified VBN O
in IN O
all PDT O
the DT O
12 CD O
malignant JJ O
continuous JJ O
white JJ O
cell NN O
lines NNS O
studied VBN O
. . O

Large JJ O
cells NNS O
contained VBD O
more RBR O
GR NNP B-Gene
than IN O
the DT O
smaller JJR O
ones NNS O
. . O

There EX O
was VBD O
no DT O
apparent JJ O
correlation NN O
between IN O
the DT O
GR NNP B-Gene
concentration NN O
and CC O
the DT O
sensitivity NN O
of IN O
the DT O
cells NNS O
in IN O
vitro NN O
to TO O
glucocorticoids NNS O
as IN O
judged VBN O
by IN O
[ $ O
3H CD O
] NNP O
thymidine NN O
incorporation NN O
studies NNS O
. . O

Distribution NN O
of IN O
the DT O
surface NN O
markers NNS O
in IN O
the DT O
leukemic JJ O
cell NN O
lines NNS O
did VBD O
not RB O
relate VB O
to TO O
the DT O
GR NNP B-Gene
concentration NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
presence NN O
of IN O
GR NNP B-Gene
is VBZ O
probably RB O
a DT O
universal JJ O
feature NN O
of IN O
the DT O
leukemic JJ O
cells NNS O
, , O
and CC O
, , O
from IN O
a DT O
clinical JJ O
standpoint NN O
, , O
probably RB O
does VBZ O
not RB O
alone VB O
imply NN O
steroid JJ O
responsiveness NN O
. . O

Evidence NN O
for IN O
a DT O
steroid JJ B-Gene
receptor NN I-Gene
in IN O
rheumatoid JJ O
synovial JJ O
tissue NN O
cells NNS O
. . O

One CD O
mechanism NN O
by IN O
which WDT O
glucocorticoids NNS O
could MD O
exert VB O
their PRP$ O
anti JJ O
- : O
inflammatory JJ O
action NN O
is VBZ O
via IN O
rapidly RB O
saturable JJ O
, , O
stereo JJ B-Gene
- : I-Gene
specific JJ I-Gene
cytoplasmic JJ I-Gene
protein NN I-Gene
receptors NNS I-Gene
. . O

This DT O
report NN O
is VBZ O
of IN O
an DT O
investigation NN O
into IN O
such PDT O
a DT O
possibility NN O
in IN O
synovial JJ O
cells NNS O
. . O

Synovium NN O
, , O
obtained VBN O
from IN O
knee JJ O
joints NNS O
of IN O
rheumatoid JJ O
patients NNS O
undergoing VBG O
surgery NN O
, , O
was VBD O
incubated VBN O
with IN O
clostridiopeptidase NN B-Gene
A NNP I-Gene
and CC O
trypsin SYM B-Gene
- : I-Gene
EDTA NN I-Gene
to TO O
obtain VB O
cell NN O
suspensions NNS O
. . O

These DT O
, , O
together RB O
with IN O
cells NNS O
obtained VBN O
from IN O
synovial JJ O
fluid NN O
aspirated VBN O
from IN O
patients NNS O
with IN O
rheumatoid JJ O
arthritis NN O
, , O
were VBD O
identified VBN O
by IN O
electron NN O
microscopy NN O
. . O

Duplicate NNP O
samples NNS O
of IN O
these DT O
cell NN O
suspensions NNS O
were VBD O
incubated VBN O
with IN O
increasing VBG O
concentrations NNS O
of IN O
H3Dexamethasone NNP O
( ( O
1 CD O
x RB O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
- : O
1 CD O
x JJ O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
) ) O
for IN O
30 CD O
minutes NNS O
at IN O
37 CD O
degrees NNS O
C NNP O
. . O

Analysis NN O
of IN O
the DT O
proportion NN O
of IN O
steroid NN O
bound NN O
to TO O
whole VB O
cells NNS O
showed VBD O
evidence NN O
for IN O
specific JJ O
, , O
rapidly RB O
saturable JJ O
, , O
receptors NNS O
in IN O
the DT O
cells NNS O
obtained VBN O
from IN O
synovial JJ O
tissue NN O
, , O
but CC O
this DT O
was VBD O
not RB O
found VBN O
in IN O
synovial JJ O
fluid NN O
cells NNS O
. . O

Electron NNP O
micrographs NN O
showed VBD O
that IN O
cells NNS O
obtained VBN O
from IN O
synovial JJ O
tissue NN O
consisted VBN O
of IN O
synovial JJ O
fibroblast NN O
- : O
and CC O
macrophage VB O
- : O
types NNS O
, , O
lymphocytes NNS O
, , O
monocytes NNS O
and CC O
macrophages NNS O
. . O

Polymorphonuclear JJ O
leucocytes NNS O
appeared VBD O
to TO O
be VB O
absent JJ O
. . O

However RB O
, , O
in IN O
synovial JJ O
fluid NN O
cell NN O
type NN O
polymorphonuclear NN O
leucocytes NNS O
were VBD O
the DT O
predominant NN O
cell NN O
type NN O
. . O

We PRP O
concluded VBD O
from IN O
this DT O
, , O
that WDT O
one CD O
or CC O
more JJR O
of IN O
the DT O
cell NN O
types VBZ O
present JJ O
in IN O
synovial JJ O
tissue NN O
contain NN O
a DT O
specific JJ B-Gene
steroid NN I-Gene
receptor NN I-Gene
, , O
but CC O
that IN O
this DT O
is VBZ O
lacking VBG O
in IN O
synovial JJ O
fluid NN O
polymorphonuclear NN O
leucocytes VBZ O
. . O

Clinical JJ O
implications NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
human JJ O
leukemia NN O
. . O

Glucorticoid JJ B-Gene
receptors NNS I-Gene
were VBD O
studied VBN O
in IN O
various JJ O
populations NNS O
of IN O
normal JJ O
human JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
and CC O
leukemic JJ O
lymphoblasts NNS O
. . O

Normal JJ O
lymphocytes NNS O
contain VBP O
low JJ O
levels NNS O
of IN O
glucocorticoid NN B-Gene
receptor NN I-Gene
( ( O
approximately RB O
2 CD O
, , O
500 CD O
sites NNS O
/ NNP O
cell NN O
) ) O
which WDT O
are VBP O
identical JJ O
in IN O
T NNP O
- : O
and CC O
non JJ O
- : O
T NNP O
- : O
fractions NNS O
. . O

Phytohemagglutinin NNP B-Gene
treatment NN O
increases NNS O
levels NNS O
about IN O
3 CD O
- : O
fold NN O
. . O

Leukemic JJ O
lymphoblasts NNS O
contain VBP O
larger JJR O
numbers NNS O
of IN O
receptor NN O
sites NNS O
. . O

Presence NN O
of IN O
receptor NN O
is VBZ O
correlated VBN O
with IN O
in IN O
vitro NN O
sensitivitiy NN O
to TO O
glucocorticoids NNS O
and CC O
in IN O
vivo JJ O
response NN O
to TO O
therapy NN O
. . O

Quantity NN O
of IN O
receptor NN O
is VBZ O
also RB O
correlated VBN O
with IN O
complete JJ O
remission NN O
duration NN O
independently RB O
of IN O
leukemic JJ O
cell NN O
type NN O
( ( O
T NNP O
or CC O
null NN O
) ) O
, , O
initial JJ O
WBC NNP O
, , O
or CC O
age NN O
of IN O
patient NN O
. . O

Quantitative JJ O
determination NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
in IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
may MD O
be VB O
of IN O
value NN O
both CC O
as IN O
an DT O
independent JJ O
prognostic JJ O
variable NN O
and CC O
in IN O
suggesting VBG O
which WDT O
patients NNS O
should MD O
receive VB O
glucocorticoid NN O
therapy NN O
. . O

Functional NNP O
and CC O
physical JJ O
interaction NN O
of IN O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinases VBZ I-Gene
Fyn NNP I-Gene
and CC I-Gene
Csk NNP I-Gene
in IN O
the DT O
T NNP O
- : O
cell NN O
signaling VBG O
system NN O
. . O

The DT O
Src NNP B-Gene
- : I-Gene
like IN I-Gene
protein SYM I-Gene
- : I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
Fyn NNP B-Gene
is VBZ O
associated VBN O
with IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
. . O

Transient JJ O
expression NN O
of IN O
actively RB O
mutated VBN O
Fyn NNP B-Gene
, , O
having VBG O
Phe NNP O
- : O
528 CD O
instead RB O
of IN O
Tyr NNP O
- : O
528 CD O
or CC O
Thr NNP O
- : O
338 CD O
instead RB O
of IN O
Ile NNP O
- : O
338 CD O
, , O
in IN O
Jurkat NNP O
T NNP O
- : O
cells NNS O
stimulated VBD B-Gene
the DT I-Gene
serum NN I-Gene
response NN I-Gene
element NN I-Gene
( ( O
SRE NNP B-Gene
) ) O
, , O
12 CD B-Gene
- : I-Gene
O NNP I-Gene
- : I-Gene
tetradecanoyl NN I-Gene
- : I-Gene
phorbol NN I-Gene
- : I-Gene
13 CD I-Gene
- : I-Gene
acetate NN I-Gene
response NN I-Gene
element NN I-Gene
, , O
cyclic JJ B-Gene
AMP NNP I-Gene
response NN I-Gene
element NN I-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
promoter NN I-Gene
. . O

The DT O
stimulation NN O
of IN O
SRE NNP B-Gene
was VBD O
particularly RB O
prominent JJ O
not RB O
only RB O
with IN O
active JJ O
Fyn NNP B-Gene
but CC O
also RB O
with IN O
normal JJ B-Gene
( ( I-Gene
wild JJ I-Gene
- : I-Gene
type NN I-Gene
) ) I-Gene
Fyn NNP I-Gene
. . O

SRE NNP B-Gene
was VBD O
also RB O
stimulated VBN O
by IN O
both DT O
normal JJ B-Gene
and CC I-Gene
active JJ I-Gene
Lck NNP I-Gene
. . O

Furthermore RB O
, , O
normal JJ B-Gene
and CC I-Gene
active JJ I-Gene
Fyn NNP I-Gene
stimulated VBD O
transcription NN O
from IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
when WRB O
transfected VBN O
cells NNS O
were VBD O
stimulated VBN O
by IN O
concanavalin NN B-Gene
A NNP I-Gene
plus CC O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
. . O

Under IN O
the DT O
same JJ O
conditions NNS O
, , O
Lck NNP B-Gene
did VBD O
not RB O
stimulate VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
unless IN O
it PRP O
was VBD O
activated VBN O
by IN O
mutation NN O
. . O

Interestingly RB O
, , O
a DT O
mutant JJ B-Gene
Fyn NNP I-Gene
, , O
which WDT O
has VBZ O
deletions NNS O
within IN O
the DT O
SH2 NNP B-Gene
region NN I-Gene
and CC O
so RB O
is VBZ O
able JJ O
to TO O
transform VB O
chicken JJ O
embryo NN O
fibroblasts NNS O
, , O
did VBD O
not RB O
stimulate VB O
either CC O
the DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
or CC I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
, , O
suggesting VBG O
the DT O
importance NN O
of IN O
this DT O
region NN O
in IN O
T NNP O
- : O
cell NN O
signaling NN O
. . O

Csk NNP B-Gene
, , O
which WDT O
phosphorylates VBZ O
tyrosine NN O
residues NNS O
in IN O
the DT O
negative JJ O
regulatory JJ O
sites NNS O
of IN O
Src NNP B-Gene
family NN I-Gene
kinases NNS I-Gene
, , O
down RB O
- : O
regulated VBN O
Fyn NNP O
- : O
and CC O
Lck NNP O
- : O
mediated VBD O
stimulation NN O
of IN O
the DT O
serum NN B-Gene
response NN I-Gene
element NN I-Gene
and CC O
Fyn NNP O
- : O
mediated VBD O
enhancement NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
Fyn NNP B-Gene
and CC O
Lck NNP B-Gene
, , O
whose WP$ O
activities NNS O
are VBP O
regulated VBN O
by IN O
Csk NNP B-Gene
, , O
are VBP O
involved VBN O
in IN O
different JJ O
phases NNS O
of IN O
T NNP O
- : O
cell NN O
activation NN O
. . O

A DT O
novel JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
containing VBG O
p65 NN B-Gene
homodimers NNS I-Gene
: : O
implications NNS O
for IN O
transcriptional JJ O
control NN O
at IN O
the DT O
level NN O
of IN O
subunit JJ O
dimerization NN O
. . O

The DT O
predominant NN O
inducible JJ O
form NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
is VBZ O
a DT O
heteromeric JJ B-Gene
complex JJ I-Gene
containing VBG O
two CD O
Rel NNP B-Gene
- : I-Gene
related VBN I-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
subunits NNS I-Gene
, , O
termed VBD B-Gene
p65 NN I-Gene
and CC O
p50 NN B-Gene
. . O

Prior NNP O
transfection NN O
studies NNS O
have VBP O
shown VBN O
that IN O
when WRB O
these DT O
p65 NNS B-Gene
and CC I-Gene
p50 NN I-Gene
subunits NNS I-Gene
are VBP O
expressed VBN O
independently RB O
as IN O
stable JJ B-Gene
homodimers NNS I-Gene
, , O
p65 NN B-Gene
stimulates NNS O
kappa VBP O
B NNP O
- : O
directed JJ O
transcription NN O
, , O
whereas WP O
p50 JJ B-Gene
functions NNS O
as IN O
a DT O
kappa NN O
B NNP O
- : O
specific NN O
repressor NN O
. . O

While IN O
authentic JJ O
p50 NN B-Gene
homodimers NNS I-Gene
( ( O
previously RB O
termed VBN O
KBF1 NNP B-Gene
) ) O
have VBP O
been VBN O
detected VBN O
in IN O
nuclear JJ O
extracts NNS O
from IN O
nontransfected JJ O
cells NNS O
, , O
experimental JJ O
evidence NN O
supporting VBG O
the DT O
existence NN O
of IN O
p65 NN B-Gene
homodimers NNS I-Gene
in IN O
vivo NN O
was VBD O
lacking VBG O
. . O

We PRP O
now RB O
provide VBP O
direct JJ O
biochemical JJ O
evidence NN O
for IN O
the DT O
presence NN O
of IN O
an DT O
endogenous JJ O
pool NN O
of IN O
inducible JJ O
p65 NN B-Gene
homodimers NNS I-Gene
in IN O
intact JJ O
human JJ O
T NNP O
cells NNS O
. . O

As IN O
with IN O
the DT O
prototypical JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p50 NN I-Gene
- : I-Gene
p65 NN I-Gene
heterodimer NN I-Gene
, , O
this DT O
novel JJ O
p65 NN B-Gene
homodimeric JJ I-Gene
form NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
functionally RB O
sequestered VBN O
in IN O
the DT O
cytoplasm NN O
but CC O
rapidly RB O
appears VBZ O
in IN O
the DT O
nuclear JJ O
compartment NN O
following VBG O
cellular JJ O
stimulation NN O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
studies NNS O
indicate VBP O
that IN O
the DT O
homodimerization NN O
function NN O
of IN O
p65 NN B-Gene
is VBZ O
dependent JJ O
upon IN O
the DT O
presence NN O
of IN O
cysteine NN O
216 CD O
and CC O
a DT O
conserved JJ O
recognition NN O
motif NN O
for IN O
protein NN B-Gene
kinase NN I-Gene
A NNP I-Gene
( ( O
RRPS NNP B-Gene
; : O
amino JJ O
acids NNS O
273 CD O
to TO O
276 CD O
) ) O
, , O
both DT O
of IN O
which WDT O
reside NN O
within IN O
a DT O
91 CD O
- : O
amino NN O
- : O
acid NN O
segment NN O
of IN O
the DT O
Rel NNP B-Gene
homology NN I-Gene
domain NN I-Gene
that WDT O
mediates VBZ O
self PRP O
- : O
association NN O
. . O

In IN O
contrast NN O
, , O
mutations NNS O
at IN O
these DT O
two CD O
sites NNS O
do VBP O
not RB O
affect VB O
heterodimerization NN O
of IN O
p65 NN B-Gene
with IN O
p50 NN B-Gene
or CC O
its PRP$ O
functional JJ O
interaction NN O
with IN O
I PRP O
kappa VBP O
B NNP O
alpha NN O
. . O

These DT O
later JJ O
findings NNS O
indicate VBP O
that IN O
neither CC O
homo VB O
- : O
nor CC O
heterodimer JJ O
formation NN O
is VBZ O
an DT O
absolute JJ O
prerequisite NN O
for IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
recognition NN O
of IN O
p65 NN B-Gene
. . O

Taken VBN O
together RB O
with IN O
prior JJ O
in IN O
vivo JJ O
transcription NN O
studies NNS O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
the DT O
biological JJ O
activities NNS O
of IN O
p65 NN B-Gene
and CC I-Gene
p50 NN I-Gene
homodimers NNS I-Gene
are VBP O
independently RB O
regulated VBN O
, , O
thereby RB O
providing VBG O
an DT O
integrated VBN O
and CC O
flexible JJ O
control NN O
mechanism NN O
for IN O
the DT O
rapid JJ O
activation NN O
and CC O
repression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP O
Rel NNP B-Gene
- : O
directed VBD O
gene NN O
expression NN O
. . O

Carrier NNP O
determination NN O
for IN O
X NNP O
- : O
linked VBD O
agammaglobulinemia JJ O
using VBG O
X JJ O
inactivation NN O
analysis NN O
of IN O
purified JJ O
B NNP O
cells NNS O
. . O

We PRP O
report VBP O
the DT O
development NN O
of IN O
a DT O
relatively RB O
quick JJ O
and CC O
simple JJ O
method NN O
for IN O
the DT O
assessment NN O
of IN O
X NNP O
inactivation NN O
status NN O
for IN O
carrier NN O
determination NN O
in IN O
families NNS O
affected VBN O
by IN O
X NNP O
- : O
linked VBN O
agammaglobulinemia NN O
( ( O
XLA NNP O
) ) O
. . O

This DT O
method NN O
utilises VBZ O
an DT O
immunomagnetic JJ O
separation NN O
technique NN O
for IN O
B NNP O
cell NN O
purification NN O
and CC O
a DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
based VBN O
assay NN O
for IN O
the DT O
determination NN O
of IN O
methylation NN O
status NN O
at IN O
the DT O
androgen NN B-Gene
receptor NN I-Gene
( ( I-Gene
AR NNP I-Gene
) ) I-Gene
gene NN I-Gene
locus NN I-Gene
to TO O
assess VB O
whether IN O
X JJ O
inactivation NN O
is VBZ O
random JJ O
or CC O
non JJ O
- : O
random NN O
at IN O
this DT O
locus NN O
. . O

We PRP O
report VBP O
the DT O
results NNS O
we PRP O
have VBP O
obtained VBN O
using VBG O
this DT O
assay NN O
to TO O
investigate VB O
females NNS O
known VBN O
to TO O
be VB O
carriers NNS O
of IN O
various JJ O
X NNP O
- : O
linked VBD O
immunodeficiency NN O
disorders NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
investigated VBD O
four CD O
females NNS O
from IN O
different JJ O
families NNS O
affected VBN O
by IN O
XLA NNP O
, , O
two CD O
of IN O
whom WP O
were VBD O
of IN O
unknown JJ O
carrier NN O
status NN O
, , O
and CC O
we PRP O
discuss VBP O
the DT O
results NNS O
obtained VBD O
with IN O
this DT O
and CC O
other JJ O
X NNP O
- : O
inactivation NN O
assays NNS O
. . O

A DT O
similar JJ O
assay NN O
has VBZ O
recently RB O
been VBN O
described VBN O
by IN O
Allen NNP O
et CC O
al NN O
. . O
( ( O
1992 CD O
) ) O
and CC O
applied VBN O
to TO O
members NNS O
of IN O
one CD O
family NN O
affected VBN O
by IN O
XLA NNP O
. . O

Effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
Fc NNP B-Gene
gamma NNP I-Gene
receptor NN I-Gene
II NNP I-Gene
engagement NN O
on IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
during IN O
stimulation NN O
of IN O
B NNP O
lymphocytes NNS O
by IN O
membrane NN O
immunoglobulin NN O
crosslinking NN O
. . O

Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
an DT O
immediate JJ B-Gene
early JJ I-Gene
gene NN I-Gene
that WDT O
is VBZ O
rapidly RB O
upregulated JJ O
in IN O
response NN O
to TO O
mitogenic JJ O
signals NNS O
induced VBN O
by IN O
antigen NN O
receptor NN O
crosslinking VBG O
on IN O
murine NN O
B NNP O
lymphocytes VBZ O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
levels NNS O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
are VBP O
closely RB O
correlated VBN O
with IN O
B NNP O
cell NN O
proliferation NN O
in IN O
several JJ O
models NNS O
of IN O
B NNP O
cell NN O
activation NN O
and CC O
tolerance NN O
. . O

We PRP O
compared VBN O
the DT O
expression NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
during IN O
B NNP O
cell NN O
stimulation NN O
with IN O
Fab NNP B-Gene
' POS I-Gene
2 CD I-Gene
and CC O
IgG NNP B-Gene
anti VBP I-Gene
- : I-Gene
immunoglobulin NN I-Gene
( ( O
anti JJ B-Gene
- : I-Gene
Ig NN I-Gene
) ) O
, , O
since IN O
it PRP O
is VBZ O
known VBN O
that IN O
Fab NNP B-Gene
' POS I-Gene
2 CD I-Gene
anti NNS I-Gene
- : I-Gene
Ig NNP I-Gene
is VBZ O
mitogenic JJ O
while IN O
IgG NNP B-Gene
anti SYM I-Gene
- : I-Gene
Ig NN I-Gene
is VBZ O
not RB O
, , O
owing VBG O
to TO O
a DT O
dominant JJ O
inhibitory JJ O
effect NN O
of IN O
crosslinking VBG O
the DT O
B NNP B-Gene
cell NN I-Gene
Fc NNP I-Gene
gamma NN I-Gene
RII NNP I-Gene
to TO O
membrane VB B-Gene
Ig NNP I-Gene
. . O

While IN O
mitogenic JJ O
doses NNS O
of IN O
Fab NNP B-Gene
' POS I-Gene
2 CD I-Gene
anti NNS I-Gene
- : I-Gene
Ig NNP I-Gene
induce VB O
large JJ O
and CC O
rapid JJ O
increases NNS O
in IN O
Egr NNP O
- : O
1 CD O
expression NN O
, , O
IgG NNP B-Gene
anti SYM I-Gene
- : I-Gene
Ig JJ I-Gene
results NNS O
in IN O
smaller JJR O
increases NNS O
in IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
, , O
comparable JJ O
to TO O
that DT O
seen VBN O
with IN O
submitogenic JJ O
concentrations NNS O
of IN O
Fab NNP B-Gene
' POS I-Gene
2 CD I-Gene
anti NNS I-Gene
- : I-Gene
Ig NNP I-Gene
. . O

However RB O
, , O
the DT O
correlation NN O
between IN O
Egr NNP O
- : O
1 CD O
expression NN O
and CC O
B NNP O
cell NN O
proliferation NN O
breaks NNS O
down RP O
when WRB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
added VBN O
as IN O
a DT O
co NN O
- : O
mitogen NN O
to TO O
induce VB O
B NNP O
cell NN O
proliferation NN O
with IN O
IgG NNP B-Gene
anti SYM I-Gene
- : I-Gene
Ig NN I-Gene
or CC O
submitogenic JJ O
concentrations NNS O
of IN O
Fab NNP B-Gene
' POS I-Gene
2 CD I-Gene
anti NNS I-Gene
- : I-Gene
Ig NNP I-Gene
. . O

No DT O
corresponding JJ O
increases NNS O
in IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
levels NNS O
are VBP O
observed VBN O
when WRB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
added VBN O
. . O

Therefore RB O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
overcomes NNS O
Fc NNP O
receptor NN O
- : O
mediated VBN O
inhibition NN O
of IN O
B NNP O
cell NN O
proliferation NN O
without IN O
affecting VBG O
inhibition NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
induction NN O
, , O
as IN O
demonstrated VBN O
earlier RBR O
for IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
mRNA NN I-Gene
in IN O
this DT O
system NN O
. . O

Identification NN O
of IN O
a DT O
novel JJ O
cyclosporin NN B-Gene
- : I-Gene
sensitive JJ I-Gene
element NN I-Gene
in IN O
the DT O
human JJ B-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha JJ I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
a DT O
cytokine NN B-Gene
with IN O
pleiotropic JJ O
biological JJ O
effects NNS O
, , O
is VBZ O
produced VBN O
by IN O
a DT O
variety NN O
of IN O
cell NN O
types NNS O
in IN O
response NN O
to TO O
induction NN O
by IN O
diverse JJ O
stimuli NNS O
. . O

In IN O
this DT O
paper NN O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
mRNA NN I-Gene
is VBZ O
shown VBN O
to TO O
be VB O
highly RB O
induced VBN O
in IN O
a DT O
murine NN O
T NNP O
cell NN O
clone NN O
by IN O
stimulation NN O
with IN O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
ligands VBZ O
or CC O
by IN O
calcium JJ O
ionophores NNS O
alone RB O
. . O

Induction NN O
is VBZ O
rapid JJ O
, , O
does VBZ O
not RB O
require VB O
de IN O
novo FW O
protein JJ O
synthesis NN O
, , O
and CC O
is VBZ O
completely RB O
blocked VBN O
by IN O
the DT O
immunosuppressant JJ O
cyclosporin NN O
A NNP O
( ( O
CsA NNP O
) ) O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
human JJ B-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
element NN I-Gene
, , O
kappa VB B-Gene
3 CD I-Gene
, , O
which WDT O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
the DT O
calcium NN O
- : O
mediated VBN O
inducibility NN O
and CC O
CsA NNP O
sensitivity NN O
of IN O
the DT O
gene NN O
. . O

In IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
, , O
an DT O
oligonucleotide NN O
containing VBG O
kappa $ B-Gene
3 CD I-Gene
forms NNS O
two CD O
DNA NNP O
protein NN O
complexes NNS O
with IN O
proteins NNS O
that WDT O
are VBP O
present JJ O
in IN O
extracts NNS O
from IN O
unstimulated JJ O
T NNP O
cells NNS O
. . O

These DT O
complexes NNS O
appear VBP O
in IN O
nuclear JJ O
extracts NNS O
only RB O
after IN O
T NNP O
cell NN O
stimulation NN O
. . O

Induction NN O
of IN O
the DT O
inducible JJ O
nuclear JJ B-Gene
complexes NNS I-Gene
is VBZ O
rapid JJ O
, , O
independent JJ O
of IN O
protein JJ O
synthesis NN O
, , O
and CC O
blocked VBN O
by IN O
CsA NNP O
, , O
and CC O
thus RB O
, , O
exactly RB O
parallels VBZ O
the DT O
induction NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
mRNA NN I-Gene
by IN O
TCR NNP O
ligands NNS O
or CC O
by IN O
calcium NN O
ionophore NN O
. . O

Our PRP$ O
studies NNS O
indicate VBP O
that IN O
the DT O
kappa NN B-Gene
3 CD I-Gene
binding NN I-Gene
factor NN I-Gene
resembles VBZ O
the DT O
preexisting VBG O
component NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
of IN O
activated JJ O
T NNP O
cells NNS O
. . O

Thus RB O
, , O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN I-Gene
is VBZ O
an DT O
immediate JJ O
early JJ O
gene NN O
in IN O
activated JJ O
T NNP O
cells NNS O
and CC O
provides VBZ O
a DT O
new JJ O
model NN O
system NN O
in IN O
which WDT O
to TO O
study VB O
CsA NNP B-Gene
- : I-Gene
sensitive JJ I-Gene
gene NN I-Gene
induction NN O
in IN O
activated JJ O
T NNP O
cells NNS O
. . O

Differences NNS O
in IN O
expression NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
in IN O
human JJ O
promyelocytic JJ O
HL NNP O
- : O
60 CD O
cells NNS O
during IN O
differentiation NN O
towards NNS O
macrophages VBZ O
versus NN O
granulocytes NNS O
. . O

Commitment NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
to TO O
macrophage VB O
or CC O
granulocytic JJ O
differentiation NN O
was VBD O
achieved VBN O
by IN O
incubation NN O
with IN O
4 CD O
beta NN O
- : O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
for IN O
30 CD O
- : O
60 CD O
min NN O
or CC O
with IN O
dimethyl JJ O
sulphoxide NN O
( ( O
DMSO NNP O
) ) O
for IN O
24 CD O
h NN O
respectively RB O
. . O

The DT O
commitment NN O
stage NN O
towards NNS O
PMA NNP O
- : O
induced JJ O
macrophage NN O
differentiation NN O
was VBD O
associated VBN O
with IN O
increases NNS O
in IN O
jun NN O
B NNP O
and CC O
c SYM O
- : O
fos NN O
mRNA NN O
levels NNS O
, , O
as RB O
well RB O
as IN O
with IN O
an DT O
increase NN O
in IN O
the DT O
binding NN O
activity NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Nevertheless RB O
, , O
gel JJ O
retardation NN O
analysis NN O
indicated VBD O
that IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
detected VBN O
in IN O
untreated JJ O
cells NNS O
was VBD O
drastically RB O
reduced VBN O
during IN O
the DT O
commitment JJ O
stage NN O
of IN O
DMSO NNP O
- : O
induced VBD O
HL NNP O
- : O
60 CD O
differentiation NN O
towards NNS O
granulocytes NNS O
. . O

When WRB O
HL NNP O
- : O
60 CD O
cells NNS O
were VBD O
treated VBN O
with IN O
sodium NN O
butyrate NN O
, , O
which WDT O
induced VBD O
monocytic JJ O
differentiation NN O
, , O
a DT O
remarkable JJ O
increase NN O
in IN O
AP NNP O
- : O
1 CD O
binding NN O
activity NN O
was VBD O
detected VBN O
. . O

Treatment NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
with IN O
1 CD O
alpha NNS O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
, , O
another DT O
monocytic JJ O
differentiation NN O
agent NN O
, , O
induced VBD O
a DT O
weak JJ O
, , O
but CC O
appreciable JJ O
, , O
increase NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
. . O

Furthermore RB O
, , O
addition NN O
of IN O
sodium NN O
butyrate NN O
or CC O
1 CD O
alpha NNS O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
to TO O
HL NNP O
- : O
60 CD O
cells NNS O
induced VBD O
the DT O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
, , I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
, , I-Gene
jun NN I-Gene
B NNP I-Gene
and CC I-Gene
jun NN I-Gene
D NNP I-Gene
proto NN I-Gene
- : I-Gene
oncogenes NNS I-Gene
. . O

In IN O
contrast NN O
, , O
when WRB O
HL NNP O
- : O
60 CD O
cells NNS O
were VBD O
treated VBN O
with IN O
retinoic JJ O
acid NN O
, , O
a DT O
granulocytic JJ O
differentiation NN O
inducer NN O
, , O
no DT O
enhanced JJ O
AP NNP O
- : O
1 CD O
binding NN O
activity NN O
was VBD O
observed VBN O
, , O
and CC O
only RB O
a DT O
weak JJ O
increase NN O
in IN O
jun JJ B-Gene
D NNP I-Gene
mRNA NN I-Gene
level NN O
was VBD O
detected VBN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
formation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
not RB O
required VBN O
for IN O
the DT O
induction NN O
of IN O
HL NNP O
- : O
60 CD O
differentiation NN O
towards NNS O
granulocytes NNS O
, , O
whereas JJ O
induction NN O
of IN O
monocytic JJ O
differentiation NN O
is VBZ O
correlated VBN O
with IN O
an DT O
increase NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
. . O

The DT O
differential JJ O
expression NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
may MD O
be VB O
critical JJ O
in IN O
the DT O
differentiation NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
towards NNS O
monocytic JJ O
or CC O
granulocytic JJ O
lineages NNS O

Glucocorticoid NNP B-Gene
receptors NNS I-Gene
and CC O
sensitivity NN O
in IN O
leukemias NN O
. . O

In IN O
an DT O
attempt NN O
to TO O
investigate VB O
the DT O
utility NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
determination NN O
to TO O
predict VB O
clinical JJ O
responsiveness NN O
in IN O
human JJ O
leukemias NN O
we PRP O
have VBP O
studied VBN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
the DT O
leukemic JJ O
cells NNS O
from IN O
46 CD O
patients NNS O
and CC O
in IN O
the DT O
lymphocytes NNS O
from IN O
18 CD O
normal JJ O
donors NNS O
. . O

In IN O
the DT O
normal JJ O
lymphocytes NNS O
there EX O
were VBD O
3 CD O
, , O
875 CD O
( ( O
Median JJ O
) ) O
specific JJ O
binding VBG O
sites NNS O
per IN O
cell NN O
. . O

The DT O
blasts NNS O
from IN O
17 CD O
patients NNS O
with IN O
ANLL NNP O
had VBD O
on IN O
average NN O
higher JJR O
levels NNS O
of IN O
binding VBG B-Gene
sites NNS I-Gene
per IN O
cell NN O
( ( O
Median JJ O
= NN O
7 CD O
, , O
250 CD O
, , O
range NN O
: : O
0 CD O
to TO O
15 CD O
, , O
295 CD O
) ) O
than IN O
the DT O
other JJ O
leukemias NN O
. . O

Of IN O
the DT O
15 CD O
patients NNS O
with IN O
CLL NNP O
, , O
six CD O
had VBD O
received VBN O
glucocorticoid JJ O
treatment NN O
for IN O
3 CD O
to TO O
5 CD O
years NNS O
. . O

Their PRP$ O
lymphocytes NNS O
had VBD O
lower JJR O
number NN O
of IN O
receptors NNS O
( ( O
Median JJ O
= NN O
2 CD O
, , O
0 CD O
) ) O
than IN O
the DT O
other JJ O
cases NNS O
which WDT O
were VBD O
newly RB O
diagnosed VBN O
( ( O
Median JJ O
= NN O
4 CD O
, , O
500 CD O
) ) O
. . O

Four CD O
patients NNS O
had VBD O
ALL NNP O
/ NNP O
AUL NNP O
, , O
three CD O
patients NNS O
had VBD O
blast VBN O
crisis NN O
as IN O
terminal JJ O
phase NN O
of IN O
CML NNP O
, , O
and CC O
seven CD O
had VBD O
leukemic JJ O
Non NNP O
- : O
Hodgkin NNP O
lymphomas NN O
( ( O
Median JJ O
= NN O
3 CD O
, , O
500 CD O
sites NNS O
/ NNP O
cell NN O
) ) O
. . O

In IN O
24 CD O
patients NNS O
we PRP O
have VBP O
also RB O
studied VBN O
the DT O
in IN O
vitro JJ O
sensitivity NN O
of IN O
the DT O
leukemic JJ O
cells NNS O
to TO O
dexamethasone VB O
. . O

There EX O
was VBD O
no DT O
marked JJ O
correlation NN O
between IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
and CC O
in IN O
vitro JJ O
sensitivity NN O
. . O

An DT O
attempt NN O
to TO O
correlate VB O
receptor NN O
levels NNS O
with IN O
clinical JJ O
responsiveness NN O
demonstrated VBD O
that IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
determination NN O
might MD O
be VB O
of IN O
value NN O
in IN O
patients NNS O
with IN O
lymphoid JJ O
malignancies NNS O
but CC O
probably RB O
not RB O
in IN O
patients NNS O
with IN O
other JJ O
leukemias NNS O
. . O

' POS B-Gene
Activation NNP I-Gene
- : I-Gene
labile NN I-Gene
' '' I-Gene
glucocorticoid JJ I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
of IN O
a DT O
steroid JJ O
- : O
resistant JJ O
variant NN O
of IN O
CEM NNP O
- : O
C7 NNP O
human JJ O
lymphoid NN O
cells NNS O
. . O

For IN O
cytoplasmic JJ B-Gene
glucocorticoid NN I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
to TO O
enter VB O
and CC O
accumulate VB O
in IN O
the DT O
nucleus NN O
a DT O
temperature NN O
- : O
dependent JJ O
event NN O
, , O
' '' O
activation NN O
' '' O
is VBZ O
required VBN O
. . O

Activation NN O
can MD O
be VB O
achieved VBN O
in IN O
vitro NN O
by IN O
increased VBN O
ionic JJ O
strength NN O
, , O
dilution NN O
or CC O
gel JJ O
filtration NN O
and CC O
is VBZ O
manifested VBN O
by IN O
an DT O
increased JJ O
affinity NN O
of IN O
steroid JJ B-Gene
- : I-Gene
receptor NN I-Gene
complex NN I-Gene
for IN O
DNA NNP B-Gene
and CC O
an DT O
altered JJ O
elution NN O
profile NN O
from IN O
ion NN O
- : O
exchange NN O
resins NNS O
. . O

Munck NNP O
and CC O
Foley NNP O
have VBP O
shown VBN O
that IN O
activated VBD B-Gene
complexes NNS I-Gene
isolated VBN O
from IN O
thymocytes NNS O
elute VBP O
from IN O
DEAE NNP O
- : O
cellulose NN O
in IN O
a DT O
manner NN O
identical JJ O
to TO O
complexes VB O
activated VBN O
in IN O
vitro NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
DEAE NNP O
- : O
cellulose JJ O
chromatography NN O
of IN O
steroid JJ B-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
from IN O
CEM NNP O
- : O
C7 NNP O
, , O
a DT O
cloned JJ O
human JJ O
leukaemic JJ O
T NNP O
- : O
cell NN O
line NN O
sensitive JJ O
to TO O
the DT O
cytolytic JJ O
action NN O
of IN O
glucocorticoids NNS O
, , O
and CC O
its PRP$ O
steroid JJ O
- : O
resistant JJ O
subclone NN O
4R4 CD O
demonstrated VBD O
that IN O
steroid JJ B-Gene
receptors NNS I-Gene
of IN O
clone NN O
4R4 CD O
can MD O
not RB O
form VB O
stable JJ O
activated VBN O
complexes NNS O
. . O

This DT O
defines VBZ O
a DT O
new JJ O
defect NN O
in IN O
receptor NN O
action NN O
, , O
activation NN O
lability NN O
( ( O
r JJ O
+ NNP O
act1 NN O
) ) O
, , O
which WDT O
is VBZ O
unlike IN O
either CC O
the DT O
r NN O
- : O
, , O
r VB O
+ NNP O
nt SYM O
- : O
, , O
or CC O
r NN O
+ JJ O
nti JJ O
phenotypes NNS O
previously RB O
described VBN O
for IN O
mouse NN O
lymphoid JJ O
variants NNS O
. . O

Granulocytes NNS O
in IN O
the DT O
endometrium NN O
of IN O
post NN O
- : O
partum NN O
women NNS O
. . O

Endometrial JJ O
samples NNS O
of IN O
women NNS O
at IN O
various JJ O
stages NNS O
of IN O
gonadal NN O
activity NN O
after IN O
parturition NN O
were VBD O
examined VBN O
for IN O
the DT O
presence NN O
and CC O
numbers NNS O
of IN O
endometrial JJ O
granulocytes NNS O
. . O

Although IN O
samples NNS O
at IN O
all PDT O
the DT O
stages NNS O
contained VBN O
significant JJ O
numbers NNS O
of IN O
the DT O
granulocytes NNS O
( ( O
i NN O
. . O
e NN O
. . O
greater JJR O
than IN O
7 CD O
/ JJ O
high JJ O
- : O
power NN O
field NN O
) ) O
, , O
the DT O
100 CD O
% NN O
values NNS O
for IN O
late JJ O
- : O
proliferative NN O
and CC O
adaptation NN O
hyperplasia NN O
were VBD O
significantly RB O
higher JJR O
than IN O
the DT O
values NNS O
for IN O
the DT O
resting NN O
( ( O
81 CD O
. . O
8 CD O
% NN O
) ) O
, , O
early JJ O
( ( O
82 CD O
. . O
4 CD O
% NN O
) ) O
and CC O
mid $ O
- : O
( ( O
87 CD O
. . O
9 CD O
% NN O
) ) O
proliferative NN O
and CC O
secretory NN O
( ( O
83 CD O
. . O
3 CD O
% NN O
) ) O
phases VBZ O
. . O

We PRP O
suggest VBP O
that IN O
this DT O
correlates VBZ O
with IN O
the DT O
suggestion NN O
that IN O
the DT O
granulocytes NNS O
constitute VBP O
a DT O
receptor NN O
system NN O
for IN O
oestrogens NNS O
. . O

Interaction NN O
of IN O
glucocorticoids NNS O
with IN O
macrophages NNS O
. . O

Identification NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
monocytes NNS O
and CC O
macrophages NNS O
. . O

Glucocorticoid NNP O
binding NN O
was VBD O
measured VBN O
in IN O
resident NN O
and CC O
thioglycollate VB O
- : O
elicited VBN O
mouse NN O
peritoneal NN O
macrophages NNS O
, , O
rabbit NN O
alveolar JJ O
macrophages NNS O
, , O
and CC O
human JJ O
monocytes NNS O
. . O

Two CD O
assays NNS O
of IN O
binding VBG O
were VBD O
used VBN O
- : O
- : O
an DT O
assay NN O
with IN O
intact JJ O
cells NNS O
in IN O
suspension NN O
or CC O
monolayers NNS O
, , O
and CC O
an DT O
assay NN O
of IN O
cytosol NN O
and CC O
nuclear JJ O
forms NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
. . O

The DT O
mononuclear JJ O
phagocytes NNS O
contained VBD O
approximately RB O
equal JJ O
to TO O
4 CD O
- : O
- : O
10 CD O
X NN O
10 CD O
( ( O
3 CD O
) ) O
high JJ B-Gene
affinity NN I-Gene
receptor NN I-Gene
sites VBZ I-Gene
per IN O
cell NN O
, , O
with IN O
dissociation NN O
constants NNS O
of IN O
approximately RB O
equal JJ O
to TO O
2 CD O
- : O
- : O
8 CD O
nM JJ O
dexamethasone NN O
. . O

The DT O
binding NN O
to TO O
the DT O
saturable JJ B-Gene
sites NNS I-Gene
was VBD O
specific JJ O
for IN O
steroids NNS O
with IN O
glucocorticoid NN O
or CC O
antiglucocorticoid JJ O
activity NN O
. . O

Cortisol NNP O
, , O
corticosterone NN O
, , O
and CC O
progesterone NN O
competed VBN O
with IN O
dexamethasone NN O
for IN O
binding NN O
, , O
whereas JJ O
estradiol NN O
, , O
dihydrotestosterone NN O
, , O
and CC O
11 CD O
- : O
epicortisol NN O
competed VBD O
very RB O
little JJ O
. . O

Binding NNP O
of IN O
dexamethasone NN O
to TO O
cytosol VB O
and CC O
nuclear JJ O
forms NNS O
of IN O
the DT O
receptor NN B-Gene
complex NN I-Gene
and CC O
temperature NN O
- : O
sensitive JJ O
translocation NN O
of IN O
cytosol NN O
forms NNS O
to TO O
nuclear JJ O
forms NNS O
were VBD O
shown VBN O
. . O

At IN O
37 CD O
degrees NNS O
C NNP O
the DT O
predominant JJ O
form NN O
of IN O
the DT O
hormone NN B-Gene
- : I-Gene
receptor NN I-Gene
complex NN I-Gene
was VBD O
nuclear JJ O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
corticosteroids NNS O
interact VBP O
with IN O
macrophages NNS O
at IN O
physiological JJ O
concentrations NNS O
. . O

Nitric NNP O
oxide MD O
signaling VBG O
: : O
a DT O
possible JJ O
role NN O
for IN O
G NNP B-Gene
proteins NNS I-Gene
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
various JJ O
inductive JJ O
effects NNS O
of IN O
nitric JJ O
oxide NN O
on IN O
human JJ O
PBMC NNP O
. . O

We PRP O
describe VBP O
a DT O
novel NN O
and CC O
potentially RB O
important JJ O
mechanism NN O
of IN O
nitric JJ O
oxide IN O
signaling VBG O
- : O
through IN O
direct JJ O
activation NN O
of IN O
guanine NN B-Gene
nucleotide IN I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
( ( O
G NNP B-Gene
proteins VBZ I-Gene
) ) O
. . O

We PRP O
have VBP O
found VBN O
that IN O
nitric JJ O
oxide JJ O
treatment NN O
of IN O
membranes NNS O
isolated VBN O
from IN O
fresh JJ O
human JJ O
PBMC NNP O
enhances VBZ O
the DT O
ability NN O
of IN O
these DT O
membranes NNS O
to TO O
hydrolyze VB O
[ NNP O
gamma SYM O
- : O
32P CD O
] JJ O
GTP NNP O
and CC O
bind VB O
[ JJ O
gamma NN O
- : O
35S CD O
] JJ O
GTP NNP O
. . O

In IN O
addition NN O
, , O
treatment NN O
of IN O
whole JJ O
cells NNS O
with IN O
nitric JJ O
oxide NN O
yielded VBN O
membranes NNS O
with IN O
enhanced JJ O
GTPase NNP O
activity NN O
. . O

Furthermore RB O
, , O
the DT O
GTPase NNP O
activity NN O
of IN O
pure NN O
, , O
recombinant JJ O
Gs NNP B-Gene
alpha NN I-Gene
, , O
Gi NNP B-Gene
alpha VBZ I-Gene
1 CD I-Gene
, , O
and CC O
p21ras NN B-Gene
was VBD O
greatly RB O
enhanced VBN O
by IN O
nitric JJ O
oxide NN O
. . O

In IN O
support NN O
of IN O
the DT O
existence NN O
of IN O
this DT O
pathway NN O
in IN O
whole JJ O
cells NNS O
, , O
we PRP O
found VBD O
that IN O
the DT O
G NNP O
protein NN O
inhibitor NN O
, , O
GDP NNP O
- : O
beta NN O
- : O
S NNP O
, , O
blocked VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
translocation NN O
induced VBN O
by IN O
nitric JJ O
oxide NN O
or CC O
LPS NNP O
in IN O
permeabilized JJ O
cells NNS O
. . O

In IN O
addition NN O
, , O
nitric JJ O
oxide NN O
greatly RB O
reduced VBD O
the DT O
pertussis NN O
toxin NN O
- : O
mediated VBN O
ADP NNP O
- : O
ribosylation NN O
of IN O
45 CD B-Gene
- : I-Gene
and CC I-Gene
41 CD I-Gene
- : I-Gene
kDa NN I-Gene
proteins NNS I-Gene
in IN O
membranes NNS O
of IN O
these DT O
cells NNS O
. . O

Because IN O
G NNP B-Gene
proteins VBZ I-Gene
play VB O
a DT O
central JJ O
role NN O
in IN O
many JJ O
diverse JJ O
signaling VBG O
systems NNS O
, , O
activation NN O
by IN O
an DT O
endogenous JJ O
and CC O
inducible JJ O
oxidant NN O
may MD O
represent VB O
a DT O
novel NN O
signaling VBG O
pathway NN O
. . O

The DT O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
promoter NN I-Gene
cis SYM I-Gene
- : I-Gene
acting VBG I-Gene
element NN I-Gene
CLE0 NNP B-Gene
mediates VBZ O
induction NN O
signals NNS O
in IN O
T NNP O
cells NNS O
and CC O
is VBZ O
recognized VBN O
by IN O
factors NNS O
related VBN O
to TO O
AP1 NNP B-Gene
and CC O
NFAT NNP B-Gene
. . O

Expression NN O
of IN O
the DT O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( I-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
) ) I-Gene
gene NN I-Gene
in IN O
T NNP O
cells NNS O
is VBZ O
activated VBN O
by IN O
the DT O
combination NN O
of IN O
phorbol NN O
ester NN O
( ( O
phorbol JJ O
myristate NN O
acetate NN O
) ) O
and CC O
calcium NN O
ionophore NN O
( ( O
A23187 NNP O
) ) O
, , O
which WDT O
mimic VBP O
antigen NN O
stimulation NN O
through IN O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
a DT O
fragment NN O
containing VBG O
bp SYM B-Gene
- : I-Gene
95 CD I-Gene
to TO I-Gene
+ VB I-Gene
27 CD I-Gene
of IN O
the DT O
mouse NN B-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
can MD O
confer VB O
inducibility NN O
to TO O
reporter VB B-Gene
genes NNS I-Gene
in IN O
the DT O
human JJ O
Jurkat NNP O
T NNP O
- : O
cell NN O
line NN O
. . O

Here RB O
we PRP O
use VBP O
an DT O
in IN O
vitro NN O
transcription NN O
system NN O
to TO O
demonstrate VB O
that IN O
a DT O
cis NN B-Gene
- : I-Gene
acting VBG I-Gene
element NN I-Gene
( ( O
positions NNS B-Gene
- : I-Gene
54 CD I-Gene
to TO I-Gene
- : I-Gene
40 CD I-Gene
) ) O
, , O
referred VBD O
to TO O
as IN O
CLE0 NNP B-Gene
, , O
is VBZ O
a DT O
target NN O
for IN O
the DT O
induction NN O
signals NNS O
. . O

We PRP O
observed VBD O
induction NN O
with IN O
templates NNS O
containing VBG O
intact JJ O
CLE0 NNP B-Gene
but CC O
not RB O
with IN O
templates NNS O
with IN O
deleted JJ B-Gene
or CC I-Gene
mutated VBN I-Gene
CLE0 NNP I-Gene
. . O

We PRP O
also RB O
observed VBD O
that IN O
two CD O
distinct JJ O
signals NNS O
were VBD O
required VBN O
for IN O
the DT O
stimulation NN O
through IN O
CLE0 NNP B-Gene
, , O
since IN O
only RB O
extracts VBZ O
from IN O
cells NNS O
treated VBN O
with IN O
both DT O
phorbol NN O
myristate NN O
acetate NN O
and CC O
A23187 NNP O
supported VBD O
optimal JJ O
induction NN O
. . O

Stimulation NN O
probably RB O
was VBD O
mediated VBN O
by IN O
CLE0 NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
because IN O
depletion NN O
of IN O
these DT O
proteins NNS O
specifically RB O
reduced VBD O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
transcription NN O
. . O

One CD O
of IN O
the DT O
binding NN B-Gene
factors NNS I-Gene
possessed VBD O
biochemical JJ O
and CC O
immunological JJ O
features NNS O
identical JJ O
to TO O
those DT O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP1 NNP I-Gene
. . O

Another DT O
factor NN O
resembled VBD O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
NFAT NNP I-Gene
. . O

The DT O
characteristics NNS O
of IN O
these DT O
two CD O
factors NNS O
are VBP O
consistent JJ O
with IN O
their PRP$ O
involvement NN O
in IN O
GM NNP O
- : O
CSF NNP O
induction NN O
. . O

The DT O
presence NN O
of IN O
CLE0 NNP B-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
in IN O
the DT O
promoters NNS B-Gene
of IN O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
3 CD I-Gene
) ) I-Gene
, , I-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
, , I-Gene
IL NNP I-Gene
- : I-Gene
5 CD I-Gene
, , I-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
, , I-Gene
and CC I-Gene
NFAT NNP I-Gene
sites NNS I-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
suggests VBZ O
that IN O
the DT O
factors NNS O
we PRP O
detected VBD O
, , O
or CC O
related JJ O
factors NNS O
that WDT O
recognize VBP O
these DT O
sites NNS O
, , O
may MD O
account VB O
for IN O
the DT O
coordinate JJ O
induction NN O
of IN O
these DT O
genes NNS O
during IN O
T NNP O
- : O
cell NN O
activation NN O
. . O

Identification NN O
and CC O
characterization NN O
of IN O
an DT O
Alu NNP B-Gene
- : I-Gene
containing NN I-Gene
, , I-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
located VBN O
in IN O
the DT O
last JJ O
intron NN B-Gene
of IN O
the DT O
human JJ B-Gene
CD8 NNP I-Gene
alpha NN I-Gene
gene NN I-Gene
. . O

Expression NN O
of IN O
the DT O
human JJ B-Gene
CD8 NNP I-Gene
alpha NN I-Gene
gene NN I-Gene
is VBZ O
restricted VBN O
to TO O
cells NNS O
of IN O
the DT O
lymphoid JJ O
lineage NN O
and CC O
developmentally RB O
regulated VBN O
during IN O
thymopoiesis NN O
. . O

As IN O
an DT O
initial JJ O
step NN O
towards NNS O
understanding VBG O
the DT O
molecular JJ O
basis NN O
for IN O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
this DT O
gene NN O
, , O
we PRP O
surveyed VBD O
the DT O
surrounding VBG O
chromatin NN O
structure NN O
for IN O
potential JJ O
cis NN B-Gene
- : I-Gene
acting VBG I-Gene
regulatory JJ I-Gene
regions NNS I-Gene
by IN O
DNase NNP B-Gene
I PRP I-Gene
hypersensitivity VBP O
mapping VBG O
and CC O
found VBD O
four CD O
hypersensitive NN O
sites NNS O
, , O
three CD O
of IN O
which WDT O
were VBD O
T NNP O
cell NN O
restricted VBD O
. . O

By IN O
using VBG O
a DT O
reporter NN O
- : O
based VBN O
expression NN O
approach NN O
, , O
a DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
was VBD O
identified VBN O
by IN O
its PRP$ O
close JJ O
association NN O
with IN O
a DT O
prominent JJ O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
restricted VBN I-Gene
hypersensitive JJ I-Gene
sites NNS I-Gene
in IN O
the DT O
last JJ O
intron NN O
of IN O
the DT O
CD8 NNP B-Gene
alpha NN I-Gene
gene NN I-Gene
. . O

Deletion NNP O
studies NNS O
demonstrated VBD O
that IN O
the DT O
minimal JJ O
enhancer NN O
is VBZ O
adjacent JJ O
to TO O
a DT O
negative JJ O
regulatory JJ O
element NN O
. . O

DNA NN O
sequence NN O
analysis NN O
of IN O
the DT O
minimal JJ B-Gene
enhancer NN I-Gene
revealed VBD O
a DT O
striking JJ O
cluster NN O
of IN O
consensus NN B-Gene
binding NN I-Gene
sites NNS I-Gene
for IN O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
TCF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
CRE NNP I-Gene
, , I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
, , I-Gene
LyF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
and CC I-Gene
bHLH NN I-Gene
proteins NNS I-Gene
which WDT O
were VBD O
verified VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
. . O

In IN O
addition NN O
, , O
the DT O
5 CD B-Gene
' POS I-Gene
end NN I-Gene
of IN O
the DT O
enhancer NN B-Gene
was VBD O
composed VBN O
of IN O
an DT O
Alu NNP O
repeat NN O
which WDT O
contained VBD O
the DT O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
, , I-Gene
bHLH NN I-Gene
, , I-Gene
and CC I-Gene
LyF NNP I-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Site NNP O
- : O
directed VBD O
mutation NN O
of IN O
the DT O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
sites NNS I-Gene
dramatically RB O
reduced JJ O
enhancer NN O
activity NN O
. . O

The DT O
functional JJ O
importance NN O
of IN O
the DT O
other JJ O
binding NN O
sites NNS O
only RB O
became VBD O
apparent JJ O
when WRB O
combinations NNS O
of IN O
mutations NNS O
were VBD O
analyzed VBN O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
the DT O
human JJ B-Gene
CD8 NNP I-Gene
alpha NN I-Gene
gene NN I-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
interaction NN O
of IN O
multiple JJ O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
nuclear JJ I-Gene
proteins VBZ I-Gene
with IN O
a DT O
transcriptional JJ O
enhancer NN O
located VBN O
in IN O
the DT O
last JJ O
intron NN B-Gene
of IN O
the DT O
gene NN O
. . O

Comparison NNP O
of IN O
the DT O
CD8 NNP B-Gene
alpha NN I-Gene
enhancer NN I-Gene
with IN O
other JJ O
recently RB O
identified VBN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
regulatory JJ I-Gene
elements NNS I-Gene
suggests VBZ O
that IN O
a DT O
common JJ O
set NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
regulates VBZ O
several JJ O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
genes NNS I-Gene
. . O

Molecular JJ O
regulation NN O
of IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
: : O
inducible JJ O
T NNP O
cell NN O
- : O
restricted VBN O
expression NN O
requires VBZ O
intact JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
nuclear JJ I-Gene
protein NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
. . O

Interleukin NNP B-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
is VBZ O
a DT O
hematopoietic JJ B-Gene
stem NN I-Gene
- : I-Gene
cell NN I-Gene
growth NN I-Gene
and CC I-Gene
differentiation NN I-Gene
factor NN I-Gene
that WDT O
is VBZ O
expressed VBN O
solely RB O
in IN O
activated JJ O
T NNP O
and CC O
NK NNP O
cells NNS O
. . O

Studies NNS O
to TO O
date NN O
have VB O
identified VBN O
elements NNS O
5 CD O
' '' O
to TO O
the DT O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
coding NN I-Gene
sequences NNS I-Gene
that WDT O
regulate VBP O
its PRP$ O
transcription NN O
, , O
but CC O
the DT O
sequences NNS O
that WDT O
confer VBP O
T NNP O
cell NN O
- : O
specific JJ O
expression NN O
remain NN O
to TO O
be VB O
clearly RB O
defined VBN O
. . O

We PRP O
have VBP O
now RB O
identified VBN O
DNA NN B-Gene
sequences NNS I-Gene
that WDT O
are VBP O
required VBN O
for IN O
T NNP O
cell NN O
- : O
restricted VBN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
transcription NN O
. . O

A DT O
series NN O
of IN O
transient JJ O
transfections NNS O
performed VBN O
with IN O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
( ( I-Gene
CAT NNP I-Gene
) ) I-Gene
reporter NN I-Gene
plasmids NNS I-Gene
in IN O
T NNP O
and CC O
non SYM O
- : O
T NNP O
cells NNS O
revealed VBD O
that IN O
a DT O
plasmid NN B-Gene
containing VBG O
319 CD O
bp NN O
of IN O
5 CD B-Gene
' POS I-Gene
flanking NN I-Gene
sequences NNS I-Gene
was VBD O
active JJ O
exclusively RB O
in IN O
T NNP O
cells NNS O
. . O

Deletion NN O
analysis NN O
revealed VBD O
that IN O
T NNP O
cell VBP O
specificity NN O
was VBD O
conferred VBN O
by IN O
a DT O
49 CD B-Gene
- : I-Gene
bp NN I-Gene
fragment NN I-Gene
( ( O
bp SYM B-Gene
- : I-Gene
319 CD I-Gene
to TO I-Gene
- : I-Gene
270 CD I-Gene
) ) O
that WDT O
included VBD O
a DT O
potential JJ B-Gene
binding NN I-Gene
site NN I-Gene
for IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factors NNS I-Gene
6 CD O
bp JJ O
upstream NN O
of IN O
a DT O
binding NN B-Gene
site NN I-Gene
for IN I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
member NN O
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

DNaseI NNP B-Gene
footprint NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
analyses NNS O
performed VBN O
with IN O
MLA NNP O
- : O
144 CD O
T NNP O
cell NN O
nuclear JJ O
extracts NNS O
demonstrated VBD O
that IN O
this DT O
49 CD B-Gene
- : I-Gene
bp NN I-Gene
region NN I-Gene
contains VBZ O
a DT O
nuclear JJ B-Gene
protein NN I-Gene
binding VBG I-Gene
region NN I-Gene
that WDT O
includes VBZ O
consensus NN B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

In IN O
addition NN O
, , O
extracts NNS O
prepared VBD O
from IN O
purified VBN O
human JJ O
T NNP O
cells NNS O
contained VBD O
proteins NNS O
that WDT O
bound VBP O
to TO O
synthetic JJ O
oligonucleotides NNS O
corresponding VBG O
to TO O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

In IN O
vitro JJ O
- : O
transcribed NN O
and CC O
- : O
translated VBN O
Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
bound VBD O
specifically RB O
to TO O
the DT O
Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
, , O
and CC O
Elf NNP O
- : O
1 CD O
antisera NN O
competed VBN O
and CC O
super JJ O
shifted VBN O
nuclear JJ O
protein NN O
complexes NNS O
present JJ O
in IN O
MLA NNP O
- : O
144 CD O
nuclear JJ O
extracts NNS O
. . O

Moreover RB O
, , O
addition NN O
of IN O
anti JJ O
- : O
Jun NNP O
family NN O
antiserum NN O
in IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
reactions NNS O
completely RB O
blocked VBD O
formation NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
related VBN I-Gene
complexes NNS I-Gene
. . O

Transient JJ O
transfection NN O
studies NNS O
in IN O
MLA NNP O
- : O
144 CD O
T NNP O
cells NNS O
revealed VBD O
that IN O
constructs NNS O
containing VBG O
mutations NNS O
in IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
almost RB O
completely RB O
abolished JJ O
CAT NNP O
activity NN O
while IN O
mutation NN O
of IN O
the DT O
Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
or CC O
the DT O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
3 CD I-Gene
site NN I-Gene
, , O
a DT O
previously RB O
described VBN O
nuclear JJ B-Gene
protein NN I-Gene
binding VBG I-Gene
site NN I-Gene
( ( O
bp NN B-Gene
. . I-Gene
- : I-Gene
155 CD I-Gene
to TO I-Gene
- : I-Gene
148 CD I-Gene
) ) O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
promoter NN I-Gene
, , O
reduced VBD O
CAT NNP O
activity NN O
to TO O
< VB O
25 CD O
% NN O
of IN O
the DT O
activity NN O
given VBN O
by IN O
wild JJ O
- : O
type NN O
constructs NNS O
. . O

We PRP O
conclude VBP O
that DT O
expression NN O
of IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
requires VBZ O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
; : O
however RB O
, , O
unlike IN O
other JJ O
previously RB O
characterized VBN O
cytokine NN B-Gene
genes NNS I-Gene
such JJ O
as IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
factors NNS I-Gene
can MD O
bind VB O
independently RB O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

Combination NNP O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
reduces NNS O
glucocorticoid JJ O
receptor NN O
- : O
binding NN O
affinity NN O
and CC O
T NNP O
cell VBP O
response NN O
to TO O
glucocorticoids NNS O
. . O

The DT O
mechanisms NN O
contributing VBG O
to TO O
persistent JJ O
T NNP O
cell NN O
activation NN O
and CC O
poor JJ O
response NN O
to TO O
glucocorticoids NNS O
in IN O
chronic JJ O
inflammatory NN O
illnesses NNS O
such JJ O
as IN O
steroid JJ O
resistant NN O
( ( O
SR NNP O
) ) O
asthma NN O
are VBP O
poorly RB O
defined VBN O
. . O

We PRP O
examined VBD O
the DT O
possibility NN O
that WDT O
certain JJ O
cytokines NNS O
, , O
specifically RB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
could MD O
affect VB O
T NNP O
cell NN O
response NN O
to TO O
glucocorticoids NNS O
. . O

A DT O
[ JJ O
3H CD O
] JJ O
dexamethasone NN O
radioligand NN O
- : O
binding NN O
assay NN O
was VBD O
used VBN O
to TO O
measure VB O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
and CC O
dissociation NN O
constant NN O
( ( O
Kd NNP O
) ) O
in IN O
PBMC NNP O
from IN O
normal JJ O
donors NNS O
and CC O
patients NNS O
with IN O
SR NNP O
asthma NN O
, , O
cultured VBN O
in IN O
the DT O
absence NN O
and CC O
presence NN O
of IN O
these DT O
cytokines NNS B-Gene
. . O

PBMC NN O
from IN O
normal JJ O
donors NNS O
incubated VBD O
for IN O
48 CD O
h NN O
in IN O
the DT O
presence NN O
of IN O
combination NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
+ NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
had VBD O
nuclear JJ O
GR NNP O
with IN O
significantly RB O
reduced VBN O
binding NN O
affinity NN O
( ( O
GR NNP O
Kd NNP O
= VBD O
36 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
63 CD O
nM NN O
, , O
mean JJ O
+ NNP O
/ NNP O
- : O
SEM NN O
; : O
p CC O
= $ O
0 CD O
. . O
1 CD O
) ) O
as IN O
compared VBN O
with IN O
PBMC NNP O
incubated VBD O
with IN O
medium NN O
alone RB O
( ( O
GR NNP O
Kd NNP O
= VBD O
6 CD O
. . O
74 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
46 CD O
nM NN O
) ) O
. . O

The DT O
cytosolic JJ O
GR NNP O
Kd NNP O
remained VBD O
unchanged JJ O
. . O

However RB O
, , O
when WRB O
PBMC NNP O
were VBD O
incubated VBN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
alone RB O
or CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
alone RB O
, , O
no DT O
change NN O
in IN O
GR NNP O
- : O
binding NN O
affinity NN O
was VBD O
observed VBN O
. . O

Furthermore RB O
, , O
when WRB O
T NNP O
cells NNS O
and CC O
non JJ O
- : O
T NN O
cells NNS O
were VBD O
individually RB O
stimulated VBN O
with IN O
combination NN O
IL NNP O
- : O
2 CD O
+ NN O
IL NNP O
- : O
4 CD O
, , O
a DT O
significant JJ O
reduction NN O
in IN O
GR NNP O
- : O
binding NN O
affinity NN O
was VBD O
observed VBN O
only RB O
in IN O
the DT O
T NNP O
cell NN O
population NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
IL NNP O
- : O
2 CD O
+ NN O
IL NNP O
- : O
4 CD O
- : O
induced JJ O
alteration NN O
in IN O
PBMC NNP O
GR NNP O
Kd NNP O
was VBD O
associated VBN O
with IN O
an DT O
increase NN O
in IN O
GR NNP O
number NN O
( ( O
8348 CD O
+ NNP O
/ NNP O
- : O
964 CD O
vs NN O
1710 CD O
+ NN O
/ NNP O
- : O
228 CD O
sites NNS O
/ NNP O
cell NN O
; : O
p CC O
= $ O
0 CD O
. . O
3 CD O
) ) O
. . O

More RBR O
importantly RB O
, , O
the DT O
alteration NN O
in IN O
PBMC NNP O
GR NNP O
- : O
binding NN O
affinity NN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
+ NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
was VBD O
associated VBN O
with IN O
a DT O
functional JJ O
change NN O
in IN O
T NNP O
cell NN O
response NN O
to TO O
methylprednisolone VB O
MPN NNP O
, , O
i NN O
. . O
e NN O
. . O
, , O
a DT O
reduced JJ O
inhibitory JJ O
effect NN O
of IN O
MPN NNP O
on IN O
PMA NNP O
/ NNP O
ionomycin SYM O
- : O
induced JJ O
T NNP O
cell NN O
proliferation NN O
. . O

These DT O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
+ NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
on IN O
PBMC NNP O
GR NNP B-Gene
affinity NN O
and CC O
response NN O
to TO O
MPN NNP O
were VBD O
blocked VBN O
by IN O
co NN O
- : O
incubation NN O
with IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

Freshly RB O
isolated VBN O
PBMC NNP O
from IN O
four CD O
patients NNS O
with IN O
SR NNP O
asthma NN O
had VBD O
a DT O
significantly RB O
reduced VBN O
GR NNP O
- : O
binding NN O
affinity NN O
( ( O
Kd NNP O
= VBZ O
40 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
68 CD O
nM NN O
; : O
p CC O
= $ O
0 CD O
. . O
1 CD O
) ) O
when WRB O
compared VBN O
with IN O
seven CD O
normal JJ O
subjects NNS O
( ( O
7 CD O
. . O
15 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
41 CD O
nM NN O
) ) O
. . O

The DT O
altered JJ O
PBMC NNP O
GR NNP O
binding VBG O
from IN O
patients NNS O
with IN O
SR NNP O
asthma NN O
reversed VBD O
to TO O
normal JJ O
when WRB O
incubated VBN O
with IN O
medium NN O
alone RB O
, , O
but CC O
was VBD O
sustained VBN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
+ NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

These DT O
observations NNS O
suggest VBP O
that IN O
with IN O
persistent JJ O
inflammation NN O
certain JJ O
cytokines NNS B-Gene
may MD O
contribute VB O
to TO O
an DT O
impaired JJ O
response NN O
to TO O
glucocorticoids NNS O
. . O

Furthermore RB O
, , O
the DT O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
were VBD O
blocked VBN O
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

Characterization NN O
of IN O
the DT O
human JJ B-Gene
CD4 NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
: : O
transcription NN O
from IN O
the DT O
CD4 NNP B-Gene
gene NN I-Gene
core NN I-Gene
promoter NN I-Gene
is VBZ O
tissue JJ O
- : O
specific NN O
and CC O
is VBZ O
activated VBN O
by IN O
Ets NNP B-Gene
proteins NNS I-Gene
. . O

We PRP O
analyzed VBD O
the DT O
5 CD B-Gene
' POS I-Gene
transcription NN I-Gene
control NN I-Gene
sequences NNS I-Gene
of IN O
the DT O
human JJ B-Gene
CD4 NNP I-Gene
gene NN I-Gene
. . O

We PRP O
located VBD O
the DT O
transcription NN B-Gene
initiation NN I-Gene
site NN I-Gene
and CC O
showed VBD O
that IN O
the DT O
CD4 NNP B-Gene
core NN I-Gene
promoter NN I-Gene
( ( O
positions NNS B-Gene
- : I-Gene
40 CD I-Gene
to TO I-Gene
+ VB I-Gene
16 CD I-Gene
) ) O
lacks VBZ O
a DT O
classical JJ O
` `` O
` `` O
TATA NN O
' '' O
' '' O
or CC O
initiator VB B-Gene
positioning VBG I-Gene
consensus NN I-Gene
sequence NN I-Gene
but CC O
directs NNS O
precise JJ O
and CC O
efficient JJ O
transcription NN O
when WRB O
coupled VBN O
to TO O
the DT O
ubiquitously RB O
active JJ O
simian JJ B-Gene
virus NN I-Gene
40 CD I-Gene
enhancer NN I-Gene
. . O

The DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
CD4 NNP B-Gene
gene NN I-Gene
promoter NN I-Gene
correlated VBN O
with IN O
CD4 NNP O
expression NN O
in IN O
various JJ O
cell NN O
types NNS O
. . O

Interestingly RB O
, , O
the DT O
CD4 NNP B-Gene
core NN I-Gene
promoter NN I-Gene
also RB O
displayed VBD O
a DT O
tissue NN O
- : O
specific JJ O
transcriptional JJ O
activity NN O
. . O

Within IN O
this DT O
fragment NN O
, , O
three CD O
nucleic JJ O
acid NN O
sequences NNS O
are VBP O
completely RB O
conserved VBN O
in IN O
the DT O
murine NN B-Gene
CD4 NNP I-Gene
gene NN I-Gene
. . O

One CD O
of IN O
these DT O
sequences NNS O
contains VBZ O
a DT O
perfect JJ B-Gene
ETS NNP I-Gene
consensus NN I-Gene
sequence NN I-Gene
. . O

Another DT O
ETS NNP B-Gene
consensus NN I-Gene
sequence NN I-Gene
is VBZ O
located VBN O
1060 CD O
nt JJ O
upstream NN O
. . O

Electrophoretic JJ O
- : O
mobility NN O
- : O
shift NN O
assays NNS O
showed VBD O
that IN O
the DT O
core NN O
promoter NN O
ETS NNP O
motif NNP O
binds VBZ O
an DT O
Ets NNP B-Gene
- : I-Gene
related JJ I-Gene
protein NN I-Gene
specifically RB O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
CD4 NNP O
+ NNP O
cells NNS O
. . O

Moreover RB O
, , O
in IN O
CD4 NNP O
- : O
cells NNS O
, , O
overexpression NN O
of IN O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
Ets NNP B-Gene
- : I-Gene
2 CD I-Gene
efficiently RB O
and CC O
specifically RB O
activated JJ O
transcription NN O
from IN O
the DT O
CD4 NNP B-Gene
promoter NN I-Gene
and CC O
core NN B-Gene
promoter NN I-Gene
. . O

These DT O
data NNS O
indicate VBP O
that IN O
Ets NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
play VBP O
a DT O
central JJ O
role NN O
in IN O
controlling VBG O
CD4 NNP O
gene NN O
expression NN O
, , O
by IN O
binding VBG O
to TO O
both DT O
a DT O
classical JJ B-Gene
remote NN I-Gene
site NN I-Gene
and CC O
an DT O
unusual JJ O
proximal NN B-Gene
activator NN I-Gene
sequence NN I-Gene

Glucocorticoid NNP O
receptor NN O
activation NN O
and CC O
inactivation NN O
in IN O
c NN O
ultured JJ O
human JJ O
lymphocytes NNS O
. . O

Although IN O
glucocorticoids NNS O
are VBP O
not RB O
cytolytic JJ O
for IN O
and CC O
do VB O
not RB O
inhibit VB O
the DT O
growth NN O
of IN O
the DT O
IM NNP O
- : O
9 CD O
line NN O
of IN O
cultured JJ O
human JJ O
lymphoblasts NNS O
, , O
these DT O
cells NNS O
have VBP O
a DT O
high JJ O
steroid NN O
- : O
binding NN O
capacity NN O
. . O

We PRP O
have VBP O
used VBN O
IM NNP O
- : O
9 CD O
cells NNS O
in IN O
order NN O
to TO O
examine VB O
whether IN O
unoccupied JJ B-Gene
glucocorticoid JJ I-Gene
receptors NNS I-Gene
are VBP O
inactivated VBN O
and CC O
activated VBN O
in IN O
intact JJ O
cells NNS O
. . O

when WRB O
IM NNP O
- : O
9 CD O
cells NNS O
are VBP O
incubated VBN O
in IN O
glucose JJ O
- : O
free JJ O
medium NN O
in IN O
a DT O
nitrogen NN O
atmosphere NN O
, , O
both DT O
their PRP$ O
ability NN O
to TO O
bind VB O
triamcinolone NN O
acetonide NN O
and CC O
their PRP$ O
ATP NNP O
levels NNS O
decline NN O
and CC O
, , O
when WRB O
glucose NN O
and CC O
oxygen NN O
are VBP O
reintroduced VBN O
, , O
ATP NNP O
levels NNS O
and CC O
receptor NN O
activity NN O
return NN O
. . O

The DT O
specific JJ O
glucocorticoid NN O
- : O
binding NN O
activity NN O
of IN O
cytosol NN O
prepared VBN O
from IN O
cells NNS O
exposed VBN O
to TO O
various JJ O
degrees NNS O
of IN O
energy NN O
limitation NN O
is VBZ O
directly RB O
correlated VBN O
with IN O
the DT O
ATP NNP O
content NN O
. . O

Receptor NNP O
activation NN O
in IN O
intact JJ O
cells NNS O
is VBZ O
rapid JJ O
and CC O
independent JJ O
of IN O
protein JJ O
synthesis NN O
. . O

Cytosol NNP O
prepared VBD O
from IN O
inactivated JJ O
cells NNS O
can MD O
not RB O
be VB O
activated VBN O
by IN O
addition NN O
of IN O
ATP NNP O
. . O

The DT O
inactivation NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
that WDT O
occurs VBZ O
when WRB O
cytosol NN O
from IN O
normal JJ O
IM NNP O
- : O
9 CD O
cells NNS O
is VBZ O
incubated VBN O
at IN O
25 CD O
degrees NNS O
C NNP O
is VBZ O
inhibited VBN O
by IN O
molybdate NN O
, , O
vanadate NN O
, , O
fluoride RB O
, , O
ATP NNP O
, , O
and CC O
several JJ O
other JJ O
nucleotides NNS O
. . O

The DT O
experiments NNS O
with IN O
intact JJ O
human JJ O
lymphoblasts VBZ O
suggest VBP O
that IN O
assays NNS O
of IN O
specific JJ O
glucocorticoid JJ O
- : O
binding NN O
capacity NN O
do VBP O
not RB O
necessarily RB O
reflect VB O
the DT O
cellular JJ O
content NN O
of IN O
receptor NN B-Gene
protein NN I-Gene
. . O

Glucocorticoids NNS O
and CC O
lymphocytes NNS O
. . O

II NNP O
. . O

Cell NNP O
cycle NN O
- : O
dependent NN O
changes NNS O
in IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
content NN O
. . O

To TO O
study VB O
variations NNS O
in IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
during IN O
the DT O
cell NN O
cycle NN O
, , O
we PRP O
have VBP O
separated VBN O
mitogen NN O
- : O
stimulated VBN O
human JJ O
peripheral JJ O
lymphocytes NNS O
and CC O
rat VB O
lymph JJ O
node NN O
cells NNS O
by IN O
unit NN O
gravity NN O
sedimentation NN O
and CC O
measured VBN O
glucocorticoid JJ O
binding NN O
in IN O
the DT O
resultant JJ O
fractions NNS O
. . O

By IN O
morphologic JJ O
criteria NNS O
and CC O
thymidine JJ O
incorporation NN O
, , O
the DT O
fractions NNS O
were VBD O
separated VBN O
into IN O
populations NNS O
of IN O
G0 NNP O
and CC O
G1 NNP O
phase NN O
and CC O
S NNP O
and CC O
post NN O
- : O
S NNP O
phase NN O
cells NNS O
. . O

A DT O
2 CD O
- : O
to TO O
3 CD O
- : O
fold JJ O
increase NN O
in IN O
glucocorticoid JJ O
receptor NN O
sites NNS O
per IN O
cell NN O
, , O
for IN O
cells NNS O
in IN O
the DT O
S NNP O
and CC O
post NN O
- : O
S NNP O
phase NN O
over IN O
those DT O
in IN O
G0 NNP O
and CC O
G1 NNP O
, , O
was VBD O
observed VBN O
with IN O
both DT O
nonstimulated JJ O
rat NN O
lymph NN O
node NN O
cell NN O
suspensions NNS O
and CC O
concanavalin VB O
A NNP O
- : O
stimulated VBN O
human JJ O
peripheral JJ O
lymphocytes NNS O
. . O

These DT O
observations NNS O
together RB O
with IN O
those DT O
from IN O
other JJ O
studies NNS O
indicate VBP O
that IN O
formation NN O
of IN O
new JJ O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
near IN O
the DT O
S NNP O
phase NN O
may MD O
be VB O
a DT O
general JJ O
phenomenon NN O
in IN O
proliferating VBG O
cells NNS O
. . O

We PRP O
propose VBP O
that IN O
this DT O
increase NN O
in IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
during IN O
the DT O
cell NN O
cycle NN O
may MD O
explain VB O
the DT O
increase NN O
in IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
mitogen NN O
- : O
stimulated VBN O
lymphocytes NNS O
. . O

The DT O
leukocyte JJ O
migration NN O
inhibition NN O
response NN O
to TO O
certain JJ O
breast NN B-Gene
cancer NN I-Gene
- : I-Gene
related VBN I-Gene
antigens NNS I-Gene
( ( O
MCF NNP B-Gene
- : I-Gene
7 CD I-Gene
and CC O
MuMTV NNP B-Gene
) ) O
: : O
their PRP$ O
potential JJ O
as IN O
discriminants NNS O
. . O

Certain NNP O
oncogenic JJ O
viruses NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
human JJ O
breast NN O
cancer NN O
, , O
including VBG O
the DT O
murine NN O
mammary JJ O
tumor NN O
virus NN O
( ( O
MuMTV NNP O
) ) O
and CC O
the DT O
Mason NNP O
- : O
Pfizer NNP O
monkey JJ O
virus NN O
( ( O
MPMV NNP O
) ) O
. . O

We PRP O
have VBP O
used VBN O
the DT O
leukocyte JJ O
migration NN O
inhibition NN O
( ( O
LMI NNP O
) ) O
response NN O
to TO O
assay VB O
the DT O
response NN O
to TO O
several JJ O
potential JJ O
breast NN O
cancer NN O
- : O
related VBN O
antigens NNS O
, , O
including VBG O
MuMTV NNP B-Gene
, , O
MPMV NNP B-Gene
, , O
and CC O
a DT O
breast NN O
cancer NN O
cultured VBD O
cell NN O
line NN O
, , O
MCF NNP O
- : O
7 CD O
, , O
in IN O
96 CD O
breast NN O
cancer NN O
patients NNS O
, , O
in IN O
32 CD O
women NNS O
with IN O
benign JJ O
breast NN O
disease NN O
, , O
and CC O
in IN O
67 CD O
normal JJ O
women NNS O
. . O

The DT O
lowest JJS O
tenth JJ O
percentile NN O
of IN O
control NN O
( ( O
LMI NNP O
) ) O
responses VBZ O
was VBD O
used VBN O
as IN O
the DT O
cutoff NN O
point NN O
to TO O
designate VB O
responders NNS O
. . O

Breast NNP O
cancer NN O
patients NNS O
showed VBD O
significant JJ O
responses NNS O
to TO O
MuMTV NNP B-Gene
( ( O
49 CD O
% NN O
and CC O
to TO O
MCF NNP O
- : O
7 CD O
( ( O
50 CD O
% NN O
) ) O
, , O
but CC O
not RB O
to TO O
MPMV NNP B-Gene
( ( O
29 CD O
% NN O
) ) O
. . O

In IN O
a DT O
paired JJ O
- : O
antigen NN O
study NN O
using VBG O
MuMTV NNP B-Gene
and CC O
MCF NNP B-Gene
- : I-Gene
7 CD I-Gene
, , O
75 CD O
% NN O
of IN O
the DT O
breast NN O
cancer NN O
patients NNS O
responded VBD O
, , O
versus FW O
18 CD O
% NN O
of IN O
the DT O
normal JJ O
women NNS O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
50 CD O
) ) O
. . O

The DT O
potential NN O
for IN O
this DT O
assay NN O
to TO O
distinguish VB O
` `` O
` `` O
normal JJ O
' '' O
' '' O
from IN O
` `` O
` `` O
breast NN O
cancer NN O
' '' O
' '' O
was VBD O
analyzed VBN O
using VBG O
a DT O
migration NN O
index NN O
derived VBD O
from IN O
discriminant JJ O
analysis NN O
. . O

The DT O
ability NN O
of IN O
the DT O
assay NN O
to TO O
discriminate VB O
` `` O
` `` O
normal JJ O
' '' O
' '' O
from IN O
` `` O
` `` O
cancer NN O
' '' O
' '' O
was VBD O
significant JJ O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
showed VBD O
a DT O
sensitivity NN O
of IN O
detecting VBG O
` `` O
` `` O
cancer NN O
' '' O
' '' O
of IN O
75 CD O
% NN O
. . O

The DT O
overall JJ O
responses NNS O
to TO O
MuMTV NNP B-Gene
and CC O
MCF NNP B-Gene
- : I-Gene
7 CD I-Gene
were VBD O
analyzed VBN O
with IN O
reference NN O
to TO O
certain JJ O
prognostic JJ O
factors NNS O
, , O
but CC O
showed VBD O
no DT O
relation NN O
to TO O
age NN O
, , O
menstrual JJ O
status NN O
, , O
estrogen NN O
receptor NN O
status NN O
, , O
or CC O
stage NN O
of IN O
disease NN O
. . O

The DT O
above JJ O
reactions NNS O
suggest VBP O
that IN O
a DT O
large JJ O
proportion NN O
of IN O
breast NN O
cancer NN O
patients NNS O
exhibit VBP O
presensitization NN O
to TO O
antigenfs VB O
found VBN O
in IN O
MuMTV NNP B-Gene
and CC O
MCF NNP B-Gene
- : I-Gene
7 CD I-Gene
, , O
which WDT O
may MD O
be VB O
cross SYM O
- : O
reactive NN O
with IN O
antigens NNS O
in IN O
the DT O
primary JJ O
cancer NN O
. . O

These DT O
responses NNS O
appear VBP O
to TO O
be VB O
independent JJ O
of IN O
major JJ O
prognostic JJ O
variables NNS O
. . O

Further JJ O
refinement NN O
of IN O
this DT O
assay NN O
may MD O
yield VB O
one CD O
which WDT O
is VBZ O
more RBR O
highly RB O
discriminating VBG O
for IN O
breast NN O
cancer NN O
. . O

Chronic NNP O
lymphatic JJ O
leukaemia NN O
: : O
cellular JJ O
effects NNS O
of IN O
glucocorticoids NNS O
in IN O
vitro NN O
. . O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
levels NNS O
and CC O
steroid NN O
induced JJ O
inhibition NN O
of IN O
nucleic JJ O
acid NN O
precursors NNS O
have VBP O
been VBN O
examined VBN O
in IN O
lymphocytes NNS O
from IN O
27 CD O
patients NNS O
at IN O
different JJ O
stages NNS O
of IN O
chronic JJ O
lymphatic JJ O
leukaemia NN O
. . O

No DT O
correlation NN O
can MD O
be VB O
found VBN O
between IN O
the DT O
level NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
and CC O
the DT O
stage NN O
of IN O
the DT O
disease NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
a DT O
significant JJ O
difference NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
was VBD O
found VBN O
between IN O
stage NN O
O NNP O
and CC O
stage NN O
III NNP O
/ NNP O
IV NNP O
patients NNS O
, , O
in IN O
terms NNS O
of IN O
the DT O
in IN O
vitro JJ O
effect NN O
of IN O
dexamethasone NN O
on IN O
[ $ O
3H CD O
] NNP O
uridine JJ O
incorporation NN O
. . O

Pyrrolidine NNP O
dithiocarbamate NN O
inhibits NNS O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
mobilization NN O
and CC O
TNF NNP O
production NN O
in IN O
human JJ O
monocytes NNS O
. . O

The DT O
human JJ B-Gene
TNF NNP I-Gene
promoter NN I-Gene
contains VBZ O
four CD O
potential JJ O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
with IN O
the DT O
strongest JJS O
binding NN O
seen VBN O
for IN O
the DT O
- : O
605 CD O
motif NN O
. . O

Nuclear JJ O
extracts NNS O
from IN O
unstimulated JJ O
cells NNS O
of IN O
the DT O
human JJ O
monocytic JJ O
cell NN O
line NN O
, , O
Mono NNP O
Mac NNP O
6 CD O
, , O
contain VBP O
one CD O
specific JJ B-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
complex JJ B-Gene
II NNP I-Gene
) ) O
, , O
consistent JJ O
with IN O
a DT O
constitutive JJ B-Gene
p50 NN I-Gene
homodimer NN I-Gene
. . O

Stimulation NN O
of IN O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
with IN O
LPS NNP O
will MD O
increase VB O
complex JJ B-Gene
II NNP I-Gene
and CC O
will MD O
strongly RB O
induce VB O
a DT O
second JJ O
specific NN O
complex NN O
( ( O
complex JJ B-Gene
I PRP I-Gene
) ) O
, , O
which WDT O
represents VBZ O
the DT O
p50 NN B-Gene
/ VBZ I-Gene
65 CD I-Gene
heterodimer NN I-Gene
. . O

Treatment NN O
of IN O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
with IN O
pyrrolidine JJ O
- : O
dithiocarbamate NN O
( ( O
PDTC NNP O
) ) O
at IN O
300 CD O
microM NN O
will MD O
block VB O
the DT O
LPS NNP B-Gene
- : I-Gene
induced VBD I-Gene
complex JJ I-Gene
I PRP I-Gene
almost RB O
completely RB O
and CC O
will MD O
reduce VB O
complex JJ B-Gene
II NNP I-Gene
to TO O
the DT O
constitutive JJ O
level NN O
. . O

Binding VBG O
activity NN O
of IN O
other JJ O
nuclear JJ B-Gene
factors NNS I-Gene
that WDT O
recognize VBP O
the DT O
SP NNP O
- : O
1 CD O
and CC O
c VB O
/ NNP O
EBP NNP O
motifs NN O
of IN O
the DT O
human JJ B-Gene
TNF NNP I-Gene
promoter NN I-Gene
is VBZ O
not RB O
affected VBN O
by IN O
such JJ O
treatment NN O
. . O

Northern NNP O
blot NN O
analysis NN O
demonstrates VBZ O
that IN O
PDTC NNP O
treatment NN O
will MD O
strongly RB O
reduce VB O
LPS NNP B-Gene
- : I-Gene
induced VBD I-Gene
TNF NNP I-Gene
transcripts NNS I-Gene
. . O

Secreted VBN O
TNF NNP B-Gene
protein NN I-Gene
as IN O
detected VBN O
in IN O
the DT O
Wehi NNP O
164S CD O
/ NNP O
ActD NNP O
bioassay NN O
and CC O
in IN O
a DT O
sandwich JJ O
immunoassay NN O
was VBD O
similarly RB O
reduced VBN O
by IN O
PDTC NNP O
. . O

Kinetic JJ O
analyses NNS O
show VBP O
that IN O
after IN O
LPS NNP O
stimulation NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
will MD O
peak VB O
at IN O
1 CD O
h NN O
, , O
TNF NNP O
transcript NN O
prevalence NN O
at IN O
2 CD O
h NN O
, , O
and CC O
TNF NNP B-Gene
protein VBP I-Gene
at IN O
4 CD O
h NN O
. . O

PDTC NNP O
did VBD O
not RB O
shift VB O
this DT O
response NN O
to TO O
LPS NNP O
to TO O
a DT O
later JJ O
time NN O
, , O
but CC O
suppressed VBD O
NF NNP O
- : O
kappa NN O
B NNP O
mobilization NN O
, , O
TNF NNP B-Gene
transcripts NNS I-Gene
, , O
and CC O
TNF NNP B-Gene
protein NN I-Gene
over IN O
the DT O
entire JJ O
8 CD O
- : O
h NN O
observation NN O
period NN O
. . O

Analysis NN O
of IN O
freshly RB O
isolated VBN O
, , O
LPS NNP O
- : O
stimulated VBD O
blood NN O
monocytes NNS O
showed VBD O
a DT O
similar JJ O
blockade NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Furthermore RB O
, , O
in IN O
these DT O
primary JJ O
cells NNS O
, , O
induction NN O
of IN O
TNF NNP B-Gene
transcripts NNS I-Gene
, , O
as IN O
determined VBN O
by IN O
Northern NNP O
blot NN O
analysis NN O
and CC O
by IN O
quantitative JJ O
polymerase NN O
chain NN O
reaction NN O
, , O
was VBD O
prevented VBN O
by IN O
PDTC NNP O
as IN O
was VBD O
TNF NNP B-Gene
protein JJ I-Gene
production NN O
. . O

These DT O
data NNS O
show VBP O
that IN O
dithiocarbamates NNS O
can MD O
profoundly RB O
affect VB O
cytokine NN O
expression NN O
and CC O
suggest VBP O
that IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
involved VBN O
in IN O
LPS NNP O
- : O
induced VBD O
TNF NNP O
gene NN O
expression NN O
in IN O
human JJ O
monocytes NNS O
. . O

Comparing VBG O
regions NNS O
of IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
ZEBRA NNP I-Gene
protein NN I-Gene
which WDT O
function NN O
as IN O
transcriptional JJ B-Gene
activating NN I-Gene
sequences NNS I-Gene
in IN O
Saccharomyces NNP O
cerevisiae NN O
and CC O
in IN O
B NNP O
cells NNS O
. . O

The DT O
ZEBRA NNP B-Gene
protein NN I-Gene
activates VBZ O
expression NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus VBP O
early JJ B-Gene
- : I-Gene
lytic JJ I-Gene
- : I-Gene
cycle NN I-Gene
genes NNS I-Gene
in IN O
human JJ O
B NNP O
lymphocytes NNS O
. . O

Here RB O
it PRP O
is VBZ O
shown VBN O
that IN O
ZEBRA NNP B-Gene
also RB O
behaves VBZ O
as IN O
a DT O
sequence NN B-Gene
- : I-Gene
specific JJ I-Gene
transcriptional JJ I-Gene
activator NN I-Gene
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Deletional JJ O
mutagenesis NN O
defined VBD O
three CD O
regions NNS O
of IN O
ZEBRA NNP B-Gene
that WDT O
participate VBP O
in IN O
activation NN O
in IN O
S NNP O
. . O
cerevisiae NN O
. . O

These DT O
regions NNS O
are VBP O
designated VBN O
YI NNP B-Gene
( ( O
amino JJ B-Gene
acids NNS I-Gene
[ VBP I-Gene
aa JJ I-Gene
] $ I-Gene
1 CD I-Gene
to TO I-Gene
25 CD I-Gene
) ) O
, , O
YII NNP B-Gene
( ( O
aa RB B-Gene
51 CD I-Gene
to TO I-Gene
102 CD I-Gene
) ) O
, , O
and CC O
YIII NNP B-Gene
( ( O
aa RB B-Gene
228 CD I-Gene
to TO I-Gene
245 CD I-Gene
) ) O
. . O

Two CD O
of IN O
the DT O
three CD O
regions NNS O
of IN O
the DT O
native JJ O
ZEBRA NNP B-Gene
protein NN I-Gene
act NN O
together RB O
to TO O
mediate VB O
activation NN O
when WRB O
assayed VBN O
on IN O
ZEBRA NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
. . O

However RB O
, , O
when WRB O
fused VBN O
to TO O
the DT O
DNA NNP B-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
GAL NNP B-Gene
4 CD O
and CC O
assayed VBN O
on IN O
GAL4 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
, , O
regions NNS B-Gene
YII NNP I-Gene
and CC I-Gene
YIII NNP I-Gene
were VBD O
each DT O
sufficient NN O
to TO O
confer VB O
activation NN O
in IN O
S NNP O
. . O
cerevisiae NN O
. . O

Regions NNS O
of IN O
ZEBRA NNP B-Gene
which WDT O
affected VBD O
activation NN O
in IN O
S NNP O
. . O
cerevisiae NN O
were VBD O
also RB O
required VBN O
in IN O
human JJ O
B NNP O
lymphocytes NNS O
. . O

The DT O
amino NN B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
of IN O
ZEBRA NNP B-Gene
( ( O
aa RB B-Gene
1 CD I-Gene
to TO I-Gene
98 CD I-Gene
) ) O
was VBD O
required VBN O
for IN O
activation NN O
both DT O
in IN O
S NNP O
. . O
cerevisiae NN O
and CC O
in IN O
human JJ O
B NNP O
cells NNS O
; : O
deletion NN O
of IN O
the DT O
carboxy JJ B-Gene
- : I-Gene
terminal JJ I-Gene
18 CD I-Gene
aa NN I-Gene
also RB O
significantly RB O
reduced VBN O
activation NN O
in IN O
both DT O
cell NN O
types NNS O
. . O

Thus RB O
, , O
the DT O
behavior NN O
of IN O
ZEBRA NNP B-Gene
in IN O
human JJ O
B NNP O
cells NNS O
and CC O
S NNP O
. . O
cerevisiae NN O
suggests VBZ O
that IN O
the DT O
protein NN O
contains VBZ O
universal JJ B-Gene
activation NN I-Gene
motifs NNS I-Gene
that WDT O
interact VBP O
with IN O
conserved JJ O
components NNS O
of IN O
the DT O
transcription NN O
machinery NN O
. . O

However RB O
, , O
certain JJ O
deletion NN B-Gene
mutants NNS I-Gene
of IN O
ZEBRA NNP B-Gene
containing VBG O
mutations NNS O
in IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
exhibited VBD O
discordant JJ O
behaviors NNS O
in IN O
S NNP O
. . O
cerevisiae NN O
and CC O
in IN O
B NNP O
cells NNS O
. . O

For IN O
example NN O
, , O
deletion NN O
of IN O
ZEBRA NNP B-Gene
aa $ I-Gene
26 CD I-Gene
to TO I-Gene
51 CD I-Gene
impaired JJ O
activation NN O
to TO O
a DT O
great JJ O
extent NN O
in IN O
B NNP O
cells NNS O
but CC O
had VBD O
little JJ O
or CC O
no DT O
effect NN O
in IN O
S NNP O
. . O
cerevisiae NN O
. . O

The DT O
discordant JJ O
mutants NNS O
may MD O
reflect VB O
interactions NNS O
with IN O
a DT O
variable JJ B-Gene
domain NN I-Gene
of IN O
a DT O
conserved JJ O
component NN O
or CC O
unique JJ O
interactions NNS O
with IN O
specialized JJ O
components NNS O
of IN O
the DT O
basal NN O
transcription NN O
apparatus NN O
in IN O
different JJ O
cells NNS O
. . O

Functional JJ O
interaction NN O
of IN O
the DT O
v NN B-Gene
- : I-Gene
Rel NN I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Rel NN I-Gene
oncoproteins VBZ I-Gene
with IN O
the DT O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
and CC O
association NN O
with IN O
transcription NN B-Gene
factor NN I-Gene
IIB NNP I-Gene
. . O

Rel NNP B-Gene
family NN I-Gene
proteins VBZ I-Gene
regulate VB O
the DT O
expression NN O
of IN O
genes NNS O
linked VBN O
to TO O
kappa VB O
B NNP O
- : O
binding NN O
motifs NNS O
. . O

Little JJ O
is VBZ O
known VBN O
, , O
however RB O
, , O
of IN O
the DT O
mechanism NN O
by IN O
which WDT O
they PRP O
enhance VBP O
transcription NN O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
ability NN O
of IN O
the DT O
v NN B-Gene
- : I-Gene
Rel NN I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Rel NN I-Gene
oncoproteins VBZ I-Gene
to TO O
interact VB O
with IN O
components NNS O
of IN O
the DT O
basal NN O
transcription NN O
machinery NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
both PDT O
the DT O
acidic JJ O
transcription NN O
activation NN O
domain NN O
mapping NN O
to TO O
the DT O
unique JJ O
C NNP B-Gene
terminus NN I-Gene
of IN O
chicken NN B-Gene
c SYM I-Gene
- : I-Gene
Rel NN I-Gene
and CC O
the DT O
F9 NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
activation NN I-Gene
region NN I-Gene
common JJ O
to TO O
both DT O
v FW B-Gene
- : I-Gene
Rel NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
interact NN O
with IN O
the DT O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
TBP NNP B-Gene
) ) O
and CC O
transcription NN B-Gene
factor NN I-Gene
IIB NNP I-Gene
( ( O
TFIIB NNP B-Gene
) ) O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

We PRP O
also RB O
demonstrate VBP O
that IN O
TPB NNP B-Gene
interaction NN O
with IN O
Rel NNP B-Gene
activation NN I-Gene
regions NNS I-Gene
leads VBZ O
to TO O
synergistic JJ O
activation NN O
of IN O
transcription NN O
of IN O
a DT O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
linked VBN I-Gene
reporter NN I-Gene
gene NN I-Gene
. . O

Combined VBN O
with IN O
the DT O
observation NN O
that IN O
the DT O
mouse NN B-Gene
c SYM I-Gene
- : I-Gene
Rel NN I-Gene
and CC I-Gene
human JJ I-Gene
RelA NNP I-Gene
proteins NNS I-Gene
also RB O
interact VBP O
with IN O
TBP NNP B-Gene
and CC O
TFIIB NNP B-Gene
in IN O
vitro NN O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
association NN O
with IN O
basal JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
is VBZ O
important JJ O
for IN O
the DT O
transcriptional JJ O
activities NNS O
of IN O
Rel NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
. . O

p21ras NNS B-Gene
and CC O
calcineurin NN O
synergize NN O
to TO O
regulate VB O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN O
activated JJ O
T NNP O
cells NNS O
. . O

In IN O
T NNP O
lymphocytes NNS O
, , O
triggering VBG O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
induces VBZ O
several JJ O
signaling VBG O
cascades NNS O
which WDT O
ultimately RB O
synergize VBP O
to TO O
induce VB O
the DT O
activity NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN O
activated JJ O
T NNP O
cells NNS O
( ( O
NFAT NNP O
) ) O
, , O
a DT O
DNA NN B-Gene
binding VBG I-Gene
complex JJ I-Gene
critical JJ O
to TO O
the DT O
inducibility NN O
and CC O
T NNP O
cell VBP O
specificity NN O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
growth NN I-Gene
factor NN I-Gene
interleukin JJ B-Gene
2 CD I-Gene
. . O

One CD O
immediate JJ O
consequence NN O
of IN O
T NNP O
cell NN O
activation NN O
via IN O
the DT O
TCR NNP B-Gene
is VBZ O
an DT O
increase NN O
in IN O
cytosolic JJ O
calcium NN O
. . O

Calcium NN O
signals NNS O
are VBP O
important JJ O
for IN O
NFAT NNP O
induction NN O
, , O
and CC O
recent JJ O
studies NNS O
have VBP O
identified VBN O
calcineurin NN B-Gene
, , O
a DT O
calcium NN B-Gene
- : I-Gene
calmodulin NN I-Gene
dependent JJ I-Gene
serine NN I-Gene
- : I-Gene
threonine NN I-Gene
phosphatase NN I-Gene
, , O
as IN O
a DT O
prominent JJ O
component NN O
of IN O
the DT O
calcium NN O
signaling VBG O
pathway NN O
in IN O
T NNP O
cells NNS O
. . O

A DT O
second JJ O
important JJ O
molecule NN O
in IN O
TCR NNP O
signal JJ O
transduction NN O
is VBZ O
the DT O
guanine JJ B-Gene
nucleotide NN I-Gene
binding VBG I-Gene
protein NN I-Gene
, , O
p21ras NNS B-Gene
, , O
which WDT O
is VBZ O
coupled VBN O
to TO O
the DT O
TCR NNP B-Gene
by IN O
a DT O
protein NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
dependent JJ O
mechanism NN O
. . O

The DT O
experiments NNS O
presented VBN O
here RB O
show VBP O
that IN O
expression NN O
by IN O
transfection NN O
of IN O
mutationally RB O
activated VBN O
calcineurin NN B-Gene
or CC O
activated VBN O
p21ras NNS B-Gene
alone RB O
is VBZ O
insufficient JJ O
for IN O
NFAT NNP O
transactivation NN O
. . O

However RB O
, , O
coexpression NN O
of IN O
the DT O
activated JJ O
calcineurin NN O
with IN O
activated JJ O
p21ras NNS O
could MD O
mimic VB O
TCR NNP O
signals NNS O
in IN O
NFAT NNP O
induction NN O
. . O

These DT O
data NNS O
identify VBP O
calcineurin NN B-Gene
and CC O
p21ras NN B-Gene
as IN O
cooperative JJ O
partners NNS O
in IN O
T NNP O
cell NN O
activation NN O
. . O

Expression NN O
of IN O
the DT O
chicken NN B-Gene
GATA NNP I-Gene
factor NN I-Gene
family NN I-Gene
during IN O
early JJ O
erythroid NN O
development NN O
and CC O
differentiation NN O
. . O

The DT O
DNA NNP O
motif NN O
WGATAR NNP O
has VBZ O
been VBN O
identified VBN O
within IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
domains NNS I-Gene
of IN O
globin NN B-Gene
and CC O
other JJ O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
and CC O
the DT O
activator NN B-Gene
proteins VBZ I-Gene
that IN O
bind NN O
to TO O
this DT O
regulatory JJ B-Gene
element NN I-Gene
, , O
the DT O
GATA NNP B-Gene
factors NNS I-Gene
, , O
belong RB O
to TO O
a DT O
multi NN B-Gene
- : I-Gene
gene NN I-Gene
family NN I-Gene
that WDT O
is VBZ O
expressed VBN O
in IN O
chicken NN O
erythroid NN O
cells NNS O
. . O

Here RB O
we PRP O
show VBP O
that RB O
, , O
as IN O
in IN O
chickens NNS O
, , O
multiple JJ O
members NNS O
of IN O
the DT O
GATA NNP B-Gene
factor NN I-Gene
family NN I-Gene
are VBP O
expressed VBN O
in IN O
human NN O
and CC O
murine NN O
erythroid NN O
cells NNS O
. . O

During IN O
the DT O
early JJ O
stages NNS O
of IN O
chicken NN O
embryogenesis NN O
( ( O
well RB O
before RB O
blood NN O
island NN O
formation NN O
) ) O
, , O
each DT O
of IN O
the DT O
GATA NNP B-Gene
family NN I-Gene
members NNS I-Gene
is VBZ O
transcribed VBN O
with IN O
a DT O
unique JJ O
temporal JJ O
and CC O
spatial JJ O
pattern NN O
. . O

In IN O
the DT O
primitive JJ O
erythroid NN O
lineage NN O
, , O
transcription NN O
of IN O
the DT O
embryonic JJ B-Gene
epsilon NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
parallels NNS O
GATA NNP O
- : O
1 CD O
expression NN O
while IN O
the DT O
switch NN O
to TO O
beta VB O
- : O
globin NN O
transcription NN O
in IN O
definitive JJ O
erythroid NN O
cells NNS O
is VBZ O
directly RB O
preceded VBN O
by IN O
a DT O
pronounced JJ O
increase NN O
in IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
accumulation NN O
. . O

The DT O
timing NN O
and CC O
pattern NN O
of IN O
expression NN O
of IN O
these DT O
different JJ O
mRNAs NN B-Gene
during IN O
avian JJ O
erythroid NN O
development NN O
and CC O
differentiation NN O
suggests VBZ O
that IN O
temporally RB O
regulated VBN O
changes NNS O
in IN O
GATA NNP B-Gene
factor NN I-Gene
expression NN O
are VBP O
required VBN O
for IN O
vertebrate JJ O
hematopoiesis NN O
. . O

Molecular JJ O
regulation NN O
of IN O
human JJ B-Gene
interleukin JJ I-Gene
2 CD I-Gene
and CC O
T NNP O
- : O
cell NN O
function NN O
by IN O
interleukin JJ B-Gene
4 CD I-Gene
. . O

Distinct NNP O
functional JJ O
T NNP O
- : O
cell NN O
subsets NNS O
, , O
differing VBG O
in IN O
the DT O
patterns NNS O
of IN O
lymphokines NNS B-Gene
produced VBN O
, , O
regulate VB O
cell NN O
- : O
mediated VBN O
and CC O
humoral JJ O
immune NN O
responses NNS O
. . O

The DT O
two CD O
major JJ O
types NNS O
and CC O
their PRP$ O
principal JJ O
products NNS O
, , O
interleukin JJ B-Gene
4 CD I-Gene
and CC O
interferon VB B-Gene
gamma NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
, , O
are VBP O
reciprocally RB O
negatively RB O
interactive JJ O
. . O

To TO O
analyze VB O
the DT O
molecular JJ O
mechanism NN O
of IN O
IL NNP O
- : O
4 CD O
- : O
mediated VBN O
suppression NN O
of IN O
cell NN O
- : O
mediated VBN O
immunity NN O
we PRP O
studied VBD O
its PRP$ O
effects NNS O
on IN O
expression NN O
of IN O
interleukin JJ B-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
pretreatment NN O
of IN O
Jurkat NNP O
cells NNS O
prior RB O
to TO O
stimulation NN O
resulted VBN O
in IN O
a DT O
decrease NN O
in IN O
transcription NN O
of IN O
the DT O
IL2 NNP B-Gene
gene NN I-Gene
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
suppressed VBD O
IL NNP O
- : O
2 CD O
and CC O
IFN NNP O
- : O
gamma NN O
mRNA NN O
levels NNS O
in IN O
primary JJ O
human JJ O
T NNP O
cells NNS O
, , O
and CC O
addition NN O
of IN O
anti JJ B-Gene
- : I-Gene
CD28 NN I-Gene
antibodies NNS I-Gene
relieved VBD O
this DT O
suppression NN O
. . O

Using VBG O
enhancer SYM B-Gene
- : I-Gene
reporter NN I-Gene
constructs NNS I-Gene
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
specifically RB O
down RP O
- : O
regulated VBN O
the DT O
NFIL NNP B-Gene
- : I-Gene
2B CD I-Gene
element NN I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
using VBG O
a DT O
DNA NN O
oligomer NN O
containing VBG O
the DT O
NFIL NNP B-Gene
- : I-Gene
2B CD I-Gene
binding VBG I-Gene
site NN I-Gene
indicated VBD O
that IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
inhibited VBD O
the DT O
NFIL NNP B-Gene
- : I-Gene
2B CD I-Gene
complex JJ I-Gene
and CC O
that IN O
the DT O
NFIL NNP B-Gene
- : I-Gene
2B CD I-Gene
DNA NN I-Gene
binding NN I-Gene
factor NN I-Gene
is VBZ O
distinct JJ O
from IN O
AP NNP B-Gene
- : I-Gene
1 CD O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
may MD O
regulate VB O
development NN O
and CC O
function NN O
of IN O
T NNP O
- : O
cell NN O
subsets NNS O
involved VBN O
in IN O
cell NN O
- : O
mediated VBN O
immunity NN O
in IN O
part NN O
by IN O
inhibiting VBG B-Gene
factors NNS I-Gene
required VBN O
for IN O
transcription NN O
of IN O
the DT O
IL2 NNP B-Gene
gene NN I-Gene

Immunochemical JJ O
differences NNS O
between IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
from IN O
corticoid JJ O
- : O
sensitive JJ O
and CC O
- : O
resistant NN O
malignant JJ O
lymphocytes NNS O
. . O

We PRP O
have VBP O
explored VBN O
the DT O
possibility NN O
of IN O
using VBG O
antibodies NNS B-Gene
against IN O
purified JJ O
rat NN O
liver NN O
glucocorticoid NN B-Gene
receptors NNS I-Gene
to TO O
study VB O
the DT O
immunochemical JJ O
properties NNS O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
from IN O
murine NN O
and CC O
human JJ O
malignant NN O
lymphocytes NNS O
. . O

For IN O
this DT O
purpose NN O
, , O
purified VBN B-Gene
immune JJ I-Gene
immunoglobulin NN I-Gene
G NNP I-Gene
was VBD O
covalently RB O
linked VBN O
to TO O
Sepharose NNP B-Gene
CL NNP I-Gene
- : I-Gene
4B CD I-Gene
. . O

We PRP O
then RB O
examined VBD O
the DT O
ability NN O
of IN O
the DT O
affinity NN O
gel NN O
to TO O
recognize VB O
cytosolic JJ B-Gene
[ NNP I-Gene
3H CD I-Gene
] NNP I-Gene
triamcinolone NN I-Gene
acetonide NN I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
from IN O
the DT O
corticoid NN O
- : O
sensitive JJ O
( ( O
CS NNP O
) ) O
and CC O
- : O
resistant JJ O
strains NNS O
of IN O
mouse NN O
lymphoma NN O
P1798 NNP O
, , O
from IN O
CS NNP O
lymphocytes NNS O
of IN O
patients NNS O
with IN O
chronic JJ O
lymphatic JJ O
leukemia NN O
, , O
and CC O
from IN O
a DT O
CS NNP O
clone NN O
of IN O
human JJ O
leukemic JJ O
lymphoblasts NNS O
in IN O
tissue NN O
culture NN O
( ( O
CH6 NNP O
) ) O
. . O

Mouse NNP O
thymus NN O
was VBD O
used VBN O
as IN O
a DT O
source NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
from IN O
normal JJ O
CS NNP O
lymphocytes NNS O
. . O

Whereas IN O
the DT O
immunoaffinity NN O
column NN O
retained VBD O
70 CD O
to TO O
84 CD O
% NN O
of IN O
the DT O
58 CD O
- : O
to TO O
62 CD O
- : O
A NN O
( ( O
Stokes NNP O
radius NN O
) ) O
[ VBZ B-Gene
3H CD I-Gene
] NN I-Gene
triamcinolone NN I-Gene
acetonide IN I-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
characteristic NN O
of IN O
the DT O
CS NNP O
mouse NN O
and CC O
human JJ O
lymphocytes NNS O
, , O
it PRP O
failed VBD O
to TO O
recognize VB O
the DT O
27 CD O
- : O
to TO O
28 CD O
- : O
A NN O
( ( O
Stokes NNP O
radius NN O
) ) O
glucocorticoid NN B-Gene
receptor NN I-Gene
present NN O
in IN O
corticoid JJ O
- : O
resistant NN O
mouse NN O
lymphoma NN O
P1798 NNP O
cells NNS O
. . O

Therefore RB O
, , O
under IN O
appropriate JJ O
experimental JJ O
conditions NNS O
, , O
it PRP O
was VBD O
possible JJ O
to TO O
demonstrate VB O
cross NN O
- : O
reactivity NN O
between IN O
the DT O
antiserum NN O
against IN O
rat NN B-Gene
liver NN I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
and CC O
the DT O
58 CD O
- : O
to TO O
62 CD O
- : O
A NN O
( ( O
Stokes NNP O
radius NN O
) ) O
glucocorticoid NN B-Gene
receptor NN I-Gene
from IN O
species NNS O
as RB O
diverse JJ O
as IN O
mouse NN O
and CC O
humans NNS O
. . O

Heterogeneity NN O
of IN O
the DT O
in IN O
vitro JJ O
responses NNS O
to TO O
glucocorticoids NNS O
in IN O
acute JJ O
leukemia NN O
. . O

In IN O
leukocyte JJ O
population NN O
freshly RB O
isolated VBN O
from IN O
the DT O
blood NN O
of IN O
26 CD O
patients NNS O
with IN O
acute JJ O
leukemia NN O
, , O
we PRP O
have VBP O
measured VBN O
several JJ O
parameters NNS O
including VBG O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
, , O
nucleoside JJ O
incorporation NN O
, , O
percentage NN O
of IN O
cells NNS O
in IN O
S NNP O
phase NN O
, , O
and CC O
steroid SYM O
- : O
induced VBN O
cell NN O
lysis NN O
. . O

In IN O
addition NN O
, , O
in IN O
some DT O
cases NNS O
, , O
the DT O
short JJ O
- : O
term NN O
response NN O
to TO O
steroid VB O
therapy NN O
was VBD O
determined VBN O
. . O

Although IN O
, , O
in IN O
all PDT O
the DT O
patients NNS O
studied VBN O
, , O
leukocytes NNS O
were VBD O
found VBN O
to TO O
contain VB O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
, , O
we PRP O
failed VBD O
to TO O
demonstrate VB O
any DT O
correlation NN O
between IN O
the DT O
level NN O
of IN O
binding VBG O
sites NNS O
and CC O
the DT O
in IN O
vitro NN O
or CC O
in IN O
vivo JJ O
response NN O
to TO O
glucocorticoids NNS O
. . O

This DT O
absence NN O
of IN O
correlation NN O
could MD O
be VB O
in IN O
part NN O
explained VBN O
by IN O
the DT O
marked JJ O
heterogeneity NN O
of IN O
the DT O
steroid JJ O
response NN O
demonstrated VBD O
in IN O
leukocyte JJ O
subpopulations NNS O
. . O

It PRP O
appears VBZ O
, , O
however RB O
, , O
that IN O
the DT O
degree NN O
of IN O
steroid JJ O
action NN O
in IN O
vitro NN O
as RB O
well RB O
as IN O
the DT O
extent NN O
of IN O
spontaneous JJ O
and CC O
dexamethasone JJ O
- : O
induced VBN O
cell VBP O
death NN O
may MD O
be VB O
related VBN O
to TO O
the DT O
number NN O
of IN O
cells NNS O
in IN O
the DT O
S NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
cytosol NN O
and CC O
nuclear JJ O
extract NN O
of IN O
human JJ O
leukocytes NNS O
. . O

Cortisol NNP O
binding NN O
by IN O
cytosol NN O
and CC O
0 CD O
. . O
4 CD O
M NNP O
KCl NNP O
extract NN O
of IN O
the DT O
nuclear JJ O
fraction NN O
of IN O
human JJ O
leukocytes NNS O
were VBD O
studied VBN O
by IN O
gel NN O
chromatography NN O
and CC O
ion NN O
exchange NN O
filtration NN O
on IN O
DEAE NNP O
cellulose NN O
. . O

The DT O
cytoplasmic JJ B-Gene
cortisol NN I-Gene
binding VBG I-Gene
protein NN I-Gene
has VBZ O
a DT O
molecular JJ O
weight NN O
95 CD O
0 CD O
and CC O
the DT O
soluble JJ B-Gene
nuclear JJ I-Gene
binding NN I-Gene
protein NN I-Gene
50 CD O
0 CD O
. . O

The DT O
absence NN O
of IN O
the DT O
uptake NN O
of IN O
radioactive JJ O
cortisol NN O
by IN O
isolated JJ O
nuclei NN O
and CC O
the DT O
apparent JJ O
requirement NN O
of IN O
the DT O
cytosol NN O
for IN O
glucocorticoid NN O
specific JJ O
binding NN O
in IN O
nuclear JJ O
receptor NN O
sites NNS O
was VBD O
observed VBN O
. . O

The DT O
association NN O
constant JJ O
characterising VBG O
the DT O
binding NN O
of IN O
cortisol NN O
to TO O
cytosol VB O
was VBD O
KA NNP O
= NNP O
3 CD O
. . O
5 CD O
. . O
10 CD O
( ( O
9 CD O
) ) O
l NN O
/ JJ O
mol NN O
. . O

Corticosteroid NNP O
- : O
induced VBD O
lymphopenia NN O
, , O
immunosuppression NN O
, , O
and CC O
body NN O
defense NN O
. . O

The DT O
apparent JJ O
paradox NN O
of IN O
heightened VBN O
adrenal JJ O
corticosteroid NN O
levels NNS O
associated VBN O
with IN O
reduction NN O
in IN O
the DT O
competence NN O
of IN O
the DT O
body NN O
' POS O
s JJ O
defensive JJ O
apparatus NN O
to TO O
cope VB O
with IN O
exposure NN O
to TO O
new JJ O
microbial JJ B-Gene
antigens NNS I-Gene
is VBZ O
considered VBN O
. . O

The DT O
question NN O
is VBZ O
asked VBN O
how WRB O
this DT O
lowered VBD O
defensive JJ O
capability NN O
, , O
which WDT O
occurs VBZ O
in IN O
the DT O
face NN O
of IN O
a DT O
threat NN O
to TO O
body NN O
integrity NN O
, , O
is VBZ O
consistent JJ O
with IN O
Cannon NNP O
' POS O
s JJ O
principals NNS O
of IN O
the DT O
` `` O
` `` O
wisdom NN O
of IN O
the DT O
body NN O
. . O
' '' O
' '' O

The DT O
suggestion NN O
is VBZ O
offered VBN O
that IN O
the DT O
immunologic JJ O
response NN O
to TO O
self VB B-Gene
- : I-Gene
antigens NNS I-Gene
exposed VBN O
by IN O
disease NN O
or CC O
trauma NN O
may MD O
be VB O
suppressed VBN O
by IN O
corticosteroid NN O
to TO O
offset VB O
the DT O
likelihood NN O
of IN O
autoimmune JJ O
attack NN O
. . O

Protein NNP B-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
activation NN O
is VBZ O
required VBN O
for IN O
lipopolysaccharide JJ O
induction NN O
of IN O
cytokines NNS B-Gene
in IN O
human JJ O
blood NN O
monocytes NNS O
. . O

Bacterial NNP O
LPS NNP O
induce VB O
production NN O
of IN O
cytokines NNS B-Gene
such JJ O
as IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
and CC O
TNF NNP B-Gene
in IN O
mononuclear JJ O
phagocytes NNS O
, , O
and CC O
this DT O
represents VBZ O
a DT O
central JJ O
component NN O
in IN O
the DT O
pathogenesis NN O
of IN O
septic JJ O
shock NN O
syndrome NN O
. . O

However RB O
, , O
the DT O
mechanisms NNS O
by IN O
which WDT O
LPS NNP O
activates VBZ O
these DT O
cells NNS O
to TO O
express VB O
cytokines NNS B-Gene
are VBP O
not RB O
completely RB O
characterized VBN O
. . O

The DT O
present JJ O
study NN O
addressed VBD O
the DT O
role NN O
of IN O
different JJ O
protein NN B-Gene
kinases NNS I-Gene
in IN O
the DT O
LPS NNP O
induction NN O
of IN O
cytokines NNS B-Gene
. . O

It PRP O
is VBZ O
shown VBN O
that IN O
LPS NNP O
induced VBD O
a DT O
12 CD O
- : O
to TO O
16 CD O
- : O
fold JJ O
increase NN O
in IN O
IL NNP O
- : O
1 CD O
beta NN O
, , O
IL NNP O
- : O
6 CD O
, , O
and CC O
TNF NNP O
- : O
alpha NN O
mRNA NN O
levels NNS O
, , O
and CC O
this DT O
was VBD O
completely RB O
or CC O
more JJR O
than IN O
80 CD O
% NN O
blocked VBN O
by IN O
the DT O
protein NN O
tyrosine NN O
kinase NN O
specific JJ O
inhibitors NNS O
herbimycin VBP O
A DT O
and CC O
genistein NN O
at IN O
the DT O
concentrations NNS O
of IN O
1 CD O
. . O
7 CD O
and CC O
37 CD O
microM NN O
, , O
respectively RB O
. . O

Protein NNP B-Gene
kinase VBD I-Gene
C NNP I-Gene
inhibition NN O
by IN O
staurosporine NN O
reduced VBN O
LPS NNP O
induction NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
whereas IN O
it PRP O
had VBD O
no DT O
effects NNS O
on IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
IL NNP O
- : O
1 CD O
beta NN O
. . O

Inhibition NN O
of IN O
protein NN B-Gene
kinase NN I-Gene
A NNP I-Gene
by IN O
H89 NNP O
reduced VBD O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
levels NNS O
but CC O
did VBD O
not RB O
detectably RB O
change VBP O
IL NNP O
- : O
1 CD O
beta NN O
or CC O
TNF NNP O
- : O
alpha NN O
mRNA NN O
levels NNS O
. . O

In IN O
contrast NN O
, , O
LPS NNP O
did VBD O
not RB O
increase VB O
leukemia NN B-Gene
inhibitory JJ I-Gene
factor NN I-Gene
mRNA NN I-Gene
, , O
which WDT O
was VBD O
constitutively RB O
expressed VBN O
and CC O
not RB O
significantly RB O
reduced VBN O
by IN O
these DT O
inhibitors NNS O
. . O

In IN O
addition NN O
to TO O
cytokine VB B-Gene
mRNA NN I-Gene
levels NNS O
, , O
LPS NNP O
- : O
induced VBD O
IL NNP O
- : O
6 CD O
protein NN O
synthesis NN O
and CC O
IL NNP O
- : O
6 CD O
bioactivity NN O
were VBD O
also RB O
reduced VBN O
to TO O
baseline VB O
levels NNS O
by IN O
the DT O
PTK NNP O
inhibitors NNS O
herbimycin VBP O
A DT O
and CC O
genistein NN O
. . O

Both DT O
PTK NNP O
inhibitors NNS O
also RB O
reduced VBD O
the DT O
LPS NNP O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
, , O
which WDT O
is VBZ O
a DT O
transcription NN B-Gene
factor NN I-Gene
involved VBN O
in IN O
the DT O
expression NN O
of IN O
cytokine NN B-Gene
genes NNS I-Gene
such JJ O
as IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

The DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
also RB O
reduced VBN O
by IN O
H89 NNP O
, , O
whereas JJ O
staurosporine NN O
had VBD O
no DT O
effect NN O
on IN O
this DT O
response NN O
. . O

In IN O
summary JJ O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
protein NN B-Gene
kinase VB I-Gene
C NNP I-Gene
and CC O
protein JJ B-Gene
kinase VB I-Gene
A DT I-Gene
appear NN O
to TO O
have VB O
selective JJ O
effects NNS O
in IN O
the DT O
LPS NNP O
induction NN O
of IN O
cytokines NNS B-Gene
, , O
whereas NNS O
PTK NNP B-Gene
is VBZ O
required VBN O
for IN O
LPS NNP O
induction NN O
of IN O
a DT O
broad JJ O
spectrum NN O
of IN O
cytokines NNS B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
in IN O
monocytes NNS O
. . O

In IN O
vivo JJ O
control NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
by IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
stored VBN O
in IN O
the DT O
cytoplasm NN O
in IN O
complexes NNS O
with IN O
the DT O
inhibitor NN B-Gene
protein NN I-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
in IN O
vitro NN O
that IN O
dissociation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
from IN O
these DT O
complexes NNS O
results NNS O
in IN O
active JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

In IN O
this DT O
report NN O
we PRP O
show VBP O
that IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
- : O
induced JJ O
activation NN O
of IN O
B NNP O
or CC O
pre VB O
- : O
B NNP O
cells NNS O
results NNS O
in IN O
loss NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
from IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complexes NN I-Gene
in IN O
vivo NN O
. . O

Many JJ O
liberated VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
dimers NNS I-Gene
reached VBD O
the DT O
nucleus NN O
, , O
where WRB O
increased VBN O
c SYM B-Gene
- : I-Gene
rel NN I-Gene
, , O
p65 NN O
and CC O
p50 NN O
were VBD O
detected VBN O
by IN O
immunoblotting VBG O
and CC O
by IN O
DNA NNP O
binding VBG O
assays NNS O
. . O

Some DT O
liberated JJ B-Gene
dimers NNS I-Gene
were VBD O
retained VBN O
in IN O
the DT O
cytoplasm NN O
, , O
however RB O
, , O
through IN O
binding VBG O
to TO O
newly RB O
synthesized VBN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
a DT O
finding NN O
which WDT O
strongly RB O
suggests VBZ O
( ( O
i NN O
) ) O
that IN O
the DT O
LPS NNP O
- : O
induced VBD O
signal JJ O
causes NNS O
dissociation NN O
of IN O
complexes NNS O
rather RB O
than IN O
preventing VBG O
their PRP$ O
association NN O
and CC O
( ( O
ii NN O
) ) O
that IN O
dissociation NN O
results NNS O
from IN O
modification NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
and CC O
not RB O
of IN O
c SYM B-Gene
- : I-Gene
rel NN I-Gene
or CC O
p65 NN B-Gene
. . O

No DT O
effect NN O
of IN O
LPS NNP O
treatment NN O
was VBD O
detected VBN O
on IN O
p105 NN B-Gene
or CC O
p100 NN B-Gene
, , O
which WDT O
also RB O
retain VBP O
rel JJ B-Gene
family NN I-Gene
members NNS I-Gene
in IN O
the DT O
cytoplasm NN O
. . O

Quite RB O
unexpectedly RB O
, , O
we PRP O
also RB O
found VBD O
that IN O
in IN O
unstimulated JJ O
cells NNS O
there EX O
is VBZ O
a DT O
constant JJ O
ongoing NN O
process NN O
of IN O
degradation NN O
and CC O
replacement NN O
of IN O
complexed NN B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
. . O

We PRP O
propose VBP O
that IN O
this DT O
turnover NN O
results NNS O
in IN O
the DT O
low JJ O
level NN O
of IN O
active JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
presumably RB O
necessary JJ O
even RB O
in IN O
the DT O
unstimulated JJ O
cell NN O
, , O
and CC O
that IN O
the DT O
high JJ O
rate NN O
of IN O
synthesis NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
provides VBZ O
the DT O
ability NN O
to TO O
turn VB O
off RP O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
rapidly RB O
as RB O
soon RB O
as IN O
the DT O
activating VBG O
signal JJ O
ceases NNS O
. . O

Identification NN O
of IN O
a DT O
killer NN B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
regulatory JJ I-Gene
element NN I-Gene
of IN O
the DT O
mouse NN B-Gene
perforin JJ I-Gene
gene NN I-Gene
: : O
an DT O
Ets NNP O
- : O
binding NN O
site NN O
- : O
homologous JJ O
motif NN O
that WDT O
interacts VBZ O
with IN O
Ets NNP B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
. . O

The DT O
gene NN O
encoding VBG O
the DT O
cytolytic JJ B-Gene
protein NN I-Gene
perforin NN B-Gene
is VBZ O
selectively RB O
expressed VBN O
by IN O
activated JJ O
killer NN O
lymphocytes NNS O
. . O

To TO O
understand VB O
the DT O
mechanisms NN O
underlying VBG O
the DT O
cell NN O
- : O
type NN O
- : O
specific JJ O
expression NN O
of IN O
this DT O
gene NN O
, , O
we PRP O
have VBP O
characterized VBN O
the DT O
regulatory JJ O
functions NNS O
and CC O
the DT O
DNA NNP O
- : O
protein NN O
interactions NNS O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
flanking VBG I-Gene
region NN I-Gene
of IN O
the DT O
mouse NN B-Gene
perforin NN I-Gene
gene NN I-Gene
( ( O
Pfp NNP B-Gene
) ) O
. . O

A DT O
region NN O
extending VBG O
from IN O
residues NNS B-Gene
+ $ I-Gene
62 CD I-Gene
through IN I-Gene
- : I-Gene
141 CD I-Gene
, , O
which WDT O
possesses VBZ O
the DT O
essential JJ O
promoter NN O
activity NN O
, , O
and CC O
regions NNS O
further RBR O
upstream NN O
, , O
which WDT O
are VBP O
able JJ O
to TO O
either DT O
enhance NN O
or CC O
suppress JJ O
gene NN O
expression NN O
, , O
were VBD O
identified VBN O
. . O

The DT O
region NN O
between IN O
residues NNS B-Gene
- : I-Gene
411 CD I-Gene
and CC I-Gene
- : I-Gene
566 CD I-Gene
was VBD O
chosen VBN O
for IN O
further JJ O
characterization NN O
, , O
since IN O
it PRP O
contains VBZ O
an DT O
enhancer NN O
- : O
like IN O
activity NN O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
32 CD O
- : O
mer NN O
sequence NN O
( ( O
residues VBZ B-Gene
- : I-Gene
491 CD I-Gene
to TO I-Gene
- : I-Gene
522 CD I-Gene
) ) O
which WDT O
appeared VBD O
to TO O
be VB O
capable JJ O
of IN O
enhancing VBG O
gene NN O
expression NN O
in IN O
a DT O
killer NN O
cell NN O
- : O
specific JJ O
manner NN O
. . O

Within IN O
this DT O
segment NN O
, , O
a DT O
9 CD O
- : O
mer NN O
motif NN O
( ( O
5 CD O
' '' O
- : O
ACAGGAAGT NNP O
- : O
3 CD O
' '' O
, , O
residues VBZ B-Gene
- : I-Gene
505 CD I-Gene
to TO I-Gene
- : I-Gene
497 CD I-Gene
; : O
designated VBN O
NF NNP O
- : O
P NNP O
motif NN O
) ) O
, , O
which WDT O
is VBZ O
highly RB O
homologous JJ O
to TO O
the DT O
Ets NNP B-Gene
proto SYM I-Gene
- : I-Gene
oncoprotein SYM I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
, , O
was VBD O
found VBN O
to TO O
interact VB O
with IN O
two CD O
proteins NNS O
, , O
NF NNP B-Gene
- : I-Gene
P1 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
P2 NN I-Gene
. . O

NF NNP B-Gene
- : I-Gene
P2 NN I-Gene
appears VBZ O
to TO O
be VB O
induced VBN O
by IN O
reagents NNS O
known VBN O
to TO O
up RP O
- : O
regulate VB O
the DT O
perforin JJ O
message NN O
level NN O
and CC O
is VBZ O
present JJ O
exclusively RB O
in IN O
killer NN O
cells NNS O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
and CC O
UV NNP O
cross VBP O
- : O
linking VBG O
experiments NNS O
revealed VBD O
that IN O
NF NNP B-Gene
- : I-Gene
P1 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
P2 NN I-Gene
may MD O
possess VB O
common JJ O
DNA NNP B-Gene
- : I-Gene
binding VBG I-Gene
subunits NNS I-Gene
. . O

However RB O
, , O
the DT O
larger JJR O
native JJ O
molecular JJ O
mass NN O
of IN O
NF NNP B-Gene
- : I-Gene
P1 NN I-Gene
suggests VBZ O
that IN O
NF NNP B-Gene
- : I-Gene
P1 NN I-Gene
contains VBZ O
an DT O
additional JJ O
non NN B-Gene
- : I-Gene
DNA NN I-Gene
- : I-Gene
binding NN I-Gene
subunit NN I-Gene
( ( O
s NN O
) ) O
. . O

In IN O
view NN O
of IN O
the DT O
homology NN O
between IN O
the DT O
NF NNP B-Gene
- : I-Gene
P NNP I-Gene
motif NN I-Gene
and CC O
other JJ O
Ets NNP B-Gene
proto SYM I-Gene
- : I-Gene
oncoprotein SYM I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
it PRP O
is VBZ O
postulated VBN O
that IN O
NF NNP B-Gene
- : I-Gene
P1 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
P2 NN I-Gene
belong NN O
to TO O
the DT O
Ets NNP B-Gene
protein VBD I-Gene
family NN I-Gene
. . O

Results NNS O
obtained VBD O
from IN O
the DT O
binding VBG O
competition NN O
assay NN O
, , O
nevertheless RB O
, , O
suggest VBP O
that IN O
NF NNP B-Gene
- : I-Gene
P1 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
P2 NN I-Gene
are VBP O
related VBN O
to TO O
but CC O
distinct JJ O
from IN O
Ets NNP B-Gene
proteins NNS I-Gene
, , O
e NN O
. . O
g NN O
. . O
, , O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
Ets NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
and CC O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
/ NNP I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
known VBN O
to TO O
be VB O
expressed VBN O
in IN O
T NNP O
cells NNS O
. . O

The DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
( ( I-Gene
p50 JJ I-Gene
/ NNP I-Gene
p105 NN I-Gene
) ) I-Gene
gene NN I-Gene
expression NN O
in IN O
activation NN O
of IN O
human JJ O
blood NN O
T NNP O
- : O
lymphocytes VBZ O
via IN O
CD2 NNP B-Gene
and CC I-Gene
CD28 NNP I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
. . O

Stimulation NN O
of IN O
primary JJ O
human JJ O
T NNP O
- : O
lymphocytes VBZ O
via IN O
CD2 NNP B-Gene
and CC I-Gene
CD28 NNP I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
induces VBZ O
a DT O
long JJ O
- : O
lasting NN O
proliferation NN O
( ( O
> JJ O
3 CD O
weeks NNS O
) ) O
. . O

This DT O
potent JJ O
activation NN O
does VBZ O
not RB O
require VB O
accessory NN O
cells NNS O
, , O
such JJ O
as IN O
monocytes NNS O
, , O
but CC O
depends VBZ O
on IN O
persistent JJ O
interleukin JJ B-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
secretion NN O
and CC O
receptivity NN O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
high JJ O
and CC O
prolonged JJ O
expression NN O
of IN O
the DT O
inducible JJ O
CD25 NNP B-Gene
/ NNP I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) I-Gene
chain NN I-Gene
gene NN I-Gene
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
participates VBZ O
in IN O
the DT O
regulation NN O
of IN O
both DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
genes NNS I-Gene
, , O
as RB O
well RB O
as IN O
multiple JJ B-Gene
cellular JJ I-Gene
genes NNS I-Gene
involved VBN O
in IN O
T NNP O
- : O
cell NN O
proliferation NN O
. . O

To TO O
evaluate VB O
the DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
human JJ O
peripheral JJ O
blood NN O
T NNP O
- : O
lymphocytes NNS O
, , O
we PRP O
previously RB O
analyzed VBD O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
related JJ I-Gene
complexes NNS I-Gene
in IN O
response NN O
to TO O
CD2 NNP O
+ NNP O
CD28 NNP O
costimulation NN O
. . O

We PRP O
demonstrated VBD O
a DT O
long JJ O
- : O
term NN O
induction NN O
of IN O
p50 NN B-Gene
/ NNP I-Gene
p65 NN I-Gene
heterodimer NN I-Gene
, , O
a DT O
putative JJ B-Gene
p65 NN I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
Rel JJ I-Gene
heterodimer NN I-Gene
, , O
and CC O
a DT O
constitutive JJ O
nuclear JJ O
expression NN O
of IN O
KBF1 NNP B-Gene
/ NNP I-Gene
p50 NN I-Gene
homodimers NNS I-Gene
. . I-Gene

As IN O
the DT O
role NN O
of IN O
p50 NN B-Gene
remains NNS O
unclear JJ O
, , O
we PRP O
focused VBD O
our PRP$ O
present JJ O
study NN O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
( ( O
p50 JJ B-Gene
/ NNP I-Gene
p105 NN I-Gene
) ) O
gene NN O
regulation NN O
. . O

Using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
and CC O
Western NNP O
and CC O
Northern NNP O
blot NN O
analyses NNS O
, , O
we PRP O
studied VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
gene NN I-Gene
expression NN O
during IN O
T NNP O
- : O
cell NN O
stimulation NN O
via IN O
CD2 NNP B-Gene
+ NNP I-Gene
CD28 NNP I-Gene
. . O

We PRP O
observed VBD O
a DT O
transient NN O
4 CD O
- : O
to TO O
5 CD O
- : O
fold JJ O
increase NN O
of IN O
NF NNP O
- : O
kappa NN O
B1 NNP O
gene NN O
expression NN O
at IN O
both DT O
the DT O
mRNA NN O
and CC O
protein NN O
levels NNS O
, , O
lasting VBG O
for IN O
at IN O
least JJS O
24 CD O
h NN O
. . O

p50 NN O
DNA NNP O
- : O
binding NN O
activity NN O
apparently RB O
stays VBZ O
highly RB O
controlled VBN O
when WRB O
p105 NN O
expression NN O
is VBZ O
enhanced VBN O
by IN O
a DT O
physiological JJ O
stimulus NN O
of IN O
peripheral JJ O
blood NN O
T NNP O
- : O
cells NNS O
. . O

Partial JJ O
inhibition NN O
of IN O
p50 NN O
and CC O
p105 JJ O
expression NN O
by IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
antisense NN O
oligonucleotides VBZ O
significantly RB O
reduced VBN O
T NNP O
- : O
cell NN O
proliferation NN O
and CC O
CD25 NNP B-Gene
/ NNP I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
cell NN O
surface NN O
expression NN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Vitamin NNP B-Gene
D NNP I-Gene
receptor NN I-Gene
quantitation NN O
in IN O
human JJ O
blood NN O
mononuclear NN O
cells NNS O
in IN O
health NN O
and CC O
disease NN O
. . O

Vitamin NNP B-Gene
D NNP I-Gene
receptor NN I-Gene
( ( O
VDR NNP O
) ) O
concentration NN O
was VBD O
quantitated VBN O
in IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
from IN O
patients NNS O
with IN O
absorptive JJ O
hypercalciuria NNS O
( ( O
AH NNP O
) ) O
and CC O
patients NNS O
with IN O
high JJ O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
due JJ O
to TO O
acquired VBD O
or CC O
transient JJ O
disease NN O
states NNS O
and CC O
the DT O
results NNS O
compared VBN O
to TO O
those DT O
in IN O
normal JJ O
subjects NNS O
. . O

VDR NNP O
concentration NN O
in IN O
resting VBG O
cells NNS O
was VBD O
not RB O
different JJ O
between IN O
the DT O
three CD O
groups NNS O
and CC O
represented VBD O
constitutive JJ O
receptor NN O
expression NN O
of IN O
monocytes NNS O
. . O

Following VBG O
activation NN O
with IN O
phytohemagglutinin NN B-Gene
, , O
patients NNS O
with IN O
hypercalcitriolemia NN O
demonstrated VBN O
significantly RB O
greater JJR O
VDR NNP O
concentrations NNS O
. . O

Patients NNS O
with IN O
AH NNP O
demonstrated VBD O
a DT O
normal JJ O
value NN O
for IN O
the DT O
group NN O
, , O
but CC O
6 CD O
patients NNS O
had VBD O
significantly RB O
greater JJR O
concentrations NNS O
of IN O
VDR NNP B-Gene
despite IN O
normal JJ O
plasma NN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
in IN O
four CD O
of IN O
the DT O
patients NNS O
. . O

Proliferation NN O
, , O
as IN O
assessed VBN O
from IN O
[ JJ O
3H CD O
] JJ O
thymidine NN O
incorporation NN O
was VBD O
inversely RB O
correlated VBN O
with IN O
serum NN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
and CC O
was VBD O
significant JJ O
( ( O
R NNP O
= NNP O
- : O
0 CD O
. . O
299 CD O
, , O
p NN O
= VBD O
0 CD O
. . O
48 CD O
) ) O
. . O

Taken VBN O
together RB O
, , O
the DT O
results NNS O
suggest VBP O
that IN O
PBMC NNP O
provide VB O
a DT O
useful JJ O
system NN O
for IN O
studying VBG O
VDR NNP B-Gene
status NN O
in IN O
transient NN O
or CC O
acquired VBN O
states NNS O
of IN O
hypercalcitriolemia NN O
. . O

Furthermore RB O
, , O
the DT O
studies NNS O
in IN O
patients NNS O
with IN O
absorptive JJ O
hypercalciuria NNS O
disclosed VBD O
it PRP O
to TO O
be VB O
a DT O
heterogeneous JJ O
disorder NN O
, , O
characterized VBN O
by IN O
both DT O
vitamin NNP O
D NNP O
- : O
dependent NN O
and CC O
D NNP O
- : O
independent JJ O
forms NNS O
of IN O
receptor NN O
up IN O
- : O
regulation NN O
. . O

Reactive JJ O
oxygen NN O
intermediates NNS O
activate VBP O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
a DT O
tyrosine NN O
kinase NN O
- : O
dependent NN O
mechanism NN O
and CC O
in IN O
combination NN O
with IN O
vanadate JJ O
activate VBP O
the DT O
p56lck NN B-Gene
and CC I-Gene
p59fyn JJ I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
in IN O
human JJ O
lymphocytes NNS O
. . O

We PRP O
have VBP O
previously RB O
observed VBN O
that IN O
ionizing VBG O
radiation NN O
induces NNS O
tyrosine VBP O
phosphorylation NN O
in IN O
human JJ O
B NNP O
- : O
lymphocyte NN O
precursors NNS O
by IN O
stimulation NN O
of IN O
unidentified JJ O
tyrosine NN B-Gene
kinases NNS I-Gene
and CC O
this DT O
phosphorylation NN O
is VBZ O
substantially RB O
augmented VBN O
by IN O
vanadate NN O
. . O

Ionizing VBG O
radiation NN O
generates NNS O
reactive VBP O
oxygen NN O
intermediates NNS O
( ( O
ROI NNP O
) ) O
. . O

Because IN O
H2O2 NNP O
is VBZ O
a DT O
potent JJ O
ROI NNP O
generator NN O
that WDT O
readily RB O
crosses VBZ O
the DT O
plasma NN O
membrane NN O
, , O
we PRP O
used VBD O
H2O2 NNP O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
ROI NNP O
on IN O
signal JJ O
transduction NN O
. . O

We PRP O
now RB O
provide VBP O
evidence NN O
that IN O
the DT O
tyrosine JJ O
kinase NN O
inhibitor NN O
herbimycin VBD O
A DT O
and CC O
the DT O
free JJ O
radical JJ O
scavenger NN O
N NNP O
- : O
acetyl NN O
- : O
cysteine NN O
inhibit NN O
both DT O
radiation NN O
- : O
induced JJ O
and CC O
H2O2 NNP O
- : O
induced JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
indicating VBG O
that IN O
activation NN O
triggered VBN O
by IN O
ROI NNP O
is VBZ O
dependent JJ O
on IN O
tyrosine JJ O
kinase NN O
activity NN O
. . O

H2O2 NNP O
was VBD O
found VBN O
to TO O
stimulate VB O
Ins NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
4 CD I-Gene
, , I-Gene
5 CD I-Gene
- : I-Gene
P3 NN I-Gene
production NN O
in IN O
a DT O
tyrosine NN O
kinase NN O
- : O
dependent JJ O
manner NN O
and CC O
to TO O
induce VB O
calcium NN O
signals NNS O
that WDT O
were VBD O
greatly RB O
augmented VBN O
by IN O
vanadate NN O
. . O

The DT O
synergistic JJ O
induction NN O
of IN O
tyrosine JJ O
phosphorylation NN O
by IN O
H2O2 NNP O
plus CC O
vanadate NN O
included VBD O
physiologically RB O
relevant JJ O
proteins NNS O
such JJ O
as IN O
PLC NNP B-Gene
gamma VBD I-Gene
1 CD I-Gene
. . O

Although IN O
treatment NN O
of IN O
cells NNS O
with IN O
H2O2 NNP O
alone RB O
did VBD O
not RB O
affect VB O
the DT O
activity NN O
of IN O
src JJ B-Gene
family NN I-Gene
kinases NNS I-Gene
, , O
treatment NN O
with IN O
H2O2 NNP O
plus CC O
vanadate NN O
led VBD O
to TO O
activation NN O
of IN O
the DT O
p56lck NN B-Gene
and CC I-Gene
p59fyn JJ I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
. . O

The DT O
combined JJ O
inhibition NN O
of IN O
phosphatases NNS B-Gene
and CC O
activation NN O
of IN O
kinases NNS B-Gene
provides VBZ O
a DT O
potent NN O
mechanism NN O
for IN O
the DT O
synergistic JJ O
effects NNS O
of IN O
H2O2 NNP O
plus CC O
vanadate NN O
. . O

Induction NN O
of IN O
tyrosine JJ O
phosphorylation NN O
by IN O
ROI NNP O
may MD O
thus RB O
lead VB O
to TO O
many JJ O
of IN O
the DT O
pleiotropic NN O
effects NNS O
of IN O
ROI NNP O
in IN O
lymphoid JJ O
cells NNS O
, , O
including VBG O
downstream JJ O
activation NN O
of IN O
PLC NNP B-Gene
gamma NN I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene

Influence NN O
of IN O
sex NN B-Gene
hormone NN I-Gene
binding VBG I-Gene
globulin NN I-Gene
and CC O
serum NN B-Gene
albumin NN I-Gene
on IN O
the DT O
conversion NN O
of IN O
androstenedione NN O
to TO O
testosterone VB O
by IN O
human JJ O
erythrocytes NNS O
. . O

The DT O
influence NN O
of IN O
human JJ B-Gene
serum NN I-Gene
albumin NN I-Gene
and CC O
sex NN B-Gene
hormone NN I-Gene
binding VBG I-Gene
globulin NN I-Gene
( ( O
SHBG NNP B-Gene
) ) O
on IN O
the DT O
enzymic JJ O
conversion NN O
of IN O
androstenedione NN O
to TO O
testosterone VB O
in IN O
human JJ O
erythrocytes NNS O
was VBD O
investigated VBN O
in IN O
vitro NN O
. . O

Total JJ O
plasma NN O
and CC O
albumin NN B-Gene
delayed VBD O
the DT O
conversion NN O
rate NN O
of IN O
androstenedione NN O
, , O
while IN O
SHBG NNP B-Gene
increased VBD O
it PRP O
markedly RB O
. . O

The DT O
effect NN O
of IN O
SHBG NNP B-Gene
was VBD O
largely RB O
abolished VBN O
by IN O
heating VBG O
to TO O
60 CD O
degrees NNS O
C NNP O
for IN O
1 CD O
h NNS O
and CC O
by IN O
saturating VBG O
its PRP$ O
binding NN O
sites NNS O
by IN O
DHT NNP O
. . O

The DT O
effect NN O
of IN O
both DT O
proteins NNS O
was VBD O
found VBN O
to TO O
be VB O
related VBN O
to TO O
their PRP$ O
concentration NN O
. . O

It PRP O
appears VBZ O
that IN O
the DT O
binding NN O
sites NNS O
of IN O
albumin JJ B-Gene
provide VBP O
a DT O
mechanism NN O
for IN O
retarding VBG O
androstenedione JJ O
uptake NN O
by IN O
the DT O
erythrocytes NNS O
and CC O
that IN O
the DT O
high JJ O
binding NN O
affinity NN O
of IN O
SHBG NNP B-Gene
for IN O
testosterone NN O
facilitates VBZ O
the DT O
diffusion NN O
of IN O
this DT O
steroid NN O
out IN O
of IN O
the DT O
cell NN O
and CC O
thus RB O
, , O
displaces VBZ O
the DT O
chemical NN O
equilibrium NN O
within IN O
the DT O
cell NN O
. . O

Glucocorticoids NNS O
and CC O
lymphocytes NNS O
. . O

I PRP O
. . O

Increased VBN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
in IN O
antigen NN O
- : O
stimulated VBN O
lymphocytes NNS O
. . O

Recently RB O
a DT O
2 CD O
- : O
to TO O
3 CD O
- : O
fold JJ O
increase NN O
in IN O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
human JJ O
peripheral JJ O
lymphocytes NNS O
has VBZ O
been VBN O
noted VBN O
after IN O
in IN O
vitro JJ O
mitogen NN O
stimulation NN O
. . O

Here RB O
, , O
we PRP O
extend VBP O
these DT O
observations NNS O
to TO O
in IN O
vivo JJ O
immunization NN O
. . O

After IN O
unilateral JJ O
immunization NN O
of IN O
adrenalectomized JJ O
male NN O
rats NNS O
, , O
a DT O
50 CD O
% NN O
increase NN O
in IN O
glucocorticoid JJ O
receptor NN O
sites NNS O
per IN O
cell NN O
, , O
determined VBN O
by IN O
binding VBG O
of IN O
dexamethasone NN O
, , O
was VBD O
observed VBN O
in IN O
cell NN O
suspensions NNS O
of IN O
homolateral JJ O
lymph NN O
nodes NNS O
over IN O
those DT O
from IN O
the DT O
contralateral JJ O
nonimmunized JJ O
side NN O
of IN O
the DT O
same JJ O
animal NN O
. . O

The DT O
association NN O
constant NN O
for IN O
dexamethasone NN O
was VBD O
similar JJ O
in IN O
both DT O
groups NNS O
, , O
as IN O
was VBD O
the DT O
stereospecificity NN O
for IN O
various JJ O
steroids NNS O
, , O
the DT O
time NN O
course NN O
of IN O
cytoplasmic JJ O
and CC O
nuclear JJ O
association NN O
, , O
and CC O
cytoplasmic JJ O
- : O
to TO O
- : O
nuclear JJ O
translocation NN O
. . O

Despite IN O
a DT O
50 CD O
% NN O
increase NN O
in IN O
the DT O
number NN O
of IN O
glucocorticoid JJ O
receptor NN O
sites NNS O
per IN O
cell NN O
, , O
the DT O
cells NNS O
from IN O
the DT O
homolateral JJ O
and CC O
controlateral JJ O
lymph NN O
nodes NNS O
were VBD O
equally RB O
sensitive JJ O
to TO O
the DT O
inhibitory JJ O
effects NNS O
of IN O
dexamethasone NN O
, , O
as IN O
determined VBN O
by IN O
measurements NNS O
of IN O
the DT O
incorporation NN O
of IN O
radiolabeled JJ O
precursors NNS O
of IN O
protein NN O
, , O
RNA NNP O
, , O
and CC O
DNA NNP O
, , O
or CC O
measurements NNS O
of IN O
in IN O
vitro NN O
cell NN O
survival NN O
. . O

Glucocorticoid NNP O
receptors NNS O
and CC O
actions NNS O
in IN O
rat NN O
thymocytes NNS O
and CC O
immunologically RB O
stimulated VBN O
human JJ O
peripheral JJ O
lymphocytes NNS O
. . O

After IN O
reviewing VBG O
briefly NN O
our PRP$ O
earlier JJR O
studies NNS O
on IN O
glucocorticoid JJ O
receptors NNS O
and CC O
mechanisms NNS O
in IN O
thymus NN O
cells NNS O
, , O
we PRP O
have VBP O
outlined VBN O
results NNS O
from IN O
the DT O
following VBG O
two CD O
areas NNS O
of IN O
current JJ O
interest NN O
in IN O
our PRP$ O
laboratories NNS O
: : O
the DT O
` `` O
` `` O
life NN O
- : O
cycle NN O
' '' O
' '' O
of IN O
glucocorticoid JJ O
receptors NNS O
and CC O
complexes NNS O
in IN O
thymus NN O
cells NNS O
, , O
and CC O
the DT O
levels NNS O
of IN O
glucocorticoid NN O
receptors NNS O
and CC O
sensitivity NN O
in IN O
immunologically RB O
stimulated VBN O
human JJ O
peripheral JJ O
lymphocytes NNS O
. . O

Several JJ O
of IN O
our PRP$ O
results NNS O
on IN O
energetics NNS O
and CC O
kinetics NNS O
of IN O
hormone NN O
binding NN O
to TO O
glucocorticoid VB B-Gene
receptors NNS I-Gene
in IN O
rat NN O
thymus NN O
cells NNS O
seem VBP O
to TO O
require VB O
extension NN O
of IN O
the DT O
simplest JJS O
model NN O
of IN O
hormone NN O
- : O
receptor NN O
transformations NNS O
in IN O
intact JJ O
cells NNS O
. . O

ATP NNP O
- : O
depletion NN O
experiments NNS O
suggest VBP O
the DT O
existence NN O
of IN O
a DT O
nonbinding JJ O
form NN O
of IN O
the DT O
receptor NN O
; : O
` `` O
` `` O
chase NN O
' '' O
' POS O
experiments NNS O
suggest VBP O
reaction NN O
of IN O
hormone NN O
directly RB O
with IN O
nuclear JJ O
- : O
bound NN O
receptor NN O
; : O
experiments NNS O
on IN O
depletion NN O
and CC O
replenishment NN O
of IN O
cytoplasmic JJ B-Gene
receptor NN I-Gene
using VBG O
cortisol NN O
and CC O
dexamethasone NN O
suggest VBP O
the DT O
existence NN O
of IN O
at IN O
least JJS O
two CD O
subpopulations NNS O
of IN O
nuclear JJ B-Gene
- : I-Gene
bound NN I-Gene
hormone NN I-Gene
- : I-Gene
receptor NN I-Gene
complex NN I-Gene
. . O

We PRP O
have VBP O
found VBN O
that IN O
mitogen NN O
or CC O
immunologic JJ O
stimulation NN O
of IN O
human JJ O
peripheral JJ O
lymphocytes NNS O
in IN O
culture NN O
leads NNS O
within IN O
24 CD O
h NN O
or CC O
so RB O
to TO O
a DT O
striking JJ O
increase NN O
in IN O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
sites NNS O
per IN O
cell NN O
. . O

We PRP O
believe VBP O
this DT O
increase NN O
may MD O
be VB O
due JJ O
to TO O
partial JJ O
synchronization NN O
of IN O
the DT O
cell NN O
population NN O
in IN O
a DT O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
in IN O
which WDT O
receptor NN O
content NN O
is VBZ O
high JJ O
. . O

Contrary JJ O
to TO O
the DT O
widely RB O
held VBN O
view NN O
that IN O
mitogen NN O
- : O
stimulated JJ O
cells NNS O
become VBP O
insensitive JJ O
to TO O
glucocorticoids NNS O
, , O
our PRP$ O
experiments NNS O
show VBP O
that IN O
with IN O
respect NN O
to TO O
inhibition NN O
of IN O
thymidine NN O
and CC O
uridine JJ O
incorporation NN O
and CC O
glucose JJ O
uptake NN O
, , O
the DT O
cells NNS O
are VBP O
highly RB O
sensitive JJ O
to TO O
dexamethasone VB O
at IN O
24 CD O
, , O
48 CD O
, , O
and CC O
72 CD O
h NN O
after IN O
stimulation NN O
with IN O
concanavalin NN B-Gene
A NNP I-Gene
. . O

Nuclear JJ O
glucocorticoid NN O
binding NN O
in IN O
chronic JJ O
lymphatic JJ O
leukemia NN O
lymphocytes NNS O
. . O

A DT O
reliable JJ O
procedure NN O
is VBZ O
described VBN O
for IN O
isolating VBG O
3H CD B-Gene
- : I-Gene
triamcinolone NN I-Gene
acetonide NN I-Gene
( ( I-Gene
3H CD I-Gene
- : I-Gene
TA NN I-Gene
) ) I-Gene
receptor NN I-Gene
complexes NNS I-Gene
from IN O
purified VBN O
chronic JJ O
lymphatic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
lymphocyte NN O
nuclei NN O
, , O
based VBN O
on IN O
the DT O
use NN O
of IN O
carbobenzoxy JJ O
- : O
L NNP O
- : O
phenylalanine NN O
( ( O
CBZ NNP O
- : O
L NNP O
- : O
phe NN O
) ) O
to TO O
prevent VB O
breakdown NN O
of IN O
hormone NN B-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
during IN O
extraction NN O
of IN O
nuclei NN O
with IN O
0 CD O
. . O
6M CD O
KCl NNP O
. . O

Using VBG O
this DT O
method NN O
, , O
specific JJ O
nuclear JJ O
glucocorticoid NN O
binding NN O
was VBD O
demonstrated VBN O
in IN O
14 CD O
/ JJ O
14 CD O
patients NNS O
with IN O
untreated JJ O
CLL NNP O
. . O

No DT O
correlation NN O
was VBD O
found VBN O
between IN O
levels NNS O
of IN O
nuclear JJ O
- : O
associated VBN O
3H CD O
- : O
TA NN O
and CC O
peripheral JJ O
white JJ O
blood NN O
cell NN O
count NN O
or CC O
rosetting VBG O
ability NN O
of IN O
circulating VBG O
lymphocytes NNS O
. . O

Multiple NNP O
closely RB O
- : O
linked VBN O
NFAT NNP B-Gene
/ NNP I-Gene
octamer NN I-Gene
and CC O
HMG NNP B-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
binding NN I-Gene
sites NNS I-Gene
are VBP O
part NN O
of IN O
the DT O
interleukin JJ O
- : O
4 CD O
promoter NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
immediate JJ B-Gene
upstream JJ I-Gene
region NN I-Gene
( ( O
from IN O
position NN O
- : O
12 CD O
to TO O
- : O
270 CD O
) ) O
of IN O
the DT O
murine NN B-Gene
interleukin NN I-Gene
4 CD I-Gene
( ( I-Gene
Il NNP I-Gene
- : I-Gene
4 CD I-Gene
) ) I-Gene
gene NN I-Gene
harbors NNS O
a DT O
strong JJ O
cell NN O
- : O
type NN O
specific JJ O
transcriptional JJ B-Gene
enhancer NN I-Gene
. . O

In IN O
T NNP O
lymphoma NN O
cells NNS O
, , O
the DT O
activity NN O
of IN O
the DT O
Il NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
/ NN I-Gene
enhancer NN I-Gene
is VBZ O
stimulated VBN O
by IN O
phorbol NN O
esters NNS O
, , O
Ca NNP O
+ NNP O
+ NNP O
ionophores NNS O
and CC O
agonists NNS O
of IN O
protein NN B-Gene
kinase VB I-Gene
A NNP I-Gene
and CC O
inhibited VBN O
by IN O
low JJ O
doses NNS O
of IN O
the DT O
immunosuppressant JJ O
cyclosporin NN O
A NNP O
. . O

The DT O
Il NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
/ NN I-Gene
enhancer NN I-Gene
is VBZ O
transcriptionally RB O
inactive JJ O
in IN O
B NNP O
lymphoma NN O
cells NNS O
and CC O
HeLa NNP O
cells NNS O
. . O

DNase NNP O
I PRP O
footprint VBP O
protection NN O
experiments NNS O
revealed VBD O
six CD O
sites NNS O
of IN O
the DT O
Il NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
/ NN I-Gene
enhancer NN I-Gene
to TO O
be VB O
bound VBN O
by IN O
nuclear JJ B-Gene
proteins NNS I-Gene
from IN O
lymphoid NN O
and CC O
myeloid JJ O
cells NNS O
. . O

Among IN O
them PRP O
are VBP O
four CD O
purine NN O
boxes NNS O
which WDT O
have VBP O
been VBN O
described VBN O
to TO O
be VB O
important JJ O
sequence NN O
motifs NNS O
of IN O
the DT O
Il NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

They PRP O
contain VBP O
the DT O
motif NN O
GGAAA NNP O
and CC O
are VBP O
recognized VBN O
by IN O
the DT O
inducible JJ B-Gene
and CC I-Gene
cyclosporin VB I-Gene
A NNP I-Gene
- : I-Gene
sensitive JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
NFAT NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Three CD O
of IN O
the DT O
Il NNP B-Gene
- : I-Gene
4 CD I-Gene
NFAT NNP I-Gene
- : I-Gene
1 CD I-Gene
sites NNS I-Gene
are VBP O
closely RB O
linked VBN O
to TO O
weak JJ O
binding VBG O
sites NNS O
of IN O
Octamer NNP B-Gene
factors NNS I-Gene
. . O

Several JJ O
purine NN O
boxes NNS O
and CC O
an DT O
AT NNP B-Gene
- : I-Gene
rich JJ I-Gene
protein NN I-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
of IN O
the DT O
Il NNP O
- : O
4 CD O
promoter NN O
are VBP O
also RB O
recognized VBN O
by IN O
the DT O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
protein VBD I-Gene
HMG NNP B-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) O
. . O

Whereas IN O
the DT O
binding NN O
of IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Octamer NNP B-Gene
factors NNS I-Gene
enhance VBP O
the DT O
activity NN O
of IN O
the DT O
Il NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
, , O
the DT O
binding NN O
of IN O
HMG NNP O
I PRP O
( ( O
Y NNP O
) ) O
suppresses VBZ O
its PRP$ O
activity NN O
and CC O
, , O
therefore RB O
, , O
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
the DT O
suppression NN O
of IN O
Il NNP B-Gene
- : I-Gene
4 CD I-Gene
transcription NN O
in IN O
resting VBG O
T NNP O
lymphocytes NNS O
. . O

Reversibility NN O
of IN O
the DT O
differentiated JJ O
state NN O
in IN O
somatic JJ O
cells NNS O
. . O

Analysis NN O
of IN O
de FW O
novo FW O
gene NN O
activation NN O
in IN O
multinucleated JJ O
heterokaryons NNS O
has VBZ O
shown VBN O
that IN O
the DT O
differentiated JJ O
state NN O
, , O
although IN O
stable JJ O
, , O
is VBZ O
not RB O
irreversible JJ O
, , O
and CC O
can MD O
be VB O
reprogrammed VBN O
in IN O
the DT O
presence NN O
of IN O
appropriate JJ O
combinations NNS O
of IN O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
regulatory JJ I-Gene
molecules NNS I-Gene
. . O

These DT O
properties NNS O
have VBP O
been VBN O
exploited VBN O
to TO O
design VB O
strategies NNS O
for IN O
identifying VBG O
novel JJ O
regulators NNS O
of IN O
cellular JJ O
differentiation NN O
. . O

Phosphatidylcholine NNP O
hydrolysis NN O
activates VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
increases VBZ O
human JJ O
immunodeficiency NN O
virus NN O
replication NN O
in IN O
human JJ O
monocytes NNS O
and CC O
T NNP O
lymphocytes NNS O
. . O

We PRP O
have VBP O
tested VBN O
whether IN O
breakdown NN O
of IN O
phosphatidylcholine NN O
( ( O
PC NN O
) ) O
initiated VBN O
by IN O
exogenous JJ O
addition NN O
of IN O
a DT O
PC NN B-Gene
- : I-Gene
specific JJ I-Gene
phospholipase NN I-Gene
C NNP I-Gene
( ( O
PC NNP B-Gene
- : I-Gene
PLC NNP I-Gene
) ) O
from IN O
Bacillus NNP O
cereus NNS O
or CC O
by IN O
endogenous JJ O
overexpression NN O
of IN O
PC NNP B-Gene
- : I-Gene
PLC NNP I-Gene
induces VBZ O
functional JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
increases VBZ O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
( ( I-Gene
HIV NNP I-Gene
) ) I-Gene
enhancer NN I-Gene
activity NN O
. . O

PC NN O
- : O
PLC NNP O
- : O
activated VBD O
hydrolysis NN O
of IN O
PC NN O
was VBD O
found VBN O
to TO O
induce VB O
bona JJ O
fide NN O
p50 NN B-Gene
/ NNP I-Gene
p65 NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
activity NN O
in IN O
three CD O
different JJ O
cell NN O
lines NNS O
of IN O
human NN O
or CC O
murine NN O
origin NN O
. . O

No DT O
significant JJ O
changes NNS O
in IN O
the DT O
turnover NN O
of IN O
other JJ O
cellular JJ O
phospholipids NNS O
were VBD O
detected VBN O
in IN O
PC NNP O
- : O
PLC NNP O
- : O
treated VBD O
cells NNS O
. . O

Induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
by IN O
PC NNP B-Gene
- : I-Gene
PLC NNP I-Gene
did VBD O
not RB O
depend VB O
on IN O
de FW O
novo FW O
synthesis NN O
of IN O
proteins NNS O
or CC O
autocrine JJ O
secretion NN O
of IN O
either DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
or CC O
interleukin JJ B-Gene
1 CD I-Gene
. . O

In IN O
human JJ O
monocytic JJ O
and CC O
lymphoblastoid JJ O
T NNP O
- : O
cell NN O
lines NNS O
, , O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
by IN O
PC NNP B-Gene
- : I-Gene
PLC NNP I-Gene
resulted VBD O
in IN O
clear JJ O
induction NN O
of IN O
luciferase JJ B-Gene
expression NN O
vectors NNS O
placed VBD O
under IN O
the DT O
control NN O
of IN O
synthetic JJ B-Gene
kappa NN I-Gene
B NNP I-Gene
enhancers NNS I-Gene
or CC O
wild JJ O
type NN O
, , O
but CC O
not RB O
kappa VB O
B NNP O
- : O
mutated VBD O
, , O
HIV NNP B-Gene
long RB I-Gene
terminal JJ I-Gene
repeat NN I-Gene
constructs NNS I-Gene
. . O

HIV NNP O
replication NN O
was VBD O
increased VBN O
by IN O
PC NNP B-Gene
- : I-Gene
PLC NNP I-Gene
in IN O
chronically RB O
infected VBN O
monocytes NNS O
and CC O
T NNP O
lymphocytes NNS O
. . O

NF NNP O
- : O
kappa NN O
B NNP O
activation NN O
promoted VBN O
by IN O
addition NN O
of IN O
exogenous JJ B-Gene
PC NNP I-Gene
- : I-Gene
PLC NNP I-Gene
correlated VBD O
with IN O
an DT O
intense JJ O
production NN O
of IN O
diacylglycerol NN O
. . O

However RB O
, , O
addition NN O
of IN O
a DT O
phosphatidylinositol NN B-Gene
- : I-Gene
specific JJ I-Gene
PLC NNP I-Gene
from IN O
B NNP O
. . O
cereus NN O
also RB O
induced VBD O
diacylglycerol NN O
but CC O
did VBD O
not RB O
activate VB O
kappa NN B-Gene
B NNP I-Gene
enhancer NN I-Gene
- : I-Gene
directed JJ I-Gene
vectors NNS I-Gene
. . O

PC NN O
- : O
PLC NNP O
- : O
induced VBD O
NF NNP O
- : O
kappa NN O
B NNP O
activation NN O
could MD O
not RB O
be VB O
blocked VBN O
by IN O
a DT O
specific JJ O
inhibitor NN O
of IN O
phorbol NN B-Gene
ester NN I-Gene
- : I-Gene
inducible JJ I-Gene
protein NN I-Gene
kinases VBZ I-Gene
C NNP I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
a DT O
cellular JJ O
transduction NN O
pathway NN O
, , O
dependent NN O
on IN O
specific JJ O
PC NNP O
breakdown NN O
, , O
is VBZ O
functional JJ O
in IN O
T NNP O
lymphocytes NNS O
and CC O
monocytes NNS O
and CC O
may MD O
be VB O
used VBN O
by IN O
various JJ O
transmembrane NN O
receptors NNS O
to TO O
activate VB O
HIV NNP O
transcription NN O
through IN O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
dependent JJ O
induction NN O
of IN O
the DT O
HIV NNP B-Gene
enhancer NN I-Gene
. . O

Novel NNP O
mechanism NN O
for IN O
inhibition NN O
of IN O
human JJ O
T NNP O
cells NNS O
by IN O
glucocorticoids NNS O
. . O

Glucocorticoids NNP O
inhibit NN O
signal JJ O
transduction NN O
through IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
. . O

Interaction NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
with IN O
its PRP$ O
high JJ B-Gene
affinity NN I-Gene
membrane NN I-Gene
receptor NN I-Gene
complex NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
) ) O
present NN O
on IN O
activated JJ O
T NNP O
lymphocytes VBZ O
induces NNS O
cell NN O
proliferation NN O
and CC O
mediates NNS O
effector VBP O
functions NNS O
. . O

Glucocorticoids NNP O
inhibit NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
by IN O
inhibiting VBG O
TCR NNP O
- : O
mediated VBD O
signal JJ O
transduction NN O
. . O

We PRP O
asked VBD O
whether IN O
they PRP O
also RB O
inhibit VBP O
the DT O
action NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
by IN O
inhibiting VBG O
signal JJ O
transduction NN O
through IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
. . O

Human NNP O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
, , O
stimulated VBN O
with IN O
PMA NNP O
for IN O
48 CD O
h NN O
( ( O
PMA NNP O
blasts NNS O
) ) O
, , O
were VBD O
incubated VBN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
the DT O
presence NN O
of IN O
incremental JJ O
dosages NNS O
of IN O
dexamethasone NN O
( ( O
Dex NNP O
; : O
10 CD O
( ( O
- : O
5 CD O
) ) O
- : O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
) ) O
. . O

Dex NNP O
inhibited VBD O
the DT O
IL NNP O
- : O
2 CD O
- : O
dependent JJ O
proliferation NN O
of IN O
PMA NNP O
blasts NNS O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
fashion NN O
( ( O
IC50 NNP O
, , O
5 CD O
x NN O
10 CD O
( ( O
- : O
8 CD O
) ) O
M NNP O
) ) O
. . O

Cell NNP O
surface NN O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
- : I-Gene
and CC I-Gene
beta VB I-Gene
- : I-Gene
chains NNS I-Gene
as IN O
determined VBN O
by IN O
immunofluorescence NN O
analysis NN O
was VBD O
not RB O
affected VBN O
by IN O
Dex NNP O
. . O

In IN O
addition NN O
, , O
Scatchard NNP O
plot NN O
analysis NN O
of IN O
125I CD B-Gene
- : I-Gene
labeled VBN I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
showed VBD O
that IN O
Dex NNP O
did VBD O
not RB O
affect VB O
the DT O
binding NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
thus RB O
suggesting VBG O
that DT O
inhibition NN O
is VBZ O
due JJ O
to TO O
a DT O
postreceptor NN O
effect NN O
. . O

Inhibition NN O
of IN O
T NNP O
cell NN O
proliferation NN O
by IN O
Dex NNP O
was VBD O
associated VBN O
with IN O
decreased JJ O
IL NNP O
- : O
2 CD O
- : O
dependent JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
several JJ O
intracellular JJ B-Gene
proteins NNS I-Gene
and CC O
decreased JJ O
phosphorylation NN O
of IN O
the DT O
retinoblastoma NN B-Gene
gene NN I-Gene
product NN I-Gene
Rb NNP I-Gene
, , O
a DT O
protein NN O
essential JJ O
for IN O
controlling VBG O
the DT O
progression NN O
of IN O
cells NNS O
through IN O
the DT O
cell NN O
cycle NN O
. . O

IL NNP O
- : O
2 CD O
- : O
dependent NN O
IL NNP O
- : O
2R CD O
alpha JJ O
expression NN O
in IN O
PMA NNP O
blasts NNS O
and CC O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
induction NN O
in IN O
resting VBG O
human JJ O
T NNP O
cells NNS O
were VBD O
also RB O
inhibited VBN O
by IN O
Dex NNP O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
glucocorticoids NNS O
inhibit RB O
preactivated VBD O
T NNP O
cells NNS O
by IN O
down IN O
- : O
regulating VBG O
signal JJ O
transduction NN O
through IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
. . O

Chronic NNP O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
infection NN O
stimulates NNS O
distinct VBP O
NF NNP O
- : O
kappa NN O
B NNP O
/ NNP O
rel NN O
DNA NNP O
binding NN O
activities NNS O
in IN O
myelomonoblastic JJ O
cells NNS O
. . O

The DT O
relationship NN O
between IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
infection NN O
and CC O
the DT O
induction NN O
of IN O
NF NNP O
- : O
kappa NN O
B NNP O
binding NN O
activity NN O
was VBD O
examined VBN O
in IN O
a DT O
myeloid NN O
cell NN O
model NN O
of IN O
HIV NNP O
- : O
1 CD O
infection NN O
derived VBN O
from IN O
the DT O
PLB NNP O
- : O
985 CD O
cell NN O
line NN O
. . O

Chronic JJ O
infection NN O
of IN O
PLB NNP O
- : O
985 CD O
cells NNS O
led VBN O
to TO O
increased VBN O
monocyte NN O
- : O
specific JJ O
surface NN O
marker NN O
expression NN O
, , O
increased VBD O
c SYM O
- : O
fms JJ O
gene NN O
transcription NN O
, , O
and CC O
morphological JJ O
alterations NNS O
consistent JJ O
with IN O
differentiation NN O
along IN O
the DT O
monocytic JJ O
pathway NN O
. . O

PLB NNP O
- : O
IIIB NNP O
cells NNS O
displayed VBD O
a DT O
constitutive JJ O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
like IN O
binding VBG O
activity NN O
that WDT O
was VBD O
distinct JJ O
from IN O
that DT O
induced VBN O
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
or CC O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
treatment NN O
of IN O
the DT O
parental JJ O
PLB NNP O
- : O
985 CD O
cell NN O
line NN O
. . O

This DT O
unique JJ O
DNA NNP O
binding NN O
activity NN O
consisted VBN O
of IN O
proteins NNS O
of IN O
70 CD B-Gene
, , I-Gene
90 CD I-Gene
, , I-Gene
and CC I-Gene
100 CD I-Gene
kDa NN I-Gene
with IN O
a DT O
high JJ O
degree NN O
of IN O
binding VBG O
specificity NN O
for IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
within IN O
the DT O
PRDII NNP B-Gene
domain NN I-Gene
of IN O
beta NN B-Gene
interferon NN I-Gene
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
characterize VBP O
the DT O
nature NN O
of IN O
these DT O
proteins NNS O
and CC O
demonstrate VB O
that IN O
binding NN O
of IN O
these DT O
proteins NNS O
is VBZ O
also RB O
induced JJ O
following VBG O
Sendai NNP O
paramyxovirus JJ O
infection NN O
. . O

The DT O
70 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
corresponds VBZ O
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
RelA NNP I-Gene
( ( I-Gene
p65 NN I-Gene
) ) I-Gene
subunit NN I-Gene
, , O
which WDT O
is VBZ O
activated VBN O
in IN O
response NN O
to TO O
an DT O
acute JJ O
paramyxovirus NN O
infection NN O
or CC O
a DT O
chronic JJ O
HIV NNP O
- : O
1 CD O
infection NN O
. . O

Virus NNP O
infection NN O
does VBZ O
not RB O
appear VB O
to TO O
alter VB O
the DT O
amount NN O
of IN O
RelA NNP B-Gene
( ( O
p65 NN B-Gene
) ) O
or CC O
NFKB1 NNP B-Gene
( ( O
p50 NN B-Gene
) ) O
but CC O
rather RB O
affects VBZ O
the DT O
capacity NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
to TO O
sequester VB O
RelA NNP B-Gene
( ( I-Gene
p65 NN I-Gene
) ) I-Gene
, , O
therefore RB O
leading VBG O
to TO O
constitutive JJ O
levels NNS O
of IN O
RelA NNP O
DNA NNP O
binding NN O
activity NN O
and CC O
to TO O
increased VBN O
levels NNS O
of IN O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
dependent JJ O
gene NN O
activity NN O
. . O

The DT O
virally RB O
induced JJ O
90 CD B-Gene
- : I-Gene
to TO I-Gene
100 CD I-Gene
- : I-Gene
kDa NN I-Gene
proteins NNS I-Gene
have VBP O
a DT O
distinct JJ O
binding NN O
specificity NN O
for IN O
the DT O
PRDII NNP B-Gene
domain NN I-Gene
and CC O
an DT O
AT NNP B-Gene
- : I-Gene
rich JJ I-Gene
sequence NN I-Gene
but CC O
do VBP O
not RB O
cross VB O
- : O
react NN O
with IN O
NF NNP O
- : O
kappa NN O
B NNP O
subunit NN O
- : O
specific JJ O
antisera NN O
directed VBN O
against IN O
NFKB1 NNP B-Gene
( ( O
p105 NN B-Gene
or CC O
p50 NN B-Gene
) ) O
, , O
NFKB2 NNP B-Gene
( ( O
p100 NN B-Gene
or CC O
p52 NN B-Gene
) ) O
, , O
RelA NNP B-Gene
( ( O
p65 NN B-Gene
) ) O
, , O
or CC O
c SYM B-Gene
- : I-Gene
rel NN I-Gene
. . O

DNA NN O
binding NN O
of IN O
the DT O
90 CD B-Gene
- : I-Gene
to TO I-Gene
100 CD I-Gene
- : I-Gene
kDa NN I-Gene
proteins NNS I-Gene
was VBD O
not RB O
inhibited VBN O
by IN O
recombinant NN B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
/ NNP I-Gene
MAD NNP I-Gene
- : I-Gene
3 CD I-Gene
and CC O
was VBD O
resistant JJ O
to TO O
tryptic JJ O
digestion NN O
, , O
suggesting VBG O
that IN O
these DT O
proteins NNS O
may MD O
not RB O
be VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
related VBN I-Gene
. . O

Transient JJ O
cotransfection NN O
experiments NNS O
demonstrated VBD O
that IN O
RelA NNP O
and CC O
NFKB1 NNP O
expression NN O
maximally RB O
stimulated VBD O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
- : I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
dependent NN I-Gene
reporter NN I-Gene
genes NNS I-Gene
; : O
differences NNS O
in IN O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
like IN O
binding VBG O
activity NN O
were VBD O
also RB O
reflected VBN O
in IN O
higher JJR O
constitutive NN O
levels NNS O
of IN O
NF NNP O
- : O
kappa NN O
B NNP O
- : O
regulated VBN O
gene NN O
expression NN O
in IN O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
myeloid JJ O
cells NNS O
. . O

Presence NN O
of IN O
estrogen NN O
- : O
binding NN O
sites NNS O
on IN O
macrophage NN O
- : O
like IN O
synoviocytes NNS O
and CC O
CD8 NNP O
+ NNP O
, , O
CD29 NNP O
+ NNP O
, , O
CD45RO NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
in IN O
normal JJ O
and CC O
rheumatoid JJ O
synovium NN O
. . O

OBJECTIVE NNP O
. . O

To TO O
study VB O
the DT O
presence NN O
of IN O
estrogen NN O
- : O
binding NN O
sites NNS O
( ( O
EBS NNP O
) ) O
in IN O
the DT O
synovial JJ O
tissues NNS O
of IN O
male NN O
and CC O
female JJ O
patients NNS O
with IN O
rheumatoid JJ O
arthritis NN O
( ( O
RA NNP O
) ) O
and CC O
in IN O
age NN O
- : O
and CC O
sex NN O
- : O
matched VBN O
healthy JJ O
controls NNS O
. . O

METHODS NNP O
. . O

Both DT O
type JJ O
1 CD O
( ( O
high JJ O
affinity NN O
, , O
low JJ O
binding NN O
capacity NN O
) ) O
and CC O
type $ O
2 CD O
( ( O
reduced VBN O
affinity NN O
, , O
higher JJR O
binding VBG O
capacity NN O
) ) O
EBS NNP O
were VBD O
investigated VBN O
in IN O
both DT O
soluble JJ O
and CC O
nuclear JJ O
fractions NNS O
of IN O
homogenized JJ O
synovial JJ O
tissue NN O
samples NNS O
by IN O
a DT O
dextran NN O
- : O
coated VBN O
charcoal NN O
method NN O
. . O

To TO O
determine VB O
what WP O
type NN O
of IN O
synovial JJ O
cell NN O
was VBD O
positive JJ O
for IN O
EBS NNP O
, , O
cryosections NNS O
of IN O
synovial JJ O
tissues NNS O
were VBD O
immunostained VBN O
with IN O
a DT O
specific JJ O
monoclonal JJ B-Gene
anti NN I-Gene
- : I-Gene
estrogen NN I-Gene
receptor NN I-Gene
antibody NN I-Gene
( ( O
anti JJ B-Gene
- : I-Gene
ER NNP I-Gene
MAb NNP I-Gene
) ) O
using VBG O
both DT O
immunofluorescence NN O
and CC O
immunoperoxidase NN O
techniques NNS O
. . O

Double JJ O
immunostaining VBG O
with IN O
the DT O
anti JJ B-Gene
- : I-Gene
ER NNP I-Gene
MAb NNP I-Gene
and CC O
with IN O
specific JJ B-Gene
MAb NNP I-Gene
to TO O
detect VB O
different JJ O
macrophage NN B-Gene
antigens NNS I-Gene
( ( O
Ber NNP B-Gene
- : I-Gene
MAC3 NNP I-Gene
, , O
MAC387 NNP B-Gene
, , O
CD68 NNP B-Gene
) ) O
and CC O
CD8 NNP O
+ NNP O
T NNP O
cell NN O
subsets NNS O
( ( O
CD29 NNP O
+ NNP O
, , O
CD45RO NNP O
+ NNP O
and CC O
CD29 NNP O
- : O
, , O
CD45RO NNP O
- : O
) ) O
was VBD O
performed VBN O
. . O

RESULTS NNP O
. . O

Higher JJR O
affinity NN O
EBS NNP O
were VBD O
found VBN O
mostly RB O
in IN O
nuclear JJ O
cell NN O
fractions NNS O
of IN O
either DT O
RA NNP O
or CC O
control VB O
synovial JJ O
tissues NNS O
( ( O
28 CD O
of IN O
the DT O
33 CD O
) ) O
. . O

These DT O
EBS NNP O
were VBD O
present JJ O
to TO O
a DT O
lesser JJR O
extent NN O
in IN O
soluble JJ O
cell NN O
fractions NNS O
( ( O
11 CD O
of IN O
the DT O
33 CD O
) ) O
. . O

Immunostaining VBG O
showed VBD O
the DT O
estrogen NN O
receptor NN O
- : O
positive JJ O
cells NNS O
to TO O
be VB O
the DT O
macrophage NN O
- : O
like IN O
synoviocytes NNS O
and CC O
the DT O
CD8 NNP O
+ NNP O
, , O
CD29 NNP O
+ NNP O
T NNP O
cells NNS O
both DT O
in IN O
RA NNP O
and CC O
in IN O
control NN O
synovial JJ O
tissues NNS O
. . O

Higher JJR O
nuclear JJ O
content NN O
of IN O
EBS NNP O
was VBD O
consistent JJ O
with IN O
more RBR O
intense JJ O
nuclear JJ O
staining NN O
of IN O
synoviocytes NNS O
and CC O
T NNP O
cells NNS O
. . O

CONCLUSION NNP O
. . O

It PRP O
is VBZ O
conceivable JJ O
that IN O
the DT O
immunomodulatory NN O
activity NN O
exerted VBN O
by IN O
estrogens NNS O
is VBZ O
at IN O
least JJS O
partly RB O
mediated VBN O
through IN O
their PRP$ O
interaction NN O
with IN O
EBS NNP O
that WDT O
are VBP O
present JJ O
on IN O
macrophage NN O
- : O
like IN O
synoviocytes NNS O
, , O
functioning VBG O
as IN O
antigen NN O
- : O
processing NN O
and CC O
antigen NN O
- : O
presenting NN O
cells NNS O
, , O
and CC O
on IN O
antigen NN O
- : O
experienced JJ O
( ( O
memory NN O
) ) O
CD8 NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
( ( O
CD29 NNP O
+ NNP O
, , O
CD45RO NNP O
+ NNP O
